Citrus Sinensis ID: 036471
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | 2.2.26 [Sep-21-2011] | |||||||
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.608 | 0.352 | 0.472 | 1e-71 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.478 | 0.306 | 0.513 | 3e-71 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.381 | 0.242 | 0.611 | 7e-70 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.374 | 0.232 | 0.479 | 8e-47 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.377 | 0.237 | 0.497 | 9e-47 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.461 | 0.272 | 0.415 | 6e-44 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.370 | 0.230 | 0.466 | 1e-42 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.356 | 0.225 | 0.475 | 2e-42 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.377 | 0.223 | 0.438 | 2e-42 | |
| C0LGV0 | 895 | Probable LRR receptor-lik | no | no | 0.480 | 0.277 | 0.381 | 6e-41 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 271 bits (692), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 162/343 (47%), Positives = 212/343 (61%), Gaps = 29/343 (8%)
Query: 181 KTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCAESRECNDCLKKRG 240
+TR + D M ++ I C C GG C + ++ C K G
Sbjct: 421 QTRPNQDNLKMALDQ-GFRMLITSDCERCRGSGGACGYN--------QTSSGFGCYCKDG 471
Query: 241 HCHFDDKENFQCENER---TGHEKSELKLGLGLGGGSIVLIALLS--FWIMFYRKFSSYD 295
C ++ + F + R T + + LG L G IV + LL F + +RK + D
Sbjct: 472 KCGYEYDDGFFRRHRRFIATLVRYTFIALG-ALTGVVIVFLVLLCPCFRVQIFRKRKTSD 530
Query: 296 STGSCLNIETFLRNHGSLAP-RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVA 354
E L+ +L P + Y+YA++KKMT SF +G+GG+G VY G L D S VA
Sbjct: 531 --------EVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVA 582
Query: 355 VKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIY 413
VKVL DSKG +GE+FINEVAS+S+TSHVN+V+LLGFC EG RRA+IYEF+ NGSL+KFI
Sbjct: 583 VKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFIS 642
Query: 414 RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473
SS L +TL IA+G+ARGLEYLH GC TRI+HFDIKP N+LLD++ CPK+SD
Sbjct: 643 DKSSV----NLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSD 698
Query: 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
FGLAK+C +KESI+S+ RGT+GYIAPE+ R G VS+KSD
Sbjct: 699 FGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSD 741
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 134/261 (51%), Positives = 183/261 (70%), Gaps = 14/261 (5%)
Query: 256 RTGHEKSELKLGLGLGGGSIVLIALLSFWIMFYRKFSSYDSTGSCLNIETFLRNHGSLAP 315
++ H ++ + +G G G + +L W+ R+ + + + L N
Sbjct: 436 KSSHLLVKIFIAVGPGTGLATFVVVLMLWM---RQMKRKNRKEERVVMFKKLLNM----- 487
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASI 375
Y+YA++KK+T SF Y +G+GG+G+VY G L +G VAVKVL D KG+ E+FINEVAS+
Sbjct: 488 --YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASM 545
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
S+TSHVN+V+LLGFCFEG +RA++YEF+ NGSL++F+ RN S ++ TL IA+G
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVT----TLYGIALG 601
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
IARGLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C ++ES++S+ RGT
Sbjct: 602 IARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGT 661
Query: 496 VGYIAPEVFCRNIGEVSYKSD 516
+GYIAPEVF R G VS+KSD
Sbjct: 662 IGYIAPEVFSRMYGRVSHKSD 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 7e-70, Method: Compositional matrix adjust.
Identities = 123/201 (61%), Positives = 162/201 (80%), Gaps = 4/201 (1%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASI 375
++Y YA++KK+T SF + +G+GG+G+VY+G L +G VAVKVL D KGNG++FINEV S+
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
S+TSHVN+V+LLGFC+EG +RA+I EF+ +GSL++FI RN S N TL IA+G
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPN----VTTLYGIALG 599
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
IARGLEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+C ++ESI+S+ RGT
Sbjct: 600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659
Query: 496 VGYIAPEVFCRNIGEVSYKSD 516
+GYIAPEV R G +S+KSD
Sbjct: 660 IGYIAPEVVSRMYGGISHKSD 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 94/196 (47%), Positives = 135/196 (68%), Gaps = 3/196 (1%)
Query: 307 LRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE 366
L + S AP +++Y ++++ T SFK KLG GG+G+VY+G L + + VAVK L + +
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEK 522
Query: 367 EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW 426
+F EVA+IS T H+N+V L+GFC +GR R L+YEF+ NGSL+ F++ S+ LTW
Sbjct: 523 QFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSA---KFLTW 579
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486
E IA+G A+G+ YLH C I+H DIKP NIL+D++F K+SDFGLAK+ N K++
Sbjct: 580 EYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR 639
Query: 487 ISMTGARGTVGYIAPE 502
+M+ RGT GY+APE
Sbjct: 640 YNMSSVRGTRGYLAPE 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 99/199 (49%), Positives = 131/199 (65%), Gaps = 4/199 (2%)
Query: 304 ETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG 363
+ FL N + P R++Y D++ TN+F KLGQGG+GSVY+G L DGS +AVK L
Sbjct: 470 DNFLENLSGM-PIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQ 528
Query: 364 NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK 423
+EF EV+ I H+++V L GFC EG R L YEF+S GSLE++I+R +
Sbjct: 529 GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDG--DVL 586
Query: 424 LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
L W+T IA+G A+GL YLH C RI+H DIKP NILLD++F K+SDFGLAK+ R+
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 484 ESIISMTGARGTVGYIAPE 502
+S + T RGT GY+APE
Sbjct: 647 QSHV-FTTMRGTRGYLAPE 664
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 103/248 (41%), Positives = 148/248 (59%), Gaps = 10/248 (4%)
Query: 256 RTGHEKSELKLGLGLGGGSIVLIALLSFWIMFYRKFSSYDSTGSCLNIETFLRNHGSLAP 315
R H + L + + G +VL+ALL ++ Y + L + +P
Sbjct: 464 RKSHGLRQKVLVIPIVVGMLVLVALLG--MLLYYNLDRKRTLKRAAKNSLILCD----SP 517
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE-EFINEVAS 374
++Y D++ TN+F LG GG+G+VYKG + + VAVK L+ + +GE EFI EV +
Sbjct: 518 VSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNT 577
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
I H+N+V L G+C E R L+YE++ NGSL+K+I+ SS + L W T +IAV
Sbjct: 578 IGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIF--SSEQTANLLDWRTRFEIAV 635
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
A+G+ Y H C RI+H DIKP NILLD++FCPK+SDFGLAK+ R+ S + +T RG
Sbjct: 636 ATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRG 694
Query: 495 TVGYIAPE 502
T GY+APE
Sbjct: 695 TRGYLAPE 702
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 91/195 (46%), Positives = 125/195 (64%), Gaps = 4/195 (2%)
Query: 308 RNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE 367
+ G+L+ +SY +++ T +F KLG GG+GSV+KG L D S++AVK L ++
Sbjct: 475 KGDGTLSA--FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQ 532
Query: 368 FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
F EV +I HVN+V L GFC EG ++ L+Y+++ NGSL+ ++ N E L W+
Sbjct: 533 FRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVE-EKIVLGWK 591
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
QIA+G ARGL YLH C I+H DIKP NILLD FCPK++DFGLAK+ R S +
Sbjct: 592 LRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV 651
Query: 488 SMTGARGTVGYIAPE 502
+T RGT GY+APE
Sbjct: 652 -LTTMRGTRGYLAPE 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 89/187 (47%), Positives = 121/187 (64%), Gaps = 3/187 (1%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASI 375
RRYSY ++ K T FK +LG+G G+VYKG L D +VAVK L + + E F E++ I
Sbjct: 522 RRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQGKEVFQAELSVI 581
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
R +H+N+V + GFC EG R L+ E+V NGSL ++ +I L WE IA+G
Sbjct: 582 GRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNI---LLDWEGRFNIALG 638
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
+A+GL YLH C ++H D+KP NILLD+ F PKI+DFGL K+ NR S +++ RGT
Sbjct: 639 VAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGT 698
Query: 496 VGYIAPE 502
+GYIAPE
Sbjct: 699 LGYIAPE 705
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 89/203 (43%), Positives = 133/203 (65%), Gaps = 8/203 (3%)
Query: 315 PRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-EEFINEVA 373
P+++ + ++++ T +FK ++G GG+GSVYKG L D + +AVK + + +G +EF E+A
Sbjct: 502 PQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIA 561
Query: 374 SISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
I H N+V L GFC GR+ L+YE++++GSLEK ++ + + L W+ IA
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPV----LEWQERFDIA 617
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
+G ARGL YLH GC +I+H D+KP NILL + F PKISDFGL+K+ N++ES + T R
Sbjct: 618 LGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMR 676
Query: 494 GTVGYIAPEVFCRNIGEVSYKSD 516
GT GY+APE +S K+D
Sbjct: 677 GTRGYLAPEWITN--AAISEKAD 697
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 100/262 (38%), Positives = 157/262 (59%), Gaps = 14/262 (5%)
Query: 259 HEKSELKLGLGLGGGSIVLIALL-SFWIMFYRKF--SSYDSTGSCLNIETFLRNHGSLAP 315
+++ + + LG+ GG++ L+ F +F R+ D T + L ++ + A
Sbjct: 540 RKQNRIAILLGVSGGALFATFLVFVFMSIFTRRQRNKERDITRAQLKMQNWN------AS 593
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-EEFINEVAS 374
R +S+ +IK T +FK +G+G +G+VY+GKL DG VAVKV D G + FINEV
Sbjct: 594 RIFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHL 653
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
+S+ H N+V+ GFC+E +R+ L+YE++S GSL +Y S + H L W + L++AV
Sbjct: 654 LSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRS--KRHSLNWVSRLKVAV 711
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
A+GL+YLH G RI+H D+K NILLD+D K+SDFGL+K + ++ T +G
Sbjct: 712 DAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKG 771
Query: 495 TVGYIAPEVFCRNIGEVSYKSD 516
T GY+ PE + + +++ KSD
Sbjct: 772 TAGYLDPEYY--STLQLTEKSD 791
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| 147795963 | 624 | hypothetical protein VITISV_039936 [Viti | 0.930 | 0.769 | 0.499 | 1e-133 | |
| 359472674 | 637 | PREDICTED: probable receptor-like protei | 0.930 | 0.753 | 0.499 | 1e-132 | |
| 147769927 | 1001 | hypothetical protein VITISV_010117 [Viti | 0.796 | 0.410 | 0.506 | 1e-120 | |
| 145839451 | 627 | receptor-like protein kinase [Capsicum a | 0.883 | 0.727 | 0.480 | 1e-114 | |
| 356574202 | 694 | PREDICTED: probable receptor-like protei | 0.905 | 0.672 | 0.440 | 1e-109 | |
| 356574204 | 736 | PREDICTED: G-type lectin S-receptor-like | 0.906 | 0.635 | 0.432 | 1e-108 | |
| 356574212 | 621 | PREDICTED: probable receptor-like protei | 0.879 | 0.731 | 0.444 | 1e-103 | |
| 357444697 | 642 | Protein kinase-coding resistance protein | 0.906 | 0.728 | 0.427 | 1e-102 | |
| 356574208 | 587 | PREDICTED: probable receptor-like protei | 0.848 | 0.746 | 0.439 | 1e-100 | |
| 356574206 | 619 | PREDICTED: probable receptor-like protei | 0.893 | 0.744 | 0.441 | 1e-100 |
| >gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-133, Method: Compositional matrix adjust.
Identities = 271/543 (49%), Positives = 356/543 (65%), Gaps = 63/543 (11%)
Query: 1 MACYSFLVFFVISQLLLLSSAEEESELNKTCPSFFPSCGNLGQFFFPFTNRTHPECGLML 60
M SFLV F++S +LLSSAEEE + TCP F C LG+ FPF N T+ ECGL
Sbjct: 1 MGSVSFLVLFLLSHSVLLSSAEEERKHPPTCPPF--DCEKLGRLHFPFKNETNSECGLCT 58
Query: 61 VDNCNKPVQRIRLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCESFENLTLPTSAS 120
+ C + + RI+L + G ++ + NI+Q +I ++D+ Q HL CE +NLT S S
Sbjct: 59 IVRCTEELPRIQLERGGRYFGLKNISQADTIVIQDERLQEHLQRGICEFIDNLTRFRSPS 118
Query: 121 LSFHIKSNP-----SLFRCTHKLEKNLPSFH-FTCNHNSFIYYNHPDDALPRIVPP---- 170
+SF K P +LF+C L +L + H +T + I+YNHP+ ++PP
Sbjct: 119 VSF--KPVPPLAELTLFKCHRNLNIDLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHN 174
Query: 171 --------------NCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQC 216
+CS+IQ P+N + D+L +LTS +L+V + C +C + GGQC
Sbjct: 175 QPNHTPTLPAPPPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHFSGGQC 234
Query: 217 RSDSEGKFQCAESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIV 276
R DD+ F+C + TG++K+ LKL LGL
Sbjct: 235 R---------------------------DDEGKFRCAH--TGNDKT-LKLALGLAISITG 264
Query: 277 LIALLSFWIMFYRKFSSY---DSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYK 333
+ L+ F +KF S TG+ LN+ETFLRNH SLAP+RY Y++++KMT+SFK +
Sbjct: 265 IGIPLALTFYFSKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDR 324
Query: 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG 393
+G+GGYG+VYKGKL++G VAVKVL+++KGNGEEFINE+ASISRTSHVN+V+LLGFCF+G
Sbjct: 325 VGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQG 384
Query: 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILH 453
+RALIYEF+ NGSLEKFIY +SS+ KL WETL IA+GIARGLEYLH GC+TRILH
Sbjct: 385 SKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILH 444
Query: 454 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 513
DIKPHNILL++DFCPKISDFGL+K+C RKESI+SM+GARGT GYIAPEVFCRN G+VS
Sbjct: 445 LDIKPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSP 504
Query: 514 KSD 516
KSD
Sbjct: 505 KSD 507
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1234), Expect = e-132, Method: Compositional matrix adjust.
Identities = 271/543 (49%), Positives = 356/543 (65%), Gaps = 63/543 (11%)
Query: 1 MACYSFLVFFVISQLLLLSSAEEESELNKTCPSFFPSCGNLGQFFFPFTNRTHPECGLML 60
M SFLV F++S +LLSSAEEE + TCP F C LG+ FPF N T+ ECGL
Sbjct: 14 MGSVSFLVLFLLSHSVLLSSAEEERKHPPTCPPF--DCEKLGRLHFPFKNETNSECGLCT 71
Query: 61 VDNCNKPVQRIRLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCESFENLTLPTSAS 120
+ C + + RI+L + G ++ + NI+Q +I ++D+ Q HL CE +NLT S S
Sbjct: 72 IVRCTEELPRIQLERGGRYFGLKNISQADTIVIQDERLQEHLQRGICEFIDNLTRFRSPS 131
Query: 121 LSFHIKSNP-----SLFRCTHKLEKNLPSFH-FTCNHNSFIYYNHPDDALPRIVPP---- 170
+SF K P +LF+C L +L + H +T + I+YNHP+ ++PP
Sbjct: 132 VSF--KPVPPLAELTLFKCHRNLNIDLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHN 187
Query: 171 --------------NCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQC 216
+CS+IQ P+N + D+L +LTS +L+V + C +C + GGQC
Sbjct: 188 QPNHTPTLPAPPPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRKCHFSGGQC 247
Query: 217 RSDSEGKFQCAESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIV 276
R DD+ F+C + TG++K+ LKL LGL
Sbjct: 248 R---------------------------DDEGKFRCAH--TGNDKT-LKLALGLAISITG 277
Query: 277 LIALLSFWIMFYRKFSSY---DSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYK 333
+ L+ F +KF S TG+ LN+ETFLRNH SLAP+RY Y++++KMT+SFK +
Sbjct: 278 IGIPLALTFYFSKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDR 337
Query: 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG 393
+G+GGYG+VYKGKL++G VAVKVL+++KGNGEEFINE+ASISRTSHVN+V+LLGFCF+G
Sbjct: 338 VGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQG 397
Query: 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILH 453
+RALIYEF+ NGSLEKFIY +SS+ KL WETL IA+GIARGLEYLH GC+TRILH
Sbjct: 398 SKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLEYLHRGCNTRILH 457
Query: 454 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 513
DIKPHNILL++DFCPKISDFGL+K+C RKESI+SM+GARGT GYIAPEVFCRN G+VS
Sbjct: 458 LDIKPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAPEVFCRNFGDVSP 517
Query: 514 KSD 516
KSD
Sbjct: 518 KSD 520
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1128), Expect = e-120, Method: Compositional matrix adjust.
Identities = 239/472 (50%), Positives = 314/472 (66%), Gaps = 61/472 (12%)
Query: 72 RLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCESFENLTLPTSASLSFHIKSNP-- 129
+L + G ++ + NI+Q +I ++D+ Q HL CE +NLT S S+SF K P
Sbjct: 447 QLERGGRYFGVKNISQADTIVIQDEWLQEHLQRGICEFIDNLTRFRSPSVSF--KPVPPL 504
Query: 130 ---SLFRCTHKLEKNLPSFH-FTCNHNSFIYYNHPDDALPRIVPP--------------- 170
+LF+C L +L + H +T + I+YNHP+ ++PP
Sbjct: 505 AELTLFKCHRNLNIHLTTDHTYTGCQDYIIHYNHPNHT--SLLPPLPHNQPNHTPTLPAP 562
Query: 171 ---NCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCA 227
+CS+IQ P+N + D+L +LTS +L+V + C EC + GGQCR
Sbjct: 563 PPLDCSIIQYPINMSLGMDNLVALLTSDITLEVHLSRECRECHFSGGQCR---------- 612
Query: 228 ESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIVLIALLSFWIMF 287
D++ F+C + TG++K+ LKL LGL + L+ F
Sbjct: 613 -----------------DEEGKFRCAH--TGNDKT-LKLALGLAISITGIGIPLALTFYF 652
Query: 288 YRKFSSY---DSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYK 344
+KF S TG+ LN+ETFLRNH SLAP+RY Y++++KMT+SFK ++G+GGYG+VYK
Sbjct: 653 SKKFRSIFKEKQTGNHLNVETFLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYK 712
Query: 345 GKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404
GKL++G VAVKVL+++KGNGEEFINE+ASISRTSHVN+V+LLGFCF+G +RALIYEF+
Sbjct: 713 GKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMP 772
Query: 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD 464
NGSLEKFIY +SS+ HKL WETL IA+GIARGLEYLH GC+TRILH DIKPHNILL+
Sbjct: 773 NGSLEKFIYDKNSSMTYHKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLN 832
Query: 465 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+DFCPKISDFGL+K+C RKESIISM+GARGT GYIAPEVFCRN G+VS KSD
Sbjct: 833 QDFCPKISDFGLSKLCTRKESIISMSGARGTAGYIAPEVFCRNFGDVSPKSD 884
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1071), Expect = e-114, Method: Compositional matrix adjust.
Identities = 246/512 (48%), Positives = 314/512 (61%), Gaps = 56/512 (10%)
Query: 28 NKTCPSFFPSCGNLGQFFFPFTNRTHPECGLMLVDNCN-KPVQRIRLGKAGPFYNILNIA 86
+ TCP F SCGN FPF+ PECG++ + C+ KP +IRL +Y L
Sbjct: 25 DSTCPKSF-SCGNFTNLSFPFSLSAQPECGILRMSGCDDKPFPKIRLLPGRDWYYALQ-Q 82
Query: 87 QDASITLEDQVFQNHLGNSSCESF-ENLTLPTSASLSFHIKSNPSLFRCTHKLEKN--LP 143
D+S+ L DQ Q L C++F +N +LP S S+SF++ + + +C+ +KN
Sbjct: 83 HDSSVWLGDQKLQTTLTQHKCQAFNKNFSLPNSPSISFNMININNFIKCSSTQKKNDRFA 142
Query: 144 SFHFTCNHNSF-IYYNHPDDALPRI----VPPNCSLIQLPVNKTRKSDDLFNMLTSVFSL 198
++ F IYY D I +P NCSLI+LP++K DLFN L F +
Sbjct: 143 GYNMYNGCEGFSIYYKLTRDDDKNIEAHNLPTNCSLIKLPIHKN--DGDLFNRLGPEFLV 200
Query: 199 QVEIPWFCWECGWRGGQCRSDSEGKFQCAESRECNDCLKKRGHCHFDDKENFQCENERTG 258
+ ++ C EC GG+C++D KF CLK
Sbjct: 201 EWKLSDDCSECHHYGGRCQTDKTNKFY---------CLKDVA------------------ 233
Query: 259 HEKSELKLG-------LGLGGGSIVLIALLSFWIMFYRKFSSYDST---GSCL----NIE 304
E S+L G L G S+ + LL F K Y GS + NIE
Sbjct: 234 -EVSKLPAGISKRFWFLAATGASLFTVGLLVLLFFFRNKVLWYKYIRLWGSKVEDHRNIE 292
Query: 305 TFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN 364
FL+N+GS AP+RY+Y DIK++T+ FK KL QGG+G+VY+G L +GS VAVKVLN+ KG+
Sbjct: 293 EFLKNYGSYAPKRYNYTDIKRITSRFKNKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGS 352
Query: 365 GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL 424
GE FINEVASISRTSHVNVV+L+GFCFEGR+RAL+YEF+ NGSLEKFIY S +L
Sbjct: 353 GENFINEVASISRTSHVNVVSLVGFCFEGRKRALVYEFMPNGSLEKFIYEERSDTV-RQL 411
Query: 425 TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484
W TL +IA+GIARGLEYLH GC+TRILHFDIKPHNILLDEDFCPKISDFGLAK+C + E
Sbjct: 412 GWPTLYKIALGIARGLEYLHRGCTTRILHFDIKPHNILLDEDFCPKISDFGLAKLCMKNE 471
Query: 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
SI+SM GARGT+GYIAPE+ CRN+G VS+KSD
Sbjct: 472 SIVSMLGARGTIGYIAPEIVCRNLGGVSHKSD 503
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574202|ref|XP_003555240.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 233/529 (44%), Positives = 309/529 (58%), Gaps = 62/529 (11%)
Query: 1 MACYSFLVFFVISQLLLLSSAEEESELNKTCPSFFPSCGNLGQFFFPFTNRTHPECGLML 60
MA F + L+L+ SA + ++ CP F +CGNLG F +PFT P+CGL+
Sbjct: 1 MAIVDLFCFLLFCHLVLILSAGYGNG-HQDCPHSF-TCGNLGTFHYPFTKAEKPDCGLIA 58
Query: 61 VDNCNKPVQR---IRLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCESFEN-LTLP 116
+ +C+ P Q I+L K G + +AQ +I++ D+ F L C + +N +LP
Sbjct: 59 IHDCDNPHQHRKMIQLEKNGKSIVLTGVAQQNAISILDEDFHKLLQQDPCGTLKNNYSLP 118
Query: 117 TSASL-SFHIKSNPSLFRCTHKLEKNLPSFHFTCNHN--------SFIYYNHPDDALPRI 167
+ SL S HIK N +LFRC H L+ P+ +F NH+ + P+D
Sbjct: 119 SPFSLYSIHIKFNVTLFRCKHSLKMKPPAHYF--NHSCPDYDYDIYYDSLPSPNDKEVHS 176
Query: 168 VPPNCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCA 227
+ +CS+IQ+ ++D+ + +++ LQV + C +C R G
Sbjct: 177 LFSSCSVIQISSKDLTNTNDILSFVSAEMVLQVVLSNDCDQCYNRWG------------- 223
Query: 228 ESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIVLIALLSFWIMF 287
G C D + F CE V IALL +M
Sbjct: 224 ------------GQCRLDANQEFYCEKA--------------------VTIALLLVMVMI 251
Query: 288 YRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKL 347
Y + I+ FL G L +RY Y++IKK+TNSF+ KLGQGG+GSVYKGKL
Sbjct: 252 YHTRWKKKQNPTNQQIKIFLERQGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKL 311
Query: 348 IDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407
DG VAVK+L++ K NGE+FINEVA+ISRTSH+N+V LLGFC EG +RAL+YEF+SNGS
Sbjct: 312 PDGRYVAVKILSELKDNGEDFINEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGS 371
Query: 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF 467
LEKFI+ + + +L +T+ IAVG+ARGLEYLH GC+TRILHFDIKPHNILLDE+F
Sbjct: 372 LEKFIFEENVVKTDRQLDCQTIYHIAVGVARGLEYLHQGCNTRILHFDIKPHNILLDENF 431
Query: 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
PKISDFGLAKIC RKES+IS+ GARGT GYIAPEVF RN G VS+KSD
Sbjct: 432 NPKISDFGLAKICTRKESMISIFGARGTAGYIAPEVFSRNFGAVSHKSD 480
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574204|ref|XP_003555241.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-108, Method: Compositional matrix adjust.
Identities = 229/529 (43%), Positives = 309/529 (58%), Gaps = 61/529 (11%)
Query: 1 MACYSFLVFFVISQLLLLSSAEEESELNKTCPSFFPSCGNLGQFFFPFTNRTHPECGLML 60
MA F + L+L+ SA + ++ CP F +CGNLG F +PFT P+CGL+
Sbjct: 1 MAIVDLFCFLLFCHLVLILSAGYGNG-HQDCPHSF-TCGNLGTFHYPFTKAEKPDCGLLA 58
Query: 61 VDNCNKPVQR---IRLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCESFEN---LT 114
+ +C+ P Q I+L G ++ +AQ +I++ D+ F L + C + +N L
Sbjct: 59 IHDCDNPHQHRKMIQLELNGKGIVLIGVAQQNAISILDEDFHKRLQQNPCGTLKNNYSLP 118
Query: 115 LPTSASLSFHIKSNPSLFRCTHKLEKNLPSFHFT--CNHNSF-IYYNH---PDDALPRIV 168
P S+ S HIK N +LF+C L+ P+ +F C + IYY+ P+ +
Sbjct: 119 SPFSSLYSIHIKFNVTLFKCKQSLKMKPPTHYFNHPCPEYDYDIYYDSLPTPNSKEAHSL 178
Query: 169 PPNCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCAE 228
+CS+IQ+ ++D+ + +++ LQV +
Sbjct: 179 FSSCSVIQISTKDLTDTNDILSFVSAEMVLQVVL-------------------------- 212
Query: 229 SRECNDCLKKRG-HCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIVLIALLSFWIMF 287
S +C+ C RG C D + F C+ V IALL +M
Sbjct: 213 SNDCDQCYNHRGGQCRLDANQKFYCKEA--------------------VTIALLLVMVMI 252
Query: 288 YRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKL 347
Y + I+ FL G L +RY Y++IKK+TNSF+ KLGQGG+GSVYKGKL
Sbjct: 253 YHTRWKQKQNPTNQQIKIFLERQGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKL 312
Query: 348 IDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407
DG VAVK+L++ K NGE+FINEVA+ISRTSH+N+V LLGFC EG +RAL+YEF+SNGS
Sbjct: 313 PDGRYVAVKILSELKDNGEDFINEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGS 372
Query: 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF 467
LEKFI+ + + +L +T+ IAVG+ARGLEYLH GC+TRILHFDIKPHNILLDE+F
Sbjct: 373 LEKFIFEENVGKTDRQLDCQTIYHIAVGVARGLEYLHQGCNTRILHFDIKPHNILLDENF 432
Query: 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
PKISDFGLAKIC RKES+IS+ GARGT GYIAPEVF RN G VS+KSD
Sbjct: 433 NPKISDFGLAKICTRKESMISIFGARGTAGYIAPEVFSRNFGAVSHKSD 481
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574212|ref|XP_003555245.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 382 bits (982), Expect = e-103, Method: Compositional matrix adjust.
Identities = 226/509 (44%), Positives = 298/509 (58%), Gaps = 55/509 (10%)
Query: 31 CPSFFPSCGNLGQFFFPFTNRTHPECGLMLVDNCNKPVQ--RIRLGKAGPFYNILNIAQD 88
CP FP CG L FPFT P+CGL+ + NC+ P++ I+L K G ++ ++ + Q
Sbjct: 29 CPPSFP-CGYLSNISFPFTLTERPDCGLLPIRNCDDPLKPIMIQLHKNGVWFQLVRVTQH 87
Query: 89 --------ASITLEDQVFQNHLGNSSCESFEN-LTLPTSASL---SFHIKSNPSLFRCTH 136
+ D+ + L N SCE+F N TLP S SFHI N +LFRC
Sbjct: 88 FRSPTTPLTTFHFRDKNLYDLLQNESCEAFRNNYTLPFPHSFHFASFHIHYNTTLFRCNR 147
Query: 137 KLEKN--LPSFHFT-CNHNSFIYYNHP--DDALPRIVPPNCSLIQLPVNKTRKSDDLFNM 191
L + +H+T C Y N+P +DA R C+ LP+ +++ F
Sbjct: 148 SLHVSPLTSMYHYTKCPDYDLYYNNNPKAEDASLRA----CTKALLPIKDVPDANNPFTF 203
Query: 192 LTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCAESRECNDCLKKRGHCHFDDKENFQ 251
+T+ S V + C C +R G G C D +E F
Sbjct: 204 VTADISTIVVLTDECAACHYRRG-------------------------GQCQLDSREIFF 238
Query: 252 CENERTGHEKSE---LKLGLGLGGGSIVLIALLSFWIMFYR-KFSSYDSTGSCLNIETFL 307
C + S + + + ++ + ALL + Y ++ + T I+ FL
Sbjct: 239 CATANSIALLSHPYIIIFLIPITSPAVTIAALLLVMVKIYHTRWKKQNPTNQ--QIKIFL 296
Query: 308 RNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE 367
G L +RY Y++IKK+TNSF+ KLGQGG+GSVYKGKL DG VAVK+L++ K NGE+
Sbjct: 297 EREGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSELKDNGED 356
Query: 368 FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
FINEVA+ISRTSH+N+V LLGFC EG +RAL+YEF+SNGSLEKFI+ + + +L E
Sbjct: 357 FINEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGSLEKFIFEENVIKTDRQLDCE 416
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
T+ IA+G+ARGLEYLH GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC RKES+I
Sbjct: 417 TIYHIAIGVARGLEYLHQGCNTRILHFDIKPHNILLDENFNPKISDFGLAKICTRKESMI 476
Query: 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
S+ GARGT GYIAPEVF RN G VS+KSD
Sbjct: 477 SIFGARGTAGYIAPEVFSRNFGAVSHKSD 505
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357444697|ref|XP_003592626.1| Protein kinase-coding resistance protein [Medicago truncatula] gi|355481674|gb|AES62877.1| Protein kinase-coding resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 377 bits (969), Expect = e-102, Method: Compositional matrix adjust.
Identities = 229/536 (42%), Positives = 321/536 (59%), Gaps = 68/536 (12%)
Query: 10 FVISQLLLLSSAEEESELNKTCPSFFPSCGNLGQFFFPFTNRTHPECGLMLVDNCN--KP 67
+I QLLL S CPS +CG LG+ FPFT+ HP+CG++++ C +P
Sbjct: 12 LLIKQLLLSSC---------ICPSSI-TCGFLGEIEFPFTSTQHPDCGMLVIHGCEDYEP 61
Query: 68 VQRIRLGKAGPFYNILNIAQDASITLEDQVFQNHLGNSSCE--SFENLTLPTSASLSFHI 125
+ + +++IL I + +IT++D + L SC+ +++++ + + +S +
Sbjct: 62 QSKKTIQNNKRWFDILKI-EPFTITIKDDQLHDLLLQKSCDILTYDSMFMVNTPLVSSRL 120
Query: 126 KSNPSLFRCTHKLEKNLPSFHFT------CNHNSFIYYNHPDDALPR----IVPPN---- 171
+ ++F C +L ++ C ++ Y D + +V +
Sbjct: 121 EYYVTVFGCNSNNSLDLQQYYSVSNSSSICREDTTTLYGVSDSDIKSNKTIVVVTDSVSN 180
Query: 172 ------CSLIQLPV-NKTRKSD--DLFNMLTSVFSLQVEIPWFCWEC-GWRGGQCRSDSE 221
CS ++LP +K + + DLF +L+ S+++++ C C GGQC D+
Sbjct: 181 SNHLKGCSNVELPTYSKVDRLEPADLFKVLSGEISIKLQVSQNCSSCHDLYGGQCLLDNN 240
Query: 222 GKFQCAESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGLGLGGGSIVLIALL 281
G+F C+ E++ +K+ LK+ G+ +
Sbjct: 241 GQFY--------------------------CKQEKS--KKTRLKVTAGICIFCWSTGSSD 272
Query: 282 SFWIMFYRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGS 341
FW F R+ + IE FL+NHG LA +RY+YA+IKK TNSFKYKLGQGGYGS
Sbjct: 273 FFWSWFLRRHYFNNKNPPYQIIELFLKNHGHLAAKRYTYAEIKKATNSFKYKLGQGGYGS 332
Query: 342 VYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401
VYKGKL DGS VAVKVL++S+GNGEEFINEVASIS TSHVN+V LLGF EG +RALIY+
Sbjct: 333 VYKGKLQDGSLVAVKVLSESEGNGEEFINEVASISVTSHVNIVGLLGFYLEGSKRALIYD 392
Query: 402 FVSNGSLEKFIYRNSSSIE-NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460
++ NGSLEKFIY N ++ N +L+ +T+ IA+G+ARGLEYLH GC+T+ILHFDIKPHN
Sbjct: 393 YMPNGSLEKFIYENKDPLKLNLQLSCKTVYNIAIGVARGLEYLHKGCNTKILHFDIKPHN 452
Query: 461 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
ILLD+DFCPK+SDFGLAK+C RKESIIS+ GARGT GYIAPEVF RN G VS+KSD
Sbjct: 453 ILLDDDFCPKVSDFGLAKVCPRKESIISLLGARGTAGYIAPEVFSRNFGGVSHKSD 508
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574208|ref|XP_003555243.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 223/507 (43%), Positives = 295/507 (58%), Gaps = 69/507 (13%)
Query: 31 CPSFFPSCGNLGQFFFPFTNRTHPECGLMLVDNCNKPVQ--RIRLGKAGPFYNILNIAQ- 87
CP FP CG L FPFT P+CGL+ + NC+ P++ I+L K G ++ ++ +AQ
Sbjct: 13 CPPSFP-CGYLDNISFPFTLTERPDCGLLPISNCDDPLKPKMIQLHKNGLWFPLVRVAQL 71
Query: 88 ----DASIT---LEDQVFQNHLGNSSCESF-ENLTLP----TSASLSFHIKSNPSLFRCT 135
S+T D + L N +CE+F N TLP + + S +I+ +LFRC
Sbjct: 72 FSSPTTSLTAFQFRDTNLYHLLLNENCEAFGNNYTLPFPHSSGFAASLYIQYYTTLFRCN 131
Query: 136 HKLEKNLPS--FHFTCNHNSFIYYN---HPDDALPRIVPPNCSLIQLPVNKTRKSDDLFN 190
L + P+ ++T + +YYN +DA R C+ + LP+ +++ F
Sbjct: 132 RSLHVSPPTNMHNYTKCPDYDLYYNDNPKAEDASLRA----CTKVLLPIKDAPDANNPFT 187
Query: 191 MLTSVFSLQVEIPWFCWECGWRGGQCRSDSEGKFQCAESRECNDCLKKRGHCHFDDKENF 250
T+ +VE+ C C +R G G C D +E F
Sbjct: 188 FATADIFTKVELTDECAACHYRRG-------------------------GQCQLDSREIF 222
Query: 251 QCENERTGHEKSELKLGLGLGGGSIVLIALLSFWIMFYR-KFSSYDSTGSCLNIETFLRN 309
C V IALL + Y ++ + T I FL
Sbjct: 223 FC----------------ATANSIAVTIALLLVMVKIYHTRWKKQNPTNQ--QIRIFLER 264
Query: 310 HGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFI 369
G L +RY Y++IKK+TNSF+ KLGQGG+GSVYKGKL DG VAVK+L++ K NGE+FI
Sbjct: 265 EGPLQTKRYDYSEIKKVTNSFRNKLGQGGFGSVYKGKLPDGRYVAVKILSELKDNGEDFI 324
Query: 370 NEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETL 429
NEVA+ISRTSH+N+V LLGFC EG +RAL+YEF+SNGSLEKFI+ + + +L +T+
Sbjct: 325 NEVATISRTSHINIVNLLGFCCEGSKRALVYEFMSNGSLEKFIFEENVIKTDRQLDCQTI 384
Query: 430 LQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489
IA+G+ARGLEYLH GC+TRILHFDIKPHNILLDE+F PKISDFGLAKIC RKES+IS+
Sbjct: 385 YHIAIGVARGLEYLHQGCNTRILHFDIKPHNILLDENFNPKISDFGLAKICTRKESMISI 444
Query: 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516
GARGT GYIAPEVF RN G VS+KSD
Sbjct: 445 FGARGTAGYIAPEVFSRNFGTVSHKSD 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574206|ref|XP_003555242.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 371 bits (952), Expect = e-100, Method: Compositional matrix adjust.
Identities = 216/489 (44%), Positives = 299/489 (61%), Gaps = 28/489 (5%)
Query: 46 FPFTNRTHPECGLMLVDNCN--KPVQRIRLGKAGPFYNILNIAQDASITLEDQVFQNHLG 103
FPFTN H +CG++++ C+ +P + + +++++ + Q +IT++D + L
Sbjct: 14 FPFTNTLHQDCGILVIHGCDDKEPGAKKTIKCNNTWFDVVGLDQ-FTITIKDDKLHDLLL 72
Query: 104 NSSCESFE---NLTLPTSASLSFHIKSNPSLFRCTHKL---EKNLPSFHFTCNHNSFIYY 157
SC++F T+ + + +K + RC H L K S + C + +
Sbjct: 73 QRSCDTFSYSSTFTVSSPLLKASRLKHYLEILRCNHTLGHPPKKSVSNNTLCKNETLYSM 132
Query: 158 NHPDDALPRIVPPN-CSLIQLPV-------NKTRKSDDLFNMLTSVFSLQVEIPWFCWEC 209
P+ + N CS++ +P + S D F +T ++++E+ C C
Sbjct: 133 VDPNPSGSGYSHHNGCSMLLIPTCLQLLDRHGHLYSSDPFEFITDNIAVEIELSPDCSTC 192
Query: 210 GW-RGGQCRSDSEGKFQCAESRECNDCLKKRGHCHFDDKENFQCENERTGHEKSELKLGL 268
+ GGQCR D+ KF C + + + L C F K + + + +
Sbjct: 193 IYAHGGQCRLDNTQKFYCYKGNK-STLLIAASMCVF--KSTYAARHYFLSSIINNVVASA 249
Query: 269 GLGGGSIVLIALLSFWIMFYRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTN 328
G G+++ + W + R + + T IE FL HG LA +RYSY++IKK TN
Sbjct: 250 GGALGAMIFL----IWCIRRRFYKKKNPTHQI--IEMFLNTHGHLAAKRYSYSEIKKATN 303
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
SF+YKLG GGYGSVYKGKL DGS VAVKVL+DS GNGEEFINEVASIS TSHVN+V+LLG
Sbjct: 304 SFRYKLGHGGYGSVYKGKLQDGSLVAVKVLSDSIGNGEEFINEVASISVTSHVNIVSLLG 363
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIE-NHKLTWETLLQIAVGIARGLEYLHLGC 447
FC EG +RALIY+++ NGSLEKFIY + ++ N +L+ +T+ IA+G+ARGLEYLH GC
Sbjct: 364 FCLEGSKRALIYKYMPNGSLEKFIYEDKDPLKLNLQLSCKTIYNIAIGVARGLEYLHRGC 423
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
+T+ILHFDIKPHNILLDEDFCPKISDFGLAKIC +KESI+S+ G RGT GYIAPEVF RN
Sbjct: 424 NTKILHFDIKPHNILLDEDFCPKISDFGLAKICPKKESIVSLLGTRGTAGYIAPEVFSRN 483
Query: 508 IGEVSYKSD 516
GEVS+KSD
Sbjct: 484 FGEVSHKSD 492
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.381 | 0.230 | 0.655 | 3e-77 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.405 | 0.234 | 0.618 | 4.8e-75 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.397 | 0.307 | 0.619 | 1.2e-73 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.391 | 0.316 | 0.601 | 2.9e-73 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.381 | 0.296 | 0.673 | 1.1e-72 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.381 | 0.246 | 0.643 | 8.6e-71 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.389 | 0.298 | 0.608 | 8.5e-70 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.377 | 0.241 | 0.633 | 1.1e-66 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.381 | 0.242 | 0.616 | 9.4e-66 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.335 | 0.294 | 0.606 | 8.8e-61 |
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 3.0e-77, Sum P(3) = 3.0e-77
Identities = 133/203 (65%), Positives = 168/203 (82%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID--GSNVAVKVLNDSKGNGEEFINEVA 373
+RYS+ +KKMTNSF + +G+GG+G+VYKGKL D G ++A+K+L +SKGNGEEFINE+
Sbjct: 507 KRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELV 566
Query: 374 SISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
S+SR SHVN+V+L GFC+EG +RA+IYEF+ NGSL+KFI N S+ K+ W+TL IA
Sbjct: 567 SMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMST----KIEWKTLYNIA 622
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
VG+ARGLEYLH C ++I+HFDIKP NIL+DED CPKISDFGLAK+C +KESIISM AR
Sbjct: 623 VGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDAR 682
Query: 494 GTVGYIAPEVFCRNIGEVSYKSD 516
GTVGYIAPE+F +N G VS+KSD
Sbjct: 683 GTVGYIAPEMFSKNYGGVSHKSD 705
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 4.8e-75, Sum P(3) = 4.8e-75
Identities = 133/215 (61%), Positives = 168/215 (78%)
Query: 304 ETFLRNHGSLAP-RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK 362
E L+ +L P + Y+YA++KKMT SF +G+GG+G VY G L D S VAVKVL DSK
Sbjct: 531 EVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSK 590
Query: 363 G-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIEN 421
G +GE+FINEVAS+S+TSHVN+V+LLGFC EG RRA+IYEF+ NGSL+KFI + SS+
Sbjct: 591 GTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI-SDKSSVN- 648
Query: 422 HKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481
L +TL IA+G+ARGLEYLH GC TRI+HFDIKP N+LLD++ CPK+SDFGLAK+C
Sbjct: 649 --LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCE 706
Query: 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+KESI+S+ RGT+GYIAPE+ R G VS+KSD
Sbjct: 707 KKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSD 741
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 1.2e-73, Sum P(2) = 1.2e-73
Identities = 130/210 (61%), Positives = 166/210 (79%)
Query: 308 RNHGSLAP-RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE 366
+N +L P + YSYA + +T SF +G+GG+G+VY+G L DG +VAVKVL +S+GNGE
Sbjct: 327 QNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGE 386
Query: 367 EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW 426
+FINEVAS+S+TSHVN+VTLLGFC EG +RA+IYEF+ NGSL+KFI SS ++ + W
Sbjct: 387 DFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFI----SSKKSSTMDW 442
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486
L IA+G+ARGLEYLH GC TRI+HFDIKP N+LLD++ PK+SDFGLAK+C RKESI
Sbjct: 443 RELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESI 502
Query: 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+S+ RGT+GYIAPEVF R G VS+KSD
Sbjct: 503 LSLMDTRGTIGYIAPEVFSRVYGRVSHKSD 532
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.9e-73, Sum P(3) = 2.9e-73
Identities = 124/206 (60%), Positives = 163/206 (79%)
Query: 311 GSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFIN 370
G + ++YSYA+++K+T F + LG+GG+G+VY G L DG VAVK+L D K NGE+FIN
Sbjct: 304 GLVQLKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFIN 363
Query: 371 EVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL 430
EVAS+S+TSHVN+V+LLGFC+EG +RA++YEF+ NGSL++F+ S L TL
Sbjct: 364 EVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSL----NLDVSTLY 419
Query: 431 QIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490
+IA+G+ARGL+YLH GC TRI+HFDIKP NILLD+ FCPK+SDFGLAK+C ++ESI+S+
Sbjct: 420 RIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLL 479
Query: 491 GARGTVGYIAPEVFCRNIGEVSYKSD 516
ARGT+GYIAPEVF G VS+KSD
Sbjct: 480 DARGTIGYIAPEVFSGMYGRVSHKSD 505
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 711 (255.3 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
Identities = 136/202 (67%), Positives = 165/202 (81%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVAS 374
+RYSY +KKMTNSF + LG+GG+G+VYKGKL D G +VAVK+L S+GNGEEFINEVAS
Sbjct: 319 KRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVAS 378
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
+SRTSHVN+V+LLGFC+E +RA+IYEF+ NGSL+K+I N S+ K+ WE L +AV
Sbjct: 379 MSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMST----KMEWERLYDVAV 434
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
GI+RGLEYLH C TRI+HFDIKP NIL+DE+ CPKISDFGLAK+C KESIISM RG
Sbjct: 435 GISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRG 494
Query: 495 TVGYIAPEVFCRNIGEVSYKSD 516
T GYIAPE+F +N G VS+KSD
Sbjct: 495 TFGYIAPEMFSKNFGAVSHKSD 516
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 8.6e-71, Sum P(2) = 8.6e-71
Identities = 130/202 (64%), Positives = 165/202 (81%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGS-NVAVKVLNDSKGNGEEFINEVAS 374
+R+SY +KKMT SF+ LG+GG+G+VYKGKL DGS +VAVK+L +S +GE+FINE+AS
Sbjct: 447 KRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIAS 506
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
+SRTSH N+V+LLGFC+EGR++A+IYE + NGSL+KFI +N S+ K+ W+TL IAV
Sbjct: 507 MSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSA----KMEWKTLYNIAV 562
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
G++ GLEYLH C +RI+HFDIKP NIL+D D CPKISDFGLAK+C ESIISM ARG
Sbjct: 563 GVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARG 622
Query: 495 TVGYIAPEVFCRNIGEVSYKSD 516
T+GYIAPEVF +N G VS+KSD
Sbjct: 623 TIGYIAPEVFSQNFGGVSHKSD 644
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 646 (232.5 bits), Expect = 8.5e-70, Sum P(3) = 8.5e-70
Identities = 126/207 (60%), Positives = 162/207 (78%)
Query: 312 SLAP-RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-EEFI 369
+L P + Y+YA +K+MT SF +G+GG+G VY+G L DG VAVKVL +SKGN E+FI
Sbjct: 329 ALIPLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFI 388
Query: 370 NEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETL 429
NEV+S+S+TSHVN+V+LLGFC EG RRA+IYEF+ NGSL+KFI +S I + LT L
Sbjct: 389 NEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILD--LT--AL 444
Query: 430 LQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489
IA+G+ARGLEYLH GC TRI+HFDIKP N+LLD++ PK+SDFGLAK+C +KES++S+
Sbjct: 445 YGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSL 504
Query: 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516
RGT+GYIAPE+ R G VS+KSD
Sbjct: 505 MDTRGTIGYIAPEMISRVYGSVSHKSD 531
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 678 (243.7 bits), Expect = 1.1e-66, P = 1.1e-66
Identities = 126/199 (63%), Positives = 163/199 (81%)
Query: 318 YSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR 377
Y+YA++KK+T SF Y +G+GG+G+VY G L +G VAVKVL D KG+ E+FINEVAS+S+
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547
Query: 378 TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
TSHVN+V+LLGFCFEG +RA++YEF+ NGSL++F+ RN S ++ +T TL IA+GIA
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQD--VT--TLYGIALGIA 603
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 497
RGLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAK+C ++ES++S+ RGT+G
Sbjct: 604 RGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIG 663
Query: 498 YIAPEVFCRNIGEVSYKSD 516
YIAPEVF R G VS+KSD
Sbjct: 664 YIAPEVFSRMYGRVSHKSD 682
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
Identities = 124/201 (61%), Positives = 164/201 (81%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASI 375
++Y YA++KK+T SF + +G+GG+G+VY+G L +G VAVKVL D KGNG++FINEV S+
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
S+TSHVN+V+LLGFC+EG +RA+I EF+ +GSL++FI RN S N +T TL IA+G
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTPN--VT--TLYGIALG 599
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
IARGLEYLH GC TRI+HFDIKP NILLD++FCPK++DFGLAK+C ++ESI+S+ RGT
Sbjct: 600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659
Query: 496 VGYIAPEVFCRNIGEVSYKSD 516
+GYIAPEV R G +S+KSD
Sbjct: 660 IGYIAPEVVSRMYGGISHKSD 680
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 8.8e-61, Sum P(2) = 8.8e-61
Identities = 111/183 (60%), Positives = 145/183 (79%)
Query: 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG 393
+G+GG+G+VYKG L DG VAVK+L DS GN E+FINEVASIS+TSHVN+V+LLGFCFE
Sbjct: 287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346
Query: 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILH 453
+RA++YEF+ NGSL++ SS+++ TL IA+G+ARG+EYLH GC RI+H
Sbjct: 347 SKRAIVYEFLENGSLDQ-----SSNLDV-----STLYGIALGVARGIEYLHFGCKKRIVH 396
Query: 454 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 513
FDIKP N+LLDE+ PK++DFGLAK+C ++ESI+S+ RGT+GYIAPE+F R G VS+
Sbjct: 397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456
Query: 514 KSD 516
KSD
Sbjct: 457 KSD 459
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.X.99.1 | hypothetical protein (324 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 516 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-46
Identities = 69/187 (36%), Positives = 102/187 (54%), Gaps = 15/187 (8%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
LG+GG+G+VY + G VA+K++ DS EE + E+ + + +H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ L+ E+ GSL+ + N KL+ + +L+I + I GLEYLH S
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH---SNG 112
Query: 451 ILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
I+H D+KP NILLD D K++DFGL+K+ +S+ + GT Y+APEV G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKG 169
Query: 510 EVSYKSD 516
S KSD
Sbjct: 170 YYSEKSD 176
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 66/191 (34%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGS-----NVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVT 385
KLG+G +G VYKGKL VAVK L + EEF+ E + + H NVV
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C E ++ E++ G L ++ +N KL+ LL A+ IARG+EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-----PKLSLSDLLSFALQIARGMEYLE- 119
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
S +H D+ N L+ E+ KISDFGL++ + G + + ++APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYRKRGGKLPIRWMAPESLK 176
Query: 506 RNIGEVSYKSD 516
G+ + KSD
Sbjct: 177 E--GKFTSKSD 185
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-40
Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLNDSKGNGE--EFINEVASISRTSHVNVVTL 386
KLG+G +G VYKGKL VAVK L + E +F+ E + + H NVV L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH----KLTWETLLQIAVGIARGLEY 442
LG C E L+ E++ G L ++ R S + L+ + LL A+ IA+G+EY
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYL-RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
L S + +H D+ N L+ ED KISDFGL++ + TG + + ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 503 VFCRNIGEVSYKSD 516
I + KSD
Sbjct: 178 SLKDGI--FTSKSD 189
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 63/191 (32%), Positives = 95/191 (49%), Gaps = 17/191 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGS-----NVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVT 385
KLG+G +G VYKG L VAVK L + EEF+ E + + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C E ++ E++ G L ++ +N +L+ LL A+ IARG+EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN----RPKELSLSDLLSFALQIARGMEYLE- 120
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
S +H D+ N L+ E+ KISDFGL++ + + G + + ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWMAPESLK 177
Query: 506 RNIGEVSYKSD 516
G+ + KSD
Sbjct: 178 E--GKFTSKSD 186
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 17/191 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLNDSKG--NGEEFINEVASISRTSHVNVVT 385
KLG+G +G VYKG L VAVK L + EEF+ E + + + SH N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C +G ++ E++ G L F+ ++ KLT + LLQ+A+ IA+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
S +H D+ N L+ E+ KISDFGL++ + G + + ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL- 176
Query: 506 RNIGEVSYKSD 516
G+ + KSD
Sbjct: 177 -KDGKFTSKSD 186
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 67/175 (38%), Positives = 92/175 (52%), Gaps = 15/175 (8%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG G +G+VYK K G VAVK+L + + E+ + R SH N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L+ E+ G L ++ L+ + +IA+ I RGLEYLH S
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I+H D+KP NILLDE+ KI+DFGLAK + S S+T GT Y+APEV
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS--SLTTFVGTPWYMAPEV 169
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 17/187 (9%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVTLLGF 389
KLG+G +G VY + G VA+KV+ K E + E+ + + H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ + L+ E+ G L + + +L+ + I LEYLH S
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL------KKRGRLSEDEARFYLRQILSALEYLH---SK 116
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
I+H D+KP NILLDED K++DFGLA+ + E + + GT Y+APEV
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK-- 171
Query: 510 EVSYKSD 516
D
Sbjct: 172 GYGKAVD 178
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 66/191 (34%), Positives = 91/191 (47%), Gaps = 19/191 (9%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLLG 388
LG+G +GSVY D G +AVK + S + EE E+ +S H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 389 FCFEGRRRAL-IY-EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEYLHL 445
+ + L I+ E+VS GSL + + KL E +++ I GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFG------KLP-EPVIRKYTRQILEGLAYLH- 118
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
S I+H DIK NIL+D D K++DFG AK E+ RGT ++APEV
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-I 175
Query: 506 RNIGEVSYKSD 516
R E +D
Sbjct: 176 RG-EEYGRAAD 185
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 65/190 (34%), Positives = 99/190 (52%), Gaps = 15/190 (7%)
Query: 329 SFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTL 386
K+G+GG+G VYK + G VA+KV+ +SK E+ INE+ + + H N+V
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G + ++ EF S GSL+ + +++ N LT + + + +GLEYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKD-LLKST----NQTLTESQIAYVCKELLKGLEYLH-- 115
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S I+H DIK NILL D K+ DFGL+ + ++ +M GT ++APEV
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI-- 169
Query: 507 NIGEVSYKSD 516
N YK+D
Sbjct: 170 NGKPYDYKAD 179
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 15/187 (8%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G +G V G G VAVK L D + F+ E + ++ H N+V LLG
Sbjct: 10 LGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+G ++ E+++ GSL ++ S +T L A+ + G+EYL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLE---EK 121
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+H D+ N+L+ ED K+SDFGLA KE+ + V + APE R
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEAL-RE-K 174
Query: 510 EVSYKSD 516
+ S KSD
Sbjct: 175 KFSTKSD 181
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 323 IKKMTNSFKYK-LGQGGYGSVYKGKLI-DGSN----VAVKVLNDSKG--NGEEFINEVAS 374
I K T K K LG G +G+VYKG I +G VA+KVL + +E ++E
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
++ H +VV LLG C + LI + + G L ++ + +I + + LL V
Sbjct: 63 MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-----QYLLNWCV 116
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
IA+G+ YL R++H D+ N+L+ KI+DFGLAK+ + E G +
Sbjct: 117 QIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 495 TVGYIAPEVFCRNIGEVSYKSD 516
+ ++A E ++KSD
Sbjct: 174 PIKWMALE--SILHRIYTHKSD 193
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 12/185 (6%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
KLG G +G V++G + VA+K+L +D ++F EV ++ R H ++++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
G +I E + GSL F+ S E L +L+ +A +A G+ YL
Sbjct: 73 VGEPVYIITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNS 125
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 511
+H D+ NIL+ ED K++DFGLA++ KE + + + + APE + G
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAA--SHGTF 181
Query: 512 SYKSD 516
S KSD
Sbjct: 182 STKSD 186
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 8e-25
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLLG 388
++G+G +G VY + DG +K ++ S + +E +NEV + + +H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
E + ++ E+ G L + I E E +L V + L+YLH S
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLH---S 121
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFC 505
+ILH DIKP NI L + K+ DFG++K+ + + A+ VG Y++PE+ C
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-----AKTVVGTPYYLSPEL-C 175
Query: 506 RNIGEVSYKSD 516
+N +YKSD
Sbjct: 176 QNKP-YNYKSD 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 323 IKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN 382
I +F +LG G +G V+ GK +VA+K++ + + ++FI E + + SH N
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+V L G C + R ++ E+++NG L ++ KL E LL + + +EY
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEY 115
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
L S +H D+ N L+ ED K+SDFGLA+ + S G + V + PE
Sbjct: 116 LE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPE 171
Query: 503 VFCRNIGEVSYKSD 516
VF + S KSD
Sbjct: 172 VF--DYSRFSSKSD 183
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 54/160 (33%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 333 KLGQGGYGSVYKGKL-IDGSN----VAVKVLNDSKGNGE--EFINEVASISRTSHVNVVT 385
+LG+G +G V + G N VAVK LN S +F E+ + H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 386 LLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G C + R+ LI E++ +GSL ++ R+ I N K LL + I +G++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLK----RLLLFSSQICKGMDYL 125
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
S R +H D+ NIL++ + KISDFGLAK+
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 19/172 (11%)
Query: 323 IKKMTNSFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNG--EEFINEVAS 374
+++ T K +LG+G +G V+ G+ VAVK L ++ N ++F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI--------ENHKLTW 426
++ H N+V G C EG +++E++ +G L KF+ + +LT
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
LLQIAV IA G+ YL S +H D+ N L+ D KI DFG+++
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 19/189 (10%)
Query: 333 KLGQGGYGSVYKG-KLIDGSNVAVK---VLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G VYKG L G VA+K + + + + E+ + H N+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEYLHLGC 447
+I E+ NGSL + I + E+L+ + V + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKK------FGPFP-ESLVAVYVYQVLQGLAYLH--- 116
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
++H DIK NIL +D K++DFG+A N GT ++APEV
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVI--E 172
Query: 508 IGEVSYKSD 516
+ S SD
Sbjct: 173 MSGASTASD 181
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
LGQG G VYK + G A+K ++ + ++ + E+ ++ VV G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
++ +++ E++ GSL + + K+ L IA I +GL+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHT--KR 119
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPEVF 504
I+H DIKP N+L++ KI+DFG++K ++ T + GTV Y++PE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERI 172
Query: 505 CRNIGEVSYKSD 516
SY +D
Sbjct: 173 --QGESYSYAAD 182
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 11/188 (5%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+ ++G G +G V+ G ++ VA+K + + + E+FI E + + SH +V L G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
C E L++EF+ +G L ++ + K + ETLL + + + G+ YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL-----RAQRGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
++H D+ N L+ E+ K+SDFG+ + + S TG + V + +PEVF +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVF--SF 175
Query: 509 GEVSYKSD 516
+ S KSD
Sbjct: 176 SKYSSKSD 183
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.3 bits (243), Expect = 3e-22
Identities = 67/195 (34%), Positives = 91/195 (46%), Gaps = 19/195 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVL----NDSKGNGEEFINEVASISRTSH-VNVVTLL 387
KLG+G +G VY + VA+KVL E F+ E+ ++ +H N+V L
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F + L+ E+V GSLE + L+ L I I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLH--- 118
Query: 448 STRILHFDIKPHNILLDED-FCPKISDFGLAKI----CNRKESIISMTGARGTVGYIAPE 502
S I+H DIKP NILLD D K+ DFGLAK+ + + + GT GY+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 503 VF-CRNIGEVSYKSD 516
V ++ S SD
Sbjct: 179 VLLGLSLAYASSSSD 193
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 60/190 (31%), Positives = 87/190 (45%), Gaps = 19/190 (10%)
Query: 334 LGQGGYGSVYKGKLI--DGS--NVAVKVL--NDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG G +GSV KG + G VAVK L +EF+ E + +++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G C +G L+ E G L K++ + I L E Q+A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLK-ELAHQVA----MGMAYLE--- 112
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFCR 506
S +H D+ N+LL KISDFG+++ + T R + + APE C
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE--CI 170
Query: 507 NIGEVSYKSD 516
N G+ S KSD
Sbjct: 171 NYGKFSSKSD 180
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 11/189 (5%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN-VAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLL 387
+ K+KLG G YG VY+G S VAVK L + EEF+ E A + H N+V LL
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G C +I EF++ G+L ++ + ++ LL +A I+ +EYL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSAMEYLE--- 121
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
+H D+ N L+ E+ K++DFGL+++ ++ + GA+ + + APE N
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 508 IGEVSYKSD 516
+ S KSD
Sbjct: 181 --KFSIKSD 187
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 56/158 (35%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 334 LGQGGYGSVYKGKLI--DGS--NVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTL 386
LG+G +GSV +G+L DGS VAVK + + EEF++E A + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 387 LGFCFEGRRRA------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+G CFE +I F+ +G L F+ + KL +TLL+ V IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
EYL + +H D+ N +L ED ++DFGL+K
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 62/184 (33%), Positives = 89/184 (48%), Gaps = 10/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLG G +G V+ G + VAVK L + E F+ E + + H +V L C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E++S GSL F+ S E KL L+ +A IA G+ YL S +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D+ NIL+ E+ KI+DFGLA++ E GA+ + + APE N G +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE-GAKFPIKWTAPEAA--NYGRFT 182
Query: 513 YKSD 516
KSD
Sbjct: 183 IKSD 186
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 13/153 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG+G YG VYK + G VA+K + N+ +G + E++ + H N+V LL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
R+ L++E+ L+K++ + + + + I + RGL Y H S
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN-----LIKSIMYQLLRGLAYCH---S 116
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481
RILH D+KP NIL++ D K++DFGLA+
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 60/177 (33%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKVLN--DSKGNGEEFIN----EVASISRTSHVNVVTL 386
LG G +GSVY+G L DG AVK ++ D G+E + E+A +S+ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
LG E + E V GSL K + + S + I GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQILLGLEYLH-- 119
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+H DIK NIL+D + K++DFG+AK S +G+ ++APEV
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEV 172
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 21/167 (12%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNG--EEFINEVASISRTSHV 381
F +LG+G +G VYKG+L + VA+K L ++ +EF E +S H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS--SSIE--------NHKLTWETLLQ 431
N+V LLG C + + +++E++++G L +F+ RNS S + L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
IA+ IA G+EYL S +H D+ N L+ E KISDFGL++
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 14/175 (8%)
Query: 334 LGQGGYGSVYKGKLIDGS----NVAVKVLNDSKGNGE--EFINEVASISRTSHVNVVTLL 387
+G G +G V +G+L +VA+K L + + +F+ E + + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + R +I E++ NGSL+KF+ N K T L+ + GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
+H D+ NIL++ + K+SDFGL++ E+ + G + + + APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 37/208 (17%)
Query: 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFIN-EVASISRTS-HVNVVTLL 387
+G+G + +V K A+K+L+ K +++ E ++R + H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 388 GFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ F+ + E+ NG L ++I + S L + A I LEYLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGS------LDEKCTRFYAAEILLALEYLH-- 119
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI--------------CNRKESIISMTGA 492
S I+H D+KP NILLD+D KI+DFG AK+ N I
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 493 R----GTVGYIAPEVFCRNIGEVSYKSD 516
GT Y++PE+ SD
Sbjct: 179 FASFVGTAEYVSPELLNEKP--AGKSSD 204
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 36/199 (18%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG+G YGSVYK + G VA+KV+ + + +E I E++ + + +V G
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL--QIAV---GIARGLEYL 443
F+ ++ E+ GS+ + K+T +TL +IA +GLEYL
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIM----------KITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN----RKESIISMTGARGTVGYI 499
H S + +H DIK NILL+E+ K++DFG++ ++ ++I GT ++
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWM 166
Query: 500 APEVFCRNIGEVSY--KSD 516
APEV I E+ Y K+D
Sbjct: 167 APEV----IQEIGYNNKAD 181
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 56/188 (29%), Positives = 96/188 (51%), Gaps = 11/188 (5%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+F +LG G +G V GK +VA+K++ + + +EFI E + + SH +V L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
C + R ++ E++SNG L ++ + + LL++ + G+ YL S
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLE---S 118
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+ +H D+ N L+D+ C K+SDFGL++ E S+ G++ V + PEV +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLLYS- 176
Query: 509 GEVSYKSD 516
+ S KSD
Sbjct: 177 -KFSSKSD 183
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 20/190 (10%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
K+G+G +G VYKG L + VAVK +F+ E + + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ + ++ E V GSL F+ + + +LT + LLQ+++ A G+EYL S
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLE---SKN 113
Query: 451 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT----VGYIAPEVFCR 506
+H D+ N L+ E+ KISDFG++ R+E T + G + + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-- 167
Query: 507 NIGEVSYKSD 516
N G + +SD
Sbjct: 168 NYGRYTSESD 177
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLG 388
K+G G +G VY +D G +AVK + +E +E+ + H N+V G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 389 FCFEGRRRALIY-EFVSNGSLEKFIYRNSSSIENHKLTWETLLQI-AVGIARGLEYLHLG 446
R + I+ E+ S G+LE+ + E+ ++ E ++++ + + GL YLH
Sbjct: 67 VEVH-REKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLH-- 116
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGARGTVGYIAPEVF 504
S I+H DIKP NI LD + K+ DFG A + + + GT Y+APEV
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 505 CRN 507
Sbjct: 176 TGG 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+G +G V + D + A+KVL K E + E +SR +H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ + L+ E+ G L + + + + E A I LEYLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE------GRFSEERARFYAAEIVLALEYLH--- 110
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKI-CNRKESIISMTGARGTVGYIAPEV 503
S I++ D+KP NILLD D K++DFGLAK + + GT Y+APEV
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + G VA+K + +S+G + + E+ + +H N++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK---LTWETLLQIAVGIARGLEYLHL 445
L++EF+ L K I + ++ L +GL + H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLL--------QGLAFCH- 115
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S ILH D+KP N+L++ + K++DFGLA+ T T Y APE+
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVTRWYRAPEL 169
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 334 LGQGGYGSVYKGKLID------GSNVAVKVLNDSKGNGE--EFINEVASISRT-SHVNVV 384
LG+G +G V K + + S VAVK+L D + + ++E+ + H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRN------SSSIENH----KLTWETLLQIAV 434
LLG C + ++ E+ ++G+L F+ +S + LT + L+ A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
+ARG+E+L S + +H D+ N+L+ ED KI+DFGLA+ + + T R
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 495 TVGYIAPE 502
V ++APE
Sbjct: 197 PVKWMAPE 204
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 11/188 (5%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+F +LG G +G V+ GK VA+K +N+ + E+FI E + + SH +V L G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
C + + ++ EF+ NG L ++ + KL+ + LL + + G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLE---R 118
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+H D+ N L+ K+SDFG+ + E S +GA+ V + PEVF N
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NF 175
Query: 509 GEVSYKSD 516
+ S KSD
Sbjct: 176 SKYSSKSD 183
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 61/191 (31%), Positives = 92/191 (48%), Gaps = 22/191 (11%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISR 377
S D +++ + + K+G+G G VYK G VA+K + K N E INE+ +
Sbjct: 13 SEGDPRELYKNLE-KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71
Query: 378 TSHVNVVTLLGFCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV-- 434
H N+V + G ++ E++ GSL I +N + QIA
Sbjct: 72 CKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP--------QIAYVC 122
Query: 435 -GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGA 492
+ +GLEYLH S ++H DIK NILL +D K++DFG A++ K S+
Sbjct: 123 REVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-- 177
Query: 493 RGTVGYIAPEV 503
GT ++APEV
Sbjct: 178 -GTPYWMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 7e-19
Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 21/191 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG+G YGSVYK K L D A+K ++ S+ E+ +NE+ ++ +H N+++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+G + ++ E+ G L K I + + + + + +I + + RGL+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISK--RKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNR---KESIISMTGARGTVGYIAPEVFC 505
+ILH D+K NILL + KI D G++K+ + K I GT Y+APEV+
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-------GTPHYMAPEVWK 174
Query: 506 RNIGEVSYKSD 516
SYKSD
Sbjct: 175 GR--PYSYKSD 183
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV 381
+I + + KLG G +G V++G + + VAVK L + ++F+ E + + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
++ L C ++ E + GSL +++ + L L+ +A +A G+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMA 117
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIA 500
YL + +H D+ N+L+ E+ K++DFGLA++ KE I + GA+ + + A
Sbjct: 118 YLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTA 172
Query: 501 PEVFCRNIGEVSYKSD 516
PE N S KSD
Sbjct: 173 PEAALYN--RFSIKSD 186
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 55/160 (34%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 334 LGQGGYGSVYKGKL--IDGSN----VAVKVLNDSKGNGEE--FINEVASISRTSHVNVVT 385
LG G +G VY+G DG VAVK L +S +E F+ E +S+ +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIEN-HKLTWETLLQIAVGIARGLEYLH 444
L+G FE R ++ E ++ G L+ F+ N E LT + LL A +A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 445 LGCSTRILHFDIKPHNILLDEDFCP------KISDFGLAK 478
+H DI N LL C KI+DFG+A+
Sbjct: 134 ---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/182 (32%), Positives = 92/182 (50%), Gaps = 23/182 (12%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVK---VLNDSKGNGEEFINEVA---SISRTSHVNVVTL 386
+G+G YG+VYK + L G VA+K V +G + E+A + H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 387 LGFCFEGRRR-----ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
L C R L++E V L ++ + L ET+ + + RG++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP----GLPPETIKDLMRQLLRGVD 121
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
+LH S RI+H D+KP NIL+ D KI+DFGLA+I + + +++T T+ Y AP
Sbjct: 122 FLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYRAP 175
Query: 502 EV 503
EV
Sbjct: 176 EV 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 17/187 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLG G +G V+ G + VA+K L + E F+ E + + H +V L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 393 GRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ IY E++ NGSL F+ + E KLT L+ +A IA G+ ++
Sbjct: 71 --TQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RK 121
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+H D++ NIL+ E C KI+DFGLA++ E + GA+ + + APE N G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYG 178
Query: 510 EVSYKSD 516
+ KSD
Sbjct: 179 TFTIKSD 185
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 17/184 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G+V +G+ G VAVK + + F+ E A +++ H N+V LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E +S G+L F+ ++ + LLQ ++ +A G+EYL S +++
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVI----QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D+ NIL+ ED K+SDFGLA++ + + ++ V + APE + S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEALKHK--KFS 175
Query: 513 YKSD 516
KSD
Sbjct: 176 SKSD 179
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 63/178 (35%), Positives = 95/178 (53%), Gaps = 17/178 (9%)
Query: 334 LGQGGYGSVYKGKLIDGS----NVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLL 387
+G+G +G VY G LID + AVK LN E+F+ E + SH NV++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 388 GFCFEGRRRALI-YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G C L+ ++ +G L FI R+ E H T + L+ + +A+G+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-RS----ETHNPTVKDLIGFGLQVAKGMEYL--- 114
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPE 502
S + +H D+ N +LDE F K++DFGLA+ KE S+ + TGA+ V ++A E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 63/183 (34%), Positives = 92/183 (50%), Gaps = 32/183 (17%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
++G G YG VYK + I G VA+KV+ G+ E I E++ + H N+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETL--LQIAVGIAR----GLEYLH 444
+ ++ E+ GSL+ IY ++T L LQIA + R GL YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IY---------QVTRGPLSELQIAY-VCRETLKGLAYLH 118
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICN---RKESIISMTGARGTVGYIA 500
T +H DIK NILL ED K++DFG+ A++ +++S I GT ++A
Sbjct: 119 ---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMA 169
Query: 501 PEV 503
PEV
Sbjct: 170 PEV 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 13/177 (7%)
Query: 331 KYKLGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTL 386
K+G+G +G V+K + D A+K ++ SK N EE I+E +++ ++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ + ++ E+ NG L K + W +QI +G L +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLH-- 118
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S +ILH DIK N+ LD KI D G+AK+ + + + T GT Y++PE+
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANT-IVGTPYYLSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 61/183 (33%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEFIN-----EVASISRTSHVNVVT 385
KLG+G Y VYK + G VA+K + + ++ IN E+ + H N++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIEN-HKLTWETLLQIAVGIARGLEYLH 444
LL L++EF+ LEK I S + ++ +L RGLEYLH
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSY--MLMTL----RGLEYLH 119
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC---NRKESIISMTGARGTVGYIAP 501
S ILH D+KP+N+L+ D K++DFGLA+ NRK MT T Y AP
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK-----MTHQVVTRWYRAP 171
Query: 502 EVF 504
E+
Sbjct: 172 ELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLL 387
+G+G +G+V K + DG + K ++ +E ++EV + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 388 GFCFEGRRRALIY---EFVSNGSLEKFI---YRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ R +Y E+ G L + I + IE + W L Q+ L
Sbjct: 66 DRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLL----LALY 119
Query: 442 YLHLGC--STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
H +LH D+KP NI LD + K+ DFGLAKI +S + T GT Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYV-GTPYYM 177
Query: 500 APEVFCRNIGEVSY--KSD 516
+PE + +SY KSD
Sbjct: 178 SPEQ----LNHMSYDEKSD 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTLLG 388
++G+G +G V+K K + G VA+K + + G + + E+ ++ H VV LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR----GLEYLH 444
G L+ E++ L + + R+ L R G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVL-RDEE----RPLP----EAQVKSYMRMLLKGVAYMH 116
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+ I+H D+KP N+L+ D KI+DFGLA++ + +E + T Y APE+
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 19/184 (10%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNV-AVKVLN----DSKGNGEEFINEVASISRTSHVNV 383
+G+G +G V + D + A+K +N KG+ +NE + +H +
Sbjct: 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62
Query: 384 VTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
V L + F+ L+ + + G L + + K + E + I LEY
Sbjct: 63 VNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEY 115
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
LH S I+H DIKP NILLDE I+DF +A S + GT GY+APE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPE 169
Query: 503 VFCR 506
V CR
Sbjct: 170 VLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 30/200 (15%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFC 390
+G+G YG VYK + G VA+K++ D + EE I E +I R ++H N+ T G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 391 FEGRRRA-------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
F + L+ E GS+ + + +L E + I RGL YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VG---YI 499
H +++H DIK NILL ++ K+ DFG++ + G R T +G ++
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL------GRRNTFIGTPYWM 180
Query: 500 APEVF-CRNIGEVSY--KSD 516
APEV C + SY +SD
Sbjct: 181 APEVIACDEQPDASYDARSD 200
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/190 (28%), Positives = 101/190 (53%), Gaps = 18/190 (9%)
Query: 334 LGQGGYGSVYKGKLI-DGSNV----AVKVLNDSKGNGE--EFINEVASISRTSHVNVVTL 386
LG G +G+VYKG + +G V A+K+LN++ G EF++E ++ H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
LG C + L+ + + +G L +++ + +I + + LL V IA+G+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS-----QLLLNWCVQIAKGMMYLE-- 126
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
R++H D+ N+L+ KI+DFGLA++ E + G + + ++A E C
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--CI 183
Query: 507 NIGEVSYKSD 516
+ + +++SD
Sbjct: 184 HYRKFTHQSD 193
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 334 LGQGGYGSVYKG--KLIDGS--NVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTL 386
LG+G +GSV + K DGS VAVK+L S + EEF+ E A + H NV+ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 387 LGFCFEGRRRA------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+G R + +I F+ +G L F+ + E L +TL++ + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
EYL S +H D+ N +L+E+ ++DFGL+K
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 58/186 (31%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 332 YKL----GQGGYGSVYKGKLIDGS-NVAVKVLNDSKGNG--EEFINEVASISRTSHVNVV 384
Y+L G G VY + + VA+K ++ K +E EV ++S+ +H NVV
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLE---KFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
G L+ ++S GSL K Y E T+L+ + +GLE
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA---IIATVLK---EVLKGLE 116
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVG 497
YLH S +H DIK NILL ED KI+DFG++ + + R GT
Sbjct: 117 YLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPC 171
Query: 498 YIAPEV 503
++APEV
Sbjct: 172 WMAPEV 177
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 24/192 (12%)
Query: 334 LGQGGYGSVY--------KGKLIDGSNVAVKVLNDSKGNGE--EFINEVASISRT-SHVN 382
LG+G +G V K K VAVK+L D + + + ++E+ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----------NSSSIENHKLTWETLLQI 432
++ LLG C + ++ E+ S G+L +++ ++ + +LT++ L+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
A +ARG+EYL S + +H D+ N+L+ ED KI+DFGLA+ + + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 493 RGTVGYIAPEVF 504
R V ++APE
Sbjct: 197 RLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 57/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 333 KLGQGGYGSVYKG---KLIDG---SNVAVKVLNDSKGNGE--EFINEVASISRTSHVNVV 384
+LGQG +G VY+G +I G + VAVK +N+S E EF+NE + + + +VV
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK----LTWETLLQIAVGIARGL 440
LLG +G+ ++ E +++G L+ ++ EN+ T + ++Q+A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 498
YL+ + + +H D+ N ++ DF KI DFG+ + + E+ G +G V +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187
Query: 499 IAPE 502
+APE
Sbjct: 188 MAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 10/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLG G +G V+ G + + VAVK L + + F+ E + H +V L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
+I E+++ GSL F+ S E K+ L+ + IA G+ Y+ +
Sbjct: 73 EEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ N+L+ E KI+DFGLA++ E + GA+ + + APE N G +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFT 182
Query: 513 YKSD 516
KSD
Sbjct: 183 IKSD 186
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 49/151 (32%), Positives = 82/151 (54%), Gaps = 12/151 (7%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + G VA+K + + +G I E++ + +H N+V LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L++EF+ + L+K++ + + + L L Q+ GIA Y H S
Sbjct: 66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YCH---S 117
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
R+LH D+KP N+L+D + K++DFGLA+
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 334 LGQGGYGSVYKGKLID------GSNVAVKVLNDSKGNGE--EFINEVASISR--TSHVNV 383
LGQG +G VY+G + VA+K +N++ E EF+NE AS+ + H +V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCH-HV 71
Query: 384 VTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL----TWETLLQIAVGIARG 439
V LLG G+ ++ E ++ G L+ ++ EN+ T + +Q+A IA G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
+ YL + + +H D+ N ++ ED KI DFG+ + + V ++
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 500 APE 502
APE
Sbjct: 189 APE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 16/154 (10%)
Query: 334 LGQGGYGSVYKGK---LID--GSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+G +GSV + L D G VAVK L + + + +F E+ + H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 388 GFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
G C+ RR L+ E++ GSL ++ ++ +L LL A I +G+EYL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-----RERLDHRKLLLYASQICKGMEYLG- 125
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
S R +H D+ NIL++ + KI DFGL K+
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 17/189 (8%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGF 389
++G+G +G V+ G+L D + VAVK ++ +F+ E + + SH N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
C + + ++ E V G F+ R E +L + L+Q+ A G+EYL S
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL-RT----EGPRLKVKELIQMVENAAAGMEYLE---SK 113
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--RGTVGYIAPEVFCRN 507
+H D+ N L+ E KISDFG+++ ++ + + TG + V + APE N
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL--N 169
Query: 508 IGEVSYKSD 516
G S +SD
Sbjct: 170 YGRYSSESD 178
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE--FINEVASISRTSHVNVVTLLGFCF 391
LG+G +G V+KG L D + VAVK + + F++E + + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+ + ++ E V G F+ + + +L + L++ A+ A G+ YL S
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRK-----KKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPEVFCRNIGE 510
+H D+ N L+ E+ KISDFG+++ + I S +G + + + APE N G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGR 170
Query: 511 VSYKSD 516
S +SD
Sbjct: 171 YSSESD 176
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 48/150 (32%), Positives = 82/150 (54%), Gaps = 12/150 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + G VA+K + +++G I E++ + +H N+V LL
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L++EF+ + L+KF+ + S L L Q+ G+A + H S
Sbjct: 67 VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCH---S 118
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAK 478
R+LH D+KP N+L++ + K++DFGLA+
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 53/192 (27%), Positives = 96/192 (50%), Gaps = 24/192 (12%)
Query: 334 LGQGGYGSVY--------KGKLIDGSNVAVKVLND--SKGNGEEFINEVASISRTS-HVN 382
LG+G +G V K K + VAVK+L D ++ + + ++E+ + H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----------NSSSIENHKLTWETLLQI 432
++ LLG C + +I E+ S G+L +++ + + + + ++T++ L+
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
+ARG+EYL S + +H D+ N+L+ E+ KI+DFGLA+ N + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 493 RGTVGYIAPEVF 504
R V ++APE
Sbjct: 200 RLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 54/184 (29%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 333 KLGQGGYGSVYKG------KLIDGSNVAVKVLNDSKGNGE--EFINEVASISRTSHVNVV 384
+LGQG +G VY+G K + VA+K +N++ E EF+NE + + + +VV
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL----TWETLLQIAVGIARGL 440
LLG +G+ +I E ++ G L+ ++ +EN+ + + + ++Q+A IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGY 498
YL+ + + +H D+ N ++ EDF KI DFG+ + + E+ G +G V +
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187
Query: 499 IAPE 502
++PE
Sbjct: 188 MSPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFIN--EVASISR-TSHVNVVTLLG 388
+LG G +GSVY + + G VA+K + + EE +N EV S+ + H N+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
E ++E++ G+L + + + + + I I +GL ++H
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLM----KDRKGKPFSESVIRSIIYQILQGLAHIH---K 117
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCR 506
H D+KP N+L+ KI+DFGLA+ I +R T T Y APE+ R
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLR 172
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 21/184 (11%)
Query: 334 LGQGGYGSVYK-------GKLIDGSNVAVKVLNDSKGNGE------EFINEVASISRT-S 379
LG G +G VYK L+ + V K E + ++EV I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
H N+V E R ++ + + L + NS + + T E + I V +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF--NSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
L YLH RI+H D+ P+NI+L ED I+DFGLAK + +T GT+ Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 500 APEV 503
PE+
Sbjct: 181 CPEI 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 334 LGQGGYGSVYKGKLID-------GSNVAVKVLNDSKGNGE--EFINEVASISRTSHVNVV 384
LG G +G VY+G D VAVK L + E EF+ E +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYR-NSSSIENHKLTWETLLQIAVGIARGLEYL 443
LLG C + +I E + G L ++ LT + LL I + +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 444 HLGCSTRILHFDIKPHNILLDED--FCP---KISDFGLAK 478
+H D+ N L+ E KI DFGLA+
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 54/185 (29%), Positives = 81/185 (43%), Gaps = 27/185 (14%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVL--------NDS---KGNGEEFINEVASISRTSHV 381
+G+G YG VY + G +AVK + K + +E+ ++ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIAR 438
N+V LGF ++ E+V GS+ R E T + L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQVL--------E 119
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
GL YLH S ILH D+K N+L+D D KISDFG++K + +G+V +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 499 IAPEV 503
+APEV
Sbjct: 177 MAPEV 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 27/169 (15%)
Query: 334 LGQGGYGSVYKGK---LIDGSN---VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
+GQG +G V++ + L+ VAVK+L + S +F E A ++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNS----------------SSIENHKLTWETL 429
LLG C G+ L++E+++ G L +F+ S + L+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 430 LQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
L IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 27/171 (15%)
Query: 329 SFKYKLGQGGYGSVY------------KGKLIDGSN-----VAVKVL--NDSKGNGEEFI 369
+F KLG+G +G V+ K + + VAVKVL + S E+F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 370 NEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR-----NSSSIENHKL 424
EV +SR S N+ LLG C +I E++ NG L +F+ + + + + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 425 TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475
++ TLL +A IA G+ YL S +H D+ N L+ +++ KI+DFG
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 58/194 (29%), Positives = 80/194 (41%), Gaps = 23/194 (11%)
Query: 333 KLGQGGYGSVYKG-------KLIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNV 383
KLG G +G V +G K+I VAVK L K ++F+ E A + H N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVI---PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 384 VTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+ L G ++ E GSL + +++ TL AV IA G+ YL
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGH----FLISTLCDYAVQIANGMRYL 113
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VGYIAPE 502
S R +H D+ NILL D KI DFGL + + E M + APE
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 503 VFCRNIGEVSYKSD 516
S+ SD
Sbjct: 171 --SLRTRTFSHASD 182
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 334 LGQGGYGSVYKGKLIDGSNVAVK--VLNDSKGNGEE-----FINEVASISRTSHVNVVTL 386
LG+G YG+VY G G +AVK L+ S E EV + HVN+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
LG C + ++ EFV GS+ + R E + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE------PVFCKYTKQILDGVAYLHNN 121
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA--------RGTVGY 498
C ++H DIK +N++L + K+ DFG C R+ + + + G GT +
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFG----CARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 499 IAPEVFCRNIGEVSY--KSD 516
+APEV I E Y KSD
Sbjct: 175 MAPEV----INESGYGRKSD 190
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 24/190 (12%)
Query: 334 LGQGGYGSVYKGKL--IDGSN------VAVKVLNDSKGNGE--EFINEVASISRTS-HVN 382
LG+G +G V + + ID S VAVK+L D+ + + + I+E+ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----------NSSSIENHKLTWETLLQI 432
++ LLG C + +I E+ + G+L +F+ + + + +L+++ L+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
A +ARG+EYL S R +H D+ N+L+ ED KI+DFGLA+ + + +
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 493 RGTVGYIAPE 502
R V ++APE
Sbjct: 197 RLPVKWMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 323 IKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGNG-EEFINEVASI 375
IK+ K++LG+G +G V+ + D VAVK L ++ + ++F E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF---------IYRNSSSIENHKLTW 426
+ H ++V G C EGR +++E++ +G L +F I + +LT
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+L IA IA G+ YL S +H D+ N L+ + KI DFG+++
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 30/197 (15%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-----DSKGNGEEFINEVASISRTSHVNVVTL 386
K+G+G + VYK L+DG VA+K + D+K ++ + E+ + + H NV+
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQLDHPNVIKY 67
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFI--YRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L E ++ E G L + I ++ + + W+ +Q+ LE++H
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMH 123
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAP 501
S RI+H DIKP N+ + K+ D GL + + K T A VG Y++P
Sbjct: 124 ---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSP 175
Query: 502 EVFCRNIGEVSY--KSD 516
E I E Y KSD
Sbjct: 176 ER----IHENGYNFKSD 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV 381
+I + + + KLGQG +G V+ G + VA+K L + E F+ E + + H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+V L E ++ E++S GSL F+ L L+ +A IA G+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMA 116
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
Y+ +H D++ NIL+ E+ K++DFGLA++ E + GA+ + + AP
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 172
Query: 502 EVFCRNIGEVSYKSD 516
E G + KSD
Sbjct: 173 EAAL--YGRFTIKSD 185
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 29/195 (14%)
Query: 334 LGQGGYGSVYKGKL--IDG----SNVAVKVLNDSKGNGE--EFINEVASISRTSHVNVVT 385
LG+G +G V K + G + VAVK+L ++ + E + ++E + + +H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFI---------------YRNSSSIEN---HKLTWE 427
L G C + LI E+ GSL F+ RNSS ++N LT
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
L+ A I+RG++YL +++H D+ N+L+ E KISDFGL++ ++S +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 488 SMTGARGTVGYIAPE 502
+ R V ++A E
Sbjct: 185 KRSKGRIPVKWMAIE 199
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLG G +G V+ G + VAVK L + E F+ E + + H +V L E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E++S GSL F+ E L L+ +A +A G+ Y+ +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ + KI+DFGLA++ E + GA+ + + APE G +
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFT 181
Query: 513 YKSD 516
KSD
Sbjct: 182 IKSD 185
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 318 YSYADIKKMTNSFKYKLGQGGYGSVYKGKL--IDGSN----VAVKVLNDSKGNG--EEFI 369
+ ++++++T LG+G +G V+ K I+ V VK L +K EF
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 370 NEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK---LTW 426
E+ + SH NVV LLG C E +I E+ G L++F+ S E K L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+ + + IA G+++L + R +H D+ N L+ K+S L+K
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 323 IKKMTNSFKYK-LGQGGYGSVYKGKLI-DGSN----VAVKVLNDS---KGNGEEFINEVA 373
I K T K K LG G +G+VYKG I +G VA+K L ++ K N +E ++E
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAY 61
Query: 374 SISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI-ENHKLTWETLLQI 432
++ + +V LLG C + LI + + G L ++ + +I + L W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------ 114
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
V IA+G+ YL R++H D+ N+L+ KI+DFGLAK+ E G
Sbjct: 115 CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 493 RGTVGYIAPE 502
+ + ++A E
Sbjct: 172 KVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 334 LGQGGYGSVYKGKLI----DGSN----VAVKVLND--SKGNGEEFINEVASISRT-SHVN 382
LG+G +G V + I + N VAVK+L ++ + + I+E+ + H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIY----------RNSSSIENHKLTWETLLQI 432
++ LLG C + +I E+ S G+L +++ N + + +L+++ L+
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
A +ARG+EYL S + +H D+ N+L+ ED KI+DFGLA+ + + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 493 RGTVGYIAPEVFCRNIGEVSYKSD 516
R V ++APE I +++SD
Sbjct: 203 RLPVKWMAPEALFDRI--YTHQSD 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 23/156 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYKG+ G VA+K + ++ +G I E++ + H N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 389 FCFEGRRRALIYEFVSNG------SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+ R LI+EF+S SL K Y ++ ++++ L QI GI +
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSY------LYQILQGIL----F 116
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
H S R+LH D+KP N+L+D K++DFGLA+
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSN---VAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLL 387
LG+G +GSV +G+L + VAVK + ++ E+F++E + H NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 388 GFCFEGRRR------ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
G C + +I F+ +G L F+ + L + L++ IA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
YL S +H D+ N +L+E+ ++DFGL+K
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 23/184 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVA---VKVLNDSKGNGEEFINEVASISRTS---HVNVVT 385
++G G YG+VYK + G VA V+V + G + EVA + R H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 386 LLGFCFEGR-----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
L+ C R + L++E V L ++ + L ET+ + RGL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
++LH C I+H D+KP NIL+ K++DFGLA+I + + +++T T+ Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRA 175
Query: 501 PEVF 504
PEV
Sbjct: 176 PEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV 381
+I + + KLGQG +G V+ G + VA+K L E F+ E + + H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+V L E ++ EF+ GSL F+ + L L+ +A IA G+
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMA 116
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
Y+ +H D++ NIL+ ++ KI+DFGLA++ E + GA+ + + AP
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172
Query: 502 EVFCRNIGEVSYKSD 516
E G + KSD
Sbjct: 173 EAAL--YGRFTIKSD 185
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEF---INEVASISRTSHVNVVTLLG 388
+LG G G V K G +AVK + + N + E+ + + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ ++ E++ GSL+K + I L +IAV + +GL YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPER-----ILGKIAVAVLKGLTYLH---E 118
Query: 449 TR-ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPE 502
I+H D+KP NIL++ K+ DFG++ + + S+ GT Y+APE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 331 KYK----LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---EEFINEVASISRTSHVN 382
KY+ +G+G YG V K + G VA+K +S+ + + + EV + + H N
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKF-IYRNSSSIENHKL-TWETLLQIAVGIARGL 440
+V L R L++E+V LE + + W+ L + +
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLL--------QAI 113
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYI 499
Y H S I+H DIKP NIL+ E K+ DFG A+ + R S +T T Y
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--PLTDYVATRWYR 168
Query: 500 APEVFCRNIGEVSY 513
APE+ +G+ +Y
Sbjct: 169 APELL---VGDTNY 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 323 IKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGNG-EEFINEVASI 375
IK+ K +LG+G +G V+ + D VAVK L D+ N ++F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRN-------SSSIENHKLTWET 428
+ H ++V G C EG +++E++ +G L KF+ + + +LT
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+L IA IA G+ YL S +H D+ N L+ E+ KI DFG+++
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGS----NVAVKV--LNDSKGNGEEFINEVASISRTSHVN 382
+ +G+G +G VY+G + VAVK S E+F+ E + + H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+V L+G E ++ E G L ++ N S L +L+ + ++ L Y
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS-----LDLASLILYSYQLSTALAY 122
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
L S R +H DI N+L+ C K+ DFGL++
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 47/176 (26%), Positives = 96/176 (54%), Gaps = 15/176 (8%)
Query: 334 LGQGGYGSVYKGKL-IDG---SNVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLL 387
+G G +G V++G L + G VA+K L ++ ++F++E + + + SH N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + + +I E++ NG+L+K++ + +++ L+ + GIA G++YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-----LVGMLRGIAAGMKYL---S 124
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPE 502
+H D+ NIL++ + K+SDFGL+++ + E + +G + + + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G V G G+ VAVK + ND+ + F+ E + +++ H N+V LLG E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 393 GRRRALIY-EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+ I E+++ GSL ++ S+ L + LL+ ++ + +EYL +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLE---ANNF 123
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 511
+H D+ N+L+ ED K+SDFGL KE+ + + V + APE +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREK--KF 176
Query: 512 SYKSD 516
S KSD
Sbjct: 177 STKSD 181
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 16/176 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNG--EEFINEVASISRTSHVNVVTLLGF 389
+LG+G GSV K +L + + A+K + ++ + E+ +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 390 CFEGRRR--ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ + E+ GSL+ IY+ ++ + L +IA + +GL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDS-IYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH--- 122
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPE 502
S +I+H DIKP NILL K+ DFG++ E + S+ G GT Y+APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 58/183 (31%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 329 SFKYKLGQGGYGSVYK------GKLIDGSNVAVKVLNDSKGNGEE--FINEVASISRT-S 379
SF LG G +G V + K VAVK+L + + E ++E+ +S +
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
H N+V LLG C G +I E+ G L F+ R S LT E LL + +A+G
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF----LTLEDLLSFSYQVAKG 153
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
+ +L S +H D+ N+LL KI DFGLA+ + + AR V ++
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 500 APE 502
APE
Sbjct: 211 APE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEF----INEVASISRTSHVNVVTLL 387
++G+G YG VYK + G VA+K + E F I E+ + + H N+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEK-EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 388 GFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+ + +++E++ + L + K T + + GL+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSP-----EVKFTESQIKCYMKQLLEGLQYLH- 117
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
S ILH DIK NIL++ D K++DFGLA+ K + T T+ Y PE
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 26/172 (15%)
Query: 330 FKYKLGQGGYGSVYKGK-------LIDGSN--------VAVKVL--NDSKGNGEEFINEV 372
K KLG+G +G V+ + L +G+ VAVK+L + +K +F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 373 ASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFI----YRNSSSIENH--KLTW 426
+SR + N++ LLG C +I E++ NG L +F+ ++ + N+ ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
LL +AV IA G++YL S +H D+ N L+ + KI+DFG+++
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 21/167 (12%)
Query: 330 FKYKLGQGGYGSVYKGKL-IDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVN 382
F +LG+ +G +YKG L + G + VA+K L D + EF E + ++ H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS-------SSIEN----HKLTWETLLQ 431
+V LLG + + +++E+++ G L +F+ S SS E+ L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
IA+ IA G+EYL S +H D+ NIL+ E KISD GL++
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 17/178 (9%)
Query: 334 LGQGGYGSVYKGKL-IDGSN---VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLL 387
+G G +G V +G+L + G VA+K L ++ +F++E + + + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + R +I EF+ NG+L+ F+ +N + T L+ + GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYL---S 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG---TVGYIAPE 502
+H D+ NIL++ + K+SDFGL++ S + T + G + + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 29/197 (14%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEFI-NEVASIS 376
S D KK F+ K+GQG G+VY + G VA+K +N + +E I NE+ +
Sbjct: 13 SVGDPKKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 377 RTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL---QIA 433
H N+V L G ++ E+++ GSL + ET + QIA
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-------------ETCMDEGQIA 118
Query: 434 V---GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISM 489
+ LE+LH S +++H DIK NILL D K++DFG A+I + +M
Sbjct: 119 AVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 490 TGARGTVGYIAPEVFCR 506
GT ++APEV R
Sbjct: 176 V---GTPYWMAPEVVTR 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 55/154 (35%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 334 LGQGGYGSV----YKGKLID-GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTL 386
LG+G +G V Y G VAVK L G N + E+ + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 387 LGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
G C E + LI E+V GSL ++ + HKL LL A I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLH 124
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
S +H D+ N+LLD D KI DFGLAK
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 334 LGQGGYGSVYKGKLI-DGSN----VAVKVL--NDSKGNGEEFINEVASISRTSHVNVVTL 386
LG G +G+VYKG I DG N VA+KVL N S +E ++E ++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
LG C + L+ + + G L ++ N I + + LL V IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGS-----QDLLNWCVQIAKGMSYLE-- 126
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
R++H D+ N+L+ KI+DFGLA++ + E+ G + + ++A E
Sbjct: 127 -EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 507 NIGEVSYKSD 516
+++SD
Sbjct: 186 R--RFTHQSD 193
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 27/174 (15%)
Query: 329 SFKYKLGQGGYGSVY------------KGKLIDGSN-----VAVKVLN-DSKGNGE-EFI 369
+FK KLG+G +G V+ K +D S VAVK+L D+ N +F+
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 370 NEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----NSSSIENHK-L 424
E+ +SR N++ LL C +I E++ NG L +F+ R ++ + +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 425 TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
++ TL+ +A IA G++YL S +H D+ N L+ +++ KI+DFG+++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
KLG+G Y +VYKG+ + G VA+K L +G I E + + H N+VTL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFI--YRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ L++E++ L++++ S+ N +L LL RGL Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCH--- 120
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490
R+LH D+KP N+L+ E K++DFGLA R +S+ S T
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLA----RAKSVPSKT 159
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 29/200 (14%)
Query: 320 YADIKKMTNSFKYKLGQGGYGSVYKGKL-IDG--SNVAVKVLND--SKGNGEEFINEVAS 374
+ DIK F+ +G+G +G V K ++ DG + A+K + + SK + +F E+
Sbjct: 6 WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 375 ISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIEN-----------H 422
+ + H N++ LLG C L E+ +G+L F+ R S +E
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTAS 119
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482
L+ + LL A +ARG++YL + +H D+ NIL+ E++ KI+DFGL++
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---G 173
Query: 483 KESIISMTGARGTVGYIAPE 502
+E + T R V ++A E
Sbjct: 174 QEVYVKKTMGRLPVRWMAIE 193
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 47/176 (26%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 334 LGQGGYGSVYKGKL-IDGSN---VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLL 387
+G G +G V G+L + G VA+K L ++ +F++E + + + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + + ++ E++ NGSL+ F+ ++ + T L+ + GIA G++YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYL---S 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPE 502
+H D+ NIL++ + K+SDFGL+++ + E+ + G + + + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 27/186 (14%)
Query: 333 KLGQGGYGSVY--KGKLIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLL 387
K+G+G +G +Y K K D + +K ++ +K +E EV +++ H N+VT
Sbjct: 7 KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI--ENHKLTWETLLQIAVGIARGLEYLHL 445
E R ++ E+ G L K I R + E+ L+W V I+ GL+++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH- 118
Query: 446 GCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVG---YIAP 501
+ILH DIK NI L ++ K+ DFG+A+ N SM A VG Y++P
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSP 171
Query: 502 EVFCRN 507
E+ C+N
Sbjct: 172 EI-CQN 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV 381
+I + + + KLG G +G V+ + VAVK + + E F+ E + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 382 NVVTLLGFCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
+V L + IY EF++ GSL F+ S E K L+ + IA
Sbjct: 62 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAE 113
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
G+ ++ +H D++ NIL+ KI+DFGLA++ E + GA+ + +
Sbjct: 114 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKW 169
Query: 499 IAPEVFCRNIGEVSYKSD 516
APE N G + KSD
Sbjct: 170 TAPEAI--NFGSFTIKSD 185
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEF--INEVASISRTSHVNVVTLLGF 389
KLG+G Y +VYKGK ++G VA+KV+ + G F I E + + H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSI--ENHKLTWETLLQIAVGIARGLEYLHLGC 447
L++E+V L +++ ++ + EN KL LL RGL Y+H
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIH--- 120
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFC 505
ILH D+KP N+L+ + K++DFGLA R +S+ S T + T+ Y P+V
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLA----RAKSVPSHTYSNEVVTLWYRPPDVL- 175
Query: 506 RNIGEVSYKS 515
+G Y +
Sbjct: 176 --LGSTEYST 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGS------NVAVKVLNDSKGNG---EEFINEV 372
+I T F +LG+ +G VYKG L + VA+K L D K G EEF +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEA 59
Query: 373 ASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS-----SSIENHKLTWE 427
SR H N+V LLG + + ++I+ + S+ L +F+ S S ++ K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 428 TL-----LQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482
TL + I IA G+E+L S ++H D+ N+L+ + KISD GL +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+ M + + +++PE G+ S SD
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSD 208
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 60/194 (30%), Positives = 101/194 (52%), Gaps = 25/194 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLLG-F 389
+LG G +G VYK K + G+ A KV+ S+ E+++ E+ ++ +H +V LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
++G+ +I EF G+++ + + LT + I + L+YLH S
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLE-----LDRGLTEPQIQVICRQMLEALQYLH---SM 129
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPE-VF 504
+I+H D+K N+LL D K++DFG++ K R++S I GT ++APE V
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVM 183
Query: 505 CRNIGEV--SYKSD 516
C + + YK+D
Sbjct: 184 CETMKDTPYDYKAD 197
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 35/181 (19%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSN-----------------VAVKVL--NDSKGNGEEFIN 370
FK KLG+G +G V+ ++++ + VAVK+L + +K +F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 371 EVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----------NSSSIE 420
EV +SR N++ LLG C + +I E++ NG L +F+ N +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 421 NHKL---TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
H L ++ +LL +A+ IA G++YL S +H D+ N L+ E+ KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 478 K 478
+
Sbjct: 186 R 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + +A+K + + +G I E++ + H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+R L++E++ + L+K + + +N +L L QI GIA Y H S
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH---S 120
Query: 449 TRILHFDIKPHNILLDEDFCP-KISDFGLAK 478
R+LH D+KP N+L+D K++DFGLA+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 31/194 (15%)
Query: 333 KLGQGGYGSVYKGKLID---GSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLL 387
+G+G +G VYK ID VA+KV++ +++ E+ E+ +S+ +
Sbjct: 8 CIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G +G + +I E+ GS ++ KL + I + GLEYLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSC-------LDLLKPGKLDETYIAFILREVLLGLEYLH--- 115
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPE 502
+H DIK NILL E+ K++DFG++ ++ T ++ GT ++APE
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPE 168
Query: 503 VFCRNIGEVSYKSD 516
V + K+D
Sbjct: 169 VIKQ--SGYDEKAD 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSN---VAVKVLNDSKGNGEEF----INEVASISRTSHVN 382
+ +G+G YG VYK K +G + A+K K E+A + H N
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 383 VVTLLGFCFEGRRRA--LIYEFVSNGSLE--KFIYRNSSSIENHKLTWETLL-QIAVGIA 437
VV+L+ E ++ L++++ + + KF +R + + ++LL QI G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICN 481
YLH S +LH D+KP NIL+ E KI D GLA++ N
Sbjct: 123 ----YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 59/186 (31%), Positives = 85/186 (45%), Gaps = 26/186 (13%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNG----------EEFINEVASISRTSHVN 382
+G G +GSVY G G +AVK + + + E+A + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV-GIARGLE 441
+V LG + + E+V GS+ + N + E ETL++ V I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFE------ETLVRNFVRQILKGLN 120
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVG 497
YLH + I+H DIK NIL+D KISDFG++K GAR G+V
Sbjct: 121 YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 498 YIAPEV 503
++APEV
Sbjct: 178 WMAPEV 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 23/193 (11%)
Query: 333 KLGQGGYGSVYKG------KLIDGSNVAVKVL--NDSKGNGEEFINEVASISRTSHVNVV 384
+LG G +G V KG K ID VA+KVL + K +E + E + + + +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID---VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
++G C E L+ E S G L KF+ S + ++T ++++ ++ G++YL
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEV 503
+H D+ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 113 ---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE- 168
Query: 504 FCRNIGEVSYKSD 516
C N + S +SD
Sbjct: 169 -CINFRKFSSRSD 180
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 53/184 (28%), Positives = 76/184 (41%), Gaps = 35/184 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG G +G V + A+K+L+ +K E +NE + H +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L+ E+V G L F + S + A + LEYLH S
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL--FSHLRKS----GRFPEPVARFYAAQVVLALEYLH---S 119
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAK--------ICNRKESIISMTGARGTVGYIA 500
I++ D+KP N+LLD D KI+DFG AK +C GT Y+A
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-------------GTPEYLA 166
Query: 501 PEVF 504
PE+
Sbjct: 167 PEII 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 19/191 (9%)
Query: 333 KLGQGGYGSVYKG--KLIDGSN-VAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTL 386
+LG G +G+V KG K+ VAVK+L + + +E + E + + + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G C E L+ E G L KF+ +N + +T E + Q+++G ++YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKH-VTEKNIT-ELVHQVSMG----MKYLE-- 112
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFC 505
T +H D+ N+LL KISDFGL+K E+ + T + V + APE C
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 506 RNIGEVSYKSD 516
N + S KSD
Sbjct: 170 MNYYKFSSKSD 180
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 21/183 (11%)
Query: 331 KYK----LGQGGYGSVY--KGKLIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHV 381
KY+ +G+G +G V+ + K D V +K + + +E NE + SH
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
N++ E + ++ E+ G+L ++I + +S+ L +T+L V I L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL----LDEDTILHFFVQILLALH 115
Query: 442 YLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
++H + ILH D+K NILLD+ KI DFG++KI + K ++ GT YI+
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYIS 169
Query: 501 PEV 503
PE+
Sbjct: 170 PEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 321 ADIKKMTNSFKYK-LGQGGYGSVYKGKLI-DGSN----VAVKVLNDSKGNG--EEFINEV 372
A I K T K K LG G +G+V+KG I +G + VA+K + D G +E + +
Sbjct: 1 ARILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM 60
Query: 373 ASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQI 432
++ H +V LLG C G L+ + GSL + ++ S++ +L L
Sbjct: 61 LAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNW 114
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
V IA+G+ YL R++H ++ NILL D +I+DFG+A +
Sbjct: 115 CVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 333 KLGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEF--INEVASISRTSHVNVVTLLGF 389
KLG+G Y +VYKG I+G VA+KV++ G F I E + + H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
++E++ L +++ ++ + + + + RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPY-----NVRLFMFQLLRGLAYIH---GQ 122
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFCRN 507
ILH D+KP N+L+ K++DFGLA R +SI S T + T+ Y P+V
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTYSSEVVTLWYRPPDVL--- 175
Query: 508 IGEVSYKSD 516
+G Y S
Sbjct: 176 LGATDYSSA 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+ +G G+ YKGK I +G VK +ND +E+A + + H N+V L+G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGLCRS 754
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
+ LI+E++ +L + + RN L+WE +IA+GIA+ L +LH CS ++
Sbjct: 755 EKGAYLIHEYIEGKNLSE-VLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
++ P I++D P + +C + IS Y+APE R +++
Sbjct: 806 VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFIS-------SAYVAPET--RETKDIT 856
Query: 513 YKSD 516
KSD
Sbjct: 857 EKSD 860
|
Length = 968 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKG-KLIDGSNVAVKVLN-DSKGNGEEFINEVASIS 376
S D KK F+ K+GQG G+VY + G VA+K +N + E INE+ +
Sbjct: 13 SVGDPKKKYTRFE-KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 377 RTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
+ N+V L G ++ E+++ GSL + LQ
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 126
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGT 495
L++LH S +++H DIK NILL D K++DFG A+I + +M GT
Sbjct: 127 --ALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GT 178
Query: 496 VGYIAPEVFCR 506
++APEV R
Sbjct: 179 PYWMAPEVVTR 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 28/198 (14%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFCF 391
+G G YG VYKG+ + G A+KV++ + EE E+ + + SH N+ T G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 392 EGR------RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+ + L+ EF GS+ I + + + L E + I I RGL +LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHLH- 128
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAP 501
+++H DIK N+LL E+ K+ DFG L + R+ + I GT ++AP
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 180
Query: 502 EVF-CRNIGEVSY--KSD 516
EV C + +Y KSD
Sbjct: 181 EVIACDENPDATYDFKSD 198
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 58/177 (32%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSN---VAVKVL--NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G YG VY + D S +A+K + DS+ + E+A S H N+V LG
Sbjct: 16 LGKGTYGIVYAAR--DLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
E + E V GSL + +++++ +T++ I GL+YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE---QTIIFYTKQILEGLKYLH---D 126
Query: 449 TRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPEV 503
+I+H DIK N+L++ KISDFG +K R I T GT+ Y+APEV
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK---RLAGINPCTETFTGTLQYMAPEV 180
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 24/185 (12%)
Query: 333 KLGQGGYGSVYKGKLID--GSNVA---VKVLNDSKGNGEEFINEVASISRTS---HVNVV 384
++G+G YG V+K + + G VA V+V +G I EVA + H NVV
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 385 TLLGFCFEGR-----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
L C R + L++E V L ++ + + + ET+ + + RG
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK----VPEPGVPTETIKDMMFQLLRG 122
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
L++LH S R++H D+KP NIL+ K++DFGLA+I + + ++ S+ T+ Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 176
Query: 500 APEVF 504
APEV
Sbjct: 177 APEVL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 17/191 (8%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKG-KLIDGSNVAVKVLN-DSKGNGEEFINEVASIS 376
S D KK F+ K+GQG G+VY + G VA++ +N + E INE+ +
Sbjct: 14 SVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 377 RTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
+ N+V L G ++ E+++ GSL + LQ
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----- 127
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGT 495
LE+LH S +++H DIK NILL D K++DFG A+I + +M GT
Sbjct: 128 --ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GT 179
Query: 496 VGYIAPEVFCR 506
++APEV R
Sbjct: 180 PYWMAPEVVTR 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 60/190 (31%), Positives = 97/190 (51%), Gaps = 25/190 (13%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
KLG+G Y +V+KG+ + + VA+K L +G I EV+ + H N+VTL
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYR--NSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
R L++E++ + L++++ N S+ N K+ LL RGL Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCH--- 120
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVFC 505
+ILH D+KP N+L++E K++DFGLA R +S+ + T + T+ Y P+V
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVL- 175
Query: 506 RNIGEVSYKS 515
+G Y +
Sbjct: 176 --LGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 34/184 (18%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G YG V G VA+K L+ S + + E+ + H NV+ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 390 CFEGRRRALIYEFVSNGSLEKF--IY-------RNSSSIENH-KLTWETLLQIAVGIARG 439
F SLE F +Y + ++I KL+ + + + I RG
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
L+Y+H S I+H D+KP NI ++ED KI DFGLA+ + + MTG T Y
Sbjct: 131 LKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 182
Query: 500 APEV 503
APE+
Sbjct: 183 APEI 186
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 57/181 (31%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 334 LGQGGYGSVYKGKLI-----DGSNVAVKVLNDSKGNGEEFIN----EVASISRTSHVNVV 384
LG+G +G V + G VAVK L +G I E+ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIV 69
Query: 385 TLLGFCFE--GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
G C E G LI EF+ +GSL++++ RN + K+ + L+ AV I +G++Y
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDY 124
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAP 501
L S + +H D+ N+L++ + KI DFGL K I KE V + AP
Sbjct: 125 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 502 E 502
E
Sbjct: 182 E 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 63/191 (32%), Positives = 99/191 (51%), Gaps = 27/191 (14%)
Query: 333 KLGQGGYGSVYKG--KLIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG+G Y +VYKG KL D + VA+K L +G I EV+ + H N+VTL
Sbjct: 13 KLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYR--NSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ L++E++ + L++++ NS ++ N KL LL RGL Y H
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL-------RGLNYCH-- 121
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG--TVGYIAPEVF 504
++LH D+KP N+L++E K++DFGLA R +SI + T + T+ Y P++
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLA----RAKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 505 CRNIGEVSYKS 515
+G Y +
Sbjct: 177 ---LGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 22/182 (12%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEFINEVAS----ISRTSHVNVVTLLG 388
+ +G YG V+ K G A+KV+ + + +++V + +S+ VV L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+G++ L+ E++ G L + ++ + L + I LEYLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLL----ENVGS--LDEDVARIYIAEIVLALEYLH--- 110
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKI-CNRKESIISMTGAR-----GTVGYIAP 501
S I+H D+KP NIL+D + K++DFGL+K+ R++ ++ GT YIAP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 502 EV 503
EV
Sbjct: 171 EV 172
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DS-KGNGEEFINEVASISRTSHVNVVTLLGF 389
KLG+G Y +VYKG+ G VA+K ++ D+ +G I E++ + H N+V L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 390 CFEGRRRALIYEFVSNGSLEKF--IYRNSSSIE---NHKLTWETLLQIAVGIARGLEYLH 444
+ L++E++ L+K+ + +++ T++ L +G+ + H
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIAFCH 117
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
R+LH D+KP N+L+++ K++DFGLA+
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 57/176 (32%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+GG+G V ++ G A K L+ K GE+ +NE + + S +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ FE + L+ ++ G L+ IY ++ + A I GLE+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY----NVGEPGFPEARAIFYAAQIICGLEHLH--- 112
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
RI++ D+KP N+LLD+ +ISD GLA + I G GT GY+APEV
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 27/193 (13%)
Query: 334 LGQGGYGS--VYKGKLIDGSNVAVKVLN----DSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+G +G +Y+ + D S V K +N K + +NE+ +S H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYY 65
Query: 388 GFCFEGRRRALI-YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
F LI E+ + G+L I R + ++ L QI ++ Y+H
Sbjct: 66 NH-FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS----YIH-- 118
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEV 503
ILH DIK NI L + K+ DFG++KI + S A VG Y++PE+
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-----MAETVVGTPYYMSPEL 172
Query: 504 FCRNIGEVSYKSD 516
C+ + + ++KSD
Sbjct: 173 -CQGV-KYNFKSD 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 24/188 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLLG 388
+G+G YG V K K + G VA+K +S+ + + E+ + + H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 389 FCFEGRRRALIYEFVSN---GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+R L++EFV + LEK+ + L + + I RG+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKY---------PNGLDESRVRKYLFQILRGIEFCH- 117
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
S I+H DIKP NIL+ + K+ DFG A+ + T T Y APE+
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELL- 172
Query: 506 RNIGEVSY 513
+G+ Y
Sbjct: 173 --VGDTKY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 9/176 (5%)
Query: 333 KLGQGGYGSVYKGK---LIDGSNVAVKVLNDSKGNGEE--FINEVASISRTSHVNVVTLL 387
++G G +G V G+ + + V VK L S E+ F+ EV +H NV+ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G C E L+ EF G L+ ++ R++ + + L ++A +A GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+H D+ N L D KI D+GLA ++ I+ + ++APE+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGE------EFINEVASISRTSHVNVVTL 386
LGQG +G VY +D G +AVK + + E E+ + H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 387 LGFCFEGRRRALIY-EFVSNGSLEKFIYRNSSSIEN--HKLTWETLLQIAVGIARGLEYL 443
G C I+ E++ GS++ + + E K T + I G+EYL
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ--------ILEGVEYL 120
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGYI 499
H S I+H DIK NIL D K+ DFG +K IC+ + S+T GT ++
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWM 174
Query: 500 APEV 503
+PEV
Sbjct: 175 SPEV 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSN----VAVKVLNDSKGNGEE--FINEVASISRTSHVNVVTLL 387
LG G +G + +G L S VA+ L + + F+ E ++ + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL-HLG 446
G G ++ E++SNG+L+ F+ ++ +L L+ + G+A G++YL +G
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
+H + H +L++ D KIS F + ++ E+I + + V + APE
Sbjct: 128 ----YVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 57/177 (32%), Positives = 84/177 (47%), Gaps = 23/177 (12%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
+G G +G V+ + I A+KV+ + + NE + SH ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIY-RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ R ++ E+V G L F Y RNS N T L A I LEYLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSN-----STGLFYASEIVCALEYLH--- 118
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 503
S I++ D+KP NILLD++ K++DFG AK + +R ++ GT Y+APEV
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC------GTPEYLAPEV 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 27/183 (14%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFCF 391
+G G YG VYKG+ + G A+KV++ ++ EE E+ + + SH N+ T G F
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG-AF 82
Query: 392 EGRRRA-------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
+ L+ EF GS+ + + + + L + + I I RGL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLV----KNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIA 500
+ +++H DIK N+LL E+ K+ DFG L + R+ + I GT ++A
Sbjct: 139 ---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMA 189
Query: 501 PEV 503
PEV
Sbjct: 190 PEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 24/181 (13%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
K+G+G G V G VAVK ++ K E + NEV + H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENH-KLTWETLLQIAVGIARGLEYLHLGCST 449
G ++ EF+ G+L + I H ++ E + + + + + L +LH +
Sbjct: 86 LVGDELWVVMEFLEGGAL--------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQ 134
Query: 450 RILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFC 505
++H DIK +ILL D K+SDFG ++K R++S++ GT ++APEV
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVIS 188
Query: 506 R 506
R
Sbjct: 189 R 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 28/195 (14%)
Query: 318 YSYADIKKMTNSFKYKLGQGGYGSVYK------GKLIDGSNVAVKVLNDSKGNGEE--FI 369
++ D+K + ++G+G +G+V K G ++ AVK + + E+ +
Sbjct: 1 FTAEDLKDLG-----EIGRGAFGTVNKMLHKPSGTIM-----AVKRIRSTVDEKEQKRLL 50
Query: 370 NEVASISRTSH-VNVVTLLGFCF-EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
++ + R+S +V G F EG I + + SL+KF Y+ + + E
Sbjct: 51 MDLDVVMRSSDCPYIVKFYGALFREGD--CWICMELMDISLDKF-YKYVYEVLKSVIPEE 107
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
L +IAV + L YL +I+H D+KP NILLD + K+ DFG I + I
Sbjct: 108 ILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSI 162
Query: 488 SMTGARGTVGYIAPE 502
+ T G Y+APE
Sbjct: 163 AKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 39/200 (19%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK---VLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+GQG +G V+K + VA+K + N+ +G + E+ + H NVV L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 389 FCF-----EGRRRA---LIYEF-------VSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
C R + L++EF + + KF ++ K + LL
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF------TLSEIKKVMKMLLN-- 130
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTG 491
GL Y+H +ILH D+K NIL+ +D K++DFGLA+ ++ T
Sbjct: 131 -----GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 492 ARGTVGYIAPEVF--CRNIG 509
T+ Y PE+ R+ G
Sbjct: 183 RVVTLWYRPPELLLGERDYG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 53/180 (29%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
K+G+G G V + G VAVK+++ K E + NEV + H NVV +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
G ++ EF+ G+L + + +L E + + + + L YLH S
Sbjct: 88 LVGEELWVLMEFLQGGAL-------TDIVSQTRLNEEQIATVCESVLQALCYLH---SQG 137
Query: 451 ILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCR 506
++H DIK +ILL D K+SDFG ++K +++S++ GT ++APEV R
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISR 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 36/182 (19%)
Query: 333 KLGQGGYGSVYK------GKLIDGSNVAVKVLNDSKGNGEEFI-----NEVASISRTSHV 381
++G G G+VYK G+L A+KV+ GN E+ + E+ + +H
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLY-----ALKVI---YGNHEDTVRRQICREIEILRDVNHP 132
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL-QIAVGIARGL 440
NVV ++ EF+ GSLE + E L +A I G+
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLE-----------GTHIADEQFLADVARQILSGI 181
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
YLH I+H DIKP N+L++ KI+DFG+++I +++ + GT+ Y++
Sbjct: 182 AYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMS 236
Query: 501 PE 502
PE
Sbjct: 237 PE 238
|
Length = 353 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/178 (33%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 334 LGQGGYGSV------YKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+GG+G V GK+ + K + KG +NE + + + VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQFVVNL- 65
Query: 388 GFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ +E + L+ ++ G L+ IY ++ N E L A I GLE LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
++ D+KP NILLD+ +ISD GLA ESI G GTVGY+APEV
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI---RGRVGTVGYMAPEVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 323 IKKMTNSFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNG-EEFINEVASI 375
IK+ K +LG+G +G V+ + + S VAVK L D ++F E +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI----------ENHKLT 425
+ H ++V G C +G +++E++ +G L KF+ + +L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 426 WETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+L IA IA G+ YL S +H D+ N L+ + KI DFG+++
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 17/191 (8%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI-NEVASIS 376
S D KK ++ K+GQG G+V+ + G VA+K +N K +E I NE+ +
Sbjct: 13 SIGDPKKKYTRYE-KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 377 RTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
+ N+V L G ++ E+++ GSL + LQ
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ----- 126
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGT 495
LE+LH + +++H DIK N+LL D K++DFG A+I + +M GT
Sbjct: 127 --ALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GT 178
Query: 496 VGYIAPEVFCR 506
++APEV R
Sbjct: 179 PYWMAPEVVTR 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 16/151 (10%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-VAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
KLG+G Y +V+KG+ N VA+K L +G I EV+ + H N+VTL
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYR--NSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ L++E++ + L++++ N S+ N K+ L QI RGL Y H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF---LYQIL----RGLAYCH--- 121
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAK 478
++LH D+KP N+L++E K++DFGLA+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 329 SFKYKLGQGGYGSVYKGKLI-DGS--NVAVKVLND--SKGNGEEFINEVASISRTS-HVN 382
F+ +G+G +G V + + DG N A+K+L + S+ + +F E+ + + H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 383 VVTLLGFCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIEN-----------HKLTWET 428
++ LLG C R +Y E+ G+L F+ R S +E LT +
Sbjct: 65 IINLLGAC---ENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488
LLQ A +A G++YL + +H D+ N+L+ E+ KI+DFGL++ +E +
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK 174
Query: 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516
T R V ++A E N + KSD
Sbjct: 175 KTMGRLPVRWMAIESL--NYSVYTTKSD 200
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 61/176 (34%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 334 LGQGGYGSVYKGKL-IDGSNVAVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+GG+G V ++ G A K L K GE +NE + + + VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ +E + L+ ++ G L+ IY ++ N E + A I GLE LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFYAAEITCGLEDLH--- 119
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
RI++ D+KP NILLD+ +ISD GLA E+I G GTVGY+APEV
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI---RGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 56/181 (30%), Positives = 84/181 (46%), Gaps = 29/181 (16%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFIN-EVASISRTSHVNVVTLLGFC 390
++G G YG VYK + + G AVK++ G+ I E+ + H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW---ETLLQIAVGIARGLEYLHLGC 447
+ + E+ GSL+ IY + + ++ + ETL +GL YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETL--------QGLAYLH--- 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGL-----AKICNRKESIISMTGARGTVGYIAPE 502
S +H DIK NILL ++ K++DFG+ A I RK I GT ++APE
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-------GTPYWMAPE 176
Query: 503 V 503
V
Sbjct: 177 V 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSN---VAVKVLNDSKGNGEE--FINEVASISRTSHVNVVTLL 387
++G G +G V G++ G V VK L S E+ F+ E H N++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G C E L+ EF G L+ ++ R+ E TL ++A IA GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+H D+ N LL D KI D+GL+ +++ ++ + +IAPE+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 26/195 (13%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKV-----LNDSKGNGEEFINEVASISRTSHVNVVTL 386
K+G+G + VY+ L+DG VA+K L D+K + I E+ + + +H NV+
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKY 67
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFI--YRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
E ++ E G L + I ++ + K W+ +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAP 501
S R++H DIKP N+ + K+ D GL + + K T A VG Y++P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSP 175
Query: 502 EVFCRNIGEVSYKSD 516
E N ++KSD
Sbjct: 176 ERIHEN--GYNFKSD 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 40/150 (26%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG+V+K K + VA+K + +D +G + E+ + H N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
++ L++E+ L+K+ + I+ + + +GL + H S
Sbjct: 67 VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPE-----IVKSFMFQLLKGLAFCH---S 117
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+LH D+KP N+L++++ K++DFGLA+
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 26/179 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
++G G +G+VY + + VA+K ++ S E I EV + + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 388 GFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLH 444
G C+ A L+ E+ GS S +E HK L + I G +GL YLH
Sbjct: 82 G-CYLREHTAWLVMEYCL-GSA-------SDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S +H DIK NILL E K++DFG A + + S + GT ++APEV
Sbjct: 133 ---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/178 (32%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 334 LGQGGYGSV------YKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+GG+G V GK+ + K + KG +NE + + + VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSRFVVSL- 65
Query: 388 GFCFEGRRR-ALIYEFVSNGSLEKFIYR-NSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+ +E + L+ ++ G L+ IY + E + + A I GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-----YAAEICCGLEDLH- 119
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
RI++ D+KP NILLD+ +ISD GLA ++I G GTVGY+APEV
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 32/192 (16%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE-------FINEVASISRTSHVNVV 384
K+G+G YG V+K + + G VA+K +S E+ + E+ + + H N+V
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES----EDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLE 441
L+ R+ L++E+ + L + + +N + H K+ W+TL +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQ--------AVN 114
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
+ H +H D+KP NIL+ + K+ DFG A+I T T Y AP
Sbjct: 115 FCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAP 169
Query: 502 EVFCRNIGEVSY 513
E+ +G+ Y
Sbjct: 170 ELL---VGDTQY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 30/182 (16%)
Query: 334 LGQGGYGSVYKGKLI-DGSNVAVKVLN-DSKGNGEEFI-NEVASISRTSHV---NVVTLL 387
+G+G YG+VY+GK + G VA+K++N D+ + I EVA +S+ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLHL 445
G +G R +I E+ GS+ + + E + + E L+ L+Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLV--------ALKYIH- 118
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR----GTVGYIAP 501
++H DIK NIL+ K+ DFG+A + + R GT ++AP
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAP 170
Query: 502 EV 503
EV
Sbjct: 171 EV 172
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEE--FINEVASISRTSH-VNVVTLLGF 389
LG+G YG V K + + G+ +AVK + + + E+ + ++ R+ VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
F I V + SL+KF Y+ + + L +IAV I + LEYLH S
Sbjct: 69 LF-REGDVWICMEVMDTSLDKF-YKKVYDKGLT-IPEDILGKIAVSIVKALEYLHSKLS- 124
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
++H D+KP N+L++ + K+ DFG I ++ T G Y+APE
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 60/186 (32%), Positives = 98/186 (52%), Gaps = 28/186 (15%)
Query: 334 LGQGGYGSVYKGKLIDGSN----VAVKVLNDSK--GNGEEFINEVAS---ISRTSHVNVV 384
LG+GGYG V++ + + G++ A+KVL + N ++ + A + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 385 TLLGFCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
L+ + F+ G + LI E++S G L + R +E+ + L +I++ LE+L
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--LSEISLA----LEHL 116
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGAR-GTVGYIA 500
H I++ D+KP NILLD K++DFGL C KESI ++T GT+ Y+A
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGL---C--KESIHEGTVTHTFCGTIEYMA 168
Query: 501 PEVFCR 506
PE+ R
Sbjct: 169 PEILMR 174
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 34/188 (18%)
Query: 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVVT 385
LG G + S Y+ + + G+ +AVK + + E E+ ++R +H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+LG E L E+++ GS+ + + + E + Q + RGL YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA--VIINYTEQ----LLRGLSYLH- 120
Query: 446 GCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGAR-------GT 495
+I+H D+K N+L+D + +I+DFG A K TGA GT
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK-----GTGAGEFQGQLLGT 171
Query: 496 VGYIAPEV 503
+ ++APEV
Sbjct: 172 IAFMAPEV 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 321 ADIKKMTNSFKYKLGQGGYGSV-YKGKLIDGSNVAVKVLNDSKGNGEEFI-NEVASISRT 378
D ++ +SF K+G+G G V + G VAVK ++ K E + NEV +
Sbjct: 18 GDPREYLDSF-IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY 76
Query: 379 SHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
H NVV + G ++ EF+ G+L + + + ++ E + + + + R
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLSVLR 129
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARG 494
L YLH + ++H DIK +ILL D K+SDFG ++K +++S++ G
Sbjct: 130 ALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------G 180
Query: 495 TVGYIAPEVFCR 506
T ++APEV R
Sbjct: 181 TPYWMAPEVISR 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 334 LGQGGYGSVYK-GKLIDGSNVAVKVLNDSKGNGEEFINEVASI-SRTSHVNVVTLLGFCF 391
+G+G YG VYK DGS AVK+L+ EE E + S +H NVV G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 392 E-----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ G + L+ E + GS+ + + I +L + I G GL++LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH-- 145
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-------GTVGYI 499
+ RI+H D+K +NILL + K+ DFG++ +T R GT ++
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVSA---------QLTSTRLRRNTSVGTPFWM 195
Query: 500 APEVF-CRNIGEVSYKS 515
APEV C + SY +
Sbjct: 196 APEVIACEQQYDYSYDA 212
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 56/173 (32%), Positives = 90/173 (52%), Gaps = 22/173 (12%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
LG G G+VYK L+ +AVKV L+ + ++ ++E+ + + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
F R ++ EF+ GSL+ +YR I H L +IAV + +GL YL S +
Sbjct: 69 FVENRISICTEFMDGGSLD--VYR---KIPEH-----VLGRIAVAVVKGLTYL---WSLK 115
Query: 451 ILHFDIKPHNILLDEDFCPKISDFGLA-KICNRKESIISMTGARGTVGYIAPE 502
ILH D+KP N+L++ K+ DFG++ ++ N I+ T GT Y+APE
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYV-GTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 34/192 (17%)
Query: 334 LGQGGYGSVYKGKLIDGSN-----------VAVKVLNDSKGNGEEFINEVASISRTSHVN 382
LGQG + ++YKG L S+ V +KVL + F + +S+ SH +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+V L G C ++ E+V G L+ F++R +++ H W L +A +A L Y
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLH---W--KLDVAKQLASALHY 116
Query: 443 LHLGCSTRILHFDIKPHNILL----DEDFCP---KISDFGLAKICNRKESIISMTGARGT 495
L +++H ++ NIL+ + K+SD G+ +E +
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------R 167
Query: 496 VGYIAPEVFCRN 507
+ +IAPE RN
Sbjct: 168 IPWIAPE-CIRN 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 25/193 (12%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLL-GFC 390
LG G +G VYK + G A K++ +S+ E+F+ E+ +S H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+E + LI EF G+L+ + LT + + + L +LH S +
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLE-----LERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 451 ILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVF-C 505
++H D+K NILL D K++DFG ++++ I GT ++APEV C
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVAC 177
Query: 506 RNIGEVSY--KSD 516
+ Y K+D
Sbjct: 178 ETFKDNPYDYKAD 190
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 56/181 (30%), Positives = 84/181 (46%), Gaps = 29/181 (16%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFIN-EVASISRTSHVNVVTLLGFC 390
++G G YG VYK + ++ G A+KV+ G + E+ + H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW---ETLLQIAVGIARGLEYLHLGC 447
+ + EF GSL+ IY + + ++ + ETL +GL YLH
Sbjct: 76 LRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETL--------QGLYYLH--- 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGL-----AKICNRKESIISMTGARGTVGYIAPE 502
S +H DIK NILL ++ K++DFG+ A I RK I GT ++APE
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-------GTPYWMAPE 176
Query: 503 V 503
V
Sbjct: 177 V 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 26/195 (13%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-----DSKGNGEEFINEVASISRTSHVNVVTL 386
K+G+G + VY+ L+D VA+K + D+K ++ + E+ + + +H NV+
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKY 67
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFI--YRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L E ++ E G L + I ++ + + W+ +Q+ +E++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMH 123
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAP 501
S R++H DIKP N+ + K+ D GL + + K T A VG Y++P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSP 175
Query: 502 EVFCRNIGEVSYKSD 516
E N ++KSD
Sbjct: 176 ERIHEN--GYNFKSD 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 33/68 (48%), Positives = 41/68 (60%), Gaps = 4/68 (5%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
I RGL+YLH S ILH DIKP N+L++ + KI DFGLA++ ES MT T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVVT 167
Query: 496 VGYIAPEV 503
Y APE+
Sbjct: 168 QYYRAPEI 175
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 19/176 (10%)
Query: 333 KLGQGGYGSVYKGKLIDGSN---VAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLL 387
++G+G +G VYKG ID VA+K+ L +++ E+ E+ +S+ +
Sbjct: 11 RIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G +G + +I E++ GS + +E + T+L+ I +GL+YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIA--TILR---EILKGLDYLH--- 118
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S R +H DIK N+LL E K++DFG+A ++ I GT ++APEV
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 55/164 (33%), Positives = 78/164 (47%), Gaps = 31/164 (18%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVK---VLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
KLG+G +G VYK + I G VA+K + N+ G + E+ + + H NVV L+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 389 FCFE-----GRRRALIYEFVS-------NGSLEK-FIYRNSSSIENHKLTWETLLQIAVG 435
E R+R +Y V+ +G LE + S I+ + +LQ+ G
Sbjct: 75 MAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLENPSVKLTESQIKCY------MLQLLEG 127
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
I YLH ILH DIK NIL+D KI+DFGLA+
Sbjct: 128 I----NYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE--EFINEVASISRTSHVNVVTLL-GF 389
+LG G +G VYK + + +A + D+K E +++ E+ ++ H N+V LL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+E LI EF + G+++ + + T QI V + LE L+
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPL--------TEPQIRVVCKQTLEALNYLHEN 122
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLA----KICNRKESIISMTGARGTVGYIAPEV 503
+I+H D+K NIL D K++DFG++ + R++S I GT ++APEV
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 54/178 (30%), Positives = 76/178 (42%), Gaps = 16/178 (8%)
Query: 334 LGQGGYGSVY------KGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+GG+G V GKL + K L KG + + I H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEK--RILAKVHSRFIVSL 58
Query: 388 GFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ F+ + L+ ++ G L IY EN I GLE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLH-- 114
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
RI++ D+KP N+LLD D +ISD GLA K+ G GT G++APE+
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELL 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 334 LGQGGYGSV------YKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+GG+G V GK+ + K + KG +NE + + + VV+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSRFVVSL- 65
Query: 388 GFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ +E + L+ ++ G L+ IY ++ N + + A + GLE L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
RI++ D+KP NILLD+ +ISD GLA E++ G GTVGY+APEV
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV---RGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 17/139 (12%)
Query: 334 LGQGGYGSVYKGK---LIDG-----SNVAVKVLNDSKGNGEEFINEVASI-SRTSHVNVV 384
LGQG + ++KG + D + V +KVL+ S N E E AS+ S+ SH ++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
G C G ++ E+V GSL+ ++ +N + I ++W+ L++A +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI---NISWK--LEVAKQLAWALHFLE 117
Query: 445 LGCSTRILHFDIKPHNILL 463
+ H ++ N+LL
Sbjct: 118 ---DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 62/184 (33%), Positives = 90/184 (48%), Gaps = 26/184 (14%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDSKGNGEEFI---NEVASISRTSHVNVVTL 386
LGQG +G V+ + I G + A+KVL + + + E ++ +H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 387 -LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
F EG+ LI +F+ G L R S + T E + +A L++LH
Sbjct: 64 HYAFQTEGKLY-LILDFLRGGDL---FTRLSKEV---MFTEEDVKFYLAELALALDHLH- 115
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPE 502
S I++ D+KP NILLDE+ K++DFGL+ KESI A GTV Y+APE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPE 168
Query: 503 VFCR 506
V R
Sbjct: 169 VVNR 172
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 336 QGGYGSVYKGKLIDGSN-----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLG 388
+G +G ++ G LID V VK + D S+ + E + SH N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 389 FCFEGRRRALI-YEFVSNGSLEKFIY--RNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
C E + Y +++ G+L+ F+ R + L+ + L+ +A+ IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
++H DI N ++DE+ KI+D L++
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
K+G+G G V + G VAVK ++ K E + NEV + H NVV +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
G ++ EF+ G+L + + + ++ E + + + + + L LH +
Sbjct: 87 LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 451 ILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEVFCR 506
++H DIK +ILL D K+SDFG ++K R++S++ GT ++APE+ R
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISR 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 31/68 (45%), Positives = 43/68 (63%), Gaps = 8/68 (11%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
I RGL+Y+H S ++H D+KP NIL++E+ KI DFGLA+I + + MTG T
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVST 168
Query: 496 VGYIAPEV 503
Y APE+
Sbjct: 169 RYYRAPEI 176
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 32/203 (15%)
Query: 334 LGQGGYGSVYKGKLI-DG--SNVAVKVLND--SKGNGEEFINEVASISRTSH-VNVVTLL 387
+G+G +G V K ++ DG + A+K + + SK + +F E+ + + H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 388 GFCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIEN-----------HKLTWETLLQIA 433
G C R +Y E+ +G+L F+ R S +E L+ + LL A
Sbjct: 63 GAC---EHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
+ARG++YL + +H D+ NIL+ E++ KI+DFGL++ +E + T R
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 172
Query: 494 GTVGYIAPEVFCRNIGEVSYKSD 516
V ++A E N + SD
Sbjct: 173 LPVRWMAIESL--NYSVYTTNSD 193
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 333 KLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVT 385
K+G+G +G K L+ DG +K +N SK + EE EVA +S H N+V
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI--ENHKLTWETLLQIAVGIARGLEYL 443
E ++ ++ G L K I + E+ L W V I L+++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHV 117
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIA 500
H +ILH DIK NI L +D K+ DFG+A++ N ++ AR GT Y++
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLS 169
Query: 501 PEVFCRN 507
PE+ C N
Sbjct: 170 PEI-CEN 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 333 KLGQGGYGSVYKGKLIDGSN---VAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLL 387
K+G+G +G V+KG ID VA+K+ L +++ E+ E+ +S+ V
Sbjct: 11 KIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + + +I E++ GS + E L + I I +GL+YLH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH--- 118
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S + +H DIK N+LL E K++DFG+A ++ I GT ++APEV
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV---- 172
Query: 508 IGEVSYKS 515
I + +Y S
Sbjct: 173 IKQSAYDS 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK---VLNDSKGNGEEFINEVASISRTSHVN-VVTLL 387
K+G+G YG VYK + G VA+K + D +G + E++ + S +V LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 388 GFCFEGRRRA-------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
E L++E++ + L+KF+ N L +T+ + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGV 123
Query: 441 EYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
+ H ++H D+KP N+L+D+ KI+D GL + + S T T+ Y
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR--AFSIPVKSYTHEIVTLWYR 178
Query: 500 APEV 503
APEV
Sbjct: 179 APEV 182
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 333 KLGQGGYGSVYKGKLIDG---SNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLL 387
++G+G +G V+KG ID VA+K+ L +++ E+ E+ +S+ V
Sbjct: 11 RIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G +G + +I E++ GS + + + ++ T+L+ I +GL+YLH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIA--TMLK---EILKGLDYLH--- 118
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S + +H DIK N+LL E K++DFG+A ++ I GT ++APEV
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 30/185 (16%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G YG V G VA+K ++ D + + + E+ + H N++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 390 -------CFEGRRRALIYEFVSN---GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
F +Y V+ L K I LT + + I RG
Sbjct: 68 LRPPSPEDFND-----VY-IVTELMETDLHKVIKSP------QPLTDDHIQYFLYQILRG 115
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS-MTGARGTVGY 498
L+YLH S ++H D+KP NIL++ + KI DFGLA+ + E +T T Y
Sbjct: 116 LKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 499 IAPEV 503
APE+
Sbjct: 173 RAPEL 177
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 56/185 (30%), Positives = 83/185 (44%), Gaps = 37/185 (20%)
Query: 334 LGQGGYGSVYKGKLID---GSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLL 387
+G G YGSV ID G VA+K L+ S+ + E+ + H NV+ LL
Sbjct: 23 VGSGAYGSVCSA--IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 388 GFCFEGRRRALIYEFVSNGSLEKF---------IYRNSSSIENHKLTWETLLQIAVGIAR 438
F S S ++F + + I H L+ + + + +
Sbjct: 81 DV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
GL+Y+H S I+H D+KP N+ ++ED KI DFGLA+ + + MTG T Y
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWY 180
Query: 499 IAPEV 503
APEV
Sbjct: 181 RAPEV 185
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 333 KLGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
++G G +G+VY + + + V A+K ++ S E I EV + R H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLHL 445
G L+ E+ + S +E HK L + I G +GL YLH
Sbjct: 92 GCYLREHTAWLVMEYCLGSA--------SDLLEVHKKPLQEVEIAAITHGALQGLAYLH- 142
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S ++H DIK NILL E K++DFG A I + S + GT ++APEV
Sbjct: 143 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEV 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 23/175 (13%)
Query: 336 QGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV-----NVVTLLGF 389
+G +GSVY K G A+KVL S + + V + + V L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-Y 64
Query: 390 CFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
F+ + L+ E+++ G I E+ W Q + G+E LH
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED----W--AKQYIAEVVLGVEDLH---Q 115
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I+H DIKP N+L+D+ K++DFGL++ + + GT Y+APE
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPET 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 34/184 (18%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G YGSV G VAVK L+ S + + E+ + H NV+ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 390 CFEGRRRALIYEFVSNGSLEKF--IYRNS--------SSIENHKLTWETLLQIAVGIARG 439
F SLE+F +Y + + ++ KLT + + + I RG
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
L+Y+H S I+H D+KP N+ ++ED KI DFGLA+ + + MTG T Y
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184
Query: 500 APEV 503
APE+
Sbjct: 185 APEI 188
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDS---KGNGEEFI-NEVASISRTSHVNVVTLL 387
++GQGGYG V+ K D G VA+K + S K N + E ++ T +V LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 388 GFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH-L 445
+ F+ L E+V G + E+H + + AV + LH L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV------DALHEL 120
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 503
G +H D+KP N L+D K++DFGL+K I S++ G+ Y+APEV
Sbjct: 121 G----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEV 169
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 25/186 (13%)
Query: 331 KYK----LGQGGYGSVYKGKLID-GSNVAVKVLN---DSKGNGEEFINEVASISRTSHVN 382
KY +G+G YG V K + VA+K + D++ + + + E+ + H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 383 VVTLLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
V+ + R A ++YE + L + I + + ++H + L Q+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF--LYQLL---- 118
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 497
RGL+Y+H S +LH D+KP N+LL+ + KI DFGLA+ + K MT T
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRW 173
Query: 498 YIAPEV 503
Y APE+
Sbjct: 174 YRAPEL 179
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 325 KMTNSFKYK-------LGQGGYGSVYKGKLIDGS--NVAVKVLNDSKGNGEEFINEVAS- 374
K N KY+ LG G +G V + VA+K SK ++ ++ V S
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 375 ---ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQ 431
++ +H V L G + L+ EFV G F+ RN + +
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCF 135
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
A I EYL S I++ D+KP N+LLD+D K++DFG AK+ + + +
Sbjct: 136 YAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC--- 189
Query: 492 ARGTVGYIAPEVFCRNIG 509
GT YIAPE+ N+G
Sbjct: 190 --GTPEYIAPEILL-NVG 204
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 27/70 (38%), Positives = 42/70 (60%), Gaps = 5/70 (7%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNR-KESIISMTGAR 493
+ RGL+Y+H S ++H D+KP N+L++ED +I DFG+A+ + + E MT
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 494 GTVGYIAPEV 503
T Y APE+
Sbjct: 173 ATRWYRAPEL 182
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 22/182 (12%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-----EEFINEVASISRTSHVNVVTLL 387
++G G +G V ++ + VA V+ + K N EF+ + H N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFI------YRNSSSIENHKLTWETLLQIAVGIARGLE 441
G C E L++E+ G L+ ++ RNS + L ++A IA G+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL--------LQRMACEIAAGVT 113
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
++H LH D+ N L D K+ D+G+ +++ I + + ++AP
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 502 EV 503
E+
Sbjct: 171 EL 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 333 KLGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
++G G +G+VY + + S V A+K ++ S E I EV + + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLHL 445
G L+ E+ + S +E HK L + + G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSA--------SDLLEVHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S ++H D+K NILL E K+ DFG A I + GT ++APEV
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 38/186 (20%)
Query: 334 LGQGGYGSV---YKGKLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLL 387
+G G YGSV Y +L VAVK L+ S + E+ + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 388 GFCFEGRRRALIYEFVSNGSLEKF--IYRNSS--------SIENHKLTWETLLQIAVGIA 437
F S+E F +Y ++ ++ KL+ E + + +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 497
RGL+Y+H S I+H D+KP N+ ++ED +I DFGLA+ + + MTG T
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180
Query: 498 YIAPEV 503
Y APE+
Sbjct: 181 YRAPEI 186
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 24/190 (12%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK---GNGEEF-INE--VASISRTSHVNVVTL 386
+G+GG+G VY + D G A+K L+ + GE +NE + S+ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 387 LGFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+ + F + + I + ++ G L + ++ E + A I GLE++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMH- 114
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
+ +++ D+KP NILLDE +ISD GLA ++K+ S+ GT GY+APEV
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168
Query: 506 RNIGEVSYKS 515
+ V+Y S
Sbjct: 169 KG---VAYDS 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 32/167 (19%)
Query: 332 YKLGQGGYGSVYKGKLID---GSNVAVK--VLNDSKGNGEEFINEVASISRTSHVNVVTL 386
LG G G V+ +D VAVK VL D + + + + E+ I R H N+V +
Sbjct: 11 RPLGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKV 67
Query: 387 LGFCFEGRRR-------------ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
I + L + + S E+ +L LL
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL--- 124
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKI 479
RGL+Y+H S +LH D+KP N+ ++ ED KI DFGLA+I
Sbjct: 125 ----RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFIN--EVASISR-TSHVNVVTLLG 388
K+G+G + V K + G A+K + + E+ N E+ ++ R + H N++ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 389 FCFEGR--RRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLH 444
F+ + R AL++E ++ +Y I+ K L + + + + L+++H
Sbjct: 66 VLFDRKTGRLALVFEL-----MDMNLY---ELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
I H DIKP NIL+ +D K++DFG +
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 23/180 (12%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK---GNGEEF-INE--VASISRTSHVNVVTL 386
+G+GG+G VY + D G A+K L+ + GE +NE + S+ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 387 LGFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQI-AVGIARGLEYLH 444
+ + F + I + ++ G L + H + E ++ A I GLE++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLH-------YHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+ +++ D+KP NILLDE +ISD GLA ++K+ S+ GT GY+APEV
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 17/177 (9%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+GG+G V ++ + G A K L+ K +GE+ + E + + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ FE + L+ ++ G L+ IY ++ L E ++ + I G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITCGILHLH--- 112
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S I++ D+KP N+LLD+ ++SD GLA ++I T GT GY+APE+
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEIL 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 30/70 (42%), Positives = 40/70 (57%), Gaps = 5/70 (7%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGAR 493
I GL+Y+H S +LH D+KP N+L++ D KI DFGLA+ N E+ MT
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 494 GTVGYIAPEV 503
T Y APE+
Sbjct: 171 ATRWYRAPEI 180
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 63/214 (29%)
Query: 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID---GSNVAVKVLNDSKGNGEE----- 367
R+Y +I + KLG+G YG V+K ID VA+K + D+ N +
Sbjct: 7 RKY---EILQ-------KLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTF 54
Query: 368 ----FINEVASISRTSHVNVVTLLGFCFEGRRRA-------LIYEFVSNGSLEKFIYRNS 416
F+ E+ H N+V LL +A L++E++ L I N
Sbjct: 55 REIMFLQEL-----GDHPNIVKLLNVI-----KAENDKDIYLVFEYMET-DLHAVIRAN- 102
Query: 417 SSI--ENHK--LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472
I + HK + ++ L + L+Y+H S ++H D+KP NILL+ D K++
Sbjct: 103 --ILEDVHKRYIMYQLL--------KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLA 149
Query: 473 DFGLAK-ICNRKE--SIISMTGARGTVGYIAPEV 503
DFGLA+ + +E +T T Y APE+
Sbjct: 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 52/206 (25%), Positives = 76/206 (36%), Gaps = 43/206 (20%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G +G V+ + D V A+KVL S K N + I + + L +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 390 CFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH-LGC 447
F+ L+ E++ G L + I ET + L+ +H LG
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLL------IRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-------------- 493
+H DIKP NIL+D D K++DFGL K N+ +
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 494 -------------GTVGYIAPEVFCR 506
GT YIAPEV
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRG 204
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 28/169 (16%)
Query: 350 GSNVAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL--GFCFEGRRRALIYEFV 403
G VA+K+L E F E A +R H N+V LL G G A ++E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 404 SNGSLEKFIYRNS--SSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461
+L + + + + E +L + L +A +G I+H D+KP NI
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG-----------IVHRDLKPQNI 110
Query: 462 LL---DEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPE 502
++ K+ DFG+ + T R GT Y APE
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 34/184 (18%)
Query: 334 LGQGGYGSV-YKGKLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G YG+V G+ VA+K L S+ + E+ + H NV+ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 390 CFEGRRRALIYEFVSNGSLEKF---------IYRNSSSIENHKLTWETLLQIAV-GIARG 439
F + SL++F + + + H+ E +Q V + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
L+Y+H + I+H D+KP N+ ++ED KI DFGLA+ + + MTG T Y
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYR 182
Query: 500 APEV 503
APEV
Sbjct: 183 APEV 186
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 330 FKY---KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEF--INEVASISRTSHVNVV 384
F+Y K+G+G YG VYK K DG + L +G G E+A + H NV+
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 385 TL--LGFCFEGRRRALIYEFVSNG--SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
L + R+ L++++ + + KF + ++ + +L + + I G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 441 EYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRK-ESIISMTGARGT 495
YLH + +LH D+KP NIL+ E KI+D G A++ N + + + T
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 496 VGYIAPEVF 504
Y APE+
Sbjct: 179 FWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 334 LGQGGYGSVYK-GKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCF 391
+G+G YG V+K +GS AVK+L+ EE E + S H NVV G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 392 E-----GRRRALIYEFVSNGS---LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+ G + L+ E + GS L K + +E + + +L A+ GL++L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY--ILHEAL---MGLQHL 140
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGL-AKICNRKESIISMTGARGTVGYIAPE 502
H + +H D+K +NILL + K+ DFG+ A++ + + + + GT ++APE
Sbjct: 141 H---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPE 194
Query: 503 VF-CRNIGEVSY 513
V C + +Y
Sbjct: 195 VIACEQQLDSTY 206
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 19/190 (10%)
Query: 330 FKY---KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEF--INEVASISRTSHVNVV 384
F+Y K+G+G YG VYK K DG + L +G G E+A + H NV+
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 385 TL--LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK---LTWETLLQIAVGIARG 439
+L + R+ L++++ + L I + +S N K L + + I G
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 440 LEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRK-ESIISMTGARG 494
+ YLH + +LH D+KP NIL+ E KI+D G A++ N + + +
Sbjct: 121 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 495 TVGYIAPEVF 504
T Y APE+
Sbjct: 178 TFWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 334 LGQGGYGSVYKGKLIDGSN----VAVKVLNDS-----KGNGEEFINEVASISRTSHVNVV 384
LG G YG V+ + + G + A+KVL + E E + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 385 TLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEY 442
L + F+ + LI ++V+ G L +Y+ E+ E+ +++ + I L++
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQR----EHFT---ESEVRVYIAEIVLALDH 120
Query: 443 LH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI--CNRKESIISMTGARGTVGYI 499
LH LG I++ DIK NILLD + ++DFGL+K +E S GT+ Y+
Sbjct: 121 LHQLG----IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYM 173
Query: 500 APEV 503
APEV
Sbjct: 174 APEV 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 332 YKLGQGGYGSVYKGKLIDGSN-VAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTL 386
+++G G +G+VY + VAVK ++ S E I EV + + H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLH 444
G + L+ E+ + S +E HK L + I G +GL YLH
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSA--------SDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
++H DIK NILL E K++DFG A + S + GT ++APEV
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEV 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 58/180 (32%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDS---KGNGEEFINEVAS--ISRTSHVNVVTLL 387
+G+G +G V K DG AVKVL K ++ I + + H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 388 GFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ F+ + + ++V+ G L + R S E + A IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY------AAEIASALGYLH-- 113
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-ISMTGAR--GTVGYIAPEV 503
S I++ D+KP NILLD ++DFGL C KE I S T + GT Y+APEV
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGL---C--KEGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEF--INEVASISRTSHVNVVTLLG 388
++G+G YG VY+ + G VA+K V D++ +G + E+ + H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARGLEYLHLG 446
G+ I F+ E+ + +S ++N + + + + + RGL+YLH
Sbjct: 74 VV-VGKHLDSI--FLVMEYCEQDL---ASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII--SMTGARGTVGYIAPEV 503
I+H D+K N+LL + C KI+DFGLA R + MT T+ Y APE+
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLA----RTYGLPAKPMTPKVVTLWYRAPEL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEF---------------INEVASISR 377
LG+G YG V K + G VA+K + + + + + E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 378 TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
H N++ L+ EG L+ + ++ L+K + R E+ LLQI
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKC--ILLQIL---- 129
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480
GL LH +H D+ P NI ++ KI+DFGLA+
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 30/185 (16%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDSKGNGEEFINEVASISRT--SHVN----V 383
LG G YG V+ + + G + A+KVL + + E R HV +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 384 VTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLE 441
VTL + F+ + LI ++VS G + +Y+ + E+ ++ G I LE
Sbjct: 68 VTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYSGEIILALE 119
Query: 442 YLH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGY 498
+LH LG I++ DIK NILLD + ++DFGL+K + KE S GT+ Y
Sbjct: 120 HLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEY 172
Query: 499 IAPEV 503
+APE+
Sbjct: 173 MAPEI 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 63/234 (26%), Positives = 93/234 (39%), Gaps = 68/234 (29%)
Query: 334 LGQGGYGSVYKGKL--IDGSN----VAVKVLNDSKGNGEE--FINEVAS-ISRTSHVNVV 384
LG+G +G V + I+ S VAVK+L + E + E+ I H+NVV
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 385 TLLGFCFE-GRRRALIYEFVSNGSLEKFI---------YRN------------------- 415
LLG C + G +I E+ G+L ++ YRN
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 416 ---------SSSIENHK------------------LTWETLLQIAVGIARGLEYLHLGCS 448
SS K LT E L+ + +ARG+E+L S
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
+ +H D+ NILL E+ KI DFGLA+ + + AR + ++APE
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 29/69 (42%), Positives = 40/69 (57%), Gaps = 4/69 (5%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARG 494
I RGL+Y+H S +LH D+KP N+LL+ + KI DFGLA+I + +T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 495 TVGYIAPEV 503
T Y APE+
Sbjct: 172 TRWYRAPEI 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 32/196 (16%)
Query: 334 LGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTL 386
+G+G YG V L+ DG +K LN + E E +S+ H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 387 LGFCFEGRRRAL--IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
+EG L + F G L Y + L +++ V IA L+YLH
Sbjct: 65 RE-SWEGEDGLLYIVMGFCEGGDL----YHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI----CNRKESIISMTGARGTVGYIA 500
ILH D+K N+ L K+ D G+A++ C+ ++I GT Y++
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI------GTPYYMS 170
Query: 501 PEVFCRNIGEVSYKSD 516
PE+F +YKSD
Sbjct: 171 PELFSNK--PYNYKSD 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 334 LGQGGYGSV----YKGKLIDGSNVAVKVLNDSKGNGEEFI----NEVASISRTSHVNVVT 385
LG+G +G V KG AVKVL ++ + E ++ +T
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 386 LLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L CF+ + R + E+V+ G L I R+ E + A I GL++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVLGLQFLH 113
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGYIAPE 502
I++ D+K N+LLD + KI+DFG+ K I + + GT YIAPE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFCGTPDYIAPE 166
Query: 503 V 503
+
Sbjct: 167 I 167
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 37/191 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSN-------------VAVKVLNDSKGNGEEFINEVASISR-TS 379
LG+G +Y G L + V +KVL+ S + E AS+ R S
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
H ++V L G C ++ EFV G L+ F++R S + W+ ++A +A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT---PWK--FKVAKQLASA 117
Query: 440 LEYLHLGCSTRILHFDIKPHNILL-----DEDFCP--KISDFGLA-KICNRKESIISMTG 491
L YL ++H ++ NILL D + P K+SD G+ + +R+E +
Sbjct: 118 LSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV----- 169
Query: 492 ARGTVGYIAPE 502
+ +IAPE
Sbjct: 170 --ERIPWIAPE 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 29/180 (16%)
Query: 334 LGQGGYGSVYKGKL-IDGSNVAVKVLNDS---KGNGEEFINEVASI-SRTSHVNVVTLLG 388
LG G +G V K G A+K L K + + + SI SH +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIY-RNSSSIENHKLTW---ETLLQIAVGIARGLEYLH 444
+ R + EFV G E F + R + N + E +L EYLH
Sbjct: 86 SFQDENRVYFLLEFVVGG--ELFTHLRKAGRFPNDVAKFYHAELVL--------AFEYLH 135
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 503
S I++ D+KP N+LLD K++DFG AK + +R ++ GT Y+APEV
Sbjct: 136 ---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC------GTPEYLAPEV 186
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 12/67 (17%)
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE---SIISMTGARGTV 496
EYLH + I++ D+KP N+LLD + K+ DFG AK + + GT
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTP 156
Query: 497 GYIAPEV 503
Y+APE+
Sbjct: 157 EYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 21/179 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G V +L + + AVKVL + E + E +S + +T L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 389 FCFEGRRRAL-IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
CF+ R + EFV+ G L I ++ E + A I L +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEITSALMFLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGYIAPEVF 504
I++ D+K N+LLD + K++DFG+ K I N + T GT YIAPE+
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFC-GTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G V + G A+K+L +K + E + T H +T L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLK 61
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ + R + E+V+ G L + R E+ + I L+YLH G
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY------GAEIVSALDYLHSG- 114
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII---SMTGARGTVGYIAPEVF 504
+I++ D+K N++LD+D KI+DFGL KE I +M GT Y+APEV
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLC-----KEGITDAATMKTFCGTPEYLAPEVL 167
Query: 505 CRN 507
N
Sbjct: 168 EDN 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 18/180 (10%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G V + G A+K+L +K + E + T H +T L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALK 61
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ R + E+ + G L + R E + I LEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY------GAEIVSALEYLH--- 112
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S +++ DIK N++LD+D KI+DFGL K + +M GT Y+APEV N
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLN---DSKGNGEEFIN----EVASISRTSHVNVVT 385
LG+G +G VY D G +AVK + DS+ +E +N E+ + H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 386 LLGFCF---EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
G C E ++ ++ E++ GS++ + + EN +T QI +G+ Y
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN--VTRRYTRQIL----QGVSY 121
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGY 498
LH S I+H DIK NIL D K+ DFG +K IC I S+T GT +
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT---GTPYW 175
Query: 499 IAPEV 503
++PEV
Sbjct: 176 MSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 57/184 (30%), Positives = 83/184 (45%), Gaps = 27/184 (14%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLN---DSKGNGEEFIN----EVASISRTSHVNVVT 385
LGQG +G VY D G +AVK + +S +E +N E+ + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 386 LLGFCFEGRRRAL--IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G + R L E + GS++ + + EN +T + QI G+ YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN--VTRKYTRQIL----EGVSYL 122
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK----ICNRKESIISMTGARGTVGYI 499
H S I+H DIK NIL D K+ DFG +K IC + S+T GT ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWM 176
Query: 500 APEV 503
+PEV
Sbjct: 177 SPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 53/183 (28%), Positives = 83/183 (45%), Gaps = 26/183 (14%)
Query: 334 LGQGGYGSVYKGKLID---GSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLL 387
+G+G YG V ID G VA+K +ND + + E+ + H ++V +
Sbjct: 8 IGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 388 GFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSS-SIENHKLTWETLLQIAVGIARGLE 441
RR +++E + + L + I N + E+H+ LL R L+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLL-------RALK 117
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIA 500
Y+H + + H D+KP NIL + D KI DFGLA++ N + I T T Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 501 PEV 503
PE+
Sbjct: 175 PEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G YG VYK + G VA+K + N+ +G I E+ + + +H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 390 C--------FEGRRRA--LIYEFVSN---GSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
F+ + A L++E++ + G LE + S ++ K + LL+
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIKSFMKQLLE----- 127
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTV 496
GL Y H LH DIK NILL+ K++DFGLA++ N E T T+
Sbjct: 128 --GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEESRPYTNKVITL 181
Query: 497 GYIAPEVFCRNIGEVSY 513
Y PE+ +GE Y
Sbjct: 182 WYRPPELL---LGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 24/179 (13%)
Query: 333 KLGQGGYGSVYK------GKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTL 386
+LG+G YGSVYK G + + ++ L++SK N I E+ + + +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQ--IIMELDILHKAVSPYIVDF 64
Query: 387 LG-FCFEGRRRALIY--EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G F EG A+ E++ GSL+K +Y + E + + L +I + +GL++L
Sbjct: 65 YGAFFIEG---AVYMCMEYMDAGSLDK-LYAGGVATE--GIPEDVLRRITYAVVKGLKFL 118
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
I+H D+KP N+L++ + K+ DFG++ + ++ T G Y+APE
Sbjct: 119 KE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNI-GCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFINEVASISRTSHV-----NVVTLL 387
+G+G Y V +L + A+KV+ N +E I+ V + HV N L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQT---EKHVFETASNHPFLV 59
Query: 388 GF--CFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
G CF+ R + EFVS G L + R E H + + +A L +LH
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLH 113
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I++ D+K N+LLD + K++D+G+ K R S GT YIAPE+
Sbjct: 114 ---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDSK-----GNGEEFINEVASISRTSHVNVV 384
LG G YG V+ + + G + A+KVL + E E + +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 385 TLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEY 442
L + F+ + LI ++++ G L + + E +QI G I LE+
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE-------VQIYSGEIVLALEH 120
Query: 443 LH-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK--ICNRKESIISMTGARGTVGYI 499
LH LG I++ DIK NILLD + ++DFGL+K + E S GT+ Y+
Sbjct: 121 LHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYM 173
Query: 500 APEV 503
AP++
Sbjct: 174 APDI 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 29/79 (36%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 424 LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
LT E L+ + +ARG+E+L S + +H D+ NILL E+ KI DFGLA+ +
Sbjct: 171 LTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 484 ESIISMTGARGTVGYIAPE 502
+ AR + ++APE
Sbjct: 228 PDYVRKGSARLPLKWMAPE 246
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 31/197 (15%)
Query: 333 KLGQGGYGSVYKG-KLIDGSNVAVKV----LNDSKGNGEEFINEVASISRTSHVNVVTLL 387
+G+GG G VY + VA+K L+++ + F+ E + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRN-----SSSIENH-KLTWETLLQIAVGIARGLE 441
C +G ++ +L K + ++ S S E K + L I I +E
Sbjct: 69 SICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-----ISMTGAR--- 493
Y+H S +LH D+KP NILL I D+G A +E +
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 494 --------GTVGYIAPE 502
GT Y+APE
Sbjct: 185 MTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 54/206 (26%), Positives = 78/206 (37%), Gaps = 45/206 (21%)
Query: 333 KLGQGGYGSVYKGKLIDGSNV-AVKVL------NDSKGNGEEFINEVASISRTSHVNVVT 385
LG+G G V+ +L + A+KVL +K E+ ++ H + T
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH- 444
L L+ ++ G L + + R L+ E A + LEYLH
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC----LSEEVARFYAAEVLLALEYLHL 121
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN---RKESIISMTGAR-------- 493
LG I++ D+KP NILL E +SDF L+K + S G+R
Sbjct: 122 LG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 494 ----------------GTVGYIAPEV 503
GT YIAPEV
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEV 203
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 43/124 (34%), Positives = 62/124 (50%), Gaps = 18/124 (14%)
Query: 384 VTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+T L CF+ R + E+V+ G L I + E H + + A IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIGLFF 116
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYI 499
LH S I++ D+K N++LD + KI+DFG+ C KE+I R GT YI
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGM---C--KENIFGGKTTRTFCGTPDYI 168
Query: 500 APEV 503
APE+
Sbjct: 169 APEI 172
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 42/189 (22%)
Query: 334 LGQGGYGSV----YKGKLIDGSNVAVKVLNDSKGNGEEFI---NEVASI----------S 376
LG+G +G V YK G A+K L + I +EV S+ +
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALK------KGDIIARDEVESLMCEKRIFETAN 57
Query: 377 RTSHVNVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
H +V L CF+ + E+ + G L I+ + S A
Sbjct: 58 SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-------YAAC 109
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-G 494
+ GL+YLH +I++ D+K N+LLD + KI+DFGL C T G
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCG 163
Query: 495 TVGYIAPEV 503
T ++APEV
Sbjct: 164 TPEFLAPEV 172
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFINEVAS----ISRTSHVNVVTLLG 388
+G+G Y V +L + A+KV+ N +E I+ V + + S+ + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 389 FCFEGRRRAL-IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
CF+ R + E+V+ G L + R E H + + +A L YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I++ D+K N+LLD + K++D+G+ K R S GT YIAPE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 19/174 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSNVAVK--VLNDSKGN-GEEFINEVASISRTSHVNVVTLLG-F 389
LG G GSV K K I V K V +K + ++ + E+ + +V+ G F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
E + EF+ GSL++ IY+ I E L +IAV + GL YL+
Sbjct: 73 LNENNI-CMCMEFMDCGSLDR-IYKKGGPI-----PVEILGKIAVAVVEGLTYLYN--VH 123
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPE 502
RI+H DIKP NIL++ K+ DFG++ E I S+ GT Y++PE
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 27/65 (41%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
G+++LH S I+H D+KP NI++ D KI DFGLA+ + MT T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183
Query: 499 IAPEV 503
APEV
Sbjct: 184 RAPEV 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 424 LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
LT E L+ + +A+G+E+L S + +H D+ NILL E+ KI DFGLA+ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 484 ESIISMTGARGTVGYIAPE 502
+ AR + ++APE
Sbjct: 233 PDYVRKGDARLPLKWMAPE 251
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 322 DIKKMTNSFKYKLGQ----GGYGSVYKGKLIDGS-NVAVK-VLNDSKGNGEEFINEVASI 375
DI + N YKLG G +G VY+ ID S VA+K VL D + E + +
Sbjct: 59 DINRSPNK-SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IM 113
Query: 376 SRTSHVNVVTLLGF----CFEGRRRAL----IYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
+H+N++ L + CF+ + + + EF+ ++ K Y + NH L
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHK--YMKHYARNNHALPLF 170
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESI 486
+ + + R L Y+H S I H D+KP N+L+D + K+ DFG AK
Sbjct: 171 LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------- 219
Query: 487 ISMTGARGTVGYI------APEVFCRNIGEVSYKS 515
++ + +V YI APE+ +G +Y +
Sbjct: 220 -NLLAGQRSVSYICSRFYRAPELM---LGATNYTT 250
|
Length = 440 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 12/136 (8%)
Query: 371 EVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL 430
E + +H +V+ + G ++ + L ++ + S L + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR-----PLPIDQAL 160
Query: 431 QIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490
I I GL YLH + RI+H D+K NI +++ I D G A+ +
Sbjct: 161 IIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAP--AFL 214
Query: 491 GARGTVGYIAPEVFCR 506
G GTV APEV R
Sbjct: 215 GLAGTVETNAPEVLAR 230
|
Length = 357 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 27/184 (14%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLN---DSKGNGEEFIN---EVASISRTSHVNVVTL 386
LGQG +G VY +D G +A K + +S +E E+ + H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 387 LGFCFE--GRRRALIY-EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G C + I+ E++ GS++ + + LT + I G+ YL
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYL 122
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-ISMTGARGTVG---YI 499
H S I+H DIK NIL D K+ DFG +K R ++I +S TG R G ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWM 176
Query: 500 APEV 503
+PEV
Sbjct: 177 SPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 17/177 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFINEVAS----ISRTSHVNVVTLLG 388
+G+G Y V +L + A+KV+ + +E I+ V + + S + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
CF+ R L+ E+V+ G L + R E H + + IA L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I++ D+K N+LLD D K++D+G+ K S GT YIAPE+
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC--GTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 42/147 (28%)
Query: 383 VVTLLGFCFEGRRR-ALIYEFVSNG---SLEKFIYRNSSSIENHKLTW-ETLLQIAVGIA 437
VV++ FE +R ++ E+V G +L K I + ++ ++ + ET+L
Sbjct: 63 VVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVL------- 112
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT------- 490
LEYLH + I+H D+KP N+L+ K++DFGL+KI ++S+T
Sbjct: 113 -ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-----GLMSLTTNLYEGH 163
Query: 491 ---GAR--------GTVGYIAPEVFCR 506
R GT YIAPEV R
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILR 190
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 52/178 (29%), Positives = 73/178 (41%), Gaps = 25/178 (14%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFIN-----EVASISRTSHVNVVTLL 387
+G G G VYK + +V AVK + + GN EE +V S +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVVLKSHDCP-YIVKCY 80
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL---H 444
G F I + + L+K + R I L ++ V I + L YL H
Sbjct: 81 G-YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKEKH 134
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
++H D+KP NILLD K+ DFG I R + T + G Y+APE
Sbjct: 135 -----GVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 367 EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW 426
+ I E+ + + +V G + ++ E + GSL++ + E ++
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------EAKRIPE 102
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486
E L ++++ + RGL YL +I+H D+KP NIL++ K+ DFG++ + I
Sbjct: 103 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLI 155
Query: 487 ISMTGA-RGTVGYIAPE 502
SM + GT Y++PE
Sbjct: 156 DSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 11/71 (15%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII---SMTGA 492
I L YLH S +++ D+K N++LD+D KI+DFGL KE I +M
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTF 155
Query: 493 RGTVGYIAPEV 503
GT Y+APEV
Sbjct: 156 CGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 41/121 (33%), Positives = 62/121 (51%), Gaps = 12/121 (9%)
Query: 384 VTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+T L CF+ R + E+V+ G L I + E H + + A IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAIGLFF 116
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
LH S I++ D+K N++LD + KI+DFG+ K N + + + T GT YIAPE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC-GTPDYIAPE 171
Query: 503 V 503
+
Sbjct: 172 I 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 31/183 (16%)
Query: 334 LGQGGYGSVYKG-KLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G G V + G NVAVK L+ ++ + + E+ + +H N+++LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 390 CFEGRRRALIYEFVSNGSLEKF--IY-------RNSSSIENHKLTWETLLQIAVGIARGL 440
F SLE+F +Y N + + +L E + + + G+
Sbjct: 89 ------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
++LH S I+H D+KP NI++ D KI DFGLA+ MT T Y A
Sbjct: 137 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRA 190
Query: 501 PEV 503
PEV
Sbjct: 191 PEV 193
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 334 LGQGGYGSVYKGKL-IDGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V K +DG AVKVL ++ + + E + + + L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ + + +FV+ G L + R S E + A IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY------AAEIASALGYLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVF 504
S I++ D+KP NILLD ++DFGL C + T GT Y+APEV
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGL---CKEGIAQSDTTTTFCGTPEYLAPEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 17/177 (9%)
Query: 334 LGQGGYGSVYKGKL-IDGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V K DGS AVKVL K + E + + + L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 389 FCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ + + ++V+ G L + R +E + A +A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY------AAEVASAIGYLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S I++ D+KP NILLD ++DFGL K E S GT Y+APEV
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 20/187 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G +G V + V A+K+L+ K + F E I ++ V L +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 390 CFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKL--TWETLLQIAVGIARGLEYLHLG 446
F+ R ++ E++ G L + N+ + W V +A L+ +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWARFYTAEVVLA--LDAIH-- 159
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S +H D+KP N+LLD+ K++DFG N KE ++ A GT YI+PEV
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKS 217
Query: 507 NIGEVSY 513
G+ Y
Sbjct: 218 QGGDGYY 224
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 18/124 (14%)
Query: 384 VTLLGFCFEG-RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+T L CF+ R + E+V+ G L I + E + + A I+ GL +
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFF 116
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYI 499
LH I++ D+K N++LD + KI+DFG+ KE ++ R GT YI
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPDYI 168
Query: 500 APEV 503
APE+
Sbjct: 169 APEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 424 LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
L E LL + +A+G+ +L S +H D+ NILL KI DFGLA+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 484 ESIISMTGARGTVGYIAPE 502
+ + AR V ++APE
Sbjct: 268 SNYVVKGNARLPVKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 30/164 (18%)
Query: 352 NVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408
NVA+K L+ ++ + + E+ + +H N+++LL F SL
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSL 91
Query: 409 EKF--IY-------RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459
E+F +Y N + +L E + + + G+++LH S I+H D+KP
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 148
Query: 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
NI++ D KI DFGLA+ + MT T Y APEV
Sbjct: 149 NIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 20/106 (18%)
Query: 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL---HLGCSTRILHFDIK 457
E + GSL++ + + EN L +I++ + RGL YL H +I+H D+K
Sbjct: 79 EHMDGGSLDQVLKKAGRIPEN------ILGKISIAVLRGLTYLREKH-----KIMHRDVK 127
Query: 458 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGA-RGTVGYIAPE 502
P NIL++ K+ DFG++ + I SM + GT Y++PE
Sbjct: 128 PSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 11/75 (14%)
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
A I GL++LH S I++ D+K NILLD D KI+DFG+ KE+++
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMC-----KENMLGDAKT 153
Query: 493 R---GTVGYIAPEVF 504
GT YIAPE+
Sbjct: 154 CTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 50/203 (24%)
Query: 332 YKLGQGGYGSVYKGKLID-GSNVAVKVL-NDSKGNGEEF----INEVASISRTSHVNVVT 385
++ +G YG VY+ + G VA+K L + + G F + E+ + + H N+VT
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQHPNIVT 68
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEK-FIYRN------SSSIENHK---LTWET---LLQI 432
+ E V +L+K ++ S +E K L E +LQ+
Sbjct: 69 -------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL 115
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK--ESIISMT 490
G+A +LH ILH D+K N+LL+ KI DFGLA R+ + T
Sbjct: 116 LSGVA----HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYT 164
Query: 491 GARGTVGYIAPEVFCRNIGEVSY 513
T+ Y APE+ +G Y
Sbjct: 165 QLVVTLWYRAPELL---LGAKEY 184
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 29/74 (39%), Positives = 41/74 (55%), Gaps = 11/74 (14%)
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
A I GL++LH I++ D+K N+LLD+D KI+DFG+ KE++ A
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMC-----KENMNGEGKA 153
Query: 493 R---GTVGYIAPEV 503
GT YIAPE+
Sbjct: 154 STFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 21/153 (13%)
Query: 334 LGQGGYGSVYKGKLIDGSN-VAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLL-G 388
+G+G YG V K + + VA+K DS+ N E + E+ + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 389 FCFEGRRRA---LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
F RRR L++E+V LE + ++ I + ++ +H
Sbjct: 69 F----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY---------IYQLIKAIHW 115
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
I+H DIKP N+L+ + K+ DFG A+
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 358 LNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNS 416
L S E+ E +++ H N+V FE ++ E+ G L + I
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQR 93
Query: 417 SSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476
+ +T+LQ V + G++++H R+LH DIK NI L ++ K+ DFG
Sbjct: 94 GKL----FPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 477 AKICNRKESIISMTGARGTVGYIAPEVF 504
A++ + GT Y+ PE++
Sbjct: 147 ARLLTSPGAYACTY--VGTPYYVPPEIW 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G V K G A+K+L +K + E + + H +T L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALK 61
Query: 389 FCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ R + E+ + G L + R E+ + I L+YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALDYLH--S 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTVGYIAPEVF 504
+++ D+K N++LD+D KI+DFGL KE I +M GT Y+APEV
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 505 CRN 507
N
Sbjct: 169 EDN 171
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 34/147 (23%), Positives = 66/147 (44%), Gaps = 17/147 (11%)
Query: 341 SVYKGKLIDGSNVAVKVL----NDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-- 394
S+YKG + V ++ K + NE+ ++ R N++ + GF +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 395 --RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
R +LI E+ + G L + + + L+++T L +A+ +GL L+ T
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYK--YTNKP 145
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKI 479
+ ++ + L+ E++ KI GL KI
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 17/177 (9%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V + + AVKVL K + ++E + + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F F+ + + ++++ G L + R +E + A IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY------AAEIASALGYLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S I++ D+KP NILLD ++DFGL K E + + GT Y+APEV
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 17/110 (15%)
Query: 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIK 457
+ EF++ G L F ++ + ++ T+ A I GL++LH S I++ D+K
Sbjct: 73 FVMEFLNGGDL-MFHIQDKGRFDLYRATF-----YAAEIVCGLQFLH---SKGIIYRDLK 123
Query: 458 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEVF 504
N++LD D KI+DFG+ KE++ A GT YIAPE+
Sbjct: 124 LDNVMLDRDGHIKIADFGMC-----KENVFGDNRASTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVA---VKVLND---SKGNGEEFIN---EVASISRTSHVNV 383
+LG+G +G+VY + D VA +KVL + + N E + E +S+ H +
Sbjct: 7 RLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 384 VTLLGFCFEGRRRALIYEFVSNGSLEKFI--YRNSSSI--ENHKLTWETLLQIAVGIARG 439
V E +I E+ L+ + +++ EN W +Q+ +G+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW--FIQLLLGV--- 119
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
Y+H RILH D+K NI L + KI DFG++ S T GT Y+
Sbjct: 120 -HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVS--RLLMGSCDLATTFTGTPYYM 172
Query: 500 APE 502
+PE
Sbjct: 173 SPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 30/164 (18%)
Query: 352 NVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408
NVA+K L+ ++ + + E+ + +H N++ LL F SL
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 409 EKF--IY-------RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459
E+F +Y N + +L E + + + G+++LH S I+H D+KP
Sbjct: 99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 155
Query: 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
NI++ D KI DFGLA+ + MT T Y APEV
Sbjct: 156 NIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEV 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 19/184 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G VY+ + D + A+KVL+ +K I E + RT ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 389 FCFEGRRRA---LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
F + + L+ +++S G L + + E+ + L +A LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA------LEHLH- 113
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
I++ D+KP NILLD + DFGL+K N ++ + T GT Y+APEV
Sbjct: 114 --KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEVLL 169
Query: 506 RNIG 509
G
Sbjct: 170 DEKG 173
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G V +L V A+KVL + + + E ++ + +T L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 389 FCFEGRRRAL-IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
CF+ + R + E+V+ G L I R+ E + A + L +LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY------AAEVTLALMFLH--- 113
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI---ISMTGARGTVGYIAPEV 503
+++ D+K NILLD + K++DFG+ KE I ++ T GT YIAPE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMC-----KEGILNGVTTTTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 33/137 (24%), Positives = 67/137 (48%), Gaps = 14/137 (10%)
Query: 367 EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW 426
+ I E+ + + +V G + ++ E + GSL++ + + ++
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG------RIPE 102
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486
+ L ++++ + +GL YL +I+H D+KP NIL++ K+ DFG++ + I
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLI 155
Query: 487 ISMTGA-RGTVGYIAPE 502
SM + GT Y++PE
Sbjct: 156 DSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 59/215 (27%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFINEVASISRTSHVNV------VTL 386
+G+G +G V + D ++ A+K+L + +E +VA I + V V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE---QVAHIRAERDILVEADGAWVVK 65
Query: 387 LGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTW--ETLLQIAVGIARGLEYL 443
+ + F+ +R LI EF+ G + + + + E + ET+L I + +
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI--------DAI 117
Query: 444 H-LGCSTRILHFDIKPHNILLDEDFCPKISDFGLA---KICNRKE-------------SI 486
H LG +H DIKP N+LLD K+SDFGL K +R E S
Sbjct: 118 HQLG----FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 487 ISMTGAR-----------------GTVGYIAPEVF 504
+M R GT YIAPEVF
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF 208
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 27/89 (30%), Positives = 32/89 (35%), Gaps = 36/89 (40%)
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAK-------------------------IC---NRK 483
+H DIKP N+LLD K+SDFGL I + K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 484 ESIISMTGAR--------GTVGYIAPEVF 504
+ R GT YIAPEVF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVF 211
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 420 ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
E+ L++ L+ + +A G+E+L S +H D+ N+L+ E KI DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 480 CNRKESIISMTGARGTVGYIAPEVFCRNI 508
R + IS + ++APE N+
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNL 317
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 50/217 (23%)
Query: 334 LGQGGYGSVYKGKL-IDGS------------------------NVAVKVLNDSKGNGEEF 368
LGQG ++Y G+L ++G V +KVL+ S +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 369 INEVASI-SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
E AS+ S+ SH+++ + G C G ++ EFV +G L+ + + + + W+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV---PVAWK 119
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL-----LDEDFCP--KISDFGLA-KI 479
+ +A +A L YL ++H ++ NIL L E P K+SD G++
Sbjct: 120 --ITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+R+E + + +IAPE +S +D
Sbjct: 175 LSREERV-------ERIPWIAPECV-PGGNSLSTAAD 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 334 LGQGGYGSV-YKGKLIDGSNVAVKVLNDSKGNGEEFIN----EVASISRTSHVNVVTLLG 388
LG G G+V ++ DG AVKV+ D +G E N EV + ++V
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVV-DMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 389 FCFEGRRR------------ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
C E + AL+ ++ + G L + I + + + LL I V +
Sbjct: 96 -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR--- 493
A + ++H S ++H DIK NILL + K+ DFG +K+ + +S R
Sbjct: 155 A--VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFC 206
Query: 494 GTVGYIAPEVFCR 506
GT Y+APE++ R
Sbjct: 207 GTPYYVAPEIWRR 219
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 8/66 (12%)
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR--KESIISMTGARGTVG 497
L+ +H S +H D+KP N+LLD+ K++DFG C + ++ A GT
Sbjct: 155 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMDANGMVRCDTAVGTPD 208
Query: 498 YIAPEV 503
YI+PEV
Sbjct: 209 YISPEV 214
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 334 LGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTL 386
+G+G +G V +++ G A+KV+ S +E F E I S+ +
Sbjct: 9 VGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 387 LGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L + F+ + L+ E+ G L + R + E + Q +A + +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD------EDMAQFY--LAELVLAIHS 117
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+H DIKP N+L+D K++DFG A + + S GT YIAPEV
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEV 174
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 424 LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483
LT LL +ARG+E+L S +H D+ N+LL + KI DFGLA+
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 484 ESIISMTGARGTVGYIAPEVFCRNI 508
+ +S V ++APE N+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNL 315
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 76/242 (31%)
Query: 334 LGQGGYGSVYK------GKLIDGSNVAVKVLNDSKGNGEE--FINEVASISRT-SHVNVV 384
LG G +G V + GK + VAVK+L S E ++E+ +S H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 385 TLLGFCFEG-------------------RRRALIY-EFVS-------------NGSLEKF 411
LLG C G R++A + FV N +LEK
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165
Query: 412 IYRNSSSI-------------------------------ENHKLTWETLLQIAVGIARGL 440
R+ S ++ L + LL+ + +A+G+
Sbjct: 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
++L S +H D+ N+LL + KI DFGLA+ + + AR V ++A
Sbjct: 226 DFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMA 282
Query: 501 PE 502
PE
Sbjct: 283 PE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSK-GNGEEFINEVASISRTSHVN--VVTLLGF 389
+G+G +G V + + D + A+K + + + E + +A + + VN + L F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 390 CFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
F+ + L+ F++ G L + R + + L A LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA------LENLH---K 111
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+++ D+KP NILLD + DFGL K+ N K+ + T GT Y+APE+
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFC-GTPEYLAPELL 165
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 19/49 (38%), Positives = 31/49 (63%), Gaps = 3/49 (6%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484
+A L+YLH I+H D+KP N+L+ + K++DFGL+K+ +E
Sbjct: 113 VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 20/55 (36%), Positives = 32/55 (58%), Gaps = 1/55 (1%)
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+H DIKP N+LLD + +++DFG N ++ + + A GT YI+PE+
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN-QDGTVQSSVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 30/81 (37%), Positives = 39/81 (48%), Gaps = 12/81 (14%)
Query: 429 LLQIAVGIARGL----EYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNR 482
L Q+ +AR L +Y+H I+H DIK N+L++ ED C + DFG A
Sbjct: 259 LAQVT-AVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARG 312
Query: 483 KESIISMTGARGTVGYIAPEV 503
S G GTV APEV
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEV 333
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 51/214 (23%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFINEVAS----ISRTSHVNVVTLLG 388
+G+G +G V + D +V A+K+L + +E + + + + + VV +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF- 67
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH-LG 446
+ F+ + LI EF+ G + + + + E ET IA + ++ +H LG
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE-----ETQFYIAETVL-AIDSIHQLG 121
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLA---KICNRKE-------------SIISMT 490
+H DIKP N+LLD K+SDFGL K +R E + +M
Sbjct: 122 ----FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 491 GAR-----------------GTVGYIAPEVFCRN 507
R GT YIAPEVF +
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.94 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.93 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.93 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.93 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.91 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.91 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.91 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.91 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.9 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.9 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.9 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.89 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.89 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.88 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.88 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.87 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.83 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.81 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.81 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.65 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.49 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.47 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.33 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.22 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.54 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.51 | |
| PLN02236 | 344 | choline kinase | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.04 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.99 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.97 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.92 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.8 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.47 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.34 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.06 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.54 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.48 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.26 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.2 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=319.95 Aligned_cols=194 Identities=51% Similarity=0.883 Sum_probs=172.8
Q ss_pred CCccccHHHHHHHHHhhh--hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC-chhHHHHHHHhhccCCcceeeEEEEE
Q 036471 314 APRRYSYADIKKMTNSFK--YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-GEEFINEVASISRTSHVNVVTLLGFC 390 (516)
Q Consensus 314 ~~~~~~~~el~~~~~~~~--~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~ 390 (516)
..+.|++.||.++|++|. ..||+|+||.||+|.+.+|+.||||++...... .++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 677899999999999998 689999999999999999999999988765554 67799999999999999999999999
Q ss_pred eecC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcE
Q 036471 391 FEGR-RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 469 (516)
Q Consensus 391 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 469 (516)
.+.+ ...||||||++|+|.++|+.... . .++|..+++||.++|+||+|||..+...||||||||+|||||+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~---~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG---E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC---C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9998 59999999999999999987542 1 88999999999999999999998777789999999999999999999
Q ss_pred EEeecCCcccccC-CCcceeeccC-CCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNR-KESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||+|+.... .... ... .||.+|+|||++.. |..+.|||
T Consensus 217 KlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~--g~lt~KsD 260 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYAST--GKLTEKSD 260 (361)
T ss_pred EccCccCcccCCccccce---eeecCCCCccCChhhhcc--CCcCcccc
Confidence 9999999976554 3221 112 79999999999944 89999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=297.02 Aligned_cols=173 Identities=31% Similarity=0.493 Sum_probs=154.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.++||+|+|++||+|+++ ++..||||.+.... ...+.+..|+.+|+.++|||||+++++.++++..+|||||+.|
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 3456999999999999986 48999999996543 3446678999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC------CcEEEeecCCccc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED------FCPKISDFGLAKI 479 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~Dfg~a~~ 479 (516)
|+|.+||+++ +.+++..+..++.|||.||++|| +++||||||||+||||+.. -.+||+|||+|+.
T Consensus 94 GDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 94 GDLSDYIRRR------GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999876 47999999999999999999999 9999999999999999764 4689999999999
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... ....|++.|||||+++. .+|+.|+|
T Consensus 165 L~~~~~a---~tlcGSplYMAPEV~~~--~~YdAKAD 196 (429)
T KOG0595|consen 165 LQPGSMA---ETLCGSPLYMAPEVIMS--QQYDAKAD 196 (429)
T ss_pred CCchhHH---HHhhCCccccCHHHHHh--ccccchhh
Confidence 9866543 45789999999999954 79999988
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=287.71 Aligned_cols=179 Identities=37% Similarity=0.572 Sum_probs=154.6
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecC-eeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGR-RRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~ 404 (516)
.+.+.||+|+||+||+|.+.....||+|++...... .++|.+|+.+|.+++|||||+++|++.+.. ...|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345669999999999999965555999999754322 468999999999999999999999999988 7999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCCCcEEECCCC-cEEEeecCCcccccC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR-ILHFDIKPHNILLDEDF-CPKISDFGLAKICNR 482 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 482 (516)
+|+|.+++++. ....+++..+++++.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 124 ~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 124 GGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999874 2368999999999999999999999 888 99999999999999998 999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ...+...||+.|||||++.++...++.|+|
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~D 228 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSD 228 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccch
Confidence 32 233557899999999999642357999988
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=274.48 Aligned_cols=174 Identities=28% Similarity=0.374 Sum_probs=154.9
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||+||+++.++ ++.+|+|++++. ....+...+|..+|.+++||.||+++..|++.+.+|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 55789999999999998765 889999999763 2345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
||.|..+|++. ..+++..+.-++.+|+.||.||| +++||||||||+|||||.+|+++|+|||+++..-...
T Consensus 109 GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999765 67999999999999999999999 9999999999999999999999999999998654443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|||||++++ ..++.++|
T Consensus 180 ~~--t~tfcGT~eYmAPEil~~--~gy~~~vD 207 (357)
T KOG0598|consen 180 DA--TRTFCGTPEYMAPEILLG--KGYDKAVD 207 (357)
T ss_pred Cc--cccccCCccccChHHHhc--CCCCcccc
Confidence 22 244789999999999977 58888887
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=272.23 Aligned_cols=181 Identities=29% Similarity=0.430 Sum_probs=157.5
Q ss_pred cccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec--CCCCchhHHHHHHHhhccCCcceeeEEEEEeec
Q 036471 317 RYSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLGFCFEG 393 (516)
Q Consensus 317 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 393 (516)
..+..||+. .+.||+|..|+||+++++ +++.+|+|++.. .....+++.+|++++++.+||+||+++|.|...
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 355556653 357999999999999987 478899999943 344558899999999999999999999999999
Q ss_pred Ce-eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 394 RR-RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 394 ~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
+. ..|+||||++|+|++++... +.+++..+.+|+.+|++||.|||. .++||||||||+||||+..|.+||+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEec
Confidence 84 99999999999999999654 579999999999999999999994 3999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||.++.+.... .....||..|||||.+.+ ..|+.++|
T Consensus 222 DFGVS~~lvnS~----a~tfvGT~~YMsPERi~g--~~Ys~~sD 259 (364)
T KOG0581|consen 222 DFGVSGILVNSI----ANTFVGTSAYMSPERISG--ESYSVKSD 259 (364)
T ss_pred cccccHHhhhhh----cccccccccccChhhhcC--CcCCcccc
Confidence 999998776551 256889999999999965 68999888
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=284.33 Aligned_cols=187 Identities=33% Similarity=0.542 Sum_probs=166.5
Q ss_pred HHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 320 YADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 320 ~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
..++.+....+.++||+|-||+||.|.+.....||+|.++......++|.+|+++|++++|+|||++++++..++.++||
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34555556667889999999999999998888999999998777779999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
||||+.|+|.++|+.. .+..+...+++.++.|||+||+||. ++++|||||.++||||+++..+||+|||+|+.
T Consensus 280 tE~m~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999873 3477999999999999999999999 99999999999999999999999999999996
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...+... ...+..-+..|.|||.+ +.+.+|.|||
T Consensus 353 ~~d~~Y~-~~~~~kfPIkWtAPEa~--~~~~FS~kSD 386 (468)
T KOG0197|consen 353 IGDDEYT-ASEGGKFPIKWTAPEAL--NYGKFSSKSD 386 (468)
T ss_pred cCCCcee-ecCCCCCCceecCHHHH--hhCCcccccc
Confidence 5555443 33555668899999999 5589999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=273.79 Aligned_cols=169 Identities=33% Similarity=0.470 Sum_probs=146.5
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
.+-+.+.+|+|+||.|-+|..+ +|+.||||++++... ......+|+++|++++|||||+++++++..+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3445678999999999999864 699999999975321 2244679999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CcEEEeec
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDF 474 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Df 474 (516)
+||||++||+|.+.+-.. +.+.++.-..+++|++.|+.||| ++||+||||||+|||+..+ ..+||+||
T Consensus 253 mVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred EEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999654 56888888999999999999999 9999999999999999766 78999999
Q ss_pred CCcccccCCCcceeeccCCCCcccccccccccc
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
|+|+...... .+....|||.|.|||++...
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~k 353 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASK 353 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecC
Confidence 9999876433 24668899999999999664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.57 Aligned_cols=178 Identities=31% Similarity=0.441 Sum_probs=158.3
Q ss_pred HHHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+|...+.||+|||+.+|+++. ..|+.||+|++.+ .....+.+.+|+++.++++|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3455567899999999999998 6799999999976 4556688999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
|+++.++|.++++++ ++++|.+++.+++||+.||.||| +.+|+|||||..|+||+++.++||+|||+|..+
T Consensus 98 ELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeee
Confidence 999999999999854 68999999999999999999999 999999999999999999999999999999888
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..++.. .....|||.|+|||++.+ ...+..+|
T Consensus 169 e~~~Er--k~TlCGTPNYIAPEVl~k--~gHsfEvD 200 (592)
T KOG0575|consen 169 EYDGER--KKTLCGTPNYIAPEVLNK--SGHSFEVD 200 (592)
T ss_pred cCcccc--cceecCCCcccChhHhcc--CCCCCchh
Confidence 755322 134789999999999965 56677766
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.67 Aligned_cols=182 Identities=27% Similarity=0.444 Sum_probs=155.0
Q ss_pred HhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEE-EeecCe-eEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGF-CFEGRR-RALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~-~~~~~~-~~lv~e 401 (516)
+.+.++||+|.||+||++.. .+|..||.|.++-.. ...++...|+.+|++++|||||+++++ +.++.. ++||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 34567899999999999974 589999999987432 334678999999999999999999984 444444 899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|+..|+|..++++.+. +.+.+++..+|+++.|++.||.++|... .+ |+||||||.||+|+.+|.+||+|||+++.
T Consensus 101 ~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred hhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999987753 4578999999999999999999999321 44 89999999999999999999999999999
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....+. ..+.+|||.||+||.+.+ ..|+.|||
T Consensus 178 l~s~~tf--A~S~VGTPyYMSPE~i~~--~~Y~~kSD 210 (375)
T KOG0591|consen 178 LSSKTTF--AHSLVGTPYYMSPERIHE--SGYNFKSD 210 (375)
T ss_pred hcchhHH--HHhhcCCCcccCHHHHhc--CCCCcchh
Confidence 8776543 256889999999999966 68999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=271.65 Aligned_cols=175 Identities=30% Similarity=0.411 Sum_probs=153.4
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEecC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEFVS 404 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 404 (516)
.++||+|+||.||+|+.. +|+.||+|++..+. ....-..+|+.+|++++||||+++.+...+. ..+|||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 357999999999999864 69999999997543 3346678999999999999999999998876 68999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
. +|.-++... .-.+++.++..+++|++.||+|+| .+||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 202 h-DL~GLl~~p-----~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 202 H-DLSGLLSSP-----GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred c-hhhhhhcCC-----CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 7 899888653 357999999999999999999999 9999999999999999999999999999999877665
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ++..+-|..|+|||.|++. ..|+.+.|
T Consensus 273 ~~~-~T~rVvTLWYRpPELLLG~-t~Yg~aVD 302 (560)
T KOG0600|consen 273 SAP-YTSRVVTLWYRPPELLLGA-TSYGTAVD 302 (560)
T ss_pred Ccc-cccceEEeeccChHHhcCC-ccccccee
Confidence 432 4667789999999999986 58888876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=253.72 Aligned_cols=178 Identities=31% Similarity=0.419 Sum_probs=157.8
Q ss_pred ccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEee
Q 036471 318 YSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFE 392 (516)
Q Consensus 318 ~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 392 (516)
++++|.+ +.+.||.|+||.|.+++.+ +|..+|+|++++.. .+.+...+|..+|+.+.||.++++++.+.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 6777665 3467999999999999976 47889999997542 344678899999999999999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
.+.+++||||++||.|..+|++. +++++..+.-++.||+.||+||| +.+|++|||||+|||||++|.+||+
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKit 186 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKIT 186 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEE
Confidence 99999999999999999999865 57999999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+|+...... -...|||.|+|||++.. +.++.++|
T Consensus 187 DFGFAK~v~~rT-----~TlCGTPeYLAPEii~s--k~ynkavD 223 (355)
T KOG0616|consen 187 DFGFAKRVSGRT-----WTLCGTPEYLAPEIIQS--KGYNKAVD 223 (355)
T ss_pred eccceEEecCcE-----EEecCCccccChHHhhc--CCCCcchh
Confidence 999999776552 34789999999999955 68888877
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=272.93 Aligned_cols=178 Identities=31% Similarity=0.417 Sum_probs=156.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhH--HHHHHHhhccC-CcceeeEEEEEeecC-eeEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEF--INEVASISRTS-HVNVVTLLGFCFEGR-RRALIY 400 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv~ 400 (516)
.+|...++||.|+||.||+|+.+ +|..||||++++.-...++. +||+..|++++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 35566788999999999999865 58999999998765555444 68999999998 999999999999988 999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
|||+. +|.++++++. ..+++..+..|+.||++||+|+| .+|+.||||||+|||+.....+||+|||+|+.+
T Consensus 90 E~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred Hhhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence 99965 9999998764 78999999999999999999999 999999999999999998889999999999987
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .+..+.|..|+|||+|++. +.|+.+.|
T Consensus 161 ~SkpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD 192 (538)
T KOG0661|consen 161 RSKPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVD 192 (538)
T ss_pred ccCCC---cchhhhcccccchHHhhhc-cccCCchH
Confidence 65543 4667789999999999885 78888877
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=263.29 Aligned_cols=167 Identities=34% Similarity=0.510 Sum_probs=143.2
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhc--cCCcceeeEEEEEeecC----eeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFCFEGR----RRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e~~ 403 (516)
+.+.||+|+||.||+|.+ +++.||||++.. ++.+.|.+|-++.+. ++|+||+++++.-.... .++||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 456799999999999998 569999999954 334567777776664 58999999999877655 889999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL------GCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+.|+|.++|.. ..++|....+|+..+++||+|||. ++...|+|||||.+||||..|++..|+|||+|
T Consensus 291 ~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 291 PKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred cCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999965 579999999999999999999995 34567999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccc
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
..+............+||.+|||||+|.+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence 98876655544556789999999999943
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=252.25 Aligned_cols=173 Identities=25% Similarity=0.399 Sum_probs=149.8
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCc---hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
.++|+|+||.||+++.++ |+.||||++..+..+. +-.++|+.+|++++|+|+|.++++|......+||+||++. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 469999999999999875 8999999997655432 5578999999999999999999999999999999999987 5
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
+.+.|.+.. ..++.+.+.+++.|++.|+.|+| ++++|||||||+||||+.+|.+||+|||+|+.+......
T Consensus 87 vL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~- 157 (396)
T KOG0593|consen 87 VLHELERYP-----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN- 157 (396)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch-
Confidence 555555532 56899999999999999999999 999999999999999999999999999999998754332
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+....|..|+|||.+.+. -+|+..+|
T Consensus 158 -YTDYVATRWYRaPELLvGD-tqYG~pVD 184 (396)
T KOG0593|consen 158 -YTDYVATRWYRAPELLVGD-TQYGKPVD 184 (396)
T ss_pred -hhhhhhhhhccChhhhccc-CcCCCccc
Confidence 3667789999999999875 47777766
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=276.34 Aligned_cols=190 Identities=27% Similarity=0.509 Sum_probs=162.2
Q ss_pred cccHHHHHHHHHhh-----------hhhcccCCcEEEEEEEECC----CCEEEEEEeecC--CCCchhHHHHHHHhhccC
Q 036471 317 RYSYADIKKMTNSF-----------KYKLGQGGYGSVYKGKLID----GSNVAVKVLNDS--KGNGEEFINEVASISRTS 379 (516)
Q Consensus 317 ~~~~~el~~~~~~~-----------~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~ 379 (516)
.++|+|-..+..+| .+.||.|.||+|++|+++- ...||||.++.. ..+..+|+.|+.+|.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 45666655555544 3569999999999999863 357999999864 455689999999999999
Q ss_pred CcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 036471 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459 (516)
Q Consensus 380 h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~ 459 (516)
||||++|.|+.......+||+|||++|+|+.+|+.+. ..+++.++..++++||.||+||- +.++|||||.++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAAR 760 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAAR 760 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhh
Confidence 9999999999999999999999999999999998764 56999999999999999999999 999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCC-cceeeccCCCCccccccccccccccccccCCC
Q 036471 460 NILLDEDFCPKISDFGLAKICNRKE-SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 460 NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||||+.+..+||+|||+++.+.++. ......+.+-+.+|.|||.| .+.+++.+||
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI--a~RKFTsASD 816 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI--AYRKFTSASD 816 (996)
T ss_pred heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHh--hhcccCchhh
Confidence 9999999999999999999886654 22223344557899999999 5589999988
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=241.88 Aligned_cols=175 Identities=31% Similarity=0.439 Sum_probs=152.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
-.+++|+|.||.||+|++. +|+.||+|+++..... ....++|+..|+.++|+||+.+++++...+...||+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 3467999999999999864 6999999999754322 36789999999999999999999999999999999999976
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|+..++.. ...++..++..++.++++||+|+| .+.|+||||||.|+||+++|.+||+|||+|+.+.....
T Consensus 86 -dLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 86 -DLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred -cHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 999999764 367999999999999999999999 99999999999999999999999999999999876654
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. +..+-|..|+|||.+.+. ..|+...|
T Consensus 157 ~~--~~~V~TRWYRAPELLfGs-r~Yg~~VD 184 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGS-RQYGTGVD 184 (318)
T ss_pred cc--ccceeeeeccChHHhccc-hhcCCcch
Confidence 33 233669999999999874 56766655
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=265.24 Aligned_cols=176 Identities=31% Similarity=0.424 Sum_probs=153.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
|.+.||.|+|++|++|+.+ .++.+|||++.+. ....+-+.+|-+.|.+| .||.|++|+-.|.++..+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 6778999999999999875 5899999999653 23335677888999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.++|++. +.+++.....++.||+.||+||| ++|||||||||+|||||+|+++||+|||.|+.+...
T Consensus 157 ~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 157 PNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999876 57999999999999999999999 999999999999999999999999999999988654
Q ss_pred Ccc-----------eeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESI-----------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....++||..|.+||+|.+ +..++.+|
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sD 269 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSD 269 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccc
Confidence 322 01144789999999999955 78888887
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=282.48 Aligned_cols=191 Identities=31% Similarity=0.523 Sum_probs=161.4
Q ss_pred HHHHHHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEee
Q 036471 321 ADIKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFE 392 (516)
Q Consensus 321 ~el~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 392 (516)
.++.+....+.++||+|+||+||+|+.. +...||||.+++... ..++|.+|++++..++|||||+++|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3455555557788999999999999843 356799999987543 45899999999999999999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIE--------NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD 464 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~ 464 (516)
++.+++|+|||..|||.++|+.+..... ..+++..+.+.||.|||.||+||- ++.+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 9999999999999999999987643211 234899999999999999999999 99999999999999999
Q ss_pred CCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 465 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 465 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++..|||+|||+++.+-..+.........-+.+|||||.|+. ++||.+||
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSD 687 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESD 687 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--Ccccchhh
Confidence 999999999999988765554433223335789999999954 89999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=253.90 Aligned_cols=168 Identities=29% Similarity=0.473 Sum_probs=141.8
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhc--cCCcceeeEEEEEeec----CeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFCFEG----RRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~lv~e~ 402 (516)
.+.+.||+|.||+||+|++ .|+.||||++.. .+++.+.+|.++.+. ++|+||+.+++.-..+ .+++||++|
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 3457799999999999999 799999999954 345678888888776 4999999999876543 378999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
.+.|||.|||.+ ..++.+.+++++..+|.||+|||.+ ....|+|||||++||||.+++.+.|+|+|+|
T Consensus 291 He~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 291 HEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred ccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999965 5699999999999999999999952 3567999999999999999999999999999
Q ss_pred ccccCCCcc--eeeccCCCCccccccccccc
Q 036471 478 KICNRKESI--ISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 478 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~ 506 (516)
.....+... .......||.+|||||+|.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhh
Confidence 776655332 23355779999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=253.85 Aligned_cols=183 Identities=26% Similarity=0.366 Sum_probs=160.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.|++.+.||.|..++||+|+.. .++.||||+++-. ..+.+.+.+|+..++.++||||++++..|..++.+|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 4456678999999999999854 5899999999753 344688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
.+|++.++++..- ...+++..+..|++++++||.||| .+|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus 107 a~GS~ldIik~~~----~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 107 AGGSLLDIIKTYY----PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred cCCcHHHHHHHHc----cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999998763 245999999999999999999999 999999999999999999999999999998766544
Q ss_pred Cccee--eccCCCCccccccccccccccccccCCC
Q 036471 484 ESIIS--MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|||||+++++...|+.|+|
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaD 214 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKAD 214 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhh
Confidence 32211 1457899999999998888889999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=262.42 Aligned_cols=175 Identities=33% Similarity=0.459 Sum_probs=156.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.+.||+|.||.||||+-+ +.+.||+|.+.+.... .+.+.+|++++++++|||||.++++|+....+++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 345578999999999999876 5789999999765433 466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
.| +|..+|... ..++++.+..++.|++.||.||| +.+|+|||+||.|||++.++.+|++|||+|+.+...
T Consensus 84 ~g-~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 77 999999754 67999999999999999999999 999999999999999999999999999999988776
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .+..+|||.|||||++.+ +.|+..+|
T Consensus 154 t~v--ltsikGtPlYmAPElv~e--~pyd~~sD 182 (808)
T KOG0597|consen 154 TSV--LTSIKGTPLYMAPELVEE--QPYDHTSD 182 (808)
T ss_pred cee--eeeccCcccccCHHHHcC--CCccchhh
Confidence 443 477899999999999954 78988887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=249.81 Aligned_cols=180 Identities=36% Similarity=0.446 Sum_probs=148.6
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecC--eeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--RRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~ 403 (516)
+...+.||+|+||.||++...+ |+..|||.+.... ...+.+.+|+.+|.+++|||||+++|...... .++++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3445779999999999999865 8999999986542 12567899999999999999999999755444 688999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 482 (516)
++|+|.+++.+.. ..+++..+..+++||++||+||| ++||+|+||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred CCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999998753 26999999999999999999999 999999999999999999 79999999999987764
Q ss_pred CC-cceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KE-SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ........+||+.|||||++.. ......++|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sD 204 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESD 204 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccch
Confidence 11 1122345789999999999964 122334666
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=265.48 Aligned_cols=184 Identities=34% Similarity=0.557 Sum_probs=155.8
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
||......+.+.||+|.||+||+|+|. ..||||+++.. ....+.|.+|+..+++.+|.||+-+.|++..... .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333333345678999999999999983 57999999753 3456889999999999999999999999988877 99
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
|+.+++|-+|+.+|+..+ .+++..+.+.|+.||++||.||| .++|||||||..||++.++++|||+|||++.
T Consensus 465 iTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999998653 77999999999999999999999 9999999999999999999999999999996
Q ss_pred cccCCCcceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
.-.............|..-|||||+++.+ ..+|++.||
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSD 575 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSD 575 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccc
Confidence 55444333333456688999999999654 368888888
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=250.54 Aligned_cols=171 Identities=26% Similarity=0.390 Sum_probs=153.3
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.++++.+.||+|+||+|-+|.. ..|+.||||.+++++ ++.-.+.+|+++|+.++||||+.++++|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345677788999999999999986 679999999997643 334567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||..+|.|.+|+.++ +.+++.++..+++||..|+.|.| .++++|||||.+|||+|+++++||+|||++.
T Consensus 131 vMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhh
Confidence 99999999999999765 67999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccc
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
++..+.- ...+.|+|-|.+||++-+
T Consensus 202 ly~~~kf---LqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 202 LYADKKF---LQTFCGSPLYASPEIVNG 226 (668)
T ss_pred hhccccH---HHHhcCCcccCCccccCC
Confidence 8776653 356889999999999944
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=261.46 Aligned_cols=171 Identities=32% Similarity=0.480 Sum_probs=153.9
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCc-hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG-EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
++||+|+.|.||.++.. +++.||+|++....+.. +-+++|+.+|+..+|+|||.+++-|...+.+|+|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 46999999999999754 68899999998765544 56789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+.+.. ..+++.++..|.+++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+...... .
T Consensus 359 DvVt~-------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R 426 (550)
T KOG0578|consen 359 DVVTK-------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--R 426 (550)
T ss_pred hhhhc-------ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--c
Confidence 99854 56999999999999999999999 999999999999999999999999999999888766542 2
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....|||.|||||++.+ +.|++|.|
T Consensus 427 ~TmVGTPYWMAPEVvtr--k~YG~KVD 451 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTR--KPYGPKVD 451 (550)
T ss_pred ccccCCCCccchhhhhh--cccCcccc
Confidence 56789999999999976 78999988
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.73 Aligned_cols=141 Identities=27% Similarity=0.334 Sum_probs=129.6
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.++||+|+||+||+++-+ +|..+|+|+++++ ..+.+.+..|-.+|...++|.||+++..|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 467999999999999876 4899999999874 34567888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
|++..+|.+. ..|+++.+..++.+++.|++.|| ..|+|||||||+|+|||..|++||+|||++.-+
T Consensus 226 GD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 226 GDMMTLLMRK------DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred ccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999654 67999999999999999999999 999999999999999999999999999998443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=242.57 Aligned_cols=173 Identities=27% Similarity=0.349 Sum_probs=150.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~ 405 (516)
..|++|+||.||+|+++ +++.||+|+++.++.. .-.-++|+.+|.+++|||||.+-.+... -+..|+||||++.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 46999999999999986 5889999999765422 1356899999999999999999998774 3579999999987
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|..++.... .++...++..+..|+++||+||| .+.|+|||||++|+|++..|.+||+|||+|+.+.....
T Consensus 162 -DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 162 -DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred -hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999997643 67999999999999999999999 99999999999999999999999999999998876643
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.++...-|..|+|||.+++. ..|+.+.|
T Consensus 233 --~~T~lVVTLWYRaPELLLG~-~tyst~iD 260 (419)
T KOG0663|consen 233 --PYTPLVVTLWYRAPELLLGA-KTYSTAVD 260 (419)
T ss_pred --cCcceEEEeeecCHHHhcCC-cccCcchh
Confidence 34667789999999999874 67887766
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=258.92 Aligned_cols=188 Identities=28% Similarity=0.448 Sum_probs=163.5
Q ss_pred HHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 320 YADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 320 ~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..|+.+....+.++||+|-||+|.++....+..||||+++... ....+|.+|+.+|.+++||||++++|+|..++.+.
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 4466666677889999999999999999778999999997643 33489999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+|+|||++|+|.+++..+.. ..+......+|+.||+.||+||. +.++|||||.++|+|++.++++||+|||++
T Consensus 612 mI~EYmEnGDLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC----cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 99999999999999987632 22455667789999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+-..+.........-+.+|||||.+.- |+++.+||
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSD 721 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASD 721 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHh--ccccchhh
Confidence 97766665544444566889999999965 89999998
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=240.65 Aligned_cols=177 Identities=32% Similarity=0.440 Sum_probs=150.1
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcc-eeeEEEEEeecC------eeEEE
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVN-VVTLLGFCFEGR------RRALI 399 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~~~lv 399 (516)
.++||+|+||+||+|+.+ +|+.||+|+++.... ......+|+.++++++|+| |+.+++++.+.+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 356999999999999865 689999999975443 3356799999999999999 999999998877 88999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+||++. +|.+++...... ...++...+..++.||+.||+||| +++|+||||||.||||+++|.+||+|||+|+.
T Consensus 96 fe~~d~-DL~~ymd~~~~~--~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKK--PQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEeecc-cHHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 999965 999999875421 145777899999999999999999 99999999999999999999999999999986
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..-... ..+...+|..|+|||++++. ..|+...|
T Consensus 170 ~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vD 203 (323)
T KOG0594|consen 170 FSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVD 203 (323)
T ss_pred hcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcc
Confidence 653332 24667889999999999885 45777665
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=256.78 Aligned_cols=177 Identities=30% Similarity=0.452 Sum_probs=150.7
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----C--CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----K--GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||+|+.|... +++.||+|++.+. . ...+.+.+|+.++++++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4456678999999999999765 6899999977553 1 22356678999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLA 477 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a 477 (516)
||||+.+|+|.+++.+. .++.+..+..++.|++.|++|+| ++||+||||||+|||++.+ +++||+|||++
T Consensus 98 vmEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999763 67899999999999999999999 9999999999999999999 99999999999
Q ss_pred cccc-CCCcceeeccCCCCccccccccccccccccc-cCCC
Q 036471 478 KICN-RKESIISMTGARGTVGYIAPEVFCRNIGEVS-YKSD 516 (516)
Q Consensus 478 ~~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s-~~sD 516 (516)
.... .+. ......||+.|+|||++.+. +.|+ .++|
T Consensus 169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aD 205 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGSPAYAAPEVLSGK-GTYSGKAAD 205 (370)
T ss_pred cccCCCCC---cccCCCCCcccCCHHHhCCC-CCcCCchhh
Confidence 9874 222 23567899999999999764 2143 5554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=260.40 Aligned_cols=175 Identities=35% Similarity=0.544 Sum_probs=149.0
Q ss_pred hhhhcccCCcEEEEEEEECC--C---CEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLID--G---SNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~--~---~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.++||+|+||+||+|+++. + ..||+|..+. ......++++|++++++++|||||+++|+...+..++|||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45789999999999998753 2 2389999874 2344578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
|++.||+|.++|+... ..++..+.+.++.+.|.||+||| +++++||||.++|+|++.++.+||+|||+++.-
T Consensus 241 El~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 9999999999998753 36999999999999999999999 999999999999999999999999999998754
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .........-+.+|+|||.+ +.+.+|++||
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl--~~~~~s~kTD 344 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETL--NTGIFSFKTD 344 (474)
T ss_pred cc--eeeccccccCcceecChhhh--ccCccccccc
Confidence 31 11111123457899999999 4479999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=251.92 Aligned_cols=186 Identities=30% Similarity=0.464 Sum_probs=149.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeec-Ce
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEG-RR 395 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~ 395 (516)
..+.+.++||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+.++.++ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3455678899999999999974 235689999997533 2335789999999999 899999999988764 45
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC--------------------------------------------------------C
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSS--------------------------------------------------------I 419 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~ 419 (516)
.+++|||+++|+|.++++..... .
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999999754210 0
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCcccc
Q 036471 420 ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499 (516)
Q Consensus 420 ~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 499 (516)
....+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.+.............+++.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 1235888999999999999999999 8999999999999999999999999999998764433322223345678899
Q ss_pred ccccccccccccccCCC
Q 036471 500 APEVFCRNIGEVSYKSD 516 (516)
Q Consensus 500 aPE~l~~~~~~~s~~sD 516 (516)
|||++.+ +.++.++|
T Consensus 244 aPE~~~~--~~~~~~sD 258 (338)
T cd05102 244 APESIFD--KVYTTQSD 258 (338)
T ss_pred CcHHhhc--CCCCcccC
Confidence 9999955 67888888
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=248.46 Aligned_cols=172 Identities=27% Similarity=0.349 Sum_probs=147.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+++.. +|+.||+|+++.. ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999875 5899999999753 223356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 999998653 56899999999999999999999 99999999999999999999999999999875432221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 151 -~~~~~~gt~~y~aPE~~~~--~~~~~~~D 177 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLED--NDYGRAVD 177 (323)
T ss_pred -cccceecCccccChhhhcC--CCCCcccc
Confidence 1234568999999999955 57788887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=228.10 Aligned_cols=186 Identities=27% Similarity=0.385 Sum_probs=157.7
Q ss_pred CCCccccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEE
Q 036471 313 LAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLL 387 (516)
Q Consensus 313 ~~~~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~ 387 (516)
...+.++.++++ +.+.||+|.||.||.|+.+ ++-.||+|++.++. ...+++.+|+++.+.++||||++++
T Consensus 14 ~~~~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 14 RATKTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred ccccccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence 344566666654 6788999999999999875 47789999997542 3447889999999999999999999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF 467 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 467 (516)
+++.++...||++||.+.|+|...|+..+ ...+++...+.++.|+|.||.|+| .++++||||||+|+|++.++
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~----~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~ 161 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGR----MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAG 161 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcc----cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCC
Confidence 99999999999999999999999998653 367899999999999999999999 99999999999999999999
Q ss_pred cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 468 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+||+|||-+..-.... .....||..|.|||+..+ ...+.+.|
T Consensus 162 ~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~--~~hd~~Vd 204 (281)
T KOG0580|consen 162 ELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEG--RGHDKFVD 204 (281)
T ss_pred CeeccCCCceeecCCCC----ceeeecccccCCHhhcCC--CCccchhh
Confidence 99999999987654222 144678999999999944 56666655
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=247.13 Aligned_cols=185 Identities=29% Similarity=0.472 Sum_probs=150.4
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-----------------CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-----------------GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLL 387 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~ 387 (516)
.+.+.++||+|+||.||++.+.+ +..||+|.+..... ...++.+|+.++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 44566789999999999997532 33699999865322 235789999999999999999999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSS-------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHF 454 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~ 454 (516)
+++.+.+..++||||+++++|.+++...... .....+++..++.++.||+.||+||| +.+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 9999999999999999999999999754211 11235788999999999999999999 8999999
Q ss_pred CCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 455 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 455 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||||+|||+++++.+||+|||+++.+.............++..|+|||++.. +.++.++|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 222 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASD 222 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhh
Confidence 9999999999999999999999986644432222223446789999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=249.86 Aligned_cols=173 Identities=27% Similarity=0.365 Sum_probs=150.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++.+.+++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345678999999999999986 5889999998643 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 100 VVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999754 46889999999999999999999 99999999999999999999999999999986643
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....|++.|+|||++.+ ..++.++|
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 197 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQS--KGHGKAVD 197 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcC--CCCCCcce
Confidence 32 23468999999999955 56788887
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=272.77 Aligned_cols=189 Identities=32% Similarity=0.538 Sum_probs=160.4
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECC--CC----EEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecC
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLID--GS----NVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR 394 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~--~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 394 (516)
+.+....+.+.||+|.||.||+|...+ |. .||+|.+++. .+...+|++|..+|+.++|||||+++|++.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445555567789999999999998754 43 4899999764 455689999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSI-ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
..+|++|||++|+|..+|++.+... ....++..+++.++.|||+|++||+ ++++|||||.++|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999999864322 2467999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|+.+-..+.........-..+|||||.+.+ +.++.|||
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSD 886 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSD 886 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh--cccccccc
Confidence 999996655554333222345679999999965 89999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=242.98 Aligned_cols=169 Identities=30% Similarity=0.417 Sum_probs=140.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---------------CchhHHHHHHHhhccCCcceeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---------------NGEEFINEVASISRTSHVNVVTLLGFCF 391 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 391 (516)
+.+.+.||+|.||.|-+|+.. +++.||||++.+.+. ..++..+|+.+|++++|||||+|+++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 345678999999999999975 689999999964211 1257889999999999999999999987
Q ss_pred e--cCeeEEEEEecCCCCHHHHHhhcCCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc
Q 036471 392 E--GRRRALIYEFVSNGSLEKFIYRNSSSIENHK-LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 468 (516)
Q Consensus 392 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 468 (516)
+ .+.+|||+||+..|.+...= ...+ +++.++++++++++.||+||| .+|||||||||+|+||+++|+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 6 46899999999988876532 2234 999999999999999999999 999999999999999999999
Q ss_pred EEEeecCCcccccCC---CcceeeccCCCCccccccccccc
Q 036471 469 PKISDFGLAKICNRK---ESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 469 ~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
+||+|||.+...... ..........|||.|||||...+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999999999766322 11122344789999999999866
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=245.09 Aligned_cols=170 Identities=22% Similarity=0.324 Sum_probs=146.8
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999976 4789999998642 23346778899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 81 FHHLQRE------GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 9999653 46899999999999999999999 99999999999999999999999999999975433222 1
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 150 ~~~~~gt~~y~aPE~~~~--~~~~~~~D 175 (312)
T cd05585 150 TNTFCGTPEYLAPELLLG--HGYTKAVD 175 (312)
T ss_pred cccccCCcccCCHHHHcC--CCCCCccc
Confidence 234568999999999955 57888887
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=246.80 Aligned_cols=172 Identities=30% Similarity=0.364 Sum_probs=147.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+++.. +|+.||+|+++.. ......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 35899999999999875 5899999999753 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 81 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 999988653 46899999999999999999999 89999999999999999999999999999875432221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......|++.|+|||++.+ +.++.++|
T Consensus 151 -~~~~~~gt~~y~aPE~~~~--~~~~~~~D 177 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLED--NDYGRAVD 177 (323)
T ss_pred -ccccccCCcCcCCcccccC--CCCCchhc
Confidence 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=251.74 Aligned_cols=176 Identities=26% Similarity=0.330 Sum_probs=149.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||+||+++.. +++.||+|++... ......+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999876 5889999999653 2233567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 85 GGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999753 56899999999999999999999 9999999999999999999999999999987653211
Q ss_pred cc---------------------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 485 SI---------------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .......||+.|+|||++.+ ..++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~D 218 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCD 218 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchh
Confidence 00 00123469999999999965 57888887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=245.80 Aligned_cols=172 Identities=28% Similarity=0.373 Sum_probs=147.6
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999875 5899999999753 233467788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 999988653 46899999999999999999999 99999999999999999999999999999875432221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ +.++.++|
T Consensus 151 -~~~~~~gt~~y~aPE~~~~--~~~~~~~D 177 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLED--NDYGRAVD 177 (328)
T ss_pred -ccccccCCcCccChhhhcC--CCCCccCC
Confidence 1234568999999999954 57788887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=252.57 Aligned_cols=170 Identities=30% Similarity=0.432 Sum_probs=149.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||.|+||.||-|++. +.+.||||++.-+ .....+++.|+..|.+++|||++.+-|+|..+...||||||+- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 45999999999999875 5788999999643 2334789999999999999999999999999999999999995 5
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+-.|++.-.+ +++.+..+..|..+.++||+||| +.+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 8888887654 68999999999999999999999 999999999999999999999999999999877655
Q ss_pred eeeccCCCCcccccccccccc-ccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
..++|||.|||||+|+-- .|.|+-|+|
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvD 207 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVD 207 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccc
Confidence 447899999999998432 478888877
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=248.65 Aligned_cols=174 Identities=30% Similarity=0.401 Sum_probs=149.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECC--CCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID--GSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+|.+.+ +..||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 34566789999999999998643 368999998642 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 111 Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 111 EFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999754 46899999999999999999999 999999999999999999999999999999866
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....||+.|+|||++.+ ..++.++|
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 210 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILLN--VGHGKAAD 210 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHhC--CCCCcccc
Confidence 4322 33568999999999954 56777877
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=240.35 Aligned_cols=175 Identities=31% Similarity=0.425 Sum_probs=149.6
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
..+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.+++|++|+++++.+.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4467999999999999874 68999999986432 223467899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.... ...+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 84 GGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred CCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999998886532 246899999999999999999999 9999999999999999999999999999998654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~--~~~~~~~D 183 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINN--EKYTFSPD 183 (285)
T ss_pred e---ecCCCCCCCccCHhhhcC--CCCCcccC
Confidence 2 234568999999999954 67888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=238.42 Aligned_cols=172 Identities=33% Similarity=0.441 Sum_probs=142.3
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~ 405 (516)
+.+|+|+||.||+|.... ++.||||+.-.++. ---+|+++|+.++|||||+++-+|.... ...+||||||.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 579999999999999764 68999999854432 2247999999999999999998886532 23489999987
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 484 (516)
+|.++++... ..+..++...+.-+..||.+||+||| ..+|+||||||.|||+|.+ |.+||+|||.|+.+...+
T Consensus 107 -tL~~~~r~~~--~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 107 -TLYRVIRHYT--RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred -HHHHHHHHHh--hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 9999998642 13467888889999999999999999 8999999999999999976 899999999999988776
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...+ ..-|..|+|||.+.+- ..|+.+.|
T Consensus 181 pniS---YicSRyYRaPELifga-~~Yt~~ID 208 (364)
T KOG0658|consen 181 PNIS---YICSRYYRAPELIFGA-TEYTTSID 208 (364)
T ss_pred Ccee---EEEeccccCHHHHcCc-cccCceeE
Confidence 5433 3458899999999874 67877765
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=244.24 Aligned_cols=172 Identities=27% Similarity=0.355 Sum_probs=146.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++..++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999875 6899999999753 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.+++.+. ..+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 999988653 46899999999999999999999 6 7999999999999999999999999999875432222
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+ +.++.++|
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (325)
T cd05594 152 T--MKTFCGTPEYLAPEVLED--NDYGRAVD 178 (325)
T ss_pred c--cccccCCcccCCHHHHcc--CCCCCccc
Confidence 1 233568999999999954 67888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=245.60 Aligned_cols=172 Identities=29% Similarity=0.356 Sum_probs=149.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 34578999999999999976 58999999986432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++++. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 84 PGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999754 46899999999999999999999 999999999999999999999999999999866432
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....|++.|+|||++.+ ..++.++|
T Consensus 155 ~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 180 (291)
T cd05612 155 T-----WTLCGTPEYLAPEVIQS--KGHNKAVD 180 (291)
T ss_pred c-----ccccCChhhcCHHHHcC--CCCCchhh
Confidence 2 23468999999999855 56788877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=248.17 Aligned_cols=178 Identities=30% Similarity=0.409 Sum_probs=157.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCe-eEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRR-RALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~ 402 (516)
+...++||+|+||.++..+.+ ++..+++|++.-.. ...+...+|+.++++++|||||.+.+.|.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 345678999999999999865 57899999986433 334577899999999999999999999999888 8999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++||+|.+.|.+.+ +..++++.+..++.|++.|++||| +++|+|||||+.||++++++.|||+|||+|+.+..
T Consensus 86 ~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred cCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999998864 367999999999999999999999 99999999999999999999999999999999887
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+... .....||+.||.||++.+ .+|+.|||
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d--~pYn~KSD 188 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSD--IPYNEKSD 188 (426)
T ss_pred chhh--hheecCCCcccCHHHhCC--CCCCccCc
Confidence 7532 255789999999999955 79999998
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=250.31 Aligned_cols=179 Identities=22% Similarity=0.309 Sum_probs=149.9
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+++.+.||+|+||.||+++.. +++.+|+|++.+. ....+.+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3445578999999999999986 4789999998642 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||++....
T Consensus 124 y~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 124 YMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999854 34788999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCcceeeccCCCCccccccccccccc--cccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
..... ......||+.|+|||++.+.. +.++.++|
T Consensus 194 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~D 229 (370)
T cd05621 194 ETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229 (370)
T ss_pred cCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccC
Confidence 33221 123467999999999996532 23677777
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=247.20 Aligned_cols=172 Identities=26% Similarity=0.362 Sum_probs=150.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|++++.+++||||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999986 48899999997532 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 84 PGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 999999999653 46889999999999999999999 999999999999999999999999999999765431
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 155 -----~~~~~gt~~y~aPE~~~~--~~~~~~~D 180 (333)
T cd05600 155 -----ANSVVGSPDYMAPEVLRG--KGYDFTVD 180 (333)
T ss_pred -----cCCcccCccccChhHhcC--CCCCCccc
Confidence 234568999999999965 57888887
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=251.32 Aligned_cols=176 Identities=23% Similarity=0.281 Sum_probs=147.4
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4467999999999999875 57899999996532 234568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.+. ..+++..+..++.||+.||+||| ..+|+||||||+||||+.++++||+|||+++.+....
T Consensus 85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 85 GGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999754 46889999999999999999999 9999999999999999999999999999986432110
Q ss_pred cc---------------------------------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 485 SI---------------------------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~---------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .......||+.|+|||++.+ ..++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~D 230 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCD 230 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccc
Confidence 00 00013468999999999965 56888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=252.46 Aligned_cols=173 Identities=27% Similarity=0.366 Sum_probs=150.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.++||+|.||+|+++..+ +++.+|||++++. ..+.+..+.|..++... +||.++.++..|...+++++||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 5688999999999999987 4789999999874 35567788899988887 5999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
.||++..+.+ ...+++..+.-++..|+.||+||| +++||+||||.+|||||.+|++||+|||+++..-..
T Consensus 452 ~Ggdm~~~~~-------~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 452 AGGDLMHHIH-------TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred CCCcEEEEEe-------cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999544432 257999999999999999999999 999999999999999999999999999999865422
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......|||.|||||++.+ ..|+.++|
T Consensus 522 g~--~TsTfCGTpey~aPEil~e--~~Yt~aVD 550 (694)
T KOG0694|consen 522 GD--RTSTFCGTPEFLAPEVLTE--QSYTRAVD 550 (694)
T ss_pred CC--ccccccCChhhcChhhhcc--Ccccchhh
Confidence 22 2356889999999999966 68998887
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=250.48 Aligned_cols=142 Identities=26% Similarity=0.305 Sum_probs=127.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.++||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 34578999999999999875 6889999998643 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 84 PGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999653 46889999999999999999999 99999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=249.97 Aligned_cols=177 Identities=26% Similarity=0.309 Sum_probs=149.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++..++||||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34578999999999999976 5899999999653 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 84 PGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999653 46899999999999999999999 999999999999999999999999999998755322
Q ss_pred Ccce------------------------------------eeccCCCCccccccccccccccccccCCC
Q 036471 484 ESII------------------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 221 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECD 221 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeee
Confidence 1100 0012458999999999955 56788887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=249.53 Aligned_cols=177 Identities=23% Similarity=0.302 Sum_probs=147.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.++||+|+||.||+++.. +++.||+|++... ......+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999875 5889999998642 233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 84 PGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999653 46889999999999999999999 999999999999999999999999999997533110
Q ss_pred Cc-----------------------------------------ceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ES-----------------------------------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ........||+.|||||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 226 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCD 226 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCccee
Confidence 00 000113468999999999955 56788887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=242.23 Aligned_cols=172 Identities=31% Similarity=0.425 Sum_probs=145.6
Q ss_pred hhcccCCcEEEEEEEEC----CCCEEEEEEeecC-----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLI----DGSNVAVKVLNDS-----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.||+|+||.||+++.. +++.||+|+++.. ......+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46999999999999853 5789999998642 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+. ..+.+..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999999654 46788999999999999999999 99999999999999999999999999999875432
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....|++.|+|||++.+ ..++.++|
T Consensus 153 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 182 (323)
T cd05584 153 EGTV--THTFCGTIEYMAPEILMR--SGHGKAVD 182 (323)
T ss_pred CCCc--ccccCCCccccChhhccC--CCCCCcce
Confidence 2221 133568999999999955 56777777
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=249.23 Aligned_cols=141 Identities=22% Similarity=0.299 Sum_probs=126.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.++||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4567999999999999875 57899999986532 234578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 85 GGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999653 46889999999999999999999 89999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=241.98 Aligned_cols=172 Identities=27% Similarity=0.348 Sum_probs=146.2
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999876 58899999997532 2335678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+. ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 9999988643 56999999999999999999999 99999999999999999999999999999875322211
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRG--EDYGFSVD 178 (329)
T ss_pred --ccccccCCccccCHHHHcC--CCCCCccc
Confidence 1234568999999999955 57888887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=241.35 Aligned_cols=172 Identities=27% Similarity=0.351 Sum_probs=145.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 35999999999999976 47899999997532 2334577888888776 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|..++.+. ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 9999988653 46899999999999999999999 99999999999999999999999999999875432221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRG--EDYGFSVD 178 (329)
T ss_pred --ccccccCCccccCHHHHcC--CCCCCccc
Confidence 1134568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=240.71 Aligned_cols=172 Identities=27% Similarity=0.318 Sum_probs=145.7
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.. +++.||+|++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999876 4789999998753 23335677888888866 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|..++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 9999998654 46899999999999999999999 99999999999999999999999999999875432222
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (321)
T cd05591 152 T--TTTFCGTPDYIAPEILQE--LEYGPSVD 178 (321)
T ss_pred c--ccccccCccccCHHHHcC--CCCCCccc
Confidence 1 234568999999999854 57888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=246.55 Aligned_cols=186 Identities=32% Similarity=0.489 Sum_probs=151.2
Q ss_pred HHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||+++++++.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3455678899999999999963 235689999986533 2345788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCC----------------------------------------------------------
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSS---------------------------------------------------------- 418 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------- 418 (516)
++||||+++|+|.+++++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999999754210
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 419 -----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 419 -----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
.....+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01135789999999999999999999 8999999999999999999999999999998765443222
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.+ +.++.++|
T Consensus 272 ~~~~~~~~~~y~aPE~~~~--~~~~~~sD 298 (375)
T cd05104 272 VKGNARLPVKWMAPESIFN--CVYTFESD 298 (375)
T ss_pred ccCCCCCCcceeChhHhcC--CCCCCCCC
Confidence 2222345678999999954 67888887
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=246.43 Aligned_cols=179 Identities=22% Similarity=0.299 Sum_probs=149.6
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3445678999999999999876 5889999999642 2233557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+ ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++....
T Consensus 124 y~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 124 YMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999854 35788899999999999999999 8999999999999999999999999999998664
Q ss_pred CCCcceeeccCCCCccccccccccccc--cccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
..... ......||+.|+|||++.+.. +.++.++|
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D 229 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCcee
Confidence 33221 113457899999999985431 34677776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=243.18 Aligned_cols=179 Identities=24% Similarity=0.286 Sum_probs=151.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.+++.++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45578999999999999876 58899999997532 24456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.+.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 84 PGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999997642 46899999999999999999999 999999999999999999999999999999876544
Q ss_pred CcceeeccCCCCcccccccccccc----ccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN----IGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~sD 516 (516)
.... .....||+.|+|||++... .+.++.++|
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 191 (330)
T cd05601 156 KMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191 (330)
T ss_pred Ccee-eecccCCccccCHHHhccccccccCCCCCcce
Confidence 3321 2335689999999998531 245667776
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=244.57 Aligned_cols=175 Identities=33% Similarity=0.537 Sum_probs=152.3
Q ss_pred ccccHHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe
Q 036471 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 316 ~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 395 (516)
..+.+++|.+.. =||.|+.|.||+|++ .++.||||+++.-+ ..++.-|++|+|+||+.+.|+|.....
T Consensus 119 WeiPFe~IsELe-----WlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELE-----WLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhh-----hhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 345677766543 399999999999998 67999999986432 246788999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
+.|||||++.|-|.+.|+.. .+++...+..|.++||.||.||| .+.|||||||.-||||..+..|||+|||
T Consensus 187 yCIiMEfCa~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eEEeeeccccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999754 67899999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.++......+ +-.+.||..|||||+|.. .+.++|+|
T Consensus 258 TS~e~~~~ST---kMSFaGTVaWMAPEvIrn--ePcsEKVD 293 (904)
T KOG4721|consen 258 TSKELSDKST---KMSFAGTVAWMAPEVIRN--EPCSEKVD 293 (904)
T ss_pred chHhhhhhhh---hhhhhhhHhhhCHHHhhc--CCcccccc
Confidence 9988766533 245789999999999955 68899987
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=241.99 Aligned_cols=179 Identities=22% Similarity=0.299 Sum_probs=149.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +++.||+|++.+. ....+.+.+|..++..++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45678999999999999976 4889999999642 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999997532 46899999999999999999999 999999999999999999999999999998765443
Q ss_pred CcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
.... .....||+.|+|||++... .+.++.++|
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (331)
T cd05597 156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECD 190 (331)
T ss_pred CCcc-ccceeccccccCHHHHhhccccccCCCCcce
Confidence 3211 1224589999999998531 245667776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=244.46 Aligned_cols=176 Identities=26% Similarity=0.337 Sum_probs=148.6
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++.+++|++|+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4567999999999999876 5889999999642 2334677889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 85 GGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999653 46899999999999999999999 9999999999999999999999999999987543211
Q ss_pred cc---------------------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 485 SI---------------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .......||+.|+|||++.+ ..++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~D 218 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCD 218 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcce
Confidence 00 00113468999999999965 57888887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=245.78 Aligned_cols=180 Identities=23% Similarity=0.308 Sum_probs=150.4
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
..+.+.+.||+|+||.||+++.. +++.+|+|++... ....+.+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 44455678999999999999986 4789999998642 223355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.+
T Consensus 123 Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 123 EYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999854 34788899999999999999999 999999999999999999999999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccc--cccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
...... ......||+.|+|||++.+.. +.++.++|
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~D 229 (371)
T cd05622 193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229 (371)
T ss_pred CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccc
Confidence 543221 123456899999999986532 23677877
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=240.38 Aligned_cols=172 Identities=28% Similarity=0.347 Sum_probs=145.8
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.+ +++.||+|++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999976 4789999998643 23345677888888876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 9999998654 46899999999999999999999 99999999999999999999999999999875432221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQE--MLYGPSVD 178 (320)
T ss_pred --cccccccCccccCHHHHcC--CCCCCccc
Confidence 1234568999999999954 57788877
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=239.22 Aligned_cols=172 Identities=27% Similarity=0.340 Sum_probs=144.0
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.. +++.||+|.++.. ....+.+..|..++... +||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999875 4789999999753 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 9999998653 46899999999999999999999 89999999999999999999999999999976433221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKG--QKYNESVD 178 (316)
T ss_pred --ccccccCCccccCHHHHcC--CCCCCccc
Confidence 1234568999999999955 56888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=245.27 Aligned_cols=174 Identities=27% Similarity=0.387 Sum_probs=151.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
++++.||+|+-|.|-.|++. +|+.+|||++.+. ......+.+|+.+|+.+.|||++++++++++..++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 45678999999999999874 6999999999653 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|.|.++|-+. +++++.++.+++.||+.|+.|.| ..+|+||||||+|+|||..+++||+|||+|.+-..+
T Consensus 95 ~gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 95 PGGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred CCchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999765 68999999999999999999999 999999999999999999999999999999865554
Q ss_pred CcceeeccCCCCcccccccccccccccc-ccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEV-SYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~-s~~sD 516 (516)
.- .....|+|.|.|||++++. +| +.+||
T Consensus 166 kl---LeTSCGSPHYA~PEIV~G~--pYdG~~sD 194 (786)
T KOG0588|consen 166 KL---LETSCGSPHYAAPEIVSGR--PYDGRPSD 194 (786)
T ss_pred cc---ccccCCCcccCCchhhcCC--CCCCCccc
Confidence 43 2446899999999999774 33 45555
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=241.46 Aligned_cols=177 Identities=28% Similarity=0.344 Sum_probs=147.9
Q ss_pred hhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecC-----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDS-----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.||+|+||.||+++.. +++.||+|++.+. ....+.+.+|+.++.++ +|++|+++++++..++..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45678999999999999753 5789999998642 12335678899999999 59999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 83 v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 83 ILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999653 46899999999999999999999 9999999999999999999999999999997
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....||+.|+|||++.+. ..++.++|
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~D 189 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVD 189 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCC-CCCCCccc
Confidence 654332221 1345689999999998542 34677777
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=239.37 Aligned_cols=172 Identities=31% Similarity=0.365 Sum_probs=146.7
Q ss_pred hhcccCCcEEEEEEEE----CCCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 332 YKLGQGGYGSVYKGKL----IDGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.||+|+||.||+++. .+|+.||+|++.... .....+.+|++++++++||||+++++.+.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999975 357899999997532 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+. ..+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999998653 46899999999999999999999 9999999999999999999999999999997654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|++.|+|||++.+ ..++.++|
T Consensus 153 ~~--~~~~~g~~~y~aPE~~~~--~~~~~~~D 180 (318)
T cd05582 153 KK--AYSFCGTVEYMAPEVVNR--RGHTQSAD 180 (318)
T ss_pred Cc--eecccCChhhcCHHHHcC--CCCCCccc
Confidence 21 234568999999999954 56777877
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=240.91 Aligned_cols=179 Identities=22% Similarity=0.306 Sum_probs=149.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|..++..++|++|+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45578999999999999976 5788999998642 223345788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 84 VGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999997632 46889999999999999999999 999999999999999999999999999999876544
Q ss_pred CcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
.... .....|++.|+|||++.+. .+.++.++|
T Consensus 156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (331)
T cd05624 156 GTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECD 190 (331)
T ss_pred Ccee-eccccCCcccCCHHHHhccccCCCCCCCccc
Confidence 3221 1335689999999998531 135677777
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=239.37 Aligned_cols=172 Identities=30% Similarity=0.380 Sum_probs=143.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHH-HhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVA-SISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||+||+|+.. +++.||+|++... ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35999999999999986 5899999999643 222344555555 45778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 9999998653 46899999999999999999999 89999999999999999999999999999875432221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ +.++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRK--QPYDRTVD 178 (323)
T ss_pred --ccccccCChhhcChhhhcC--CCCCcccc
Confidence 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=239.40 Aligned_cols=172 Identities=30% Similarity=0.383 Sum_probs=143.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHH-HhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVA-SISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||+||+++.. +|+.+|+|++... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35999999999999875 5899999999643 122345556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|..++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 9999988643 56899999999999999999999 99999999999999999999999999999875322211
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......|++.|+|||++.+ +.++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRK--QPYDNTVD 178 (325)
T ss_pred --CcccccCChhhCCHHHHcC--CCCCCcCc
Confidence 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=233.73 Aligned_cols=174 Identities=31% Similarity=0.416 Sum_probs=147.5
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|+||+||++... +++.||+|++.... ...+.+..|+.++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999875 58899999986432 1235677899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++..... ....+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||++..+......
T Consensus 81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 988865321 2356899999999999999999999 899999999999999999999999999999766543321
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|++.|+|||++.+ +.++.++|
T Consensus 154 ~~~~~g~~~y~aPE~~~~--~~~~~~~D 179 (280)
T cd05608 154 TKGYAGTPGFMAPELLQG--EEYDFSVD 179 (280)
T ss_pred ccccCCCcCccCHHHhcC--CCCCcccc
Confidence 234578999999999954 67888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=245.47 Aligned_cols=177 Identities=27% Similarity=0.376 Sum_probs=151.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+|+.. +++.||+|+++.. ......+.+|+.++..++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 45578999999999999986 5899999999753 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.+. ..+++..++.++.|++.||+||| .++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 84 PGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999754 46899999999999999999999 899999999999999999999999999999866543
Q ss_pred C---------------------------cceeeccCCCCccccccccccccccccccCCC
Q 036471 484 E---------------------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .........||+.|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 212 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECD 212 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCcee
Confidence 3 0011233568999999999965 57888887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=238.90 Aligned_cols=172 Identities=29% Similarity=0.369 Sum_probs=142.8
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHH-HhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVA-SISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.. +++.||+|++.... .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999986 58899999986432 22344555554 57788999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|...+.+. ..+++..+..++.||+.||+||| +.+|+||||||+||+|+.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 9999888643 46889999999999999999999 89999999999999999999999999999875322221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......|++.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRK--EPYDRTVD 178 (321)
T ss_pred --ccccccCCcccCCHHHhcC--CCCCCcCc
Confidence 1234568999999999954 57888887
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=238.05 Aligned_cols=172 Identities=29% Similarity=0.363 Sum_probs=144.7
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+..+ ++.||+|+++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 359999999999999764 789999999753 23345667788888764 999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 9999999653 46889999999999999999999 99999999999999999999999999999875322221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLG--QKYNTSVD 178 (316)
T ss_pred --ceeeecCCccccCHHHHcC--CCCCchhh
Confidence 1134568999999999954 57888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=235.92 Aligned_cols=177 Identities=29% Similarity=0.441 Sum_probs=147.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 344578999999999999875 58899999986432 234577899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+ +|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 87 S-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred c-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 5 9999886542 45789999999999999999999 9999999999999999999999999999997654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+++.|+|||++.+. ..++.++|
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 186 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTPID 186 (288)
T ss_pred c--cccCceecccccChHHhcCC-cccCcHHH
Confidence 2 12345679999999998542 45666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=238.96 Aligned_cols=176 Identities=31% Similarity=0.412 Sum_probs=153.4
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC----CchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG----NGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 399 (516)
..+.+.+.||+|.||.||+++.+. |+.+|+|.+.+... ..+.+.+|+.+|+++. |||||.+.+.+++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 345566889999999999999875 99999999976432 3468999999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC----CCcEEEeecC
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE----DFCPKISDFG 475 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Dfg 475 (516)
||++.||.|.+.+... .+++..+..++.|++.|++||| ..||+||||||+|+|+.. ++.+|++|||
T Consensus 115 mEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999653 2999999999999999999999 999999999999999953 3579999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++....... ......||+.|+|||++.+ ..++.++|
T Consensus 185 la~~~~~~~---~~~~~~Gtp~y~APEvl~~--~~y~~~~D 220 (382)
T KOG0032|consen 185 LAKFIKPGE---RLHTIVGTPEYVAPEVLGG--RPYGDEVD 220 (382)
T ss_pred CceEccCCc---eEeeecCCccccCchhhcC--CCCCcccc
Confidence 999887632 2366889999999999954 57887776
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=238.20 Aligned_cols=172 Identities=27% Similarity=0.355 Sum_probs=145.0
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.+ +++.||+|.++.. ....+.+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35999999999999986 5889999999753 23345667788887754 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 9999998653 46889999999999999999999 99999999999999999999999999999874322211
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQG--LKYTFSVD 178 (316)
T ss_pred --ceeccCCCcCccCHHHHcC--CCCCcccc
Confidence 1234568999999999955 57888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=230.72 Aligned_cols=178 Identities=32% Similarity=0.518 Sum_probs=151.7
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
..+.+.||+|+||.||++.++++..+|+|.+.......+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 34557799999999999999888899999987665566789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.++++... ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||.++........
T Consensus 86 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 86 LLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999987532 35889999999999999999999 999999999999999999999999999999765433221
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.. ..++.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNF--SKYSSKSD 183 (256)
T ss_pred ccCCCCCchhhCChhhccc--Cccchhhh
Confidence 1123345678999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=238.77 Aligned_cols=175 Identities=27% Similarity=0.316 Sum_probs=146.3
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhccCCc-ceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRTSHV-NVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.||+|+||.||+|+..+ ++.||+|++... ....+.+..|..++..++|+ +|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 355789999999999998764 789999999753 23446778899999999765 588899999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 83 VNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999998653 46889999999999999999999 89999999999999999999999999999875322
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......||+.|+|||++.+ +.++.++|
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 183 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAY--QPYGKSVD 183 (324)
T ss_pred CCC--ceeeecCCccccChhhhcC--CCCCcccc
Confidence 221 1234568999999999955 57788887
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=233.44 Aligned_cols=181 Identities=25% Similarity=0.412 Sum_probs=149.4
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
...+.+.+.||+|+||.||+|.++ .+..||+|.++... ...+.+.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344556788999999999999763 35689999987543 223578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++|+|.+++.+.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+.
T Consensus 84 v~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999997542 46899999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ......++..|+|||++.+ +.++.++|
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 190 (266)
T cd05064 156 EDKSEAIY-TTMSGKSPVLWAAPEAIQY--HHFSSASD 190 (266)
T ss_pred cccccchh-cccCCCCceeecCHHHHhh--CCccchhH
Confidence 54322111 1122345678999999854 67888877
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=252.15 Aligned_cols=182 Identities=23% Similarity=0.259 Sum_probs=150.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-C-CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-D-GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|++|.||+|... + ++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 455678999999999999764 3 5778888764432 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.++++.... ...++++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 149 gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999865321 2356899999999999999999999 8999999999999999999999999999998765433
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.........||+.|+|||++.+ ..++.++|
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 253 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWER--KRYSKKAD 253 (478)
T ss_pred ccccccccCCCccccCHhHhCC--CCCCcHHh
Confidence 2222234568999999999954 57888877
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=239.05 Aligned_cols=179 Identities=22% Similarity=0.308 Sum_probs=149.4
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.++||+|+||.||+++.+. ++.+|+|++.+. ....+.+.+|+.++..++|++|+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 355789999999999999764 778999998642 223345788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999997632 46899999999999999999999 999999999999999999999999999999765433
Q ss_pred CcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
... ......||+.|+|||++... .+.++.++|
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 190 (332)
T cd05623 156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190 (332)
T ss_pred Ccc-eecccccCccccCHHHHhccccCCCCCCCcCC
Confidence 321 11335689999999998531 245777887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=238.52 Aligned_cols=172 Identities=27% Similarity=0.348 Sum_probs=142.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHH-HhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVA-SISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+++.. +++.||+|++.... .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 35999999999999976 47889999986432 22234455544 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++... ..+.+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 9999999653 45788899999999999999999 99999999999999999999999999999975432221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHK--QPYDRTVD 178 (325)
T ss_pred --CcccccCCccccCHHHHcC--CCCCCccc
Confidence 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=222.24 Aligned_cols=163 Identities=29% Similarity=0.440 Sum_probs=143.2
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-----CCCc----hhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEE
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-----KGNG----EEFINEVASISRT-SHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~----~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 399 (516)
++.+|+|..+.|.+...+ +|...|+|++... .... ++-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999888765 5889999998532 1112 4456799999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|.|+.|.|.++|... -.+++....+|++|+.+|++||| .++||||||||+|||++++.++||+|||+|..
T Consensus 102 Fdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999653 67999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcccccccccc
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 505 (516)
+.+.+.. ....|||+|+|||.+.
T Consensus 173 l~~GekL---relCGTPgYLAPEtik 195 (411)
T KOG0599|consen 173 LEPGEKL---RELCGTPGYLAPETIK 195 (411)
T ss_pred cCCchhH---HHhcCCCcccChhhee
Confidence 8877653 5578999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=243.58 Aligned_cols=186 Identities=30% Similarity=0.480 Sum_probs=150.0
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.+.||+|+||.||+|+.. ++..||+|+++.... ..+.+.+|+++++.+ +|+||+++++.+.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 34456788999999999999742 245799999965432 235688999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCC----------------------------------------------------------
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSS---------------------------------------------------------- 418 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------- 418 (516)
++||||+++|+|.++++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999999653210
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccC
Q 036471 419 ------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492 (516)
Q Consensus 419 ------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 492 (516)
.....+++..+++++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01135788999999999999999999 899999999999999999999999999999766443322222223
Q ss_pred CCCccccccccccccccccccCCC
Q 036471 493 RGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 493 ~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+++.|||||++.+ +.++.++|
T Consensus 275 ~~~~~y~aPE~~~~--~~~~~~~D 296 (374)
T cd05106 275 RLPVKWMAPESIFD--CVYTVQSD 296 (374)
T ss_pred CCccceeCHHHhcC--CCCCcccc
Confidence 45678999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=229.16 Aligned_cols=178 Identities=33% Similarity=0.520 Sum_probs=151.4
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
..+.+.||+|++|.||++.++++..+|+|.+.......+++.+|++++++++|+||+++++++.+.+..++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 44667899999999999998878899999987655556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++........
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 86 LLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999997542 46899999999999999999999 899999999999999999999999999999765433221
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||.+.+ +.++.++|
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~--~~~~~~~D 183 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDY--SRFSSKSD 183 (256)
T ss_pred ccCCCCCCccccCHHHhcc--CCCCchhh
Confidence 1122234568999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=241.07 Aligned_cols=172 Identities=28% Similarity=0.409 Sum_probs=152.9
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeec--CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.||+|.||.||+|.+. .++.||+|++.. .....+++.+|+.+|.+++++||.++++.+..+..++++|||+.||++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 56999999999999875 588999999964 345567899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.++|+.. ..+.+..+.-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+..+.......
T Consensus 99 ~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 99 LDLLKSG------NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hhhhccC------CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999643 44588888999999999999999 9999999999999999999999999999998776654432
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...+|||.|||||++.+ ..|+.|+|
T Consensus 169 -~tfvGTPfwMAPEVI~~--~~Y~~KAD 193 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQ--SGYDTKAD 193 (467)
T ss_pred -ccccccccccchhhhcc--ccccchhh
Confidence 56889999999999964 58899988
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=233.77 Aligned_cols=184 Identities=22% Similarity=0.334 Sum_probs=151.6
Q ss_pred CccccHHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEE
Q 036471 315 PRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFC 390 (516)
Q Consensus 315 ~~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~ 390 (516)
.+.++.+|++..+ ...|++|+++.||+|.+ +|+.||||+++..... .+.+.+|+.++.+++||||+++++++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 3455666663221 13599999999999998 7899999999765433 35677999999999999999999998
Q ss_pred ee----cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECC
Q 036471 391 FE----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDE 465 (516)
Q Consensus 391 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~ 465 (516)
.+ ....++||||+++|+|.+++... ..+++...+.++.|++.||+||| . .+++||||||+||++++
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTE 158 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECC
Confidence 77 34678999999999999999653 46889999999999999999999 6 48999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+++.+.... ....|+..|+|||++.+..+.++.++|
T Consensus 159 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~D 204 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDD 204 (283)
T ss_pred CCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhh
Confidence 9999999999998654332 234578999999999654467888887
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=230.21 Aligned_cols=183 Identities=26% Similarity=0.454 Sum_probs=155.0
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+..+++.+.||+|++|.||+|.+.+++.||+|.++......+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34455667889999999999999878889999999776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.... ...+++..+..++.|++.||.||| +++|+|+||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999997542 246899999999999999999999 899999999999999999999999999999876533
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .......+..|+|||++.. ..++.++|
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 186 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALY--NRFSIKSD 186 (261)
T ss_pred ccc-ccCCCcCceeccCcccccc--CCCCchhh
Confidence 211 1122333568999999854 57788877
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=236.04 Aligned_cols=177 Identities=31% Similarity=0.442 Sum_probs=146.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.++||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++.++...++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 345578999999999999986 68899999986432 233567899999999999999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.... ..++++.+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 87 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 87 -TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred -cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 58888886532 46889999999999999999999 9999999999999999999999999999987543322
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+++.|+|||++.+. ..++.++|
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 186 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLD 186 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCC-CCCCcHHH
Confidence 1 12345679999999998543 34666665
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=238.36 Aligned_cols=178 Identities=24% Similarity=0.363 Sum_probs=150.4
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
....+++.++||+|+||.||++.+. ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3445566788999999999999986 578899998865422 2357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
||+++++|.+++.+. ..+++..+..++.|++.||+||| + .+|+|+||||+|||+++++.+||+|||++..
T Consensus 83 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 83 EHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred ecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999999653 45889999999999999999999 5 4799999999999999999999999999876
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....|+..|+|||++.+ ..++.++|
T Consensus 154 ~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~D 184 (333)
T cd06650 154 LIDSM----ANSFVGTRSYMSPERLQG--THYSVQSD 184 (333)
T ss_pred hhhhc----cccCCCCccccCHHHhcC--CCCCcHHH
Confidence 53322 133568999999999954 56777776
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=237.73 Aligned_cols=172 Identities=28% Similarity=0.345 Sum_probs=146.0
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 35999999999999876 47899999997532 2335678899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 9999988653 46999999999999999999999 89999999999999999999999999999875322211
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ ..++.++|
T Consensus 152 --~~~~~~gt~~y~aPE~~~~--~~~~~~~D 178 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRG--EEYGFSVD 178 (327)
T ss_pred --ceecccCCcccCCHHHHCC--CCCCchhe
Confidence 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=237.24 Aligned_cols=175 Identities=26% Similarity=0.311 Sum_probs=146.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
++.+.||+|+||.||+|+.. +++.||+|++.+.. ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34578999999999999876 47899999987532 2234567788888777 689999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 83 VNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999998654 46889999999999999999999 89999999999999999999999999999975432
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......||+.|+|||++.+ +.++.++|
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 183 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVD 183 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcC--CCCCCccc
Confidence 221 1234568999999999955 67888887
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=230.38 Aligned_cols=180 Identities=28% Similarity=0.478 Sum_probs=154.0
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.++||+|++|.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 34456789999999999999888889999998765555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++++.. ...+++..++.++.|++.||+||| ..+++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 87 SLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred cHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999997642 356889999999999999999999 899999999999999999999999999999876543221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.. +.++.++|
T Consensus 160 -~~~~~~~~~~y~aPE~~~~--~~~~~~~D 186 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINF--GSFTIKSD 186 (261)
T ss_pred -ccCCCccceecCCHHHhcc--CCCChhhh
Confidence 1123446778999999854 67787777
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=226.69 Aligned_cols=143 Identities=27% Similarity=0.328 Sum_probs=129.3
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|.-|+||++++.+ +..+|+|++.+.. ....+...|-++|+.++||.++.+|..++.++..+++|||++
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45679999999999999875 5899999997532 233567779999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
||+|..+++++. .+.+++..+.-++.+++-||+||| ..|||.|||||+||||.++|++.|+||.++..
T Consensus 161 GGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 161 GGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred CccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999998763 478999999999999999999999 99999999999999999999999999998744
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=231.78 Aligned_cols=186 Identities=30% Similarity=0.494 Sum_probs=153.8
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
.++.+.+.||+|+||.||+|...+ ++.||+|.++..... .+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445667889999999999998643 478999998754433 468899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcE
Q 036471 398 LIYEFVSNGSLEKFIYRNSS--------SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 469 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 469 (516)
+||||+++++|.++++.... ......+++..+..++.|++.||+||| +++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 99999999999999976532 122356899999999999999999999 8999999999999999999999
Q ss_pred EEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||+++...............+++.|+|||++.+ +.++.++|
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 206 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESD 206 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhh
Confidence 9999999976543322211223345788999999954 67888887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=237.94 Aligned_cols=175 Identities=26% Similarity=0.312 Sum_probs=146.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
++.+.||+|+||.||+|+.. +++.||+|++... ....+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45578999999999999875 5889999999753 223356778888888885 57788899999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.+. ..+++.+++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++....
T Consensus 83 ~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 83 VNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999998653 46899999999999999999999 89999999999999999999999999999875433
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......||+.|+|||++.+ +.++.++|
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 183 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAY--QPYGKSVD 183 (323)
T ss_pred CCc--cccCccCCccccCHHHHcC--CCCCCccc
Confidence 221 1234568999999999954 57888887
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=238.19 Aligned_cols=173 Identities=26% Similarity=0.357 Sum_probs=144.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHh---hccCCcceeeEEEEEeecCeeEEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASI---SRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++ ++++||||+++++++.+.+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4567999999999999875 5899999999743 22335566666554 56789999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|..++++ ..+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 83 YAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred CCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999988743 46899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......|++.|+|||++.+ ..++.++|
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~~~D 183 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTE--TSYTRAVD 183 (324)
T ss_pred CCCC--cccccccCccccCHhHhcC--CCCCcccc
Confidence 2221 1234568999999999955 57788887
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=237.91 Aligned_cols=174 Identities=25% Similarity=0.367 Sum_probs=148.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++..+.||+|+||.||+++.. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 344577999999999999976 57889999986532 223578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+++|.+++.+. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 87 GGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999754 45899999999999999999999 64 6999999999999999999999999999765433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~--~~~~~~~D 184 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQG--THYSVQSD 184 (331)
T ss_pred c----cccCCCCcCcCCHhHhcC--CCCCchHh
Confidence 2 134568999999999954 56888877
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=228.70 Aligned_cols=174 Identities=30% Similarity=0.415 Sum_probs=150.1
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeec---CCCCchhHHHHHHHhhccCCcceeeEEEEEee-----cCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGFCFE-----GRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~e~ 402 (516)
+.||+|++|.|..+..+ +|+.||+|++.+ .....++..+|+.+|+.++|+||+.+.+.+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 46999999999999876 589999999863 34455788999999999999999999999875 3478999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
| +-+|...++.. ..++.+.+..++.|+++||.|+| +.+|+||||||+|++++.+..+||+|||+|+....
T Consensus 108 M-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred H-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccc
Confidence 9 45999999653 45999999999999999999999 99999999999999999999999999999998865
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++....|..|.|||++.. ...|+.+.|
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiD 210 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLN-SSEYTKAID 210 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhc-cccccchhh
Confidence 433334577788999999999854 478888776
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=242.11 Aligned_cols=186 Identities=28% Similarity=0.416 Sum_probs=150.4
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCC--CCchhHHHHHHHhhccC-CcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSK--GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.+.||+|+||.||+|.+.. +..||+|+++... ...+.+.+|+++++++. ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 344566789999999999998531 3479999996533 23467899999999996 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCC----------------------------------------------------------
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSS---------------------------------------------------------- 418 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------- 418 (516)
++||||+++|+|.++|......
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999998754210
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC
Q 036471 419 --------------------------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED 466 (516)
Q Consensus 419 --------------------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 466 (516)
.....+++..++.++.|+++||+||| ..+|+|+||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCC
Confidence 00134788899999999999999999 8999999999999999999
Q ss_pred CcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+||+|||+++...............+++.|+|||++.+ +.++.++|
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 321 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--NLYTTLSD 321 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--CCCCchhh
Confidence 9999999999987644332222233456788999999854 57888887
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=246.32 Aligned_cols=176 Identities=30% Similarity=0.464 Sum_probs=150.3
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecC------eeEEEEE
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR------RRALIYE 401 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~e 401 (516)
.+.||+|+||.||+|+.+ .|+.||||.++.. ....+...+|+++|++++|+|||++++.-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999965 6999999999763 456688899999999999999999999765433 4579999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCC--cEEEeecCCc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDF--CPKISDFGLA 477 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~Dfg~a 477 (516)
|+.+|||...|++.. +...+++.+++.++.++..||.||| +++|+||||||.||++- .+| .-||+|||.|
T Consensus 98 yC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999998754 4467999999999999999999999 99999999999999983 333 5799999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+..+.. ..+..||..|.+||++.+ .+.|+...|
T Consensus 172 rel~d~s~---~~S~vGT~~YLhPel~E~-q~~y~~tVD 206 (732)
T KOG4250|consen 172 RELDDNSL---FTSLVGTEEYLHPELYER-QKKYTATVD 206 (732)
T ss_pred ccCCCCCe---eeeecCchhhcChHHHhh-ccCcCceee
Confidence 98877763 467889999999999954 367776665
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=233.23 Aligned_cols=177 Identities=24% Similarity=0.313 Sum_probs=148.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+++.+ +++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 345578999999999999986 47889999987532 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+++.+..+... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 83 EKNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 98777655432 246899999999999999999999 999999999999999999999999999999876443
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......|++.|+|||++.+ ..++.++|
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLG--APYGKAVD 183 (287)
T ss_pred ccc-cccccccccccCCcHHHcC--CCCCCchh
Confidence 221 1233568999999999955 56788887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=228.05 Aligned_cols=178 Identities=31% Similarity=0.542 Sum_probs=151.7
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.+.||+|++|.||+++..++..+|+|.+.......+++.+|+.++++++||||+++++++.+....+++|||+++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 34567899999999999998777789999987655556789999999999999999999999999899999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.++........
T Consensus 86 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 86 LLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999997532 36899999999999999999999 999999999999999999999999999998766443221
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.. +.++.++|
T Consensus 157 ~~~~~~~~~~y~~pe~~~~--~~~~~~~D 183 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY--SKFSSKSD 183 (256)
T ss_pred ecCCCccChhhCCHHHHhc--CcccchhH
Confidence 1123345678999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=223.01 Aligned_cols=176 Identities=30% Similarity=0.397 Sum_probs=150.8
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec---CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.+.||+|.|+.|++.... .|+.+|+|+++. +....+++.+|+.+-+.++||||+++++.+.+.+..|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3456678999999999999764 589999998854 334567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKI 479 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~ 479 (516)
|.|++|..-|-.+ ..+++..+...+.||++||.|.| .++|||||+||+|+++.. .--+||+|||+|..
T Consensus 92 m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 92 VTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999997766433 56889999999999999999999 999999999999999943 34699999999998
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++... ...+..|||+|||||++.+ .+++..+|
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrk--dpy~kpvD 194 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKK--DPYSKPVD 194 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhc--CCCCCcch
Confidence 87332 3467889999999999966 57887776
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=228.95 Aligned_cols=174 Identities=29% Similarity=0.400 Sum_probs=152.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.++||+|+||.||++.++ .|+.||+|.+... .+.++++.|+.++.+.+.|++|+++|-+.....+++||||+..|+.
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 4467999999999999876 4899999998543 4568899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.++++.++ ++++++++..++++.+.||+||| ...-+|||||+.|||++.+|.+||+|||.|..+......
T Consensus 116 SDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-- 185 (502)
T KOG0574|consen 116 SDIMRARR-----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-- 185 (502)
T ss_pred HHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--
Confidence 99998764 78999999999999999999999 899999999999999999999999999999776543221
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...+.|||.|||||++.+ -.|+.++|
T Consensus 186 RNTVIGTPFWMAPEVI~E--IGY~~~AD 211 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE--IGYDTKAD 211 (502)
T ss_pred hCccccCcccccHHHHHH--hccchhhh
Confidence 245789999999999943 45666655
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=231.10 Aligned_cols=176 Identities=32% Similarity=0.428 Sum_probs=149.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+..+.||+|+||+||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34567999999999999875 58899999986432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 83 NGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred CCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999886542 246899999999999999999999 899999999999999999999999999999765433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|++.|+|||++.+ ..++.++|
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKN--ERYTFSPD 183 (285)
T ss_pred Cc---cccccCCCCccCcHHhcC--CCCCcccc
Confidence 22 133568999999999954 57788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=226.63 Aligned_cols=183 Identities=29% Similarity=0.400 Sum_probs=153.7
Q ss_pred HhhhhhcccCCcEEEEEEEECC-----CCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-----GSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l 398 (516)
++....||+|++|.||+|.-++ ...+|+|+++.++ .-.....+|+.+++.++|||++.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 3445679999999999996432 2378999997543 223678899999999999999999999987 788999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC----CcEEEeec
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED----FCPKISDF 474 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Df 474 (516)
++||.+. +|..+|+-++.... +.++...+..|+.||+.|+.||| ++-|+||||||.||||..+ |.+||+|+
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999987 99999987765433 68999999999999999999999 8999999999999999877 89999999
Q ss_pred CCcccccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++++...-... +...++-|..|+|||.+++. ..|+++.|
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiD 222 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAID 222 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhh
Confidence 9999987664433 34556789999999999874 67888766
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=235.97 Aligned_cols=180 Identities=29% Similarity=0.483 Sum_probs=147.6
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC-CC----EEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID-GS----NVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
..++..+.||+|+||.||+|++.. ++ .||+|+++... ...+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 344556789999999999998643 33 48999986432 2346788999999999999999999998764 5779
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
++||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++
T Consensus 86 v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999997642 46889999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...............++..|+|||++.+ +.++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~D 193 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILH--RIYTHQSD 193 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhcc--CCCCchhh
Confidence 7765443332233345678999999854 67788877
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=235.29 Aligned_cols=172 Identities=28% Similarity=0.343 Sum_probs=145.8
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999876 4789999999753 23345677888888887 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 9999998653 46899999999999999999999 99999999999999999999999999999865322221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 152 ~--~~~~~g~~~y~aPE~~~~--~~~~~~~D 178 (318)
T cd05570 152 T--TSTFCGTPDYIAPEILSY--QPYGPAVD 178 (318)
T ss_pred c--ccceecCccccCHHHhcC--CCCCcchh
Confidence 1 133468999999999955 67888887
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=235.68 Aligned_cols=171 Identities=26% Similarity=0.320 Sum_probs=141.3
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhcc---CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRT---SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
||+|+||+||+|+.. +++.||+|++.... .....+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 58999999986421 2223455666776665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+. ..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 9999998653 56899999999999999999999 99999999999999999999999999999875433222
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+. ..++.++|
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~~D 179 (330)
T cd05586 152 T--TNTFCGTTEYLAPEVLLDE-KGYTKHVD 179 (330)
T ss_pred C--ccCccCCccccCHHHHcCC-CCCCCccc
Confidence 1 2345689999999998642 34677777
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=230.60 Aligned_cols=170 Identities=32% Similarity=0.456 Sum_probs=146.0
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.||+|.||+||-|+.+ +|+.||||++.+. .....++.+|+.+|.+++||.||.+...++..++.++|||.+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 67999999999999875 6999999999653 3455789999999999999999999999999999999999995 57
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CcEEEeecCCcccccCCC
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAKICNRKE 484 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~ 484 (516)
+.++|-.. +...+++..-..++.||+.||.||| .++|+|.||||+|||+... -.+||+|||+|+.+.+..
T Consensus 649 MLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSS----EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 66666543 3478999999999999999999999 9999999999999999643 379999999999988765
Q ss_pred cceeeccCCCCccccccccccccccccccC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYK 514 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~ 514 (516)
-. ..+.|||.|+|||+++. +.|...
T Consensus 722 FR---rsVVGTPAYLaPEVLrn--kGyNrS 746 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRN--KGYNRS 746 (888)
T ss_pred hh---hhhcCCccccCHHHHhh--cccccc
Confidence 32 56889999999999965 455543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=238.07 Aligned_cols=178 Identities=27% Similarity=0.403 Sum_probs=145.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALI 399 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv 399 (516)
.+.++||+|+||.||+|+.. +++.||+|++... ......+.+|+.++++++||||+++++++...+ ..++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 45678999999999999875 5899999998642 223456889999999999999999999886432 47999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++ ++|.+++.+. ..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 83 FELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99995 6899988643 46899999999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCc-ceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKES-IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ........|++.|+|||++.+....++.++|
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~D 190 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAID 190 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhH
Confidence 533221 1122345689999999998543356777777
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=241.06 Aligned_cols=172 Identities=22% Similarity=0.254 Sum_probs=145.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.+.||+|+||.||++... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 3455678999999999999875 58899999753 2457899999999999999999999999999999999995
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 167 TDLYCYLAAK------RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 6898888643 46889999999999999999999 89999999999999999999999999999975432221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......||+.|+|||++.+ ..++.++|
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~~D 265 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLAR--DPYGPAVD 265 (391)
T ss_pred c-ccccccCccCCCChhhhcC--CCCCcHHH
Confidence 1 1234578999999999955 57888877
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=243.01 Aligned_cols=171 Identities=25% Similarity=0.290 Sum_probs=144.4
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.+.||+|+||.||++.... ++.||+|... ...+.+|++++++++|+||+++++++..++..++|||++. ++|
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 44679999999999999764 7889999642 2356789999999999999999999999999999999995 689
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.... ..+++..++.|+.|++.||+||| +++|+||||||+||||+.++.+||+|||+++..........
T Consensus 247 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 247 YTYLGARL-----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 88886532 46999999999999999999999 89999999999999999999999999999987644322222
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 319 ~~~~~GT~~Y~APE~~~~--~~~~~~sD 344 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAG--DPYTPSVD 344 (461)
T ss_pred ccccCCCcCCcCHHHHcC--CCCCchHH
Confidence 234568999999999955 56888877
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=226.47 Aligned_cols=171 Identities=29% Similarity=0.432 Sum_probs=145.5
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|+||.||+++.+ +|+.+|+|.+.... .....+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999875 58999999986422 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 81 KYHIYNVG----ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred HHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 99886542 245889999999999999999999 99999999999999999999999999999976654322
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|++.|+|||++.. +.++.++|
T Consensus 151 ~~~~~~~~~y~aPE~~~~--~~~~~~~D 176 (277)
T cd05607 151 ITQRAGTNGYMAPEILKE--EPYSYPVD 176 (277)
T ss_pred eeccCCCCCccCHHHHcc--CCCCCchh
Confidence 133568999999999955 56888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=227.35 Aligned_cols=180 Identities=32% Similarity=0.516 Sum_probs=151.9
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.++||+|++|.||+|... .++.|++|.+.......+++.+|++++++++|+||+++++++..++..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 3445678999999999999875 488999999876665667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..++.++.|+++||+||| .++++||||||+||++++++.+||+|||++........
T Consensus 87 ~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 87 GNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999996542 246899999999999999999999 89999999999999999999999999999987654322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......++..|+|||++.. ..++.++|
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 187 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAY--NKFSIKSD 187 (263)
T ss_pred e-ccCCCCCccccCCHHHhcc--CCCCchhH
Confidence 1 1122334678999999844 57777776
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=224.95 Aligned_cols=183 Identities=31% Similarity=0.512 Sum_probs=154.9
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.++++.++||+|+||.||+|..++++.||+|.+.......+++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 445666778899999999999999888999999999876666788999999999999999999999864 4578999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.... ...+++.+++.++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+.....
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999986542 356899999999999999999999 89999999999999999999999999999976653
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......++..|+|||++.. +.++.++|
T Consensus 155 ~~~~-~~~~~~~~~~y~~pe~~~~--~~~~~~~D 185 (260)
T cd05067 155 NEYT-AREGAKFPIKWTAPEAINY--GTFTIKSD 185 (260)
T ss_pred CCcc-cccCCcccccccCHHHhcc--CCcCcccc
Confidence 3221 1123445778999999844 66777777
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=230.04 Aligned_cols=178 Identities=37% Similarity=0.623 Sum_probs=146.2
Q ss_pred hhhhcccCCcEEEEEEEEC-----CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-----DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.||.|.||.||+|.+. .+..|+||.++.... ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567999999999999986 256899999965332 357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.++|+.. ....+++..++.|+.|+++||+||| +++++|+||+++||++++++.+||+|||++.....
T Consensus 83 ~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 83 CPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp -TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 2357999999999999999999999 89999999999999999999999999999987743
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...............|+|||.+.. +.++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~ksD 187 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKD--GEYTKKSD 187 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHH--SEESHHHH
T ss_pred cccccccccccccccccccccccc--cccccccc
Confidence 333222234557889999999955 55777766
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=236.15 Aligned_cols=161 Identities=30% Similarity=0.446 Sum_probs=137.6
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.++||+|+||.||+++.. +++.||+|++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4567999999999999875 589999999865432 2367889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+. ...++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.+......
T Consensus 158 ~L~~~----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 158 SLEGT----------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ccccc----------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 98643 23567888899999999999999 999999999999999999999999999999876433221
Q ss_pred eeeccCCCCcccccccccc
Q 036471 487 ISMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~ 505 (516)
.....|+..|+|||++.
T Consensus 225 --~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 --CNSSVGTIAYMSPERIN 241 (353)
T ss_pred --ccccccCccccCccccc
Confidence 23456899999999984
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=228.30 Aligned_cols=186 Identities=27% Similarity=0.463 Sum_probs=149.9
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..+++.+.||+|++|.||+|... .+..||+|++.... ....++.+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 34556678999999999999753 24679999986432 23356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIE----NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
+||||+++++|.+++.+.+.... ...+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECC
Confidence 99999999999999976432111 234678899999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++...............+++.|+|||++.+ +.++.++|
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 203 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSD 203 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhH
Confidence 999976544332222222345788999999854 67788877
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=223.72 Aligned_cols=175 Identities=30% Similarity=0.483 Sum_probs=144.6
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.||+|+||.||+|.+. +++.||+|.+.... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 68899999876432 2236789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.+.. ..+++..++.++.|++.||+||| +++++|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99996532 46889999999999999999999 99999999999999999999999999999876543221111
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+..|+|||.+.. +.++.++|
T Consensus 153 ~~~~~~~~~y~aPE~~~~--~~~~~~~D 178 (252)
T cd05084 153 GGMKQIPVKWTAPEALNY--GRYSSESD 178 (252)
T ss_pred CCCCCCceeecCchhhcC--CCCChHHH
Confidence 111223567999999844 66777776
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=225.08 Aligned_cols=179 Identities=30% Similarity=0.522 Sum_probs=149.8
Q ss_pred HhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|.++. ...|++|.++.... ...++.+|+.++++++||||+++++.+.+.+..+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4456789999999999998753 45799999865432 33578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.... ..+++..++.++.|++.||+||| +++|+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 86 YMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred cCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999997542 46899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
............+++.|+|||.+.+ ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~D 190 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY--RKFTSASD 190 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc--CCCccccc
Confidence 3322222223345678999999854 57788877
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=228.65 Aligned_cols=184 Identities=30% Similarity=0.495 Sum_probs=149.6
Q ss_pred HhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.++.++||+|+||.||+|.+ ..+..|++|.+..... ...++.+|++++++++||||+++++++..++..+++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 44667899999999999985 2457899999864332 2357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcE
Q 036471 401 EFVSNGSLEKFIYRNSSS-----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 469 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 469 (516)
||+++++|.+++...... .....+++..++.++.|++.||+||| +++++|+||||+||++++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence 999999999999643210 01235889999999999999999999 8999999999999999999999
Q ss_pred EEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||+++...............++..|+|||++.+ +.++.++|
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 208 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSD 208 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhh
Confidence 9999999986644332222233445778999999854 56788877
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=226.22 Aligned_cols=180 Identities=29% Similarity=0.479 Sum_probs=150.8
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.+.++||+|++|.||+|.+.+...||+|+++......+++.+|++++++++|+||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 345677889999999999999877778999999865555678999999999999999999999874 4567999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+.. ...++++.++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||.++.+.....
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 85 GSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999997532 246799999999999999999999 89999999999999999999999999999976654332
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||++.+ +.++.++|
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~--~~~~~~~D 185 (262)
T cd05071 158 TA-RQGAKFPIKWTAPEAALY--GRFTIKSD 185 (262)
T ss_pred cc-ccCCcccceecCHhHhcc--CCCCchhh
Confidence 11 123446778999999844 56777776
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=245.87 Aligned_cols=183 Identities=26% Similarity=0.298 Sum_probs=149.8
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecC--------
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGR-------- 394 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 394 (516)
.+.+.+.||+|+||+||+++.. +++.||+|++..... ....+.+|+..+..++|+||+++++.+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 4455678999999999999865 689999999865432 2356788999999999999999988765432
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..++||||+++|+|.++++.... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 36799999999999999976432 2357999999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++.+.............||+.|+|||++.+ +.++.++|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~D 227 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKAD 227 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCC--CCCCcHHH
Confidence 99987654322222234568999999999954 67888877
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.96 Aligned_cols=179 Identities=29% Similarity=0.484 Sum_probs=151.0
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.++||+|++|.||+|...++..+|+|.+.......+++.+|+.++++++|+||+++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 45567889999999999999888889999999876666678999999999999999999999875 45688999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.++++... ...+++..++.++.|++.||+||| +.+|+|+||||+||++++++.++|+|||.+..+......
T Consensus 86 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 86 SLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999997532 246899999999999999999999 899999999999999999999999999999776443321
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....++..|+|||++.+ +.++.++|
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~--~~~~~~~D 185 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALY--GRFTIKSD 185 (260)
T ss_pred c-ccCCCCCccccChHHHhc--CCCcchhh
Confidence 1 122345678999999844 57787877
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=234.86 Aligned_cols=174 Identities=27% Similarity=0.419 Sum_probs=151.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.++||+|.|++|.+|+.. .+..||+|.+.++..+ .+.+.+|+++|..++|||||+++.+...+..+|+||||..+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 4568999999999999875 5899999999875433 35689999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|.+.+++.++ ..+.+..+..++.|+.+|++|+| ++.|+|||||++||||+.+.++||+|||++..+.....
T Consensus 140 ge~~~yl~~~------gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 140 GELFDYLVKH------GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred chhHHHHHhc------ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 9999999876 45666889999999999999999 99999999999999999999999999999988764443
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|++.|.|||++.+. +.-++++|
T Consensus 211 ---lqt~cgsppyAaPEl~~g~-~y~gpe~D 237 (596)
T KOG0586|consen 211 ---LQTFCGSPPYAAPELFNGK-KYDGPEVD 237 (596)
T ss_pred ---ccccCCCCCccChHhhcCc-ccCCccee
Confidence 2457899999999999664 33345544
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=240.91 Aligned_cols=173 Identities=25% Similarity=0.399 Sum_probs=145.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEe-----ecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe--eEEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVL-----NDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR--RALIYE 401 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~e 401 (516)
|.++||+|+|-+||+|.+. +|-.||--.+ .++....++|..|+++|+.|+||||++++..|.+..+ ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4467999999999999875 4777774333 2344555899999999999999999999999998766 778999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKIC 480 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~ 480 (516)
.+..|+|..|+++. +.++...+..|++||++||.|||+ ...+|||||||.+||+|+. .|.|||+|+|+|..+
T Consensus 124 L~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred cccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999877 568889999999999999999994 4678999999999999975 579999999999887
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....|||.|||||++.+ .|++..|
T Consensus 197 r~s~a----ksvIGTPEFMAPEmYEE---~YnE~VD 225 (632)
T KOG0584|consen 197 RKSHA----KSVIGTPEFMAPEMYEE---NYNELVD 225 (632)
T ss_pred hcccc----ceeccCccccChHHHhh---hcchhhh
Confidence 65543 34789999999999943 5666665
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=239.29 Aligned_cols=188 Identities=31% Similarity=0.495 Sum_probs=165.0
Q ss_pred cHHHHHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 319 SYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 319 ~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
...|+++....+..+||-|.||.||.|.|+. .-.||||.++.+....++|+.|+.+|+.++|||+|+++|+|..+..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 4445555555567889999999999999976 567999999998888999999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
||+|||..|+|.+||++.. +..++.-.++.++.||+.||+||. .+++|||||.++|.|+.++..+||+|||++
T Consensus 340 IiTEfM~yGNLLdYLRecn----r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECN----RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEecccCccHHHHHHHhc----hhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999998763 366788889999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++..+...- -.+..-.+.|.|||-| .+..++.|||
T Consensus 413 RlMtgDTYTA-HAGAKFPIKWTAPEsL--AyNtFSiKSD 448 (1157)
T KOG4278|consen 413 RLMTGDTYTA-HAGAKFPIKWTAPESL--AYNTFSIKSD 448 (1157)
T ss_pred hhhcCCceec-ccCccCcccccCcccc--cccccccchh
Confidence 9987765321 1334457889999999 5578999998
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.92 Aligned_cols=180 Identities=29% Similarity=0.512 Sum_probs=154.4
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
..+.+.++||+|++|.||+|...+++.+++|.+..... ...++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34556788999999999999998899999999976543 45788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++++.. ...+++..++.++.|++.||+||| +++++|+||||+||++++++.+||+|||.+.......
T Consensus 86 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 86 KGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999997642 356899999999999999999999 8999999999999999999999999999997764432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||++.+ +.++.++|
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~--~~~~~~~D 186 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASH--GTFSTKSD 186 (261)
T ss_pred cc--ccCCCCceEecCHHHHcc--CCCCchhh
Confidence 21 123456778999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=225.17 Aligned_cols=180 Identities=28% Similarity=0.405 Sum_probs=142.3
Q ss_pred hcccCCcEEEEEEEECC---CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLID---GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+||+|+||.||+|...+ ...+++|.+..... ....+.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 35688887754322 23567899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++...... .....++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999775421 1234578888999999999999999 9999999999999999999999999999987544332222
Q ss_pred eeccCCCCcccccccccccc-----ccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRN-----IGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~-----~~~~s~~sD 516 (516)
......+++.|+|||++... ...++.++|
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhH
Confidence 22334457789999997431 124456665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=227.57 Aligned_cols=176 Identities=32% Similarity=0.503 Sum_probs=142.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC--CCCEEEEEEeecCC---CCchhHHHHHHHhhcc---CCcceeeEEEEEee-----cC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI--DGSNVAVKVLNDSK---GNGEEFINEVASISRT---SHVNVVTLLGFCFE-----GR 394 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 394 (516)
+++.+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 345678999999999999873 46789999986432 2234566787777665 69999999998852 45
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..++||||++ ++|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 6889999996 59999987542 245899999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++...... ......|++.|+|||++.+ ..++.++|
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~D 191 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQ--SSYATPVD 191 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhC--CCCCCccc
Confidence 9997654332 1234568999999999954 57888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=226.81 Aligned_cols=185 Identities=31% Similarity=0.482 Sum_probs=150.6
Q ss_pred HHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+++.++||+|+||.||+|...+ +..||+|+++..... .+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45567889999999999998642 478999999754322 3568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 468 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 468 (516)
++||+++++|.+++...... .....+++..++.++.|++.||+||| +++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999998643110 11245888999999999999999999 999999999999999999999
Q ss_pred EEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 469 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 469 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+||+|||+++...............+++.|+|||++.. +.++.++|
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 208 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSD 208 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchh
Confidence 99999999886644332222233456789999999854 67888877
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=226.89 Aligned_cols=183 Identities=33% Similarity=0.578 Sum_probs=149.9
Q ss_pred hhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.||+|++|.||+|.... ...|++|.+..... ...++.+|+..+.+++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 356789999999999998643 25799999864332 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEE
Q 036471 401 EFVSNGSLEKFIYRNSSSI----------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK 470 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 470 (516)
||+++++|.+++.+..... ....+++..++.++.|++.||+||| +.+++|+||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence 9999999999997653211 1156889999999999999999999 89999999999999999999999
Q ss_pred EeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 471 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 471 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|||+++...............+++.|+|||.+.+ +.++.++|
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sD 208 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESD 208 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhh
Confidence 999999976544332222233456889999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=225.65 Aligned_cols=175 Identities=31% Similarity=0.417 Sum_probs=148.5
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
..+.||+|+||.||++... +++.||+|.+..... ..+.+.+|+.++++++|++|+.+++.+.+.+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3467999999999999875 588999999864321 22457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 84 g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 84 GGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred CCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999986542 246899999999999999999999 9999999999999999999999999999987654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....|+..|+|||++.+ +.++.++|
T Consensus 157 ~~---~~~~g~~~y~aPE~~~~--~~~~~~~D 183 (285)
T cd05630 157 TI---KGRVGTVGYMAPEVVKN--ERYTFSPD 183 (285)
T ss_pred cc---cCCCCCccccChHHHcC--CCCCCccc
Confidence 21 23468999999999954 67888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=227.01 Aligned_cols=187 Identities=27% Similarity=0.474 Sum_probs=151.6
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
+..+.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 334456678999999999999752 24568999886543 23467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEE
Q 036471 398 LIYEFVSNGSLEKFIYRNSSS-------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK 470 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 470 (516)
+||||+++++|.+++...... .....+++..++.++.|++.||+||| +++++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 999999999999999754310 11235899999999999999999999 99999999999999999999999
Q ss_pred EeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 471 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 471 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|||+++...............+++.|+|||++.. ..++.++|
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sD 204 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESD 204 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhh
Confidence 999999986644332222233445778999999854 57788887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=244.10 Aligned_cols=177 Identities=30% Similarity=0.501 Sum_probs=156.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CC----CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DG----SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
...++||+|+||+||+|.+. +| -+||+|++.... ...+++++|+-.|.+++|||++++++++.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999863 33 468999986543 34588999999999999999999999998766 889999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|++.|+|.++++.++ ..+..+.++.|..|||+||.||| .++++||||.++||||.+-..+||.|||+++.+.
T Consensus 778 ~mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred hcccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999998865 56888999999999999999999 9999999999999999999999999999999998
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.++.........-.+.|||-|.+.. ..++.+||
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~--~~~thqSD 882 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRI--RKYTHQSD 882 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhc--cCCCchhh
Confidence 8877766666677889999999954 78999998
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.97 Aligned_cols=182 Identities=32% Similarity=0.527 Sum_probs=154.6
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+..+.+.++||+|++|.||+|...+++.|++|.+.......+++.+|+.++++++|+||+++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 34455678899999999999998888899999998766667889999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.... ...+++..+..++.|++.||+||| +++++|+||||+||++++++.+||+|||.+..+....
T Consensus 85 ~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 85 KGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999997542 256899999999999999999999 8999999999999999999999999999998765432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......++..|+|||.+.+ +.++.++|
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~D 186 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANY--GRFTIKSD 186 (261)
T ss_pred hh-hhhccCCCccccCHHHhcc--CCcCchhH
Confidence 11 1122334678999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=235.25 Aligned_cols=190 Identities=28% Similarity=0.448 Sum_probs=152.0
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccC-CcceeeEEEEEee
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTS-HVNVVTLLGFCFE 392 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 392 (516)
++......+.++||+|+||.||+|++. .++.||+|+++.... ..+.+.+|+.++.++. ||||+++++.+..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344444556788999999999999863 246899999975432 2357889999999997 9999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCC------------------------------------------------------
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSS------------------------------------------------------ 418 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 418 (516)
.+..++||||+++|+|.+++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 99999999999999999999764310
Q ss_pred --------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 419 --------------------------------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 419 --------------------------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
.....+++..++.++.|++.||+||| +++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence 01134778889999999999999999 8999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++++.+||+|||+++...............+++.|+|||++.+ +.++.++|
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 323 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSD 323 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhH
Confidence 9999999999999999986543322222223456789999999954 56777776
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=250.76 Aligned_cols=183 Identities=25% Similarity=0.303 Sum_probs=149.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.++||+|+||.||+|... +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 44578999999999999976 489999999865322 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 404 SNGSLEKFIYRNSSS-----IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
++++|.+++.+.... .....+++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999753210 01234677888999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcc----------------eeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESI----------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .......||+.|||||++.+ ..++.++|
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSD 213 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTD 213 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhH
Confidence 66221100 00112468999999999855 57788877
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=260.27 Aligned_cols=178 Identities=29% Similarity=0.495 Sum_probs=144.1
Q ss_pred cccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe
Q 036471 317 RYSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 317 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 395 (516)
.++++++... ....+.||+|+||.||+|+.. ++..||+|+++..... ..+|++.+++++|||||++++++.+++.
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3455555432 223457999999999999974 6899999998654322 2356888999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.++||||+++|+|.++++ .++|..+.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. |+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 999999999999999993 37899999999999999999996667799999999999999999888875 66
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+...... ....+++.|||||++.+ +.++.|+|
T Consensus 828 ~~~~~~~~------~~~~~t~~y~aPE~~~~--~~~~~~sD 860 (968)
T PLN00113 828 LPGLLCTD------TKCFISSAYVAPETRET--KDITEKSD 860 (968)
T ss_pred cccccccC------CCccccccccCcccccC--CCCCcccc
Confidence 55433221 22357899999999854 67899988
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-28 Score=252.95 Aligned_cols=182 Identities=26% Similarity=0.310 Sum_probs=156.4
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeec---C-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLND---S-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~---~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
...+.+.+.||+|+||.|..++.+. ++.+|+|++++ . .....-|..|-.+|..-+.+=|+.++-.|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3344566899999999999999864 78899999976 2 33446678888899988999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
||||+||+|-.+|.+. .+++++.+..++..|+.||.-|| +.|+|||||||+|||||..|++||+|||.+..
T Consensus 154 MdY~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred EecccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999654 37999999999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCcceeeccCCCCcccccccccccc--c-cccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRN--I-GEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~-~~~s~~sD 516 (516)
+..+..... ...+|||.|++||+|... . |.|+...|
T Consensus 225 m~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecD 263 (1317)
T KOG0612|consen 225 MDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECD 263 (1317)
T ss_pred cCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccc
Confidence 887766554 557899999999999433 2 45666655
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=224.90 Aligned_cols=174 Identities=33% Similarity=0.412 Sum_probs=148.1
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.||+|+||+||++... +++.+|+|.+.... .....+.+|++++++++|+||+.+.+.+..++..+++|||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 467999999999999875 58899999986532 2234578899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 85 GDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999886532 246999999999999999999999 99999999999999999999999999999976543322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|+..|+|||++.+ ..++.++|
T Consensus 158 ---~~~~~g~~~~~aPE~~~~--~~~~~~~D 183 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNN--QRYTLSPD 183 (285)
T ss_pred ---ccCCCCCcCccChHHhcC--CCCCcccc
Confidence 133568999999999954 57788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=228.73 Aligned_cols=189 Identities=28% Similarity=0.498 Sum_probs=153.0
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEe
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCF 391 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 391 (516)
+....+.+.+.||+|+||.||+++.. ++..||+|.+.... ...+++.+|+.+++.+ +||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33445556788999999999999741 24579999986432 3346789999999999 8999999999999
Q ss_pred ecCeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 392 EGRRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 392 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
..+..+++|||+++++|.+++.+.+.. .....+++..++.++.|++.||+||| +++++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 999999999999999999999875321 11246888999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++++++.+||+|||.++...............+++.|+|||++.+ +.++.++|
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 221 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSD 221 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc--CCCCchhh
Confidence 999999999999999987654433222233456778999999854 56788877
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=228.70 Aligned_cols=187 Identities=28% Similarity=0.424 Sum_probs=149.3
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC---------------CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID---------------GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLL 387 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~ 387 (516)
+..+++.++||+|+||.||+++..+ ...||+|.++... ...+.+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3445667889999999999987532 2358999986532 2235688999999999999999999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSS------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
+++...+..++||||+++++|.+++...... .....+++..++.++.|++.||+||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 9999999999999999999999999653210 01124788999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++++++.+||+|||++................++..|+|||++.+ +.++.++|
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 213 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASD 213 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhh
Confidence 999999999999999976543332221223345778999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=221.74 Aligned_cols=180 Identities=28% Similarity=0.396 Sum_probs=144.2
Q ss_pred hcccCCcEEEEEEEECC---CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLID---GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
.||+|+||.||+|...+ +..+++|.++.... ....+.+|+.++++++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 45789998865432 23578889999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.++++.... ......++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.++.........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999976432 12235677888899999999999999 8999999999999999999999999999997554333222
Q ss_pred eeccCCCCcccccccccccccc-----ccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIG-----EVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~-----~~s~~sD 516 (516)
......++..|+|||++.+..+ .++.++|
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccch
Confidence 2223456788999999854211 2466766
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=228.81 Aligned_cols=177 Identities=28% Similarity=0.439 Sum_probs=146.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.++||+|+||.||+|+.+ +++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 344567999999999999876 57889999986432 233567899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+ +|.+++.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 88 K-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred C-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 5 8888886542 45889999999999999999999 8999999999999999999999999999997654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||++.+. ..++.++|
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 187 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGS-SEYSTQID 187 (309)
T ss_pred cc--cccccccccccCCHHHhCC-CCCCcHHH
Confidence 21 1234578999999998543 45666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=220.06 Aligned_cols=180 Identities=36% Similarity=0.616 Sum_probs=152.4
Q ss_pred hhcccCCcEEEEEEEECC----CCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||++.... +..|++|.+...... .+.+.+|++.+.+++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999998764 788999999765433 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSS---IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++|.+++...... .....+++..++.++.|++.||+||| +++++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764210 01267999999999999999999999 89999999999999999999999999999987765
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...........++..|+|||.+.. +.++.++|
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKD--GIFTSKSD 189 (262)
T ss_pred ccccccccCCCcCccccCHHHhcc--CCcchhhc
Confidence 543222344567889999999854 46777777
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=221.46 Aligned_cols=182 Identities=34% Similarity=0.486 Sum_probs=148.0
Q ss_pred hhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCe------e
Q 036471 330 FKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRR------R 396 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~ 396 (516)
+.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|++.++.++|+||+++++.+.+... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998643 36799999875432 23578899999999999999999998876554 7
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++++||+++++|.+++...........+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence 899999999999999976543223457999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++...............++..|+|||++.. ..++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~D 197 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSD 197 (273)
T ss_pred eeeccccccccccccccCCccccCHhhccc--CCCCcccc
Confidence 987654432222222335678999999844 67888887
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=222.49 Aligned_cols=182 Identities=27% Similarity=0.458 Sum_probs=153.0
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
....+.+.++||+|+||.||++...++..+++|.+.......+.+.+|+.++++++|+||+++++.+.+ ...+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 344556778899999999999998788889999987655556789999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.+.. ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.+......
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 83 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999997642 356888999999999999999999 899999999999999999999999999999766433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......++..|+|||++.. +.++.++|
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~D 185 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINF--GSFTIKSD 185 (260)
T ss_pred Ccc-cccCCcccccccCHhHhcc--CCcCcccc
Confidence 221 1123345678999999854 67787777
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=223.78 Aligned_cols=187 Identities=27% Similarity=0.449 Sum_probs=152.1
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCee
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 396 (516)
...+.+.+.||+|+||.||+|...+ +..|++|.+.... .....+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3344556789999999999998643 3689999986443 2235688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSI----ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
++||||+++++|.+++....... ....+++..++.++.|++.||.||| +.+++|+||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997643211 1235789999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+++...............++..|+|||++.+ +.++.++|
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 203 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSD 203 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccc
Confidence 9999976654432222233456789999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=225.28 Aligned_cols=187 Identities=28% Similarity=0.463 Sum_probs=149.2
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCee
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 396 (516)
...+.+.+.||+|+||.||+|..+ .+..||+|.++.... ....+.+|+..+++++|+||+++++.+.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344556788999999999999753 245799998864432 234678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSI----ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
++||||+++|+|.+++++..... .....++..+..++.|++.||.||| +++|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999997643211 1244677889999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+++...............++..|+|||.+.+ +.++.++|
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~D 203 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSD 203 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc--CCCChHhH
Confidence 9999986544332222222345678999999854 56787776
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=230.88 Aligned_cols=186 Identities=30% Similarity=0.480 Sum_probs=149.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEee-cCe
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFE-GRR 395 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-~~~ 395 (516)
..+++.+.||+|+||.||+|... .++.||+|+++.... ..+.+.+|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 35667788999999999999642 247899999875332 235678899999999 89999999998865 457
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC-------------------------------------------------------CC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSS-------------------------------------------------------IE 420 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------~~ 420 (516)
.+++|||+++++|.+++...... ..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999999653210 00
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccc
Q 036471 421 NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500 (516)
Q Consensus 421 ~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 500 (516)
...+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999 99999999999999999999999999999987654433322233456788999
Q ss_pred cccccccccccccCCC
Q 036471 501 PEVFCRNIGEVSYKSD 516 (516)
Q Consensus 501 PE~l~~~~~~~s~~sD 516 (516)
||++.+ ..++.++|
T Consensus 244 PE~~~~--~~~~~~~D 257 (337)
T cd05054 244 PESIFD--KVYTTQSD 257 (337)
T ss_pred cHHhcC--CCCCcccc
Confidence 999855 67888887
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=221.48 Aligned_cols=180 Identities=29% Similarity=0.483 Sum_probs=149.4
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.+.++||+|++|.||++.+..+..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 345566789999999999999877778999998765555578899999999999999999999875 4568899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++++.. ...+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||.+........
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 85 GSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999997542 245889999999999999999999 89999999999999999999999999999976644322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......++..|+|||++.+ +.++.++|
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~D 185 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALY--GRFTIKSD 185 (260)
T ss_pred c-ccCCCccchhhCCHHHhcc--CCcChHHH
Confidence 1 1123345778999999844 56777666
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=223.68 Aligned_cols=176 Identities=29% Similarity=0.460 Sum_probs=143.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCC----EEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGS----NVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.||+|+||.||+|.+. +++ .+++|.+.... ....++..|+..+++++||||+++++++. +...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 4567999999999999875 344 47777775332 22356777888899999999999999875 4567889999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.... ..+++..++.++.|++.||+||| +++++|+||||+||++++++.+||+|||+++....
T Consensus 90 ~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 90 SPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999997643 46899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...........++..|+|||++.. +.++.++|
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~D 193 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF--GRYTHQSD 193 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc--CCcCchhh
Confidence 433222234557789999999954 67888887
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=226.95 Aligned_cols=179 Identities=28% Similarity=0.397 Sum_probs=142.2
Q ss_pred hhcccCCcEEEEEEEEC---CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g 406 (516)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++.+.. +...+++|||++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 57999999999999865 46789999986543 23567899999999999999999998864 456789999986 4
Q ss_pred CHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCcEEEeecCCccc
Q 036471 407 SLEKFIYRNSSS---IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKI 479 (516)
Q Consensus 407 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~~ 479 (516)
+|.+++...... .....+++..+..++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888887643211 11235899999999999999999999 9999999999999999 4567999999999987
Q ss_pred ccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .......||+.|+|||++.+. ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~D 198 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAID 198 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhh
Confidence 6543221 112346789999999998652 45777776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=239.11 Aligned_cols=179 Identities=26% Similarity=0.401 Sum_probs=151.5
Q ss_pred HhhhhhcccCCcEEEEEEEECCCC-EEEEEEeec-CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGS-NVAVKVLND-SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++...||.|+||.||+|..++.. ..|.|++.. +....++++-|+++|...+||+||++++.|..++.++++.||+.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 344556999999999999987644 446677753 455668999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|....++-.- +..+++.++..+.+|++.||.||| +++|||||||+.|||++-+|.++|+|||.+.......
T Consensus 114 GAVDaimlEL-----~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 114 GAVDAIMLEL-----GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred chHhHHHHHh-----ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 9999988654 378999999999999999999999 9999999999999999999999999999986543322
Q ss_pred ceeeccCCCCccccccccccccc---cccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNI---GEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~---~~~s~~sD 516 (516)
.....+.|||.|||||+.+-+. .+|++++|
T Consensus 185 -qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaD 217 (1187)
T KOG0579|consen 185 -QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKAD 217 (1187)
T ss_pred -hhhccccCCcccccchheeeccccCCCchhhhh
Confidence 1235688999999999985442 57777776
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=218.73 Aligned_cols=173 Identities=29% Similarity=0.486 Sum_probs=145.4
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
.||+|++|.||+|...+++.+|+|.+...... ...+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 58999999999999888899999998654322 3468899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeec
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 490 (516)
++.+.. ..+++..++.++.|++.||.||| +++++|+||||+||++++++.+||+|||++.......... ..
T Consensus 82 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (250)
T cd05085 82 FLRKKK-----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SG 152 (250)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-CC
Confidence 986532 45889999999999999999999 9999999999999999999999999999987543332111 11
Q ss_pred cCCCCccccccccccccccccccCCC
Q 036471 491 GARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 491 ~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...++..|+|||++.. +.++.++|
T Consensus 153 ~~~~~~~y~aPE~~~~--~~~~~~~D 176 (250)
T cd05085 153 LKQIPIKWTAPEALNY--GRYSSESD 176 (250)
T ss_pred CCCCcccccCHHHhcc--CCCCchhH
Confidence 2234678999999844 67777776
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=223.11 Aligned_cols=182 Identities=30% Similarity=0.460 Sum_probs=144.6
Q ss_pred hhhhcccCCcEEEEEEEECCC-C--EEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 330 FKYKLGQGGYGSVYKGKLIDG-S--NVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~-~--~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+.++||+|+||.||+|.+.+. . .||+|.++... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999997653 2 58999886542 2346788899999999999999999987532 2468
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
++|||+++|+|.+++...+.......+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998854332223356899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...............+++.|+|||++.+ ..++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~D 196 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD--RVYTTKSD 196 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC--CCcChHHH
Confidence 87654332211122345778999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=228.14 Aligned_cols=187 Identities=29% Similarity=0.484 Sum_probs=150.2
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeec
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEG 393 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 393 (516)
...+.+.+.||+|+||.||+++.. +...+|+|.+.... ....++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345667789999999999999753 23569999987542 2335688899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
+..++||||+++++|.+++...... .....+++.+++.++.|++.||+||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 9999999999999999999865321 11245899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 464 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++++.+||+|||.++...............+++.|+|||++.+ +.++.++|
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 224 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSD 224 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHH
Confidence 9999999999999976543322111122334578999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=232.25 Aligned_cols=182 Identities=29% Similarity=0.541 Sum_probs=156.3
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECC---CC--EEEEEEeec--CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLID---GS--NVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~---~~--~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 395 (516)
|.+....+.+.||.|-||.||+|...+ |+ .||||.-+. +..+.+.|+.|..+|++++||||++++|++.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 444444567889999999999998643 33 588898865 34567899999999999999999999999876 56
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.+||||.++-|.|..||+.+. ..++...+..++.||..||+||| ++++|||||..+|||+.....+||+|||
T Consensus 465 ~WivmEL~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeEEEecccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccc
Confidence 899999999999999998764 57899999999999999999999 9999999999999999999999999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++.+........ +...-+..|||||.+ ++.+++.+||
T Consensus 537 LSR~~ed~~yYka-S~~kLPIKWmaPESI--NfRrFTtASD 574 (974)
T KOG4257|consen 537 LSRYLEDDAYYKA-SRGKLPIKWMAPESI--NFRRFTTASD 574 (974)
T ss_pred hhhhccccchhhc-cccccceeecCcccc--chhcccchhh
Confidence 9998876654433 345567899999999 8889999998
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=225.67 Aligned_cols=185 Identities=31% Similarity=0.477 Sum_probs=151.4
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-----------------CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-----------------GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLL 387 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~ 387 (516)
.+++.++||+|+||.||++...+ +..||+|.+.... ...+.+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34566789999999999997643 2458999986543 2346788999999999999999999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSS-----IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
+++..++..+++|||+++++|.+++.+.... .....+++..++.++.|++.||+||| +.+|+|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhcee
Confidence 9999999999999999999999999765311 01236899999999999999999999 899999999999999
Q ss_pred ECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 463 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.++.++|+|||+++...............+++.|+|||++.+ +.++.++|
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 214 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSD 214 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccch
Confidence 99999999999999976544432222234456789999999854 57888887
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=222.49 Aligned_cols=180 Identities=29% Similarity=0.469 Sum_probs=148.4
Q ss_pred HHhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 397 (516)
++...+.||+|+||.||+++. .++..||+|.++... ...+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 344557799999999999974 247889999986432 2336789999999999999999999998775 5688
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++++|.+++.+.. ..+++..++.++.|++.||+||| +++++||||||+||+++.++.+||+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999996532 45899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+........ .....++..|+|||++.+ +.++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~D 194 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASD 194 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhcc--CCCCcccc
Confidence 87654432211 123456778999999854 56788887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=231.75 Aligned_cols=172 Identities=26% Similarity=0.357 Sum_probs=144.6
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
..+.+.+.||+|+||.||+|+.. +++.||+|+... .....|+.++++++|+||+++++++.+.+..++|+|++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 34556688999999999999976 467899997533 234679999999999999999999999999999999995
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.... ..+++..++.|+.||+.||+||| .++|+||||||+|||++.++.+||+|||+++......
T Consensus 141 -~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 141 -SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred -CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 58888886532 56899999999999999999999 8999999999999999999999999999997543222
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+ ..++.++|
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 238 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLAR--DKYNSKAD 238 (357)
T ss_pred c---cccccccccccCCeecCC--CCCCchhh
Confidence 1 134568999999999955 57888887
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=231.16 Aligned_cols=187 Identities=29% Similarity=0.463 Sum_probs=148.1
Q ss_pred HHHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeec-C
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEG-R 394 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 394 (516)
...+.+.+.||+|+||.||+|.+ .+++.||||+++.... ..+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34566778999999999999974 3467899999975432 235688999999999 789999999987654 4
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCC-------------------------------------------------------
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSI------------------------------------------------------- 419 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 419 (516)
..+++|||+++|+|.++++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999997532100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCC
Q 036471 420 ------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493 (516)
Q Consensus 420 ------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 493 (516)
....+++..+..++.|+++||+||| +++|+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0134788899999999999999999 9999999999999999999999999999997654332222222344
Q ss_pred CCccccccccccccccccccCCC
Q 036471 494 GTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 494 gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++..|+|||++.. +.++.++|
T Consensus 243 ~~~~y~aPE~~~~--~~~~~~~D 263 (343)
T cd05103 243 LPLKWMAPETIFD--RVYTIQSD 263 (343)
T ss_pred CCcceECcHHhcC--CCCCchhh
Confidence 5678999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=220.41 Aligned_cols=170 Identities=27% Similarity=0.444 Sum_probs=142.5
Q ss_pred hhcccCCcEEEEEEEECCCC-----------EEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDGS-----------NVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.||+|+||.||+|.+.+.. .+++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 35899999999999986533 57788776544436789999999999999999999999888 7789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-------cEEEee
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-------CPKISD 473 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~D 473 (516)
||+++++|.+++.+.. ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++ .+||+|
T Consensus 80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999997642 36899999999999999999999 99999999999999999887 799999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++...... ....++..|+|||++......++.++|
T Consensus 152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~D 188 (259)
T cd05037 152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAAD 188 (259)
T ss_pred CCcccccccc------cccccCCCccChhhhcCCCCCcchhhH
Confidence 9999765432 224467789999998653236677766
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=224.19 Aligned_cols=184 Identities=30% Similarity=0.504 Sum_probs=149.9
Q ss_pred HhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 398 (516)
+.+.+.||+|++|.||++...+ ...+|+|.+..... ...++.+|++++.++ +|+||+++++++..++..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 4455789999999999998642 36789999865332 235688999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 468 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 468 (516)
+|||+++++|.+++++.... .....+++..++.++.|++.||+||| +++|+||||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCe
Confidence 99999999999999764210 12356899999999999999999999 899999999999999999999
Q ss_pred EEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 469 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 469 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+||+|||+++.+.............++..|+|||++.. ..++.++|
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 216 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSD 216 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccc
Confidence 99999999987654432222233345678999999844 57788877
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=234.00 Aligned_cols=175 Identities=30% Similarity=0.403 Sum_probs=145.1
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~ 400 (516)
+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+++++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4567999999999999975 68999999986432 23367889999999999999999999998776 789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+. ++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 84 ELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9996 5888887532 56899999999999999999999 999999999999999999999999999999765
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......+++.|+|||++.+. ..++.++|
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 187 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVD 187 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHH
Confidence 433221 12345678999999998653 35677776
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=235.99 Aligned_cols=176 Identities=23% Similarity=0.292 Sum_probs=147.9
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC---CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
...+.+.+.||+|+||.||++... .+..|++|.+... +...+|++++++++||||+++++.+......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 345666788999999999999753 3578999988543 345689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
++. ++|.+++... ..+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||++..+.
T Consensus 167 ~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 167 KYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 996 5888888432 56899999999999999999999 8999999999999999999999999999997665
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
............||+.|+|||++.. ..++.++|
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 269 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLAL--DPYCAKTD 269 (392)
T ss_pred cccccccccccccccCccCHhHhcC--CCCCchhh
Confidence 4433222234678999999999954 57888877
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=219.12 Aligned_cols=179 Identities=27% Similarity=0.376 Sum_probs=149.8
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++.+..++..++||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 4456678999999999999974 68899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||+|+||+++.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 90 GGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999998643 46899999999999999999999 8999999999999999999999999999998664322
Q ss_pred cceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
. ......+++.|+|||.+... .+.++.++|
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~D 191 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhh
Confidence 1 11335678999999998432 245666766
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-26 Score=218.28 Aligned_cols=179 Identities=27% Similarity=0.378 Sum_probs=150.3
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4456678999999999999875 58899999986543 333567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 90 GGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999998653 46899999999999999999999 8999999999999999999999999999987654332
Q ss_pred cceeeccCCCCccccccccccc-cccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
. ......|+..|+|||++.. ..+.++.++|
T Consensus 161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~D 191 (267)
T cd06645 161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191 (267)
T ss_pred c--ccccccCcccccChhhhccccCCCCCchhh
Confidence 1 1234568999999999742 1245777776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.79 Aligned_cols=176 Identities=38% Similarity=0.565 Sum_probs=147.9
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCch---hHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGE---EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++.+.||+|+||.||+++... ++.+|+|.+........ ...+|+..+++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 456789999999999999875 56899999976543332 33569999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ..+++..++.++.|+++||++|| +.+|+|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 82 GGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccc------ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999733 56899999999999999999999 8999999999999999999999999999997642222
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.......++..|+|||++.. ...++.++|
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~~D 181 (260)
T PF00069_consen 153 --ENFNPFVGTPEYMAPEVLQQ-GKKYTRKSD 181 (260)
T ss_dssp --SEBSSSSSSGGGSCHHHHTT-TSSBSTHHH
T ss_pred --cccccccccccccccccccc-ccccccccc
Confidence 12345678999999999851 256666655
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-26 Score=218.93 Aligned_cols=180 Identities=31% Similarity=0.471 Sum_probs=149.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeec------CeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEG------RRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~~lv 399 (516)
+++.+.||+|+||.||+|... +++.||+|.+.........+.+|+.++.++ +|+||+++++.+... ...+++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 344567999999999999875 478999999977666667889999999998 799999999998753 457899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.+++.... ...+++..+..++.|++.||+||| +++|+|+||||+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 88 MEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999997642 256899999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
...... ......|++.|+|||++..+ ...++.++|
T Consensus 161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~D 198 (272)
T cd06637 161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSD 198 (272)
T ss_pred cccccc--cCCcccccccccCHhHhccccCcCCCCCchhh
Confidence 543321 12345689999999998532 235666776
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=228.47 Aligned_cols=190 Identities=29% Similarity=0.501 Sum_probs=152.5
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECC--------CCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEE
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLID--------GSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFC 390 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 390 (516)
++...++.+.+.||+|+||.||++.... +..||+|.++... ...+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3444566777899999999999997421 2368999886432 2346789999999999 899999999999
Q ss_pred eecCeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 391 FEGRRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 391 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
.+.+..++++||+++|+|.+++.+.... .....+++..++.++.|++.||+||| .++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccce
Confidence 9999999999999999999999764321 12346889999999999999999999 8999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++.++.+||+|||+++...............++..|+|||++.+ ..++.++|
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 218 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSD 218 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--CCcCchhh
Confidence 9999999999999999986654332222223345678999999955 56777776
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=217.47 Aligned_cols=177 Identities=28% Similarity=0.404 Sum_probs=151.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||++... +++.|++|.+... ....+++.+|++++++++||||+++++.+.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 34577999999999999875 5889999998643 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 83 NGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999997642 257899999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|++.|+|||++.+ +.++.++|
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCED--KPYNEKSD 183 (256)
T ss_pred ch--hhccccCccccCHHHhcC--CCCCCccc
Confidence 22 133467899999999854 56788887
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=219.05 Aligned_cols=175 Identities=31% Similarity=0.552 Sum_probs=150.4
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.+.||+|++|.||++.. .++.||+|.+.......+++.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 344667899999999999987 4899999999766555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.++++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++......
T Consensus 86 ~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 86 SLVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999997642 236899999999999999999999 9999999999999999999999999999998763322
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+..|+|||++.. +.++.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~--~~~~~~~D 181 (256)
T cd05039 157 ---DSGKLPVKWTAPEALRE--KKFSTKSD 181 (256)
T ss_pred ---ccCCCcccccCchhhcC--CcCCcHHH
Confidence 12344678999999854 56777766
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=219.22 Aligned_cols=170 Identities=28% Similarity=0.405 Sum_probs=140.1
Q ss_pred hhcccCCcEEEEEEEECC-------------CCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 332 YKLGQGGYGSVYKGKLID-------------GSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
+.||+|+||.||+|+..+ ...|++|.+..... ....+.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 23588898765432 3357888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-------EE
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-------PK 470 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~k 470 (516)
+||||+++++|..++.+.. ..+++..++.++.||++||+||| +++|+||||||+|||++.++. +|
T Consensus 81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999886532 46899999999999999999999 999999999999999987664 89
Q ss_pred EeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 471 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 471 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++|||++...... ....++..|+|||++.. ...++.++|
T Consensus 153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~~D 191 (262)
T cd05077 153 LSDPGIPITVLSR------QECVERIPWIAPECVED-SKNLSIAAD 191 (262)
T ss_pred eCCCCCCccccCc------ccccccccccChhhhcC-CCCCCchhH
Confidence 9999998655322 23456889999999853 256777776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-26 Score=217.40 Aligned_cols=173 Identities=28% Similarity=0.494 Sum_probs=141.6
Q ss_pred hcccCCcEEEEEEEEC---CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799999865432 2356889999999999999999999875 457899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..++.++.|++.||+||| +++++|+||||+||+++.++.+||+|||++..........
T Consensus 81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999986532 56899999999999999999999 8999999999999999999999999999997654443221
Q ss_pred e-eccCCCCccccccccccccccccccCCC
Q 036471 488 S-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....++..|+|||++.. +.++.++|
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 180 (257)
T cd05115 153 KARSAGKWPLKWYAPECINF--RKFSSRSD 180 (257)
T ss_pred eccCCCCCCcccCCHHHHcc--CCCCchhh
Confidence 1 122334678999999844 56787777
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=218.55 Aligned_cols=178 Identities=30% Similarity=0.556 Sum_probs=151.1
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.+.||+|++|.||++.+.+++.+++|.+........++.+|++++++++||||+++++++......++||||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34567899999999999998778899999987666666789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..++++.++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus 86 L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 86 LSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999987532 45889999999999999999999 8999999999999999999999999999987654332211
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||++.+ +.++.++|
T Consensus 158 -~~~~~~~~~~~aPe~~~~--~~~~~~~D 183 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSF--SKYSSKSD 183 (256)
T ss_pred -cCCCccchhhcCHhHhcc--CCcChHHH
Confidence 122335678999999854 56777766
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=222.13 Aligned_cols=178 Identities=30% Similarity=0.522 Sum_probs=145.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCC----EEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGS----NVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.++.++||+|+||.||+|++. +++ .||+|+++... ...+.+.+|+.++..++|+||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 345578999999999999854 444 48999986432 234678899999999999999999998875 4577999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+||++++++.+||+|||+++..
T Consensus 88 ~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 88 QLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999997532 46899999999999999999999 999999999999999999999999999999877
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.............+++.|+|||++.+ +.++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 193 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH--RRFTHQSD 193 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc--CCCCchhH
Confidence 54433222223345778999999854 56788877
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=242.42 Aligned_cols=184 Identities=24% Similarity=0.317 Sum_probs=145.0
Q ss_pred HhhhhhcccCCcEEEEEEEECCC-CEEEEEEee-cCCCCchhHHHHHHHhhccC-CcceeeEEE-EEee---c---CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDG-SNVAVKVLN-DSKGNGEEFINEVASISRTS-HVNVVTLLG-FCFE---G---RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~-~~~~---~---~~~~ 397 (516)
..+.+.|++|||+.||.|.+..+ ..+|+|++- .+....+.+.+|+++|++|. |+|||.+++ .... . -.++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34557899999999999998776 999999874 35556688999999999996 999999999 3322 1 2567
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
|+||||++|.|-+++..+. ...|++.++++|+.|+++|+++|| ....+|||||||-+||||+.++..||+|||.|
T Consensus 119 lLmEyC~gg~Lvd~mn~Rl----q~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRL----QTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eehhhccCCcHHHHHHHHH----hccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 8999999999999998763 255999999999999999999999 23456999999999999999999999999998
Q ss_pred ccccCCC-ccee------eccCCCCccccccccccc-cccccccCCC
Q 036471 478 KICNRKE-SIIS------MTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~-~~~~------~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
...-... .... .-....|+.|+|||++.- ....+++|+|
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsD 240 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSD 240 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhH
Confidence 4332211 1100 011236999999999711 1257788887
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=224.80 Aligned_cols=186 Identities=30% Similarity=0.495 Sum_probs=149.1
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGR 394 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 394 (516)
..+.+.++||+|+||.||+++.. ....+|+|.++.... ...++.+|+.+++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34446688999999999999742 245689999875332 335688999999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD 464 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~ 464 (516)
..+++|||+++|+|.+++...... .....+++..+..++.|++.||+||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999999764321 11246899999999999999999999 89999999999999999
Q ss_pred CCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 465 EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 465 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++.+||+|||.++...............++..|+|||++.+ +.++.++|
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 218 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSD 218 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccch
Confidence 999999999999986644322111122334568999999854 67888887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=237.09 Aligned_cols=176 Identities=24% Similarity=0.374 Sum_probs=140.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeec--------CeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG--------RRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~l 398 (516)
+.+.+.||+|+||.||+|... +++.||+|++.... ....+|+.++++++||||+++++++... ...++
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 445678999999999999875 58899999885432 3345799999999999999999887532 24668
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLA 477 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a 477 (516)
||||+++ +|.+++.... .....+++..++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||++
T Consensus 145 vmE~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEecCCc-cHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 9999975 7877775432 12367999999999999999999999 99999999999999998665 7999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+...... ....||+.|+|||++.+. ..++.++|
T Consensus 219 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~D 253 (440)
T PTZ00036 219 KNLLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHID 253 (440)
T ss_pred hhccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHH
Confidence 876543321 235679999999998653 45777766
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=220.36 Aligned_cols=168 Identities=30% Similarity=0.458 Sum_probs=144.4
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.||+|++|.||+|... +++.||+|.+.... ...+++.+|++++.+++||||+++++.+...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 4567999999999999864 68899999986542 23357889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|..+ ..+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 85 SLDVY----------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred ChHHh----------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99654 24678899999999999999999 9999999999999999999999999999997654332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|+..|+|||++.+ ..++.++|
T Consensus 150 --~~~~~~~~~y~aPE~~~~--~~~~~~~D 175 (279)
T cd06619 150 --AKTYVGTNAYMAPERISG--EQYGIHSD 175 (279)
T ss_pred --ccCCCCChhhcCceeecC--CCCCCcch
Confidence 134568999999999965 56788887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=222.18 Aligned_cols=172 Identities=31% Similarity=0.425 Sum_probs=149.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|++|.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++.+.+++..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 45578999999999999876 58999999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.+. ..+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 84 PGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999654 56899999999999999999999 899999999999999999999999999999876544
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....+++.|+|||.+.. +..+.++|
T Consensus 155 ~-----~~~~~~~~y~aPE~~~~--~~~~~~~D 180 (290)
T cd05580 155 T-----YTLCGTPEYLAPEIILS--KGYGKAVD 180 (290)
T ss_pred C-----CCCCCCccccChhhhcC--CCCCcccc
Confidence 1 33467899999999854 56777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=223.62 Aligned_cols=184 Identities=26% Similarity=0.454 Sum_probs=150.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.+.||+|+||.||+++.. ++..+++|.+..... ..+.+.+|++.+++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 345578999999999999742 345688898865432 3367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEE
Q 036471 401 EFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK 470 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 470 (516)
||+++++|.+++...... .....+++..++.++.|++.||+||| +++|+||||||+||+++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 999999999999764310 11245899999999999999999999 99999999999999999999999
Q ss_pred EeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 471 ISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 471 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|||++................++..|+|||++.+ ..++.++|
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 207 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESD 207 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhcc--CCCCchhh
Confidence 999999976544332222233456788999999855 57788887
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=220.12 Aligned_cols=180 Identities=24% Similarity=0.423 Sum_probs=150.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|++++++++||||+++++++.+.+..++++||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 345678999999999999875 68999999875422 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++..... ....+++..++.++.|++.||+||| +++++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 84 ADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999865321 2356899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....+++.|+|||.+.+ ..++.++|
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~--~~~~~~~D 188 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHE--NGYNFKSD 188 (267)
T ss_pred hhHH--HhcCCCCccccChhhhcc--CCCCchhh
Confidence 3321 133567889999999854 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=232.63 Aligned_cols=175 Identities=26% Similarity=0.342 Sum_probs=151.7
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-C-----cceeeEEEEEeecCeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-H-----VNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lv 399 (516)
+|.+.+.||+|+||+|.+|.+. +++.||||++++.+.-.++...|+.+|.+++ | -|+|++++++...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 5556788999999999999875 5999999999988877788889999999996 3 4799999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC--cEEEeecCCc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF--CPKISDFGLA 477 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a 477 (516)
+|.++. +|.++|+.++ ...++...+..|+.||+.||.+|| ..+|||+||||+||||.+-. .+||+|||.|
T Consensus 267 fELL~~-NLYellK~n~----f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNK----FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ehhhhh-hHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 999954 9999998764 356999999999999999999999 99999999999999996433 7999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......-. ....+..|+|||+|++ .+|+.+.|
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILG--lpY~~~ID 370 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILG--LPYDTAID 370 (586)
T ss_pred cccCCcce-----eeeeccccccchhhcc--CCCCCccc
Confidence 76554432 2345889999999988 78988877
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=224.48 Aligned_cols=185 Identities=28% Similarity=0.462 Sum_probs=148.9
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-----------------CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-----------------DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLL 387 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~ 387 (516)
.+.+.++||+|+||.||++... +...||+|++.... ....++.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3456678999999999998642 23468999986532 2346789999999999999999999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI-----ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
+++...+..+++|||+++++|.+++....... ....+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEE
Confidence 99999999999999999999999997643211 1235788899999999999999999 899999999999999
Q ss_pred ECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 463 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++++.++|+|||+++.+.............+++.|+|||+..+ +.++.++|
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~D 214 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASD 214 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhh
Confidence 99999999999999986644332211122344678999998754 67888887
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=229.68 Aligned_cols=172 Identities=29% Similarity=0.327 Sum_probs=142.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC------eeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR------RRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 397 (516)
+.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++...+ ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 445578999999999999875 58999999986432 33467789999999999999999999986543 478
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++ +|.+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 103 lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 103 LVMELMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred EEEeCCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 99999975 6666653 34788999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....||+.|+|||++.+ ..++.++|
T Consensus 171 ~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~~D 204 (359)
T cd07876 171 RTACTNFM---MTPYVVTRYYRAPEVILG--MGYKENVD 204 (359)
T ss_pred cccccCcc---CCCCcccCCCCCchhccC--CCCCcchh
Confidence 75433221 234568999999999955 57888887
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=219.86 Aligned_cols=180 Identities=26% Similarity=0.484 Sum_probs=148.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-C---CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-D---GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+|... + +..+|+|.++... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3445678999999999999864 2 3379999986533 23367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.+.. ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.+
T Consensus 85 e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 85 EYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999997542 46899999999999999999999 999999999999999999999999999999876
Q ss_pred cCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .....++..|+|||++.. +.++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~D 191 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASD 191 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhh
Confidence 54332211 122234568999999954 56787776
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=221.51 Aligned_cols=179 Identities=29% Similarity=0.493 Sum_probs=147.0
Q ss_pred HhhhhhcccCCcEEEEEEEECC-C---CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-G---SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+++.+.||+|+||.||+|.... + ..|++|.+.... ...+++.+|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4567889999999999998753 3 369999986532 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.... ..+++.+++.++.|++.||+||| +++++|+||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 86 FMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred cCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999997532 46899999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCcceeeccCC---CCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGAR---GTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~---gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
............ .+..|+|||++.+ +.++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 193 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASD 193 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--Ccccchhh
Confidence 433221111111 2457999999854 67777776
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=220.38 Aligned_cols=179 Identities=31% Similarity=0.520 Sum_probs=147.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-CC----EEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-GS----NVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
.+++.+.||+|+||.||+|.+++ ++ .+++|.+..... ...++.+|+..+++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 34556789999999999998653 33 589998865433 33678899999999999999999999887 788999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++|+|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.++.
T Consensus 87 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999997643 45899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..............++..|+|||.+.. +.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 193 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSD 193 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhc--CCcCchhh
Confidence 764443322223334678999999843 56777776
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=221.36 Aligned_cols=175 Identities=32% Similarity=0.488 Sum_probs=142.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhcc---CCcceeeEEEEEee-----cCee
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRT---SHVNVVTLLGFCFE-----GRRR 396 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~~ 396 (516)
.+.+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+++++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34577999999999999876 58899999986432 2224566777777665 79999999998864 3457
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
+++|||+++ +|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred EEEEccccc-CHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 899999975 8998886542 245899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++....... .....++..|+|||++.+ +.++.++|
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQ--STYATPVD 189 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhC--CCCCCcch
Confidence 986643322 133567899999999955 57888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=216.05 Aligned_cols=177 Identities=28% Similarity=0.349 Sum_probs=148.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
...+.||+|++|.||++... +++.+++|.+..... ..+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 34578999999999999875 589999999864321 23568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||+++...
T Consensus 85 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 85 YMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred ECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999998654 45889999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....++..|+|||++.+ ..++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKAD 189 (263)
T ss_pred ccccccccccCCCcCccccCcceecc--CCCCchhh
Confidence 3321111 123457889999999965 45777777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=223.56 Aligned_cols=182 Identities=32% Similarity=0.478 Sum_probs=149.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
....+.+.||+|+||.||++... .+..||+|+++.... ..+.+.+|+.+++++ +|+||+++++.+...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34556688999999999999742 245799999865432 235688999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
+++|||+++++|.+++++.. ...+++.+++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR----ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999997542 134899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+.............++..|+|||++.+ +.++.++|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 225 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESD 225 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhcc--CCCCcHhH
Confidence 986654432222223446788999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=247.88 Aligned_cols=190 Identities=24% Similarity=0.337 Sum_probs=149.7
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee--cCe
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE--GRR 395 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 395 (516)
+.....+.+.++||+|+||+||+++... +..||+|.+.... .....+.+|+.++.+++|||||++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3333445566889999999999999764 6788999886432 234678899999999999999999998865 356
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeeCCCCCCcEEECC------
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC----STRILHFDIKPHNILLDE------ 465 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~----~~~ivH~dlkp~NIll~~------ 465 (516)
++|||||+++++|.++|..... ....+++..++.|+.||+.||+|||... ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 8999999999999999975421 2256999999999999999999999311 145999999999999964
Q ss_pred -----------CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 -----------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+.+||+|||++..+..... .....||+.|+|||++.+....++.++|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhH
Confidence 23589999999986643322 1345689999999999665456788877
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=222.11 Aligned_cols=183 Identities=28% Similarity=0.458 Sum_probs=147.8
Q ss_pred hhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.||+|+||.||+|.... ...+++|.+..... ..+++.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 345779999999999998632 35688888865432 2357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 401 EFVSNGSLEKFIYRNSSS------------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
||+++++|.+++...... .....+++..++.++.|++.||+||| +.+|+||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEE
Confidence 999999999998754211 11245889999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 463 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++++.+||+|||+++...............++..|+|||++.+ ..++.++|
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~D 211 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--HIYTTQSD 211 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--CCcchHhH
Confidence 99999999999999976544332222233456778999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=217.86 Aligned_cols=179 Identities=27% Similarity=0.414 Sum_probs=148.6
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++.+.||+|+||.||++.... +..+++|.+.... ...+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 3455779999999999999764 6788888885432 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|..++.+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 87 GAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999886532 56899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeeccCCCCccccccccccc---cccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCR---NIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~---~~~~~s~~sD 516 (516)
......+++.|+|||++.. +...++.++|
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 190 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 190 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccch
Confidence 1233568999999999842 1245667776
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=222.70 Aligned_cols=173 Identities=25% Similarity=0.361 Sum_probs=146.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++.+.||+|+||.||++... ++..+++|.+..... ...++.+|++++.+++||||+++++.+.+++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 34577999999999999875 477888898864322 235688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++++. ..+++..+..++.|+++||.||| + .+++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 84 GSLDQVLKKA------GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999754 46899999999999999999999 6 589999999999999999999999999987553322
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....+++.|+|||++.+ ..++.++|
T Consensus 155 ~----~~~~~~~~~~aPE~~~~--~~~~~~~D 180 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQG--THYTVQSD 180 (308)
T ss_pred c----ccCCCCcCccChhHhcC--CCCCccch
Confidence 1 33567899999999854 56777776
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=215.00 Aligned_cols=175 Identities=32% Similarity=0.521 Sum_probs=147.3
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
++||+|++|.||++.+.+++.|++|.+..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999987799999999865433 3467899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++.+.. ..+++..++.++.+++.||+||| +++++||||||+||+++.++.+||+|||++............
T Consensus 81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9996532 46889999999999999999999 999999999999999999999999999999765432221111
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+..|+|||++.+ +.++.++|
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~D 177 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESD 177 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchh
Confidence 12234667999999854 67888877
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=221.32 Aligned_cols=184 Identities=27% Similarity=0.485 Sum_probs=149.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
..+.++||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345678999999999999642 35678999886433 33467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEE
Q 036471 401 EFVSNGSLEKFIYRNSSS---------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 471 (516)
||+++++|.+++.+.... .....+++..++.++.|++.||+||| +.+++|+||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEE
Confidence 999999999999765311 11235899999999999999999999 999999999999999999999999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||++................+++.|+|||++.+ ..++.++|
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 206 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESD 206 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhcc--CCcCchhh
Confidence 99999976543322111122345788999999854 56888877
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=231.93 Aligned_cols=176 Identities=31% Similarity=0.397 Sum_probs=149.6
Q ss_pred hcccCCcEEEEEEEECC-CCEEEEEEeec-CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 333 KLGQGGYGSVYKGKLID-GSNVAVKVLND-SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~-~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
.+|+|+||+||-|++.+ ...+|||.+.. .....+-+.+|+.+-++++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 49999999999999875 56789999864 44555778999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCcEEEeecCCcccccCCCcceee
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+|+..-+ .-+=++..+-.+.+||++||.||| .+.|||||||-+|+||+ -.|.+||+|||.++.+..-... .
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--T 733 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--T 733 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcc--c
Confidence 9987542 122378889999999999999999 99999999999999996 5789999999999887655432 2
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..+.||..|||||++.+....|+.++|
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aAD 760 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAAD 760 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhh
Confidence 457799999999999665556777766
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=226.53 Aligned_cols=174 Identities=32% Similarity=0.433 Sum_probs=153.1
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
-+.||+|+||+|+-+... +|+.+|.|++.+. +......++|-.+|.+++.+.||.+--.|++.+.+.+|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 367999999999998765 5899999988542 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.-+|.... +..+++..+.-++.+|+-||++|| ..+||.|||||+|||+|+.|+++|+|+|+|..+...+.
T Consensus 270 GDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 270 GDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred CceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 99999997653 367999999999999999999999 99999999999999999999999999999998877765
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .+..||.+|||||++.. +.|+...|
T Consensus 343 ~---~~rvGT~GYMAPEvl~n--e~Y~~s~D 368 (591)
T KOG0986|consen 343 I---RGRVGTVGYMAPEVLQN--EVYDFSPD 368 (591)
T ss_pred c---ccccCcccccCHHHHcC--CcccCCcc
Confidence 3 45689999999999955 56887776
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=220.56 Aligned_cols=169 Identities=26% Similarity=0.411 Sum_probs=138.0
Q ss_pred hcccCCcEEEEEEEECC-------------------------CCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeE
Q 036471 333 KLGQGGYGSVYKGKLID-------------------------GSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTL 386 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l 386 (516)
.||+|+||.||+|.+.. ...|++|++..... ...++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588898865332 23578889999999999999999
Q ss_pred EEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC
Q 036471 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED 466 (516)
Q Consensus 387 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 466 (516)
++++.+....++||||+++++|..++.+.. ..+++..+..++.|+++||+||| +++|+||||||+||++++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 999999999999999999999999986532 56889999999999999999999 8999999999999999764
Q ss_pred C-------cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 F-------CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+ .+|++|||.+...... ....++..|+|||.+.+. ..++.++|
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~D 203 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAAD 203 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHH
Confidence 4 4899999988644322 223467889999998543 45677776
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=195.91 Aligned_cols=173 Identities=27% Similarity=0.410 Sum_probs=146.9
Q ss_pred hhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 331 KYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.++||+|.+|+||+|+..+ ++.||+|.++.+.. -....++|+-+++.++|+|||+++++.-.+.+..+|+||+..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 3579999999999999764 78899999865432 236789999999999999999999999999999999999954
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|..+...- ++.++.+.+..++.|+++||.+.| ++++.||||||.|+||+.+|.+||+|||+++.+.-.-..
T Consensus 86 dlkkyfdsl-----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 DLKKYFDSL-----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHHHHHHhc-----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 898888654 367999999999999999999999 999999999999999999999999999999877654322
Q ss_pred eeeccCCCCccccccccccccccccccCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKS 515 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~s 515 (516)
.+...-|..|.+|.++.+. +-|+..-
T Consensus 158 --ysaevvtlwyrppdvlfga-kly~tsi 183 (292)
T KOG0662|consen 158 --YSAEVVTLWYRPPDVLFGA-KLYSTSI 183 (292)
T ss_pred --eeceeeeeeccCcceeeee-ehhccch
Confidence 2445679999999999763 5555543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=214.88 Aligned_cols=177 Identities=24% Similarity=0.335 Sum_probs=149.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.++||+|++|.||++... +++.+++|.++.. ....+.+.+|+.++++++|+||+++++.+.+++..+++|||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 34578999999999999876 5889999998643 33446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..++.++.|++.||.||| +++|+|+||||+||++++++.++|+|||.+........
T Consensus 83 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 83 GDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999986542 246889999999999999999999 99999999999999999999999999999976644322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~--~~~~~~~D 182 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWEN--MPYNNKSD 182 (255)
T ss_pred c--cccccCCccccCHHHHcc--CCcCchhh
Confidence 1 123567899999999854 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=216.92 Aligned_cols=176 Identities=31% Similarity=0.437 Sum_probs=147.8
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
..+.||+|+||+||+|...+++.+|+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4567999999999999988899999999864321 124678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+. ..+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||++.....
T Consensus 84 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999654 45889999999999999999999 89999999999999999999999999999876532
Q ss_pred CCc----ceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KES----IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ........++..|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~D 190 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSD 190 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhh
Confidence 111 111233568999999999854 56677776
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=220.28 Aligned_cols=178 Identities=32% Similarity=0.444 Sum_probs=146.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 34567999999999999875 58999999986432 233678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.... ....+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 83 -~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 83 -MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred -CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 58988886542 2356899999999999999999999 9999999999999999999999999999997654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+++.|+|||++.+. ..++.++|
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 184 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGS-PRYSTPVD 184 (285)
T ss_pred c--cccCCcccccccChHHhcCC-CCcCcHHH
Confidence 1 11334568899999998543 34566665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=217.81 Aligned_cols=169 Identities=23% Similarity=0.416 Sum_probs=136.0
Q ss_pred hcccCCcEEEEEEEECCC---CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLIDG---SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+||+|+||.||+++..++ ..+++|.+.... ...+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976443 345667665432 234688999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++++... .....++..++.++.||++||+||| +.+++||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999976431 1245677788999999999999999 8999999999999999999999999999986432221111
Q ss_pred eeccCCCCccccccccccc
Q 036471 488 SMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~ 506 (516)
......++..|+|||++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cccCCcCcccccCchhccc
Confidence 1233557889999999843
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=219.96 Aligned_cols=183 Identities=32% Similarity=0.488 Sum_probs=147.4
Q ss_pred hhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.||+|++|.||+|.+.+ +..|++|.+..... ....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 345789999999999998754 46788998864332 2356899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEeecCC
Q 036471 401 EFVSNGSLEKFIYRNSSSI-ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGL 476 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~ 476 (516)
||+++++|.+++.+.+... ....+++..++.++.||+.||+||| +++++|+||||+||+++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999997754211 1236899999999999999999999 89999999999999998654 699999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+..............+..|+|||++.+ +.++.++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 203 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTD 203 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhH
Confidence 987643322111122234568999999954 67888887
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=220.78 Aligned_cols=178 Identities=31% Similarity=0.524 Sum_probs=144.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-----CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-----DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 400 (516)
.+.+.||+|+||.||++... +++.|++|.+.... ...+.+.+|++++++++||||+++++++.. ....++||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 45577999999999999742 57899999986543 334678899999999999999999998754 34688999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.+.. ..+++..++.++.|++.||+||| +++|+||||||+||++++++.+||+|||++...
T Consensus 87 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 87 EYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999996532 46899999999999999999999 999999999999999999999999999999876
Q ss_pred cCCCcceee-ccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISM-TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... ....++..|+|||++.+ +.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 193 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASD 193 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHH
Confidence 544322111 12223456999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=216.14 Aligned_cols=174 Identities=29% Similarity=0.518 Sum_probs=145.5
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEe-ecCeeEEEEEecCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF-EGRRRALIYEFVSN 405 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~~ 405 (516)
.+.+.+.||+|++|.||++.. .+..|++|.++... ..+.+.+|+.++++++|+|++++++++. +++..+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 344567899999999999987 57889999986433 3467899999999999999999999765 45678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.++++... ...+++..++.++.|++.||+||| +++++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 85 GSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999997642 245889999999999999999999 9999999999999999999999999999987554332
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....++..|+|||++.. ..++.++|
T Consensus 157 ----~~~~~~~~y~aPE~~~~--~~~~~~~D 181 (256)
T cd05082 157 ----DTGKLPVKWTAPEALRE--KKFSTKSD 181 (256)
T ss_pred ----CCCccceeecCHHHHcc--CCCCchhh
Confidence 22344678999999844 56777777
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=216.28 Aligned_cols=180 Identities=27% Similarity=0.440 Sum_probs=151.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.+.||+|++|.||+|... +++.|++|.++.. ....+.+.+|++++++++|+||+++++.+.+.+..+++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 445678999999999999987 7899999988632 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+... ....+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 84 ADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999975431 2356899999999999999999999 99999999999999999999999999999876544
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....+++.|+|||.+.+ ..++.++|
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~--~~~~~~~D 188 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHE--NGYNFKSD 188 (267)
T ss_pred CCcc--cceecCCccccCHHHhcc--CCCCchhc
Confidence 3221 133457889999999854 56777777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=222.56 Aligned_cols=179 Identities=28% Similarity=0.400 Sum_probs=141.3
Q ss_pred hhcccCCcEEEEEEEECC---CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLID---GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g 406 (516)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 469999999999998653 5789999986543 23567899999999999999999998854 4577899999865
Q ss_pred CHHHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCcEEEeecCCccc
Q 036471 407 SLEKFIYRNSSS---IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKI 479 (516)
Q Consensus 407 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~~ 479 (516)
+|.+++...... .....+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 888887543211 12245899999999999999999999 8999999999999999 5677999999999987
Q ss_pred ccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .......+|+.|+|||++.+. ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~D 198 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAID 198 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHH
Confidence 6543221 112345689999999998542 45677776
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=218.22 Aligned_cols=180 Identities=26% Similarity=0.437 Sum_probs=151.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.+.||+|++|.||++... +++.+++|.+.... ....++.+|+.+++.++|+||+++++.+.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 345678999999999999864 78999999886422 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 84 ADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999875321 2356899999999999999999999 99999999999999999999999999999876654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....++..|+|||++.+ ..++.++|
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~--~~~~~~~D 188 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHE--NGYNFKSD 188 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcC--CCccchhh
Confidence 3321 133467899999999854 56777777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=223.02 Aligned_cols=180 Identities=18% Similarity=0.216 Sum_probs=145.4
Q ss_pred hhhhcccC--CcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQG--GYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.++||+| ++++||++..+ +|+.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 68899999875 68999999996542 22346778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+++.||+........
T Consensus 82 ~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 82 AYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 9999999996542 245899999999999999999999 899999999999999999999999999876443221
Q ss_pred Cccee-----eccCCCCccccccccccccccccccCCC
Q 036471 484 ESIIS-----MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....++..|+|||++.++...++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhh
Confidence 11100 0123467789999999654346788877
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=219.08 Aligned_cols=179 Identities=31% Similarity=0.493 Sum_probs=146.7
Q ss_pred hcccCCcEEEEEEEECC-------CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 333 KLGQGGYGSVYKGKLID-------GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.||+|++|.||+|+..+ ++.+++|.+.... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998643 2578999886533 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-----cEEEeecCCc
Q 036471 404 SNGSLEKFIYRNSSSI-ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-----CPKISDFGLA 477 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Dfg~a 477 (516)
++++|.+++.+..... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997643211 2245889999999999999999999 89999999999999999877 8999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...............++..|+|||++.+ +.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 195 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSD 195 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc--CCcccchh
Confidence 76644332211122345788999999854 67888887
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=214.87 Aligned_cols=172 Identities=30% Similarity=0.509 Sum_probs=141.6
Q ss_pred hcccCCcEEEEEEEEC---CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 333 KLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+||+|+||.||+|.+. ++..+|+|+++.... ..+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 478899999864432 2367889999999999999999999875 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999643 46899999999999999999999 999999999999999999999999999999876544332
Q ss_pred ee-eccCCCCccccccccccccccccccCCC
Q 036471 487 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||.+.. +.++.++|
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 180 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNY--YKFSSKSD 180 (257)
T ss_pred eeecCCCCCCccccCHhHhcc--CCcCchhH
Confidence 11 122334678999999843 56777776
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=219.13 Aligned_cols=187 Identities=26% Similarity=0.402 Sum_probs=151.4
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC-----CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEee-cCee
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID-----GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRR 396 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 396 (516)
...+.+.+.||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3445566889999999999999765 6889999886432 234668899999999999999999998776 4678
Q ss_pred EEEEEecCCCCHHHHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSS--IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
++++||+++++|.+++...... .....+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999999764321 01256899999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++.+.............++..|+|||++.. ..++.++|
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~D 201 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN--KEYSSASD 201 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc--CCCCchhh
Confidence 99987654433222233446778999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=221.55 Aligned_cols=184 Identities=27% Similarity=0.484 Sum_probs=148.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+++.+.||+|+||.||++... ++..||+|.+..... ..+++.+|+.++++++||||+++++++.++...+++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 345578999999999999863 467899999865332 236688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 400 YEFVSNGSLEKFIYRNSSS----------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
|||+++++|.+++...... .....+++..++.++.|++.||+||| .++++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEe
Confidence 9999999999999754211 11235788999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 464 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++++.+||+|||++.................+..|+|||++.+ +.++.++|
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 214 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESD 214 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhH
Confidence 9999999999999876543322111122334678999999854 57888877
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=217.09 Aligned_cols=175 Identities=30% Similarity=0.398 Sum_probs=145.2
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
..||+|+||.||+|.+. ++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 46999999999999865 57889999886543 34467899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccccCCCcc
Q 036471 410 KFIYRNSSSIENHKL--TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l--~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+++.... ..+ ++..+..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||.+.........
T Consensus 94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 9997642 234 78889999999999999999 899999999999999976 679999999998765433221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+++.|+|||++.+....++.++|
T Consensus 166 --~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 166 --TETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred --cccCCCCccccChhhhccccccCCchhh
Confidence 1234578999999998553334667776
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=218.61 Aligned_cols=176 Identities=35% Similarity=0.477 Sum_probs=144.6
Q ss_pred hhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALI 399 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 399 (516)
.+.+.||+|+||+||++.. .+++.||+|.++.... ....+.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4557899999999988653 3578899999875432 446788999999999999999999987653 457899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.+++.. ..+++.+++.++.|++.||+||| +++|+|+||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999964 35899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....++..|+|||++.+ +.++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~D 192 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASD 192 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccc
Confidence 654332111 122345677999999854 57888887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=214.70 Aligned_cols=176 Identities=32% Similarity=0.450 Sum_probs=151.9
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+++.+.||+|++|.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 4456789999999999999875 78999999865433 678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++.........
T Consensus 84 ~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 84 SVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999996532 57899999999999999999999 899999999999999999999999999999876544321
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||++.+ ..++.++|
T Consensus 156 --~~~~~~~~~y~~PE~~~~--~~~~~~~D 181 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQE--IGYNNKAD 181 (256)
T ss_pred --cccccCCccccCHHHHhc--CCCCchhh
Confidence 123457889999999854 56777776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=219.71 Aligned_cols=174 Identities=29% Similarity=0.432 Sum_probs=148.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.||+|++|.||+|+.. +++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||++++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 34467999999999999864 58899999986533 33467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.+ ..+++.+++.++.|++.||+||| ..+|+|+||||+||+++.++.+||+|||++.........
T Consensus 103 ~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 103 SLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999853 35789999999999999999999 899999999999999999999999999998765433221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+++.|+|||.+.+ ..++.++|
T Consensus 173 --~~~~~~~~~y~aPE~~~~--~~~~~~~D 198 (296)
T cd06654 173 --RSTMVGTPYWMAPEVVTR--KAYGPKVD 198 (296)
T ss_pred --cCcccCCccccCHHHHcC--CCCCccch
Confidence 123467899999999854 56777777
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=216.92 Aligned_cols=179 Identities=28% Similarity=0.423 Sum_probs=148.4
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++.++||+|++|.||+|+... ++.+++|.+.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 4456789999999999999864 8899999986543 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|..++.+.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 94 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 94 GAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99998886532 46899999999999999999999 89999999999999999999999999999875433221
Q ss_pred ceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
. .....+++.|+|||++..+ ...++.++|
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 197 (292)
T cd06644 166 R--RDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197 (292)
T ss_pred c--cceecCCccccCceeeccccccCCCCCchhh
Confidence 1 1234578899999998531 234566666
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=218.71 Aligned_cols=181 Identities=27% Similarity=0.375 Sum_probs=147.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEe-----ecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCF-----EGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-----~~~~~~lv~e 401 (516)
.+.+.||+|+||.||++... +++.+|+|++........++.+|+.+++++ +||||+++++++. .++..++|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 34477999999999999875 478999999865544456788999999999 7999999999874 3456899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++..... ....+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++.+.
T Consensus 101 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 101 LCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred ecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 9999999998865321 2356899999999999999999999 8999999999999999999999999999997664
Q ss_pred CCCcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
..... .....|++.|+|||++..+ ...++.++|
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 211 (286)
T cd06638 176 STRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211 (286)
T ss_pred cCCCc--cccccCCCcccChhhhchhhhccccccchhh
Confidence 33211 1335689999999998432 134677776
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=215.53 Aligned_cols=177 Identities=29% Similarity=0.423 Sum_probs=147.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----------chhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
.+.+.||+|++|.||+|... +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 34567999999999999875 5789999988643211 146788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
++|||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999654 46888999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcce----eeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESII----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+......... ......|+..|+|||.+.+ +.++.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~D 194 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKAD 194 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhcc--CCCCchhh
Confidence 8765322111 1122457889999999854 56777776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=221.35 Aligned_cols=169 Identities=25% Similarity=0.423 Sum_probs=150.1
Q ss_pred HhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
|.+.+.||+|-|+.|-+|++ -.|+.||||++.+.+.+ ...+++|+..|+.++|||||++|++.....++|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 34557799999999999975 37999999999876543 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-CCCCcEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL-DEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~ 482 (516)
.+|+|.+||-++. ..+.++.+.+++.||+.|+.|.| ...+|||||||+|+++ .+-|-+||.|||++..+..
T Consensus 100 D~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999997764 56999999999999999999999 9999999999999976 5678999999999988877
Q ss_pred CCcceeeccCCCCcccccccccccc
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
.+. .+...|+..|-|||++++.
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGD 193 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGD 193 (864)
T ss_pred cch---hhcccchhhccCchhhhcC
Confidence 764 3567899999999999884
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=216.59 Aligned_cols=179 Identities=28% Similarity=0.402 Sum_probs=150.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|++|.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.++...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 456678999999999999875 58899999986533 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+.. ..+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 87 GALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999987542 46899999999999999999999 89999999999999999999999999999876543322
Q ss_pred ceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
. .....+++.|+|||++..+ ...++.++|
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sD 190 (280)
T cd06611 159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKAD 190 (280)
T ss_pred c--cceeecchhhcCHHHHhhcccCCCCCCcccc
Confidence 1 1334578999999998532 234666776
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=217.86 Aligned_cols=178 Identities=30% Similarity=0.398 Sum_probs=150.1
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
...+++.+.||+|++|+||++... +++.||+|++.... ...+.+.+|+++++.++||||+++++.+...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 344556788999999999999875 58889999886432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.+. ..+++..+..++.+++.||.|||+ ..+++|+||+|+||++++++.++|+|||++....
T Consensus 84 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999998653 468999999999999999999993 2589999999999999999999999999986543
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....|+..|+|||++.+ +.++.++|
T Consensus 156 ~~~~----~~~~~~~~~~aPE~~~~--~~~~~~~D 184 (284)
T cd06620 156 NSIA----DTFVGTSTYMSPERIQG--GKYTVKSD 184 (284)
T ss_pred hhcc----CccccCcccCCHHHHcc--CCCCccch
Confidence 2221 23568999999999854 57777777
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=220.86 Aligned_cols=176 Identities=27% Similarity=0.442 Sum_probs=145.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 34567999999999999875 57899999986432 233567899999999999999999999999999999999997
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+.. ..+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||++........
T Consensus 88 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 88 KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 59999886542 46889999999999999999999 99999999999999999999999999999976443221
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....+++.|+|||++.+. ..++.++|
T Consensus 160 ~--~~~~~~~~~y~~PE~~~~~-~~~~~~~D 187 (301)
T cd07873 160 T--YSNEVVTLWYRPPDILLGS-TDYSTQID 187 (301)
T ss_pred c--ccccceeecccCcHHHhCC-CCCccHHH
Confidence 1 1234568899999998543 34666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=221.91 Aligned_cols=181 Identities=28% Similarity=0.488 Sum_probs=144.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCC--EEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGS--NVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|.+. ++. .+++|.++... ...+.+.+|++++.++ +|+||+++++++.+++..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 345678999999999999875 344 45777765422 2335788899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEE
Q 036471 402 FVSNGSLEKFIYRNSSSI----------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 471 (516)
|+++++|.+++++..... ....+++..++.++.|++.||+||| +++++||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence 999999999997653210 1236899999999999999999999 999999999999999999999999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||+++...... ......++..|+|||++.+ ..++.++|
T Consensus 166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~D 205 (303)
T cd05088 166 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY--SVYTTNSD 205 (303)
T ss_pred CccccCcccchhh---hcccCCCcccccCHHHHhc--cCCccccc
Confidence 9999986432111 1122234678999999844 56788887
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=213.14 Aligned_cols=173 Identities=32% Similarity=0.519 Sum_probs=143.4
Q ss_pred hhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++||+|+||.||+|.+.. +..+|+|.+..... ..+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997532 26899999876544 4567899999999999999999999875 4567999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+. ..+++..++.++.|++.||+||| ..+++|+||||+||+++.++.+||+|||.++.......
T Consensus 80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999754 36899999999999999999999 89999999999999999999999999999987654433
Q ss_pred cee-eccCCCCccccccccccccccccccCCC
Q 036471 486 IIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....++..|+|||.+.. +.++.++|
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 180 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINY--GKFSSKSD 180 (257)
T ss_pred ccccccCccccccccCHHHhcC--CCCCccch
Confidence 211 122234568999999844 67888887
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=226.12 Aligned_cols=172 Identities=29% Similarity=0.378 Sum_probs=142.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 334467999999999999875 57899999986532 2335678899999999999999999987543 3468
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+++|++ +++|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||++
T Consensus 97 ~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 999988 7799888743 46899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... ....|++.|+|||++.+. ..++.++|
T Consensus 166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~D 198 (343)
T cd07878 166 RQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVD 198 (343)
T ss_pred eecCCCc-----CCccccccccCchHhcCC-ccCCchhh
Confidence 8654322 345689999999998542 45777776
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=219.17 Aligned_cols=176 Identities=30% Similarity=0.424 Sum_probs=149.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|++|.||++... +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3345577999999999999974 68999999986533 334667889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+ ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999854 35789999999999999999999 8999999999999999999999999999997654433
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||.+.+ +.++.++|
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 197 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTR--KAYGPKVD 197 (297)
T ss_pred cC--cCcccCCccccCHHHHcC--CCCCcHHH
Confidence 21 123457889999999854 56777766
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=214.21 Aligned_cols=176 Identities=28% Similarity=0.335 Sum_probs=144.5
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC------CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK------GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 400 (516)
+.+.||+|+||.||++... +++.|++|.+.... ...+.+.+|+.++++++||||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4577999999999999875 48999999885321 1234678899999999999999999988763 4678999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.+. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||.+...
T Consensus 86 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 86 EHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 999999999998754 35788999999999999999999 999999999999999999999999999999765
Q ss_pred cCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .......++..|+|||++.+ ..++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 191 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKAD 191 (265)
T ss_pred ccccccccccccCCCCccccChhhhcC--CCCCcchh
Confidence 432111 11233457889999999854 56777777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=215.60 Aligned_cols=178 Identities=29% Similarity=0.407 Sum_probs=147.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---C--------chhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---N--------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..+.||+|++|.||+|... +++.||+|.++.... . .+.+.+|+.++++++|+||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3467999999999999865 588999998853211 1 235778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++++|.+++++. ..+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999654 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...............++..|+|||++......++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D 194 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccch
Confidence 765433222222345678999999998653224677777
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=210.24 Aligned_cols=174 Identities=29% Similarity=0.463 Sum_probs=145.6
Q ss_pred cHHHHHHHHHhhhhhcccCCcEEEEEEE-ECCCCEEEEEEeecCCC-CchhHHHHHHHhhcc-CCcceeeEEEEEeecCe
Q 036471 319 SYADIKKMTNSFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKG-NGEEFINEVASISRT-SHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 319 ~~~el~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 395 (516)
+++|+.+.| .+.||+|+++.|--++ ..+|..+|||++.+... ...+..+|++++.+. .|+||+.++++|+++.+
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 466666665 3569999999999887 45799999999976543 446789999999998 59999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEe
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKIS 472 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~ 472 (516)
.|||||-|.||+|..+|+++ ..+++.++.++.++|+.||.||| .+||.||||||+|||-.+.. -+||+
T Consensus 151 FYLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred EEEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999865 57999999999999999999999 99999999999999986544 48999
Q ss_pred ecCCcccccCCC--c---ceeeccCCCCccccccccc
Q 036471 473 DFGLAKICNRKE--S---IISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 473 Dfg~a~~~~~~~--~---~~~~~~~~gt~~y~aPE~l 504 (516)
||.++.-+.... + ........|+..|||||+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 998874432221 1 1223457799999999986
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=214.25 Aligned_cols=175 Identities=33% Similarity=0.460 Sum_probs=146.6
Q ss_pred hhcccCCcEEEEEEEECC--C--CEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID--G--SNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|++|.||+|.+.+ + ..||+|.+..... ..+++.+|+..+++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998743 2 3689999976443 44688999999999999999999999988 889999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+... ..+++..++.++.|++.||+||| .++++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999976431 46899999999999999999999 99999999999999999999999999999987755332
Q ss_pred ceee-ccCCCCccccccccccccccccccCCC
Q 036471 486 IISM-TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~-~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....++..|+|||++.. ..++.++|
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~D 182 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRT--RTFSHASD 182 (257)
T ss_pred ceecccCCCCCceecCHHHhcc--cCcCchhh
Confidence 2111 23456789999999844 56787777
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=216.81 Aligned_cols=176 Identities=24% Similarity=0.354 Sum_probs=147.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++.+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|+.++++++|+||+++++.+......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34567999999999999986 58999999986432 233567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|..++... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 84 HTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 98888876432 46899999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||++.++ ..++.++|
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~D 183 (286)
T cd07847 155 DD--YTDYVATRWYRAPELLVGD-TQYGPPVD 183 (286)
T ss_pred cc--ccCcccccccCCHHHHhCC-CCcCchhh
Confidence 21 1234568899999998542 45677776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=227.29 Aligned_cols=172 Identities=27% Similarity=0.310 Sum_probs=142.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+.+.+.||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 445578999999999999875 58899999986532 3346788999999999999999999987643 3579
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++ +|.+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 106 lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 106 IVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEeCCCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 99999975 7777764 34788999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....+|+.|+|||++.+ ..++.++|
T Consensus 174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~~D 207 (364)
T cd07875 174 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 207 (364)
T ss_pred cccCCCCc---ccCCcccCCcCCHHHHhC--CCCCchhh
Confidence 86543321 234568999999999955 57788877
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=227.23 Aligned_cols=172 Identities=28% Similarity=0.319 Sum_probs=141.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+.+.+.||+|+||.||++... .++.||+|++.... ...+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 344578999999999999875 58899999986532 2335778899999999999999999988643 3568
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++ +|.+.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 99 lv~e~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 99 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred EEhhhhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 99999975 6776663 34788999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....||+.|+|||++.+ ..++.++|
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~~D 200 (355)
T cd07874 167 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 200 (355)
T ss_pred ccCCCccc---cCCccccCCccCHHHHcC--CCCCchhh
Confidence 76543321 234568999999999955 56788877
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=213.26 Aligned_cols=177 Identities=36% Similarity=0.617 Sum_probs=149.8
Q ss_pred hhhhcccCCcEEEEEEEECC-----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLID-----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.||+|+||.||+++..+ +..||+|.+..... ..+.+.+|+..+.+++|+||+++++.+.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45679999999999998764 38899999976543 457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 83 MEGGDLLDYLRKNR----PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred cCCCCHHHHHHhhh----hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999997642 122899999999999999999999 99999999999999999999999999999987655
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ....+++.|+|||.+.. +.++.++|
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~D 186 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKD--GKFTSKSD 186 (258)
T ss_pred cccccc-ccCCCcccccChHHhcc--CCCCcchh
Confidence 432221 12346789999999833 67788877
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.31 Aligned_cols=177 Identities=27% Similarity=0.406 Sum_probs=150.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||+|.+. +++.|++|++.... ...+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45677999999999999975 58999999986543 23467899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.... ..+++.+++.++.|+++||+||| +.+++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 999999987543 56999999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .......++..|+|||++.++ ..++.++|
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 183 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGA-RKYDPGVD 183 (286)
T ss_pred C-CccccccCcccccCceeeecc-ccCCchhH
Confidence 2 112345689999999998542 45577776
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=213.69 Aligned_cols=174 Identities=32% Similarity=0.447 Sum_probs=148.3
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC------CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
..+.||+|++|.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++.++...++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4567999999999999986 68999999986432 2336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 84 VPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999653 45889999999999999999999 89999999999999999999999999999876644
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......++..|+|||.+..+ ..++.++|
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D 184 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAAD 184 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCC-CCCCchhh
Confidence 43 12345678999999998542 23777776
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=216.71 Aligned_cols=180 Identities=25% Similarity=0.433 Sum_probs=146.3
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
...+.+.+.||+|++|.||+|...+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3345566789999999999998643 2468999886433 234678999999999999999999998875 55789
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++
T Consensus 84 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceee
Confidence 999999999999997532 45899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....++..|+|||.+.. ..++.++|
T Consensus 156 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~D 190 (270)
T cd05056 156 YLEDESYYK-ASKGKLPIKWMAPESINF--RRFTSASD 190 (270)
T ss_pred eccccccee-cCCCCccccccChhhhcc--CCCCchhh
Confidence 665442211 123345678999999844 56777776
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=212.10 Aligned_cols=177 Identities=27% Similarity=0.369 Sum_probs=150.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.||.++.. +++.+++|.+... ....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 34578999999999999865 5889999998643 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+.. ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 83 GGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred CCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999997642 256899999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||++.+ ..++.++|
T Consensus 156 ~~--~~~~~~~~~y~ape~~~~--~~~~~~~D 183 (256)
T cd08221 156 SM--AETVVGTPYYMSPELCQG--VKYNFKSD 183 (256)
T ss_pred cc--ccccCCCccccCHhhcCC--CCCCCcch
Confidence 21 234568999999999854 45677776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=216.17 Aligned_cols=175 Identities=29% Similarity=0.421 Sum_probs=147.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+...+.||+|++|.||+|.+. +++.||+|.+.... ...+.+.+|+.++++++||||+++++.+..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344567999999999999875 47889999886432 334578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.. ..+++..+..++.|+++||+||| .++++|+||+|+||++++++.++|+|||++..+....
T Consensus 86 ~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 86 GGSALDLLKP-------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999998843 45889999999999999999999 8999999999999999999999999999997665432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||++.+ ..++.++|
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (277)
T cd06642 156 IK--RNTFVGTPFWMAPEVIKQ--SAYDFKAD 183 (277)
T ss_pred hh--hhcccCcccccCHHHhCc--CCCchhhh
Confidence 21 123457889999999854 56777776
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=215.89 Aligned_cols=181 Identities=29% Similarity=0.413 Sum_probs=147.1
Q ss_pred hhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
..+.||+|+||.||+|+.+ +.+.|++|.+...... .+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4467999999999999864 2467999988654332 4678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 402 FVSNGSLEKFIYRNSSSI---ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
|+++++|.+++....... ....+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997653111 1126899999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .......++..|+|||.+.+ +.++.++|
T Consensus 166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 200 (275)
T cd05046 166 DVYNSEY-YKLRNALIPLRWLAPEAVQE--DDFSTKSD 200 (275)
T ss_pred ccCcccc-cccCCceeEEeecChhhhcc--CCCCchhh
Confidence 5433221 12233456778999999854 56677776
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=216.12 Aligned_cols=178 Identities=27% Similarity=0.492 Sum_probs=146.1
Q ss_pred hhhhhcccCCcEEEEEEEECC-C---CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-G---SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+..+.||+|++|.||+|+... + ..+++|.+.... ...+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 345789999999999998753 3 378999986542 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 88 MENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999996532 46899999999999999999999 89999999999999999999999999999976643
Q ss_pred CCccee-eccCCCCccccccccccccccccccCCC
Q 036471 483 KESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......+..|+|||++.. +.++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 192 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASD 192 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc--CCcChHhH
Confidence 322111 112223567999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=214.97 Aligned_cols=179 Identities=32% Similarity=0.523 Sum_probs=148.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-----CCCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEee--cCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-----DGSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFE--GRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 398 (516)
+.+.+.||+|+||.||++++. .+..+|+|.+...... .+.+.+|++.+++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345578999999999999853 3678999999765543 5789999999999999999999999877 557899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
+|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+.
T Consensus 86 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999997542 36999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.......... .....++..|+|||.+.. ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~D 194 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASD 194 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHcc--CCCCcccc
Confidence 7764332211 112344667999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=211.60 Aligned_cols=178 Identities=27% Similarity=0.389 Sum_probs=148.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~ 402 (516)
+.+.+.||+|++|.||++... +++.|++|.+.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 345678999999999999875 47889999986432 234568889999999999999999998764 4467899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.... ...+++.+++.++.|++.||++|| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 82 CEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999997642 256899999999999999999999 99999999999999999999999999999976644
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....+++.|+|||++.+ +.++.++|
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 184 (257)
T cd08223 155 QCDM--ASTLIGTPYYMSPELFSN--KPYNYKSD 184 (257)
T ss_pred cCCc--cccccCCcCccChhHhcC--CCCCchhh
Confidence 3221 133567899999999855 57777777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=219.18 Aligned_cols=176 Identities=33% Similarity=0.425 Sum_probs=146.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.||+|++|.||+|... +++.|++|.+...... ...+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34567999999999999875 5899999999754322 3456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+ +++|.+++.+.. ..+++..++.++.||++||+||| +++|+|+||+|+||+++.++.+||+|||++....
T Consensus 83 ~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 83 FM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred cc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 99 889999996531 36999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....+++.|+|||++.+. ..++.++|
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 185 (298)
T cd07841 154 SPNRK--MTHQVVTRWYRAPELLFGA-RHYGVGVD 185 (298)
T ss_pred CCCcc--ccccccceeeeCHHHHhCC-CCCCcHHH
Confidence 43221 1334568889999998432 45566665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=216.70 Aligned_cols=180 Identities=25% Similarity=0.366 Sum_probs=147.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+++.+.||+|+||.||++... ++..||+|.+.... .....+.+|+.++.+++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 345678999999999999986 68999999886432 223578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|..++.+.. ....+++..+..++.|++.||.|||+ +.+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 83 AGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999986532 12478999999999999999999992 2599999999999999999999999999997653332
Q ss_pred cceeeccCCCCccccccccccccc----cccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNI----GEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~----~~~s~~sD 516 (516)
. ....+++.|+|||++.+.. ..++.++|
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~D 189 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccc
Confidence 1 2345788999999984421 12456665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=219.20 Aligned_cols=176 Identities=26% Similarity=0.400 Sum_probs=146.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||+|+.. +|+.|++|.++... .....+.+|++++++++|+||+++++++.+.+..++++||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34567999999999999976 58899999986432 223567889999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.+.. ..+++..++.++.||++||.||| .++|+|+||||+||+++.++.+||+|||+++......
T Consensus 83 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 83 -QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred -CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 48888876532 56899999999999999999999 8999999999999999999999999999997654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||++.+. ..++.++|
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 182 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSID 182 (284)
T ss_pred CC--cCCCccccCCcChHHHhCC-cccCcHHH
Confidence 21 1334578899999998542 34677766
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=218.10 Aligned_cols=171 Identities=30% Similarity=0.434 Sum_probs=146.4
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.+||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++||||+++++.+..++..++++||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999875 6899999998643 234467889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++.. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 107 ~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~ 174 (297)
T cd06659 107 DIVSQ-------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R 174 (297)
T ss_pred HHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--c
Confidence 98743 45889999999999999999999 999999999999999999999999999998765433221 1
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....|+..|+|||++.+ ..++.++|
T Consensus 175 ~~~~~~~~y~aPE~~~~--~~~~~~~D 199 (297)
T cd06659 175 KSLVGTPYWMAPEVISR--TPYGTEVD 199 (297)
T ss_pred cceecCccccCHHHHcc--CCCCchhh
Confidence 33567899999999954 56777777
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=216.09 Aligned_cols=178 Identities=26% Similarity=0.334 Sum_probs=147.7
Q ss_pred hhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC-----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK-----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.||+|+||.||+++.. +|+.||+|.+.... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 34567999999999999863 68899999986432 2336678899999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 83 ILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999653 46889999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ......|+..|+|||.+.+....++.++|
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 190 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVD 190 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCcccc
Confidence 66443221 11235578999999998654345666666
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=213.65 Aligned_cols=170 Identities=28% Similarity=0.395 Sum_probs=138.1
Q ss_pred hcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhh---ccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASIS---RTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.||+|+||.||++... +++.+|+|.+...... ...+.+|..++. ..+|+||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 5889999998653221 123444544333 3479999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999998653 46999999999999999999999 8999999999999999999999999999987554332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....|++.|+|||++.. ...++.++|
T Consensus 152 ~----~~~~~~~~y~aPE~~~~-~~~~~~~~D 178 (279)
T cd05633 152 P----HASVGTHGYMAPEVLQK-GTAYDSSAD 178 (279)
T ss_pred c----cCcCCCcCccCHHHhcC-CCCCCchhh
Confidence 1 23468999999999853 245677777
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=216.45 Aligned_cols=176 Identities=30% Similarity=0.454 Sum_probs=145.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.||+|++|.||+|..+ +++.||+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 34567999999999999976 58999999986432 2235577899999999999999999999999999999999985
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.+++.+.. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 88 -~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 88 -DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred -CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9999887542 46889999999999999999999 89999999999999999999999999999865432211
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.+. ..++.++|
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~D 186 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLD 186 (291)
T ss_pred --cccccccccccCCcHHhhcC-cccCcHHH
Confidence 11223468899999998542 34666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=216.54 Aligned_cols=173 Identities=29% Similarity=0.432 Sum_probs=148.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.||.|++|.||+|... +++.|++|.+.... ...+.+.+|+..++.++||||+++++.+..++..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 3467999999999999864 68999999986533 344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.. ..+++.++..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 103 L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 103 LTDVVTE-------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred HHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 9999853 35899999999999999999999 999999999999999999999999999998766544321
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||.+.+ +.++.++|
T Consensus 172 -~~~~~~~~~y~aPE~~~~--~~~~~~~D 197 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTR--KAYGPKVD 197 (296)
T ss_pred -CCCcCCCccccCcchhcC--CCCCchhh
Confidence 123467889999999854 56777776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=212.00 Aligned_cols=169 Identities=26% Similarity=0.371 Sum_probs=146.2
Q ss_pred cccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||.|++|.||+++... ++.+++|.+.... ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999864 8999999986532 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~-- 149 (262)
T cd05572 81 WTILRDR------GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT-- 149 (262)
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc--
Confidence 9999654 45899999999999999999999 899999999999999999999999999999876544311
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||++.+ ..++.++|
T Consensus 150 -~~~~~~~~~~~PE~~~~--~~~~~~~D 174 (262)
T cd05572 150 -WTFCGTPEYVAPEIILN--KGYDFSVD 174 (262)
T ss_pred -ccccCCcCccChhHhcC--CCCCChhh
Confidence 23457889999999854 56777777
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=213.40 Aligned_cols=176 Identities=28% Similarity=0.497 Sum_probs=141.8
Q ss_pred hcccCCcEEEEEEEECC-CC--EEEEEEeecC--CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 333 KLGQGGYGSVYKGKLID-GS--NVAVKVLNDS--KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.||+|+||.||+|.+.+ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999764 43 4688888643 23346788999999999 8999999999999999999999999999
Q ss_pred CHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 407 SLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 407 sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
+|.+++...... .....++++.++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999764311 01235889999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .......+..|+|||++.. ..++.++|
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~D 193 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNY--SVYTTNSD 193 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHcc--CCCCchhh
Confidence 86322111 1112234667999999844 56787877
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=211.63 Aligned_cols=179 Identities=30% Similarity=0.413 Sum_probs=150.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|++|.||+|... +++.+++|.+.... ...+.+.+|++++++++||||+++++.+.+.+..+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 345577999999999999875 47889999987543 3457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 85 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 85 GSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999987542 46899999999999999999999 89999999999999999999999999999976543321
Q ss_pred ceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
......++..|+|||++... .+.++.++|
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~D 186 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCD 186 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhh
Confidence 11335678899999998542 126677776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=217.49 Aligned_cols=176 Identities=26% Similarity=0.310 Sum_probs=145.7
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||.||++... .++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4567999999999999876 47899999986532 233577899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 85 GGDCATLLKNI------GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999653 46899999999999999999999 8999999999999999999999999999986421110
Q ss_pred -------------cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 -------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 -------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.........++..|+|||.+.+ +.++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 198 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVD 198 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhh
Confidence 0001112457889999999855 56777776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=218.20 Aligned_cols=180 Identities=28% Similarity=0.471 Sum_probs=143.7
Q ss_pred hhhhhcccCCcEEEEEEEECC-CC--EEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GS--NVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.||+|+||.||+|...+ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++.+.+..++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 355789999999999998754 33 47888876422 2335788999999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 403 VSNGSLEKFIYRNSSSI----------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
+++++|.+++....... ....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999997643110 1135889999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||++....... .......+..|+|||++.. +.++.++|
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~D 200 (297)
T cd05089 162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNY--SVYTTKSD 200 (297)
T ss_pred CcCCCcccccee---ccCCCCcCccccCchhhcc--CCCCchhh
Confidence 999986432111 1112233567999999854 56788877
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=212.85 Aligned_cols=175 Identities=35% Similarity=0.581 Sum_probs=140.8
Q ss_pred hhcccCCcEEEEEEEECC----CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEe-ecCeeEEEEEecC
Q 036471 332 YKLGQGGYGSVYKGKLID----GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCF-EGRRRALIYEFVS 404 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~ 404 (516)
+.||+|+||.||+|.+.+ ...||+|.+.... ...+.+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 358999999999998642 3579999885432 23467889999999999999999999876 4556889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+.. ...++..+..++.|++.||+||| +.+++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999997542 34677888999999999999999 8999999999999999999999999999997654322
Q ss_pred cc--eeeccCCCCccccccccccccccccccCCC
Q 036471 485 SI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .......++..|+|||++.. ..++.++|
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 184 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQT--QKFTTKSD 184 (262)
T ss_pred ceeecccccCcCCccccChhHhcc--CccchHHH
Confidence 11 11123446778999999854 56777776
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=213.44 Aligned_cols=171 Identities=30% Similarity=0.433 Sum_probs=145.1
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|+||+||++... +|+.+++|.+.... ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 58899999986422 2345667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.+.. ...+++..++.++.|++.||.||| ..+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 81 KYHIYNVG----EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred HHHHHHcC----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 99997643 146899999999999999999999 89999999999999999999999999999876543221
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||++.+ +.++.++|
T Consensus 151 ~~~~~~~~~y~~PE~~~~--~~~~~~~D 176 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQG--EVYDFSVD 176 (277)
T ss_pred cccccCCCCcCCHHHhcC--CCCCchhh
Confidence 133457889999999854 55777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-25 Score=212.45 Aligned_cols=175 Identities=29% Similarity=0.369 Sum_probs=150.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||.|++|.||+|+.. +++.|++|.+.... .....+.+|+.+++.++|+||+++++.+.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345577999999999999976 58899999986542 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.. ..+++..++.++.|++.||.||| +++++|+||+|+||++++++.++|+|||+++.+....
T Consensus 83 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 83 GGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999854 36899999999999999999999 8999999999999999999999999999998775442
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||++.+ ..++.++|
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~--~~~~~~sD 180 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQ--SGYDEKAD 180 (274)
T ss_pred cc--cccccCCccccChhhhcc--CCCCchhh
Confidence 21 133567889999999955 56888887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=214.07 Aligned_cols=177 Identities=26% Similarity=0.330 Sum_probs=146.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 401 (516)
+.+.+.||+|++|.||+|... +++.+++|.++.... ....+.+|+.++++++||||+++++++... +..++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 445578999999999999986 488999999864322 224567899999999999999999998877 88999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 87 ~~~~-~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 87 YVEH-DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hcCc-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9975 9999987542 36899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....+++.|+|||++.+. ..++.++|
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~D 189 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGA-KEYSTAID 189 (293)
T ss_pred CCccc--cccccccccccCchhhcCC-ccccchhh
Confidence 54221 1334568899999998542 34577776
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=210.63 Aligned_cols=174 Identities=27% Similarity=0.328 Sum_probs=149.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
|.+.||+|.||+|-+++-+ .++.+|+|++++.. .....-+.|-++|+..+||.+..+--.+...+.+.+||||..
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 5678999999999999865 58999999997643 333455678899999999999999888999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
||.|.-+|.+. +.++++....+-.+|+.||.||| +++||.||||.+|+|+|++|++||+|||+++.--...
T Consensus 252 GGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 252 GGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred CceEeeehhhh------hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999988764 57899999999999999999999 9999999999999999999999999999997533222
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..+....|||.|+|||++.. ..|+.+.|
T Consensus 323 --~t~kTFCGTPEYLAPEVleD--nDYgraVD 350 (516)
T KOG0690|consen 323 --DTTKTFCGTPEYLAPEVLED--NDYGRAVD 350 (516)
T ss_pred --ceeccccCChhhcCchhhcc--ccccceee
Confidence 23456889999999999954 57777665
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=211.94 Aligned_cols=176 Identities=26% Similarity=0.337 Sum_probs=144.8
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC------CchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG------NGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 400 (516)
..+.||+|++|.||+|... +++.|++|++..... ..+.+.+|+.++++++||||+++++.+.+ ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4567999999999999875 588999999864321 22467889999999999999999998875 35778999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.+. ..+++...+.++.|++.||+||| +.+|+|+||+|+||+++.++.+||+|||+++.+
T Consensus 86 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 86 EYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 999999999999653 45889999999999999999999 999999999999999999999999999999765
Q ss_pred cCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .......++..|+|||++.+ ..++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 191 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKAD 191 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCC--CCCCchhh
Confidence 432111 11123457899999999854 56787777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=206.29 Aligned_cols=187 Identities=29% Similarity=0.375 Sum_probs=152.3
Q ss_pred HHHHhhhhhcccCCcEEEEEEE-ECCCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRA 397 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 397 (516)
..++++.+++|.|||+.||.++ ..+++.+|+|++.-. ..+.+..++|++.-++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3456677889999999999998 457899999998654 466788999999999999999999998876443 589
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCcEEEeecC
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
|+++|+..|+|.+.+++.. .++..+++.+++.|+.++.+||++|| +.. ++||||||.|||+.+++.++|.|||
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEeehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEecc
Confidence 9999999999999998765 35568999999999999999999999 555 9999999999999999999999999
Q ss_pred CcccccCC----C---cceeeccCCCCccccccccccccc-cccccCCC
Q 036471 476 LAKICNRK----E---SIISMTGARGTVGYIAPEVFCRNI-GEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~----~---~~~~~~~~~gt~~y~aPE~l~~~~-~~~s~~sD 516 (516)
.+....-. . ....+....-|..|+|||.+.-+. ..+++++|
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertD 223 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTD 223 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccc
Confidence 98654211 0 111223455799999999984332 35566666
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=211.47 Aligned_cols=172 Identities=32% Similarity=0.541 Sum_probs=144.1
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++.+... ..+++|||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 45667899999999999975 67889999986433 346789999999999999999999988654 4789999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 85 L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 85 LVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred HHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999997642 246899999999999999999999 8999999999999999999999999999987543221
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+..|+|||++.+ +.++.++|
T Consensus 155 --~~~~~~~~y~~pe~~~~--~~~~~~~D 179 (254)
T cd05083 155 --DNSKLPVKWTAPEALKH--KKFSSKSD 179 (254)
T ss_pred --CCCCCCceecCHHHhcc--CCcCchhh
Confidence 22334678999999854 67777776
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=218.64 Aligned_cols=176 Identities=30% Similarity=0.558 Sum_probs=142.4
Q ss_pred hhhhcccCCcEEEEEEEEC-CCC----EEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGS----NVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
..+.||+|+||.||+|.+. +++ .||+|.+..... ...++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3467999999999999864 343 478888765432 224688999999999999999999988754 46789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 90 MPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999987542 46889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...........++..|+|||++.. ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~D 193 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY--RKFTHQSD 193 (303)
T ss_pred cccccccCCCccccccCCHHHhcc--CCCChHHH
Confidence 433222233445778999999844 56777766
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=211.36 Aligned_cols=174 Identities=27% Similarity=0.400 Sum_probs=147.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
...+.||+|++|.||+|.+. +++.||+|.+.... .....+.+|+.++++++|+||+++++.+.++...++||||+++
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 34467999999999999875 58899999986432 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.. ..+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 87 GSALDLLRA-------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999853 35888999999999999999999 89999999999999999999999999999976644322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....++..|+|||++.+ +.++.++|
T Consensus 157 ~--~~~~~~~~~y~apE~~~~--~~~~~~~D 183 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQ--SAYDSKAD 183 (277)
T ss_pred c--cccccCcccccCHhHhcc--CCCccHHH
Confidence 1 133457889999999854 56777776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=213.14 Aligned_cols=180 Identities=30% Similarity=0.472 Sum_probs=147.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEee------cCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFE------GRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~lv 399 (516)
+.+.+.||+|+||.||+|+.. +++.+|+|.+........++..|+.++.++ +|+||+++++++.. ....+++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 344578999999999999975 578999999876655557788999999998 79999999999853 4578999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++..
T Consensus 98 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 98 MEFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 99999999999997643 245888999999999999999999 89999999999999999999999999999876
Q ss_pred ccCCCcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
...... ......|++.|+|||++..+ ...++.++|
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~D 208 (282)
T cd06636 171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSD 208 (282)
T ss_pred hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccc
Confidence 543221 11335688999999998532 245677776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=212.44 Aligned_cols=176 Identities=26% Similarity=0.416 Sum_probs=146.8
Q ss_pred hhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
..+.||+|++|.||++.. .+++.||+|.+..... ..+.+.+|+..+++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346799999999999986 4689999999864321 23578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKIC 480 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~ 480 (516)
|+++++|.+++.+. ..+++..++.++.|++.||+||| +++++|+||+|+||+++.++ .+||+|||.+..+
T Consensus 84 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 84 WMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred ccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999753 46889999999999999999999 89999999999999998776 6999999999776
Q ss_pred cCCCcce--eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......++..|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~D 190 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCD 190 (268)
T ss_pred ccccccCCccccccccccceeCHhHhcc--CCCCcccc
Confidence 5432111 1123457889999999854 56777777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=214.53 Aligned_cols=174 Identities=32% Similarity=0.435 Sum_probs=150.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +++.|++|.+.... ...+.+.+|++.+++++||||+++++.+.++...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 34578999999999999986 58999999996532 34578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||.+......
T Consensus 83 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 83 LGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999653 46899999999999999999999 899999999999999999999999999999876544
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|+..|+|||++.. ..++.++|
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~--~~~~~~~D 181 (258)
T cd05578 154 TL---TTSTSGTPGYMAPEVLCR--QGYSVAVD 181 (258)
T ss_pred cc---ccccCCChhhcCHHHHcc--cCCCCccc
Confidence 32 134567889999999855 45777777
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=213.20 Aligned_cols=174 Identities=28% Similarity=0.421 Sum_probs=149.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++.+.||+|++|.||++... +++.+++|.+.... ...+++.+|++++++++||||+++++.+..++..++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 35578999999999999986 58899999986543 3346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.+.. ..+++..+..++.|++.||+||| + .+++|+||||+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 84 GSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999997642 56899999999999999999999 8 999999999999999999999999999987654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....++..|+|||.+.+ ..++.++|
T Consensus 156 ~----~~~~~~~~y~~PE~~~~--~~~~~~~D 181 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQG--NDYSVKSD 181 (265)
T ss_pred h----hcccCChhccCHHHHcC--CCCCchhh
Confidence 2 11567889999999855 57777776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=235.63 Aligned_cols=183 Identities=20% Similarity=0.265 Sum_probs=139.6
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC--CCEEEEE------------------EeecCCCCchhHHHHHHHhhccCCcceee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID--GSNVAVK------------------VLNDSKGNGEEFINEVASISRTSHVNVVT 385 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 385 (516)
..+.+.++||+|+||+||++..+. +...+.| .+.........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 345666889999999999987532 2222222 22222223356789999999999999999
Q ss_pred EEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 386 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
+++++.+.+..++|+|++. ++|.+++....... ........+..++.||+.||+||| +++|+||||||+|||++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 9999999999999999985 57777775432111 123345677889999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+++.+....... .....||+.|+|||++.+ ..++.++|
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~D 350 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAG--DGYCEITD 350 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcC--CCCCcHHH
Confidence 9999999999998765433221 134578999999999955 56787776
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=210.43 Aligned_cols=175 Identities=28% Similarity=0.390 Sum_probs=147.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+..+.+++||||+++++.+.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 344567999999999999875 58899999886432 233678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 86 ~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 86 GGSALDLLEP-------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999853 45889999999999999999999 9999999999999999999999999999987664432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||.+.. ..++.++|
T Consensus 156 ~~--~~~~~~~~~y~~PE~~~~--~~~~~~~D 183 (277)
T cd06641 156 IK--RNTFVGTPFWMAPEVIKQ--SAYDSKAD 183 (277)
T ss_pred hh--hccccCCccccChhhhcc--CCCCchhh
Confidence 11 123457889999999844 56677766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.72 Aligned_cols=178 Identities=26% Similarity=0.333 Sum_probs=146.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC------CCCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS------KGNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 398 (516)
+++.+.||+|++|.||+|... +++.|++|.+... ......+.+|++++++++|+||+++++.+.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345678999999999999875 5899999987532 12235788899999999999999999998764 46789
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
++||+++++|.+++.+. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++
T Consensus 84 v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 99999999999998653 45889999999999999999999 9999999999999999999999999999997
Q ss_pred cccCCCc-ceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKES-IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ........++..|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 191 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKAD 191 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcC--CCCCcccc
Confidence 6543211 111233568899999999855 56777777
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=214.80 Aligned_cols=180 Identities=29% Similarity=0.394 Sum_probs=146.7
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeec-----CeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEG-----RRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-----~~~~lv~e~ 402 (516)
+.+.||+|+||.||++... +++.+|+|.+.........+.+|+.++.++ +|||++++++++... +..++||||
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 3467999999999999875 588999999876554556788899999998 899999999998754 358999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.++++.... ....+++..++.++.|++.||+||| ..+++|+||||+||++++++.+||+|||.+.....
T Consensus 106 ~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 106 CNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred CCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 999999999865321 2356899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcceeeccCCCCccccccccccccc---cccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNI---GEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~s~~sD 516 (516)
.... .....|+..|+|||++..+. ..++.++|
T Consensus 181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 215 (291)
T cd06639 181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCD 215 (291)
T ss_pred cccc--ccCccCCccccChhhhcCCCCcccccCCccc
Confidence 3221 12346788999999984321 13577776
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=231.29 Aligned_cols=172 Identities=20% Similarity=0.278 Sum_probs=137.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCC------cceeeEEEEEeec-CeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSH------VNVVTLLGFCFEG-RRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~~~-~~~~lv 399 (516)
+.+.++||+|+||+||+|... .++.||||+++......++...|+.++..++| .+++++++++..+ ...++|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 445578999999999999875 47889999997544444556677777777654 4588999988764 467889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCC-----------
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDF----------- 467 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~----------- 467 (516)
||++ +++|.+++.+. ..+++..+..|+.||+.||+||| . .+|+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred Eecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 9988 67899888653 46899999999999999999999 7 5999999999999998765
Q ss_pred -----cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 468 -----CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 468 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+||+|||.+...... .....||+.|+|||++.+ ..++.++|
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~--~~~~~~~D 327 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLG--LGWMYSTD 327 (467)
T ss_pred CCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhc--CCCCcHHH
Confidence 4999999987543222 234678999999999965 57887776
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=214.56 Aligned_cols=170 Identities=26% Similarity=0.411 Sum_probs=140.1
Q ss_pred hhcccCCcEEEEEEEECC--------CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLID--------GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.||+|+||.||+|.... ...+++|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 2348888875433 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--------EEEeec
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--------PKISDF 474 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~Df 474 (516)
+++|+|.++++... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999997543 46899999999999999999999 999999999999999987765 699999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|.+...... ....++..|+|||++.+. ..++.++|
T Consensus 153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~D 187 (258)
T cd05078 153 GISITVLPK------EILLERIPWVPPECIENP-QNLSLAAD 187 (258)
T ss_pred ccccccCCc------hhccccCCccCchhccCC-CCCCchhh
Confidence 998654332 224568899999998542 34677776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=217.01 Aligned_cols=178 Identities=28% Similarity=0.340 Sum_probs=148.4
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|++|.||++...+ ++.+|+|.+..... ..+.+.+|++++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 44679999999999998764 89999999975432 33568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+.. ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 85 GGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred CCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999987542 256899999999999999999999 8999999999999999999999999999987553221
Q ss_pred cce---------------------------eeccCCCCccccccccccccccccccCCC
Q 036471 485 SII---------------------------SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~---------------------------~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......|+..|+|||++.+ ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~D 214 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVD 214 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHH
Confidence 100 0112357889999999955 56777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=213.24 Aligned_cols=175 Identities=28% Similarity=0.408 Sum_probs=142.4
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.||+|+||.||+|... +++.|++|.+.... .....+.+|+.++++++|+||+++++++.+++..++||||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 4567999999999999875 58899999986432 223467899999999999999999999999999999999996 6
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..+..++.|++.||+||| ..+|+|+||||+||+++.++.+||+|||+++........
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 88 DLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 7877765432 45788889999999999999999 899999999999999999999999999998754332211
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....+++.|+|||++.+. ..++.++|
T Consensus 160 --~~~~~~~~~y~aPE~~~~~-~~~~~~~D 186 (291)
T cd07870 160 --YSSEVVTLWYRPPDVLLGA-TDYSSALD 186 (291)
T ss_pred --CCCccccccccCCceeecC-CCCCcHHH
Confidence 1334568899999998542 34566665
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.44 Aligned_cols=179 Identities=28% Similarity=0.434 Sum_probs=150.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
...+.||+|++|.||++... +++.|++|.++.... ..+.+.+|++++++++|+||+++++.....+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34567999999999999875 688999999876543 45788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+.......
T Consensus 83 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 83 GGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999653 45788999999999999999999 8999999999999999999999999999998765443
Q ss_pred ccee--eccCCCCccccccccccccc-cccccCCC
Q 036471 485 SIIS--MTGARGTVGYIAPEVFCRNI-GEVSYKSD 516 (516)
Q Consensus 485 ~~~~--~~~~~gt~~y~aPE~l~~~~-~~~s~~sD 516 (516)
.... .....+++.|+|||++.+.. ...+.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~D 188 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAAD 188 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccc
Confidence 2211 12346788999999986532 22667766
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=238.53 Aligned_cols=183 Identities=31% Similarity=0.419 Sum_probs=142.7
Q ss_pred HHHhhh--hhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeec-------
Q 036471 326 MTNSFK--YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEG------- 393 (516)
Q Consensus 326 ~~~~~~--~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 393 (516)
...+|. +.||+||||.||+++.+ ||+.+|||++... ......+.+|+..+++++|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 333444 46999999999999986 8999999999654 33446789999999999999999997422110
Q ss_pred --------------------------------------------------------------------------------
Q 036471 394 -------------------------------------------------------------------------------- 393 (516)
Q Consensus 394 -------------------------------------------------------------------------------- 393 (516)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 036471 394 --------------------------------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441 (516)
Q Consensus 394 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~ 441 (516)
..+||-||||+.-+|.+++++... .-....+|+++++|++||+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-----~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-----NSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-----chhhHHHHHHHHHHHHHHH
Confidence 124577999998888888865421 1146789999999999999
Q ss_pred HHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC----------------CCcceeeccCCCCcccccccccc
Q 036471 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR----------------KESIISMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 442 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~----------------~~~~~~~~~~~gt~~y~aPE~l~ 505 (516)
|+| ++|||||||||.||+++++..|||+|||+|..... .......++..||.-|+|||++.
T Consensus 712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 99999999999999999999999999999977210 01111246678999999999996
Q ss_pred cccc-ccccCCC
Q 036471 506 RNIG-EVSYKSD 516 (516)
Q Consensus 506 ~~~~-~~s~~sD 516 (516)
+..+ .|+.|+|
T Consensus 789 ~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 789 DTSSNKYNSKID 800 (1351)
T ss_pred ccccccccchhh
Confidence 6432 6888887
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=211.10 Aligned_cols=182 Identities=30% Similarity=0.470 Sum_probs=144.5
Q ss_pred hhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC------ee
Q 036471 330 FKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR------RR 396 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 396 (516)
+.+.||+|+||.||+|.+. .++.||+|.+.... ...+++.+|+.++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4567999999999999854 36889999986543 23457889999999999999999999886532 23
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++++||+++|+|.+++...........+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence 688999999999998864332122245899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++...............+++.|++||.+.. +.++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~sD 197 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLAD--NVYTTHSD 197 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhc--Cccchhhh
Confidence 987644332222223345678999999844 56777776
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=210.75 Aligned_cols=175 Identities=33% Similarity=0.475 Sum_probs=150.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.+.|++|++|.||++... +++.|++|.+.......+.+.+|++.+++++|+||+++++.+...+..++++||+++++|
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 3457999999999999986 588999999976544567889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.... ..+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 103 ~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 172 (286)
T cd06614 103 TDIITQNF-----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-- 172 (286)
T ss_pred HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--
Confidence 99997642 37999999999999999999999 899999999999999999999999999998765433221
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||++.+ ..++.++|
T Consensus 173 ~~~~~~~~~y~~PE~~~~--~~~~~~~D 198 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKR--KDYGPKVD 198 (286)
T ss_pred hccccCCcccCCHhHhcC--CCCCCccc
Confidence 123457889999999854 56788887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=210.90 Aligned_cols=182 Identities=28% Similarity=0.414 Sum_probs=150.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecC------eeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGR------RRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~------~~~lv 399 (516)
+.+.+.||+|++|.||+|..+ +++.+++|++.......+++.+|+++++++ +|+||+++++++.... ..++|
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 345578999999999999985 578999999987666667899999999999 7999999999997644 48999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.++++.... ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 88 MELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999875421 2357899999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCCcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
....... .....|+..|+|||++..+ ...++.++|
T Consensus 163 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 200 (275)
T cd06608 163 LDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSD 200 (275)
T ss_pred cccchhh--hcCccccccccCHhHhcccccccCCcccccc
Confidence 5433221 1335688999999998532 134566676
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=210.21 Aligned_cols=170 Identities=28% Similarity=0.396 Sum_probs=138.1
Q ss_pred hcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHH---HhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVA---SISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.||+|+||.||+++.. +++.||+|.+...... ...+..|.. .++...||+|+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 5889999998653211 122344433 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 99999988643 46999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....|+..|+|||++.+. ..++.++|
T Consensus 152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~D 178 (278)
T cd05606 152 P----HASVGTHGYMAPEVLQKG-VAYDSSAD 178 (278)
T ss_pred C----cCcCCCcCCcCcHHhcCC-CCCCcccc
Confidence 1 234689999999998542 35777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=216.07 Aligned_cols=171 Identities=30% Similarity=0.441 Sum_probs=145.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
..||+|+||.||++... ++..||+|.+.... ...+.+.+|+..+++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 45999999999999875 58899999986533 33467889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++.. ..+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||++......... .
T Consensus 108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~ 175 (292)
T cd06658 108 DIVTH-------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--R 175 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--C
Confidence 98843 35889999999999999999999 899999999999999999999999999998765433221 1
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....|+..|+|||++.+ ..++.++|
T Consensus 176 ~~~~~~~~y~aPE~~~~--~~~~~~~D 200 (292)
T cd06658 176 KSLVGTPYWMAPEVISR--LPYGTEVD 200 (292)
T ss_pred ceeecCccccCHHHHcc--CCCCchhh
Confidence 23457899999999854 56777777
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=210.55 Aligned_cols=175 Identities=29% Similarity=0.443 Sum_probs=147.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
++.+.||+|++|.||+|.+. +++.|++|.+... .....++.+|+.++++++ |||++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 34567999999999999974 6899999998643 234467888999999986 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.++++. ..+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 84 AEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred CCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999853 36899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....|+..|+|||++.+. ..++.++|
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 184 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEG-KYYDTKAD 184 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccC-Cccccchh
Confidence 4321 2335688999999998542 34577776
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=216.59 Aligned_cols=182 Identities=28% Similarity=0.419 Sum_probs=146.6
Q ss_pred hhhhhcccCCcEEEEEEEECC---CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID---GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALI 399 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 399 (516)
++.++||+|++|.||+|.... ++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 345679999999999999754 7899999997532 2336778999999999999999999999988 789999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC----CCcEEEeecC
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE----DFCPKISDFG 475 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Dfg 475 (516)
|||+++ +|.+++..... .....+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 83 ~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EeCCCc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999975 77777754432 12247899999999999999999999 999999999999999999 9999999999
Q ss_pred CcccccCCCc-ceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKES-IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++........ ........+++.|+|||++.+. ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 198 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAID 198 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHH
Confidence 9987644332 1122345678899999988542 35666665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=216.48 Aligned_cols=176 Identities=29% Similarity=0.393 Sum_probs=147.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++.++||+|++|.||+|.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 34578999999999999986 48899999985432 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 84 HTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99998876432 45899999999999999999999 8999999999999999999999999999987664433
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||++.+. ..++.++|
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 183 (286)
T cd07846 155 EV--YTDYVATRWYRAPELLVGD-TKYGRAVD 183 (286)
T ss_pred cc--cCcccceeeccCcHHhccc-cccCchHh
Confidence 21 2334578899999998543 34666666
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=208.82 Aligned_cols=175 Identities=30% Similarity=0.450 Sum_probs=151.4
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++.+.||+|++|.||++...+ ++.|++|++.... ...+.+.+|+..+.+++|+||+++++.+...+..+++|||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 345789999999999999874 8999999986543 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++.+. ..+++..++.++.|+++||+||| + .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 84 GSLADLLKKV------GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999754 56899999999999999999999 8 999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....++..|+|||.+.. +.++.++|
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~--~~~~~~~D 182 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQG--ESYSYAAD 182 (264)
T ss_pred Ccc--cceeecccccCHhhhCC--CCCCchhh
Confidence 321 23457889999999854 56777776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=219.90 Aligned_cols=163 Identities=26% Similarity=0.314 Sum_probs=141.2
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCc---------hhHHHHHHHhhccC---CcceeeEEEEEeecCeeEE
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---------EEFINEVASISRTS---HVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 398 (516)
+.+|.|+||.|+.+.++. ...|++|++.+.+--. -..-.|+.+|.+++ |+||++++++|++++.+||
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 569999999999999875 5679999987643222 23456999999997 9999999999999999999
Q ss_pred EEEec-CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 399 IYEFV-SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 399 v~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||-. ++.+|.++|... ..+++.++..|++|++.|+++|| +.+|||||||-+|+.++.+|-+||+|||.|
T Consensus 647 ~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccch
Confidence 99975 567899999754 57999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCcccccccccccc
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
.......- ..++||..|.|||++.++
T Consensus 718 a~~ksgpf----d~f~gtv~~aapevl~g~ 743 (772)
T KOG1152|consen 718 AYTKSGPF----DVFVGTVDYAAPEVLGGE 743 (772)
T ss_pred hhhcCCCc----ceeeeeccccchhhhCCC
Confidence 87655532 457899999999999664
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=208.52 Aligned_cols=177 Identities=30% Similarity=0.386 Sum_probs=149.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.+|++... +++.|++|.+... ....+++.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 34578999999999999875 5889999998643 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 83 GGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999987542 245789999999999999999999 8999999999999999999999999999997664432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|++.|+|||++.+ +.++.++|
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~--~~~~~~~D 183 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICEN--RPYNNKSD 183 (256)
T ss_pred hh--hhhccCCccccCHHHhCC--CCCCCccc
Confidence 21 123457889999999854 56777777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=207.47 Aligned_cols=176 Identities=30% Similarity=0.407 Sum_probs=148.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||++... +++.+++|.+.... ...+.+.+|++++++++||||+++++.+..++..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 34577999999999999875 58899999986532 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 483 (516)
+++|.+++.... ...+++..++.++.|++.||+||| +++++|+||+|+||+++++ +.+||+|||.+......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 83 GGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999997642 245899999999999999999999 8999999999999999855 46899999999876544
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....++..|+|||.+.+ ..++.++|
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~--~~~~~~~D 183 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEG--KPYNQKSD 183 (256)
T ss_pred ccc---cccccCCcccCchhccC--CCCCcccc
Confidence 321 23457889999999954 56777777
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=211.63 Aligned_cols=174 Identities=29% Similarity=0.410 Sum_probs=145.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+...+.||+|++|.||+|... +++.||+|.+..... ..+++.+|+++++.++||||+++++++.+.+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 444567999999999999875 588999999864321 225688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus 97 ~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 97 CL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 97 57877775432 46899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
. ....+++.|+|||++.+ +.+.++.++|
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sD 196 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVD 196 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccc
Confidence 2 23457889999999843 2356777777
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=207.92 Aligned_cols=182 Identities=29% Similarity=0.381 Sum_probs=152.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+++.+.||.|++|+||+|... ++..+++|++.... ...+.+.+|+..++.++|+||+++++.+...+..++++|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 345678999999999999865 57899999986433 345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++++.. ....+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++..+....
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 83 GGSLLDIMKSSY---PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCcHHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999997642 1246899999999999999999999 9999999999999999999999999999997765443
Q ss_pred cce--eeccCCCCccccccccccccccccccCCC
Q 036471 485 SII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......|+..|+|||++... ..++.++|
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~D 189 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKAD 189 (267)
T ss_pred cccccccccccCChhhcChHHHccc-cCcCcccc
Confidence 221 11234578999999998653 36777777
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=211.59 Aligned_cols=177 Identities=28% Similarity=0.449 Sum_probs=146.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.++||+|++|.||+|+.. +++.||+|.++... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4567999999999999986 58899999986543 2346778899999999999999999999999999999999985
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ....+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++........
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 83 DLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred cHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 8998886543 1246899999999999999999999 89999999999999999999999999999976543321
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||++.+. ..++.++|
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~D 183 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSID 183 (284)
T ss_pred -ccccccccccccChHHhcCC-CCCCcHHH
Confidence 11334568899999998543 34566655
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.34 Aligned_cols=172 Identities=30% Similarity=0.409 Sum_probs=145.6
Q ss_pred cccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|++|.||+++..+ ++.+++|.+.... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 8999999986543 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc---
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--- 485 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 485 (516)
.+++.+. ..+++..++.++.|+++||+||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENV------GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999764 36899999999999999999999 99999999999999999999999999999875533321
Q ss_pred ---ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 ---IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ---~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........++..|+|||.+.+ ...+.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~D 183 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILG--QGHSKTVD 183 (265)
T ss_pred ccccccccCcccCccccCHHHhcC--CCCCcchh
Confidence 011233457889999999855 45677776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=210.65 Aligned_cols=179 Identities=28% Similarity=0.412 Sum_probs=143.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHH-hhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVAS-ISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.||+++.+ +|+.||+|.++.... ...++..|+.. ++..+||||+++++++..++..+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34567999999999999976 589999999875432 23456667665 556689999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|.+++..... ....+++..++.++.|++.||+||| ++ +++||||||+||++++++.+||+|||++..+...
T Consensus 84 -~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 84 -TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred -ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 689888875432 2357999999999999999999999 76 9999999999999999999999999999765432
Q ss_pred CcceeeccCCCCccccccccccccc--cccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
.. .+...++..|+|||++.+.. ..++.++|
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~D 189 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSD 189 (283)
T ss_pred cc---cccccCCccccChhhcCCcccccccCcccc
Confidence 21 12345788999999985421 34566766
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=212.97 Aligned_cols=178 Identities=28% Similarity=0.360 Sum_probs=148.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+++.+.||+|++|.||+|... +++.|++|.++.. ....+.+.+|++++++++|+||+++++.+.+++..+++|||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999976 4789999998643 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+++.+..++.+. ..+++..++.++.|++.||+||| ..+++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 83 ERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 987776655432 45899999999999999999999 899999999999999999999999999999876554
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....++..|+|||++.+. ..++.++|
T Consensus 154 ~~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~~D 184 (288)
T cd07833 154 PASP-LTDYVATRWYRAPELLVGD-TNYGKPVD 184 (288)
T ss_pred cccc-ccCcccccCCcCCchhcCC-CCcCchhh
Confidence 3211 1335678899999999652 26777776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=209.04 Aligned_cols=178 Identities=29% Similarity=0.447 Sum_probs=146.3
Q ss_pred hhhhhcccCCcEEEEEEEECC--CCEEEEEEeecCC-----------CCchhHHHHHHHhhc-cCCcceeeEEEEEeecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLID--GSNVAVKVLNDSK-----------GNGEEFINEVASISR-TSHVNVVTLLGFCFEGR 394 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~ 394 (516)
.+.+.||+|+||.||++.... ++.+|+|.+.... ....++.+|+.++.+ ++||||+++++++.+.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345679999999999999865 6889999875321 122457778888765 79999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEee
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
..+++|||+++++|.+++..... ....+++..++.++.|++.||.||| . .+++|+||+|+||++++++.+||+|
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999865321 2356899999999999999999999 5 6899999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||.+....... ......|+..|+|||++.+ +.++.++|
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~D 195 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKAD 195 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcC--CCCchHHH
Confidence 99998765443 2244568999999999954 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=222.13 Aligned_cols=177 Identities=29% Similarity=0.476 Sum_probs=155.5
Q ss_pred hhhhcccCCcEEEEEEEECC--CC--EEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLID--GS--NVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~--~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.++||+|.||.|++|.|.. |+ .||||.++.... ...+|++|+.+|.+++|+|++++||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 56789999999999998863 43 589999986543 45899999999999999999999999887 7788999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+.|+|.+.|++. ....+-...+..++.|||.||+||- .+++|||||..+|+|+-..-.+||+|||+.+.+...
T Consensus 193 plGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred ccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999872 3467888999999999999999999 999999999999999998889999999999999888
Q ss_pred CcceeeccC-CCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGA-RGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~-~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....+... .-...|.|||.| +...++.+||
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsL--rh~kFShaSD 297 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESL--RHRKFSHASD 297 (1039)
T ss_pred CcceEecCCCcCcccccCHhHh--ccccccccch
Confidence 777665543 356789999999 4589999998
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=211.93 Aligned_cols=176 Identities=30% Similarity=0.433 Sum_probs=148.7
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||++... +++.|++|.+... ....+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 3445577999999999999865 5789999998643 3334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+ ..+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++.......
T Consensus 100 ~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999854 35788999999999999999999 9999999999999999999999999999987654433
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+++.|+|||.+.+ +.++.++|
T Consensus 170 ~~--~~~~~~~~~y~~PE~~~~--~~~~~~~D 197 (293)
T cd06647 170 SK--RSTMVGTPYWMAPEVVTR--KAYGPKVD 197 (293)
T ss_pred cc--cccccCChhhcCchhhcc--CCCCchhh
Confidence 21 133467889999999855 56777776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-24 Score=203.99 Aligned_cols=174 Identities=34% Similarity=0.540 Sum_probs=151.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++.+++++|+|++++++.+......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4467999999999999986 688999999976543 55789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..+..++.|++.||++|| ..+++|+||+|+||++++++.++|+|||.+........
T Consensus 84 L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 84 LKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999986542 46899999999999999999999 89999999999999999999999999999987655432
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||++.. +.++.++|
T Consensus 154 -~~~~~~~~~~~~PE~~~~--~~~~~~~D 179 (253)
T cd05122 154 -RNTMVGTPYWMAPEVING--KPYDYKAD 179 (253)
T ss_pred -ccceecCCcccCHHHHcC--CCCCcccc
Confidence 133567889999999854 45777777
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=210.93 Aligned_cols=180 Identities=27% Similarity=0.375 Sum_probs=144.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCe-----eEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRR-----RAL 398 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-----~~l 398 (516)
+..+.||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+++++ +|+||+++++++...+. .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 34567999999999999975 58999999986432 2336788999999999 46999999999887665 899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLA 477 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a 477 (516)
||||+++ +|.+++...... ....+++..++.++.||+.||+||| .++|+||||+|+||+++. ++.+||+|||++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 9999986 899988754321 1356899999999999999999999 899999999999999998 889999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+........ .....+++.|+|||++.+. ..++.++|
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~D 194 (295)
T cd07837 159 RAFSIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVD 194 (295)
T ss_pred eecCCCccc--cCCcccccCCCChHHhhCC-CCCCchHH
Confidence 765332211 1233568889999998542 45677776
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=211.37 Aligned_cols=176 Identities=30% Similarity=0.438 Sum_probs=145.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.||+|++|.||+|+.. +++.|++|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3467999999999999875 58899999886432 233578899999999999999999999999999999999996
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..++.++.|++.||+||| ..+++|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 83 QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 58999886532 356899999999999999999999 89999999999999999999999999999876543322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....+++.|+|||++.+. ..++.++|
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 183 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGC-KYYSTAVD 183 (284)
T ss_pred c--cccccccccccCCeEEecC-CCCCcHHH
Confidence 1 1234568899999998542 34566665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=210.09 Aligned_cols=176 Identities=28% Similarity=0.380 Sum_probs=145.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 404 (516)
..+.||+|++|.||++... +++.+|+|.+..... ...++.+|++++++++||||+++++++.+. +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3467999999999999985 578899999875432 346789999999999999999999988653 46899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++..... ....+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 85 GGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred CCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999998865321 2356899999999999999999999 8999999999999999999999999999987554332
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....++..|+|||.+.+ ..++.++|
T Consensus 160 ~----~~~~~~~~y~~pE~~~~--~~~~~~~D 185 (287)
T cd06621 160 A----GTFTGTSFYMAPERIQG--KPYSITSD 185 (287)
T ss_pred c----ccccCCccccCHHHhcC--CCCCchhh
Confidence 1 22456889999999854 56777776
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=209.12 Aligned_cols=173 Identities=30% Similarity=0.424 Sum_probs=144.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
...+.||+|+||.||+++.. ++..||+|++..... ....+.+|++++++++|+|++++++++.+++..++||||+
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 107 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107 (317)
T ss_pred hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence 34467999999999999975 588999999864322 2246888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 108 ~g-~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 108 LG-SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 75 8888775432 56899999999999999999999 899999999999999999999999999998754332
Q ss_pred CcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
....+++.|+|||++.. ..+.++.++|
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~D 206 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVD 206 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCcccc
Confidence 23457889999999743 2246777776
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=206.03 Aligned_cols=182 Identities=26% Similarity=0.388 Sum_probs=149.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~ 402 (516)
++.+.||+|++|.||++... +++.+++|.+.... ...+.+.+|+.++++++|+||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 34567999999999999865 57899999986432 233568889999999999999999998764 4567899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC--STRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+++++|.+++.+... ....+++..++.++.|++.||+|||... ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 83 ~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 83 CEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred ccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999976431 2367999999999999999999999433 578999999999999999999999999999877
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....+++.|+|||++.. +.++.++|
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~--~~~~~~~D 192 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNH--MSYDEKSD 192 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcC--CCCCchhH
Confidence 554321 133568999999999854 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=204.44 Aligned_cols=175 Identities=30% Similarity=0.416 Sum_probs=150.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||++... +++.|++|.+.... ...+.+.+|++++++++|+|++++++++.+++..+++|||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34578999999999999876 57899999997654 244678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+. ..+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 83 NGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999998654 56899999999999999999999 9999999999999999999999999999998765543
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....++..|+|||.+.+ ..++.++|
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~--~~~~~~~D 181 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEM--SGASTASD 181 (254)
T ss_pred cc--ccccccchhhcCHhhhcC--CCCCcchh
Confidence 32 133567899999999854 34666666
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=221.70 Aligned_cols=170 Identities=31% Similarity=0.488 Sum_probs=149.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEee-----cCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFE-----GRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-----~~~~~lv~e 401 (516)
.|.+.||+|.+|.||+++.. +++.+|+|++.......+++..|.++++.. +|||++.++|++.. ++++|||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 35578999999999999864 689999999988887788899999999988 79999999999874 578999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
||.+|+.-|+++... +..+.|+.+..|++.++.||.+|| ...++|||||-.|||++.++.+||.|||.+..+.
T Consensus 102 fC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999998763 578999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCcceeeccCCCCcccccccccccc
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
.... ......|||.|||||++..+
T Consensus 175 sT~g--rRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 175 STVG--RRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred cccc--cccCcCCCcccccceeeecc
Confidence 4322 22457899999999999544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=210.25 Aligned_cols=176 Identities=29% Similarity=0.411 Sum_probs=146.5
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~ 403 (516)
+.++||+|++|.||+|+..+ ++.+++|.+.... ...+.+.+|++++++++|+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 45679999999999999764 8899999997642 3335788999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++ +|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.+||+|||.+......
T Consensus 83 ~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 83 DH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 75 8988886432 46899999999999999999999 899999999999999999999999999999876544
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......++..|+|||.+.++ ..++.++|
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~D 184 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGA-TRYGPEVD 184 (287)
T ss_pred Ccc-cccccccccccCCceeeEcc-ccCChHHH
Confidence 321 12334568889999987543 35666666
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=204.85 Aligned_cols=176 Identities=34% Similarity=0.407 Sum_probs=151.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~ 403 (516)
..+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++.+++++|+||+++++.+.+. ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3467999999999999986 68899999986544 3457889999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.+. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 84 SGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999754 37899999999999999999999 899999999999999999999999999999877655
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..........++..|+|||.+.. +..+.++|
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~D 185 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRG--EEYGRAAD 185 (260)
T ss_pred cccccccCCCCCccccCHhhhcC--CCCCchhh
Confidence 43111234567899999999854 45777776
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=211.79 Aligned_cols=176 Identities=27% Similarity=0.380 Sum_probs=143.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 402 (516)
++.+.||+|++|.||+|... +|+.||+|.++.... ....+.+|+.++++++|+||+++++++.+. +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34567999999999999975 589999999864322 223567899999999999999999998765 468999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++ +|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 90 ~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 90 CEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred CCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 965 8998886532 56899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....+++.|+|||++.+. ..++.++|
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 191 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGC-TTYTTAID 191 (309)
T ss_pred ccCC--CCcccccccccChhhhcCC-CCcCchHH
Confidence 3221 1333457889999998542 45677766
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=207.08 Aligned_cols=171 Identities=28% Similarity=0.430 Sum_probs=146.1
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.++++++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 57999999999999864 68899999986433 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++.. ..+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||.+......... .
T Consensus 105 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~ 172 (285)
T cd06648 105 DIVTH-------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--R 172 (285)
T ss_pred HHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--c
Confidence 99864 35889999999999999999999 899999999999999999999999999988755433211 1
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....|++.|+|||++.+ +.++.++|
T Consensus 173 ~~~~~~~~y~aPE~~~~--~~~~~~~D 197 (285)
T cd06648 173 KSLVGTPYWMAPEVISR--LPYGTEVD 197 (285)
T ss_pred ccccCCccccCHHHhcC--CCCCCccc
Confidence 23457899999999855 56788877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=205.24 Aligned_cols=168 Identities=29% Similarity=0.333 Sum_probs=139.1
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHh-hccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASI-SRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.||+|++|.||+|... +++.||+|.+..... ....+..|..++ ...+|+||+++++.+.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999875 588999999865321 123344554443 455899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.++++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 150 (260)
T cd05611 82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-- 150 (260)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence 9999999653 46899999999999999999999 899999999999999999999999999998754331
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||.+.+ +.++.++|
T Consensus 151 ----~~~~~~~~y~~pe~~~~--~~~~~~~D 175 (260)
T cd05611 151 ----KKFVGTPDYLAPETILG--VGDDKMSD 175 (260)
T ss_pred ----ccCCCCcCccChhhhcC--CCCcchhh
Confidence 23457889999999865 45777777
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=208.94 Aligned_cols=171 Identities=28% Similarity=0.419 Sum_probs=145.6
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.+||+|++|.||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999875 68999999985432 33456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++.. ..+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++......... .
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~ 173 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R 173 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence 98743 35889999999999999999999 899999999999999999999999999998765433211 1
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||++.+ ..++.++|
T Consensus 174 ~~~~~~~~y~~pE~~~~--~~~~~~~D 198 (292)
T cd06657 174 KSLVGTPYWMAPELISR--LPYGPEVD 198 (292)
T ss_pred cccccCccccCHHHhcC--CCCCchhh
Confidence 23457899999999854 56777777
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=212.59 Aligned_cols=178 Identities=22% Similarity=0.287 Sum_probs=143.3
Q ss_pred hhcccC--CcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQG--GYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..||+| ++|+||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 89999999875 689999999865432 235678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+.. ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++||+.+........
T Consensus 84 ~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999997643 245899999999999999999999 89999999999999999999999999986543322111
Q ss_pred cee-----eccCCCCccccccccccccccccccCCC
Q 036471 486 IIS-----MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~-----~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....++..|+|||++.++...++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhh
Confidence 100 0112346679999999665455777777
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=213.25 Aligned_cols=178 Identities=29% Similarity=0.393 Sum_probs=144.9
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhcc-CCcceeeEEEEEeec--CeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRT-SHVNVVTLLGFCFEG--RRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~lv 399 (516)
.+.+.+.||+|+||.||+|.+. +++.+|+|++... ......+.+|+.+++++ +||||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4456678999999999999976 5789999988542 23335677899999999 999999999988653 367999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++ ++|.+++.. ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||++..
T Consensus 88 ~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 88 FEYME-TDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred ecccc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99997 599988853 36788999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcc---eeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESI---ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .......|+..|+|||++.+. ..++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sD 195 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVD 195 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc-ccccccch
Confidence 6543321 122335688999999998543 45677776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=209.32 Aligned_cols=177 Identities=29% Similarity=0.431 Sum_probs=142.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++.+.||+|++|.||+|+.. +++.||+|.+.... ...+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34567999999999999976 58899999986432 223578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 483 (516)
++|.+++.... ...+++..+..++.||+.||+||| +++++|+||+|+||++++ ++.+||+|||++......
T Consensus 85 -~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 85 -LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred -ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 58888875432 234688889999999999999999 899999999999999985 567999999999765432
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......+++.|+|||++.+. ..++.++|
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~D 186 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVD 186 (294)
T ss_pred cc--ccccCceeecccCHHHHhCC-CCCCcHHH
Confidence 21 11334568899999998542 45666665
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=238.86 Aligned_cols=167 Identities=28% Similarity=0.376 Sum_probs=143.3
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
..||.|.||.||.+... +|+..|+|-++-. ......+.+|+.++..++|||+|+++|+-.+.+..+|.|||+++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 35999999999999865 5888999987532 3334678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.++++.. +..++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1321 La~ll~~g------ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEHG------RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHHhc------chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999754 34666777788999999999999 9999999999999999999999999999998887653221
Q ss_pred --eeccCCCCcccccccccccc
Q 036471 488 --SMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 488 --~~~~~~gt~~y~aPE~l~~~ 507 (516)
+.....||+.|||||++.+.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred CHHHHhhcCCchhcCchhhccc
Confidence 23456799999999999764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=208.60 Aligned_cols=176 Identities=30% Similarity=0.442 Sum_probs=145.5
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.||.|++|.||+|... +|..|++|++.... ...+.+.+|++.+++++||||+++++++.+++..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3467999999999999875 68999999986432 223568899999999999999999999999999999999995
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..++.++.|+++||+||| +++++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 82 LDLKKYMDSSP----LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 69999986542 146899999999999999999999 89999999999999999999999999999976543321
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....++..|+|||++.+. ..++.++|
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~D 182 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGS-RQYSTPVD 182 (283)
T ss_pred c--cCccccccCCCCCceeecC-cccCcHHH
Confidence 1 1233568899999998542 34566665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=214.08 Aligned_cols=174 Identities=22% Similarity=0.263 Sum_probs=149.3
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeec---CCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEE
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLND---SKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 399 (516)
+...+.+.++||+||.+.||++...+.+.+|+|++.. +......|.+|+..|.++ .|.+||++++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3444556678999999999999998889999988754 334457899999999999 599999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||- ..+|..+|+... ...+...+..+..||+.|+.++| ..||||.||||.|+|+-+ |.+||+|||+|..
T Consensus 439 mE~G-d~DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred eecc-cccHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9987 459999998753 22332378889999999999999 999999999999999864 6899999999999
Q ss_pred ccCCCcceeeccCCCCcccccccccccc
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
+..+.+.+......||+.|||||.+...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhc
Confidence 9998887777788999999999999654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=213.87 Aligned_cols=175 Identities=28% Similarity=0.367 Sum_probs=142.9
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCc---------------hhHHHHHHHhhccCCcceeeEEEEEeecC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG---------------EEFINEVASISRTSHVNVVTLLGFCFEGR 394 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 394 (516)
.+.||+|++|.||+|+.. +++.||+|++....... ..+.+|++++++++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 456999999999999875 58999999986432211 24789999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..++||||++ ++|.+++... ..+++..+..++.|++.||+||| ..+|+|+||+|+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999997 5999998643 46899999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCc------------ceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKES------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++........ ........+++.|+|||++.+. ..++.++|
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 216 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVD 216 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHH
Confidence 99976641110 1111234568899999998542 34566665
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=210.45 Aligned_cols=179 Identities=27% Similarity=0.389 Sum_probs=142.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC--------e
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--------R 395 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~ 395 (516)
+.+.++||+|++|.||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 445578999999999999875 58899999986432 22245678999999999999999999987654 3
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.++||||+.+ +|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999965 8888875432 46899999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++......... .......++..|+|||++.+. ..++.++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 206 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPID 206 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhh
Confidence 99766443221 111234578899999998542 34567776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=206.93 Aligned_cols=173 Identities=27% Similarity=0.383 Sum_probs=141.8
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccC-CcceeeEEEEEeec--CeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTS-HVNVVTLLGFCFEG--RRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~ 403 (516)
+.++||+|++|.||+|... +++.||+|.++... .......+|+..+.++. |+||+++++++.+. +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4567999999999999875 58899999986532 22234567888999885 99999999999987 8899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+ ++|.+.+.... ..+++..++.++.|++.||+||| ..+++||||+|+||+++. +.+||+|||+++.+...
T Consensus 83 ~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 83 D-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred C-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 7 58888876532 46899999999999999999999 899999999999999999 99999999999876443
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....++..|+|||++... +.++.++|
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~D 181 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMD 181 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcC-CCCCcchh
Confidence 321 234578899999987442 45677776
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=208.76 Aligned_cols=179 Identities=27% Similarity=0.382 Sum_probs=144.6
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC--------
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR-------- 394 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 394 (516)
.+.+.+.||+|++|.||+|..+ +++.||+|.++... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 3445678999999999999986 48899999986432 23356788999999999999999999987654
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 395 --RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 395 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
..++|+||+++ +|.+++... ...+++..++.++.|++.||+||| +.+|+|+||||+||++++++.+||+
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 777777543 246899999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||.+......... ......++..|+|||++.++ ..++.++|
T Consensus 159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~D 200 (302)
T cd07864 159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAID 200 (302)
T ss_pred cccccccccCCccc-ccccceeccCccChHHhcCC-CCCCchhH
Confidence 99999876544321 11223457889999998542 34566666
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=205.97 Aligned_cols=177 Identities=29% Similarity=0.446 Sum_probs=148.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||++..+ +|..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 34577999999999999976 4789999998643 2344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 483 (516)
+++|.+++.+.. ...+++..+..++.|+++||+||| ..+++|+||||+||++++++ .+||+|||.+......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 83 GGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999997642 245899999999999999999999 89999999999999999885 5699999999776543
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....|++.|+|||++.. ..++.++|
T Consensus 156 ~~~~--~~~~~~~~~~ape~~~~--~~~~~~~D 184 (257)
T cd08225 156 MELA--YTCVGTPYYLSPEICQN--RPYNNKTD 184 (257)
T ss_pred cccc--cccCCCccccCHHHHcC--CCCCchhh
Confidence 3211 23458899999999844 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=209.45 Aligned_cols=178 Identities=29% Similarity=0.351 Sum_probs=146.3
Q ss_pred hhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC-----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK-----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.||+|++|.||+++.. +++.||+|.++... ...+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34567999999999999753 57889999986432 2335678999999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++... ..+++..+..++.|+++||+||| ..+++|+||+|+||+++.++.++|+|||+++
T Consensus 83 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 83 ILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999998643 46889999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.......... ....|+..|+|||.+.+.....+.++|
T Consensus 154 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~D 190 (288)
T cd05583 154 EFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVD 190 (288)
T ss_pred cccccccccc-ccccCCccccCHHHhcCCCCCCcchhh
Confidence 6654432211 234578999999998553223566665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=229.68 Aligned_cols=165 Identities=23% Similarity=0.321 Sum_probs=142.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.++||+|+||.||+|++. +++.||+|+++.... ....+.+|+.++..++|+||+++++.+...+..++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999986 589999999975322 2256788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.||+.||+||| ..+|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 87 IGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 999999999653 45888999999999999999999 899999999999999999999999999999876543
Q ss_pred CcceeeccCCCCccccccccc
Q 036471 484 ESIISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l 504 (516)
... .....+|+.|++||..
T Consensus 158 ~~~--~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 158 ELN--MMDILTTPSMAKPKND 176 (669)
T ss_pred ccc--ccccccCccccCcccc
Confidence 322 2346789999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=210.32 Aligned_cols=177 Identities=19% Similarity=0.186 Sum_probs=142.2
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.+|.|+++.|+++.. +++.||+|+++.. ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455555555555554 6899999998654 33446889999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc--
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-- 486 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 486 (516)
.+++.+.. ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 87 EDLLKTHF----PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99997653 245889999999999999999999 999999999999999999999999999988655332211
Q ss_pred ---eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ---ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ---~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.......++..|+|||++..+...++.++|
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 192 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSD 192 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchh
Confidence 111234567889999999654445777776
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=210.46 Aligned_cols=177 Identities=29% Similarity=0.430 Sum_probs=149.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.||+|++|.||++... +++.|++|++..+. ...+.+.+|++++.+++ |+||+++++.+.+.+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 35577999999999999876 68999999986532 22367888999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++.+. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 84 APNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999754 46999999999999999999999 99999999999999999999999999999976654
Q ss_pred CCcc------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESI------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .......++..|+|||++.+ +.++.++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~D 204 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSD 204 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhh
Confidence 3321 11123457899999999854 55777766
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=202.36 Aligned_cols=162 Identities=24% Similarity=0.297 Sum_probs=134.1
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCCCHHHH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF 411 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 411 (516)
||+|+||.||++..+ ++..+|+|.+........ |+.....+ +|+||+++++.+...+..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 599999999999875 578899999865432211 22222212 799999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccccCCCcceeec
Q 036471 412 IYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMT 490 (516)
Q Consensus 412 l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~ 490 (516)
+.+. ..++++.++.++.|+++||+||| +.+++||||||+||+++.++ .++|+|||++...... .
T Consensus 100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~ 164 (267)
T PHA03390 100 LKKE------GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S 164 (267)
T ss_pred HHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------c
Confidence 9653 37899999999999999999999 89999999999999999998 9999999998765433 2
Q ss_pred cCCCCccccccccccccccccccCCC
Q 036471 491 GARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 491 ~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...++..|+|||++.+ +.++.++|
T Consensus 165 ~~~~~~~y~aPE~~~~--~~~~~~~D 188 (267)
T PHA03390 165 CYDGTLDYFSPEKIKG--HNYDVSFD 188 (267)
T ss_pred cCCCCCcccChhhhcC--CCCCchhh
Confidence 2457899999999954 56777776
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=201.86 Aligned_cols=179 Identities=30% Similarity=0.482 Sum_probs=151.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||++... +++.+++|.+.... ...+.+.+|++.+++++|+|++++++.+..++..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 34567999999999999976 58899999986543 344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+... ....+++..+..++.+++.||.||| ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 83 GGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred CCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999976531 2367999999999999999999999 8999999999999999999999999999997765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....|++.|+|||.+.+ ..++.++|
T Consensus 158 ~~--~~~~~~~~~y~~pe~~~~--~~~~~~~D 185 (258)
T cd08215 158 DL--AKTVVGTPYYLSPELCQN--KPYNYKSD 185 (258)
T ss_pred ce--ecceeeeecccChhHhcc--CCCCcccc
Confidence 11 133467889999999854 56777776
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=188.32 Aligned_cols=178 Identities=30% Similarity=0.409 Sum_probs=145.4
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
...||+|++|.|-+-++. +|...|+|.+..+. +..++.++|+++..+. ..|.+|.++|...++...++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 356999999999888765 68999999997543 3446788899887765 799999999999999999999999954
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|..+-++-- ..+..+++..+-+|+..+.+||.|||+ ...++|||+||+||||+.+|++|++|||++..+.+.-
T Consensus 130 Sldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-- 203 (282)
T KOG0984|consen 130 SLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-- 203 (282)
T ss_pred hHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--
Confidence 8877765432 245779999999999999999999996 7799999999999999999999999999998765432
Q ss_pred eeeccCCCCccccccccccccc--cccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
..+...|-..|||||.+..+. ..|+-|||
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksD 234 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSD 234 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehh
Confidence 223356788999999985442 35777777
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=214.77 Aligned_cols=154 Identities=22% Similarity=0.349 Sum_probs=131.2
Q ss_pred ccccHHHHHHHHHh---hh--hhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceee
Q 036471 316 RRYSYADIKKMTNS---FK--YKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVT 385 (516)
Q Consensus 316 ~~~~~~el~~~~~~---~~--~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~ 385 (516)
+.-.|..|+++.-. |. +.||-|+||+|.+++..| ...+|+|.+++. ..+......|-.+|...+.+=||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 34455566655433 21 459999999999997655 567899998653 234456778999999999999999
Q ss_pred EEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 386 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
|+--|.+.+.+|+||||++||++-.+|-+. +.++++.+..++.++..|+++.| ..|+|||||||+|||||.
T Consensus 694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrm------gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDr 764 (1034)
T KOG0608|consen 694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM------GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDR 764 (1034)
T ss_pred EEEEeccCCceEEEEeccCCccHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEcc
Confidence 999999999999999999999999998654 67899999999999999999999 999999999999999999
Q ss_pred CCcEEEeecCCcc
Q 036471 466 DFCPKISDFGLAK 478 (516)
Q Consensus 466 ~~~~kl~Dfg~a~ 478 (516)
+|++||.|||++.
T Consensus 765 dGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 765 DGHIKLTDFGLCT 777 (1034)
T ss_pred CCceeeeeccccc
Confidence 9999999999984
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=206.96 Aligned_cols=175 Identities=28% Similarity=0.410 Sum_probs=146.2
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC--CchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG--NGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.||+|++|.||+|...+ ++.|++|.+..... ......+|+..+++++ |+||+++++.+.+++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 45779999999999999864 78899999865433 2234567999999998 999999999999999999999999 7
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ...+++..++.++.|++.+|.||| +++++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 82 GNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred CCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 89999887642 246899999999999999999999 89999999999999999999999999999976644322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....++..|+|||++.+. ..++.++|
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~-~~~~~~~D 181 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRS-TSYSSPVD 181 (283)
T ss_pred c---CCCCCcccccCceeeecC-cCcCCccc
Confidence 1 234578899999998543 45677776
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=213.54 Aligned_cols=177 Identities=28% Similarity=0.407 Sum_probs=142.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv 399 (516)
+.+.+.||+|++|.||+|... +++.||+|.+... ......+.+|+.++++++|+||+++++++.... ..+++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 345578999999999999865 5899999998642 223356888999999999999999999876543 57899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+||+++ +|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 87 ~e~~~~-~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 87 QELMET-DLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred ehhccc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 999975 88887743 46899999999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ......|++.|+|||++.+. ..++.++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 192 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAID 192 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHH
Confidence 54332211 11234678999999987542 45777776
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=207.30 Aligned_cols=174 Identities=29% Similarity=0.420 Sum_probs=144.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+...+.||+|++|.||+|+.. +++.+++|.+.... ...+++.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 334467999999999999976 57889999986422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+. ++|.+++.... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++.....
T Consensus 97 ~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 97 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred cC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 96 58888775432 45889999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
. ....+++.|+|||++.. +.+.++.++|
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~D 196 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVD 196 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccc
Confidence 2 23457889999999743 1245677776
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-26 Score=203.82 Aligned_cols=175 Identities=27% Similarity=0.476 Sum_probs=143.4
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeec---CCCCchhHHHHHHHhhccCCcceeeEEEEEee--------cCeeEEE
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGFCFE--------GRRRALI 399 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~lv 399 (516)
.+||+|.||+||+|+.++ |+.||+|++-. ...-....++|+.+|..++|+|++.+++.|.. ...+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 469999999999998764 77889887632 22333677899999999999999999887753 2358999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+++++. +|.-+|.... ..++..++.+++.++..||.|+| ...|+|||+||.|+||+.+|.+||+|||+++.
T Consensus 103 f~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred HHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 999977 8998885432 57899999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCcce--eeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...+... ..+...-|..|++||.+++. ..++++.|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iD 211 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPID 211 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcch
Confidence 75543322 12344569999999999875 67777765
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=213.06 Aligned_cols=172 Identities=28% Similarity=0.333 Sum_probs=142.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+...+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 344577999999999999875 68999999986432 2335678899999999999999999988643 3568
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+.+ +|.+.+.. .+++..+..++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 98 LVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEeccCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 99999964 88888742 2888999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....+++.|+|||++.+ ..++.++|
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 199 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 199 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhC--CCCCCchh
Confidence 86644322 233457889999999955 57788877
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-24 Score=198.23 Aligned_cols=169 Identities=27% Similarity=0.318 Sum_probs=139.0
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEee----cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFE----GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lv~e~~~~ 405 (516)
++||-|-.|.|..+..+ +++.+|+|++..+ ....+|+++--+. .|||||.++++|+. ...+.+|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 57999999999999875 5899999999654 4456788765554 79999999999874 3456789999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
|.|...++.++ ...+++.++..|++||..|+.||| +.+|.||||||+|+|... |-.+||+|||+|+.-.+
T Consensus 144 GeLfsriq~~g----~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 144 GELFSRIQDRG----DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred hHHHHHHHHcc----cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999998874 367999999999999999999999 999999999999999964 45899999999986554
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .+....-||.|.|||++.. ..|+...|
T Consensus 217 ~~---~L~TPc~TPyYvaPevlg~--eKydkscd 245 (400)
T KOG0604|consen 217 PG---DLMTPCFTPYYVAPEVLGP--EKYDKSCD 245 (400)
T ss_pred Cc---cccCCcccccccCHHHhCc--hhcCCCCC
Confidence 33 2345667999999999944 35555443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=203.18 Aligned_cols=177 Identities=32% Similarity=0.509 Sum_probs=149.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
++.+.|++|++|.||+++.. +++.+++|.+.... ....++.+|+.++++++|+||+++++.+.+....++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 34567999999999999865 57899999986532 334577889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++.+.. .....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 83 FGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred CCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999987643 12356899999999999999999999 9999999999999999999999999999998765542
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....+++.|+|||.+.+ ..++.++|
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~--~~~~~~~D 183 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKG--RPYSYKSD 183 (256)
T ss_pred c----ccccCCccccCHHHHCC--CCCCchhh
Confidence 1 23457889999999854 56777776
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=203.53 Aligned_cols=182 Identities=27% Similarity=0.376 Sum_probs=146.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC--------chhHHHHHHHhhccCCcceeeEEEEEe-ecCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN--------GEEFINEVASISRTSHVNVVTLLGFCF-EGRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~ 397 (516)
|-+...||+|||++||+|.+. ..+.||||+-...+.. .+...+|..+-+.++||.||++++++. +.+.++
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 334567999999999999754 5788999986432211 245678999999999999999999986 566788
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCcEEEeec
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDF 474 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Df 474 (516)
.|+||++|.+|.-||+.+ +.+++.++..|+.||+.||.||. +...+|||-||||.|||+. .-|.+||.||
T Consensus 545 TVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999999765 57999999999999999999998 5578899999999999994 4578999999
Q ss_pred CCcccccCCCcce-----eeccCCCCcccccccccccc--ccccccCCC
Q 036471 475 GLAKICNRKESII-----SMTGARGTVGYIAPEVFCRN--IGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~s~~sD 516 (516)
|+++++..+.... -.....||..|++||.+.-. ...++.|+|
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD 666 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD 666 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence 9999987664431 12456799999999998432 234455554
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=211.85 Aligned_cols=177 Identities=25% Similarity=0.362 Sum_probs=144.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee----cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 400 (516)
.+.+.||+|++|.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 34567999999999999875 58999999986532 334667889999999999999999988763 34679999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+. ++|.+++... ..+++..++.++.|++.||+||| .++|+||||||+||++++++.+||+|||++...
T Consensus 88 e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 88 DLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9996 5899888543 45899999999999999999999 899999999999999999999999999999765
Q ss_pred cCCCcce--eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......++..|+|||++.+. ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~D 194 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAID 194 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCC-cccccccc
Confidence 4432211 11234688999999998542 45777777
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=208.12 Aligned_cols=160 Identities=20% Similarity=0.209 Sum_probs=124.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC--CCCEEEEEEeecC------CCCchhHHHHHHHhhccCCcceee-EEEEEeecCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI--DGSNVAVKVLNDS------KGNGEEFINEVASISRTSHVNVVT-LLGFCFEGRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~l 398 (516)
+.+.+.||+|+||+||+|.+. +++.||||++... ....+.+.+|++++++++|+|++. +++ .+..++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEE
Confidence 445678999999999999875 4777899987532 112356899999999999999985 443 246899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEECCCCcEEEeecCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDI-KPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg~a 477 (516)
||||+++++|.. +. ... ...++.|+++||+||| ++||+|||| ||+|||++.++.+||+|||+|
T Consensus 96 VmE~~~G~~L~~-~~---------~~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 96 VRGWTEGVPLHL-AR---------PHG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEccCCCCHHH-hC---------ccc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 999999999963 21 011 1467889999999999 899999999 999999999999999999999
Q ss_pred ccccCCCccee------eccCCCCcccccccccccc
Q 036471 478 KICNRKESIIS------MTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 478 ~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~ 507 (516)
+.+........ .+...+++.|+|||++..+
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 87765432111 2345688899999999543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=204.83 Aligned_cols=180 Identities=27% Similarity=0.361 Sum_probs=141.8
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..++||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++..++..+++|||++.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 3467999999999999875 58999999986432 23457889999999996 99999999999999999999999864
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.++...... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.+.....
T Consensus 88 -~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 88 -SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 66554432110 122569999999999999999999992 35999999999999999999999999999976543322
Q ss_pred ceeeccCCCCccccccccccccc-cccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNI-GEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~-~~~s~~sD 516 (516)
. ....|++.|+|||++..+. ..++.++|
T Consensus 164 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~D 192 (288)
T cd06616 164 K---TRDAGCRPYMAPERIDPSARDGYDVRSD 192 (288)
T ss_pred c---ccccCccCccCHHHhccccccCCcchhh
Confidence 1 2345788999999985421 25777776
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=202.79 Aligned_cols=170 Identities=31% Similarity=0.424 Sum_probs=141.7
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
++||+|++|.||+|+.. +++.|++|++..... ..+.+.+|++++++++|||++++++++.+....++||||+. +
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 56999999999999875 588999999864322 22467889999999999999999999999999999999996 5
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 106 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 7888776532 46899999999999999999999 899999999999999999999999999998643222
Q ss_pred eeeccCCCCccccccccccc-cccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
....|+..|+|||++.. ..+.++.++|
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sD 202 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVD 202 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhh
Confidence 23567889999999842 1245676766
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=202.50 Aligned_cols=174 Identities=33% Similarity=0.521 Sum_probs=143.0
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC---CchhHHHHHHHhhcc---CCcceeeEEEEEeecCe-----eE
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG---NGEEFINEVASISRT---SHVNVVTLLGFCFEGRR-----RA 397 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----~~ 397 (516)
+.+.||+|++|.||+|+.+. ++.||+|.++.... ....+.+|+.++.++ +|+||+++++++.+.+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45679999999999999874 89999999964322 224566787777665 69999999999988776 89
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
++|||+++ +|.+++.+.. ...+++..++.++.|+++||+||| +.+++|+||+|+||++++++.+||+|||.+
T Consensus 83 l~~e~~~~-~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred EEehhccc-CHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 99999975 8999887642 246899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... ....++..|+|||++.+ ..++.++|
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~--~~~~~~~D 188 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQ--SSYATPVD 188 (287)
T ss_pred eeccCCccc---ccccccccccChHHhcc--CCCCCcch
Confidence 876544321 23457889999999955 56777777
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=199.18 Aligned_cols=170 Identities=34% Similarity=0.406 Sum_probs=145.4
Q ss_pred cccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
||+|++|.||++... +++.+++|.+..... ..+.+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 489999999865432 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++... ..+++..+..++.|+++||.||| ..+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 81 FSHLSKE------GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 9999654 36899999999999999999999 89999999999999999999999999999977654321 1
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....++..|+|||.+.+ ...+.++|
T Consensus 150 ~~~~~~~~~~~~Pe~~~~--~~~~~~~D 175 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLG--KGYGKAVD 175 (250)
T ss_pred ccCCcCCccccChHHhCC--CCCCchhh
Confidence 234567889999999855 45666666
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-25 Score=207.81 Aligned_cols=181 Identities=28% Similarity=0.314 Sum_probs=149.8
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
|+....+|...||+|+||+|.+|.-+. .+.+|||+++++. .+.+--+.|-++|... +-|.+++++.++..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 334455778899999999999998754 6789999997643 3334456677777766 577899999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
|+||||+.||+|-..++.. .++.+..+.-+|.+||-||-+|| ++||+.||||.+|||+|.+|++||+|||+
T Consensus 426 yFVMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred eeEEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccc
Confidence 9999999999999999765 56888899999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.---+.. ......|||.|+|||++. +.+|+..+|
T Consensus 497 cKEni~~~~--TTkTFCGTPdYiAPEIi~--YqPYgksvD 532 (683)
T KOG0696|consen 497 CKENIFDGV--TTKTFCGTPDYIAPEIIA--YQPYGKSVD 532 (683)
T ss_pred ccccccCCc--ceeeecCCCcccccceEE--ecccccchh
Confidence 975432221 234578999999999994 468887766
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=209.63 Aligned_cols=169 Identities=31% Similarity=0.411 Sum_probs=138.6
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeEEEE
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRALIY 400 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~ 400 (516)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++.+++|+||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 367999999999999864 68899999986532 2245678899999999999999999988643 3467888
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+++ +++|.++++. ..+++..++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 102 ~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 102 HLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred hhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 876 7799888743 35899999999999999999999 899999999999999999999999999998764
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....++..|+|||++.+ ...++.++|
T Consensus 171 ~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~~~D 200 (345)
T cd07877 171 DDEM-----TGYVATRWYRAPEIMLN-WMHYNQTVD 200 (345)
T ss_pred cccc-----cccccCCCccCHHHHhC-ccCCCchhh
Confidence 3321 33467889999999854 245677776
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=204.38 Aligned_cols=176 Identities=24% Similarity=0.398 Sum_probs=142.9
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC--CchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG--NGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|++|.||+|...+ ++.||+|.++.... ....+.+|+.++.+.. |+||+++++++.+....+++|||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456789999999999999875 89999999975432 3345677887777764 9999999999999999999999985
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|.+++.... ..+++..+..++.|++.||+||| + .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 98 -~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 98 -TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred -cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 47887775532 47899999999999999999999 6 59999999999999999999999999999765433
Q ss_pred CcceeeccCCCCccccccccccccc--cccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNI--GEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~s~~sD 516 (516)
... ....++..|+|||++.+.. +.++.++|
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~D 200 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRAD 200 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchh
Confidence 221 2345788999999986532 34677776
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=209.53 Aligned_cols=170 Identities=29% Similarity=0.390 Sum_probs=139.7
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecC------eeEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGR------RRALI 399 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv 399 (516)
..+.||+|++|.||++... +++.||+|++..... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 3467999999999999865 689999999864322 2356789999999999999999999987654 35899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+ +++|.+++.. ..+++..++.++.|++.||+||| ..+|+||||||+||+++.++.+||+|||++..
T Consensus 99 ~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 99 MPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 9998 7799988753 46899999999999999999999 99999999999999999999999999999976
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....+++.|+|||++.+. ..++.++|
T Consensus 168 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~D 198 (343)
T cd07880 168 TDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVD 198 (343)
T ss_pred cccCc-----cccccCCcccCHHHHhCC-CCCCcHHH
Confidence 54322 234578899999998542 34566555
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=223.70 Aligned_cols=191 Identities=31% Similarity=0.480 Sum_probs=155.9
Q ss_pred HHHHHHHHhhhhhcccCCcEEEEEEEECC--------CCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEE
Q 036471 321 ADIKKMTNSFKYKLGQGGYGSVYKGKLID--------GSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGF 389 (516)
Q Consensus 321 ~el~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 389 (516)
.|+.+....+.+.+|.|.||.|++|.... ...||||+++... .+.+.+..|+++|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34444444566789999999999997431 3569999997643 4457899999999999 69999999999
Q ss_pred EeecCeeEEEEEecCCCCHHHHHhhcC--CCCCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 036471 390 CFEGRRRALIYEFVSNGSLEKFIYRNS--SSIEN--------HKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459 (516)
Q Consensus 390 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~--------~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~ 459 (516)
+...+..++|+||++.|+|.++|+..+ ..... ..++..+++.++.|||.||+||+ +.++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence 999999999999999999999999876 11111 24899999999999999999999 999999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCCcceeecc-CCCCccccccccccccccccccCCC
Q 036471 460 NILLDEDFCPKISDFGLAKICNRKESIISMTG-ARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 460 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+.++..+||+|||+|+............. ..-+..|||||.+.. ..|+.|||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSD 503 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSD 503 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--Ccccccch
Confidence 99999999999999999997665554332111 113567999999954 78999998
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=203.48 Aligned_cols=175 Identities=33% Similarity=0.476 Sum_probs=147.3
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.||+|++|.||+|+..+ ++.+++|++... ....+.+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 34679999999999999864 899999999754 2334678899999999999999999999999999999999997
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.+.. ..+++..++.++.|++.||+||| ..+|+|+||+|+||++++++.+||+|||.++.......
T Consensus 82 ~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 59999997642 46899999999999999999999 89999999999999999999999999999976644332
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....++..|+|||++.+. ..++.++|
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~-~~~~~~~D 181 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGS-KHYSTAVD 181 (282)
T ss_pred c--cCccccCcCcCChHHhcCC-cCCCcccc
Confidence 1 1234457789999998553 36777776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=203.81 Aligned_cols=175 Identities=29% Similarity=0.379 Sum_probs=147.1
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.||+|++|.||++... +++.+++|.+..... ....+.+|+.++++++|+||+++++++.++...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3457999999999999875 688999999865432 346788999999999999999999999999999999999975
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.+++.... ..+++..++.++.|++.||.||| ..+|+|+||||+||++++++.+||+|||.+........
T Consensus 83 -~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 83 -DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred -CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 8888886532 57899999999999999999999 89999999999999999999999999999977655431
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|+|||.+.+. ..++.++|
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~-~~~~~~~D 181 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGD-KGYSTPVD 181 (283)
T ss_pred --cccCccCcccccCcHHHhcC-CCCCchhH
Confidence 12334578899999998542 36777776
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=209.47 Aligned_cols=174 Identities=28% Similarity=0.426 Sum_probs=143.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~ 400 (516)
..+.||+|+||.||+++.. +++.||+|.+... ......+.+|+.+++.++|+||+++++++... ...++++
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 4467999999999999875 5899999998643 23345678899999999999999999987654 3479999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+. ++|.+++... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||++...
T Consensus 89 e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 89 ELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred eCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9996 6898888543 56999999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....++..|+|||++.+. ..++.++|
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 191 (337)
T cd07858 159 SEKGDF--MTEYVVTRWYRAPELLLNC-SEYTTAID 191 (337)
T ss_pred CCCccc--ccccccccCccChHHHhcC-CCCCCccc
Confidence 443211 1334578899999998542 35777777
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=207.80 Aligned_cols=177 Identities=28% Similarity=0.338 Sum_probs=140.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-C--CCEEEEEEeecCC---CCchhHHHHHHHhhcc-CCcceeeEEEEEeec----CeeE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-D--GSNVAVKVLNDSK---GNGEEFINEVASISRT-SHVNVVTLLGFCFEG----RRRA 397 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~ 397 (516)
++.+.||+|+||.||+++.. . +..||+|.+.... ...+.+.+|+++++++ +||||+++++..... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 35577999999999999975 3 6789999986422 2245788899999999 599999999875432 4567
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+++||+. ++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 83 ~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 83 LYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 8899886 5899988543 56899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+...... .......|++.|+|||++.++ ..++.++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~D 192 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAID 192 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCC-CCCCcHHH
Confidence 866433221 112335689999999987542 35666665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=209.53 Aligned_cols=177 Identities=28% Similarity=0.390 Sum_probs=147.3
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALI 399 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv 399 (516)
.+.+.||+|++|.||+|+..+ ++.|++|++... ....+.+.+|+..++.++|+||+++++++.... ..+++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 455789999999999999764 899999998653 334468899999999999999999999988775 78999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++ ++|.+++.+. ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||.+..
T Consensus 83 ~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 83 TELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred ecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99997 4898888643 47999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .......++..|+|||++.+. ..++.++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sD 189 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAID 189 (330)
T ss_pred ecccccccccccccccccCcCCceeeecc-cCCCcchh
Confidence 6544310 112345678899999999653 26777776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=196.02 Aligned_cols=160 Identities=23% Similarity=0.208 Sum_probs=133.7
Q ss_pred CCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhc
Q 036471 337 GGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRN 415 (516)
Q Consensus 337 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 415 (516)
|.+|.||++++. +++.+|+|.+.... .+.+|...+....||||+++++++.+.+..+++|||+++++|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999875 58899999996543 2334555555667999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCC
Q 036471 416 SSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495 (516)
Q Consensus 416 ~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 495 (516)
..+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||.+....... ....++
T Consensus 80 ------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 80 ------LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred ------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 35899999999999999999999 9999999999999999999999999999886554321 234457
Q ss_pred ccccccccccccccccccCCC
Q 036471 496 VGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 496 ~~y~aPE~l~~~~~~~s~~sD 516 (516)
..|+|||++.. +.++.++|
T Consensus 146 ~~y~aPE~~~~--~~~~~~~D 164 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACD 164 (237)
T ss_pred ccccCCcccCC--CCCCchhh
Confidence 78999999843 56777776
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=207.53 Aligned_cols=168 Identities=30% Similarity=0.400 Sum_probs=137.3
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC------eeEEEE
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR------RRALIY 400 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~ 400 (516)
.+.||+|++|.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 367999999999999875 58999999986432 22356789999999999999999999987543 468999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+.. +|.+++. ..++++.+..++.|++.||+||| ..+++||||||+||+++.++.+||+|||+++..
T Consensus 100 e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 100 PYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 99964 7776641 35889999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....++..|+|||++.+. ..++.++|
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~D 197 (342)
T cd07879 168 DAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVD 197 (342)
T ss_pred CCCC-----CCceeeecccChhhhcCc-cccCchHH
Confidence 3321 334568899999998542 35666766
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=205.70 Aligned_cols=179 Identities=29% Similarity=0.399 Sum_probs=142.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC--------e
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--------R 395 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~ 395 (516)
+.+.++||+|++|.||+|... +++.+++|++.... .....+.+|++++++++|+||+++++++.+.. .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 345578999999999999976 58899999985432 22346789999999999999999999875433 4
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.++|+||+.+ +|...+... ...+++..+..++.|+++||+||| +++|+|+||||+||++++++.+||+|||
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred EEEEEecCCc-CHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 6899999965 777777543 246999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcce---------eeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESII---------SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++......... ..+...+++.|+|||++.+. ..++.++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 209 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVD 209 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhH
Confidence 997654332211 11234568889999998542 45677776
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=204.83 Aligned_cols=171 Identities=27% Similarity=0.397 Sum_probs=140.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++.+++||||+++++++.. ....++++||+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 34578999999999999865 6899999988542 2334678899999999999999999999876 55788999998
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+++|.++++. ..+++..+..++.|+++||+||| +++|+|+||+|+||++++++.+||+|||.+......
T Consensus 93 -~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 93 -GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred -ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 5689888753 45788889999999999999999 899999999999999999999999999998754332
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....++..|+|||++.+ ...++.++|
T Consensus 162 ~-----~~~~~~~~y~aPE~~~~-~~~~~~~~D 188 (328)
T cd07856 162 M-----TGYVSTRYYRAPEIMLT-WQKYDVEVD 188 (328)
T ss_pred c-----CCCcccccccCceeeec-cCCcCcHHH
Confidence 1 23456889999999743 245666665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=203.38 Aligned_cols=179 Identities=23% Similarity=0.273 Sum_probs=130.2
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCC----CEEEEEEeecCCCCc------------hhHHHHHHHhhccCCcceeeEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDG----SNVAVKVLNDSKGNG------------EEFINEVASISRTSHVNVVTLLGF 389 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~h~nIv~l~~~ 389 (516)
..+.+.++||+|+||.||+|...++ ..+++|+........ .....+...+..++|++|+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3455678899999999999987543 456666543222111 112233344566789999999997
Q ss_pred EeecC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 390 CFEGR----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 390 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
..... ..++++|+... ++.+.+... ...++..+..++.|++.||+||| +++|+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 65543 34677787643 677766542 23578889999999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+|+.+....... ......||+.|+|||++.+ ..++.++|
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~D 215 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGD 215 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHH
Confidence 9999999999998764322111 1123468999999999854 57888877
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-25 Score=197.28 Aligned_cols=188 Identities=26% Similarity=0.389 Sum_probs=149.2
Q ss_pred cccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEee
Q 036471 317 RYSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFE 392 (516)
Q Consensus 317 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 392 (516)
.|+-+++++. ..||.|+||+|++-.++ .|+..|||+++... .+.++++.|.+...+- +.||||+++|....
T Consensus 60 ~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 4555555542 36999999999999876 48999999997543 4457788888876665 79999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
++..|+-||.|. .+|..+-+.-. ......+++..+-.|+.-.+.||.||.. ...|||||+||+|||++..|.+||+
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence 999999999995 47765543211 1234679999999999999999999996 6789999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||++..+... ...+...|-..|||||-+..+...++.+||
T Consensus 211 DFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSD 251 (361)
T KOG1006|consen 211 DFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSD 251 (361)
T ss_pred cccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhh
Confidence 99999765432 223556788899999999766556887776
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=201.02 Aligned_cols=179 Identities=25% Similarity=0.362 Sum_probs=143.0
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC------CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS------KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.+.||+|++|.||+++... +..+++|.++.. .....++.+|+.++++++||||+++++.+.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 3456789999999999998754 445556655431 222345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||+|+||+++. +.+||+|||.+...
T Consensus 82 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 82 EYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999999875321 2357999999999999999999999 899999999999999975 56999999999776
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....|++.|+|||.+.+ ..++.++|
T Consensus 156 ~~~~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~D 187 (260)
T cd08222 156 MGSCDL--ATTFTGTPYYMSPEALKH--QGYDSKSD 187 (260)
T ss_pred CCCccc--ccCCCCCcCccCHHHHcc--CCCCchhh
Confidence 443321 133567889999999844 45676766
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=189.20 Aligned_cols=175 Identities=25% Similarity=0.388 Sum_probs=142.7
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
...||.|+.|.|++.+.. .|..+|||.+.++. .+.++++..+.++..- +.|.||+.+|+|..+...++-||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 346999999999999876 48899999997643 3446777777776665 489999999999999999999999853
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
-+..++++-. +++++..+-++...++.||.||.. .++|+|||+||+|||+|+.|++||+|||++..+.....+
T Consensus 176 C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 176 CAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 6777776643 679999999999999999999996 789999999999999999999999999999766544332
Q ss_pred eeeccCCCCcccccccccccc-ccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
+...|-+.|||||-+.-+ ...|+.++|
T Consensus 249 ---trsAGC~~YMaPERidp~~~~kYDiRaD 276 (391)
T KOG0983|consen 249 ---TRSAGCAAYMAPERIDPPDKPKYDIRAD 276 (391)
T ss_pred ---ccccCCccccCccccCCCCCCccchhhh
Confidence 446789999999999544 235555555
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-25 Score=200.05 Aligned_cols=173 Identities=30% Similarity=0.443 Sum_probs=144.1
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecC-----eeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGR-----RRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~ 402 (516)
+.||-|+||.||.+.+. +|+.|++|++.+-- ...+.+.+|+.+|..++|.|++..++...-.+ ..|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 45999999999999874 69999999986532 33478899999999999999999988766443 45678888
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
|.. +|.++|-. ...++.+.+.-++.||++||.||| +.+|.||||||.|+|++.+..+||+|||+++....
T Consensus 139 mQS-DLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQS-DLHKIIVS------PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHh-hhhheecc------CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 854 88887743 467999999999999999999999 99999999999999999999999999999987655
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.. .++...-|..|+|||++++. ..|+.+.|
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvD 240 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGA-RRYTGAVD 240 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcc-hhhcCccc
Confidence 5432 34566679999999999874 57777665
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=210.57 Aligned_cols=175 Identities=23% Similarity=0.284 Sum_probs=130.0
Q ss_pred HhhhhhcccCCcEEEEEEEE-----------------CCCCEEEEEEeecCCC---------------CchhHHHHHHHh
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-----------------IDGSNVAVKVLNDSKG---------------NGEEFINEVASI 375 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l 375 (516)
+.+.++||+|+||.||+|.. .+++.||||++..... ..+....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 33557899999999999964 2356899999864321 112334567777
Q ss_pred hccCCcce-----eeEEEEEee--------cCeeEEEEEecCCCCHHHHHhhcCCC------------------CCCCCC
Q 036471 376 SRTSHVNV-----VTLLGFCFE--------GRRRALIYEFVSNGSLEKFIYRNSSS------------------IENHKL 424 (516)
Q Consensus 376 ~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l 424 (516)
.+++|.++ +++++++.. .+..+|||||+++++|.++++..... .....+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766654 667777653 35689999999999999999753211 012345
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccc
Q 036471 425 TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 425 ~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l 504 (516)
++..+..++.|++.+|+||| ..+|+||||||+|||++.++.+||+|||++.......... .....+++.|+|||++
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhh
Confidence 77889999999999999999 8999999999999999999999999999997654332211 1123357899999998
Q ss_pred cc
Q 036471 505 CR 506 (516)
Q Consensus 505 ~~ 506 (516)
..
T Consensus 383 ~~ 384 (507)
T PLN03224 383 VM 384 (507)
T ss_pred cC
Confidence 54
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-23 Score=193.09 Aligned_cols=174 Identities=25% Similarity=0.330 Sum_probs=145.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.||+|+|++|.+++++ +.+.+|+|++++. ..+.+=...|-.+..+. +||.+|.++.++..+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4578999999999999976 4678899998753 23333455676777666 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+||+|--+++++ .+++++.+..+..+|..||.||| ++|||.||||.+|+|+|..|++||.|+|+++.--.+
T Consensus 334 ~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 334 NGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred cCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999998888765 57999999999999999999999 999999999999999999999999999999764333
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ..+...|||.|+|||++.+ ..|....|
T Consensus 405 gd--~tstfcgtpnyiapeilrg--eeygfsvd 433 (593)
T KOG0695|consen 405 GD--TTSTFCGTPNYIAPEILRG--EEYGFSVD 433 (593)
T ss_pred Cc--ccccccCCCcccchhhhcc--cccCceeh
Confidence 32 2356889999999999977 46665554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-24 Score=209.73 Aligned_cols=171 Identities=25% Similarity=0.309 Sum_probs=148.7
Q ss_pred hhcccCCcEEEEEEEECCCC-EEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGS-NVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
..||-|+||.|=++..+... .+|+|++++. ..+.+.+..|-++|...+.|.||++|..|.+....|++||-+-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 35999999999999875543 3889988652 345577889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
.|...|+.+ +.++......++..+++|++||| .++||.|||||+|.+++.+|-+||.|||+|+.+......
T Consensus 506 ElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 506 ELWTILRDR------GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhhhhhhhc------CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 999999765 57888999999999999999999 999999999999999999999999999999999877654
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .+.|||.|.|||+++.. ..+.++|
T Consensus 577 w---TFcGTpEYVAPEIILnK--GHD~avD 601 (732)
T KOG0614|consen 577 W---TFCGTPEYVAPEIILNK--GHDRAVD 601 (732)
T ss_pred e---eecCCcccccchhhhcc--CcchhhH
Confidence 3 47899999999999763 4444443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=203.73 Aligned_cols=177 Identities=26% Similarity=0.341 Sum_probs=140.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeec------------
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEG------------ 393 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------------ 393 (516)
+.+.+.||.|++|.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++.+...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 344577999999999999875 58899999986543 3446788999999999999999999876543
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCcEE
Q 036471 394 --RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPK 470 (516)
Q Consensus 394 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~k 470 (516)
...++||||++ ++|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+||+++ +++.+|
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 589888743 45889999999999999999999 89999999999999997 456799
Q ss_pred EeecCCcccccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 471 ISDFGLAKICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 471 l~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|||.+..+....... ......++..|+|||++.+. ..++.++|
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 201 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAID 201 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhh
Confidence 99999997654322111 11223578899999987542 45677776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-23 Score=205.00 Aligned_cols=170 Identities=30% Similarity=0.409 Sum_probs=141.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCe------eEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR------RALI 399 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv 399 (516)
+.+.||+|++|.||+|+.. +++.||+|++... ....+.+.+|+.++++++|+||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4467999999999999986 4789999998643 2233567889999999999999999988776554 8999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+||+ +++|.+++.. ..+++..++.++.|+++||+||| +.+|+|+||||+||++++++.+||+|||++..
T Consensus 99 ~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 99 THLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9998 5699998853 46899999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....++..|+|||.+.+. ..++.++|
T Consensus 168 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~D 198 (343)
T cd07851 168 TDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVD 198 (343)
T ss_pred ccccc-----cCCcccccccCHHHHhCC-CCCCchHh
Confidence 54331 334678899999998542 35666666
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=208.81 Aligned_cols=174 Identities=31% Similarity=0.407 Sum_probs=137.4
Q ss_pred hhcccCCcE-EEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYG-SVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
+.+|.|..| .||+|.. +|+.||||.+-... ..-..+|+..|+.- +|||||++++.-.+....||..|.+. .+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHH
Confidence 568888887 5899998 78999999885432 23457899998887 69999999999889999999999995 4999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---C--CcEEEeecCCcccccCCC
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---D--FCPKISDFGLAKICNRKE 484 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~~~ 484 (516)
+++..... ..........+.+..|++.||++|| +.+||||||||.||||+. + .+++|+|||+++.+..+.
T Consensus 591 dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 591 DLIESSGL--DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHhcccc--chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99986411 1111222456788999999999999 899999999999999975 3 489999999999998776
Q ss_pred ccee-eccCCCCccccccccccccccccccCCC
Q 036471 485 SIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ..+..||-+|+|||++.. ..-+.++|
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~--~~~~~avD 696 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVD 696 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc--cccCcccc
Confidence 5543 356779999999999955 33344444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=189.01 Aligned_cols=186 Identities=22% Similarity=0.299 Sum_probs=154.4
Q ss_pred ccccHHHHHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCC--c----ceeeEEE
Q 036471 316 RRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSH--V----NVVTLLG 388 (516)
Q Consensus 316 ~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~l~~ 388 (516)
-.|...|....++.+.+.+|+|.||.|-++.+.. +..||+|+++.-..-.++.+-|++++.++.+ | .+|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 3556667766777777889999999999998754 7899999998766666777889999999932 2 3788889
Q ss_pred EEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---
Q 036471 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE--- 465 (516)
Q Consensus 389 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~--- 465 (516)
++.-.+...||+|.+ |-|+.++|.... -.+++...+..|+.|+++++++|| +.+++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccce
Confidence 999999999999998 569999997653 367999999999999999999999 999999999999999931
Q ss_pred -----------------CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 -----------------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..++|+|||.|....... +..+.|..|+|||++++ -.|++++|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLg--LGwS~pCD 291 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILG--LGWSQPCD 291 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheec--cCcCCccC
Confidence 3469999999998765554 33556899999999987 57888887
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=179.22 Aligned_cols=137 Identities=17% Similarity=0.222 Sum_probs=107.6
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCC---C-------chhH-----------------HHHHHHhhccCCccee
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---N-------GEEF-----------------INEVASISRTSHVNVV 384 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~nIv 384 (516)
..||+|++|.||+|...+|+.||+|+++.... . ...| .+|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999988899999999975421 1 1122 3488999999877764
Q ss_pred eEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCCCcEEE
Q 036471 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL-HLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 385 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH~dlkp~NIll 463 (516)
....+.. ...+|||||++++++...+.. ...+++..+..++.|++.+|++| | ..+|+||||||+|||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 4333222 234899999999877654322 24688999999999999999999 7 8899999999999999
Q ss_pred CCCCcEEEeecCCcccc
Q 036471 464 DEDFCPKISDFGLAKIC 480 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~ 480 (516)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=181.48 Aligned_cols=177 Identities=36% Similarity=0.509 Sum_probs=149.1
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.|++|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.+++|+|++++++.+......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45679999999999999875 88999999976543 4678899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..+..++.+++.+|.+|| ..+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 83 DLFDYLRKKG-----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999997642 11889999999999999999999 899999999999999999999999999999877554311
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......++..|++||.+. ....++.++|
T Consensus 155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~D 182 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVD 182 (225)
T ss_pred -cccceeccCCcCCHhHhc-CCCCCCchhh
Confidence 112345678899999984 3356666666
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-23 Score=207.11 Aligned_cols=176 Identities=27% Similarity=0.380 Sum_probs=149.4
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+...+|.|++|.|||++++ .++..|+|+++... .+..-+.+|+-+++..+|+|||.++|-+......++.|||+.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 3456999999999999986 58899999998654 344567789999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+.-+.. .++++.++..+.+..+++|+||| +++-+|||||-.||++++.|.+|++|||.+..+..--.
T Consensus 99 lQdiy~~T------gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 99 LQDIYHVT------GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred ccceeeec------ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 99987543 68999999999999999999999 99999999999999999999999999999876643321
Q ss_pred eeccCCCCccccccccc-cccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVF-CRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l-~~~~~~~s~~sD 516 (516)
....+.||+.|||||+- .+..|.|..++|
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcd 197 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCD 197 (829)
T ss_pred hhhcccCCccccchhHHHHHhccccccccc
Confidence 22457899999999995 222366666665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=174.40 Aligned_cols=172 Identities=38% Similarity=0.630 Sum_probs=145.5
Q ss_pred cccCCcEEEEEEEECC-CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 89999999976544 35789999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccccCCCcceee
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
++.... ..+++..++.++.+++++|++|| ..+++|+||+|+||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 996532 36889999999999999999999 899999999999999999 89999999999987654431 11
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+...|++||.+... ...+.++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D 176 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGK-GYYSEKSD 176 (215)
T ss_pred hcccCCCCccChhHhccc-CCCCchhh
Confidence 335578899999998442 15555554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=182.43 Aligned_cols=165 Identities=33% Similarity=0.486 Sum_probs=142.6
Q ss_pred CcEEEEEEEECC-CCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhh
Q 036471 338 GYGSVYKGKLID-GSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR 414 (516)
Q Consensus 338 ~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 414 (516)
+||.||+|...+ ++.+++|++...... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 899999999754332 57899999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCC
Q 036471 415 NSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494 (516)
Q Consensus 415 ~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 494 (516)
. ..+++..++.++.+++++|.+|| ..+++|+||+|+||++++++.++|+|||.+....... ......+
T Consensus 81 ~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 81 R------GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred c------cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 3 23889999999999999999999 8999999999999999999999999999998765542 1234567
Q ss_pred CccccccccccccccccccCCC
Q 036471 495 TVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 495 t~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..|+|||.+.+ ..++.++|
T Consensus 149 ~~~~~~pE~~~~--~~~~~~~D 168 (244)
T smart00220 149 TPEYMAPEVLLG--KGYGKAVD 168 (244)
T ss_pred CcCCCCHHHHcc--CCCCchhh
Confidence 889999999853 56777776
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=174.46 Aligned_cols=140 Identities=20% Similarity=0.197 Sum_probs=110.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---------------------------chhHHHHHHHhhccCCccee
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---------------------------GEEFINEVASISRTSHVNVV 384 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~nIv 384 (516)
+.||+|++|+||+|...+|+.||||+++..... ...+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999999878999999998754211 01135788999999999875
Q ss_pred eEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEE
Q 036471 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILL 463 (516)
Q Consensus 385 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll 463 (516)
....+... ..+|||||++++++...... ...++...+..++.|++.+|.+|| . .||+||||||+||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEE
Confidence 54444333 34899999998865443211 145778899999999999999999 7 999999999999999
Q ss_pred CCCCcEEEeecCCcccccCC
Q 036471 464 DEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+ ++.++|+|||++..+...
T Consensus 152 ~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred E-CCCEEEEEcccceecCCC
Confidence 8 789999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=205.12 Aligned_cols=171 Identities=24% Similarity=0.303 Sum_probs=118.0
Q ss_pred hhhhhcccCCcEEEEEEEECC-----CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEE------EeecCeeE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-----GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF------CFEGRRRA 397 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~~~~~~~ 397 (516)
.+.++||+|+||.||+|++.+ +..||+|++...... +....| .+.+..+.+++.++.. ...+...+
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 455789999999999999754 689999988643221 111111 1222222222222211 24566889
Q ss_pred EEEEecCCCCHHHHHhhcCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSI--------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
+||||+++++|.+++....... ......+..+..++.||+.||+||| +++|+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEEE
Confidence 9999999999999987542100 0011223456789999999999999 8999999999999999
Q ss_pred CC-CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 464 DE-DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 464 ~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
+. ++.+||+|||+|+.+....... .....+++.|||||++..
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhc
Confidence 85 5799999999998664433222 234568999999997643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=182.58 Aligned_cols=180 Identities=22% Similarity=0.312 Sum_probs=149.4
Q ss_pred hhcccCCcEEEEEEEECC------CCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeec-CeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLID------GSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEG-RRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~ 402 (516)
..+.+|.||.||+|.+.+ .+.|.+|.++.. .-+...++.|.-++..+.|||+..+.+++.++ ...++++.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 457899999999996543 456888888653 34456788999999999999999999998764 567888999
Q ss_pred cCCCCHHHHHhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 403 VSNGSLEKFIYRNSS--SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+.-|+|+.+|...+. +...+.++..++..++.|++.|++||| ..++||.||.++|.+||+..++||+|=.+++.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 999999999984432 223356888899999999999999999 999999999999999999999999999999988
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
-..+.+.-......+..||+||.+.. ..|+.+||
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n--~~yssasD 480 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQN--SHYSSASD 480 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhh--hhhcchhh
Confidence 77665544444556789999999955 78999887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-21 Score=192.52 Aligned_cols=169 Identities=25% Similarity=0.358 Sum_probs=139.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+...+|.|+|+.|-++... +++..++|++.+.. .+-.+|+.++.+. +||||+++.+.+.++...|+|||.+.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 345566999999999999865 57889999997652 3345567665555 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-CCCCcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL-DEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+-|.+.+... +.....+..|+.+|+.|+.||| .+|+|||||||+|||+ ++.++++|+|||.++...+.
T Consensus 401 ~ell~ri~~~-------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 401 GELLRRIRSK-------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cHHHHHHHhc-------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9888877543 2223778889999999999999 9999999999999999 68999999999999877655
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....-|..|.|||++.+ ..+++++|
T Consensus 470 ----~~tp~~t~~y~APEvl~~--~~yt~acD 495 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAI--QEYTEACD 495 (612)
T ss_pred ----hcccchhhcccChhhhcc--CCCCcchh
Confidence 123455889999999964 68899887
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=170.44 Aligned_cols=170 Identities=23% Similarity=0.417 Sum_probs=139.5
Q ss_pred HHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEeecC--eeEEEEEe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFEGR--RRALIYEF 402 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv~e~ 402 (516)
.+.+.+++|+|.+++||.|.. .+.+.++||+++.-+ .+.+.+|+.+|..+. ||||+++++...+.. ...||+||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 345567899999999999985 468899999996533 367899999999996 999999999988754 56799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 481 (516)
+.+.+...+- ..++...+..++.+++.||.|.| ++||.|||+||.|++||.. -.++|+|+|+|....
T Consensus 117 v~n~Dfk~ly---------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 117 VNNTDFKQLY---------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hccccHHHHh---------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9998888776 56888889999999999999999 9999999999999999864 479999999998876
Q ss_pred CCCcceeeccCCCCccccccccccccccccccC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 514 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~ 514 (516)
..... .-...+..|--||.+.. ...+++.
T Consensus 185 p~~eY---nVRVASRyfKGPELLVd-y~~YDYS 213 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVD-YQMYDYS 213 (338)
T ss_pred CCcee---eeeeehhhcCCchheee-chhcccc
Confidence 65432 22344677889999854 3445443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=173.62 Aligned_cols=166 Identities=30% Similarity=0.377 Sum_probs=135.3
Q ss_pred hcccCCcEEEEEEEE-CCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeEEEEEe
Q 036471 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRALIYEF 402 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~ 402 (516)
.++.|.- .|-.+.+ -.+++||+|++... ....++..+|+..+..++|+||++++.++.-. ...|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4667766 4555543 35899999988532 33446788999999999999999999998643 367899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
|.. +|...+. ..++-+.+..|..|++.|++||| +.+|+||||||+||++..+..+||.|||+|+....
T Consensus 103 m~~-nl~~vi~--------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 103 MDA-NLCQVIL--------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hhh-HHHHHHH--------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCc
Confidence 954 9998886 34778899999999999999999 99999999999999999999999999999986544
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ..++....|..|.|||++.+. .+.+.+|
T Consensus 171 ~---~~mtpyVvtRyyrapevil~~--~~ke~vd 199 (369)
T KOG0665|consen 171 D---FMMTPYVVTRYYRAPEVILGM--GYKENVD 199 (369)
T ss_pred c---cccCchhheeeccCchheecc--CCcccch
Confidence 4 345777889999999999874 3666655
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-20 Score=167.82 Aligned_cols=162 Identities=19% Similarity=0.340 Sum_probs=133.4
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEE-EeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGF-CFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lv~e~~~ 404 (516)
+++.+.+|+|.||.+-+++++. .+.+++|.+.......++|.+|..---.+ .|.||+.-+++ ++..+.+++++||++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 4567889999999999999875 67899999988888889999998865555 69999988775 556777889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-CC-CCcEEEeecCCcccccC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL-DE-DFCPKISDFGLAKICNR 482 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll-~~-~~~~kl~Dfg~a~~~~~ 482 (516)
.|+|..-+. ...+.+....+++.|+++||.|+| ++++||||||.+|||| +. ..++||+|||..+..+.
T Consensus 106 ~gdL~snv~-------~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 106 RGDLRSNVE-------AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cchhhhhcC-------cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999988763 356888888999999999999999 9999999999999999 33 34899999999876543
Q ss_pred CCcceeeccCCCCccccccccc
Q 036471 483 KESIISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l 504 (516)
-- ....-+..|-|||..
T Consensus 176 tV-----~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELC 192 (378)
T ss_pred ee-----hhhhhhcccCCcHHH
Confidence 22 122346679999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=174.36 Aligned_cols=135 Identities=26% Similarity=0.422 Sum_probs=119.8
Q ss_pred hhhcccCCcEEEEEEEEC----CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 331 KYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.++||.|.|+.||++.+. ..+.||+|.+...... ..+.+|+++|..+ .+.||+++.+++..+++..+|+||++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 467999999999999754 3678999998654333 5689999999999 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAK 478 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~ 478 (516)
.+..++.. .++...+..++..++.||+++| .+|||||||||+|+|.+. .++-.|.|||+|.
T Consensus 120 ~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 120 DRFRDLYR---------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred cCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999883 4778899999999999999999 999999999999999974 5688999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-20 Score=180.67 Aligned_cols=189 Identities=22% Similarity=0.295 Sum_probs=157.5
Q ss_pred CccccHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC------CcceeeEE
Q 036471 315 PRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS------HVNVVTLL 387 (516)
Q Consensus 315 ~~~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~ 387 (516)
.-++.+.|+.+..|......|+|-|++|.+|.+. .|..||||++.+.....+.=+.|+++|++|+ --+.++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 3456777888888888888999999999999875 4889999999876665566788999999995 34789999
Q ss_pred EEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC
Q 036471 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF 467 (516)
Q Consensus 388 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 467 (516)
..|...++++||+|-+. .+|.++|+.... +-.|....+..++.|+.-||..|- ..+|+|.||||+||||++.-
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence 99999999999999884 499999988752 355788889999999999999999 99999999999999998754
Q ss_pred -cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 468 -CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 468 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+||+|||.|......+. +...-+..|.|||++++ -+|++.-|
T Consensus 574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG--~~yd~~iD 617 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILG--LPYDYPID 617 (752)
T ss_pred ceeeeccCccccccccccc----cHHHHHHhccCcceeec--CcccCCcc
Confidence 789999999987765543 44555778999999987 56666544
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=147.25 Aligned_cols=101 Identities=28% Similarity=0.451 Sum_probs=78.8
Q ss_pred CCCCCCCCCCCCCCCccCCCCCCCCCCCC--CceecccCCCCcceEEeecCCeEEEEEeecCc-EEEEEecccccCCCCC
Q 036471 29 KTCPSFFPSCGNLGQFFFPFTNRTHPECG--LMLVDNCNKPVQRIRLGKAGPFYNILNIAQDA-SITLEDQVFQNHLGNS 105 (516)
Q Consensus 29 ~~C~~~~~~CG~~~~I~yPF~~~~~p~Cg--p~f~l~C~~~~~~~~~~~~~~~y~V~~I~~~~-~i~v~d~~~~~~~~~~ 105 (516)
++|+. +|||+ +|+||||++. +|| |+|+|+|+++.+.+++.++++.|+|++|+|++ +|+|.++....+....
T Consensus 2 ~~C~~---~CGnv-~IpYPFgi~~--~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~ 75 (106)
T PF13947_consen 2 PGCPS---SCGNV-SIPYPFGIGP--GCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSS 75 (106)
T ss_pred CCCCC---ccCCE-eecCCCccCC--CCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCC
Confidence 57974 89999 8999999976 899 99999999986578888899999999999999 9999887654333222
Q ss_pred CCC-CCCCCCCCCceeeeccccCccEEEecCC
Q 036471 106 SCE-SFENLTLPTSASLSFHIKSNPSLFRCTH 136 (516)
Q Consensus 106 ~C~-~~~~~~l~~~f~~s~~~~n~~~~~~C~~ 136 (516)
.-. ...++++..||.++. ..|.++++||+.
T Consensus 76 ~~~~~~~~~~~~~~~~~s~-~~N~~~~~GC~t 106 (106)
T PF13947_consen 76 SSNSSNSNLSLNGPFFFSS-SSNKFTVVGCNT 106 (106)
T ss_pred CCcccccEEeecCCceEcc-CCcEEEEECCCC
Confidence 211 112444555887776 688899999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=160.09 Aligned_cols=134 Identities=19% Similarity=0.324 Sum_probs=103.9
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecC-CCCchhHHHHHHHhhcc-----CCcceeeEEEEEeecC---eeE-EEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDS-KGNGEEFINEVASISRT-----SHVNVVTLLGFCFEGR---RRA-LIYE 401 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-lv~e 401 (516)
+.||+|++|.||. ..+....+||++... ....+.+.+|+..++++ .||||++++|+++++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5699999999996 433333368888643 33457899999999999 5799999999998863 333 7899
Q ss_pred e--cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeeCCCCCCcEEECC----CCcEEEee-
Q 036471 402 F--VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL-EYLHLGCSTRILHFDIKPHNILLDE----DFCPKISD- 473 (516)
Q Consensus 402 ~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~D- 473 (516)
| .++++|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+|||++. ++.++|+|
T Consensus 86 ~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred CCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 9 5579999999542 35555 35677888777 9999 999999999999999974 34899999
Q ss_pred cCCccc
Q 036471 474 FGLAKI 479 (516)
Q Consensus 474 fg~a~~ 479 (516)
||....
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 555444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=161.90 Aligned_cols=141 Identities=19% Similarity=0.177 Sum_probs=109.6
Q ss_pred hhhhhcccCCcEEEEEEE--ECCCCEEEEEEeecCCCC-------------------------chhHHHHHHHhhccCCc
Q 036471 329 SFKYKLGQGGYGSVYKGK--LIDGSNVAVKVLNDSKGN-------------------------GEEFINEVASISRTSHV 381 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ 381 (516)
.+.+.||+|++|.||+|. ..+|+.||+|+++..... ...+.+|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 345779999999999998 567999999998643210 01246799999999753
Q ss_pred --ceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCC
Q 036471 382 --NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR-ILHFDIKP 458 (516)
Q Consensus 382 --nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-ivH~dlkp 458 (516)
.+.++++. ...++||||+++.+|...+.. ...+....+..++.|++.+|++|| ..+ |+|+||||
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp 177 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK------DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE 177 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccc------cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence 34455543 245899999999888765421 134556677899999999999999 899 99999999
Q ss_pred CcEEECCCCcEEEeecCCcccccCC
Q 036471 459 HNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 459 ~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+||+++ ++.++|+|||.+......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCc
Confidence 999999 889999999999865544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=158.07 Aligned_cols=141 Identities=14% Similarity=0.138 Sum_probs=112.9
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchh----------HHHHHHHhhccCCcceeeEEEEEe
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE----------FINEVASISRTSHVNVVTLLGFCF 391 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~nIv~l~~~~~ 391 (516)
++.+..++..+.++.|+||.||++.. ++..+|+|.+.......+. +.+|+..+.+++|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 33344445567899999999999766 6778999999754322222 578999999999999999998866
Q ss_pred ec--------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 392 EG--------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 392 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
.. +..+|+|||++|.+|.++.. +++ ....+++.+|..+| ..|++|||+||+||++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili 168 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIV 168 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEE
Confidence 43 35789999999999988741 222 24568999999999 9999999999999999
Q ss_pred CCCCcEEEeecCCccccc
Q 036471 464 DEDFCPKISDFGLAKICN 481 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~ 481 (516)
++++ ++|+|||......
T Consensus 169 ~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred eCCC-EEEEECCCccccc
Confidence 9998 9999999887654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=167.99 Aligned_cols=180 Identities=24% Similarity=0.303 Sum_probs=139.8
Q ss_pred HHhhhhhcccCCcEEEEEEEECCC--CEEEEEEeecCC-CCchhHHHHHHHhhccCC----cceeeEEEEE-eecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDG--SNVAVKVLNDSK-GNGEEFINEVASISRTSH----VNVVTLLGFC-FEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l 398 (516)
.+.+.++||+|+||.||.+..... ..+|+|...... .....+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 455668899999999999997653 478888876542 222378888998888863 5889999988 47778899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-----CcEEEee
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-----FCPKISD 473 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~D 473 (516)
||+.. |.+|.++..... ...++..++++|+.|++.+|++|| +.|++||||||.|+++... ..+.|.|
T Consensus 99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99988 779999876542 468999999999999999999999 9999999999999999754 4699999
Q ss_pred cCCcc--cccCCCcc----e-e-eccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAK--ICNRKESI----I-S-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++ ........ . . ....+||.+|.++.+..+ .+.+.+.|
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DD 219 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDD 219 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchh
Confidence 99998 33222110 1 1 134669999999998855 45555544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-18 Score=156.78 Aligned_cols=134 Identities=22% Similarity=0.304 Sum_probs=113.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.||+|++|.||+|.. +|..|++|+....... ...+.+|++++..+.|++|+....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 7788999986532211 13577899999999999988877777778888999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
++|++|.+++... .+ .+..++.+++.+|.+|| ..+++|+|++|+|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998542 12 78899999999999999 99999999999999999 789999999998754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=153.02 Aligned_cols=169 Identities=25% Similarity=0.362 Sum_probs=134.6
Q ss_pred HHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhccCC-cceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.++||.|+||.+|.|.. .+|+.||+|.-+..... .++..|..+...+++ ..|..+.-+..+...-.+|||..
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 455668899999999999985 46999999987544332 567788888888864 56777777888888999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~ 481 (516)
|-+|+++..-.. ..++..+++-++-|++.-++|+| .++++||||||+|+|+.- ..++.|+|||+|+...
T Consensus 94 GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 94 GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 779999986543 67899999999999999999999 999999999999999953 3479999999998775
Q ss_pred CCCcc--e---eeccCCCCcccccccccc
Q 036471 482 RKESI--I---SMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 482 ~~~~~--~---~~~~~~gt~~y~aPE~l~ 505 (516)
...+. + +.....||.+|.+--...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~ 194 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHL 194 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhh
Confidence 44322 1 123456899998765543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.4e-18 Score=151.61 Aligned_cols=130 Identities=21% Similarity=0.168 Sum_probs=106.8
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCch-----hHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE-----EFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..|++|+||+|+.+.. .+.+++.+.+.......+ .+.+|+++|++++ |+++++++++ +..+++|||++|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4699999999997776 788899888876554333 5789999999995 5889999886 456999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEECCCCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDI-KPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
.+|.+.+.. ....++.|++++|+++| ..||+|||| ||+|||+++++.++|+|||+|.....
T Consensus 83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 83 AAMYQRPPR-------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ccHHhhhhh-------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 998654310 11357789999999999 999999999 79999999999999999999985543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=155.68 Aligned_cols=170 Identities=23% Similarity=0.358 Sum_probs=138.7
Q ss_pred HHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
-+++.++||.|+||.++.|+. -++++||||.-.. +....++..|....+.| ..+.|..++-+-.++..-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 345678999999999999984 4799999997643 33446778888888877 5789999998888888889999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-----CcEEEeecCCccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-----FCPKISDFGLAKI 479 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~Dfg~a~~ 479 (516)
|-+|+|+..-.. ..++..++..+|.|++.-++|+| ++.+|.|||||+|+||... ..+.|+|||+|+.
T Consensus 107 GPSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 GPSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred CcCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 779999886543 67999999999999999999999 9999999999999999643 3699999999988
Q ss_pred ccCCCcce-----eeccCCCCccccccccccc
Q 036471 480 CNRKESII-----SMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 480 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~ 506 (516)
+....+.. +.....||.+||+=-..++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG 210 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG 210 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecccc
Confidence 86654321 1234569999998766544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=153.47 Aligned_cols=136 Identities=21% Similarity=0.207 Sum_probs=107.7
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC-----------------------chhHHHHHHHhhccCCcc--
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-----------------------GEEFINEVASISRTSHVN-- 382 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~n-- 382 (516)
+.+.+.|++|++|.||++...+|+.||||++...... .....+|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4456789999999999999888999999987543210 113567888888887774
Q ss_pred eeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 383 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
++..++ ....++||||+++++|.++.. ......++.+++.++.++| ..+|+|+||||+||+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil 157 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL 157 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence 444443 345689999999999876542 0335678899999999999 899999999999999
Q ss_pred ECCCCcEEEeecCCcccccC
Q 036471 463 LDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=152.11 Aligned_cols=130 Identities=23% Similarity=0.343 Sum_probs=107.0
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCC-C--------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKG-N--------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
||+|++|.||+|.+ ++..|++|....... . ...+.+|++++..++|+++.....+....+..++||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 89999999999995 678899998643211 1 2456789999999998876655555666777899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|++|.+++.... . .++.+++.+|.+|| ..+++|+|++|+||+++ ++.++++|||.+....
T Consensus 81 g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 81 GKPLKDVIEEGN------D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CccHHHHHhhcH------H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999874321 0 78999999999999 99999999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.5e-17 Score=170.25 Aligned_cols=133 Identities=18% Similarity=0.288 Sum_probs=109.2
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEE-eecCCC--------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKV-LNDSKG--------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.||+|+||.||++.+.... +++|+ +.+... ..+.+.+|++++.+++|++++....+..+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 467999999999999875443 44443 222111 12467899999999999999988888777778899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++. ....++.+++++|.+|| +.+++||||||+|||+ .++.++|+|||+++...
T Consensus 417 ~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 417 YIGGKDLKDVLE--------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred ecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999999873 34678999999999999 9999999999999999 67799999999998754
Q ss_pred C
Q 036471 482 R 482 (516)
Q Consensus 482 ~ 482 (516)
.
T Consensus 479 ~ 479 (535)
T PRK09605 479 L 479 (535)
T ss_pred c
Confidence 3
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-16 Score=157.10 Aligned_cols=169 Identities=38% Similarity=0.541 Sum_probs=141.4
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC----CchhHHHHHHHhhccCCc-ceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG----NGEEFINEVASISRTSHV-NVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||.|+|+.||++... ..+++|.+..... ....+.+|+.++..+.|+ +|+++.+.+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4467899999999999986 8899999865332 357899999999999988 79999999977777899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 483 (516)
++++.+++...... ..++......++.|++.++.|+| ..+++|||+||+||+++..+ .+++.|||.++.....
T Consensus 82 ~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 82 GGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999777543210 36899999999999999999999 89999999999999999988 7999999999866554
Q ss_pred Ccce----eeccCCCCccccccccccc
Q 036471 484 ESII----SMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 484 ~~~~----~~~~~~gt~~y~aPE~l~~ 506 (516)
.... ......|+..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred CccccccccccccccccccCCHHHhcC
Confidence 3321 2355678999999999854
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-17 Score=176.82 Aligned_cols=181 Identities=23% Similarity=0.246 Sum_probs=139.8
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeEEE
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv 399 (516)
+...++.+.+.||+|+||+||+|...+|+.||+|+-+..... +|.-=.+++.||+ -+.|..+...+.-.+.-+||
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 334445566789999999999999988999999997654332 2222223334444 23455555555667778899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-------CCCcEEEe
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-------EDFCPKIS 472 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-------~~~~~kl~ 472 (516)
+||.+.|+|.++++. .+.++|..+..++.|++..+++|| ..+|||+||||+|.||. ....++|+
T Consensus 773 ~ey~~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeccccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999973 367999999999999999999999 99999999999999994 23479999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||.+..+..-..........+|-.+--+|+..+ .+|++..|
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--rpWtYq~D 885 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--RPWTYQID 885 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcC--CCCchhhh
Confidence 9999977654433334466778999999999854 79999887
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=144.43 Aligned_cols=136 Identities=23% Similarity=0.251 Sum_probs=98.7
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCc---hhH----------------------HHHHHHhhccCCcc--e
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG---EEF----------------------INEVASISRTSHVN--V 383 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--I 383 (516)
.+.||+|+||.||+|...+++.||||+++...... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35699999999999998889999999986532211 111 24555555554332 4
Q ss_pred eeEEEEEeecCeeEEEEEecCCCCHHH-HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcE
Q 036471 384 VTLLGFCFEGRRRALIYEFVSNGSLEK-FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNI 461 (516)
Q Consensus 384 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NI 461 (516)
.+.++. ...++||||++++++.. .+... ... ..+..++.+++.++.++| . .+|+|+||||+||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI 146 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence 444443 34689999999955432 12111 011 567889999999999999 7 9999999999999
Q ss_pred EECCCCcEEEeecCCcccccC
Q 036471 462 LLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++ ++.++|+|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-16 Score=136.55 Aligned_cols=134 Identities=24% Similarity=0.201 Sum_probs=112.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCC--cceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSH--VNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
+.|++|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++.+....+..+++|||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 469999999999999854 7899999865443 5678999999999976 58999999888888899999999887665
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
.+ +......++.+++++|++||.....+++|+|++|+||++++++.++++|||.+...
T Consensus 82 ~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 32 45667788999999999999433357999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-16 Score=153.48 Aligned_cols=146 Identities=25% Similarity=0.373 Sum_probs=121.1
Q ss_pred CCccccHHHHHH-HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-----C---cce
Q 036471 314 APRRYSYADIKK-MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-----H---VNV 383 (516)
Q Consensus 314 ~~~~~~~~el~~-~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~nI 383 (516)
+.+.....|.-. .+|...++||-|-|++||++.+. +.+.||+|+.+....-.+..+.|+.+|++++ | ..|
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 344455556555 77777899999999999999975 4678999999877666688899999999983 2 469
Q ss_pred eeEEEEEee----cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 036471 384 VTLLGFCFE----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459 (516)
Q Consensus 384 v~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~ 459 (516)
|++++.|.. +.++.+|+|++ |.+|..+|.... -+.++...+..|++||+.||.|||. ..||||-||||+
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~----YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPE 217 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN----YRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPE 217 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC----CCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcc
Confidence 999999985 34788999999 668999997753 3679999999999999999999997 679999999999
Q ss_pred cEEECCC
Q 036471 460 NILLDED 466 (516)
Q Consensus 460 NIll~~~ 466 (516)
|||+..+
T Consensus 218 NvLl~~~ 224 (590)
T KOG1290|consen 218 NVLLCST 224 (590)
T ss_pred eeeeecc
Confidence 9999543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.6e-17 Score=178.41 Aligned_cols=129 Identities=17% Similarity=0.142 Sum_probs=93.3
Q ss_pred ccCC-cceeeEEEEE-------eecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 036471 377 RTSH-VNVVTLLGFC-------FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448 (516)
Q Consensus 377 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~ 448 (516)
+++| +||+++++.+ .+....++++||+ +++|.++|... ...+++.+++.++.||++||+||| +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAH---S 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHH---h
Confidence 4455 5788888877 2334567788987 55999999643 256999999999999999999999 9
Q ss_pred CCeeeCCCCCCcEEECCCC-------------------cEEEeecCCcccccCCCc--------------ceeeccCCCC
Q 036471 449 TRILHFDIKPHNILLDEDF-------------------CPKISDFGLAKICNRKES--------------IISMTGARGT 495 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt 495 (516)
++|+||||||+||||+..+ .+||+|||+++....... ........||
T Consensus 99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999996544 455566666543211000 0000113578
Q ss_pred ccccccccccccccccccCCC
Q 036471 496 VGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 496 ~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.|||||++.+ ..++.++|
T Consensus 179 ~~Y~APE~~~~--~~~~~~sD 197 (793)
T PLN00181 179 SWYTSPEEDNG--SSSNCASD 197 (793)
T ss_pred cceEChhhhcc--CCCCchhh
Confidence 89999999965 67888887
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=142.57 Aligned_cols=135 Identities=18% Similarity=0.209 Sum_probs=105.5
Q ss_pred hhcc-cCCcEEEEEEEECCCCEEEEEEeecC--------------CCCchhHHHHHHHhhccCCcce--eeEEEEEeecC
Q 036471 332 YKLG-QGGYGSVYKGKLIDGSNVAVKVLNDS--------------KGNGEEFINEVASISRTSHVNV--VTLLGFCFEGR 394 (516)
Q Consensus 332 ~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~ 394 (516)
..|| .|+.|+||.+.. ++..++||.+... ......+.+|++++.+++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 899999999988 4788999887431 1223467889999999998875 67777644322
Q ss_pred ----eeEEEEEecCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcE
Q 036471 395 ----RRALIYEFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 469 (516)
Q Consensus 395 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 469 (516)
..++|||++++ .+|.+++.. ..+++. .+.+++.+|.+|| ..||+|+||||+|||++.++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCE
Confidence 23599999997 699998853 234443 3568999999999 9999999999999999999999
Q ss_pred EEeecCCccccc
Q 036471 470 KISDFGLAKICN 481 (516)
Q Consensus 470 kl~Dfg~a~~~~ 481 (516)
+|+|||.+....
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-15 Score=158.73 Aligned_cols=171 Identities=29% Similarity=0.292 Sum_probs=131.0
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeec---CCCCc----hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLND---SKGNG----EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
...+|.|++|.|+..... .....+.|.... ..... ..+..|+-+-..+.|+|++..+....+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 356899999977777543 333344443321 11111 1255677777889999998877777766666666999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++ +|..++.+. ..+...++..+++|++.|++||| ..||.|||+|++|++++.+|.+||+|||.+.....
T Consensus 403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 999998543 46888999999999999999999 99999999999999999999999999999977655
Q ss_pred CCcc--eeeccCCCCcccccccccccccccccc
Q 036471 483 KESI--ISMTGARGTVGYIAPEVFCRNIGEVSY 513 (516)
Q Consensus 483 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~ 513 (516)
.... ....+..|+..|+|||++.+ .+|.+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydp 503 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTG--KEYDP 503 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccc--cccCc
Confidence 4433 44567889999999999965 56654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=140.21 Aligned_cols=140 Identities=24% Similarity=0.270 Sum_probs=100.0
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC-----------------------------------------chhHHH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-----------------------------------------GEEFIN 370 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~~ 370 (516)
+.||.|++|+||+|++++|+.||||+.+..... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 459999999999999999999999998543100 013445
Q ss_pred HHHHhhccC----CcceeeEEEEEe-ecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 036471 371 EVASISRTS----HVNVVTLLGFCF-EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR-GLEYLH 444 (516)
Q Consensus 371 E~~~l~~l~----h~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-aL~~LH 444 (516)
|+..+.++. |.+-+.+-.++. ..+..+|||||++|++|.++..... ... ....++.+++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCC---CHHHHHHHHHHHHHHHHH
Confidence 555555542 322233323332 2456799999999999998875321 112 23456666665 477889
Q ss_pred cCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 445 ~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
..|++|+|+||.||++++++.++|+|||++..+..
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 89999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.5e-15 Score=134.00 Aligned_cols=164 Identities=24% Similarity=0.452 Sum_probs=130.1
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeec---CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++..+|...-.|+.|+|++ .|..+++|+++- +....++|..|.-.|+-+.||||+.++|.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4556788999999999999 566777787753 334457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe--ecCCcccccCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS--DFGLAKICNRK 483 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~--Dfg~a~~~~~~ 483 (516)
|+|...|+... .-..+..++.+++.++++|++|||+ .+.-|.---|..+.++||++.+.+|. |-.++..
T Consensus 272 gslynvlhe~t----~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred hHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999998763 3567888999999999999999994 23335556789999999999987774 3222211
Q ss_pred CcceeeccCCCCcccccccccccc
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~ 507 (516)
..+..-.|.||+||.+.+.
T Consensus 343 -----e~gr~y~pawmspealqrk 361 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRK 361 (448)
T ss_pred -----ccccccCcccCCHHHHhcC
Confidence 1222337889999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.2e-15 Score=148.40 Aligned_cols=157 Identities=27% Similarity=0.293 Sum_probs=130.6
Q ss_pred cccCCcEEEEEEEE----CCCCEEEEEEeecCC---CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKL----IDGSNVAVKVLNDSK---GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+|+|.+|.|++++. ..+..+|+|.+++.. ........|..++...+ ||.+|++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998753 236778888875421 11124566778888886 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|.|...+.. ...+++.....+...++-+++++| ..+|+|||+|++||+++.+|++|+.|||+++..-..+.
T Consensus 82 g~lft~l~~------~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 82 GDLFTRLSK------EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred chhhhcccc------CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999887753 356778888888999999999999 99999999999999999999999999999987654432
Q ss_pred ceeeccCCCCcccccccccc
Q 036471 486 IISMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~ 505 (516)
..||..|||||++.
T Consensus 153 ------~cgt~eymApEI~~ 166 (612)
T KOG0603|consen 153 ------ACGTYEYRAPEIIN 166 (612)
T ss_pred ------cccchhhhhhHhhh
Confidence 27899999999994
|
|
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.8e-13 Score=109.03 Aligned_cols=82 Identities=27% Similarity=0.410 Sum_probs=64.0
Q ss_pred ecCCCCCC--ceEecCCCCCCCCCCCCCc-eEEeCCCCC------CChhhHHHHhcCceEEEEe-ccccccccccCCCcc
Q 036471 147 FTCNHNSF--IYYNHPDDALPRIVPPNCS-LIQLPVNKT------RKSDDLFNMLTSVFSLQVE-IPWFCWECGWRGGQC 216 (516)
Q Consensus 147 ~~C~~~~~--~~~~~~~~~~~~~~~~~C~-~~~vp~~~~------~~~~~~~~~l~~gf~l~w~-~~~~C~~C~~sgg~C 216 (516)
++|.++++ .+|++... ...+..|+ .+.|||... ....+|.++|++||+|+|. .+.+|.+|+.|||+|
T Consensus 1 ~~C~~~~~~~~~~~v~~~---~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~C 77 (94)
T PF14380_consen 1 INCSINSGNSVSYFVFRS---SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRC 77 (94)
T ss_pred CccccCCCCceeEEEeCC---cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEe
Confidence 46876542 33433322 44778999 688999772 2568899999999999999 567899999999999
Q ss_pred CCCCC-Cceeeccccc
Q 036471 217 RSDSE-GKFQCAESRE 231 (516)
Q Consensus 217 ~~~~~-~~~~C~~~~~ 231 (516)
||+.+ ..|.|+|+++
T Consensus 78 gy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 78 GYDSNSEQFTCFCSDG 93 (94)
T ss_pred CCCCCCceEEEECCCC
Confidence 99988 7999999644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.3e-13 Score=137.24 Aligned_cols=142 Identities=18% Similarity=0.214 Sum_probs=95.3
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecCCC---------------------------C--------------chhHH
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG---------------------------N--------------GEEFI 369 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~---------------------------~--------------~~~~~ 369 (516)
+.||+|++|+||+|++++ |+.||||+.++... . +-++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 99999999864310 0 01244
Q ss_pred HHHHHhhccC----CcceeeEEEEEee-cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 036471 370 NEVASISRTS----HVNVVTLLGFCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444 (516)
Q Consensus 370 ~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH 444 (516)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-...........+.+..+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4555555442 4444444444443 56778999999999998753211110111123333333344443 3
Q ss_pred cCCCCCeeeCCCCCCcEEECCCC----cEEEeecCCcccccCC
Q 036471 445 LGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKICNRK 483 (516)
Q Consensus 445 ~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~~~ 483 (516)
..|++|+|+||.||+++.++ .+++.|||++..+...
T Consensus 278 ---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 67999999999999999988 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=117.69 Aligned_cols=128 Identities=23% Similarity=0.169 Sum_probs=96.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
+.++.|..+.||+++. .++.+++|...........+.+|+..+..+.+.++ .+++... ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 3578899999999987 47889999986554334457889999998865554 3455443 334689999999987754
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR-----ILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
.. .....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++||+.+..-
T Consensus 81 ~~--------------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 81 ED--------------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc--------------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 20 011345678999999999 666 59999999999999 668999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-12 Score=118.00 Aligned_cols=86 Identities=27% Similarity=0.264 Sum_probs=72.9
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++++.+. ..+++.+++.++.|++.||+||| +.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-
Confidence 68999997542 56999999999999999999999 666 999999999999999 99987654322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..|++.|||||++.+ +.++.++|
T Consensus 64 ------~~g~~~y~aPE~~~~--~~~~~~~D 86 (176)
T smart00750 64 ------SRVDPYFMAPEVIQG--QSYTEKAD 86 (176)
T ss_pred ------CCCcccccChHHhcC--CCCcchhh
Confidence 257899999999955 67888887
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-11 Score=110.32 Aligned_cols=135 Identities=15% Similarity=0.162 Sum_probs=99.1
Q ss_pred hhcccCCcEEEEEEEECC-------CCEEEEEEeecCC----------------------CC-chhHH----HHHHHhhc
Q 036471 332 YKLGQGGYGSVYKGKLID-------GSNVAVKVLNDSK----------------------GN-GEEFI----NEVASISR 377 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~-~~~~~----~E~~~l~~ 377 (516)
..|+.|.-+.||.|...+ +..+|||+.+.+. .+ .+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998643 4799999874210 00 11222 78888998
Q ss_pred cCC--cceeeEEEEEeecCeeEEEEEecCCCCHHH-HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeee
Q 036471 378 TSH--VNVVTLLGFCFEGRRRALIYEFVSNGSLEK-FIYRNSSSIENHKLTWETLLQIAVGIARGLEYL-HLGCSTRILH 453 (516)
Q Consensus 378 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~L-H~~~~~~ivH 453 (516)
+.. -++..++++ ...+|||||+.+..+.. .+++ ..++.++...+..+++.+|..| | ..+++|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 853 466677764 56789999997754422 2221 2355566778889999999999 8 899999
Q ss_pred CCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 454 FDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 454 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
+||++.||+++ ++.++|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4689999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-13 Score=145.97 Aligned_cols=169 Identities=21% Similarity=0.224 Sum_probs=127.6
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecC--CCCchhHHHHHHH--hhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS--KGNGEEFINEVAS--ISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
..+.+.+|++.|=+|.++++.+|. |+||++-+. ....+.+.++++- ...++|||.+.+..+-+.....|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345578999999999999997777 999998543 3344555554443 44458999999888877777888998998
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc--c
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--N 481 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~--~ 481 (516)
.+ +|.|.|.. +.-+..-+..-|+.|++.||.-.| ..||+|||||.+||||+.-..+.|+||..-+.. .
T Consensus 104 kh-nLyDRlST------RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 104 KH-NLYDRLST------RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred hh-hhhhhhcc------chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 65 89888843 355777788899999999999999 999999999999999999999999999876443 2
Q ss_pred CCCcc---eeeccCCCCcccccccccccc
Q 036471 482 RKESI---ISMTGARGTVGYIAPEVFCRN 507 (516)
Q Consensus 482 ~~~~~---~~~~~~~gt~~y~aPE~l~~~ 507 (516)
.++.. ......+.-.-|+|||-+...
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhcc
Confidence 22111 111222334569999998653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-11 Score=118.51 Aligned_cols=165 Identities=24% Similarity=0.346 Sum_probs=102.9
Q ss_pred hhhcccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCC----------cceeeEEEEEe----
Q 036471 331 KYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSH----------VNVVTLLGFCF---- 391 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~---- 391 (516)
.+.||.|+++.||.+.+.+ ++++|+|+..... ...+++.+|......+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 3569999999999999875 8999999985322 233566777655555322 22222222221
Q ss_pred -----ec---C-----eeEEEEEecCCCCHHHHHh---hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q 036471 392 -----EG---R-----RRALIYEFVSNGSLEKFIY---RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFD 455 (516)
Q Consensus 392 -----~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~d 455 (516)
.. . +.+++|+-+ .++|.+++. .... ....+....++.+..|+++.+++|| ..|++|+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~--~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ--THSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc--ccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 11 1 235677777 458888754 2221 1123444556778899999999999 99999999
Q ss_pred CCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 456 IKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 456 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
|+|+|++++++|.++|+||+.....+.... . ...+..|.+||....
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~ 216 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESC 216 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhh
Confidence 999999999999999999987754433211 1 334678999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.2e-11 Score=104.01 Aligned_cols=132 Identities=18% Similarity=0.264 Sum_probs=102.5
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEe-ecCCCC--------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVL-NDSKGN--------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+++|+-+.++.+.+. |.++++|.= ++.... .+...+|+.++.+++--.|....-+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4789999999999874 444666643 322211 245678999999987666666666677888889999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+|..|.+.+... ...++..+-.-+.-|| ..||+|+||.++||++..+. +.++|||++..-..
T Consensus 82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 82 EGELLKDALEEA-------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred CChhHHHHHHhc-------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 999999998542 2567788888899999 99999999999999998764 99999999975433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.3e-12 Score=120.59 Aligned_cols=116 Identities=22% Similarity=0.340 Sum_probs=87.7
Q ss_pred CCcceeeEEEEEeec---------------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHH
Q 036471 379 SHVNVVTLLGFCFEG---------------------------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQ 431 (516)
Q Consensus 379 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 431 (516)
+|||||++.++|.++ ..+|+||..++. +|.+++..+ ..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence 599999999877542 356789988865 999999643 466677888
Q ss_pred HHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE--CCCC--cEEEeecCCcccccCCCccee----eccCCCCcccccccc
Q 036471 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILL--DEDF--CPKISDFGLAKICNRKESIIS----MTGARGTVGYIAPEV 503 (516)
Q Consensus 432 i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~~~~----~~~~~gt~~y~aPE~ 503 (516)
|+.|+++|+.||| .+||.|||+|.+|||| |+|+ .+.|+|||.+---....-... .-..-|...-||||+
T Consensus 346 ~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 9999999999999 9999999999999999 4554 678999998743322111111 122347788999999
Q ss_pred cc
Q 036471 504 FC 505 (516)
Q Consensus 504 l~ 505 (516)
..
T Consensus 423 ~t 424 (598)
T KOG4158|consen 423 AT 424 (598)
T ss_pred hh
Confidence 73
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.1e-11 Score=110.72 Aligned_cols=141 Identities=19% Similarity=0.197 Sum_probs=109.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCC--CchhHHHHHHHhhccCC--cceeeEEEEEeec---CeeEEEEEecC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG--NGEEFINEVASISRTSH--VNVVTLLGFCFEG---RRRALIYEFVS 404 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~---~~~~lv~e~~~ 404 (516)
+.|+.|..+.+|++...+|+.+++|....... ...++.+|++++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35889999999999987778999999865432 45678999999999975 4467777776653 36689999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC------------------------------------- 447 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------- 447 (516)
|.++.+.+.. ..+++.+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9888765421 34677778888888888888888421
Q ss_pred ----------------CCCeeeCCCCCCcEEECC--CCcEEEeecCCccc
Q 036471 448 ----------------STRILHFDIKPHNILLDE--DFCPKISDFGLAKI 479 (516)
Q Consensus 448 ----------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~ 479 (516)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-10 Score=100.14 Aligned_cols=142 Identities=21% Similarity=0.299 Sum_probs=108.2
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEe-ecCC--------CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVL-NDSK--------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
..|.||+-+.|+++.+ .|+..+||.- .+.. -..++..+|+..+.++.--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4588999999999998 6777777653 2211 1225678899999988766666555567788888899999
Q ss_pred cCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEeecCCcc
Q 036471 403 VSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAK 478 (516)
Q Consensus 403 ~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~ 478 (516)
+++ -++.+++...-. .....+....++.+|-+.+.-|| ..+|+|+||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 977 478888876532 22333444788999999999999 99999999999999997655 46899999986
Q ss_pred ccc
Q 036471 479 ICN 481 (516)
Q Consensus 479 ~~~ 481 (516)
.-.
T Consensus 165 ~s~ 167 (229)
T KOG3087|consen 165 VSR 167 (229)
T ss_pred ccc
Confidence 543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-11 Score=124.74 Aligned_cols=124 Identities=27% Similarity=0.477 Sum_probs=102.5
Q ss_pred hhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-ee
Q 036471 375 ISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI-LH 453 (516)
Q Consensus 375 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~i-vH 453 (516)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+... ...+++.....+.++++.||+||| ...| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-----~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-----DIKLDYFFILSFIRDISKGLAYLH---NSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-----ccCccHHHHHHHHHHHHHHHHHHh---cCcceee
Confidence 45689999999999999999999999999999999999763 367899999999999999999999 4444 99
Q ss_pred CCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 454 FDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 454 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
+.+++.|.++|..+.+||+|||+.................-..-|.|||.+..
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 99999999999999999999999877643111111122234567999999965
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-11 Score=129.66 Aligned_cols=138 Identities=28% Similarity=0.387 Sum_probs=93.6
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
+.|..|++|.||.++++. .+++|+|+-++. . +.+. ++.....|.+| |+-.+
T Consensus 89 klisngAygavylvrh~~trqrfa~kiNkq~-l----ilRn--ilt~a~npfvv---------------------gDc~t 140 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKINKQN-L----ILRN--ILTFAGNPFVV---------------------GDCAT 140 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcccccc-h----hhhc--cccccCCccee---------------------chhhh
Confidence 578999999999998874 567888543321 1 1111 33333444443 45555
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC------
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE------ 484 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------ 484 (516)
.++.. ++++.+ ++.+++||| +.+|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 141 llk~~------g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 141 LLKNI------GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hcccC------CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 55322 334433 278999999 9999999999999999999999999999986542110
Q ss_pred ------c-ceeeccCCCCccccccccccccccccccCCC
Q 036471 485 ------S-IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ------~-~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+.||+.|+|||++.++ .|+..+|
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvd 240 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVD 240 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhh--ccCCCcc
Confidence 0 0112346799999999999874 5665555
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1e-11 Score=123.88 Aligned_cols=111 Identities=30% Similarity=0.433 Sum_probs=93.3
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..||.|+++...+|.++|.+++ .....++...+.++.|++.|++| ++.+|+|+||.||+...+..+||+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~---~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR---TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC---cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 5789999999999999997654 33567888899999999999998 78999999999999999999999999
Q ss_pred CCcccccCCC----cceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKE----SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+........ .....+...||..||+||.+.+ ..|+.|+|
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvd 444 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVD 444 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcc
Confidence 9987665554 1122356779999999999976 58888887
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.9e-10 Score=99.43 Aligned_cols=125 Identities=26% Similarity=0.309 Sum_probs=84.5
Q ss_pred EEEEEEECCCCEEEEEEeecCC--------------C--------Cc-----hhHHHHHHHhhccCCc--ceeeEEEEEe
Q 036471 341 SVYKGKLIDGSNVAVKVLNDSK--------------G--------NG-----EEFINEVASISRTSHV--NVVTLLGFCF 391 (516)
Q Consensus 341 ~V~~~~~~~~~~vavK~~~~~~--------------~--------~~-----~~~~~E~~~l~~l~h~--nIv~l~~~~~ 391 (516)
.||.|...+|..+|+|+.+... . .. ....+|.+.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999874210 0 00 2346799999999765 56677654
Q ss_pred ecCeeEEEEEecC--CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeeCCCCCCcEEECCCCc
Q 036471 392 EGRRRALIYEFVS--NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY-LHLGCSTRILHFDIKPHNILLDEDFC 468 (516)
Q Consensus 392 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~-LH~~~~~~ivH~dlkp~NIll~~~~~ 468 (516)
....|||||++ |..+..+... .++.+....++.+++..+.. +| ..||+|+||.+.||+++++ .
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~--------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV--------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC--------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-C
T ss_pred --eCCEEEEEecCCCccchhhHHhc--------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-e
Confidence 24579999999 6666654432 12234556777788885555 57 8999999999999999988 9
Q ss_pred EEEeecCCccccc
Q 036471 469 PKISDFGLAKICN 481 (516)
Q Consensus 469 ~kl~Dfg~a~~~~ 481 (516)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=129.45 Aligned_cols=172 Identities=27% Similarity=0.316 Sum_probs=135.4
Q ss_pred hhhhhcccCCcEEEEEEEECC--CCEEEEEEeecCC---CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLID--GSNVAVKVLNDSK---GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
++.+.||+|+++.|-...... ...+|+|.+.... ...+....|..+-..+. |+|++++++...+.+..++++||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 344569999999998887643 4456667665433 22234445777777776 99999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 481 (516)
..++++.+.+... .....+......++.|+..++.|+|. ..++.|+|+||+|.+++..+ .+|++|||+|....
T Consensus 103 s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 103 SDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccccccccccC----CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999998887311 11256677788999999999999995 68999999999999999999 99999999998877
Q ss_pred C-CCcceeeccCCC-Cccccccccccc
Q 036471 482 R-KESIISMTGARG-TVGYIAPEVFCR 506 (516)
Q Consensus 482 ~-~~~~~~~~~~~g-t~~y~aPE~l~~ 506 (516)
. ...........| ++.|+|||...+
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccc
Confidence 6 444444455667 999999999866
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-09 Score=101.92 Aligned_cols=139 Identities=19% Similarity=0.091 Sum_probs=101.2
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCC------------CCchhHHHHHHHhhccCCcce--eeEEEEEee-----c
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSK------------GNGEEFINEVASISRTSHVNV--VTLLGFCFE-----G 393 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~-----~ 393 (516)
.+.......|.+..+ +|+.+.||...... .....+.+|...+.++...+| +.++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445677766 67899999764322 111247889998888854443 344555543 2
Q ss_pred CeeEEEEEecCCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-------
Q 036471 394 RRRALIYEFVSNG-SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE------- 465 (516)
Q Consensus 394 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~------- 465 (516)
...+||||++++- +|.+++.... ....+......++.+++..+.-|| ..||+|+|++++|||++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCC
Confidence 3578999999886 8999985431 134556778899999999999999 999999999999999975
Q ss_pred CCcEEEeecCCccc
Q 036471 466 DFCPKISDFGLAKI 479 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~ 479 (516)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.8e-09 Score=98.87 Aligned_cols=135 Identities=23% Similarity=0.225 Sum_probs=100.2
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCC-----------------------CCchhHHHHHHHhhccCCc--c
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-----------------------GNGEEFINEVASISRTSHV--N 382 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~--n 382 (516)
+.+..+||-|.-+.||.|....|.++|||.-+... .......+|.+.|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999999999999999643110 0113456799999998655 6
Q ss_pred eeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 383 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
+.+.+++ +...+|||+++|..|... +++.+..-.++..|++-+.-+- ..||||+|+.+-||+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL-----------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc-----------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEE
Confidence 7777664 677899999999766543 1233444455555555555555 689999999999999
Q ss_pred ECCCCcEEEeecCCcccc
Q 036471 463 LDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~ 480 (516)
+++||.++++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999766543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-09 Score=110.30 Aligned_cols=184 Identities=23% Similarity=0.230 Sum_probs=140.8
Q ss_pred HHHHHHHHHhhhhhccc--CCcEEEEEEEE---CCCCEEEEEEeec---CCCCchhHHHHHHHhhcc-CCcceeeEEEEE
Q 036471 320 YADIKKMTNSFKYKLGQ--GGYGSVYKGKL---IDGSNVAVKVLND---SKGNGEEFINEVASISRT-SHVNVVTLLGFC 390 (516)
Q Consensus 320 ~~el~~~~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 390 (516)
..+..+......+.+|. |.+|.+|.+.. .++..+|+|.-+. .......=.+|+...+++ .|+|.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 44555555556677999 99999999986 3578889987432 122334445677777777 599999999999
Q ss_pred eecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeeCCCCCCcEEECCC
Q 036471 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR----GLEYLHLGCSTRILHFDIKPHNILLDED 466 (516)
Q Consensus 391 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----aL~~LH~~~~~~ivH~dlkp~NIll~~~ 466 (516)
+..+..++-+|++. .+|.++.+... ..++...++.+..+..+ ||.++| ..+++|-|+||.||++..+
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSD 258 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccc
Confidence 99999999999985 68888876542 44777888888888888 999999 9999999999999999999
Q ss_pred -CcEEEeecCCcccccCCCccee---eccCCCCccccccccccccccccccCC
Q 036471 467 -FCPKISDFGLAKICNRKESIIS---MTGARGTVGYIAPEVFCRNIGEVSYKS 515 (516)
Q Consensus 467 -~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~s~~s 515 (516)
...+++|||+...+........ .....|...|++||.+. +.++.++
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---~l~~~~~ 308 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---GLATFAS 308 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---cccchHh
Confidence 8999999999988876652221 12235788999999983 3444444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=8.1e-09 Score=106.32 Aligned_cols=122 Identities=22% Similarity=0.222 Sum_probs=102.6
Q ss_pred EECCCCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCC
Q 036471 346 KLIDGSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL 424 (516)
Q Consensus 346 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l 424 (516)
+..++.+|.|...+.... ......+.+..|+.++||||++++..++.++..|||+|-+. .|..++++ +
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------h
Confidence 344688999988876544 23556788889999999999999999999999999999874 68888854 3
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 425 TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 425 ~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
....+...+.||+.||.|||+ ..+++|++|.-+.|+|+..|..||++|..+...
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 356677789999999999985 789999999999999999999999999887543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.3e-09 Score=108.30 Aligned_cols=144 Identities=23% Similarity=0.253 Sum_probs=94.4
Q ss_pred hhh-hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---------------------------c--------------h
Q 036471 329 SFK-YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---------------------------G--------------E 366 (516)
Q Consensus 329 ~~~-~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~ 366 (516)
+|. +.|+.++-|+||+|++++|+.||||+.++.-.. . -
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 344 458999999999999999999999987532110 0 1
Q ss_pred hHHHHHHHhhccC-----CcceeeEEEEE-eecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 036471 367 EFINEVASISRTS-----HVNVVTLLGFC-FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440 (516)
Q Consensus 367 ~~~~E~~~l~~l~-----h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL 440 (516)
++.+|...+.+++ .+++ .+=.++ +-.+...|+|||++|..+.+...... ...+...+.....++. +
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRKELAELLVRAF--L 278 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCHHHHHHHHHHHH--H
Confidence 2334554444442 3333 222333 34677889999999999988853322 2344333322222221 1
Q ss_pred HHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 441 ~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
..+- ..|++|.|.+|.||+++.+|++.+.|||+...+...
T Consensus 279 ~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 279 RQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 1222 469999999999999999999999999999776543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-09 Score=98.83 Aligned_cols=133 Identities=21% Similarity=0.304 Sum_probs=98.0
Q ss_pred HHHHHHHhhccCCcceeeEEEEEeec-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 036471 368 FINEVASISRTSHVNVVTLLGFCFEG-----RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442 (516)
Q Consensus 368 ~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~ 442 (516)
...-..-|.++.|.|||+++.++.+. ....+++|||+.|+|..+|++.+. .+..+......+|+.||+.||.|
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhh
Confidence 33344556677899999999998754 356789999999999999988653 34678888899999999999999
Q ss_pred HhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC--cceeeccCCCCcccccccc
Q 036471 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEV 503 (516)
Q Consensus 443 LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~ 503 (516)
|| .++..|+|+++..+-|++..+|-+|++--.......... .........+-++|.|||.
T Consensus 192 Lh-s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 192 LH-SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES 253 (458)
T ss_pred hh-ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence 99 568899999999999999999988885322111110000 0001122346778999986
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=87.91 Aligned_cols=108 Identities=20% Similarity=0.205 Sum_probs=85.1
Q ss_pred chhHHHHHHHhhccCCc--ceeeEEEEEeec----CeeEEEEEecCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 036471 365 GEEFINEVASISRTSHV--NVVTLLGFCFEG----RRRALIYEFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437 (516)
Q Consensus 365 ~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~ 437 (516)
.....+|...+.++... ..++.+++.+.. ...++|+|++++ .+|.+++.... ..+......++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence 35678888888877433 345666665542 245899999987 47999986532 256677889999999
Q ss_pred HHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEeecCCccccc
Q 036471 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKICN 481 (516)
Q Consensus 438 ~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~ 481 (516)
..++-|| ..||+|+|+++.|||++.+. .+.|+||+.++...
T Consensus 129 ~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 129 RLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999 99999999999999999887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-07 Score=84.97 Aligned_cols=139 Identities=16% Similarity=0.090 Sum_probs=103.6
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeec----C---CCCchhHHHHHHHhhccCCcc--eeeEEEEEee----cCeeEEEE
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLND----S---KGNGEEFINEVASISRTSHVN--VVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~----~~~~~lv~ 400 (516)
-++||.+.|++... +|..+-+|.-.. + +.....|.+|...|.++...+ +.+++..-.. .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56799999999877 455788887641 1 334578999999999985333 4444422111 12467999
Q ss_pred EecCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--EEEeecCCc
Q 036471 401 EFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLA 477 (516)
Q Consensus 401 e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a 477 (516)
|-+++ .+|.+++.... ..+.+......++.+++.++.-|| ..|+.|+|+.+.||+++.++. ++++||.-+
T Consensus 105 e~L~g~~~L~~~l~~~~----~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 105 EDMAGFISIADWYAQHA----VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EeCCCCccHHHHHhcCC----cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 97753 58999885432 135677778899999999999999 999999999999999986666 999999877
Q ss_pred ccc
Q 036471 478 KIC 480 (516)
Q Consensus 478 ~~~ 480 (516)
+..
T Consensus 178 r~~ 180 (216)
T PRK09902 178 RRR 180 (216)
T ss_pred chh
Confidence 543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.7e-07 Score=93.84 Aligned_cols=143 Identities=19% Similarity=0.267 Sum_probs=112.8
Q ss_pred cEEEEEEEEC-CCCEEEEEEeecCCC-CchhHHHHHHHhhccCCcceeeEEEEEe----ecCeeEEEEEecCC-CCHHHH
Q 036471 339 YGSVYKGKLI-DGSNVAVKVLNDSKG-NGEEFINEVASISRTSHVNVVTLLGFCF----EGRRRALIYEFVSN-GSLEKF 411 (516)
Q Consensus 339 ~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 411 (516)
-.+.|++... ||..+++|+++-.+. .......-++.++++.|.|+|++.+++. .+..+.+||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578888754 799999999943322 2224456688999999999999999887 34578899999985 567776
Q ss_pred HhhcCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 412 IYRNSS---------SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 412 l~~~~~---------~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
-..... ...+...+++.+|.++.|+..||.++| +.|+.-+-|.+++|+++.+.+++|+.-|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543321 223467889999999999999999999 99999999999999999999999998888876655
Q ss_pred CC
Q 036471 483 KE 484 (516)
Q Consensus 483 ~~ 484 (516)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=82.02 Aligned_cols=142 Identities=17% Similarity=0.226 Sum_probs=86.2
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc--eeeEEEEEeecCeeEEEEEecCCCC-H
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN--VVTLLGFCFEGRRRALIYEFVSNGS-L 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gs-L 408 (516)
..|++|..+.||+. .+..+++|...... ......+|.+.+..+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 36999999999984 35567888876433 3456789999999886433 4677777777778889999999863 2
Q ss_pred HHHH------------------hh-cCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHhc-CCCCCeeeCCCC
Q 036471 409 EKFI------------------YR-NSSSIENHKLTWETLLQIAV----------GIAR-GLEYLHL-GCSTRILHFDIK 457 (516)
Q Consensus 409 ~~~l------------------~~-~~~~~~~~~l~~~~~~~i~~----------~i~~-aL~~LH~-~~~~~ivH~dlk 457 (516)
...+ .+ +........++.. ...+.. .+.+ ..++|.. .....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 10 0000011111100 000000 0011 1122221 123457899999
Q ss_pred CCcEEECCCCcEEEeecCCccc
Q 036471 458 PHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 458 p~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=79.28 Aligned_cols=138 Identities=24% Similarity=0.303 Sum_probs=94.8
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCc--------------------hh-----HHHHHHHhhccC--Ccceee
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG--------------------EE-----FINEVASISRTS--HVNVVT 385 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~nIv~ 385 (516)
.|.+|.-+.||+|...++..+|+|+++...... ++ ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 377899999999998889999999986422111 11 124666666663 344455
Q ss_pred EEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 386 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
.+++ ....|||||+....+ .........+..++...+..++++.+.-|-. ..++||+||..=|||+.
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~------pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGL------PAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH- 201 (268)
T ss_pred ceee----cCCeEEEEeccCCCC------CCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-
Confidence 5543 245699999965311 1111122334444677888888888888872 38999999999999999
Q ss_pred CCcEEEeecCCcccccCC
Q 036471 466 DFCPKISDFGLAKICNRK 483 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~ 483 (516)
++.+.++||+-|......
T Consensus 202 ~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CCeEEEEECccccccCCC
Confidence 779999999998766533
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.1e-06 Score=80.11 Aligned_cols=127 Identities=15% Similarity=0.166 Sum_probs=79.5
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCCCc-h---------hHHHHHHHhhccCCcc---eeeEEEEEe-----ecCe
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-E---------EFINEVASISRTSHVN---VVTLLGFCF-----EGRR 395 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~---------~~~~E~~~l~~l~h~n---Iv~l~~~~~-----~~~~ 395 (516)
+.......|.+... +|+.+++|..+...... + ...+++..+.+++... .+.++.+.+ -...
T Consensus 39 ~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~ 117 (229)
T PF06176_consen 39 FKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSS 117 (229)
T ss_pred ecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeE
Confidence 33444444444444 67888888875432211 1 1233444444443222 222222222 2345
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.+++|||++|..|.++. .+++ .++..+++++.-|| ..|++|+|.+|.|++++++ .++++||+
T Consensus 118 ~~ll~EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 118 YVLLMEYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred EEEEEEEecCeecccch----------hcCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 56899999998887653 1222 35566788899999 9999999999999999866 49999998
Q ss_pred Cccc
Q 036471 476 LAKI 479 (516)
Q Consensus 476 ~a~~ 479 (516)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7e-07 Score=92.35 Aligned_cols=142 Identities=21% Similarity=0.273 Sum_probs=92.1
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCC--------------------------------------chhHHHHHH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN--------------------------------------GEEFINEVA 373 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------------------~~~~~~E~~ 373 (516)
+.|+.-+.|+||+|++++|+.||||+-++.-.. +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 459999999999999999999999976432111 013344444
Q ss_pred Hhhc----cCCcce---eeEEEEEe-ecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036471 374 SISR----TSHVNV---VTLLGFCF-EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445 (516)
Q Consensus 374 ~l~~----l~h~nI---v~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~ 445 (516)
-..+ +.|-++ |.+=.++. -.....|+|||++|..+.++-.-. ...++...+..-+.+...-+-+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-----~~gi~~~~i~~~l~~~~~~qIf--- 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-----KRGISPHDILNKLVEAYLEQIF--- 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-----HcCCCHHHHHHHHHHHHHHHHH---
Confidence 3333 235451 11222222 245778999999998877664322 2345555544444433222222
Q ss_pred CCCCCeeeCCCCCCcEEECC----CCcEEEeecCCcccccCC
Q 036471 446 GCSTRILHFDIKPHNILLDE----DFCPKISDFGLAKICNRK 483 (516)
Q Consensus 446 ~~~~~ivH~dlkp~NIll~~----~~~~kl~Dfg~a~~~~~~ 483 (516)
..|++|.|-+|.||++++ ++.+.+.|||+...+...
T Consensus 319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 568999999999999984 678999999998776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.2e-08 Score=98.00 Aligned_cols=140 Identities=26% Similarity=0.302 Sum_probs=110.1
Q ss_pred hhhcccCCcEEEEEEEEC--CCCEEEEEEeecCCC---CchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecC
Q 036471 331 KYKLGQGGYGSVYKGKLI--DGSNVAVKVLNDSKG---NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
...|+.|.|+.|+..... ++..+++|.+.+... +...-+.|+.+...+ .|.++++....+....+.++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 356999999999987643 577889988754321 112223455555555 58888888888888888889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKI 479 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~ 479 (516)
++++...+.- ...+++..++++..|++.++.++| ++.++|+|+||+||++..+ +.-+++|||....
T Consensus 350 ~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 350 GGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CcchhhhhHH------HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence 9998776622 256888899999999999999999 9999999999999999876 7889999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.8e-06 Score=80.01 Aligned_cols=143 Identities=15% Similarity=0.121 Sum_probs=87.0
Q ss_pred cccCCc-EEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCCCCHHHH
Q 036471 334 LGQGGY-GSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF 411 (516)
Q Consensus 334 ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 411 (516)
|..|.. ..||+.... +..+++|+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 789999764 5788888875433 346778888888873 44566788877776778999999999877643
Q ss_pred H----------------hhc-CCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhc----CCC
Q 036471 412 I----------------YRN-SSSIENHKLTWE--TLLQIAV--------------------GIARGLEYLHL----GCS 448 (516)
Q Consensus 412 l----------------~~~-~~~~~~~~l~~~--~~~~i~~--------------------~i~~aL~~LH~----~~~ 448 (516)
. .+- ..+....++... ....... .+...++.|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 1 110 000001111100 0000000 01111222210 113
Q ss_pred CCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 5589999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=75.79 Aligned_cols=147 Identities=20% Similarity=0.166 Sum_probs=85.1
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc--ceeeEEEEEee---cCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV--NVVTLLGFCFE---GRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~lv~e~~~~g 406 (516)
+.++.|..+.||+....+ +.+++|..... .....+.+|..++..+... .+.+++..... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 357889999999999876 79999997554 3446778888888887433 35667764433 33568999999998
Q ss_pred CHHH----------------HHhhcCCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc--
Q 036471 407 SLEK----------------FIYRNSSS-IENHKLTWET---------LLQI------------AVGIAR-GLEYLHL-- 445 (516)
Q Consensus 407 sL~~----------------~l~~~~~~-~~~~~l~~~~---------~~~i------------~~~i~~-aL~~LH~-- 445 (516)
.+.. .+..-... .......... .... ...+.+ .++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 11110000 0001111100 0000 111222 2333331
Q ss_pred --CCCCCeeeCCCCCCcEEEC-CCCcEEEeecCCcccc
Q 036471 446 --GCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKIC 480 (516)
Q Consensus 446 --~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~ 480 (516)
.....++|+|+.|+||+++ +++.+-|+||+.+..-
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1356799999999999999 6667789999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.5e-05 Score=68.31 Aligned_cols=128 Identities=21% Similarity=0.227 Sum_probs=88.0
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCccee-eEEEEEeecCeeEEEEEecCCCCHH
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVV-TLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.+.|++|++|.||++.+ .|..+|+|+-+.+ .....+..|+++|..++-.++. +++.+- ..++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 35699999999999999 4568888876543 3447788999999988776664 344432 234559999998887
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC-CCcEEECCCCcEEEeecCCcccc
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIK-PHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlk-p~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+.-.. .+.+.+.. ++++---|. ..||-|+.|. |..++|..++.+.|+||..|...
T Consensus 101 ~~~~~---------~~rk~l~~----vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIG---------GDRKHLLR----VLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhc---------ccHHHHHH----HHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 76421 13333333 333433344 7889999987 55555555559999999998743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=8.9e-06 Score=73.77 Aligned_cols=105 Identities=25% Similarity=0.261 Sum_probs=82.0
Q ss_pred HHHHHhhccCC-cceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 036471 370 NEVASISRTSH-VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448 (516)
Q Consensus 370 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~ 448 (516)
.|.-+++.+++ +++++++|.| ..+++.||...+++...-.. ...-...+|..+.+||.++++.+.+|+++..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 57778888866 6999999998 34678999987765422000 0011347899999999999999999997665
Q ss_pred CCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
..+.-.|++++|+-+++++++|++|...+....
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 678889999999999999999999998875543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.3e-05 Score=71.62 Aligned_cols=144 Identities=20% Similarity=0.179 Sum_probs=82.5
Q ss_pred hcccCCcEEEEEEEECC--CCEEEEEEeecCCCCchhHHHHHHHhhccCCcc-eeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 333 KLGQGGYGSVYKGKLID--GSNVAVKVLNDSKGNGEEFINEVASISRTSHVN-VVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.|..|-...+|+....+ ++.+++|+.........+..+|+.++..+.... .+++++... ..++|||++|.++.
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l~ 80 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTLE 80 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcCC
Confidence 46677778999998764 678999987644333334457888888884333 344544322 24899999987652
Q ss_pred H--------------HHhhcCC-CCCC-------CCC-CHHHHHHHHH----------------------HHH---HHHH
Q 036471 410 K--------------FIYRNSS-SIEN-------HKL-TWETLLQIAV----------------------GIA---RGLE 441 (516)
Q Consensus 410 ~--------------~l~~~~~-~~~~-------~~l-~~~~~~~i~~----------------------~i~---~aL~ 441 (516)
. .+.+-.. .... ... .++.+..+.. .+. ..|.
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 1 1111110 0000 011 1122212111 111 1111
Q ss_pred -HHhc-CCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccc
Q 036471 442 -YLHL-GCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKIC 480 (516)
Q Consensus 442 -~LH~-~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~ 480 (516)
.+-. .....++|+|+.+.|||+++ ++.+.|+||..|..-
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 1111 12356999999999999998 578999999988643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.4e-05 Score=86.32 Aligned_cols=76 Identities=13% Similarity=0.243 Sum_probs=55.9
Q ss_pred hhcccCCcEEEEEEEECCC---CEEEEEEeecCC--CCchhHHHHHHHhhccC-Ccce--eeEEEEEeec---CeeEEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDG---SNVAVKVLNDSK--GNGEEFINEVASISRTS-HVNV--VTLLGFCFEG---RRRALIY 400 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv~ 400 (516)
++++.|.+..+|+....++ ..+++|+..... .....+.+|..+++.+. |.++ .+++.++.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4578888999999887554 467788764422 23357889999999985 6654 7888877664 4678999
Q ss_pred EecCCCC
Q 036471 401 EFVSNGS 407 (516)
Q Consensus 401 e~~~~gs 407 (516)
||++|..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.4e-05 Score=73.01 Aligned_cols=72 Identities=17% Similarity=0.263 Sum_probs=45.3
Q ss_pred hcccCCcE-EEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc---ceeeEEEEEeec---CeeEEEEEecCC
Q 036471 333 KLGQGGYG-SVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV---NVVTLLGFCFEG---RRRALIYEFVSN 405 (516)
Q Consensus 333 ~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~---~~~~lv~e~~~~ 405 (516)
.|+.|+.. .||+. +..+++|..+. .....++.+|.+.+..+... .+.++++..... ...+++||+++|
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 46666665 58875 23577787544 22345788999998887532 344555543332 234789999998
Q ss_pred CCHH
Q 036471 406 GSLE 409 (516)
Q Consensus 406 gsL~ 409 (516)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.7e-05 Score=73.51 Aligned_cols=75 Identities=16% Similarity=0.086 Sum_probs=56.2
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCC---cceeeEEEEEee---cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSH---VNVVTLLGFCFE---GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~---~~~~~lv~e~~~~ 405 (516)
+.|+.|..+.||+....++ .+++|..+ .......+.+|.+.|+.+.. ..+.++++.+.. .+..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 3599999999999987555 46667743 32244688999999988843 467888887754 3668999999998
Q ss_pred CCH
Q 036471 406 GSL 408 (516)
Q Consensus 406 gsL 408 (516)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00013 Score=66.58 Aligned_cols=126 Identities=23% Similarity=0.313 Sum_probs=89.9
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCC-----------------CCchhHHHHHHHhhccC------CcceeeEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-----------------GNGEEFINEVASISRTS------HVNVVTLLG 388 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~nIv~l~~ 388 (516)
..||+|+.-.||.- .+.....||++.... ...++..+|+.-..++. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45999999998854 355667888875443 22356677776665555 889999999
Q ss_pred EEeecCeeEEEEEecCC------CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 389 FCFEGRRRALIYEFVSN------GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 389 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
+.+++....+|+|.+.+ -+|.+++++ ..++. .....+.++ .+||- ...|+.+|++|+||+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIV 150 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc-------CCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEE
Confidence 99999999999998642 468888843 33555 444444444 45555 778999999999999
Q ss_pred ECCCC----cEEEee
Q 036471 463 LDEDF----CPKISD 473 (516)
Q Consensus 463 l~~~~----~~kl~D 473 (516)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 95322 577877
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=3.4e-06 Score=86.79 Aligned_cols=154 Identities=21% Similarity=0.116 Sum_probs=110.2
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc-eeeEEEEEeecCeeEEEEEecCCC-CHHH
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN-VVTLLGFCFEGRRRALIYEFVSNG-SLEK 410 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g-sL~~ 410 (516)
..++++.++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...++.+++..++ +-..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 37789999999988655555556665433 44556888999999999 677777677777888999999876 2211
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeec
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 490 (516)
... .....+...+...+.+.-++++++|| +..-+|+| ||+..+ +..|..||+.+..+.+... ..
T Consensus 325 ~~~-----~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~---~~ 388 (829)
T KOG0576|consen 325 EMT-----VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK---PR 388 (829)
T ss_pred cCC-----hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcccc---cc
Confidence 110 01123444455667777889999999 66678888 777665 5789999999987766542 24
Q ss_pred cCCCCccccccccccc
Q 036471 491 GARGTVGYIAPEVFCR 506 (516)
Q Consensus 491 ~~~gt~~y~aPE~l~~ 506 (516)
...+++.|+|||+..+
T Consensus 389 t~~~~~~~~~pev~~~ 404 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQE 404 (829)
T ss_pred cCCCCCCCCCchhhcc
Confidence 5678999999998855
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00018 Score=68.97 Aligned_cols=140 Identities=11% Similarity=0.056 Sum_probs=79.5
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCCCc-hhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCCCCHHH-
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG-EEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSNGSLEK- 410 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~- 410 (516)
+..|-...+|+... +++.+++|......... -+..+|.++++.+....+ .+++... . .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 55677788998874 67788899865432221 245788888888854333 3444432 2 368999999866431
Q ss_pred -------------HHhhcC-CCCCCCCCCHH-HHHHHHHH---------HHHHHHHHhc-----CCCCCeeeCCCCCCcE
Q 036471 411 -------------FIYRNS-SSIENHKLTWE-TLLQIAVG---------IARGLEYLHL-----GCSTRILHFDIKPHNI 461 (516)
Q Consensus 411 -------------~l~~~~-~~~~~~~l~~~-~~~~i~~~---------i~~aL~~LH~-----~~~~~ivH~dlkp~NI 461 (516)
.+.+-. .+....+++.. .+..+..+ +...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 121111 11111222221 11111111 1111222211 1124589999999999
Q ss_pred EECCCCcEEEeecCCccc
Q 036471 462 LLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~ 479 (516)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00058 Score=69.09 Aligned_cols=74 Identities=15% Similarity=0.129 Sum_probs=53.8
Q ss_pred hhcccCCcEEEEEEEECCC-CEEEEEEeecC--------CCCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDG-SNVAVKVLNDS--------KGNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv 399 (516)
+.||.|....||++...+| +.|+||.-... ....+....|.+.|..+. -..+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3589999999999999877 48999985311 123456777888888762 3457777766 44667899
Q ss_pred EEecCCCC
Q 036471 400 YEFVSNGS 407 (516)
Q Consensus 400 ~e~~~~gs 407 (516)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=8.2e-06 Score=88.36 Aligned_cols=166 Identities=20% Similarity=0.196 Sum_probs=110.7
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.+|.++.++.+.-.. |...+.|.... ...+.+....+-.++-..++|-+++..--+......+|+++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 357788888888776432 33333333221 1112233334444444445666665554455677889999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC----
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR---- 482 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 482 (516)
+|...|+.. ...+.+-....+..+.+++++|| ...+.|+|++|.|+++..++..++.||+.......
T Consensus 890 ~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 890 DLPSKLHNS------GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CchhhhhcC------CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999754 23555555667777899999999 77799999999999999999999999984322110
Q ss_pred -----------------CCcc--------eeeccCCCCccccccccccc
Q 036471 483 -----------------KESI--------ISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 483 -----------------~~~~--------~~~~~~~gt~~y~aPE~l~~ 506 (516)
.... .......||+.|.|||.+.+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 0000 11123568999999999866
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00049 Score=67.52 Aligned_cols=144 Identities=18% Similarity=0.188 Sum_probs=84.5
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc--eeeEEEE------EeecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN--VVTLLGF------CFEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~~~ 404 (516)
.|..|....+|+... ++..+++|+... .....+..|++++..+.+.. +.+++.. ....+..++|++|++
T Consensus 21 ~i~~G~~n~~y~v~~-~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 21 GISAGIENTNYFVTT-DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred cccCccccceEEEEe-CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 466777789999876 445788898764 33456777888777774332 4454431 123456789999999
Q ss_pred CCCHHH-----------H---HhhcCCCCCC-----CCCCHHHHH----------HHHHHHHHHHHHHhc----CCCCCe
Q 036471 405 NGSLEK-----------F---IYRNSSSIEN-----HKLTWETLL----------QIAVGIARGLEYLHL----GCSTRI 451 (516)
Q Consensus 405 ~gsL~~-----------~---l~~~~~~~~~-----~~l~~~~~~----------~i~~~i~~aL~~LH~----~~~~~i 451 (516)
|..+.. . ++........ ....|.... .....+..++.++.. ....++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 866421 1 1111100000 111111110 011123334444441 123579
Q ss_pred eeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 452 LHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 452 vH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|+|+.|.||++++++.+.|+||+.+..
T Consensus 178 ~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 178 IHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CccCcCcccEEEeCCceEEEeehhhhcC
Confidence 9999999999999987778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0013 Score=65.31 Aligned_cols=144 Identities=15% Similarity=0.187 Sum_probs=77.5
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc--ceeeEEE------EEeecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV--NVVTLLG------FCFEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~------~~~~~~~~~lv~e~~~ 404 (516)
.|..|....+|+....+| .+++|+.. ....+.+..|+..+..+... .+.+++. +....+..++++||++
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 366677778999987555 68889875 22334444555555555321 2334332 1223556789999999
Q ss_pred CCCH-----------HHHH---hhcCCCCC-----CCCCCH-HHHHH------------HH-HHHHHHHHHHhc----CC
Q 036471 405 NGSL-----------EKFI---YRNSSSIE-----NHKLTW-ETLLQ------------IA-VGIARGLEYLHL----GC 447 (516)
Q Consensus 405 ~gsL-----------~~~l---~~~~~~~~-----~~~l~~-~~~~~------------i~-~~i~~aL~~LH~----~~ 447 (516)
|..+ .+.| +....... ...+.+ ..... .. ..+...++.+.. ..
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 8643 1111 11110000 001111 11111 11 111112222221 13
Q ss_pred CCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..+++|+|++|+||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 46899999999999999775568999998853
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0015 Score=64.53 Aligned_cols=145 Identities=19% Similarity=0.231 Sum_probs=82.3
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc--ceeeEEEEE------eecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV--NVVTLLGFC------FEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~------~~~~~~~lv~e~~~ 404 (516)
.++.|....+|+....++ .+++|+..... ..+.+..|++++..+... .+++++... ...+..++++||++
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 466676789999876444 67788775422 234556677777766322 244444321 12456789999998
Q ss_pred CCCHH-----------HH---HhhcCCCCCC---C---CCCHHHHH------------HHHHHHHHHHHHHhc----CCC
Q 036471 405 NGSLE-----------KF---IYRNSSSIEN---H---KLTWETLL------------QIAVGIARGLEYLHL----GCS 448 (516)
Q Consensus 405 ~gsL~-----------~~---l~~~~~~~~~---~---~l~~~~~~------------~i~~~i~~aL~~LH~----~~~ 448 (516)
|..+. +. ++........ . .-.|.... .....+.+.++++.. ...
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~ 186 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP 186 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 85431 11 1211110000 0 01111100 011223344555531 225
Q ss_pred CCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
.+++|+|+++.||++++++...|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 7899999999999999988778999998843
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0013 Score=64.80 Aligned_cols=144 Identities=25% Similarity=0.242 Sum_probs=84.8
Q ss_pred cccCCcEEEEEEEECC-------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKLID-------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+ .++++... -.+|+||++|
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~G 81 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIPS 81 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeCC
Confidence 5556667899988654 5789999986654444567788888888753333 34555443 2368999988
Q ss_pred CCHHHH--------------Hhhc-CCCCC--C---CCC--CHHHHHH--------------------------HHHHHH
Q 036471 406 GSLEKF--------------IYRN-SSSIE--N---HKL--TWETLLQ--------------------------IAVGIA 437 (516)
Q Consensus 406 gsL~~~--------------l~~~-~~~~~--~---~~l--~~~~~~~--------------------------i~~~i~ 437 (516)
.++... +.+- ..... . ... -+..+.. +..++.
T Consensus 82 ~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (302)
T cd05156 82 RTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEA 161 (302)
T ss_pred CcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHH
Confidence 765321 1111 10000 0 001 0111111 112222
Q ss_pred HHHHHHhc------CCCCCeeeCCCCCCcEEECCC----CcEEEeecCCccccc
Q 036471 438 RGLEYLHL------GCSTRILHFDIKPHNILLDED----FCPKISDFGLAKICN 481 (516)
Q Consensus 438 ~aL~~LH~------~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~ 481 (516)
..+++|-. .....++|+|+.+.||+++++ +.++|+||..|..-.
T Consensus 162 ~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 162 KYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred HHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 33334431 135678999999999999985 789999999986543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00056 Score=67.58 Aligned_cols=164 Identities=16% Similarity=0.170 Sum_probs=102.9
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC-chhHHHHHHHhhcc-CCcceeeEEEEE------eec-CeeEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-GEEFINEVASISRT-SHVNVVTLLGFC------FEG-RRRALIY 400 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l-~h~nIv~l~~~~------~~~-~~~~lv~ 400 (516)
..+.+|+|+.+.+|-.-. -..-+.|+....... ..+. ++.|... .||-+..-+.+= -+. ...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 346799999999996532 122355666543322 2222 2223333 455432211111 112 2355778
Q ss_pred EecCCCC-HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 401 EFVSNGS-LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 401 e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..+++.. ...++.-......-...+|+.+++.++.++.+.+-|| ..|.+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 8777643 3333321111112246899999999999999999999 99999999999999999999999998654443
Q ss_pred ccCCCcceeeccCCCCccccccccc
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l 504 (516)
...+. ......|...|.+||.-
T Consensus 167 ~~ng~---~~~cpVg~~eftPPElQ 188 (637)
T COG4248 167 NANGT---LHLCPVGVSEFTPPELQ 188 (637)
T ss_pred ccCCc---eEecccCccccCCHHHh
Confidence 32222 12457789999999985
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=60.00 Aligned_cols=122 Identities=27% Similarity=0.383 Sum_probs=85.8
Q ss_pred HhhhhhcccCCc-EEEEEEEECCCCEEEEEEeec-----C-----C------------CCchhHHHHHHHhhccC---Cc
Q 036471 328 NSFKYKLGQGGY-GSVYKGKLIDGSNVAVKVLND-----S-----K------------GNGEEFINEVASISRTS---HV 381 (516)
Q Consensus 328 ~~~~~~ig~G~~-g~V~~~~~~~~~~vavK~~~~-----~-----~------------~~~~~~~~E~~~l~~l~---h~ 381 (516)
.++.+.||.|.. |.||+++. +|+.+|+|++.. . . .....|..|.+...+++ +.
T Consensus 39 I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e 117 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE 117 (207)
T ss_pred EeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence 345577999999 99999998 788999999421 0 0 11235778888877774 55
Q ss_pred ce--eeEEEEEeec------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 036471 382 NV--VTLLGFCFEG------------------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441 (516)
Q Consensus 382 nI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~ 441 (516)
++ |+.+||..-. ....||.||++... .++. +-+.+|.+-|.
T Consensus 118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccch----hHHHHHHHHHH
Confidence 66 8889987321 12347888776532 1222 33456777788
Q ss_pred HHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 442 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
.+| ..||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899 999999999999985 3578999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0001 Score=70.58 Aligned_cols=131 Identities=18% Similarity=0.156 Sum_probs=90.7
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecC---------CC--------------CchhHHHHHHHhhccCC--cce
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---------KG--------------NGEEFINEVASISRTSH--VNV 383 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---------~~--------------~~~~~~~E~~~l~~l~h--~nI 383 (516)
.+.++||-|.-+.||.+-..+|++.++|.-+.. +. ..-...+|...|+.+.. --+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 456889999999999999999999999853210 00 01234567777777742 224
Q ss_pred eeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 384 VTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 384 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
.+.++ .+...+|||++.+-.|...-+ ..+...+ ...+..-+.-|. ..|+||+|..-=||+|
T Consensus 175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~---------v~d~~~l---y~~lm~~Iv~la---~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 175 PKPID----HNRHCVVMELVDGYPLRQVRH---------VEDPPTL---YDDLMGLIVRLA---NHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCccc----ccceeeHHHhhcccceeeeee---------cCChHHH---HHHHHHHHHHHH---HcCceecccchheeEE
Confidence 44443 356789999999888765431 2233333 333444445555 8999999999999999
Q ss_pred CCCCcEEEeecCCcc
Q 036471 464 DEDFCPKISDFGLAK 478 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~ 478 (516)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0063 Score=60.97 Aligned_cols=144 Identities=20% Similarity=0.208 Sum_probs=82.3
Q ss_pred cccCCcEEEEEEEECC-----CCEEEEEEeecCCCCchhHHHHHHHhhccCCccee-eEEEEEeecCeeEEEEEecCCCC
Q 036471 334 LGQGGYGSVYKGKLID-----GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVV-TLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+..|-...+|+....+ ++.|++|+........-+..+|..++..+...++. ++++.+..+ .|.||+++.+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~ 119 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART 119 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence 4456677889887532 36899998865443333447788888888544443 555554322 5799998766
Q ss_pred HHHH--------------HhhcCC-CCC--CCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-CCC
Q 036471 408 LEKF--------------IYRNSS-SIE--NHKLTWETLLQIAVGI-----------------ARGLEYL----HL-GCS 448 (516)
Q Consensus 408 L~~~--------------l~~~~~-~~~--~~~l~~~~~~~i~~~i-----------------~~aL~~L----H~-~~~ 448 (516)
|... +.+-.. ... .....++++.++..++ ...+..| .. ...
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 5311 111110 001 1112233333332221 1112222 11 124
Q ss_pred CCeeeCCCCCCcEEECC-CCcEEEeecCCccccc
Q 036471 449 TRILHFDIKPHNILLDE-DFCPKISDFGLAKICN 481 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 481 (516)
..++|+|+++.|||+++ ++.+.|+||..+..-.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 46899999999999986 4689999999886543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0026 Score=61.59 Aligned_cols=32 Identities=38% Similarity=0.540 Sum_probs=26.5
Q ss_pred CCeeeCCCCCCcEEECCCCc-EEEeecCCcccc
Q 036471 449 TRILHFDIKPHNILLDEDFC-PKISDFGLAKIC 480 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~~ 480 (516)
..++|+|++|.||++++++. .-|+||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00043 Score=72.50 Aligned_cols=80 Identities=23% Similarity=0.340 Sum_probs=58.2
Q ss_pred HHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc------eee-ccCCCCcccccccccc
Q 036471 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI------ISM-TGARGTVGYIAPEVFC 505 (516)
Q Consensus 433 ~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------~~~-~~~~gt~~y~aPE~l~ 505 (516)
+.+++.||.|+|. +.++||++|.|++|.++.++..||..|+++......... ... .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445699999997 789999999999999999999999999998665442111 000 0122467899999996
Q ss_pred ccccccccCCC
Q 036471 506 RNIGEVSYKSD 516 (516)
Q Consensus 506 ~~~~~~s~~sD 516 (516)
. ...+.++|
T Consensus 183 ~--~~~~~~sd 191 (700)
T KOG2137|consen 183 G--TTNTPASD 191 (700)
T ss_pred c--cccccccc
Confidence 5 34455554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0097 Score=59.08 Aligned_cols=71 Identities=18% Similarity=0.154 Sum_probs=48.1
Q ss_pred hcccCCcEEEEEEEECCC-CEEEEEEeec-------C-CCCchhHHHHHHHhhccC--Cc-ceeeEEEEEeecCeeEEEE
Q 036471 333 KLGQGGYGSVYKGKLIDG-SNVAVKVLND-------S-KGNGEEFINEVASISRTS--HV-NVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~-~~vavK~~~~-------~-~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv~ 400 (516)
.||.|....||++...+| +.|+||.-.. + +...++..-|.+.|+... -| .+++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 489999999999998654 6899997531 1 233455667777776652 23 4555554 3556677999
Q ss_pred EecCC
Q 036471 401 EFVSN 405 (516)
Q Consensus 401 e~~~~ 405 (516)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.018 Score=57.30 Aligned_cols=140 Identities=22% Similarity=0.220 Sum_probs=78.2
Q ss_pred CcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc--eeeEE---E--EEeecCeeEEEEEecCCCCH--
Q 036471 338 GYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN--VVTLL---G--FCFEGRRRALIYEFVSNGSL-- 408 (516)
Q Consensus 338 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~---~--~~~~~~~~~lv~e~~~~gsL-- 408 (516)
.-..||+....++..+++|+.+.......++..|++.+..+.... ++... | ....++..+.++++++|...
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~~~ 116 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAPEL 116 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCCCC
Confidence 446799998878889999988655555667778888777663211 22211 1 12224567789999987542
Q ss_pred ---------HHH---HhhcCC--CCC-CCCCCHHHH----------------------HHHHHHHHHHHHH-Hhc-CCCC
Q 036471 409 ---------EKF---IYRNSS--SIE-NHKLTWETL----------------------LQIAVGIARGLEY-LHL-GCST 449 (516)
Q Consensus 409 ---------~~~---l~~~~~--~~~-~~~l~~~~~----------------------~~i~~~i~~aL~~-LH~-~~~~ 449 (516)
..+ |+.... +.. +..++.... ..++.++...++- +.. ....
T Consensus 117 ~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 196 (325)
T PRK11768 117 DNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDVRL 196 (325)
T ss_pred CCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 222 222111 000 111221110 0112222111111 111 1246
Q ss_pred CeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 450 RILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 450 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+++|+|+.+.|||++ + .+.|+||+.+..
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 789999999999995 4 578999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.015 Score=57.41 Aligned_cols=31 Identities=32% Similarity=0.357 Sum_probs=26.5
Q ss_pred CCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..+++|+|+++.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 468999999999999987 5789999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.015 Score=58.80 Aligned_cols=71 Identities=13% Similarity=0.105 Sum_probs=49.6
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeec-----CC---CCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeEEEE
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLND-----SK---GNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.||.|....||+... +++.++||.-.. .. ....+-..|++.|+.+. ...+++++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 4589999999999887 456799998641 11 13344555677766553 357888888766 4567889
Q ss_pred EecCC
Q 036471 401 EFVSN 405 (516)
Q Consensus 401 e~~~~ 405 (516)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0071 Score=60.26 Aligned_cols=144 Identities=17% Similarity=0.190 Sum_probs=80.3
Q ss_pred cccCCcEEEEEEEECC----CCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGGYGSVYKGKLID----GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
|..|-...+|+....+ +..|++|+........-+..+|..+++.+...++ .++++++. .+ +|.+|+++.+|
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~l 97 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINARTL 97 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCCC
Confidence 5456667889887543 2489999886544333445678888888865555 35565542 22 58899877654
Q ss_pred HH--------------HHhhcCC-CCCC--CCCCHHHHHHHHHHH----------------------HHHHHHH---hc-
Q 036471 409 EK--------------FIYRNSS-SIEN--HKLTWETLLQIAVGI----------------------ARGLEYL---HL- 445 (516)
Q Consensus 409 ~~--------------~l~~~~~-~~~~--~~l~~~~~~~i~~~i----------------------~~aL~~L---H~- 445 (516)
.. .+++-.. .... ..--+..+.++..++ .+-+..+ ..
T Consensus 98 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~ 177 (330)
T PLN02421 98 TPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDS 177 (330)
T ss_pred ChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhcc
Confidence 21 1111111 1111 111223322222221 1111111 11
Q ss_pred -CCCCCeeeCCCCCCcEEECC-CCcEEEeecCCccccc
Q 036471 446 -GCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICN 481 (516)
Q Consensus 446 -~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~ 481 (516)
....-+.|+|+.+.|||+++ ++.++++||..|..-.
T Consensus 178 ~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 178 LKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred CCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 11223789999999999974 5789999999886543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.006 Score=59.78 Aligned_cols=138 Identities=19% Similarity=0.228 Sum_probs=95.0
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCC----------------------CCchh-----HHHHHHHhhccCCccee
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK----------------------GNGEE-----FINEVASISRTSHVNVV 384 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~-----~~~E~~~l~~l~h~nIv 384 (516)
..|..|.-+-||.+...+|..+|||+++.+. .+.+. ...|+.-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4588899999999999999999999875321 01111 12467777877655543
Q ss_pred eEEEEEeecCeeEEEEEecCCCCHH-HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 385 TLLGFCFEGRRRALIYEFVSNGSLE-KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 385 ~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
-.--... ....|||+|+...... -.| ....++...+..+-.|++.-|.-|-+ ..++||.||.--|+|+
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkL-------Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKL-------KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccc-------ccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence 2211111 2456999998532211 111 23567777888888899888888875 7789999999999998
Q ss_pred CCCCcEEEeecCCccccc
Q 036471 464 DEDFCPKISDFGLAKICN 481 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~ 481 (516)
. +|.+.|+|.+-+....
T Consensus 299 h-dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVEHD 315 (520)
T ss_pred E-CCEEEEEEccccccCC
Confidence 4 5689999998775543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=57.45 Aligned_cols=140 Identities=21% Similarity=0.289 Sum_probs=83.1
Q ss_pred CcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc------eeeEEEEEe--ecC--eeEEEEEecCCCC
Q 036471 338 GYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN------VVTLLGFCF--EGR--RRALIYEFVSNGS 407 (516)
Q Consensus 338 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~--~~~--~~~lv~e~~~~gs 407 (516)
.-..+|+....+|+. ++|+.+.. ....++..|+..+..+.-.. +...=|-.. -.. ..+-+++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 456789998877777 99998877 66677888888888773222 222222111 123 6778999999877
Q ss_pred HHH------------H---HhhcCC------CCCCCCCCHHH-------------HHHHHHHHHHHHHHHhc----CC-C
Q 036471 408 LEK------------F---IYRNSS------SIENHKLTWET-------------LLQIAVGIARGLEYLHL----GC-S 448 (516)
Q Consensus 408 L~~------------~---l~~~~~------~~~~~~l~~~~-------------~~~i~~~i~~aL~~LH~----~~-~ 448 (516)
+.. + |+.... +.......|.. -.....++...+..+.. .. .
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 762 1 111110 00111233320 01123334444444442 11 2
Q ss_pred CC--eeeCCCCCCcEEECCCCc-EEEeecCCccc
Q 036471 449 TR--ILHFDIKPHNILLDEDFC-PKISDFGLAKI 479 (516)
Q Consensus 449 ~~--ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~ 479 (516)
.+ +||+|+.|.||+++.+.. +.++||+.+..
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999998874 89999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.012 Score=57.66 Aligned_cols=146 Identities=17% Similarity=0.225 Sum_probs=80.4
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeec---CCCCchhHHHHHHHhhccCC--cceeeEEEEEeecC--eeEEEEEecCCC
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLND---SKGNGEEFINEVASISRTSH--VNVVTLLGFCFEGR--RRALIYEFVSNG 406 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~--~~~lv~e~~~~g 406 (516)
+..|..-.+|..... +++++++ ... ......+..+|+.+++.+.- .-+...++.+.++. ..+.||+|++|.
T Consensus 33 ~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 33 ISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred ccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 334444455555543 7888888 331 22344666778888887643 33445566666655 678999999884
Q ss_pred CHHH------------------HHhhcCC--CCC----C--CCCCHHHHHHHHHH--------------HHHHHHHHhc-
Q 036471 407 SLEK------------------FIYRNSS--SIE----N--HKLTWETLLQIAVG--------------IARGLEYLHL- 445 (516)
Q Consensus 407 sL~~------------------~l~~~~~--~~~----~--~~l~~~~~~~i~~~--------------i~~aL~~LH~- 445 (516)
.+.+ .|..-.. ... . ......++..+..+ ......||+.
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 2221 1111000 000 0 00011111111111 1222334432
Q ss_pred ----CCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 446 ----GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 446 ----~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
.....++|+|+++.||++++++-+-|.||+++..-.
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 112358999999999999998889999999987543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.043 Score=62.91 Aligned_cols=141 Identities=20% Similarity=0.219 Sum_probs=76.9
Q ss_pred CCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccC--Ccc--eeeEEE--------EEee-cC--eeEEEEE
Q 036471 337 GGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS--HVN--VVTLLG--------FCFE-GR--RRALIYE 401 (516)
Q Consensus 337 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~n--Iv~l~~--------~~~~-~~--~~~lv~e 401 (516)
|..-.+|+....+|+.+++|+.+... .......|...+..+. ++. +.+++- .... ++ ..+-+++
T Consensus 35 s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl~ 113 (1013)
T PRK06148 35 GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLLRLLS 113 (1013)
T ss_pred CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEEEEEe
Confidence 34567899888788899999997542 2234444555555442 122 223221 1111 22 4567899
Q ss_pred ecCCCCHHHH-----------------Hhh----cCCCCCCCCCCHHH-----------------HHHHHHHHHHHHH--
Q 036471 402 FVSNGSLEKF-----------------IYR----NSSSIENHKLTWET-----------------LLQIAVGIARGLE-- 441 (516)
Q Consensus 402 ~~~~gsL~~~-----------------l~~----~~~~~~~~~l~~~~-----------------~~~i~~~i~~aL~-- 441 (516)
|++|..|.+. ++. ...+.....+.|.. ...++.++.+...
T Consensus 114 ~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~~~~~ 193 (1013)
T PRK06148 114 WLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLARFERN 193 (1013)
T ss_pred ccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHHHHHH
Confidence 9999777551 111 11111111222221 1122222222221
Q ss_pred ---HHhcCCCCCeeeCCCCCCcEEECCCC--cEE-EeecCCccc
Q 036471 442 ---YLHLGCSTRILHFDIKPHNILLDEDF--CPK-ISDFGLAKI 479 (516)
Q Consensus 442 ---~LH~~~~~~ivH~dlkp~NIll~~~~--~~k-l~Dfg~a~~ 479 (516)
.|. ....++||+|+++.|||++.++ ++. |+|||.+..
T Consensus 194 v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 194 VAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 121 2356899999999999999875 555 999998853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0024 Score=59.18 Aligned_cols=126 Identities=18% Similarity=0.221 Sum_probs=62.3
Q ss_pred CCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCCCCHHH-------H-------Hh-
Q 036471 350 GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSNGSLEK-------F-------IY- 413 (516)
Q Consensus 350 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~-------~-------l~- 413 (516)
.+.|++|+........-...+|..+++.+....+ .++++.+..+ .|+||+++.+|.. . |+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678999987766666677788888888864444 4555544322 5678887655421 1 11
Q ss_pred --hcCC-CCCCCCCCHHHHHHH--------------------------HHHHHHHHHHHh-cCCCCCeeeCCCCCCcEEE
Q 036471 414 --RNSS-SIENHKLTWETLLQI--------------------------AVGIARGLEYLH-LGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 414 --~~~~-~~~~~~l~~~~~~~i--------------------------~~~i~~aL~~LH-~~~~~~ivH~dlkp~NIll 463 (516)
.... .......-+..+..+ ...+....+.+- .....-+.|+|+.|.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 1000 000111111222222 111111222220 0112457899999999999
Q ss_pred -CCCCcEEEeecCCccc
Q 036471 464 -DEDFCPKISDFGLAKI 479 (516)
Q Consensus 464 -~~~~~~kl~Dfg~a~~ 479 (516)
+.++.++|+||..|..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0075 Score=58.54 Aligned_cols=72 Identities=19% Similarity=0.301 Sum_probs=47.7
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc---CCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT---SHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.++.|....+|+.. .+++.+.||+-. ......|..|.+-|+.+ .--.+++++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 347888889999988 578899999886 23335678888888777 3456788999888778889999999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.024 Score=55.98 Aligned_cols=32 Identities=22% Similarity=0.223 Sum_probs=28.7
Q ss_pred CCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..+++|+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.019 Score=57.71 Aligned_cols=72 Identities=18% Similarity=0.141 Sum_probs=49.3
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeec------C-CCCchhHHHHHHHhhccC--Cc-ceeeEEEEEeecCeeEEEE
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLND------S-KGNGEEFINEVASISRTS--HV-NVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~------~-~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv~ 400 (516)
+.||.|.-..||++.+.+ ++.|+||.-.. + +...++..-|.+.|+... -| .+++++.+ ++....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 358999999999999853 67899997531 1 233456677778777652 23 45566643 556677889
Q ss_pred EecCC
Q 036471 401 EFVSN 405 (516)
Q Consensus 401 e~~~~ 405 (516)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 98854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.05 Score=55.13 Aligned_cols=72 Identities=18% Similarity=0.186 Sum_probs=44.3
Q ss_pred cccCCcEEEEEEEECCC--C-----EEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKLIDG--S-----NVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~--~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~ 405 (516)
|..|-...+|++...++ . .|+++.........-+-.+|+.+++.+...++ .++++.+. ..++.||++|
T Consensus 58 l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efIeG 133 (383)
T PTZ00384 58 MNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWVEG 133 (383)
T ss_pred eCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEecc
Confidence 54577788999876433 2 24444432222222344678899998865555 45555543 2599999998
Q ss_pred CCHH
Q 036471 406 GSLE 409 (516)
Q Consensus 406 gsL~ 409 (516)
.+|.
T Consensus 134 r~l~ 137 (383)
T PTZ00384 134 NTMG 137 (383)
T ss_pred ccCC
Confidence 7663
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.03 Score=51.20 Aligned_cols=116 Identities=18% Similarity=0.132 Sum_probs=73.2
Q ss_pred CCcEEEEEEEECCCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhh
Q 036471 337 GGYGSVYKGKLIDGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR 414 (516)
Q Consensus 337 G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 414 (516)
++.++.-.++.+- .+..+|++...+- ...-|..+..++.+++ .|+++..- ....+-++.|++-.-
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 3445555554433 3455666654332 3455678888888765 46666632 344666889987321
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 415 NSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 415 ~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+... ..++.-=+.+|.-.|++ ..+.+|+|-.|+||+-|+.|.+||.|-+.-
T Consensus 140 -------~i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 140 -------KINF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------ccch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111 11121124667778843 678999999999999999999999997643
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.043 Score=54.72 Aligned_cols=61 Identities=16% Similarity=0.210 Sum_probs=45.2
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD 464 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~ 464 (516)
...++-+|.+|.++..++.. ...+++...+++.-.++|+--+-- -.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-------~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-------KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc-------ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 34566778899999999854 345556667777767777654432 67899999999999994
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.28 Score=56.20 Aligned_cols=32 Identities=25% Similarity=0.344 Sum_probs=26.1
Q ss_pred CCCCeeeCCCCCCcEEECCCC--c---EEEeecCCcc
Q 036471 447 CSTRILHFDIKPHNILLDEDF--C---PKISDFGLAK 478 (516)
Q Consensus 447 ~~~~ivH~dlkp~NIll~~~~--~---~kl~Dfg~a~ 478 (516)
...++||+|++++||+++.+. . .-|+|||.+.
T Consensus 206 L~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 206 LPLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred CcccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 357899999999999998652 3 3799999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.053 Score=53.32 Aligned_cols=72 Identities=18% Similarity=0.128 Sum_probs=55.0
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
...|++|++. |++|... ..-.+++++.++.+-+..+.-+-. .-..-|||+.-.||||+ +|++-|+|
T Consensus 299 ~y~yl~~kdh-gt~is~i----------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 299 LYLYLHFKDH-GTPISII----------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred eEEEEEEecC-Cceeeee----------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence 3556777775 4455322 345678888888887777766653 55688999999999999 89999999
Q ss_pred cCCccc
Q 036471 474 FGLAKI 479 (516)
Q Consensus 474 fg~a~~ 479 (516)
|-+++.
T Consensus 365 fklsRl 370 (488)
T COG5072 365 FKLSRL 370 (488)
T ss_pred eeeeec
Confidence 999984
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.21 Score=46.06 Aligned_cols=163 Identities=17% Similarity=0.225 Sum_probs=93.4
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc---CCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT---SHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
++.-|-.-+.|...+ ...++.||.-.. .....|..|+.-|..+ +--.+.+++.+-.+....|+|+||.+-+.+.
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~~--~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQR--EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecch--hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 354454455555544 467888887533 2335677777666655 4466888888888999999999999876654
Q ss_pred -----------HHHhhcCCCC------------CCCCCCHH---------HHHHHHHHH--------------HHHHHHH
Q 036471 410 -----------KFIYRNSSSI------------ENHKLTWE---------TLLQIAVGI--------------ARGLEYL 443 (516)
Q Consensus 410 -----------~~l~~~~~~~------------~~~~l~~~---------~~~~i~~~i--------------~~aL~~L 443 (516)
..|+...... ...+-+|. +++.+..|+ +..+.-+
T Consensus 100 ~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg~~f~did~~~~~v~el 179 (286)
T COG3001 100 AHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERGLTFGDIDAIVEKIQEL 179 (286)
T ss_pred chhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhCCCccCHHHHHHHHHHH
Confidence 1122221110 00111121 122222222 2222222
Q ss_pred hc--CCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccc
Q 036471 444 HL--GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504 (516)
Q Consensus 444 H~--~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l 504 (516)
-. ......+|+||-..|..+..+| +.+.| -|......+....+...-|. .+||.+
T Consensus 180 L~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fD--PA~y~GDrE~Dlam~elFgg---fp~efy 236 (286)
T COG3001 180 LADHQPQPSLLHGDLWSGNCAFGKDG-PVIFD--PACYWGDRECDLAMLELFGG---FPPEFY 236 (286)
T ss_pred HhcCCCCcceeecccccccccccCCC-Ceeec--cccccCCcccceehhhhhcC---CcHHHH
Confidence 11 2236799999999999999999 77766 34445555555555544443 455655
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 516 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 3e-84
Identities = 84/206 (40%), Positives = 124/206 (60%), Gaps = 9/206 (4%)
Query: 315 PRRYSYADIKKMTNSF--KYKLGQGGYGSVYKGKLIDGSNVAVKVL--NDSKGNGEEFIN 370
+R+S +++ +++F K LG+GG+G VYKG+L DG+ VAVK L ++G +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 371 EVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL 430
EV IS H N++ L GFC R L+Y +++NGS+ + S L W
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP--LDWPKRQ 134
Query: 431 QIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT 490
+IA+G ARGL YLH C +I+H D+K NILLDE+F + DFGLAK+ + K++ ++ T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-T 193
Query: 491 GARGTVGYIAPEVFCRNIGEVSYKSD 516
RGT+G+IAPE G+ S K+D
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTD 217
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 6e-78
Identities = 85/229 (37%), Positives = 129/229 (56%), Gaps = 12/229 (5%)
Query: 292 SSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSF--KYKLGQGGYGSVYKGKLID 349
S Y + +N R D+++ TN+F K+ +G G +G VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 350 GSNVAVKVLNDSKGNGE-EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408
G+ VA+K G EF E+ ++S H ++V+L+GFC E LIY+++ NG+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 468
++ +Y + ++WE L+I +G ARGL YLH I+H D+K NILLDE+F
Sbjct: 123 KRHLYGSDLPTM--SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 469 PKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
PKI+DFG++K ++ +S T +GT+GYI PE F + G ++ KSD
Sbjct: 178 PKITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIK--GRLTEKSD 223
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-70
Identities = 74/219 (33%), Positives = 116/219 (52%), Gaps = 25/219 (11%)
Query: 312 SLAPRRYSYADIKKMTNSFK--------YKLGQGGYGSVYKGKLIDGSNVAVKVLN---- 359
+S+ ++K +TN+F K+G+GG+G VYKG + + + VAVK L
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 360 -DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSS 418
++ ++F E+ +++ H N+V LLGF +G L+Y ++ NGSL + +
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 419 IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
L+W +IA G A G+ +LH +H DIK NILLDE F KISDFGLA+
Sbjct: 128 ---PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 479 IC-NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+++++ + GT Y+APE GE++ KSD
Sbjct: 182 ASEKFAQTVMT-SRIVGTTAYMAPEAL---RGEITPKSD 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-57
Identities = 58/190 (30%), Positives = 107/190 (56%), Gaps = 12/190 (6%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTL 386
K K+G G +G+V++ + GS+VAVK+L + + EF+ EVA + R H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G + +++ E++S GSL + ++++ + +L L +A +A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
+ I+H ++K N+L+D+ + K+ DFGL+++ + + +S A GT ++APEV
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 507 NIGEVSYKSD 516
+ KSD
Sbjct: 214 E--PSNEKSD 221
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 7e-57
Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 319 SYADIKKMTNSFKY--KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASIS 376
++ + + +G +G V+K + + VAVK+ + EV S+
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 377 RTSHVNVVTLLGFCFEGRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQI 432
H N++ +G G LI F GSL F+ + ++W L I
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-------NVVSWNELCHI 126
Query: 433 AVGIARGLEYLH-------LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485
A +ARGL YLH G I H DIK N+LL + I+DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 486 IISMTGARGTVGYIAPEVFCRNI---GEVSYKSD 516
G GT Y+APEV I + + D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG--------EEFINEVASISRTSH 380
++ ++G+GG+G V+KG+L+ D S VA+K L G +EF EV +S +H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
N+V L G ++ EFV G L + H + W L++ + IA G+
Sbjct: 83 PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGI 135
Query: 441 EYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESIISMTGARGT 495
EY+ + I+H D++ NI L C K++DFGL++ S++G G
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGN 189
Query: 496 VGYIAPEVFCRNIGEVSYKSD 516
++APE + K+D
Sbjct: 190 FQWMAPETIGAEEESYTEKAD 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 15/188 (7%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+ +G+G +G V K K +VA+K + + FI E+ +SR +H N+V L G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
C L+ E+ GSL ++ T + + ++G+ YLH
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 450 RILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
++H D+KP N+LL KI DFG A MT +G+ ++APEVF +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS- 178
Query: 509 GEVSYKSD 516
S K D
Sbjct: 179 -NYSEKCD 185
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-50
Identities = 43/194 (22%), Positives = 78/194 (40%), Gaps = 19/194 (9%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVT 385
+F KL + G ++KG+ G+++ VKVL + +F E + SH NV+
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 386 LLGFCFE--GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+LG C LI ++ GSL ++ N + ++ A+ +ARG+ +L
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG----TNFVVDQSQAVKFALDMARGMAFL 127
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
H I + ++++DED +IS + G ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 504 FC-RNIGEVSYKSD 516
+ +D
Sbjct: 180 LQKKPEDTNRRSAD 193
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 58/200 (29%), Positives = 84/200 (42%), Gaps = 27/200 (13%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVL-----NDSKGNGEEFINEVASISRTSHVNVV 384
+ +G GG+G VY+ G VAVK D E E + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L G C + L+ EF G L + + ++ + L+ AV IARG+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-------SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 445 LGCSTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICNRKESIISMTGARGTV 496
I+H D+K NIL+ + KI+DFGLA R+ + A G
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAY 178
Query: 497 GYIAPEVFCRNIGEVSYKSD 516
++APEV + S SD
Sbjct: 179 AWMAPEVIRAS--MFSKGSD 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 59/195 (30%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINE--VASISRTSHVNVVTL 386
+G+G YG+VYKG L D VAVKV S N + FINE + + H N+
Sbjct: 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 387 LGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ L+ E+ NGSL K++ H W + ++A + RGL
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDWVSSCRLAHSVTRGLA 125
Query: 442 YLH------LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI------CNRKESIISM 489
YLH I H D+ N+L+ D ISDFGL+ E +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 490 TGARGTVGYIAPEVF 504
GT+ Y+APEV
Sbjct: 186 ISEVGTIRYMAPEVL 200
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-49
Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 15/191 (7%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGE---EFINEVASISRTSHVNVVTL 386
++G G +G+VYKGK +VAVK+LN + + F NEV + +T HVN++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G+ + A++ ++ SL ++ + K + L+ IA ARG++YLH
Sbjct: 86 MGYSTAPQL-AIVTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLH-- 137
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC- 505
+ I+H D+K +NI L ED KI DFGLA +R G++ ++APEV
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 506 RNIGEVSYKSD 516
++ S++SD
Sbjct: 197 QDSNPYSFQSD 207
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTL 386
+G+G +G VY G+ VA+++++ D++ + F EV + +T H NVV
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G C A+I +L + L QIA I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLH-- 147
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI---CNRKESIISMTGARGTVGYIAPEV 503
+ ILH D+K N+ D I+DFGL I + G + ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 504 FCRNIGEV-------SYKSD 516
+ + S SD
Sbjct: 206 IRQLSPDTEEDKLPFSKHSD 225
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-45
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 19/195 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
++G+G YG V+ GK G VAVKV ++ E+ H N++ + +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 393 GRRR----ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH---- 444
G LI ++ NGSL ++ L +++L++A GL +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 445 -LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGARGTVGYIAP 501
I H D+K NIL+ ++ I+D GLA + E I GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 502 EVFCRNIGEVSYKSD 516
EV ++ ++S
Sbjct: 216 EVLDESLNRNHFQSY 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G V++GK G VAVK+ + + E+ H N++ + +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 393 GRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH---- 444
L+ ++ +GSL ++ R + +T E ++++A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 445 -LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI--ISMTGARGTVGYIAP 501
I H D+K NIL+ ++ I+D GLA + I+ GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 502 EVFCRNI----GEVSYKSD 516
EV +I E ++D
Sbjct: 221 EVLDDSINMKHFESFKRAD 239
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 19/195 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G YG V++G G NVAVK+ + E+ + H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 393 GRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH---- 444
R + LI + GSL ++ L + L+I + IA GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 445 -LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC--NRKESIISMTGARGTVGYIAP 501
I H D+K NIL+ ++ I+D GLA + + + + GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 502 EVFCRNIGEVSYKSD 516
EV I + S
Sbjct: 187 EVLDETIQVDCFDSY 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 24/198 (12%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
LG+G +G K G + +K L + F+ EV + H NV+ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
++ +R I E++ G+L I + + W + A IA G+ YLH S
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 451 ILHFDIKPHNILLDEDFCPKISDFGLAKI------------CNRKESIISMTGARGTVGY 498
I+H D+ HN L+ E+ ++DFGLA++ +K G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 499 IAPEVFCRNIGEVSYKSD 516
+APE+ N K D
Sbjct: 189 MAPEMI--NGRSYDEKVD 204
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-34
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 35/210 (16%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
LGQG +G V K + +D A+K + ++ ++EV ++ +H VV
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 392 EGRRRAL----------IY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
E R ++ E+ NG+L I + + + W QI
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL----E 127
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS---------- 488
L Y+H S I+H D+KP NI +DE KI DFGLAK +R I+
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 489 --MTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+T A GT Y+A EV G + K D
Sbjct: 185 DNLTSAIGTAMYVATEV-LDGTGHYNEKID 213
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
LG G +G+VYKG I VA+K L + S +E ++E ++ + +V
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C LI + + G L ++ + + + LL V IA+G+ YL
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
R++H D+ N+L+ KI+DFGLAK+ +E G + + ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 506 RNIGEVSYKSD 516
+++SD
Sbjct: 192 -LHRIYTHQSD 201
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 18/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
LG G +G+VYKG I VA+K L + S +E ++E ++ + +V
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C LI + + G L ++ + + + LL V IA+G+ YL
Sbjct: 82 LLGICLT-STVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
R++H D+ N+L+ KI+DFGLAK+ +E G + + ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 506 RNIGEVSYKSD 516
+++SD
Sbjct: 192 -LHRIYTHQSD 201
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+F ++G G +G V+ G ++ VA+K + + + E+FI E + + SH +V L G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
C E L+ EF+ +G L ++ ETLL + + + G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
++H D+ N L+ E+ K+SDFG+ + + S TG + V + +PEVF +
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVF--SF 179
Query: 509 GEVSYKSD 516
S KSD
Sbjct: 180 SRYSSKSD 187
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 13/187 (6%)
Query: 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLGF 389
++G+G +G V+ G+L D + VAVK + +F+ E + + SH N+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
C + + ++ E V G F+ +L +TLLQ+ A G+EYL S
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+H D+ N L+ E KISDFG+++ S + V + APE N G
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYG 290
Query: 510 EVSYKSD 516
S +SD
Sbjct: 291 RYSSESD 297
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+LG G +G V GK +VAVK++ + + +EF E ++ + SH +V G C +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E++SNG L ++ + L LL++ + G+ +L S + +
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSH-----GKGLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D+ N L+D D C K+SDFG+ + + + S G + V + APEVF + + S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSAPEVF--HYFKYS 183
Query: 513 YKSD 516
KSD
Sbjct: 184 SKSD 187
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND---SKGNGEEFINEVASISRTSHVNVVT 385
LG+G +GSV + +L VAVK+L + + EEF+ E A + H +V
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 386 LLGFCFEGRRRA------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
L+G R + +I F+ +G L F+ + L +TL++ V IA G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
+EYL S +H D+ N +L ED ++DFGL++ + ++ V ++
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 500 APEVFCRNIGEVSYKSD 516
A E N+ + SD
Sbjct: 207 ALESLADNL--YTVHSD 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 17/176 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFI----NEVASISRTSHVNVVTLL 387
KLG GG +VY + I VA+K + EE + EV + S+ SH N+V+++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
E L+ E++ +L ++I + L+ +T + I G+++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI------ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPE 502
RI+H DIKP NIL+D + KI DFG+AK + E+ ++ T GTV Y +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPE 182
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLNDSKG--NGEEFINEVASISRTSHVNVVT 385
LG G +G+V+KG I V +KV+ D G + + + + +I H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C L+ +++ GSL + ++ L + LL V IA+G+ YL
Sbjct: 80 LLGLCPG-SSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLE- 132
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
++H ++ N+LL +++DFG+A + + + + A+ + ++A E
Sbjct: 133 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI- 189
Query: 506 RNIGEVSYKSD 516
+ G+ +++SD
Sbjct: 190 -HFGKYTHQSD 199
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND---SKGNGEEFINEVASISRTSHVNVVT 385
LG+G +GSV +G L VAVK + S+ EEF++E A + SH NV+
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 386 LLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
LLG C E + +I F+ G L ++ + + +TLL+ V IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
EYL + LH D+ N +L +D ++DFGL+K + A+ V +IA
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 501 PEVFCRNIGEVSYKSD 516
E + + KSD
Sbjct: 218 IESLADRV--YTSKSD 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 11/185 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGS-NVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
KLG G YG VY+G S VAVK L + EEF+ E A + H N+V LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+I EF++ G+L ++ R +++ LL +A I+ +EYL
Sbjct: 80 REPPFYIITEFMTYGNLLDYL-REC---NRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 511
+H D+ N L+ E+ K++DFGL+++ ++ + GA+ + + APE N
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK--F 189
Query: 512 SYKSD 516
S KSD
Sbjct: 190 SIKSD 194
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+LG G +G V GK +VA+K++ + + +EFI E + SH +V L G C +
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
R +I E+++NG L ++ H+ + LL++ + +EYL S + L
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D+ N L+++ K+SDFGL++ E S G++ V + PEV + S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVL--MYSKFS 199
Query: 513 YKSD 516
KSD
Sbjct: 200 SKSD 203
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 331 KYKLGQGGYGSVYKGKLIDGSN---VAVKVL--NDSKGNGEEFINEVASISRTSHVNVVT 385
+LG G +GSV +G VA+KVL K + EE + E + + + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L+G C + L+ E G L KF+ ++ + ++ ++ G++YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYL-- 126
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVF 504
+H D+ N+LL KISDFGL+K +S + + + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 505 CRNIGEVSYKSD 516
N + S +SD
Sbjct: 186 --NFRKFSSRSD 195
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 285 IMFYRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYAD----IKKMTNSFKYKLGQGGYG 340
+ + + G + S +++ + K+KLG G YG
Sbjct: 179 VHHHST----VADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYG 234
Query: 341 SVYKGKLIDGS-NVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399
VY+G S VAVK L + EEF+ E A + H N+V LLG C +I
Sbjct: 235 EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459
EF++ G+L ++ R +++ LL +A I+ +EYL +H ++
Sbjct: 295 TEFMTYGNLLDYL-REC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAAR 347
Query: 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
N L+ E+ K++DFGL+++ GA+ + + APE N S KSD
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNK--FSIKSD 401
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 17/190 (8%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASI 375
+ F +G+G +G VY G L+D AVK LN G +F+ E +
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 376 SRTSHVNVVTLLGFCFEGRRRAL-IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
SH NV++LLG C L + ++ +G L FI + H T + L+ +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGL 135
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGA 492
+A+G++YL S + +H D+ N +LDE F K++DFGLA+ KE S+ + TGA
Sbjct: 136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 493 RGTVGYIAPE 502
+ V ++A E
Sbjct: 193 KLPVKWMALE 202
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLG G +G V+ + VAVK + + E F+ E + H +V L +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
+I EF++ GSL F+ + E K L+ + IA G+ ++ +
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ KI+DFGLA++ E GA+ + + APE N G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAI--NFGSFT 363
Query: 513 YKSD 516
KSD
Sbjct: 364 IKSD 367
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 330 FKYKLGQGGYGSVYKGKLI-----DGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNV 383
F +LG+G +GSV + G VAVK L + ++ + +F E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 384 VTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
V G C+ RR LI E++ GSL ++ ++ ++ LLQ I +G+E
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 128
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIA 500
YL + R +H D+ NIL++ + KI DFGL K + KE + + A
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 501 PEVFCRNIGEVSYKSD 516
PE + S SD
Sbjct: 186 PE--SLTESKFSVASD 199
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLGQG +G V+ G + VA+K L + E F+ E + + H +V L E
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E++S GSL F+ L L+ +A IA G+ Y+ +
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ E+ K++DFGLA++ E GA+ + + APE G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 359
Query: 513 YKSD 516
KSD
Sbjct: 360 IKSD 363
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 19/193 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
+G+G +G VY G+ ID + A+K L+ E F+ E + +H NV+ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 387 LGFCFEGRRRALI-YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+G + ++ +G L +FI R+ T + L+ + +ARG+EYL
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFI-RS----PQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEV 503
+ +H D+ N +LDE F K++DFGLA+ +E S+ AR V + A E
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 504 FCRNIGEVSYKSD 516
+ KSD
Sbjct: 200 L--QTYRFTTKSD 210
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 34/202 (16%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
+G GG+G V+K K IDG +K + + E+ EV ++++ HVN+V G C+
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNG-CW 73
Query: 392 EGRRRA-----------------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV 434
+G + EF G+LE++I + + L E QI
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT- 132
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
+G++Y+H S ++++ D+KP NI L + KI DFGL G
Sbjct: 133 ---KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---G 183
Query: 495 TVGYIAPEVFCRNIGEVSYKSD 516
T+ Y++PE + + D
Sbjct: 184 TLRYMSPEQ-ISSQD-YGKEVD 203
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 55/194 (28%), Positives = 79/194 (40%), Gaps = 22/194 (11%)
Query: 333 KLGQGGYGSVYKGKLID-----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVT 385
LG+G +G V G VAVK L G + + E+ + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 386 LLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G C + + L+ E+V GSL ++ H + LL A I G+ YL
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPE 502
H + +H D+ N+LLD D KI DFGLAK + E V + APE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 503 VFCRNIGEVSYKSD 516
C + Y SD
Sbjct: 208 --CLKEYKFYYASD 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+LG G +G V+ G + VAVK L + + F+ E + + H +V L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
+I E++ NGSL F+ KLT LL +A IA G+ ++ +
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ + KI+DFGLA++ E GA+ + + APE N G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI--NYGTFT 188
Query: 513 YKSD 516
KSD
Sbjct: 189 IKSD 192
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 328 NSFKYK----LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFI-NEVASISRTSHV 381
++ Y LG+GG+ V + L DG A+K + + E E +H
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 382 NVVTLLGFCFEGRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
N++ L+ +C R L+ F G+L I + + LT + +L + +GI
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGIC 144
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA----- 492
RGLE +H + H D+KP NILL ++ P + D G
Sbjct: 145 RGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 493 --RGTVGYIAPEVF-CRNIGEVSYKSD 516
R T+ Y APE+F ++ + ++D
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTD 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 307 LRNHGSLAPRRYSYAD---IKKMTNSFKYKLGQGGYGSVYKGKLI-----DGSNVAVKVL 358
+ +H + Y+ D ++ + +LG+G +GSV + G+ VAVK L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 359 NDSKGNGE-EFINEVASISRTSHVNVVTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRN 415
S + + +F E+ + +V G + R++ L+ E++ +G L F+ R+
Sbjct: 61 QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
Query: 416 SSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475
+L LL + I +G+EYL S R +H D+ NIL++ + KI+DFG
Sbjct: 121 R-----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFG 172
Query: 476 LAK-ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
LAK + K+ + + + + APE + S +SD
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWYAPE--SLSDNIFSRQSD 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 315 PRRYSYAD---IKKMTNSFKYKLGQGGYGSVYKGKLI-----DGSNVAVKVLNDSKG--N 364
+ + D +K LG+G +G V + G VAVK L G +
Sbjct: 7 KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH 66
Query: 365 GEEFINEVASISRTSHVNVVTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENH 422
+ E+ + H N+V G C E LI EF+ +GSL++++ +N +
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-----N 121
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICN 481
K+ + L+ AV I +G++YL S + +H D+ N+L++ + KI DFGL K I
Sbjct: 122 KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
KE V + APE C + SD
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPE--CLMQSKFYIASD 211
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
KLGQG +G V+ G + VA+K L + E F+ E + + H +V L E
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
++ E++S GSL F+ L L+ +A IA G+ Y+ +
Sbjct: 334 -EPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ E+ K++DFGLA++ E GA+ + + APE G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 442
Query: 513 YKSD 516
KSD
Sbjct: 443 IKSD 446
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 17/191 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
+G G G V G+L VA+K L ++ +F++E + + + H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G GR ++ E++ NGSL+ F+ + + T L+ + G+ G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFC 505
+H D+ N+L+D + K+SDFGL++ + + ++ + TG + + + APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI- 226
Query: 506 RNIGEVSYKSD 516
S SD
Sbjct: 227 -AFRTFSSASD 236
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 19/196 (9%)
Query: 330 FKYKLGQGGYGSVYKGKLI-----DGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNV 383
F +LG+G +GSV + G VAVK L + ++ + +F E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 384 VTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
V G C+ RR LI E++ GSL ++ ++ ++ LLQ I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 159
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIA 500
YL + R +H D+ NIL++ + KI DFGL K + KE + + A
Sbjct: 160 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 501 PEVFCRNIGEVSYKSD 516
PE + S SD
Sbjct: 217 PE--SLTESKFSVASD 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 35/210 (16%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
LG+GG+G V++ K +D N A+K L + + E+ + EV ++++ H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 390 CFEG---------RRRALIY---EFVSNGSLEKFI-YRNSSSIENHKLTWETLLQIAVGI 436
E + +Y + +L+ ++ R + + LQIA
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA--- 128
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI----------CNRKESI 486
+E+LH S ++H D+KP NI D K+ DFGL +
Sbjct: 129 -EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
TG GT Y++PE S+K D
Sbjct: 185 ARHTGQVGTKLYMSPEQ-IHGNS-YSHKVD 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 19/238 (7%)
Query: 288 YRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKL 347
+ Y + ++I+ N + ++ + F +G+G +G VY G L
Sbjct: 51 AGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTL 110
Query: 348 IDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR-RALIY 400
+D AVK LN G +F+ E + SH NV++LLG C ++
Sbjct: 111 LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170
Query: 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460
++ +G L FI + H T + L+ + +A+G+++L S + +H D+ N
Sbjct: 171 PYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARN 222
Query: 461 ILLDEDFCPKISDFGLAKICNRKE--SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+LDE F K++DFGLA+ KE S+ + TGA+ V ++A E + KSD
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK--FTTKSD 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 20/192 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLL 387
K+G+G + VY+ L+DG VA+K + + I E+ + + +H NV+
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
E ++ E G L + I + + T+ + V + LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVF 504
S R++H DIKP N+ + K+ D GL + + K T A VG Y++PE
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYMSPER- 207
Query: 505 CRNIGEVSYKSD 516
G ++KSD
Sbjct: 208 IHENG-YNFKSD 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 291 FSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNS---FKYKLGQGGYGSVYKGKL 347
S S + L+ H P+ +S A + + K++LG+G +G V+ +
Sbjct: 3 MGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 348 IDGSN------VAVKVLND-SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400
+ VAVK L + S+ ++F E ++ H ++V G C EGR +++
Sbjct: 63 HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 401 EFVSNGSLEKF---------IYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
E++ +G L +F + + L LL +A +A G+ YL
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHF 179
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLA 477
+H D+ N L+ + KI DFG++
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 52/192 (27%), Positives = 98/192 (51%), Gaps = 18/192 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
+G G +G VYKG L S VA+K L ++ +F+ E + + SH N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L G + + +I E++ NG+L+KF+ + + + L+ + GIA G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVF 504
+ +H D+ NIL++ + K+SDFGL++ + + E+ + +G + + + APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 505 CRNIGEVSYKSD 516
+ + + SD
Sbjct: 223 --SYRKFTSASD 232
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN------VAVKVLND--SKGNGEEFINEVASISRTSHVNVV 384
+LGQG +G VY+G VA+K +N+ S EF+NE + + + +VV
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHK----LTWETLLQIAVGIARGL 440
LLG +G+ +I E ++ G L+ ++ ++ N+ + ++Q+A IA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
YL+ + + +H D+ N ++ EDF KI DFG+ + + V +++
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 501 PEVFCRNIGEVSYKSD 516
PE + + SD
Sbjct: 209 PESLKDGV--FTTYSD 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLLG 388
K+G+G +G K DG +K +N S+ + +E EVA ++ H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
E ++ ++ G L K I + + +L V I L+++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQ----KGVLFQEDQILDWFVQICLALKHVH---D 143
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG---YIAPEVFC 505
+ILH DIK NI L +D ++ DFG+A++ N + AR +G Y++PE+ C
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-----ARACIGTPYYLSPEI-C 197
Query: 506 RNIGEVSYKSD 516
N + KSD
Sbjct: 198 ENKP-YNNKSD 207
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFI----NEVASISRTSHVNVVTLL 387
LG GG V+ + L D +VAVKVL F E + + +H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 388 GFCFEGRRRALIY----EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+ E+V +L + +T + +++ + L +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFS 132
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPE 502
H I+H D+KP NI++ K+ DFG+A+ + ++ T A GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
+G+G +G V++G + N VA+K + S E+F+ E ++ + H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G +I E + G L F+ + L +L+ A ++ L YL
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLE-- 133
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S R +H DI N+L+ + C K+ DFGL++ + + + + ++APE
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI-- 189
Query: 507 NIGEVSYKSD 516
N + SD
Sbjct: 190 NFRRFTSASD 199
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
LG+G YG VY G+ L + +A+K + + E+A H N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEYLHLGCSTR 450
E + E V GSL + ++++ E + I GL+YLH +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDN----EQTIGFYTKQILEGLKYLH---DNQ 142
Query: 451 ILHFDIKPHNILLD-EDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFCRNI 508
I+H DIK N+L++ KISDFG +K + + T GT+ Y+APE+ +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEIIDKGP 199
Query: 509 GEVSYKSD 516
+D
Sbjct: 200 RGYGKAAD 207
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G V G G+ VAVK + + + F+ E + +++ H N+V LLG E
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 393 GRRRALI-YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+ I E+++ GSL ++ L + LL+ ++ + +EYL
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 511
+H D+ N+L+ ED K+SDFGL KE+ + + V + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKK--F 191
Query: 512 SYKSD 516
S KSD
Sbjct: 192 STKSD 196
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 20/186 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGF 389
LGQG +V++G+ G A+KV N+ + + E + + +H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 390 CFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
E EF GSL + S++ + L L + + G+ +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 447 CSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
I+H +IKP NI+ D K++DFG A+ E GT Y+ P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 503 VFCRNI 508
++ R +
Sbjct: 186 MYERAV 191
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 17/191 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
+G G +G V G+L S VA+K L ++ +F+ E + + + H N++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G + + ++ E++ NGSL+ F+ ++ + T L+ + GIA G++YL
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEVFC 505
+H D+ NIL++ + K+SDFGL + + + E+ + G + + + +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI- 222
Query: 506 RNIGEVSYKSD 516
+ + SD
Sbjct: 223 -AYRKFTSASD 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSN------VAVKVLND--SKGNGEEFINEVASISRTSHVNVV 384
LG G +G VY+G++ N VAVK L + S+ + +F+ E IS+ +H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS-SSIENHKLTWETLLQIAVGIARGLEYL 443
+G + R ++ E ++ G L+ F+ + L LL +A IA G +YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 444 HLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
+H DI N LL KI DFG+A+ R A V ++
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 501 PEVFCRNIGEVSYKSD 516
PE F I + K+D
Sbjct: 214 PEAFMEGI--FTSKTD 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G +G V G G+ VAVK + + + F+ E + +++ H N+V LLG
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 390 CFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
E + ++ E+++ GSL ++ L + LL+ ++ + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---G 307
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+H D+ N+L+ ED K+SDFGL KE+ + + V + APE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREKK 362
Query: 509 GEVSYKSD 516
S KSD
Sbjct: 363 --FSTKSD 368
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 329 SFKYKLGQGGYGSVYKGKL--IDGSN----VAVKVLNDSKGNGE--EFINEVASISR-TS 379
SF LG G +G V + + S+ VAVK+L S E ++E+ +S +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF------------IYRNSSSIENHKLTWE 427
H+N+V LLG C G +I E+ G L F + L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
LL + +A+G+ +L S +H D+ NILL KI DFGLA+ + +
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
AR V ++APE + +++SD
Sbjct: 203 VKGNARLPVKWMAPESIFNCV--YTFESD 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNGE--EFINEVASISR-TS 379
F LG G +G V + VAVK+L + E ++E+ +S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIE--------NHKLTWETLLQ 431
H N+V LLG C G +I E+ G L F+ R S +E N + LL
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
+ +A+G+ +L S +H D+ N+LL KI DFGLA+ + I
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 492 ARGTVGYIAPEVFCRNIGEVSYKSD 516
AR V ++APE + + +SD
Sbjct: 226 ARLPVKWMAPESIFDCV--YTVQSD 248
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
LG+G +G VY+G + VAVK + N E+F++E + H ++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G E +I E G L ++ RN + L TL+ ++ I + + YL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLE-- 130
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S +H DI NIL+ C K+ DFGL++ E + R + +++PE
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESI-- 186
Query: 507 NIGEVSYKSD 516
N + SD
Sbjct: 187 NFRRFTTASD 196
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 21/167 (12%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLND--SKGNGEEFINEVASISRTSH 380
F +LG+ +G VYKG L + VA+K L D EEF +E +R H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS----------SSIENHKLTWETLL 430
NVV LLG + + ++I+ + S+G L +F+ S L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 431 QIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
+ IA G+EYL S ++H D+ N+L+ + KISD GL
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 23/196 (11%)
Query: 330 FKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVT 385
F ++G+G + +VYKG VA L D K E F E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 386 LLGFCFEGRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ L+ E +++G+L+ ++ R + + L I +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQ 143
Query: 442 YLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
+LH + I+H D+K NI + KI D GLA + GT ++A
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA 198
Query: 501 PEVFCRNIGEVSYKSD 516
PE++ E D
Sbjct: 199 PEMYEEKYDE---SVD 211
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 19/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGS---NVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTL 386
+LG G +G+V KG VAVK+L + +E + E + + + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G C E L+ E G L K++ +N + + ++++ ++ G++YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLE-- 134
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVFC 505
+ +H D+ N+LL KISDFGL+K E+ + V + APE
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192
Query: 506 RNIGEVSYKSD 516
N + S KSD
Sbjct: 193 -NYYKFSSKSD 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 29/256 (11%)
Query: 285 IMFYRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYAD---IKKMTNSFKYKLGQGGYGS 341
+ +Y +D F ++ + + LG+G +G
Sbjct: 25 MGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQ 84
Query: 342 VYKGKLIDGSN--------VAVKVLNDSKGNGE--EFINEVASISR-TSHVNVVTLLGFC 390
V + I VAVK+L + + I+E+ + H N++ LLG C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 391 FEGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWETLLQIAVGIARGL 440
+ +I E+ S G+L ++ N S +L+ + L+ A +ARG+
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
EYL S + +H D+ N+L+ ED KI+DFGLA+ + + T R V ++A
Sbjct: 205 EYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 261
Query: 501 PEVFCRNIGEVSYKSD 516
PE I +++SD
Sbjct: 262 PEALFDRI--YTHQSD 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 22/205 (10%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLND-SKGNGEEFINEVASISRTSHV 381
K +LG+G +G V+ + + S VAVK L D + ++F E ++ H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWETLLQ 431
++V G C +G +++E++ +G L KF + +L +L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
IA IA G+ YL S +H D+ N L+ + KI DFG+++ +
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 492 ARGTVGYIAPEVFCRNIGEVSYKSD 516
+ ++ PE + +SD
Sbjct: 195 TMLPIRWMPPESIMYRK--FTTESD 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 26/188 (13%)
Query: 333 KLGQGGYGSVYKGKLIDGS---NVAVKVLND--SKGNGEEFINEVASI--SRTSHVNVVT 385
+G+G +G V K ++ + A+K + + SK + +F E + H N++
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE-LEVLCKLGHHPNIIN 90
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWETLLQIAVG 435
LLG C L E+ +G+L F ++ L+ + LL A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI-ISMTGARG 494
+ARG++YL + +H D+ NIL+ E++ KI+DFGL+ R + + + T R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRL 203
Query: 495 TVGYIAPE 502
V ++A E
Sbjct: 204 PVRWMAIE 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 29/196 (14%)
Query: 333 KLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNGE--EFINEVASISRTSHVNVV 384
LG+G +G V K VAVK+L ++ E + ++E + + +H +V+
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKF------------------IYRNSSSIENHKLTW 426
L G C + LI E+ GSL F + + LT
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 427 ETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486
L+ A I++G++YL +++H D+ NIL+ E KISDFGL++ ++S
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 487 ISMTGARGTVGYIAPE 502
+ + R V ++A E
Sbjct: 207 VKRSQGRIPVKWMAIE 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 46/194 (23%), Positives = 75/194 (38%), Gaps = 32/194 (16%)
Query: 333 KLGQGGYGSVYKGK--LIDGSNVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVTLLG 388
+ GG G +Y ++G V +K L S + E ++ H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 389 FCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
F R ++ E+V SL + KL + + I L YL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSL--------KRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPE 502
H S +++ D+KP NI+L E+ K+ D G I+ G GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------RINSFGYLYGTPGFQAPE 247
Query: 503 VFCRNIGEVSYKSD 516
+ R + +D
Sbjct: 248 I-VR--TGPTVATD 258
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN------VAVKVLND--SKGNGEEFINEVASISRTSHVNVV 384
LG G +G VY+G++ N VAVK L + S+ + +F+ E IS+ +H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS-SSIENHKLTWETLLQIAVGIARGLEYL 443
+G + R ++ E ++ G L+ F+ + L LL +A IA G +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 444 HLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAK 478
+H DI N LL KI DFG+A+
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 331 KYKLGQGGYGSVYKGKLIDGSN---VAVKVL--NDSKGNGEEFINEVASISRTSHVNVVT 385
+LG G +GSV +G VA+KVL K + EE + E + + + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L+G C + L+ E G L KF+ ++ + ++ ++ G++YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYL-- 452
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEVF 504
+H ++ N+LL KISDFGL+K +S + + + + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 505 CRNIGEVSYKSD 516
N + S +SD
Sbjct: 512 --NFRKFSSRSD 521
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 52/193 (26%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVTLLG 388
+G G YG K + DG + K L+ E ++EV + H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 389 FCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH- 444
R +Y E+ G L I + E L E +L++ + L+ H
Sbjct: 73 -RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 445 -LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+LH D+KP N+ LD K+ DFGLA+I N S GT Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQ 187
Query: 504 FCRNIGEVSYKSD 516
+ + KSD
Sbjct: 188 -MNRMS-YNEKSD 198
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 53/193 (27%), Positives = 79/193 (40%), Gaps = 20/193 (10%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLN----DSKGNGEEFINEVASISRTSHVNVV 384
KLG G +G V +G+ S VAVK L ++FI EV ++ H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L G ++ E GSL + ++ TL + AV +A G+ YL
Sbjct: 85 RLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLE 138
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMT-GARGTVGYIAPEV 503
S R +H D+ N+LL KI DFGL + + + M + + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 504 FCRNIGEVSYKSD 516
S+ SD
Sbjct: 196 L--KTRTFSHASD 206
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLND--SKGNGEEFINEVASISRTSH 380
+ +G+G +G V++ + VAVK+L + S +F E A ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKF------------------IYRNSSSIENH 422
N+V LLG C G+ L++E+++ G L +F SS
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
L+ L IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 333 KLGQGGYGSVYKGKLIDGSN--------VAVKVLND--SKGNGEEFINEVASISR-TSHV 381
LG+G +G V + + VAVK+L D ++ + + ++E+ + H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWETLLQ 431
N++ LLG C + +I E+ S G+L ++ + + + ++T++ L+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
+ARG+EYL S + +H D+ N+L+ E+ KI+DFGLA+ N + T
Sbjct: 162 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 492 ARGTVGYIAPEVFCRNIGEVSYKSD 516
R V ++APE + +++SD
Sbjct: 219 GRLPVKWMAPEALFDRV--YTHQSD 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN------VAVKVLNDSKGNGE--EFINEVASISR-TS 379
F LG G +G V S VAVK+L + + E ++E+ +++ S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF-----------------IYRNSSSIENH 422
H N+V LLG C LI+E+ G L + R + +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482
LT+E LL A +A+G+E+L +H D+ N+L+ KI DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+ + AR V ++APE I + KSD
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI--YTIKSD 256
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 329 SFKYKLGQGGYGSVYKGKL--IDGSN----VAVKVLND--SKGNGEEFINEVASISR-TS 379
LG+G +G V + ID + VAVK+L + + ++E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 380 HVNVVTLLGFCF-EGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWET 428
H+NVV LLG C G +I EF G+L + + LT E
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488
L+ + +A+G+E+L S + +H D+ NILL E KI DFGLA+ + +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516
AR + ++APE + + +SD
Sbjct: 207 KGDARLPLKWMAPETIFDRV--YTIQSD 232
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 46/176 (26%), Positives = 62/176 (35%), Gaps = 17/176 (9%)
Query: 333 KLGQGGYGSVYKG-KLIDGSNVAVKVLN---DSKGNGEEFINEVASISR-TSHVNVVTLL 387
+LG G YG V+K DG AVK + + EV S + H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
EG L E SL++ L + L +LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEA-----WGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S ++H D+KP NI L K+ DFGL + G Y+APE+
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL 227
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSN--------VAVKVLND--SKGNGEEFINEVASISR-T 378
LG+G +G V + + VAVK+L D ++ + + ++E+ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 379 SHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF----------IYRNSSSIENHKLTWET 428
H N++ LLG C + +I E+ S G+L ++ + + + ++T++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488
L+ +ARG+EYL S + +H D+ N+L+ E+ KI+DFGLA+ N +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516
T R V ++APE + +++SD
Sbjct: 262 TTNGRLPVKWMAPEALFDRV--YTHQSD 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 24/181 (13%)
Query: 331 KYKLGQGGYGSVYKGK-LIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLL 387
+ ++G+G +G V++ K G AVK L + + E+ + + S +V L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLY 116
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG-IARGLEYLHLG 446
G EG + E + GSL I+ E +G GLEYLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSL-------GQLIKQMGCLPEDRALYYLGQALEGLEYLH-- 167
Query: 447 CSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGA---RGTVGYIAPE 502
+ RILH D+K N+LL D + DFG A S+ GT ++APE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 503 V 503
V
Sbjct: 227 V 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 37/207 (17%), Positives = 76/207 (36%), Gaps = 21/207 (10%)
Query: 308 RNHGSLAPRRYSYADIKKMT-NSFKY----KLGQGGYGSVYKGKLIDGSNVAVKVLNDSK 362
+H S + M+ Y ++G GG V++ A+K +N +
Sbjct: 5 HHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE 64
Query: 363 GNGEE---FINEVASISRTSH--VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSS 417
+ + + NE+A +++ ++ L + + ++ E N L ++
Sbjct: 65 ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----- 118
Query: 418 SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
+ + + + +H I+H D+KP N L+ + K+ DFG+A
Sbjct: 119 -KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIA 173
Query: 478 KICNRKESIISMTGARGTVGYIAPEVF 504
+ + GTV Y+ PE
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAI 200
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-H 380
+K + S K LG G G+V G VAVK + + + E+ ++ + H
Sbjct: 12 SLKNLVVSEK-ILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68
Query: 381 VNVVTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWE-TLLQIAVGIA 437
NV+ +C E R + E N +L+ + + S EN KL E + + IA
Sbjct: 69 PNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLD-------------EDFCPKISDFGLAKICNRKE 484
G+ +LH S +I+H D+KP NIL+ E+ ISDFGL K + +
Sbjct: 126 SGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 485 SIIS--MTGARGTVGYIAPEVF 504
S + GT G+ APE+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELL 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 43/190 (22%), Positives = 78/190 (41%), Gaps = 19/190 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFI----NEVASISRTSHVNVVTLL 387
+G+GG G VY+ + + VA+K+++++ + F E + R +VV +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F + + ++ L + L + I I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML------RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCR 506
+ H D+KP NIL+ D + DFG+A + ++ G GT+ Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 507 NIGEVSYKSD 516
+Y++D
Sbjct: 210 --SHATYRAD 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 20/186 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGF 389
LGQG +V++G+ G A+KV N+ + + E + + +H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 390 CFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
E EF GSL + S++ + L L + + G+ +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 447 CSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
I+H +IKP NI+ D K++DFG A+ E +S+ GT Y+ P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPD 185
Query: 503 VFCRNI 508
++ R +
Sbjct: 186 MYERAV 191
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVTL 386
+G+G +G V++G + N VA+K + S E+F+ E ++ + H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G +I E + G L F+ L +L+ A ++ L YL
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLE-- 508
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S R +H DI N+L+ + C K+ DFGL++ + + + + ++APE
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI-- 564
Query: 507 NIGEVSYKSD 516
N + SD
Sbjct: 565 NFRRFTSASD 574
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-- 379
+ K++ K LG G G++ + D +VAVK + EV + R S
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL--PECFSFADREVQ-LLRESDE 76
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
H NV+ + + + + E + +L++++ + + L Q G
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQ----TTSG 130
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNRKESIIS-MTGAR 493
L +LH S I+H D+KPHNIL+ ISDFGL K S +G
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 494 GTVGYIAPEVFCRNIGE-VSYKSD 516
GT G+IAPE+ + E +Y D
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVD 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 33/177 (18%), Positives = 69/177 (38%), Gaps = 16/177 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSH--VNVVTLL 387
++G GG V++ A+K +N + + + + NE+A +++ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ + ++ E N L ++ + + + + +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIH--- 125
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I+H D+KP N L+ + K+ DFG+A + + GTV Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 38/209 (18%)
Query: 333 KLGQGGYGSVYKG-KLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTS-HVNVVTLL 387
K+G G +GSV+K K +DG A+K + + + EV + + H +VV
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 388 GFCFEGRRRALIY-EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ LI E+ + GSL I N L + + + RGL Y+H
Sbjct: 78 S-AWAEDDHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 447 CSTRILHFDIKPHNILLDEDFCP-------------------KISDFGLAKICNRKESII 487
S ++H DIKP NI + P KI D G + +
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
G ++A EV N K+D
Sbjct: 192 ------GDSRFLANEVLQENYTH-LPKAD 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 329 SFKYKLGQGGYGSVYKGKLIDGSN--------VAVKVLN-DSKGNGEEFINEVASISRTS 379
F LGQG + ++KG + + V +KVL+ + E F + +S+ S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 380 HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARG 439
H ++V G C G L+ EFV GSL+ ++ +N + + L++A +A
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAA 125
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCP--------KISDFGLAKICNRKESIISMTG 491
+ +L ++H ++ NILL + K+SD G++ ++
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------VLPKDI 176
Query: 492 ARGTVGYIAPEVFCRNIGEVSYKSD 516
+ + ++ PE N ++ +D
Sbjct: 177 LQERIPWVPPECI-ENPKNLNLATD 200
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 307 LRNHGSLAPR---RYSYADIKKMTNSFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLN--- 359
+ +H P ++S A + LG+G +G V K I G AVKV++
Sbjct: 5 MMDHLHATPGMFVQHSTAIFSDRY-KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 360 -DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSS 418
K + E + EV + + H N++ L F + L+ E + G L I
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ 117
Query: 419 IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFG 475
I + + +I + G+ Y+H +I+H D+KP N+LL +D +I DFG
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 510
L+ + M GT YIAPEV E
Sbjct: 175 LSTHFEASKK---MKDKIGTAYYIAPEVLHGTYDE 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 54/189 (28%), Positives = 79/189 (41%), Gaps = 19/189 (10%)
Query: 329 SFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVV 384
KLG G YG V + + A+K++ + + + EVA + H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L F + R L+ E G L I I K I + G+ YLH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 445 LGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
I+H D+KP N+LL ++D KI DFGL+ + ++ M GT YIAP
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAP 207
Query: 502 EVFCRNIGE 510
EV + E
Sbjct: 208 EVLRKKYDE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 52/187 (27%), Positives = 75/187 (40%), Gaps = 32/187 (17%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG+GG+ ++ D A K++ S E+ E++ +H +VV G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 389 FCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
FE ++ E SL + R LT I G +YLH
Sbjct: 109 -FFEDNDF--VFVVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLH- 158
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIA 500
R++H D+K N+ L+ED KI DFGLA + + G R GT YIA
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 209
Query: 501 PEVFCRN 507
PEV +
Sbjct: 210 PEVLSKK 216
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 51/187 (27%), Positives = 74/187 (39%), Gaps = 32/187 (17%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG+GG+ ++ D A K++ S E+ E++ +H +VV G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 389 FCFEGRRRALIY---EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
FE ++ E SL + LT I G +YLH
Sbjct: 83 -FFEDNDF--VFVVLELCRRRSLLELH------KRRKALTEPEARYYLRQIVLGCQYLH- 132
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIA 500
R++H D+K N+ L+ED KI DFGLA + + G R GT YIA
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------TKVEYDGERKKVLCGTPNYIA 183
Query: 501 PEVFCRN 507
PEV +
Sbjct: 184 PEVLSKK 190
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 21/213 (9%)
Query: 307 LRNHGSLAPRRYSYADIKKMTN--SFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKG 363
+ +H + R + + LG+G +G V K K I AVKV+N +
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 364 NGEE---FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIE 420
++ + EV + + H N++ L + ++ E + G L I I+
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IK 114
Query: 421 NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLA 477
+ + +I + G+ Y+H I+H D+KP NILL ++D KI DFGL+
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGE 510
+ M GT YIAPEV E
Sbjct: 172 TCFQQNTK---MKDRIGTAYYIAPEVLRGTYDE 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLL 387
F LG G + V+ K G A+K + S + + NE+A + + H N+VTL
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 388 GFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+E L+ + VS G L I +E T + + + ++YLH
Sbjct: 73 DI-YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLH-- 123
Query: 447 CSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I+H D+KP N+L +E+ I+DFGL+K+ M+ A GT GY+APEV
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEV 178
Query: 504 FCRN 507
+
Sbjct: 179 LAQK 182
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 32/177 (18%), Positives = 68/177 (38%), Gaps = 16/177 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE---FINEVASISRTSH--VNVVTLL 387
++G GG V++ A+K +N + + + + NE+A +++ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ + ++ E N L ++ + + + + +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIH--- 172
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I+H D+KP N L+ + K+ DFG+A + + G V Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 15/208 (7%)
Query: 309 NHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLN--DSKGNG 365
+H S Y I FK KLG G +G V+ + G +K +N S+
Sbjct: 6 HHSSGRENLYFQGTIDD-LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM 64
Query: 366 EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLT 425
E+ E+ + H N++ + + ++ E G L + I S+ L+
Sbjct: 65 EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV--SAQARGKALS 122
Query: 426 WETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNR 482
+ ++ + L Y H S ++H D+KP NIL KI DFGLA++
Sbjct: 123 EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 483 KESIISMTGARGTVGYIAPEVFCRNIGE 510
E T A GT Y+APEVF R++
Sbjct: 180 DEH---STNAAGTALYMAPEVFKRDVTF 204
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 26/215 (12%), Positives = 49/215 (22%), Gaps = 41/215 (19%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLLG 388
L G V+ + ++ + A+KV N E + +R +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 389 FC--------------------------FEGRRRALIYEFVSNGSLEKFIYRNSSSIENH 422
+ L+ S LE
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 423 -KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481
L + + R L S ++H P N+ + D + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+ S V Y E + ++ +
Sbjct: 246 TRGPASS-----VPVTYAPREFLNASTATFTHALN 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 19/185 (10%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVT 385
K +LG+G + V + G A K++N K + + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L E L+++ V+ G L + I + + I + Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH- 122
Query: 446 GCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
S I+H ++KP N+LL + K++DFGLA N E + G GT GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPE 177
Query: 503 VFCRN 507
V ++
Sbjct: 178 VLKKD 182
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 328 NSFKYK----LGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISR-TSH 380
+ + L +GG+ VY+ + + G A+K L + + I EV + + + H
Sbjct: 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 381 VNVVTLLGFCFEGRRRA-------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
N+V G+ + L+ + G L +F+ + S L+ +T+L+I
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES---RGPLSCDTVLKIF 142
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
R ++++H I+H D+K N+LL K+ DFG A + R
Sbjct: 143 YQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 494 ----------GTVGYIAPEVF----CRNIGEVSYKSD 516
T Y PE+ IGE K D
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGE---KQD 235
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 21/213 (9%)
Query: 307 LRNHGSLAPRRYSYADIKKMTN--SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKG 363
+ +H + R + + LG+G +G V K K AVKV+N +
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 364 NGEE---FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIE 420
++ + EV + + H N++ L + ++ E + G L I I+
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IK 114
Query: 421 NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLA 477
+ + +I + G+ Y+H I+H D+KP NILL ++D KI DFGL+
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGE 510
+ M GT YIAPEV E
Sbjct: 172 TCFQQNTK---MKDRIGTAYYIAPEVLRGTYDE 201
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 18/175 (10%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G+VY + +A+KVL ++ G + EV S H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ + R LI E+ G++ + + + K + +A L Y H S
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCH---S 127
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
R++H DIKP N+LL KI+DFG + S GT+ Y+ PE+
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLC-GTLDYLPPEM 178
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 61/206 (29%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 329 SFKYKLGQGGYGSVYKGK-LIDGSNVAVKVLN--------------DSKGNGEEFINEVA 373
KLG G YG V K S A+KV+ + + EE NE++
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 374 SISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
+ H N++ L + + L+ EF G L + I I HK I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI------INRHKFDECDAANIM 152
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMT 490
I G+ YLH I+H DIKP NILL + KI DFGL+ ++ +
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LR 206
Query: 491 GARGTVGYIAPEVFCRNIGEVSYKSD 516
GT YIAPEV + E K D
Sbjct: 207 DRLGTAYYIAPEVLKKKYNE---KCD 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/242 (21%), Positives = 92/242 (38%), Gaps = 31/242 (12%)
Query: 298 GSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKY--KLGQGGYGSVYKGKLIDGSNVAV 355
G +++ L N+ +L + K N ++ L QG + + + D A+
Sbjct: 1 GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYAL 59
Query: 356 KVLN------------------DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397
K K ++F NE+ I+ + +T G
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEV 118
Query: 398 -LIYEFVSNGSLEKFIYRNS--SSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHF 454
+IYE++ N S+ KF + + + I + Y+H I H
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHR 176
Query: 455 DIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYK 514
D+KP NIL+D++ K+SDFG ++ K+ + G+RGT ++ PE F K
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 515 SD 516
D
Sbjct: 233 VD 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 27/185 (14%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG+G + VY+ + + G VA+K+++ G + NEV + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
FE L+ E NG + +++ + I G+ YLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLH--- 129
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-----GTVGYIAPE 502
S ILH D+ N+LL + KI+DFGLA + + M + GT YI+PE
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYISPE 182
Query: 503 VFCRN 507
+ R+
Sbjct: 183 IATRS 187
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 27/193 (13%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-EEFINEVASISRTSHVNVVTLLGFC 390
+LG G +G V++ G K +N NE++ +++ H ++ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 391 FEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR----GLEYLHL 445
FE + LI EF+S G L I E++K++ E + R GL+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAA-----EDYKMS-E---AEVINYMRQACEGLKHMH- 166
Query: 446 GCSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I+H DIKP NI+ + KI DFGLA N E + T + APE+
Sbjct: 167 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEI 221
Query: 504 FCRNIGEVSYKSD 516
R V + +D
Sbjct: 222 VDRE--PVGFYTD 232
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 42/247 (17%), Positives = 78/247 (31%), Gaps = 40/247 (16%)
Query: 277 LIALLSFWIMFYRKFSSYDSTGSCLNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQ 336
L++ LS + Y + + +T + L + + LG+
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQ----LGSKLV---YVHH-------LLGE 75
Query: 337 GGYGSVYKGKLIDGSN------VAVKVLNDSKGNGEEF---INEVASISRTSHVNVVTLL 387
G + VY+ D ++ +KV N EF + + + +
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERLKPSMQHMFMKFY 133
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
L+ E S G+L I ++ E + ++ A+ + +E +H
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE-KVMPQGLVISFAMRMLYMIEQVH--- 189
Query: 448 STRILHFDIKPHNILLDEDFCP-----------KISDFGLAKICNRKESIISMTGARGTV 496
I+H DIKP N +L F + D G + T T
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 497 GYIAPEV 503
G+ E+
Sbjct: 250 GFQCVEM 256
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 21/186 (11%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE---FINEVASISRTSHVNVVT 385
K +LG+G + V + G A K++N K + + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 386 LLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L + L+++ V+ G L + I + + I + Y H
Sbjct: 93 LHDS-IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 145
Query: 445 LGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
S I+H ++KP N+LL + K++DFGLA N E+ G GT GY++P
Sbjct: 146 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSP 199
Query: 502 EVFCRN 507
EV ++
Sbjct: 200 EVLKKD 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 17/186 (9%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE-FINEVASISRTSHVNVVTLL 387
+ +G+G +G V A K + + F E+ + H N++ L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ L+ E + G L + + + +I + + Y H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 448 STRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+ H D+KP N L D K+ DFGLA + M GT Y++P+V
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVL 180
Query: 505 CRNIGE 510
G
Sbjct: 181 EGLYGP 186
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 29/196 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
+LG G +G VYK K G+ A KV+ S+ E++I E+ ++ H +V LLG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLGC 447
+ + ++ EF G+++ + + LT E QI V + L +LH
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIM-----LELDRGLT-EP--QIQVVCRQMLEALNFLH--- 134
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEV 503
S RI+H D+K N+L+ + +++DFG K +++S I GT ++APEV
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEV 188
Query: 504 -FCRNIGEVSY--KSD 516
C + + Y K+D
Sbjct: 189 VMCETMKDTPYDYKAD 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 45/193 (23%), Positives = 81/193 (41%), Gaps = 24/193 (12%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLN----------DSKGNGEEFINEVASISRT 378
K LG+G V + AVK+++ + + E + EV + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 379 S-HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
S H N++ L L+++ + G L ++ E L+ + +I +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRALL 134
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVG 497
+ LH I+H D+KP NILLD+D K++DFG + + E + GT
Sbjct: 135 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 188
Query: 498 YIAPEVFCRNIGE 510
Y+APE+ ++ +
Sbjct: 189 YLAPEIIECSMND 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 21/192 (10%)
Query: 331 KYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-EEFINEVASISRTSHVNVVTLLG 388
LG G +G V+K + G +A K++ EE NE++ +++ H N++ L
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 389 FCFEGRRR-ALIYEFVSNGSL-EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
FE + L+ E+V G L ++ I + + LT + I G+ ++H
Sbjct: 154 A-FESKNDIVLVMEYVDGGELFDRIIDES------YNLTELDTILFMKQICEGIRHMH-- 204
Query: 447 CSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
ILH D+KP NIL + KI DFGLA+ +E + GT ++APEV
Sbjct: 205 -QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVV 260
Query: 505 CRNIGEVSYKSD 516
+ VS+ +D
Sbjct: 261 NYD--FVSFPTD 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 42/192 (21%), Positives = 70/192 (36%), Gaps = 26/192 (13%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
LG+G +G V++ K + + E++ ++ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 392 EGRRRALIYEFVSNGSL-EKFIYRNSSSIENHKLTWETLLQIAVGIAR----GLEYLHLG 446
+I+EF+S + E+ E + V L++LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNE----------REIVSYVHQVCEALQFLH-- 119
Query: 447 CSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S I HFDI+P NI+ KI +FG A+ + + Y APEV
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 505 CRNIGEVSYKSD 516
+ VS +D
Sbjct: 176 QHD--VVSTATD 185
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 41/188 (21%), Positives = 71/188 (37%), Gaps = 17/188 (9%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI------NEVASISRTSHVN 382
+G+G + V + + G AVK+++ +K + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+V LL +++EF+ L I + + + + I L Y
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRY 145
Query: 443 LHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
H I+H D+KPH +LL + K+ FG+A + G GT ++
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFM 200
Query: 500 APEVFCRN 507
APEV R
Sbjct: 201 APEVVKRE 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 36/225 (16%)
Query: 306 FLRNHGSLAPRRYSYADIKKMTNSFKY----KLGQGGYGSVYKGKLID-GSNVAVKVLND 360
F+ ++ + ++ +Y LG G G V VA+++++
Sbjct: 116 FVFFDLTVDDQSVYPKALRD-----EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK 170
Query: 361 SKGNGEE---------FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKF 411
K E+ + + +H ++ + F F+ ++ E + G L
Sbjct: 171 RKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDK 229
Query: 412 IYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFC 468
+ + N +L T + ++YLH I+H D+KP N+LL +ED
Sbjct: 230 V------VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCL 280
Query: 469 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY 513
KI+DFG +KI M GT Y+APEV ++G Y
Sbjct: 281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVL-VSVGTAGY 321
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 55/197 (27%), Positives = 81/197 (41%), Gaps = 28/197 (14%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVV 384
+LG G + V K + G A K + + EE EV+ + + H NV+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 385 TLLGFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
TL +E R LI E VS G L F+ + L+ E I G+ YL
Sbjct: 79 TLHDV-YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYL 131
Query: 444 HLGCSTRILHFDIKPHNILL---DEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYI 499
H + +I HFD+KP NI+L + K+ DFGLA GT ++
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185
Query: 500 APEVFCRNIGEVSYKSD 516
APE+ + ++D
Sbjct: 186 APEIVNYE--PLGLEAD 200
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 34/195 (17%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
K+G+G G V + G VAVK+++ K E + NEV + H NVV +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLGC 447
G ++ EF+ G+L + + +L E QIA + + L YLH
Sbjct: 112 LVGEELWVLMEFLQGGAL-------TDIVSQVRLN-EE--QIATVCEAVLQALAYLH--- 158
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEV 503
+ ++H DIK +ILL D K+SDFG ++K +++S++ GT ++APEV
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEV 212
Query: 504 FCRNIGEVSY--KSD 516
I Y + D
Sbjct: 213 ----ISRSLYATEVD 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 21/184 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLND--SKGNGEEFINEVASISRTSHVNVVTLL-- 387
+LG GG+G V + G VA+K S N E + E+ + + +H NVV+
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 388 ----GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
L E+ G L K++ + + L + + I+ L YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYL 137
Query: 444 HLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
H RI+H D+KP NI+L + KI D G AK ++ E T GT+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLA 191
Query: 501 PEVF 504
PE+
Sbjct: 192 PELL 195
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 47/185 (25%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE---------FINEVASISRTSHVN 382
LG G G V VA+K+++ K E+ + + +H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
++ + F F+ ++ E + G L + + N +L T + ++Y
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLLAVQY 129
Query: 443 LHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYI 499
LH I+H D+KP N+LL +ED KI+DFG +KI M GT Y+
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYL 183
Query: 500 APEVF 504
APEV
Sbjct: 184 APEVL 188
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 34/195 (17%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
K+GQG G+VY + G VA++ +N + E INE+ + + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLGC 447
G ++ E+++ GSL + + + E QIA + LE+LH
Sbjct: 87 LVGDELWVVMEYLAGGSL-------TDVVTETCMD-EG--QIAAVCRECLQALEFLH--- 133
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEV 503
S +++H DIK NILL D K++DFG + +++ +++ GT ++APEV
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEV 187
Query: 504 FCRNIGEVSY--KSD 516
+ +Y K D
Sbjct: 188 ----VTRKAYGPKVD 198
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 34/202 (16%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFC 390
+G G YG VYKG+ + G A+KV++ + EE E+ + + S H N+ T G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 391 FEGRRRA------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLE 441
+ L+ EF GS+ I + + + L E IA I RGL
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLK-EE--WIAYICREILRGLS 143
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVG 497
+LH +++H DIK N+LL E+ K+ DFG L + R+ + I GT
Sbjct: 144 HLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPY 194
Query: 498 YIAPEVF-CRNIGEVSY--KSD 516
++APEV C + +Y KSD
Sbjct: 195 WMAPEVIACDENPDATYDFKSD 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
K+G+G +G V+KG VA+K+++ +++ E+ E+ +S+ V G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLG 446
+ + +I E++ GS +E L ET QIA I +GL+YLH
Sbjct: 89 YLKDTKLWIIMEYLGGGSA-------LDLLEPGPLD-ET--QIATILREILKGLDYLH-- 136
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPE 502
S + +H DIK N+LL E K++DFG L ++ + + GT ++APE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 189
Query: 503 VFCRNIGEVSY--KSD 516
V I + +Y K+D
Sbjct: 190 V----IKQSAYDSKAD 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 32/195 (16%)
Query: 332 YKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
KLG+G YGSVYK G VA+K + + + +E I E++ + + +VV G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLGC 447
F+ ++ E+ GS+ I + ++ E +IA +GLEYLH
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLT------ED--EIATILQSTLKGLEYLH--- 142
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGARGTVGYIAPEV 503
R +H DIK NILL+ + K++DFG L ++ ++I GT ++APEV
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEV 196
Query: 504 FCRNIGEVSY--KSD 516
I E+ Y +D
Sbjct: 197 ----IQEIGYNCVAD 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 49/188 (26%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFI-NEVASISRTSHVNVVTLLGFC 390
+LG G +G V++ G+N A K + + +E + E+ ++S H +V L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ +IYEF+S G L + + + E++K++ + ++ + +GL ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLCHMH---ENN 275
Query: 451 ILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+H D+KP NI+ K+ DFGL + K+ S+ GT + APEV
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA--EG 330
Query: 509 GEVSYKSD 516
V Y +D
Sbjct: 331 KPVGYYTD 338
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 53/196 (27%), Positives = 79/196 (40%), Gaps = 26/196 (13%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVV 384
+LG G + V K + G A K + + EE EV+ + + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
TL LI E VS G L F+ + L+ E I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 445 LGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTGARGTVGYIA 500
+ +I HFD+KP NI+L + P K+ DFGLA GT ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 501 PEVFCRNIGEVSYKSD 516
PE+ + ++D
Sbjct: 187 PEIVNYE--PLGLEAD 200
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 27/193 (13%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN----DSKGNGEEFINEVASISRTSHVNVVTLL 387
++G G +G+VY + + + VA+K ++ S ++ I EV + + H N +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLH 444
G L+ E+ GS + + ++ E +IA G +GL YLH
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ------EV--EIAAVTHGALQGLAYLH 171
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV- 503
S ++H D+K NILL E K+ DFG A I S + GT ++APEV
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVI 222
Query: 504 FCRNIGEVSYKSD 516
+ G+ K D
Sbjct: 223 LAMDEGQYDGKVD 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 20/187 (10%)
Query: 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVV 384
+LG+G + V + + G A ++N K + ++ E H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 385 TLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
L LI++ V+ G L + I + + I + +
Sbjct: 74 RLHDS-ISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHC 126
Query: 444 HLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
H ++H ++KP N+LL + K++DFGLA ++ G GT GY++
Sbjct: 127 H---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLS 181
Query: 501 PEVFCRN 507
PEV ++
Sbjct: 182 PEVLRKD 188
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 8e-23
Identities = 54/187 (28%), Positives = 74/187 (39%), Gaps = 24/187 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVV 384
+LG G + V K + G A K + + + EE EV + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
TL LI E VS G L F+ E LT + Q I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 445 LGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
S RI HFD+KP NI+L + K+ DFG+A GT ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVA 179
Query: 501 PEVFCRN 507
PE+
Sbjct: 180 PEIVNYE 186
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 8e-23
Identities = 32/219 (14%), Positives = 64/219 (29%), Gaps = 41/219 (18%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINE--------------------- 371
LGQ + + G + V V ++ I +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 372 -----VASISRTSHVNVVTLLGFCFEGRRRALIYEFV----SNGSLEKFIYRNSSSIENH 422
+ ++ + R ++ F +L+ F S H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 423 K-LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481
K L LQ+ + + R L LH ++H ++P +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 482 RKESIISMTGAR-GTVGYIAPEVFCR---NIGEVSYKSD 516
S +S G A + + +++ D
Sbjct: 263 --ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-23
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 20/177 (11%)
Query: 334 LGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLG 388
LG+G +G+VY + +A+KVL S+ G + E+ S H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F R+R L+ EF G L K + ++ + + +A L Y H
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKH------GRFDEQRSATFMEELADALHYCH--- 131
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+++H DIKP N+L+ KI+DFG + S+ T GT+ Y+ PE+
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMC-GTLDYLPPEMI 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 20/184 (10%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLL 387
K +G G Y + AVK+++ SK + E E+ + R H N++TL
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+G+ ++ E + G L I + + + I + +EYLH
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTITKTVEYLH--- 133
Query: 448 STRILHFDIKPHNILL---DEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+ ++H D+KP NIL + +I DFG AK + + + T ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEV 191
Query: 504 FCRN 507
R
Sbjct: 192 LERQ 195
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 51/229 (22%), Positives = 74/229 (32%), Gaps = 48/229 (20%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN------DSKGNGEEFINEVASISRTSHVNVVT 385
+GQG YG V + A+K++N + + E EV + + H N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG---------- 435
L + + L+ E G L + QI
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 436 ------------------------IARGLEYLHLGCSTRILHFDIKPHNILL--DEDFCP 469
I L YLH + I H DIKP N L ++ F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 470 KISDFGLAKICNRKES--IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
K+ DFGL+K + + MT GT ++APEV K D
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 56/201 (27%), Positives = 82/201 (40%), Gaps = 36/201 (17%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVV 384
+LG G + V K + G A K + + E+ EV+ + H NV+
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 385 TLLGFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR----G 439
TL +E + LI E V+ G L F+ E LT E + A + G
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFL------AEKESLT-E---EEATEFLKQILNG 126
Query: 440 LEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAKICNRKESIISMTGARGT 495
+ YLH S +I HFD+KP NI+L KI DFGLA + GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGT 180
Query: 496 VGYIAPEVFCRNIGEVSYKSD 516
++APE+ + ++D
Sbjct: 181 PEFVAPEIVNYE--PLGLEAD 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G G V VA+K +N + + +E + E+ ++S+ H N+V+
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYLHLG 446
L+ + +S GS+ I ++ + HK IA + GLEYLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT-VG---YIAPE 502
+H D+K NILL ED +I+DFG++ I+ R T VG ++APE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 503 VFCRNIG 509
V + G
Sbjct: 197 VMEQVRG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 23/192 (11%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---------EEFINEVASISRTS 379
K +G+G V + G AVK++ + E E + + +
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 380 -HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
H +++TL+ L+++ + G L ++ E L+ + I +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLE 211
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
+ +LH + I+H D+KP NILLD++ ++SDFG + E + GT GY
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGY 265
Query: 499 IAPEVFCRNIGE 510
+APE+ ++ E
Sbjct: 266 LAPEILKCSMDE 277
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 5e-22
Identities = 32/209 (15%), Positives = 61/209 (29%), Gaps = 41/209 (19%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFI----NEVASISRTSHV------- 381
LGQ + + G + V V ++ I EV + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 382 ---------NVVTLLGFCFEGRRRA-----------LIYEFVSNGSLEKFIYRNSSSIEN 421
++V R R +Y + + S S +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 422 HKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481
L LQ+ + + R L LH ++H ++P +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 482 RKESIISMTGARGTVGYIAPEVFCRNIGE 510
+ + G+ PE+ R
Sbjct: 258 ARVVS------SVSRGFEPPELEARRATI 280
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 51/214 (23%)
Query: 309 NHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVK-VLNDSKGNGEE 367
+ + R +Y + K +G G +G V++ KL++ VA+K VL D +
Sbjct: 31 DGKTGEQREIAYTNCKV--------IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KR 77
Query: 368 FIN-EVASISRTSHVNVVTLLGFCFEGRRRA------LIYEFVSNGSLEKFIYRNSSSIE 420
F N E+ + H NVV L F + + L+ E+V ++ + +
Sbjct: 78 FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL-- 134
Query: 421 NHKLTWET----LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFG 475
+ + Q+ R L Y+H S I H DIKP N+LLD K+ DFG
Sbjct: 135 KQTMPMLLIKLYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 476 LAKICNRKESIISMTGARGTVGYI------APEV 503
AKI E +S YI APE+
Sbjct: 188 SAKILIAGEPNVS---------YICSRYYRAPEL 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 331 KYK----LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK----GNGEEFIN-EVASISRTSH 380
KY LG+G YG V + AVK+L K NGE + E+ + R H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 381 VNVVTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
NV+ L+ + ++ ++ E+ G E + + +
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS-----VPEKRFPVCQAHGYFCQLID 120
Query: 439 GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGY 498
GLEYLH S I+H DIKP N+LL KIS G+A+ + + + ++G+ +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 499 IAPEVF 504
PE+
Sbjct: 178 QPPEIA 183
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 53/182 (29%), Positives = 77/182 (42%), Gaps = 19/182 (10%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLG 388
+ +LG+G VY+ K A+KVL + + + E+ + R SH N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
FE L+ E V+ G L I +E + I + YLH
Sbjct: 116 I-FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLH--- 165
Query: 448 STRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I+H D+KP N+L D KI+DFGL+KI + M GT GY APE+
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEIL 222
Query: 505 CR 506
Sbjct: 223 RG 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 64/215 (29%), Positives = 90/215 (41%), Gaps = 52/215 (24%)
Query: 309 NHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVK-VLNDSKGNGE 366
G P+ SY D K +G G +G VY+ KL D G VA+K VL D +
Sbjct: 45 GQGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---- 92
Query: 367 EFIN-EVASISRTSHVNVVTLLGFCFEGRRRA------LIYEFVSNGSLEKFIYRNSSSI 419
F N E+ + + H N+V L F + + L+ ++V ++ + S +
Sbjct: 93 -FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA- 149
Query: 420 ENHKLTWET----LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDF 474
L + Q+ R L Y+H S I H DIKP N+LLD D K+ DF
Sbjct: 150 -KQTLPVIYVKLYMYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 475 GLAKICNRKESIISMTGARGTVGYI------APEV 503
G AK R E +S YI APE+
Sbjct: 202 GSAKQLVRGEPNVS---------YICSRYYRAPEL 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 38/198 (19%), Positives = 70/198 (35%), Gaps = 24/198 (12%)
Query: 333 KLGQG--GYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTL 386
+G+G +V + G V V+ +N S E+ +H N+V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAV---GIARGLEYL 443
++ F++ GS I H + L IA G+ + L+Y+
Sbjct: 92 RATFIADNELWVVTSFMAYGSA-------KDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFG----LAKICNRKESIISMTGAR-GTVGY 498
H +H +K +IL+ D +S + R+ + + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 499 IAPEVFCRNIGEVSYKSD 516
++PEV +N+ KSD
Sbjct: 202 LSPEVLQQNLQGYDAKSD 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 13/190 (6%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKV--LNDSKGNGEEFINEVASISRTS-HVNVVTLLG 388
++G+G YGSV K G +AVK + ++ + ++ + R+S +V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
F + E + + S +K Y+ S+ + + E L +I + + L +L +
Sbjct: 89 ALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLK--EN 144
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+I+H DIKP NILLD K+ DFG I + I+ T G Y+APE +
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 509 GEVSY--KSD 516
Y +SD
Sbjct: 202 SRQGYDVRSD 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 45/204 (22%), Positives = 77/204 (37%), Gaps = 22/204 (10%)
Query: 322 DIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG---EEFINEVASISR 377
+ +LG+G + V + G A K L + E ++E+A +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 378 TSHV-NVVTLLGFCFEGRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
V+ L +E LI E+ + G + + + + + QI G
Sbjct: 85 AKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGA 492
+ YLH I+H D+KP NILL KI DFG+++ +
Sbjct: 144 V----YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREI 193
Query: 493 RGTVGYIAPEVFCRNIGEVSYKSD 516
GT Y+APE+ + ++ +D
Sbjct: 194 MGTPEYLAPEILNYD--PITTATD 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 50/198 (25%), Positives = 76/198 (38%), Gaps = 34/198 (17%)
Query: 331 KYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE-FINEVASISR-TSHVNVVTLL 387
+ LG+G + V LI AVK++ G+ EV + + H NV+ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 388 GFCFEGRRRALIYEFVSNGSL-------EKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
F E R L++E + GS+ F +S + +A L
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD-------------VASAL 124
Query: 441 EYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICN-----RKESIISMTGA 492
++LH + I H D+KP NIL ++ KI DF L S +
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 493 RGTVGYIAPEVFCRNIGE 510
G+ Y+APEV E
Sbjct: 182 CGSAEYMAPEVVEAFSEE 199
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+LG G G V+K G +A K+ L + I E+ + + +V G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ ++ E + GSL++ + + E L ++++ + +GL YL
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIKGLTYLR--EKH 151
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEVFCRNI 508
+I+H D+KP NIL++ K+ DFG++ + I SM + GT Y++PE
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT- 205
Query: 509 GEVSYKSD 516
S +SD
Sbjct: 206 -HYSVQSD 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 14/190 (7%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKV--LNDSKGNGEEFINEVASISRTS-HVNVVTLLG 388
+LG+G YG V K + + G +AVK + + + ++ RT VT G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
F + E + + SL+KF + + + + L +IAV I + LE+LH
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLH--SK 128
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
++H D+KP N+L++ K+ DFG++ + + A G Y+APE +
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDA-GCKPYMAPERINPEL 185
Query: 509 GEVSY--KSD 516
+ Y KSD
Sbjct: 186 NQKGYSVKSD 195
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 52/179 (29%), Positives = 88/179 (49%), Gaps = 19/179 (10%)
Query: 307 LRNHGSLAPRRYSYADIKKMTNSFK-YKLGQGGYGSVYKGKLIDGSNVAVKVLN-DSKGN 364
+ +H + R + M K K+G+G YG VYK K G VA+K + D++
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60
Query: 365 GEEF--INEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH 422
G I E++ + H N+V+L+ R L++EF+ L+K + N + +++
Sbjct: 61 GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS 119
Query: 423 ---KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
++ L RG+ + H RILH D+KP N+L++ D K++DFGLA+
Sbjct: 120 QIKIYLYQLL--------RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVK-VLNDSKGNGEEFIN--EVASISRTSHVNVVTLLG 388
K+G+G YG V+K + D G VA+K L + I E+ + + H N+V LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLEYLHL 445
RR L++E+ + ++ + R + H +TW+TL + + + H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL--------QAVNFCH- 119
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
+H D+KP NIL+ + K+ DFG A
Sbjct: 120 --KHNCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 23/175 (13%)
Query: 356 KVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY---EFVSNGSLEKFI 412
+ + + I R + +G + +Y + +L+ ++
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 413 -YRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471
R S H + +QIA +E+LH S ++H D+KP NI D K+
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 205
Query: 472 SDFGLAKICNR----------KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
DFGL ++ + + TG GT Y++PE N S+K D
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--NYSHKVD 258
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKV--LNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+GG+G V++ K +D N A+K L + + E+ + EV ++++ H +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW 426
E E ++ SS
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS 109
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 326 MTNSFKY----KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN-----EVASI 375
M++S ++ KLG G Y +VYKG G VA+K + K + EE E++ +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLM 57
Query: 376 SRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVG 435
H N+V L + L++EF+ N L+K++ + L +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
+ +GL + H +ILH D+KP N+L+++ K+ DFGLA
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 38/187 (20%), Positives = 72/187 (38%), Gaps = 32/187 (17%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFC 390
LG+G + K AVK+++ E+ ++ H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 391 FEGRRRALIYEFVSNGSL-------EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+ L+ E ++ G L + F +S I + + + + ++
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---------MRK----LVSAVSHM 122
Query: 444 HLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
H ++H D+KP N+L +++ KI DFG A++ + T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAA 177
Query: 501 PEVFCRN 507
PE+ +N
Sbjct: 178 PELLNQN 184
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 26/186 (13%)
Query: 331 KYKLGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLG 388
K LG G G V + G A+K+L DS + EV + S ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQASGGPHIVCILD 89
Query: 389 FCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+E +I E + G L I + E + I +++L
Sbjct: 90 V-YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD----IGTAIQFL 144
Query: 444 HLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
H S I H D+KP N+L ++D K++DFG AK + + T Y+A
Sbjct: 145 H---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVA 197
Query: 501 PEVFCR 506
PEV
Sbjct: 198 PEVLGP 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 53/183 (28%), Positives = 77/183 (42%), Gaps = 25/183 (13%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---------EVASISRTSHVNV 383
LG G +G V+ V VK + K + +I E+A +SR H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 384 VTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENH-KLTWETLLQIAVGIARGLE 441
+ +L FE + L+ E +G L+ F + I+ H +L I + +
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-LDLFAF-----IDRHPRLDEPLASYIFRQLVSAVG 144
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
YL I+H DIK NI++ EDF K+ DFG A E GT+ Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA---AYLERGKLFYTFCGTIEYCAP 198
Query: 502 EVF 504
EV
Sbjct: 199 EVL 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 18/154 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEFIN-----EVASISRTSHVNVVT 385
LG+G + +VYK + VA+K + + ++ IN E+ + SH N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL-TWETLLQIAVGIARGLEYLH 444
LL +L+++F+ LE I NS + + + +L +GLEYLH
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY--MLMTL----QGLEYLH 129
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
ILH D+KP+N+LLDE+ K++DFGLAK
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 6e-19
Identities = 48/150 (32%), Positives = 82/150 (54%), Gaps = 12/150 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEF--INEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + G VA+K + D++ G I E++ + +H N+V LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L++EF+ L+KF+ ++ + L L Q+ +GL + H S
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH---S 121
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAK 478
R+LH D+KP N+L++ + K++DFGLA+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVK-VLNDSKGNGEEFIN--EVASISRTSHVNVVTLLG 388
+G+G YG V K + D G VA+K L + I E+ + + H N+V LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLEYLHL 445
C + +R L++EFV + ++ + + ++ K ++ + G+ + H
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII--------NGIGFCH- 141
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
S I+H DIKP NIL+ + K+ DFG A
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 9e-19
Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEF--INEVASISRTSHVNVVTLLG 388
K+G+G YG+V+K K VA+K + D G + E+ + H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLEYLHL 445
++ L++EF L+K+ + ++ ++ L +GL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL--------KGLGFCH- 118
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
S +LH D+KP N+L++ + K+++FGLA+
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 9e-19
Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLN-DSKGNGEEF--INEVASISRTSHVNVVTLLGF 389
K+G+G YG VYK + G A+K + + + G I E++ + H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLEYLHLG 446
+R L++E + L+K + +E+ + L G+ Y H
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL--------NGIAYCH-- 117
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
R+LH D+KP N+L++ + KI+DFGLA+
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 20/192 (10%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKV--LNDSKGNGEEFINEVASISRTS-HVNVVTLLG 388
++G G G V+K + G +AVK + +K + + ++ + ++ +V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL-QIAVGIARGLEYLHLGC 447
+ E + EK R I E +L ++ V I + L YL
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLK--E 142
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CR 506
++H D+KP NILLDE K+ DFG++ R + + G Y+APE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 507 NIGEVSY--KSD 516
+ + Y ++D
Sbjct: 200 DPTKPDYDIRAD 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 57/180 (31%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFC 390
LG+G YG V + VAVK+++ + E E+ +H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWET----LLQIAVGIARGLEYLHLG 446
EG + L E+ S G L I + + Q+ +A G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQL---MA-GVVYLH-- 122
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+ R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 52/201 (25%), Positives = 76/201 (37%), Gaps = 32/201 (15%)
Query: 322 DIKKMTNSFKYK-----LGQGGYGSVYKG-KLIDGSNVAVKVLNDSKGNGEEFINEVASI 375
IKK YK LG G G V + A+K+L D + EV
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELH 108
Query: 376 SRTS-HVNVVTLLGFCFEGRRRA-----LIYEFVSNGSL-EKFIYRNSSSIENHKLTWET 428
R S ++V ++ +E ++ E + G L + R + T
Sbjct: 109 WRASQCPHIVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----FTERE 162
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRKES 485
+I I ++YLH S I H D+KP N+L + K++DFG AK
Sbjct: 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218
Query: 486 IISMTGARGTVGYIAPEVFCR 506
S+T T Y+APEV
Sbjct: 219 --SLTTPCYTPYYVAPEVLGP 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 23/161 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEFIN-----EVA---SISRTSHVN 382
++G G YG+VYK + G VA+K V + G G + EVA + H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 383 VVTLLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIA 437
VV L+ C R L++E V L ++ L ET+ +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLMRQFL 130
Query: 438 RGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
RGL++LH + I+H D+KP NIL+ K++DFGLA+
Sbjct: 131 RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISR-----------TSHV 381
LG+GG+G+V+ G L D VA+KV+ ++ G +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENH-KLTWETLLQIAVGIARG 439
V+ LL + FE + L+ E + F Y I L +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQ-DLFDY-----ITEKGPLGEGPSRCFFGQVVAA 151
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGY 498
+++ H S ++H DIK NIL+D K+ DFG + + + T GT Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVY 204
Query: 499 IAPEVF 504
PE
Sbjct: 205 SPPEWI 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 24/155 (15%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE-----FINEVASISRTSHVNVVTL 386
KLG+G Y +VYKGK + VA+K + + EE I EV+ + H N+VTL
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENH---KLTWETLLQIAVGIARGLEYL 443
+ L++E++ L++++ + I H ++ L RGL Y
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL--------RGLAYC 116
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
H ++LH D+KP N+L++E K++DFGLA+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 56/176 (31%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFC 390
LG+G YG V + VAVK+++ + E E+ +H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNS--SSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
EG + L E+ S G L I + + + Q+ +A G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH----QL---MA-GVVYLH---G 123
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 54/212 (25%)
Query: 331 KYK----LGQGGYGSVYKGK-LIDGSNVAVKVLNDSK--------------------GNG 365
+Y +G+G YG V D + A+KVL+ K G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 366 EEFINEVASISR-------TSHVNVVTLLGFCFE---GRRRALIY---EFVSNGSLEKFI 412
+ + + + H NVV L E +Y E V+ G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV--ME 127
Query: 413 YRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472
L+ + + +G+EYLH +I+H DIKP N+L+ ED KI+
Sbjct: 128 V-----PTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIA 179
Query: 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
DFG++ ++++S T GT ++APE
Sbjct: 180 DFGVSNEFKGSDALLSNTV--GTPAFMAPESL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 46/205 (22%)
Query: 319 SYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVK-VLNDSKGNGEEFINEVASIS 376
+ + GQG +G+V GK G +VA+K V+ D + E + + ++
Sbjct: 24 RFQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 377 RTSHVNVVTLLGFCFEGRRRA-------LIYEFVSNGSLEKFIYRNSSSIENHKLTWET- 428
H N+V L + + R ++ E+V + +L +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR--QVAPPPILI 131
Query: 429 ---LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKE 484
L Q+ R + LHL S + H DIKPHN+L++E K+ DFG AK + E
Sbjct: 132 KVFLFQLI----RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 485 SIISMTGARGTVGYI------APEV 503
++ YI APE+
Sbjct: 187 PNVA---------YICSRYYRAPEL 202
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 50/184 (27%), Positives = 70/184 (38%), Gaps = 27/184 (14%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN-------EVASISRTSHV--NV 383
LG GG+GSVY G + D VA+K + + + + EV + + S V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 384 VTLLGFCFEGRRRA-LIYEFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ LL + FE LI E L FI E L E + +
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI------TERGALQEELARSFFWQVLEAVR 163
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIA 500
+ H + +LH DIK NIL+D + K+ DFG + T GT Y
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 216
Query: 501 PEVF 504
PE
Sbjct: 217 PEWI 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 56/213 (26%), Positives = 80/213 (37%), Gaps = 45/213 (21%)
Query: 314 APRRYSYADIKKMTNSFKYK----LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEF 368
AP D+ M +S +Y +G G +G + + VAVK + E
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV 63
Query: 369 INEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWET 428
E+ + H N+V A+I E+ S G L + I + + +
Sbjct: 64 QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI------CNAGRFSEDE 117
Query: 429 LLQIAVGIAR--------GLEYLHLGCSTRILHFDIKPHNILLDEDFCP--KISDFGLAK 478
AR G+ Y H S +I H D+K N LLD P KI DFG +K
Sbjct: 118 --------ARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166
Query: 479 ICNRKESIISMTGAR-----GTVGYIAPEVFCR 506
S+ ++ GT YIAPEV R
Sbjct: 167 --------SSVLHSQPKSTVGTPAYIAPEVLLR 191
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 2e-17
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 25/186 (13%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEF-INE---VASISRTSHVNVVT 385
+G+GG+G VY + D + A+K L+ GE +NE ++ +S +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 386 LLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
+ + F + I + ++ G L + ++ E + A I GLE++H
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIILGLEHMH 309
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPEV 503
+ +++ D+KP NILLDE +ISD GLA + A GT GY+APEV
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEV 361
Query: 504 FCRNIG 509
+ +
Sbjct: 362 LQKGVA 367
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 16/175 (9%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---EVASISRTSHVNVVTLLGF 389
+G+G + V + ++ G VA+K+++ ++ N EV + +H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ LI E+ S G + ++ + + ++ + I ++Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQYCH---QK 133
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
RI+H D+K N+LLD D KI+DFG + + G Y APE+F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELF 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 19/155 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEF--INEVASISRTSHVNVVTLLG 388
KLG+G YG VYK + VA+K + + + G I EV+ + H N++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
R LI+E+ N L+K++ +N ++ L Q+ G+ + H S
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLI----NGVNFCH---S 150
Query: 449 TRILHFDIKPHNILLDEDFCP-----KISDFGLAK 478
R LH D+KP N+LL KI DFGLA+
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 32/202 (15%)
Query: 316 RRYSYADIKKMTNSF----KY----KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGE 366
R Y D + + Y KLG+G Y V++ + + V VK+L K +
Sbjct: 18 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--K 75
Query: 367 EFINEVASISR--TSHVNVVTLLGFC--FEGRRRALIYEFVSNGSLEKFIYRNSSSIENH 422
+ E+ I N++TL R AL++E V+N ++ +Y+ + +
Sbjct: 76 KIKREI-KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIR 133
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAKICN 481
+E L + L+Y H S I+H D+KPHN+++D + ++ D+GLA+ +
Sbjct: 134 FYMYEIL--------KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 482 RKESIISMTGARGTVGYIAPEV 503
+ + + PE+
Sbjct: 183 PGQ---EYNVRVASRYFKGPEL 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 28/178 (15%)
Query: 321 ADIKKMTNSFKY---KLGQGGYGSVYKGKLIDGSN---VAVKVLNDSKGNGEEFINEVAS 374
++ +++ + F+Y K+G+G YG VYK K DG + A+K + + G E+A
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIAL 71
Query: 375 ISRTSHVNVVTLLGFCFEGRRRA--LIYEFVSNGSLEKFIYRNSSSIENHKLTWET---- 428
+ H NV++L R L++++ + L I + +S N K
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 429 ---LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFGLAKI 479
L QI G+ YLH + +LH D+KP NIL+ + KI+D G A++
Sbjct: 131 KSLLYQIL----DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 19/183 (10%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V + D + A+K +N + E+ + H +V L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ ++ + + G L + +N E L I + L+YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-----VKLFIC-ELVMALDYLQ--- 132
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
+ RI+H D+KP NILLDE I+DF +A + R+ I +M GT Y+APE+F
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSR 189
Query: 508 IGE 510
G
Sbjct: 190 KGA 192
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 315 PRRYSYADIKKMTNSFKY----KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEF 368
++Y + KY K+GQG +G V+K + G VA+K VL +++ G
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61
Query: 369 --INEVASISRTSHVNVVTLLGFCFEGRRRA--------LIYEFVSNGSLEKFIYRNSSS 418
+ E+ + H NVV L+ C L+++F + L +
Sbjct: 62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL------ 114
Query: 419 IENHKLTWET------LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472
N + + + + GL Y+H +ILH D+K N+L+ D K++
Sbjct: 115 -SNVLVKFTLSEIKRVMQMLL----NGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 166
Query: 473 DFGLAKICN--RKESIISMTGARGTVGYIAPEV 503
DFGLA+ + + T T+ Y PE+
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 29/163 (17%)
Query: 333 KLGQGGYGSVYKGK--LIDGSNVAVK-VLNDSKGNGEEF--INEVA---SISRTSHVNVV 384
++G+G YG V+K + G VA+K V + G I EVA + H NVV
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 385 TLLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHKLTWET----LLQIAVG 435
L C R L++E V L ++ + + ET + Q+
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTETIKDMMFQLL-- 130
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
RGL++LH S R++H D+KP NIL+ K++DFGLA+
Sbjct: 131 --RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 44/218 (20%), Positives = 76/218 (34%), Gaps = 62/218 (28%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVK-VLNDSKGNGEEFIN-EVASISRTSHVNVVTLLGF 389
LG G +G V + I+ G A+K VL D + + N E+ + HVN++ L+ +
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDY 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTW----------------ETLLQIA 433
+ + + N + + + +TL ++
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 434 VG-------------------IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISD 473
+ R + ++H S I H DIKP N+L++ K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 474 FGLAKICNRKESIISMTGARGTVGYI------APEVFC 505
FG AK E ++ YI APE+
Sbjct: 186 FGSAKKLIPSEPSVA---------YICSRFYRAPELML 214
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEFIN-EVASISRTSHVNVVTLLG 388
LG+G + +V + + S A+K+L K N ++ E +SR H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F F+ + + NG L K+I + S E T A I LEYLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIVSALEYLH--- 147
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
I+H D+KP NILL+ED +I+DFG AK+ + + GT Y++PE+
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 18/153 (11%), Positives = 45/153 (29%), Gaps = 22/153 (14%)
Query: 333 KLGQGGYGSVYKGKLID---GSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVT 385
G ++ D VA+ ++ +E ++ +SR V
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH- 444
+L ++ E++ GSL++ + + ++ +A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--------DTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
G + P + + D ++
Sbjct: 148 AG----VALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 57/178 (32%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+GG+G V ++ + A K L K GE +NE + + + VV+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSI--ENHKLTWETLLQIAVGIARGLEYLHL 445
+ +E + L+ ++ G L+ IY + E + + A I GLE LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEICCGLEDLH- 303
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
RI++ D+KP NILLD+ +ISD GLA ++I GTVGY+APEV
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEV 356
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS---KGNGEEF-INEVASISRTSHVNVVTLLG 388
LG+GG+G V+ ++ + A K LN K G + + E +++ +V+L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ FE + L+ ++ G + IY +N + I GLE+LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPEV 503
I++ D+KP N+LLD+D +ISD GLA E T + GT G++APE+
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLA-----VELKAGQTKTKGYAGTPGFMAPEL 360
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-15
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN----EVASISRTSHVNVVTLLG 388
LG G +G V G+ + G VAVK+LN K + + E+ ++ H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 389 FCFE----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
++ ++ E+VS G L +I ++ ++ ++ I ++Y H
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGY 498
++H D+KP N+LLD KI+DFGL+ + M+ G+ Y
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNY 176
Query: 499 IAPEVF 504
APEV
Sbjct: 177 AAPEVI 182
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 22/180 (12%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G + V K+ V A+K++N +G F E + + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKL---TWETLLQIAVGIARGLEYLH 444
F F+ L+ E+ G L + + I E ++ ++ +H
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM--------AIDSVH 179
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+H DIKP NILLD +++DFG ++ S+ A GT Y++PE+
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEIL 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN----EVASISRTSHVNVVTLLG 388
LG G +G V GK + G VAVK+LN K + + E+ ++ H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
++ E+VS G L +I +N +L + ++ I G++Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI------CKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGYIAPE 502
++H D+KP N+LLD KI+DFGL+ + M+ G+ Y APE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNM---------MSDGEFLRTSCGSPNYAAPE 185
Query: 503 VF 504
V
Sbjct: 186 VI 187
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 22/179 (12%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V KL + V A+K+LN + F E + + TL
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKL---TWETLLQIAVGIARGLEYLH 444
+ F+ L+ ++ G L + + + E ++ ++ +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI--------AIDSVH 192
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
+H DIKP NIL+D + +++DFG ++ S A GT YI+PE+
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEI 247
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 18/186 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
+G+G +G V + V A+K+L+ + + F E ++ + VV L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ F+ R ++ E++ G L + + N+ + + + L+ +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL--V-----NLMSNYDVPEKWARFYTAEVVLALDAIH--- 185
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S +H D+KP N+LLD+ K++DFG N++ + T A GT YI+PEV
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQ 244
Query: 508 IGEVSY 513
G+ Y
Sbjct: 245 GGDGYY 250
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 43/192 (22%), Positives = 67/192 (34%), Gaps = 37/192 (19%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEE---FINEVASISRT----------S 379
+ G YG+V G +G VA+K + ++ +G + R
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLNHFH 87
Query: 380 HVNVVTLLG-FCFEGRRRA----LIYEFVSNGSLEKFIYRNSSSIEN-HK--LTWETLLQ 431
H N++ L F L+ E + L + I+ I H + L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL-- 144
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
GL LH ++H D+ P NILL ++ I DF LA+ + T
Sbjct: 145 ------LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192
Query: 492 ARGTVGYIAPEV 503
Y APE+
Sbjct: 193 YVTHRWYRAPEL 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 46/180 (25%), Positives = 67/180 (37%), Gaps = 29/180 (16%)
Query: 315 PRRYSYADIKKMTNSFKYK-----LGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEF 368
P S IKK YK LG G G V + A+K+L D +
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKA 57
Query: 369 INEVASISRTS-HVNVVTLLGFCFEGRRRA-----LIYEFVSNGSL-EKFIYRNSSSIEN 421
EV R S ++V ++ +E ++ E + G L + R +
Sbjct: 58 RREVELHWRASQCPHIVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-T 115
Query: 422 HKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAK 478
+ E + I I YLH S I H D+KP N+L + K++DFG AK
Sbjct: 116 EREASEIMKSIGEAIQ----YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN----EVASISRTSHVNVVTLLG 388
LG+G +G V VA+K ++ + E++ + H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
++ E+ G L +I +E ++T + + I +EY H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAIEYCH---R 126
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR------GTVGYIAPE 502
+I+H D+KP N+LLD++ KI+DFGL+ I MT G+ Y APE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---------MTDGNFLKTSCGSPNYAAPE 177
Query: 503 VF 504
V
Sbjct: 178 VI 179
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 1e-12
Identities = 64/434 (14%), Positives = 122/434 (28%), Gaps = 148/434 (34%)
Query: 48 FTNRTHPECGLMLVDNCNKPVQRIRLGKAGPFYN---ILNIAQDASITLEDQVFQNHLGN 104
++ + C L+++ N VQ + A F IL + +T D + +
Sbjct: 238 LKSKPYENC-LLVLLN----VQNAKAWNA--FNLSCKILLTTRFKQVT--DFLSAATTTH 288
Query: 105 SSCESF-ENLTLPTSASLSFHIKSNPSLFRCTHKLEKNLPSFHFTCNHN----SFI---- 155
S + LT SL L + ++LP N S I
Sbjct: 289 ISLDHHSMTLTPDEVKSL---------LLKYLDCRPQDLP--REVLTTNPRRLSIIAESI 337
Query: 156 --------YYNHPD-DALPRIVPPNCSLIQLPVNKTRKSDDLFNMLTSVFSLQVEIP--- 203
+ H + D L I+ SL L + RK +F+ L SVF IP
Sbjct: 338 RDGLATWDNWKHVNCDKLTTII--ESSLNVLEPAEYRK---MFDRL-SVFPPSAHIPTIL 391
Query: 204 ----WFCWECGWRGGQCRSDSEGKFQCAES--RECND--CLKKRG--------HCHFDDK 247
WF + + + ++K+ + + K
Sbjct: 392 LSLIWF---------------DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 248 ENFQCENERTGHEKSELKLGLGLGGGSIVLIALLSFWIMFYRKFSSYDSTGSCLNIE--- 304
+ ENE H ++ Y ++DS
Sbjct: 437 V--KLENEYALHRS---------------IVD-------HYNIPKTFDSDDLIPPYLDQY 472
Query: 305 --TFLRNHGSLAPRRYSYADIKKMTNSFKY---KLGQGGYGSVYKGKLIDGSNVAVKVLN 359
+ + +H + + F++ K+ G +++ L
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-------TLQ 525
Query: 360 DSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSI 419
K + +I + + + L+ ++ F+ + ++
Sbjct: 526 QLK-FYKPYICDN-------------------DPKYERLVN------AILDFLPKIEENL 559
Query: 420 ENHKLTWETLLQIA 433
K T LL+IA
Sbjct: 560 ICSKYT--DLLRIA 571
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 32/168 (19%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGN--------------GEEFINEVASIS 376
K+G GG+G +Y A V+ + + N ++ I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 377 RTSHVNVVTLLGF----CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQI 432
+ ++ + G R ++ E + L+K +N T+LQ+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS------GQNGTFKKSTVLQL 156
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 478
+ + LEY+H +H DIK N+LL ++ +D+GL+
Sbjct: 157 GIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 33/170 (19%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSK------------------GNGEEFINEVAS 374
+GQGG+G +Y + +V K E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 375 ISRTSHVNVVTLLGFCFEGRR----RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLL 430
+ ++ V G + R +I + + L+K N + + +T+L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN-----AKRFSRKTVL 155
Query: 431 QIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 478
Q+++ I LEY+H +H DIK N+LL+ ++ D+GLA
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 40/187 (21%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI-------SRTSHVN 382
LG+G +G V + A+K+L K E I +EVA T H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL--RK----EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 383 VVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARG 439
+ L + F+ R + E+ + G L + R E E +
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS--------A 117
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTV 496
LEYLH S +++ DIK N++LD+D KI+DFGL KE I + GT
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTFCGTP 169
Query: 497 GYIAPEV 503
Y+APEV
Sbjct: 170 EYLAPEV 176
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
+G+G Y V +L + A+KV+ K E + ++ + ++H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV--KK----ELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+V L CF+ R + E+V+ G L + R E H A I+ L
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAE-ISLAL 123
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
YLH I++ D+K N+LLD + K++D+G+ KE + GT
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPN 175
Query: 498 YIAPEV 503
YIAPE+
Sbjct: 176 YIAPEI 181
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 48/193 (24%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDSKGNGEEFINEVASI-------SRTSHVN 382
LG+GGYG V++ + + G+N A+KVL K + A H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 383 VVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR--- 438
+V L+ + F+ + LI E++S G L + R +E+ A
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--------------ACFYL 127
Query: 439 -----GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
L +LH I++ D+KP NI+L+ K++DFGL KESI T
Sbjct: 128 AEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTH 179
Query: 494 ---GTVGYIAPEV 503
GT+ Y+APE+
Sbjct: 180 TFCGTIEYMAPEI 192
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
LG+G +G V ++ + ++ AVKVL K + I ++V +H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL--KK----DVILQDDDVECTMTEKRILSLARNHP 84
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+ L CF+ R + EFV+ G L I ++ + A I L
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEIISAL 137
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
+LH I++ D+K N+LLD + K++DFG+ KE I + GT
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTTATFCGTPD 189
Query: 498 YIAPEV 503
YIAPE+
Sbjct: 190 YIAPEI 195
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 37/163 (22%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRT----------SHV 381
+G G YG V + ++ VA+K + F + + R +H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILR------VFEDLIDC-KRILREIAILNRLNHD 112
Query: 382 NVVTLLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAV 434
+VV +L ++ E + +K E H L + L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL----- 166
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
G++Y+H S ILH D+KP N L+++D K+ DFGLA
Sbjct: 167 ---VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 39/191 (20%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI-------SRTSHVN 382
LG+G +G V K A+K+L K E I +EVA + H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL--KK----EVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 383 VVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVGIARG 439
+ L + F+ R + E+ + G L + R E+ E +
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS--------A 260
Query: 440 LEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTV 496
L+YLH + +++ D+K N++LD+D KI+DFGL KE I + GT
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTFCGTP 313
Query: 497 GYIAPEVFCRN 507
Y+APEV N
Sbjct: 314 EYLAPEVLEDN 324
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
+G+G Y V +L + A++V+ K E + ++ + ++H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV--KK----ELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+V L CF+ R + E+V+ G L + R E H A I+ L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-----ARFYSAE-ISLAL 166
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
YLH I++ D+K N+LLD + K++D+G+ KE + GT
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPN 218
Query: 498 YIAPEV 503
YIAPE+
Sbjct: 219 YIAPEI 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 419 IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+ LT E L+ + +A+G+E+L S + +H D+ NILL E KI DFGLA+
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+ + AR + ++APE + + +SD
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSD 277
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 10/105 (9%)
Query: 329 SFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKGNGE--EFINEVAS-ISRTS 379
LG+G +G V + VAVK+L + + E ++E+ I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 380 HVNVVTLLGFCF-EGRRRALIYEFVSNGSLEKFIYRNSSSIENHK 423
H+NVV LLG C G +I EF G+L ++ + +K
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 17/153 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL-NDSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
K+G G +G + GK L VA+K+ S+ S + + F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFG 74
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
G+ A++ E + SLE + + + +T+L IA+ + +EY+H S
Sbjct: 75 PCGKYNAMVLELLGP-SLED--LFDLC---DRTFSLKTVLMIAIQLISRMEYVH---SKN 125
Query: 451 ILHFDIKPHNILLDEDFCPK-----ISDFGLAK 478
+++ D+KP N L+ I DF LAK
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
+G+G +G V + AVKVL K + I E I H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL--QK----KAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+V L F F+ + + ++++ G L + R +E A IA L
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAA-EIASAL 152
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
YLH S I++ D+KP NILLD ++DFGL KE+I + GT
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC-----KENIEHNSTTSTFCGTPE 204
Query: 498 YIAPEV 503
Y+APEV
Sbjct: 205 YLAPEV 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
LG+G +G V + + AVK+L K + + ++V
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+ L CF+ R + E+V+ G L I + E H + A IA GL
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-----AVFYAA-EIAIGL 134
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
+L S I++ D+K N++LD + KI+DFG+ KE+I + GT
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPD 186
Query: 498 YIAPEV 503
YIAPE+
Sbjct: 187 YIAPEI 192
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 54/190 (28%), Positives = 77/190 (40%), Gaps = 45/190 (23%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---------EVASISRTSHVN 382
+G G YGSV G VA+K L+ F + E+ + H N
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHEN 84
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKF--IY-------RNSSSIENHKLTWETLLQIA 433
V+ LL F SL F Y + I K + E + +
Sbjct: 85 VIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
+ +GL+Y+H S ++H D+KP N+ ++ED KI DFGLA+ + MTG
Sbjct: 133 YQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYV 184
Query: 494 GTVGYIAPEV 503
T Y APEV
Sbjct: 185 VTRWYRAPEV 194
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 29/169 (17%), Positives = 64/169 (37%), Gaps = 31/169 (18%)
Query: 333 KLGQGGYGSVYKGKLIDGSN---------VAVKV-LNDSKGNGE----------EFINEV 372
+ G +Y+ ++K+ D + E +N+
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 373 ASISRTSHVNVVTLLGF-CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQ 431
+ T + + T +GF + + R L+ + SL+ + + H L+ ++LQ
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP----KHVLSERSVLQ 163
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI--SDFGLAK 478
+A + LE+LH +H ++ NI +D + ++ + +G A
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 22/145 (15%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVA-----SISRTSHVN---V 383
KLG G + +V+ + VA+KV+ ++ E ++E+ S + N V
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 384 VTLLGFCFE-----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR 438
V LL F+ G +++E V L K+I ++ L + +I + +
Sbjct: 104 VQLLD-DFKISGVNGTHICMVFE-VLGHHLLKWIIKS----NYQGLPLPCVKKIIQQVLQ 157
Query: 439 GLEYLHLGCSTRILHFDIKPHNILL 463
GL+YLH C RI+H DIKP NILL
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILL 180
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 28/69 (40%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARG 494
I RGL+Y+H S +LH D+KP N+LL+ KI DFGLA++ + +T
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 495 TVGYIAPEV 503
T Y APE+
Sbjct: 194 TRWYRAPEI 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 34/194 (17%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEV--------ASISRTSHV-- 381
KLG G + +V+ K +++ ++VA+K++ K E +E+ A ++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 382 -NVVTLLG-FCFEGRRRA---LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436
+++ LL F +G +++E + +L I + E+ + + QI+ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKY----EHRGIPLIYVKQISKQL 140
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP------KISDFGLAKICNRKESIISMT 490
GL+Y+H C I+H DIKP N+L++ P KI+D G A C E +
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 491 GARGTVGYIAPEVF 504
R Y +PEV
Sbjct: 197 QTR---EYRSPEVL 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 39/187 (20%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
LG+G +G V+ + + A+K L K + + ++V H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL--KK----DVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+ + F+ + + E+++ G L I HK A I GL
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGL 131
Query: 441 EYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGAR---GTV 496
++LH S I++ D+K NILLD+D KI+DFG+ KE+++ GT
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMC-----KENMLGDAKTNTFCGTP 182
Query: 497 GYIAPEV 503
YIAPE+
Sbjct: 183 DYIAPEI 189
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 21/176 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
LG G +G V K + N A+K+L+ E +NE + + +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F F+ ++ E+V+ G + + R + + A I EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S +++ D+KP N+L+D+ +++DFG AK + + GT +APE+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEI 209
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 41/189 (21%), Positives = 75/189 (39%), Gaps = 29/189 (15%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVK-VLNDSKGNGEEFINEVASISRTSHVNVVTLLG-F 389
LG GG G V+ VA+K ++ + + + E+ I R H N+V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 390 CFEGRRRALIYEFVSNGS------------LEKFIYRNSSSIENHK-LTWETLLQIAVGI 436
G + ++ + L + + E+ + ++ L
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL------- 130
Query: 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP-KISDFGLAK-ICNRKESIISMTGARG 494
RGL+Y+H S +LH D+KP N+ ++ + KI DFGLA+ + ++
Sbjct: 131 -RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 495 TVGYIAPEV 503
T Y +P +
Sbjct: 187 TKWYRSPRL 195
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 59/181 (32%), Positives = 87/181 (48%), Gaps = 26/181 (14%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDS---KGNGEEFINEVASISRTSHVNVVTL 386
LGQG +G V+ K I GS+ A+KVL + + E + +H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 387 LGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
+ F+ + LI +F+ G L + + E +A +A L++LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLA-ELALALDHLH- 143
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVGYIAPE 502
S I++ D+KP NILLDE+ K++DFGL+ KESI A GTV Y+APE
Sbjct: 144 --SLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPE 196
Query: 503 V 503
V
Sbjct: 197 V 197
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 53/189 (28%), Positives = 77/189 (40%), Gaps = 43/189 (22%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---------EVASISRTSHVNV 383
+G G G V I NVA+K L+ F N E+ + +H N+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 384 VTLLGFCFEGRRRALIYEFVSNGSLEKF--IY-------RNSSSIENHKLTWETLLQIAV 434
+ LL F SLE+F +Y N + +L E + +
Sbjct: 87 IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
+ G+++LH S I+H D+KP NI++ D KI DFGLA+ + MT
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVV 188
Query: 495 TVGYIAPEV 503
T Y APEV
Sbjct: 189 TRYYRAPEV 197
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 28/68 (41%), Positives = 39/68 (57%), Gaps = 8/68 (11%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
+ +GL Y+H + I+H D+KP N+ ++ED KI DFGLA+ + MTG T
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVT 188
Query: 496 VGYIAPEV 503
Y APEV
Sbjct: 189 RWYRAPEV 196
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 43/189 (22%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---------EVASISRTSHVNV 383
+G G G V + NVA+K L+ F N E+ + +H N+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 384 VTLLGFCFEGRRRALIYEFVSNGSLEKF--IY-------RNSSSIENHKLTWETLLQIAV 434
++LL F +LE+F +Y N + +L E + +
Sbjct: 124 ISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 171
Query: 435 GIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494
+ G+++LH S I+H D+KP NI++ D KI DFGLA+ + MT
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVV 225
Query: 495 TVGYIAPEV 503
T Y APEV
Sbjct: 226 TRYYRAPEV 234
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 37/186 (19%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDSKGNGEEFI---NEVASI--------SRTSHV 381
LG+G +G V + + AVK+L K + + ++V
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 382 NVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
+ L CF+ R + E+V+ G L I + E H + + A IA GL
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 455
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR---GTVG 497
+L S I++ D+K N++LD + KI+DFG+ KE+I + GT
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPD 507
Query: 498 YIAPEV 503
YIAPE+
Sbjct: 508 YIAPEI 513
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 40/190 (21%)
Query: 334 LGQGGYGSVYKGKLIDGSNV----AVKVLNDSKGNGEEFINEVASI-------SRTSHVN 382
LG G YG V+ + I G + A+KVL K +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 383 VVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIAR--- 438
+ L + F+ + LI ++++ G L + + E+ +
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE--------------VQIYV 165
Query: 439 -----GLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR 493
LE+LH I++ DIK NILLD + ++DFGL+K E+ +
Sbjct: 166 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 494 GTVGYIAPEV 503
GT+ Y+AP++
Sbjct: 222 GTIEYMAPDI 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 30/68 (44%), Positives = 39/68 (57%), Gaps = 8/68 (11%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGT 495
I RGL+Y+H S I+H D+KP N+ ++ED KI DFGLA+ MTG T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 496 VGYIAPEV 503
Y APE+
Sbjct: 193 RWYRAPEI 200
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 30/153 (19%), Positives = 64/153 (41%), Gaps = 17/153 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASI-SRTSHVNVVTLLGFC 390
++G+G +G +++G L++ VA+K + + + +E + + + F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
EG L+ + + SLE + K + +T+ A + ++ +H
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIH---EKS 126
Query: 451 ILHFDIKPHNILLDEDFCPK-----ISDFGLAK 478
+++ DIKP N L+ + DFG+ K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 21/176 (11%)
Query: 334 LGQGGYGSVYKGKLIDGSNV-AVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLG 388
LG G +G V+ + A+KVL E +E +S +H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 389 FCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
F+ ++ +I +++ G L + ++ + A + LEYLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLH--- 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEV 503
S I++ D+KP NILLD++ KI+DFG AK + T GT YIAPEV
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYT-LCGTPDYIAPEV 174
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 35/162 (21%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFIN---------EVASISRTSHVN 382
+G+G YG VY NVA+K +N F + E+ ++R
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSDY 86
Query: 383 VVTLLGFCFEGRRRA-----LIYEFVSNGSLEKFIYRNSSSIENHK--LTWETLLQIAVG 435
++ L ++ E + L+K E H + + L
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL------ 139
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
G ++H + I+H D+KP N LL++D K+ DFGLA
Sbjct: 140 --LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 11/76 (14%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS------- 488
R ++ LH + ++H D+KP N+L++ + K+ DFGLA+I + + S
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 489 -MTGARGTVGYIAPEV 503
M T Y APEV
Sbjct: 178 GMVEFVATRWYRAPEV 193
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFC 390
K+G G +G +Y G + G VA+K+ K + E V + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
EG ++ E + SLE + K + +T+L +A + +EY+H S
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIH---SKN 125
Query: 451 ILHFDIKPHNILLDEDFCPK---ISDFGLAK 478
+H D+KP N L+ I DFGLAK
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 3e-09
Identities = 28/187 (14%), Positives = 52/187 (27%), Gaps = 44/187 (23%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVL---NDSKGNGE------EFINEVA---------S 374
K+G+G +G V++ D + VA+K++ NG E + E+
Sbjct: 27 KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 375 ISRTSHVNVVTLLGF--CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKL-------- 424
+ L L+ + S + ++ +L
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 425 -------------TWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471
+ T I + L R H D+ N+LL + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKL 203
Query: 472 SDFGLAK 478
K
Sbjct: 204 HYTLNGK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISR-TSHVNVVTLLGFC 390
K+G G +G +Y G + VA+K+ N K + + E + + F
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLEN-VKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
EG L+ + + SLE + KL+ +T+L +A + +E++H S
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVH---SKS 123
Query: 451 ILHFDIKPHNILLDEDFCPK---ISDFGLAK 478
LH DIKP N L+ I DFGLAK
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 3/42 (7%)
Query: 436 IARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477
+ + ++YLH S +LH D+KP NILL+ + K++DFGL+
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISR------TSHVNVVTL 386
+G+G +G V K +VA+K++ + K + E+ + + +NV+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 387 LGFCFEGRRRA-LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L F R + +E +S +L + I +N + + + A I + L+ LH
Sbjct: 165 LE-NFTFRNHICMTFELLSM-NLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALH- 217
Query: 446 GCSTRILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKES-IISMTGARGTVGYIAPE 502
RI+H D+KP NILL + K+ DFG + +++ I + Y APE
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ------SRFYRAPE 269
Query: 503 V 503
V
Sbjct: 270 V 270
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSK-----GNGE-EFINEVASISRTSHVNVVT 385
+G+G +G V K ++ VA+K++ + K E + + +V
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 386 LLG-FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L F F L++E +S +L + + ++ + A + L +L
Sbjct: 121 LKRHFMFRNHL-CLVFEMLSY-NLYDLLRNTN----FRGVSLNLTRKFAQQMCTALLFLA 174
Query: 445 LGCSTRILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
I+H D+KP NILL KI DFG + C + I +R Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSR---FYRSPE 228
Query: 503 V 503
V
Sbjct: 229 V 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.94 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.56 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.99 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.69 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.56 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.16 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.57 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=327.44 Aligned_cols=191 Identities=30% Similarity=0.476 Sum_probs=160.0
Q ss_pred HHHHHHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEee
Q 036471 321 ADIKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFE 392 (516)
Q Consensus 321 ~el~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 392 (516)
.|+...+.+|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|++.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3344445567889999999999999863 46789999996532 334789999999999999999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNIL 462 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIl 462 (516)
++..+|||||+++|+|.++|+.+... .....++|.+++.|+.|||+||+||| +++||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceE
Confidence 99999999999999999999764321 11246999999999999999999999 899999999999999
Q ss_pred ECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 463 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++++.+||+|||+|+.+.............||+.|||||++.+ +.++.+||
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksD 229 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSD 229 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccch
Confidence 99999999999999987755543333455679999999999965 78998887
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=318.59 Aligned_cols=178 Identities=28% Similarity=0.395 Sum_probs=158.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.+.||+|+||+||+|+.+ +++.||||++++. ....+.+.+|++++++++|||||++++++.+++..||||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567789999999999999975 5899999999642 34557899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.++|++. ..+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999765 56999999999999999999999 89999999999999999999999999999998765
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...........||+.|||||++.+ ..++.++|
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~--~~y~~~~D 216 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTE--KSACKSSD 216 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHH--SCBCHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcC--CCCCcHHH
Confidence 543333456789999999999965 57787776
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.44 Aligned_cols=184 Identities=28% Similarity=0.477 Sum_probs=154.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.++||+|+||+||+|++. ++..||||+++... ...++|.+|+++|++++|||||+++|++.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 346688999999999999864 36789999997543 23467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 401 EFVSNGSLEKFIYRNSS-------SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
||+++|+|.++|+.... ......++|.+++.|+.||++||+||| +++|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECC
Confidence 99999999999986421 112357999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|+...............||+.|||||++.+ +.++.|+|
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~D 212 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESD 212 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcC--CCCCchhh
Confidence 999987655543333334568999999999965 68888887
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.72 Aligned_cols=183 Identities=25% Similarity=0.482 Sum_probs=147.1
Q ss_pred hhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|++.+++..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35678999999999999864 47889999997543 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 402 FVSNGSLEKFIYRNSSS---------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
|+++|+|.++|+..... ....+++|.+++.|+.||++||+||| +++||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEc
Confidence 99999999999865321 12356999999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+|+.+.............||+.|||||++.+ +.++.++|
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sD 242 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESD 242 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTT--CCCCHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcC--CCCCcccc
Confidence 9999987755543333345679999999999955 68888877
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=319.30 Aligned_cols=177 Identities=34% Similarity=0.564 Sum_probs=145.6
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.++||+|+||+||+|++. ..||||+++.... ..++|.+|+.++++++|||||+++|++.+ +..+|||||+++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 46788999999999999874 3699999875432 33678999999999999999999998754 568999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++|+... ..+++.+++.|+.||++||+||| +++||||||||+||||++++.+||+|||+|+.......
T Consensus 116 GsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 116 SSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999997643 56999999999999999999999 89999999999999999999999999999987765443
Q ss_pred ceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
........||+.|||||++.++ .+.++.+||
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksD 219 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSD 219 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHH
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHH
Confidence 3334557899999999999643 356888877
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.99 Aligned_cols=174 Identities=27% Similarity=0.394 Sum_probs=154.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
++.++||+|+||+||+|+.+ +|+.||||+++.. ....+.+.+|+.+|++++|||||++++++.+++..||||||+++|
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 34467999999999999986 5899999999653 344577899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.+ ..+++.++..++.||+.||+||| +++|+||||||+||||+.+|.+||+|||+|+.+......
T Consensus 157 ~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 157 ALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp EHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred cHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999965 45999999999999999999999 899999999999999999999999999999877554332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|||||++.+ ..|+.++|
T Consensus 227 --~~~~~GTp~YmAPEvl~~--~~y~~~~D 252 (346)
T 4fih_A 227 --RKSLVGTPYWMAPELISR--LPYGPEVD 252 (346)
T ss_dssp --BCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred --ccccccCcCcCCHHHHCC--CCCCcHHH
Confidence 245789999999999955 67888876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.81 Aligned_cols=178 Identities=29% Similarity=0.379 Sum_probs=148.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
|.+.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+.++++++|||||++++++.+++..||||||+
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 445678999999999999975 589999999976433 2367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.++|.... ...+++.+++.|+.||+.||+||| +++|+||||||+||||++++.+||+|||+|+.+...
T Consensus 106 ~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 106 EGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp TTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999997643 256899999999999999999999 899999999999999999999999999999876543
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|||||++.+ ..++.++|
T Consensus 179 ~~~--~~~~~GT~~YmAPE~l~~--~~y~~~~D 207 (350)
T 4b9d_A 179 VEL--ARACIGTPYYLSPEICEN--KPYNNKSD 207 (350)
T ss_dssp HHH--HHHHHSCCTTCCHHHHTT--CCCCHHHH
T ss_pred ccc--ccccCCCccccCHHHHCC--CCCCcHHH
Confidence 211 234579999999999965 57888876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=305.30 Aligned_cols=172 Identities=27% Similarity=0.413 Sum_probs=147.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEee----cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 400 (516)
++.++||+|+||+||+|.+. +++.||+|++..... ..+.|.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999986 588999999965432 33678999999999999999999999875 34689999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEC-CCCcEEEeecCCc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLA 477 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a 477 (516)
||+++|+|.+++++. ..+++..+..++.||+.||+||| +++ |+||||||+||||+ +++.+||+|||+|
T Consensus 109 Ey~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999765 57999999999999999999999 787 99999999999997 4799999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... .....||+.|||||++. +.++.++|
T Consensus 180 ~~~~~~~----~~~~~GTp~YmAPE~~~---~~y~~~~D 211 (290)
T 3fpq_A 180 TLKRASF----AKAVIGTPEFMAPEMYE---EKYDESVD 211 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGG---TCCCTHHH
T ss_pred EeCCCCc----cCCcccCccccCHHHcC---CCCCcHHH
Confidence 8644332 24468999999999984 35888876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.65 Aligned_cols=175 Identities=27% Similarity=0.390 Sum_probs=154.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++.++||+|+||.||+|+.+ +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++.+||||||+++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 334567999999999999986 58999999997543 4456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++++. ..+++.++..++.||+.||+||| +++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 233 G~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 233 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999964 45999999999999999999999 89999999999999999999999999999987755433
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|||||++.+ ..|+.++|
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~--~~y~~~~D 329 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISR--LPYGPEVD 329 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTT--CCBCTHHH
T ss_pred c--ccccccCcCcCCHHHHCC--CCCCcHHH
Confidence 2 245689999999999955 67888876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.68 Aligned_cols=172 Identities=30% Similarity=0.330 Sum_probs=147.0
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||++||+|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 4567999999999999986 589999999975432 35799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccccCCCcce
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNRKESII 487 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~ 487 (516)
.++|++. ..+++.++..++.||+.||+||| +++||||||||+||||+.+| .+||+|||+|+.+.......
T Consensus 138 ~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 138 GQLIKQM------GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999765 56999999999999999999999 99999999999999999988 69999999998876543211
Q ss_pred ---eeccCCCCccccccccccccccccccCCC
Q 036471 488 ---SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ---~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|||||++.+ ..++.++|
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~D 238 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMG--KPCDAKVD 238 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTT--CCCCTHHH
T ss_pred ceecCCccccCccccCHHHHCC--CCCCcHHH
Confidence 1233579999999999965 67888876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.49 Aligned_cols=176 Identities=31% Similarity=0.349 Sum_probs=145.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+++.+.||+|+||+||+|+.. .++.||+|++++.. .....+.+|++++++++|||||++++++.+++..||||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456688999999999999863 36889999996532 23356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||++||+|.++|.+. ..+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+..
T Consensus 106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999765 56999999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....||+.|||||++.+ ..++.++|
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~--~~y~~~~D 208 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNR--RGHTQSAD 208 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHT--SCCCTHHH
T ss_pred cCCCcc--ccccccCcccCCHHHhcc--CCCCCCCc
Confidence 443321 245679999999999955 67888776
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=304.81 Aligned_cols=181 Identities=27% Similarity=0.403 Sum_probs=141.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecC----------
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGR---------- 394 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---------- 394 (516)
+++.+.||+|+||+||+|+.+ +|+.||||+++.... ..+.+.+|+.++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 445678999999999999975 589999999965432 2367899999999999999999999987654
Q ss_pred --eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 395 --RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 395 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
..|+||||+++|+|.++++... .....++..++.++.||++||+||| +++|+||||||+||||+.++.+||+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC---SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC---CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997653 1234667788999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCCcce----------eeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESII----------SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+|+.+....... ..+...||+.|||||++.+ ..++.++|
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~D 212 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVD 212 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTT--CCCCTHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHH
Confidence 999998875543221 1234569999999999965 67888877
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=299.75 Aligned_cols=175 Identities=26% Similarity=0.409 Sum_probs=138.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||+||+|+.. +|+.||+|++++.. ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 556688999999999999975 58999999997532 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+ +|+|.+++.+. ..+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 95 ~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 95 A-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp C-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred C-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9 67999999764 57999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|||||++.++ ...+.++|
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~D 194 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGK-LYAGPEVD 194 (275)
T ss_dssp -------------CTTSCHHHHSSS-SCCCTHHH
T ss_pred CCc---cCCeeECcccCChhhhcCC-CCCCChhh
Confidence 432 2446799999999999653 22356665
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.27 Aligned_cols=180 Identities=28% Similarity=0.401 Sum_probs=142.7
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecC----eeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR----RRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~ 404 (516)
.+.++||+|+||+||+|++ +|+.||||+++........+.+|+..+.+++|||||++++++.+++ ..+|||||++
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 3567899999999999998 6899999999654332233345666677899999999999998754 5799999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|+|.++|++ ..++++.+++++.|+++||+|||+. ...+|+||||||+||||+.++.+||+|||+|+.
T Consensus 85 ~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 85 HGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999975 3589999999999999999999931 123999999999999999999999999999987
Q ss_pred ccCCCccee--eccCCCCccccccccccccc----cccccCCC
Q 036471 480 CNRKESIIS--MTGARGTVGYIAPEVFCRNI----GEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~----~~~s~~sD 516 (516)
......... .....||+.|||||++.+.. +.++.|+|
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D 200 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence 765443221 23457999999999995431 24566665
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.04 Aligned_cols=190 Identities=28% Similarity=0.462 Sum_probs=157.8
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhccCC-cceeeEEEEEee
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRTSH-VNVVTLLGFCFE 392 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~ 392 (516)
||.+..+.+.++||+|+||+||+|++.. ++.||||+++.... ..++|.+|+.+|.+++| ||||+++|++.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3444555677889999999999998643 35799999976433 34679999999999965 899999999876
Q ss_pred c-CeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 393 G-RRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 393 ~-~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
. +..+|||||+++|+|.++|+..... .....+++.+++.++.|||+||+||| +++||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccce
Confidence 4 5689999999999999999864321 11345899999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++++.+||+|||+|+.+.............||+.|||||++.+ +.++.+||
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~y~~ksD 269 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSD 269 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--CCCCCccc
Confidence 999999999999999998766554444456779999999999965 68898887
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.59 Aligned_cols=174 Identities=29% Similarity=0.407 Sum_probs=148.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHH---HHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINE---VASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.||+|+||+||+|+.+ +|+.||||++++. ........+| +.+++.++|||||++++++.+.+.+||||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34578999999999999986 5899999999642 2233334444 56677889999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||++||+|.++|.+. ..+++..+..++.||+.||+||| +++||||||||+||||+.+|.+||+|||+|+.+
T Consensus 272 Ey~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999765 56999999999999999999999 999999999999999999999999999999877
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....||+.|||||++.++ ..++.++|
T Consensus 343 ~~~~~----~t~~GTp~YmAPEvl~~~-~~y~~~vD 373 (689)
T 3v5w_A 343 SKKKP----HASVGTHGYMAPEVLQKG-VAYDSSAD 373 (689)
T ss_dssp SSCCC----CSCCSCGGGCCHHHHSTT-CCCCTHHH
T ss_pred CCCCC----CCccCCcCccCHHHHhCC-CCCCcHHH
Confidence 55432 446899999999999542 35777766
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.91 Aligned_cols=178 Identities=25% Similarity=0.381 Sum_probs=147.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEee------cCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFE------GRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 397 (516)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .+.+.+|+.+|++++|||||++++++.. .+..|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 445678999999999999975 6999999999754332 3568899999999999999999998764 35789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
|||||++ |+|.+++.+. ..+++..+..++.||+.||+||| +++||||||||+|||++.++.+||+|||+|
T Consensus 136 ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 9999996 6899999643 67999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCc--ceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKES--IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+..... ........||+.|||||++.+. ..++.++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~D 245 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAID 245 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhh
Confidence 87644321 1123457899999999998653 45677665
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=287.65 Aligned_cols=175 Identities=21% Similarity=0.321 Sum_probs=145.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++++++ +||||+++++++.+.+..++||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 445678999999999999853 46789999986543 346788999999998 699999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 481 (516)
+++|+|.+++ ..+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 102 ~~g~~L~~~~---------~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 102 LEHESFLDIL---------NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp CCCCCHHHHH---------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CCcccHHHHH---------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999998 35899999999999999999999 9999999999999999876 799999999997654
Q ss_pred CCCcc--------------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESI--------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .......||+.|||||++.+. ..++.++|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~D 229 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAID 229 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHH
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccc
Confidence 32211 012345699999999999653 34676665
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.22 Aligned_cols=176 Identities=27% Similarity=0.426 Sum_probs=153.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|+||.||+|+.+ +|+.||+|++.... ...+.+.+|+.+|++++|||||++++++.+.+..+|||||+++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 456688999999999999986 58999999997543 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC--CcEEEeecCCcccccCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED--FCPKISDFGLAKICNRK 483 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~ 483 (516)
|+|.++|.+.. ..+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 239 g~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 239 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999996432 56999999999999999999999 9999999999999999854 89999999999987655
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....||+.|||||++.+ ..++.++|
T Consensus 311 ~~~---~~~~GT~~y~APEv~~~--~~y~~~~D 338 (573)
T 3uto_A 311 QSV---KVTTGTAEFAAPEVAEG--KPVGYYTD 338 (573)
T ss_dssp SEE---EEECSSGGGCCHHHHTT--CCBCHHHH
T ss_pred Cce---eeeEECccccCHHHhCC--CCCCcHHH
Confidence 432 34579999999999965 56777665
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=261.29 Aligned_cols=190 Identities=27% Similarity=0.386 Sum_probs=160.3
Q ss_pred CCCccccHHHHHHHHHh------------hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhcc
Q 036471 313 LAPRRYSYADIKKMTNS------------FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRT 378 (516)
Q Consensus 313 ~~~~~~~~~el~~~~~~------------~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l 378 (516)
..+..+++++++.++.. ..+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 44567888888887754 2357999999999999987 69999999997543 3456789999999999
Q ss_pred CCcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 036471 379 SHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKP 458 (516)
Q Consensus 379 ~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp 458 (516)
+||||+++++++...+..++||||+++++|.+++.+ ..+++..++.++.|++.||+||| +.+|+||||||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp 169 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKS 169 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence 999999999999999999999999999999999853 46899999999999999999999 89999999999
Q ss_pred CcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 459 HNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 459 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+||+++.++.+||+|||++......... .....||+.|+|||++.+ +.++.++|
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 223 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISR--SLYATEVD 223 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcC--CCCCchhh
Confidence 9999999999999999999876544322 244678999999999954 56777765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=263.32 Aligned_cols=175 Identities=29% Similarity=0.366 Sum_probs=152.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
++.+.||+|+||.||+++.+ +++.||+|++++ .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 45578999999999999986 589999999965 2345577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 88 NGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp TTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999764 46899999999999999999999 899999999999999999999999999999864333
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......||+.|+|||++.+ +.++.++|
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 187 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVLED--NDYGRAVD 187 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSS--SCBCTTHH
T ss_pred CC--cccccccChhhCChhhhcC--CCCCchhh
Confidence 22 1244678999999999955 57787776
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.82 Aligned_cols=178 Identities=23% Similarity=0.311 Sum_probs=152.3
Q ss_pred hhhhcccCCcEEEEEEEECC-CCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.++||+|+||+||+|+.++ ++.||+|++++ .....+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 44789999999999999875 78899999964 23344568999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.+.. ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++......
T Consensus 158 gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 158 GGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp TCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999997632 56999999999999999999999 8999999999999999999999999999998765544
Q ss_pred cceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
... .....||+.|+|||++... .+.++.++|
T Consensus 230 ~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~D 263 (437)
T 4aw2_A 230 TVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECD 263 (437)
T ss_dssp CEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHH
T ss_pred Ccc-cccccCCcCeeChHHHhhcccCCCCCCCcCe
Confidence 322 2446799999999999621 246777665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=257.09 Aligned_cols=174 Identities=29% Similarity=0.432 Sum_probs=151.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 34567999999999999864 6899999999653 344567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.+ ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 103 SLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp BHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999965 35899999999999999999999 899999999999999999999999999999876554332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 173 --~~~~~gt~~y~aPE~~~~--~~~~~~~D 198 (297)
T 3fxz_A 173 --RSTMVGTPYWMAPEVVTR--KAYGPKVD 198 (297)
T ss_dssp --BCCCCSCGGGCCHHHHHC--SCBCTHHH
T ss_pred --cCCccCCcCccChhhhcC--CCCCcHHH
Confidence 244679999999999955 56777766
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.00 Aligned_cols=176 Identities=24% Similarity=0.327 Sum_probs=150.9
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||+||+|+.+ +++.||+|++++ .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 4478999999999999986 488999999964 23445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++++ ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 153 gg~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 153 GGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp TEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999965 35899999999999999999999 8999999999999999999999999999998765543
Q ss_pred cceeeccCCCCcccccccccccccc--ccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIG--EVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~--~~s~~sD 516 (516)
.. ......||+.|+|||++.+..+ .++.++|
T Consensus 223 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~D 255 (410)
T 3v8s_A 223 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255 (410)
T ss_dssp EE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHH
T ss_pred cc-cccCCcCCccccCHHHhhccCCCcCCCCcce
Confidence 22 2245679999999999965321 2666665
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=256.67 Aligned_cols=179 Identities=30% Similarity=0.524 Sum_probs=157.1
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.+.||+|+||.||+|+..++..||+|+++......+++.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCC
Confidence 34456789999999999999988889999999877767788999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 89 CLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp BHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999997642 46999999999999999999999 899999999999999999999999999999876554332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+|+.|+|||++.+ ..++.++|
T Consensus 161 -~~~~~~~~~~y~aPE~~~~--~~~~~~~D 187 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHY--FKYSSKSD 187 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHH--SEEETTHH
T ss_pred -cccCCCcCcccCCHHHHhc--cCCchhhh
Confidence 2244567888999999954 56777776
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=261.11 Aligned_cols=175 Identities=25% Similarity=0.403 Sum_probs=150.8
Q ss_pred HhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+|+. .+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 34557899999999999998 4699999999976432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 97 SGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999765 46999999999999999999999 899999999999999999999999999999876544
Q ss_pred CcceeeccCCCCcccccccccccccccc-ccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEV-SYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~-s~~sD 516 (516)
.. .....||+.|+|||++.+ ..+ +.++|
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~~~D 196 (328)
T 3fe3_A 168 GK---LDAFCGAPPYAAPELFQG--KKYDGPEVD 196 (328)
T ss_dssp CG---GGTTSSSGGGCCHHHHHT--CCCCSHHHH
T ss_pred Cc---cccccCCcceeCcccccC--CCcCCchhh
Confidence 32 245679999999999965 333 35554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=256.50 Aligned_cols=178 Identities=30% Similarity=0.545 Sum_probs=155.3
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.+.||+|+||.||+|++.+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 34557899999999999999889999999998777677889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 92 LSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp HHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred HHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 999997543 56899999999999999999999 899999999999999999999999999999866443221
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+++.|+|||++.+ ..++.++|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSF--SRYSSKSD 189 (269)
T ss_dssp STTSTTCCGGGCCHHHHHH--CCCCHHHH
T ss_pred cccCcccccccCCHHHhcC--CCCCchhh
Confidence 1234567889999999954 56777665
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=258.17 Aligned_cols=178 Identities=27% Similarity=0.437 Sum_probs=150.7
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||++++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 35678999999999999986 5899999988543 334577899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 93 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 93 TLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp BHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999998643 56999999999999999999999 899999999999999999999999999999876543321
Q ss_pred ee------------eccCCCCccccccccccccccccccCCC
Q 036471 487 IS------------MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~------------~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+ ..++.++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 204 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVD 204 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT--CCCCTHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHH
Confidence 10 114568999999999955 67777766
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=264.31 Aligned_cols=182 Identities=20% Similarity=0.231 Sum_probs=152.7
Q ss_pred HHhhhhhcccCCcEEEEEEE------ECCCCEEEEEEeecCCCCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGK------LIDGSNVAVKVLNDSKGNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~ 397 (516)
.+.+.+.||+|+||.||+|. ..+++.||+|+++.. ...++.+|++++.+++ |+||+++++++...+..+
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 34455789999999999994 346889999999643 4567888888888886 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----------C
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----------D 466 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----------~ 466 (516)
+||||+++|+|.++++.... .....+++..++.++.||+.||+||| +++|+||||||+||||+. +
T Consensus 144 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999976432 12367999999999999999999999 999999999999999998 8
Q ss_pred CcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+||+|||+|+.+.............||+.|+|||++.+ ..++.++|
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 267 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQID 267 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--CCBSTHHH
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--CCCCcccc
Confidence 9999999999987654433334456789999999999965 56888776
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=257.76 Aligned_cols=172 Identities=29% Similarity=0.397 Sum_probs=151.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +|+.||+|++++. ....+.+.+|..+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 45578999999999999986 5899999999653 345577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 89 EGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999764 46899999999999999999999 999999999999999999999999999999875433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....||+.|+|||++.+ ..++.++|
T Consensus 160 ~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 185 (318)
T 1fot_A 160 T-----YTLCGTPDYIAPEVVST--KPYNKSID 185 (318)
T ss_dssp B-----CCCCSCTTTCCHHHHTT--CCBCTTHH
T ss_pred c-----ccccCCccccCHhHhcC--CCCCcccc
Confidence 2 34578999999999955 56777776
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=265.88 Aligned_cols=176 Identities=26% Similarity=0.345 Sum_probs=149.8
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+++.+. ++.||+|++++. ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 3456789999999999999864 788999999753 23345688999999887 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++...
T Consensus 134 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999764 46999999999999999999999 8999999999999999999999999999998633
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 205 ~~~~--~~~~~~gt~~Y~aPE~l~~--~~~~~~~D 235 (396)
T 4dc2_A 205 RPGD--TTSTFCGTPNYIAPEILRG--EDYGFSVD 235 (396)
T ss_dssp CTTC--CBCCCCBCGGGCCHHHHTT--CCBCTHHH
T ss_pred cCCC--ccccccCCcccCCchhhcC--CCCChHHH
Confidence 3222 1245679999999999965 56777665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=262.34 Aligned_cols=195 Identities=42% Similarity=0.743 Sum_probs=164.4
Q ss_pred CCccccHHHHHHHHHhhh--hhcccCCcEEEEEEEECCCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEE
Q 036471 314 APRRYSYADIKKMTNSFK--YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGF 389 (516)
Q Consensus 314 ~~~~~~~~el~~~~~~~~--~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~ 389 (516)
..+.+++.++.....++. +.||+|+||.||+|+..+++.||+|++.... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 346788888887666554 7899999999999998889999999996543 334578999999999999999999999
Q ss_pred EeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---CeeeCCCCCCcEEECCC
Q 036471 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST---RILHFDIKPHNILLDED 466 (516)
Q Consensus 390 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~---~ivH~dlkp~NIll~~~ 466 (516)
+.+.+..++||||+++++|.++++.... ....+++..++.++.|++.||+||| +. +|+||||||+|||++.+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTT
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCC
Confidence 9999999999999999999999986532 3356999999999999999999999 66 99999999999999999
Q ss_pred CcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+||+|||+++......... .....||+.|+|||++.+ +.++.++|
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~D 217 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLST--GKSSEKTD 217 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHH--SEECHHHH
T ss_pred CCEEeccCccccccCcccccc-cccccCCcCccCHHHhcc--CCCCcccc
Confidence 999999999998775444332 244569999999999854 56777665
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=266.22 Aligned_cols=185 Identities=29% Similarity=0.503 Sum_probs=153.6
Q ss_pred HHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 395 (516)
.+.+.+.||+|+||.||+|++. ++..||+|+++.... ..+++.+|+.+++++ +||||+++++++.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 3445678999999999999863 345799999975432 336789999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
.++||||+++|+|.+++...... .....+++..++.++.||+.||+||| +++|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECC
Confidence 99999999999999999875421 12246899999999999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+++...............+|+.|+|||++.+ +.++.++|
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 287 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSD 287 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--CCCCHHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--CCCCcHHH
Confidence 99999999999987655443333344567889999999955 56777766
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=264.53 Aligned_cols=176 Identities=28% Similarity=0.338 Sum_probs=147.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|+.+ +++.||+|++++. ....+.+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 445678999999999999986 5899999999753 34456788999999988 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++...
T Consensus 105 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 105 FVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999765 46999999999999999999999 8999999999999999999999999999998543
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 176 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 206 (353)
T 3txo_A 176 CNGV--TTATFCGTPDYIAPEILQE--MLYGPAVD 206 (353)
T ss_dssp C-----------CCGGGCCHHHHHH--HHCTTHHH
T ss_pred cCCc--cccccCCCcCeEChhhcCC--CCcCCccC
Confidence 3322 1244679999999999955 56776665
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=259.42 Aligned_cols=181 Identities=27% Similarity=0.410 Sum_probs=148.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecC----------
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGR---------- 394 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---------- 394 (516)
+.+.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 445678999999999999986 68999999997533 33477899999999999999999999986643
Q ss_pred -----------------------------------------------eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHH
Q 036471 395 -----------------------------------------------RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427 (516)
Q Consensus 395 -----------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~ 427 (516)
..++||||+++++|.+++.+.. .....++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~ 164 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---SLEDREHG 164 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---SGGGSCHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---CccchhhH
Confidence 2789999999999999998754 23456778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc----------eeeccCCCCcc
Q 036471 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI----------ISMTGARGTVG 497 (516)
Q Consensus 428 ~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~ 497 (516)
.++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999 899999999999999999999999999999877654321 11234569999
Q ss_pred ccccccccccccccccCCC
Q 036471 498 YIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 498 y~aPE~l~~~~~~~s~~sD 516 (516)
|+|||++.+ ..++.++|
T Consensus 242 y~aPE~~~~--~~~~~~~D 258 (332)
T 3qd2_B 242 YMSPEQIHG--NNYSHKVD 258 (332)
T ss_dssp GSCHHHHHC--CCCCTHHH
T ss_pred ccChHHhcC--CCCcchhh
Confidence 999999955 56777766
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=261.16 Aligned_cols=176 Identities=27% Similarity=0.351 Sum_probs=151.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|+.+ +++.||+|+++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345578999999999999986 5889999999753 34556788899999887 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 99 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999764 46899999999999999999999 8999999999999999999999999999998653
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|+|||++.+ ..++.++|
T Consensus 170 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 200 (345)
T 1xjd_A 170 LGDAK--TNTFCGTPDYIAPEILLG--QKYNHSVD 200 (345)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred cCCCc--ccCCCCCcccCChhhhcC--CCCCChhh
Confidence 32221 245679999999999965 56777665
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=268.68 Aligned_cols=178 Identities=22% Similarity=0.285 Sum_probs=152.1
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||+||+++.+ +++.||+|++++. ....+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 4478999999999999986 5899999999642 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.+.. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++++||+|||+++......
T Consensus 145 gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 145 GGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp SCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999997642 46999999999999999999999 8999999999999999999999999999998775544
Q ss_pred cceeeccCCCCcccccccccccc-----ccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRN-----IGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~-----~~~~s~~sD 516 (516)
... .....||+.|+|||++.+. .+.++.++|
T Consensus 217 ~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~D 252 (412)
T 2vd5_A 217 TVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECD 252 (412)
T ss_dssp CEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHH
T ss_pred ccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHh
Confidence 321 2346799999999999631 245666665
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=254.28 Aligned_cols=177 Identities=30% Similarity=0.393 Sum_probs=146.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 445678999999999999975 5899999998654322 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 93 IEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999765 46999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|+|||++.+ ..++.++|
T Consensus 164 ~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~D 194 (294)
T 4eqm_A 164 TSLTQ-TNHVLGTVQYFSPEQAKG--EATDECTD 194 (294)
T ss_dssp ------------CCSSCCHHHHHT--CCCCTTHH
T ss_pred ccccc-cCccccCccccCHhHhcC--CCCCchHh
Confidence 33221 234568999999999955 56777766
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=260.97 Aligned_cols=168 Identities=34% Similarity=0.487 Sum_probs=145.4
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecC----eeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR----RRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+|++. ++.||||++...........+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 345678999999999999985 799999999765555566777999999999999999999998754 369999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeeeCCCCCCcEEECCCCcEEEee
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST----------RILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~----------~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 105 ~~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 105 EKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred CCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999965 35899999999999999999999 88 999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
||+++...............||+.|+|||++.+
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred CCcccccccccCccccccCccCccccCHhhccc
Confidence 999987765544333345679999999999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=262.45 Aligned_cols=177 Identities=26% Similarity=0.385 Sum_probs=153.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345678999999999999976 4889999999642 34557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.+..
T Consensus 97 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 97 LLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999753 56999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
... .....||+.|+|||++... ...++.++|
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~D 199 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHH
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccce
Confidence 432 2456799999999999642 235777765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=259.57 Aligned_cols=179 Identities=42% Similarity=0.760 Sum_probs=153.1
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999986543 34578899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISM 489 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 489 (516)
+++..... ....+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...........
T Consensus 124 ~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 124 RHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHhccCC--CccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99865431 2346999999999999999999999 899999999999999999999999999999865543322222
Q ss_pred ccCCCCccccccccccccccccccCCC
Q 036471 490 TGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 490 ~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....||+.|+|||++.+ +.++.++|
T Consensus 199 ~~~~gt~~y~aPE~~~~--~~~~~~~D 223 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIK--GRLTEKSD 223 (321)
T ss_dssp CCCEEETTTCCHHHHHH--CBCCTHHH
T ss_pred cccCCCccccCHHHhcC--CCCCcccc
Confidence 34568999999999855 56777766
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=259.97 Aligned_cols=175 Identities=30% Similarity=0.434 Sum_probs=151.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+.+.+.||+|+||.||+++.+ +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 445678999999999999986 589999999975432 236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----cEEEeecC
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDFG 475 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg 475 (516)
|||+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 94 ~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 94 LELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999543 56999999999999999999999 89999999999999998877 79999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++........ .....||+.|+|||++.+ ..++.++|
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 200 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNY--EPLGLEAD 200 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTT--CCCCTHHH
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcC--CCCCcccc
Confidence 9987655432 244679999999999954 56777665
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=252.57 Aligned_cols=193 Identities=38% Similarity=0.637 Sum_probs=164.4
Q ss_pred CCccccHHHHHHHHHhhh--------hhcccCCcEEEEEEEECCCCEEEEEEeecCC-----CCchhHHHHHHHhhccCC
Q 036471 314 APRRYSYADIKKMTNSFK--------YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-----GNGEEFINEVASISRTSH 380 (516)
Q Consensus 314 ~~~~~~~~el~~~~~~~~--------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h 380 (516)
..+.|++.++.+++.+|. +.||+|+||.||+|.. +++.||+|++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356789999999998886 4599999999999987 68999999986432 224678899999999999
Q ss_pred cceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 381 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+|
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~N 163 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSAN 163 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHH
Confidence 999999999999999999999999999999997542 2356999999999999999999999 8999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++.++.+||+|||++................||+.|+|||++.+ .++.++|
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~D 216 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSD 216 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHH
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccch
Confidence 9999999999999999987655443333344678999999999843 4666655
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=255.89 Aligned_cols=176 Identities=31% Similarity=0.418 Sum_probs=147.8
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.++||+|+||.||+|++.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 103 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC
Confidence 34578999999999999998899999999965432 236788999999999999999999999999999999999985
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 104 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 104 -DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp -EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred -CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 8888886542 56999999999999999999999 89999999999999999999999999999987654332
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+. ..++.++|
T Consensus 175 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 202 (311)
T 3niz_A 175 S--YTHEVVTLWYRAPDVLMGS-KKYSTSVD 202 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTC-CSCCTHHH
T ss_pred c--ccCCcccCCcCCHHHhcCC-CCCCchHH
Confidence 2 2445789999999998542 45677665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=258.61 Aligned_cols=176 Identities=23% Similarity=0.305 Sum_probs=152.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.+.||+|+||.||++... +++.||+|.+.......+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 345678999999999999986 4789999999766555577899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--CCcEEEeecCCcccccCCC
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE--DFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+|||++. ++.+||+|||++.......
T Consensus 87 ~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999643 246999999999999999999999 899999999999999987 7899999999998775543
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+ +.++.++|
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 185 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQH--DVVSTATD 185 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTT--CEECHHHH
T ss_pred c---cccccCChhhcCcHHhcC--CCCCchhh
Confidence 2 234568999999999955 45666665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=259.75 Aligned_cols=172 Identities=25% Similarity=0.315 Sum_probs=151.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++.. +|+.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999986 5899999999642 345578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 124 AGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999764 46899999999999999999999 899999999999999999999999999999876543
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ....||+.|+|||++.+ ..++.++|
T Consensus 195 ~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 220 (350)
T 1rdq_E 195 T-----WTLCGTPEALAPEIILS--KGYNKAVD 220 (350)
T ss_dssp B-----CCCEECGGGCCHHHHTT--CCBCTHHH
T ss_pred c-----ccccCCccccCHHHhcC--CCCCCcCC
Confidence 2 34568999999999965 56777665
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=254.28 Aligned_cols=179 Identities=31% Similarity=0.515 Sum_probs=152.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.+.||+|+||.||++.+.++..||+|++.......+++.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 34456789999999999999988889999999877767788999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.........
T Consensus 105 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 105 CLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp BHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999997532 56999999999999999999999 899999999999999999999999999999866443221
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+|+.|+|||++.+ +.++.++|
T Consensus 177 -~~~~~~~~~~y~aPE~~~~--~~~~~~~D 203 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMY--SKFSSKSD 203 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHH--CCCSHHHH
T ss_pred -cccCCccCcccCCHHHhcc--CCCCchhh
Confidence 1234557889999999954 56777665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=258.34 Aligned_cols=175 Identities=26% Similarity=0.343 Sum_probs=149.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.||+|+||.||+++.+ +++.||+|++++... ..+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 45578999999999999986 488999999976432 234578899999988 899999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 92 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999764 46999999999999999999999 89999999999999999999999999999986433
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ......||+.|+|||++.+ ..++.++|
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 192 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILRG--EDYGFSVD 192 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred CCC--cccccCCCccccCccccCC--CCCChHHh
Confidence 222 1245679999999999965 56777665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=257.53 Aligned_cols=176 Identities=28% Similarity=0.380 Sum_probs=141.9
Q ss_pred HhhhhhcccCCcEEEEEEEE----CCCCEEEEEEeecCC-----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKL----IDGSNVAVKVLNDSK-----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
+.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 44567899999999999987 468999999997532 234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 99 ILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999764 46899999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .....||+.|+|||++.+ +.++.++|
T Consensus 170 ~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 203 (327)
T 3a62_A 170 ESIHDGTV--THTFCGTIEYMAPEILMR--SGHNRAVD 203 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHH
T ss_pred ccccCCcc--ccccCCCcCccCHhhCcC--CCCCCccc
Confidence 64433221 234678999999999955 56676665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=256.25 Aligned_cols=179 Identities=32% Similarity=0.545 Sum_probs=143.1
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+++.+.||+|+||.||+|+. +++.||+|++...... .+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 344567899999999999987 6889999999754433 357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
++++|.+++.... ....+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 117 ~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 117 SRGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp TTCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred CCCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999997542 1234999999999999999999999 889 9999999999999999999999999997654
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 221 (309)
T 3p86_A 191 STFL--SSKSAAGTPEWMAPEVLRD--EPSNEKSD 221 (309)
T ss_dssp -------------CCTTSCHHHHTT--CCCCTTHH
T ss_pred cccc--ccccCCCCccccChhhhcC--CCCCchhh
Confidence 3321 1234678999999999955 56777776
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=259.25 Aligned_cols=176 Identities=26% Similarity=0.300 Sum_probs=151.4
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|+.+. ++.||+|++++. ....+.+.+|..++..+ +||+|+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 3455789999999999999875 789999999753 34557788999999988 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 102 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999764 46999999999999999999999 8999999999999999999999999999998643
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 203 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVD 203 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTT--CCBSTHHH
T ss_pred cCCc--ccccccCCccccChhhhcC--CCcCCccc
Confidence 3222 1245679999999999955 56777665
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=259.16 Aligned_cols=178 Identities=31% Similarity=0.396 Sum_probs=149.3
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 45578999999999999986 68999999986432 3346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 90 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 90 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999988542 56999999999999999999999 89999999999999999999999999999987654443
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........||+.|+|||++.+. ...+.++|
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 190 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVD 190 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccC-CCCCCccc
Confidence 3333456799999999999552 22355554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-30 Score=254.15 Aligned_cols=176 Identities=31% Similarity=0.417 Sum_probs=152.3
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4556788999999999999986 589999999965322 24678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----cEEEeec
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDF 474 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 474 (516)
||||+++++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 92 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999643 56999999999999999999999 89999999999999999887 8999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++....... .....||+.|+|||++.+ ..++.++|
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 199 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNY--EPLGLEAD 199 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTT--CCCCTHHH
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecC--CCCCcHHH
Confidence 99987754432 234678999999999954 56777765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=258.94 Aligned_cols=180 Identities=27% Similarity=0.488 Sum_probs=148.3
Q ss_pred HHhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+|++. .+..||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3445578999999999999985 34569999997543 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 130 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 130 EYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp ECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999996542 56999999999999999999999 899999999999999999999999999999877
Q ss_pred cCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .......+|+.|+|||++.+ +.++.++|
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 236 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASD 236 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHH--CEECHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcC--CCCCcHHH
Confidence 554322 12233456889999999954 56776665
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=265.86 Aligned_cols=180 Identities=31% Similarity=0.455 Sum_probs=151.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.+.||+|+||.||+|++. +++.||||+++.... ..+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 3445678999999999999986 689999999875432 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++|+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 195 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 195 QGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999997642 46899999999999999999999 899999999999999999999999999999865433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..........+++.|+|||++.. +.++.++|
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 297 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNY--GRYSSESD 297 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHH--CEEEHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhcc--CCCCchhh
Confidence 22111112235778999999954 67777766
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=256.99 Aligned_cols=183 Identities=23% Similarity=0.298 Sum_probs=153.5
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC------CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS------KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
...+.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345667788999999999999875 5899999998532 224578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---EEEeec
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDF 474 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Df 474 (516)
+||||+++++|.+++..... ....+++..++.++.||+.||+||| +++|+||||||+|||++.++. +||+||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999988865421 2246899999999999999999999 899999999999999986654 999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++......... .....||+.|+|||++.+ ..++.++|
T Consensus 178 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 215 (351)
T 3c0i_A 178 GVAIQLGESGLV--AGGRVGTPHFMAPEVVKR--EPYGKPVD 215 (351)
T ss_dssp TTCEECCTTSCB--CCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred cceeEecCCCee--ecCCcCCcCccCHHHHcC--CCCCchHh
Confidence 999877554321 234679999999999955 56777765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=253.01 Aligned_cols=182 Identities=27% Similarity=0.414 Sum_probs=143.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 345578999999999999875 58999999997533 344788999999999999999999999999999999999998
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++|.+++...........+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 599999976532223356999999999999999999999 8999999999999999999999999999998765432
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+. ..++.++|
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 191 (317)
T 2pmi_A 163 NT--FSSEVVTLWYRAPDVLMGS-RTYSTSID 191 (317)
T ss_dssp CC--CCCCCSCCTTCCHHHHTTC-CCCCTHHH
T ss_pred cc--CCCCcccccccCchHhhCC-CCCCcHHH
Confidence 21 2345789999999998542 35677665
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-31 Score=276.05 Aligned_cols=184 Identities=31% Similarity=0.518 Sum_probs=158.6
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+....+.+.++||+|+||.||+|++.. +..||||+++......+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 333445567889999999999999875 8899999998777777899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.++++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 297 ~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 297 FMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp CCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred ccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999998642 256899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......+++.|+|||++.. +.++.++|
T Consensus 370 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sD 401 (495)
T 1opk_A 370 GDTYT-AHAGAKFPIKWTAPESLAY--NKFSIKSD 401 (495)
T ss_dssp TCCEE-CCTTCCCCGGGCCHHHHHH--CEECHHHH
T ss_pred CCcee-ecCCCcCCcceeCHhHHhc--CCCCcHHh
Confidence 44321 2234556789999999954 56777766
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=252.16 Aligned_cols=176 Identities=30% Similarity=0.413 Sum_probs=146.9
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 4557899999999999999889999999996432 3346788999999999999999999999999999999999986
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 85 -DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp -EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred -CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999987542 56899999999999999999999 89999999999999999999999999999986643322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+. ..++.++|
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 183 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVLMGS-KKYSTTID 183 (288)
T ss_dssp --------CCCTTCCHHHHTTC-CSCCTHHH
T ss_pred c--cccccccccccCchheeCC-CCCCcHHH
Confidence 1 2345689999999998542 45677665
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=270.92 Aligned_cols=180 Identities=28% Similarity=0.455 Sum_probs=154.1
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.+.+.||+|+||.||+|.+.++..||||+++......+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 344566889999999999999988899999999876667789999999999999999999999986 6678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 267 g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 267 GSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999997532 246889999999999999999999 89999999999999999999999999999987654321
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+++.|+|||++.. +.++.++|
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 367 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINF--GSFTIKSD 367 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHH--CCCCHHHH
T ss_pred e-ccCCCcccccccCHHHhcc--CCCCcHHH
Confidence 1 1233456889999999954 67887776
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=262.42 Aligned_cols=189 Identities=29% Similarity=0.463 Sum_probs=156.6
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEe
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCF 391 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 391 (516)
+....+.+.+.||+|+||.||+|+.. ++..||+|+++.... ..+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 33445556788999999999999862 235799999976433 236788999999999 9999999999999
Q ss_pred ecCeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 392 EGRRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 392 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
+.+..++||||+++|+|.+++...... .....+++..++.++.||+.||+||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 999999999999999999999875421 11246999999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++++.+||+|||+++...............+|+.|+|||++.+ +.++.++|
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 275 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSD 275 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhH
Confidence 999999999999999987765443333345667899999999955 56777765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-30 Score=256.44 Aligned_cols=177 Identities=28% Similarity=0.379 Sum_probs=151.9
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
..+.+.+.||+|+||.||++... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34566788999999999999976 5899999999765432 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CcEEEeecCCcc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDFGLAK 478 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~ 478 (516)
|+++|+|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||++.
T Consensus 109 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 109 LVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp CCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999998643 56899999999999999999999 8999999999999999865 459999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++.+ ..++.++|
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 212 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLKK--DPYSKPVD 212 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHTT--CCCCTHHH
T ss_pred EecCCcc---cccCCCCccccCHHHHcc--CCCCchhh
Confidence 7654432 244678999999999954 56777766
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=249.19 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=148.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.++||+|+||+||+|+.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 45578999999999999986 5899999999754322 3678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+ +|.+++... ...+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 85 Q-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp E-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred C-CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 6 666666543 256999999999999999999999 8999999999999999999999999999998765433
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+. ..++.++|
T Consensus 156 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 184 (292)
T 3o0g_A 156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSID 184 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHH
T ss_pred cc--ccCCccccCCcChHHHcCC-CCcCchHH
Confidence 22 2446789999999998552 34677665
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=262.87 Aligned_cols=177 Identities=24% Similarity=0.336 Sum_probs=151.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
.+.+.+.||+|+||.||++... +|+.+|+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 4556688999999999999875 688999999976443 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCcEEEeecCCccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKI 479 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~ 479 (516)
+++|+|.+.+... ..+++..+..++.||+.||+||| +++|+||||||+|||++ +++.+||+|||++..
T Consensus 92 ~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 92 VTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999764 56999999999999999999999 89999999999999998 567899999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++.+ ..++.++|
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~--~~~~~~~D 195 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRK--DPYGKPVD 195 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred ecCCCce--eecccCCcccCCHHHhcC--CCCCCccc
Confidence 6554332 245679999999999954 56777766
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=259.32 Aligned_cols=176 Identities=27% Similarity=0.346 Sum_probs=142.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHH-hhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVAS-ISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+++.+ +++.||+|++++.. ...+.+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 445688999999999999986 47899999997532 233556777776 567899999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999764 46899999999999999999999 8999999999999999999999999999998643
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 221 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHK--QPYDRTVD 221 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTT--CCCCTHHH
T ss_pred cCCC--ccccccCCccccCHHHhCC--CCCCchhh
Confidence 3322 1245679999999999955 56777665
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=248.37 Aligned_cols=178 Identities=30% Similarity=0.532 Sum_probs=154.5
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+.+.||+|+||.||++...+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34557899999999999999888999999998776667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++.... ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||++........ .
T Consensus 90 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 90 LSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred HHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 999997643 46899999999999999999999 89999999999999999999999999999986643321 1
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+++.|+|||++.+ +.++.++|
T Consensus 161 ~~~~~~~~~~y~aPE~~~~--~~~~~~~D 187 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSF--SRYSSKSD 187 (267)
T ss_dssp STTSTTCCGGGCCHHHHHH--CCCCHHHH
T ss_pred ccccccccccccChhhhcC--CCccchhc
Confidence 1234557889999999954 56676665
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=249.46 Aligned_cols=180 Identities=26% Similarity=0.260 Sum_probs=147.2
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCc---hhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG---EEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
++....+.+.++||+|+||+||+|++. +++.||||++....... ....+|+..+.++ +||||+++++++.+++..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 444456666788999999999999987 68999999986543332 3455566666555 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 9999999 679999987653 56999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+........ .....||+.|+|||++.+ .++.++|
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~D 237 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAAD 237 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT---CCSTHHH
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC---CCCchhh
Confidence 987654432 234568999999999843 5777766
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=266.59 Aligned_cols=176 Identities=27% Similarity=0.353 Sum_probs=141.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++.. .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 345578999999999999975 589999999964 234446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
+++|+|.+++.+. ..+++..+..++.||+.||+||| + ++|+||||||+||||+.++.+||+|||+++...
T Consensus 230 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 230 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999764 46899999999999999999999 7 899999999999999999999999999998643
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ +.++.++|
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~D 331 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLED--NDYGRAVD 331 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHT--SCCCTHHH
T ss_pred CCCc--ccccccCCccccCHhhcCC--CCCCCccc
Confidence 3322 2245679999999999954 67777766
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=253.36 Aligned_cols=174 Identities=25% Similarity=0.399 Sum_probs=148.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 345678999999999999974 6899999998642 33446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+ +|+|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.....
T Consensus 91 ~-~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 91 A-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp C-CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred C-CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9 68999998764 46999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCcccccccccccccccc-ccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEV-SYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-s~~sD 516 (516)
... .....||+.|+|||++.+ ..+ ++++|
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~~D 190 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVING--KLYAGPEVD 190 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCC--SGGGCHHHH
T ss_pred Ccc---cccccCCcCcCCHHHHcC--CCCCCCccc
Confidence 432 234578999999999965 333 55554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=268.69 Aligned_cols=175 Identities=31% Similarity=0.421 Sum_probs=152.1
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.||+|+||.||+|+.. +|+.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 4467999999999999986 6899999999642 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++.... ...+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++......
T Consensus 268 gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 268 GGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp SCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999997542 245999999999999999999999 8999999999999999999999999999998775443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+ +.++.++|
T Consensus 341 ~---~~~~~GT~~Y~APEvl~~--~~~~~~~D 367 (576)
T 2acx_A 341 T---IKGRVGTVGYMAPEVVKN--ERYTFSPD 367 (576)
T ss_dssp C---EECCCSCGGGCCHHHHTT--CEESSHHH
T ss_pred c---ccccCCCccccCHHHHcC--CCCCccch
Confidence 2 234579999999999955 56777665
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=254.22 Aligned_cols=184 Identities=32% Similarity=0.523 Sum_probs=158.2
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+....+.+.+.||+|+||.||+|.+.. +..||+|++.......+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 334445566789999999999999865 7889999998777777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp CCTTEEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred cCCCCcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999997642 356999999999999999999999 8999999999999999999999999999998766
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......+++.|+|||++.+ +.++.++|
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 194 (288)
T 3kfa_A 163 GDTYT-AHAGAKFPIKWTAPESLAY--NKFSIKSD 194 (288)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred CCccc-cccCCccccCcCChhhhcc--CCCCchhh
Confidence 54332 2244557889999999954 56776665
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=250.56 Aligned_cols=180 Identities=27% Similarity=0.399 Sum_probs=151.2
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecC--eeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--RRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+... ++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 3455789999999999999864 8999999997532 34577889999999999999999999988765 77999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCcEEEeecCCcc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAK 478 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 478 (516)
+++++|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 91 CPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp CTTCBHHHHHHSGG---GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred CCCCCHHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999997643 2234999999999999999999999 8999999999999999 788899999999998
Q ss_pred cccCCCcceeeccCCCCcccccccccccc------ccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRN------IGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~s~~sD 516 (516)
........ ....||+.|+|||++.+. .+.++.++|
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 205 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHH
Confidence 77554432 345689999999998521 256777766
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=257.24 Aligned_cols=167 Identities=28% Similarity=0.362 Sum_probs=140.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.+.||+|+||.||+++.. +++.||+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 445678999999999999986 6899999999877766788999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--EEEeecCCcccccCCC
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLAKICNRKE 484 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~ 484 (516)
+|.+++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++. +||+|||+++......
T Consensus 102 ~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 102 ELYERICNA------GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999764 46999999999999999999999 899999999999999987765 9999999997543332
Q ss_pred cceeeccCCCCccccccccccc
Q 036471 485 SIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
. .....||+.|+|||++.+
T Consensus 173 ~---~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 173 Q---PKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp -----------CTTSCHHHHHC
T ss_pred C---CCCCcCCCCcCChhhhcC
Confidence 2 234568999999999865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=261.10 Aligned_cols=180 Identities=26% Similarity=0.493 Sum_probs=140.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+|++. ++..||||+++.... ..+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3445678999999999999875 477899999975432 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++++.. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 126 e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 126 EYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp ECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999997542 56999999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......+++.|+|||++.+ +.++.++|
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 232 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASD 232 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhc
Confidence 5443211 1122345778999999954 56777766
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=268.20 Aligned_cols=180 Identities=30% Similarity=0.496 Sum_probs=148.5
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.+.++||+|+||.||+|.+.++..||||+++......+++.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 3445667899999999999999888889999998766667889999999999999999999999876 678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++++... ...+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 263 gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 263 GSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999997531 245899999999999999999999 89999999999999999999999999999987654322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......+++.|+|||++.. +.++.++|
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~sD 363 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALY--GRFTIKSD 363 (452)
T ss_dssp --------CCGGGSCHHHHHH--CCCCHHHH
T ss_pred e-cccCCcccccccCHhHHhc--CCCCcccc
Confidence 1 1234557889999999954 67787776
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=249.77 Aligned_cols=167 Identities=29% Similarity=0.463 Sum_probs=139.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---------------------------CchhHHHHHHHhhccC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---------------------------NGEEFINEVASISRTS 379 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~ 379 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 345678999999999999975 588999999865321 1356899999999999
Q ss_pred CcceeeEEEEEee--cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 036471 380 HVNVVTLLGFCFE--GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIK 457 (516)
Q Consensus 380 h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlk 457 (516)
||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.|++.||+||| +++|+|||||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 164 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK 164 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 9999999999987 56889999999999998754 2357999999999999999999999 8999999999
Q ss_pred CCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 458 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 458 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
|+|||++.++.+||+|||+++........ .....||+.|+|||++.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCT
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhcc
Confidence 99999999999999999999876554322 245678999999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=257.01 Aligned_cols=182 Identities=18% Similarity=0.199 Sum_probs=152.6
Q ss_pred HhhhhhcccC--CcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQG--GYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+| +||.||+|+.. +++.||||+++..... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4456789999 99999999986 5899999999754322 3567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||.+....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 107 FMAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp CCTTCBHHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred ccCCCCHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999997653 256999999999999999999999 8999999999999999999999999999986553
Q ss_pred CCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......||+.|+|||++.+....++.++|
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 219 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHH
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhH
Confidence 322111 11234689999999999664356777766
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=265.71 Aligned_cols=176 Identities=28% Similarity=0.414 Sum_probs=152.2
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+++.+ +|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 56999999999999986 5899999999643 244567899999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++..... ....+++..++.++.||+.||+||| +++|+||||||+||||+.+|.+||+|||+++.+......
T Consensus 271 ~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 271 DIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp BHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 99999976431 2356999999999999999999999 899999999999999999999999999999876544322
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 346 --~~~~~GT~~Y~APE~l~~--~~~~~~~D 371 (543)
T 3c4z_A 346 --TKGYAGTPGFMAPELLLG--EEYDFSVD 371 (543)
T ss_dssp --BCCCCSCTTTSCHHHHTT--CCBCTHHH
T ss_pred --cccccCCccccChhhhcC--CCCChHHh
Confidence 234579999999999965 56777765
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=250.44 Aligned_cols=181 Identities=29% Similarity=0.457 Sum_probs=150.6
Q ss_pred HHHhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeec--Cee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 396 (516)
..+.+.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3345667899999999999984 358899999997532 3447889999999999999999999999876 668
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++||||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 99999999999999997643 56999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.......... ......||..|+|||++.+ ..++.++|
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 211 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASD 211 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchh
Confidence 98776554322 1234568889999999855 56666655
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=253.50 Aligned_cols=178 Identities=24% Similarity=0.357 Sum_probs=141.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecCe----eEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGRR----RAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~l 398 (516)
+.+.+.||+|+||.||++++. +++.||+|+++..... .+.+.+|+.++.+++||||+++++++..... .++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 445678999999999999974 6889999999764332 2467899999999999999999999887554 399
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.++++.. ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 94 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999764 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+....... ......||+.|+|||++.+ ..++.++|
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 201 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSD 201 (311)
T ss_dssp -----------------CCTTCCHHHHHT--CCCCHHHH
T ss_pred cccccccccccccccCcCcccCCHHHhcC--CCCCchHh
Confidence 765443221 1233568999999999955 56777665
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=262.15 Aligned_cols=172 Identities=29% Similarity=0.532 Sum_probs=146.9
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecC-eeEEEEEecCCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR-RRALIYEFVSNGS 407 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~gs 407 (516)
.+.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||||+++|+
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 45578999999999999984 7899999997654 5578999999999999999999999987765 7899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.++++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 274 L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 274 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp HHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 999998753 245799999999999999999999 8999999999999999999999999999998543322
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||++.+ +.++.++|
T Consensus 344 --~~~~~~~~y~aPE~~~~--~~~~~~sD 368 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALRE--KKFSTKSD 368 (450)
T ss_dssp -----CCCTTTSCHHHHHS--SCCCHHHH
T ss_pred --cCCCCCcceeCHHHhcC--CCCCcHHH
Confidence 22356889999999954 67887776
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=256.06 Aligned_cols=184 Identities=26% Similarity=0.455 Sum_probs=151.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+.+.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 345578999999999999874 347899999975432 236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 400 YEFVSNGSLEKFIYRNSSSI------------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
|||+++++|.+++....... ....+++.+++.++.||++||+||| +++|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceE
Confidence 99999999999998743110 1257999999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++.++.+||+|||+++...............+|+.|+|||++.+ +.++.++|
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 258 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESD 258 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccc
Confidence 999999999999999987654432222344567999999999854 56777765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=251.24 Aligned_cols=185 Identities=28% Similarity=0.439 Sum_probs=153.6
Q ss_pred HHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 344567899999999999986 2357899999975432 33678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSI------------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
||||+++++|.+++....... ....+++..++.++.||++||+||| +++|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchhe
Confidence 999999999999998753210 1234899999999999999999999 8999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++.++.+||+|||+++...............+++.|+|||++.+ ..++.++|
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 234 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSD 234 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC--CCcCchhh
Confidence 9999999999999999987765544433345567899999999854 56676665
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=261.84 Aligned_cols=187 Identities=29% Similarity=0.456 Sum_probs=151.9
Q ss_pred HHHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecC-
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGR- 394 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~- 394 (516)
...+.+.+.||+|+||.||+|++ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 33455668899999999999974 2357899999975432 235789999999999 8999999999998755
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCC-------------------------------------------------------
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSI------------------------------------------------------- 419 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 419 (516)
..++||||+++|+|.++++......
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 4899999999999999998653210
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCC
Q 036471 420 -----ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARG 494 (516)
Q Consensus 420 -----~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 494 (516)
....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++...............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 0123899999999999999999999 89999999999999999999999999999987755544434455678
Q ss_pred CccccccccccccccccccCCC
Q 036471 495 TVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 495 t~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+.|+|||++.+ ..++.++|
T Consensus 258 t~~y~aPE~~~~--~~~~~~~D 277 (359)
T 3vhe_A 258 PLKWMAPETIFD--RVYTIQSD 277 (359)
T ss_dssp CGGGCCHHHHHH--CCCCHHHH
T ss_pred CceeEChhhhcC--CCCCchhh
Confidence 999999999954 56777765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=249.90 Aligned_cols=170 Identities=22% Similarity=0.328 Sum_probs=130.9
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
+.||+|+||.||+++.. +++.||||++... ....+.+|+.++.++. ||||+++++++.++...++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 56999999999999986 5899999999643 3467789999999997 999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEeecCCcccccCCCcc
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISDFGLAKICNRKESI 486 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~ 486 (516)
+++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++........
T Consensus 95 ~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 95 ERIKKK------KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHC------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999764 56999999999999999999999 89999999999999997765 8999999999866544322
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ ..++.++|
T Consensus 166 --~~~~~~t~~y~aPE~~~~--~~~~~~~D 191 (325)
T 3kn6_A 166 --LKTPCFTLHYAAPELLNQ--NGYDESCD 191 (325)
T ss_dssp ----------------------CCCCHHHH
T ss_pred --ccccCCCcCccCHHHhcC--CCCCCccc
Confidence 234568999999999954 56777665
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=254.25 Aligned_cols=186 Identities=31% Similarity=0.480 Sum_probs=152.5
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecC--CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDS--KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.+.||+|+||.||+|+.. ++..||+|++... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 34456688999999999999862 3568999999653 34457899999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSI-----------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~ 459 (516)
++||||+++|+|.+++....... ....+++..++.++.||+.||+||| +++|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence 99999999999999998653210 0134899999999999999999999 899999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 460 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||++.++.+||+|||++................||+.|+|||++.+ +.++.++|
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 256 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSD 256 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHh
Confidence 99999999999999999987765544333345567889999999855 56777665
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=260.59 Aligned_cols=186 Identities=30% Similarity=0.443 Sum_probs=152.0
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..+.+.+.||+|+||.||+|++. +++.||||+++... ....++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 34456688999999999999853 36689999996532 23357889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cEEEee
Q 036471 398 LIYEFVSNGSLEKFIYRNSSS-IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CPKISD 473 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~D 473 (516)
+||||+++|+|.++++..... .....+++..++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999875422 12256999999999999999999999 89999999999999999555 599999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++.+.............||+.|+|||++.+ +.++.++|
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 268 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTD 268 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--CCCCHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcC--CCCCcHHH
Confidence 999976543332222234567999999999955 56777765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=256.72 Aligned_cols=179 Identities=26% Similarity=0.291 Sum_probs=149.8
Q ss_pred HhhhhhcccCCcEEEEEEEE----CCCCEEEEEEeecC-----CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKL----IDGSNVAVKVLNDS-----KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 397 (516)
+.+.+.||+|+||.||+++. .+++.||||+++.. ....+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 44567899999999999997 36899999998642 23446788899999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 136 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999764 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+......... .....||+.|+|||++.+....++.++|
T Consensus 207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~D 244 (355)
T 1vzo_A 207 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVD 244 (355)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred eecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhh
Confidence 8664433221 2345689999999999653344566655
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=253.59 Aligned_cols=180 Identities=31% Similarity=0.518 Sum_probs=145.3
Q ss_pred HHhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 398 (516)
.+.+.++||+|+||.||++++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 445667899999999999984 258899999997543 2346789999999999999999999998654 46899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 91 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999997642 45999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... ......++..|+|||++.+ ..++.++|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 199 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASD 199 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHH
Confidence 775443221 1233457888999999955 56777765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=254.61 Aligned_cols=185 Identities=29% Similarity=0.456 Sum_probs=137.5
Q ss_pred HHhhhhhcccCCcEEEEEEEECCC----CEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCee---
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDG----SNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRR--- 396 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--- 396 (516)
.+.+.+.||+|+||.||+|++... ..||+|+++... ...+.+.+|+.++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 445667899999999999987543 279999997532 3346789999999999999999999999877655
Q ss_pred ---EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 397 ---ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 397 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
++||||+++++|.+++...........+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEee
Confidence 899999999999999976542222346999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++...............+++.|+|||++.+ ..++.++|
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 221 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--NLYTVHSD 221 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHH--CCCCHHHH
T ss_pred ccccccccccccccccccccCcccccCchhhcC--CCCCCccc
Confidence 999987655443333344567889999999955 56777765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=255.66 Aligned_cols=172 Identities=31% Similarity=0.438 Sum_probs=143.9
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 56999999999999875 58999999997643 34567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE--CCCCcEEEeecCCcccccCCCcce
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL--DEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 175 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~- 245 (373)
T 2x4f_A 175 DRIIDES-----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245 (373)
T ss_dssp HHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence 9987532 56899999999999999999999 8999999999999999 67789999999999877554322
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....||+.|+|||++.. +.++.++|
T Consensus 246 --~~~~gt~~y~aPE~~~~--~~~~~~~D 270 (373)
T 2x4f_A 246 --KVNFGTPEFLAPEVVNY--DFVSFPTD 270 (373)
T ss_dssp --CCCCSSCTTCCHHHHTT--CBCCHHHH
T ss_pred --ccccCCCcEeChhhccC--CCCCcHHh
Confidence 33568999999999854 56776665
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=251.63 Aligned_cols=176 Identities=25% Similarity=0.324 Sum_probs=149.8
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 34578999999999999974 68899999987543 345789999999999 9999999999999999999999999 99
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-----EEEeecCCccccc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-----PKISDFGLAKICN 481 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~ 481 (516)
+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++.+.
T Consensus 90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 90 SLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9999997642 57999999999999999999999 899999999999999998887 9999999998765
Q ss_pred CCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......||+.|+|||++.+ ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 199 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDD 199 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC--CCCCchhH
Confidence 443211 1234679999999999965 56777765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=274.44 Aligned_cols=176 Identities=26% Similarity=0.299 Sum_probs=152.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+++.+.||+|+||.||+|+.. +++.||||++++ .....+.+.+|..++..+ +||+|+++++++.+.+..+||||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445578999999999999976 478999999974 234557788999999987 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++++. ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++...
T Consensus 423 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999765 46999999999999999999999 8999999999999999999999999999998643
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~--~~~~~~~D 524 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAY--QPYGKSVD 524 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTC--CCBSTHHH
T ss_pred cCCc--ccccccCCCcccCHhhhcC--CCCCccce
Confidence 3322 1245679999999999954 57777766
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=253.13 Aligned_cols=178 Identities=29% Similarity=0.496 Sum_probs=143.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCC----EEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGS----NVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.+.||+|+||.||+|++. +++ +||+|.+... ....+.+.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 445678999999999999865 344 3688887543 344578999999999999999999999998754 78999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp ECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999998643 56999999999999999999999 899999999999999999999999999999887
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.............+|+.|+|||++.+ +.++.++|
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 201 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSD 201 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH--CCCCHHHH
T ss_pred cCCcccccccCCCccccccChHHhcc--CCCCchhh
Confidence 65554433345567889999999965 67777766
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-30 Score=246.39 Aligned_cols=179 Identities=31% Similarity=0.498 Sum_probs=152.2
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+.+.+.||+|+||.||+|...+++.||+|.+.......+.+.+|++++++++||||+++++++. .+..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 34456789999999999999988889999999877667788999999999999999999999876 45689999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+||++++++.+||+|||++.........
T Consensus 93 ~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 93 SLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp BHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999986431 136999999999999999999999 899999999999999999999999999999877544322
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......+++.|+|||++.+ +.++.++|
T Consensus 166 -~~~~~~~~~~y~aPE~~~~--~~~~~~~D 192 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINY--GTFTIKSD 192 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHH--CEECHHHH
T ss_pred -cccCCCCccCccChhhhcc--CCCCchhh
Confidence 2234557889999999854 56676665
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=240.27 Aligned_cols=175 Identities=22% Similarity=0.305 Sum_probs=152.2
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||+|.... +..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 45566889999999999999864 778999999754 4456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 481 (516)
+++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++....
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 90 GGELFERVVHK------RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp SCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999998764 46899999999999999999999 8999999999999999 788999999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....||+.|+|||++.+ .++.++|
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~D 189 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECD 189 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHH
T ss_pred Cccc---hhccCCCCCccChHHhcc---cCCchhh
Confidence 4432 234568999999999843 4777766
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=253.70 Aligned_cols=174 Identities=29% Similarity=0.393 Sum_probs=134.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.+.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 345578999999999999987 47899999997543 3467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccCC
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNRK 483 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 483 (516)
+|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 134 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 134 ELFDRIVEK------GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp BHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999643 56899999999999999999999 899999999999999975 889999999999866443
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+ ..++.++|
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 232 (349)
T 2w4o_A 205 VL---MKTVCGTPGYCAPEILRG--CAYGPEVD 232 (349)
T ss_dssp -----------CGGGSCHHHHTT--CCCCTHHH
T ss_pred cc---cccccCCCCccCHHHhcC--CCCCcccc
Confidence 22 234568999999999954 56777766
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=251.59 Aligned_cols=176 Identities=29% Similarity=0.362 Sum_probs=149.6
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---------CchhHHHHHHHhhccCCcceeeEEEEEeecCee
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 396 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 3445578999999999999875 588999999975432 335788999999999999999999999999999
Q ss_pred EEEEEecCCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 397 ALIYEFVSNG-SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 397 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
++||||+.+| +|.+++... ..+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999776 999999754 46999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcceeeccCCCCcccccccccccccccc-ccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV-SYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-s~~sD 516 (516)
+++........ ....||+.|+|||++.+ ..+ +.++|
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~~D 212 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMG--NPYRGPELE 212 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTT--CCBCSHHHH
T ss_pred cceECCCCCce---eccCCCccccChhhhcC--CCCCCCccc
Confidence 99877554332 33568999999999965 333 55554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=253.39 Aligned_cols=187 Identities=28% Similarity=0.501 Sum_probs=153.2
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC--------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeec
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEG 393 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 393 (516)
...+.+.+.||+|+||.||+|++. ++..||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 344556788999999999999863 467899999975432 336788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
+..++||||+++++|.+++...... .....+++..++.++.||+.||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 9999999999999999999865321 01235899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 464 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 464 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.++.+||+|||+++...............+++.|+|||++.+ +.++.++|
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 241 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSD 241 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC--CCcChHHH
Confidence 9999999999999987765543333344567889999999855 56676665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=250.05 Aligned_cols=185 Identities=32% Similarity=0.494 Sum_probs=154.4
Q ss_pred HHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 397 (516)
.+.+.+.||+|+||.||+|++ .+++.||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+++..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 445668899999999999985 2467899999975432 346789999999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 398 LIYEFVSNGSLEKFIYRNSSS------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
+||||+++|+|.+++...... .....+++..++.++.|++.||+||| +++|+||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcC
Confidence 999999999999999875421 11235899999999999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||++................+|+.|+|||++.+ +.++.++|
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 229 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESD 229 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHH
Confidence 99999999999987766544333344567889999999854 56777665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=246.94 Aligned_cols=177 Identities=30% Similarity=0.424 Sum_probs=152.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..+.+.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34566788999999999999986 589999999965322 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----cEEEee
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISD 473 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~D 473 (516)
+||||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999653 56899999999999999999999 89999999999999999888 799999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++........ .....||+.|+|||++.+ +.++.++|
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 200 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNY--EPLGLEAD 200 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHHTT--CCCCTHHH
T ss_pred CccceecCcccc---ccccCCCCCccCcccccC--CCCCCccc
Confidence 999987655432 234568999999999954 56777765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=250.44 Aligned_cols=174 Identities=29% Similarity=0.422 Sum_probs=148.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+...+.||+|+||.||+|+.. +++.||||++...... .+++.+|+.++++++||||+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 444577999999999999974 6889999999754322 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++ |+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 136 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp CS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 97 68888886543 57999999999999999999999 89999999999999999999999999999986643
Q ss_pred CCcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
. ....||+.|+|||++.. ..+.++.++|
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~D 235 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVD 235 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHH
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHH
Confidence 3 33568999999999853 1256777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=255.36 Aligned_cols=176 Identities=27% Similarity=0.386 Sum_probs=150.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 455678999999999999986 58899999987543 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--CCcEEEeecCCcccccCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE--DFCPKISDFGLAKICNRK 483 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~ 483 (516)
++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 133 GELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999998643 246999999999999999999999 899999999999999974 578999999999877654
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....||+.|+|||++.+ ..++.++|
T Consensus 205 ~~~---~~~~gt~~y~aPE~~~~--~~~~~~~D 232 (387)
T 1kob_A 205 EIV---KVTTATAEFAAPEIVDR--EPVGFYTD 232 (387)
T ss_dssp SCE---EEECSSGGGCCHHHHTT--CCBCHHHH
T ss_pred cce---eeeccCCCccCchhccC--CCCCCccc
Confidence 332 23468999999999955 56776665
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=241.93 Aligned_cols=176 Identities=28% Similarity=0.444 Sum_probs=132.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 34578999999999999974 6899999999642 233477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 94 HNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp TTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999997542 56899999999999999999999 899999999999999999999999999999876533
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....|++.|+|||++.+ ..++.++|
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 194 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATR--SAHGLESD 194 (278)
T ss_dssp ------------------------------CTH
T ss_pred CCc--ceeccCCCCcCCcchhcC--CCCCchhh
Confidence 221 123568999999999855 56777776
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=273.65 Aligned_cols=180 Identities=30% Similarity=0.496 Sum_probs=153.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
..+.+.++||+|+||.||+|.+.++..||||+++......+++.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 3445668899999999999999888899999998766667889999999999999999999999876 678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++|+... ...+++.+++.++.||+.||+||| +++|+||||||+||||++++.+||+|||+++.......
T Consensus 346 gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 346 GSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred CcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999997532 245899999999999999999999 89999999999999999999999999999987653321
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. ......++..|+|||++.. +.++.++|
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~sD 446 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALY--GRFTIKSD 446 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHH--CCCCHHHH
T ss_pred e-cccCCcCcccccCHHHhcc--CCCCchhh
Confidence 1 1233457889999999854 67777776
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=252.10 Aligned_cols=177 Identities=27% Similarity=0.460 Sum_probs=145.4
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCE----EEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSN----VAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.||+|+||.||+|++.. ++. |++|.+... ....+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 345789999999999998753 443 788887543 334467889999999999999999999886 567889999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 95 YLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp CCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred eCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999997532 56899999999999999999999 8999999999999999999999999999998876
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
............|++.|+|||++.+ +.++.++|
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 199 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF--GKYTHQSD 199 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH--CCCCHHHH
T ss_pred cccccccccCCCCcccccChHHhcc--CCCChhhH
Confidence 5544333355668889999999954 56777765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=261.25 Aligned_cols=176 Identities=29% Similarity=0.436 Sum_probs=150.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 345578999999999999986 6899999999643 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.+. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 98 VSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp CSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999998542 56999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|+|||++.+. ...+.++|
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~D 198 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVD 198 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTC-CBCSHHHH
T ss_pred ccc---ccccCCCcCeEChhhccCC-CCCCCcce
Confidence 432 2345789999999999652 22245554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=262.67 Aligned_cols=178 Identities=26% Similarity=0.378 Sum_probs=136.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 398 (516)
+.+.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+.++++++||||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 445678999999999999876 589999999965433 236788999999999999999999998543 56899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+ +++|.++++.. ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 135 v~e~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EECCC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEecc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 99998 56999998643 56999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcc-------------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESI-------------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ...+...||+.|+|||++... ..++.++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~D 266 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAID 266 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhH
Confidence 76432211 123445789999999987442 56777766
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=242.19 Aligned_cols=178 Identities=29% Similarity=0.467 Sum_probs=151.5
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee----------
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE---------- 392 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------- 392 (516)
....+.+.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3445556688999999999999986 68999999997543 568899999999999999999998864
Q ss_pred ------cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC
Q 036471 393 ------GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED 466 (516)
Q Consensus 393 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 466 (516)
....++||||+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+|+||||+||+++++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 445789999999999999997642 256999999999999999999999 8999999999999999999
Q ss_pred CcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+||+|||++........ .....|++.|+|||++.+ ..++.++|
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 203 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISS--QDYGKEVD 203 (284)
T ss_dssp TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHC--SCCCTHHH
T ss_pred CCEEECcchhheecccccc---ccccCCcccccChhhhcc--CCCcchhh
Confidence 9999999999987655432 234568999999999954 56777765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=250.99 Aligned_cols=176 Identities=28% Similarity=0.333 Sum_probs=151.7
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-----CcceeeEEEEEeecCeeEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-----HVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv 399 (516)
..+.+.++||+|+||.||+|+.. +++.||||+++......+.+..|+.++++++ ||||+++++++...+..++|
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 34555688999999999999985 5889999999765555567888999999986 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC--------------
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-------------- 465 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-------------- 465 (516)
|||+ +++|.+++.+.. ...+++..++.++.||+.||+||| +++|+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp ECCC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EcCC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccc
Confidence 9999 899999998653 246999999999999999999999 899999999999999975
Q ss_pred -----------CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 -----------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||++....... ....||+.|+|||++.+ ..++.++|
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 241 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILN--LGWDVSSD 241 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTT--CCCCTTHH
T ss_pred ccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcC--CCCCCccc
Confidence 7899999999998654332 34578999999999965 57888876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=246.35 Aligned_cols=176 Identities=24% Similarity=0.385 Sum_probs=144.6
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.||+|+... ++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 445789999999999999864 899999998654433 3567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 86 HTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999988643 56899999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+. ..++.++|
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~D 185 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELLVGD-TQYGPPVD 185 (311)
T ss_dssp -----------GGGCCHHHHHTC-SCCCTHHH
T ss_pred cc--cCCCcCCccccChHHHhcC-CCCCcchh
Confidence 22 2345689999999998543 45677665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=244.98 Aligned_cols=179 Identities=32% Similarity=0.489 Sum_probs=147.2
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC------CCchhHHHHHHHhhccC---CcceeeEEEEEeecC
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK------GNGEEFINEVASISRTS---HVNVVTLLGFCFEGR 394 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 394 (516)
...+.+.+.||+|+||+||+|++. +++.||+|++.... .....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 344566688999999999999974 68999999986322 22356778888877764 999999999998755
Q ss_pred -----eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcE
Q 036471 395 -----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCP 469 (516)
Q Consensus 395 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 469 (516)
..++||||++ ++|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCE
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 5789999997 59999997643 245999999999999999999999 8999999999999999999999
Q ss_pred EEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||+++....... .....||+.|+|||++.+ +.++.++|
T Consensus 160 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 201 (308)
T 3g33_A 160 KLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQ--STYATPVD 201 (308)
T ss_dssp EECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHT--SCCCSTHH
T ss_pred EEeeCccccccCCCcc---cCCccccccccCchHHcC--CCCCchHH
Confidence 9999999987654332 244678999999999955 57788776
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=240.59 Aligned_cols=177 Identities=31% Similarity=0.435 Sum_probs=149.2
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
..+.+.+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34566788999999999999986 589999999865321 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----cEEEee
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISD 473 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~D 473 (516)
+||||+++++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|
T Consensus 85 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999754 46899999999999999999999 89999999999999998877 899999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++........ .....|++.|+|||++.. +.++.++|
T Consensus 156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 193 (283)
T 3bhy_A 156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNY--EPLGLEAD 193 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTT--CCCCTHHH
T ss_pred cccceeccCCCc---ccccCCCcCccCcceecC--CCCCcchh
Confidence 999987654332 234568999999999854 56777665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=250.95 Aligned_cols=168 Identities=21% Similarity=0.317 Sum_probs=139.3
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccCC--cceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTSH--VNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||++...+++.||+|++...... .+.+.+|+.++.+++| +||+++++++.+++..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 3456789999999999999988999999999754433 2578899999999976 999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+.+++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus 90 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 90 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp CCSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 5678999999764 56899999999999999999999 89999999999999997 57899999999987765
Q ss_pred CCcceeeccCCCCccccccccccc
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
...........||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ----------CCCCSSCCHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhh
Confidence 543333345679999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=258.56 Aligned_cols=178 Identities=26% Similarity=0.378 Sum_probs=145.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 398 (516)
+.+.+.||+|+||.||+|++. +++.||||++...... .+.+.+|+.++++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 445678999999999999976 4788999999754332 36788999999999999999999999876 57899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||++ ++|.++++.. ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++
T Consensus 108 v~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999986 5999999643 56999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcc--------------------eeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESI--------------------ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ...+...||+.|+|||++... ..++.++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~D 234 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSID 234 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccc
Confidence 76543221 113556789999999997443 56777765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=241.49 Aligned_cols=173 Identities=29% Similarity=0.424 Sum_probs=146.3
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+|+... ++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 345789999999999998764 779999998642 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 92 PLGTVYRELQKL------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999764 46899999999999999999999 999999999999999999999999999998654433
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....|++.|+|||++.+ ..++.++|
T Consensus 163 ~~----~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (279)
T 3fdn_A 163 RR----TDLCGTLDYLPPEMIEG--RMHDEKVD 189 (279)
T ss_dssp ---------CCCCTTCCHHHHTT--CCCCTTHH
T ss_pred cc----cccCCCCCccCHhHhcc--CCCCccch
Confidence 21 34568999999999854 56677765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=242.68 Aligned_cols=179 Identities=29% Similarity=0.436 Sum_probs=147.2
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.+.||+|+||.||+++.. ++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 4566788999999999999975 58899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCcccc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKIC 480 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~ 480 (516)
++++|.+++..... ....+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++...
T Consensus 103 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 103 EGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp SCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999865321 2356999999999999999999999 8999999999999999 45678999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|+|||++. +.++.++|
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~---~~~~~~~D 207 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK---RDVTFKCD 207 (285)
T ss_dssp ------------CTTGGGCCHHHHT---TCCCHHHH
T ss_pred CCccc---CcCcccccCcCChHHhc---cCCCcccC
Confidence 54432 23456899999999984 35666655
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=247.46 Aligned_cols=177 Identities=24% Similarity=0.372 Sum_probs=151.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---------chhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---------GEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
+.+.+.||+|++|.||+|++. +|+.||||++...... .+.+.+|+.++.++ +||||+++++++...+..
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 444578999999999999986 6999999999754321 34678899999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+|+||||+||+++.++.+||+|||+
T Consensus 176 ~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 9999999999999999754 46999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCcccccccccccc----ccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRN----IGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~sD 516 (516)
+..+..... .....||+.|+|||++.+. ...++.++|
T Consensus 247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 287 (365)
T 2y7j_A 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287 (365)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHH
T ss_pred ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhh
Confidence 987765432 2446789999999998542 124666665
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=252.58 Aligned_cols=168 Identities=20% Similarity=0.310 Sum_probs=140.7
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccC--CcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTS--HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++.+++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4556789999999999999888999999999754332 367899999999996 5999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+.+++|.+++.+. ..+++..++.++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 5688999999764 46889999999999999999999 99999999999999996 57999999999987765
Q ss_pred CCcceeeccCCCCccccccccccc
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
...........||+.|+|||++.+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhh
Confidence 443333345679999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=246.69 Aligned_cols=175 Identities=27% Similarity=0.399 Sum_probs=141.4
Q ss_pred cHHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhc--cCCcceeeEEEEEeec---
Q 036471 319 SYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFCFEG--- 393 (516)
Q Consensus 319 ~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~--- 393 (516)
...+.....+.+.+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++.. ++||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 334444456667789999999999999985 8999999996543 2344555555554 4999999999999887
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeeeCCCCCCcEEEC
Q 036471 394 -RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST--------RILHFDIKPHNILLD 464 (516)
Q Consensus 394 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~--------~ivH~dlkp~NIll~ 464 (516)
...++||||+++|+|.++++. ..+++..++.++.|++.||+||| .. +|+||||||+|||++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCceEEEEeccCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEEC
Confidence 688999999999999999965 35899999999999999999999 77 999999999999999
Q ss_pred CCCcEEEeecCCcccccCCCccee--eccCCCCccccccccccc
Q 036471 465 EDFCPKISDFGLAKICNRKESIIS--MTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 465 ~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 506 (516)
.++.+||+|||+++.......... .....||+.|+|||++.+
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 999999999999977654432211 124578999999999955
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=244.40 Aligned_cols=180 Identities=31% Similarity=0.406 Sum_probs=145.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee-------------c
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE-------------G 393 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------------~ 393 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++.......+.+.+|+.++++++||||+++++++.+ .
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 445678999999999999975 68999999997655555788999999999999999999998865 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 57789999999999999997642 56888999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCc------------ceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKES------------IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++........ ........|++.|+|||++.+. +.++.++|
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 213 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKID 213 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhh
Confidence 999987643211 1112345689999999998542 45677665
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=239.49 Aligned_cols=174 Identities=29% Similarity=0.386 Sum_probs=149.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 44578999999999999976 5899999999754432 3567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---EEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~ 481 (516)
+++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++....
T Consensus 89 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 89 GGELFEDIVAR------EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999998764 56999999999999999999999 899999999999999986655 9999999997765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....||+.|+|||++.+ ..++.++|
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKK--DPYSKPVD 189 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred cCcc---ccCCCCCcCCcCchhhcC--CCCCcccc
Confidence 4432 234678999999999955 56777765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=240.55 Aligned_cols=174 Identities=32% Similarity=0.544 Sum_probs=145.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC--------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN--------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
+.+.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 445678999999999999985 6899999998643221 267889999999999999999999986655 69
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCc-----EEE
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFC-----PKI 471 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl 471 (516)
||||+++++|.+++.+.. ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++. +||
T Consensus 99 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred EEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 999999999999886542 57999999999999999999999 889 999999999999988776 999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||+++..... .....||+.|+|||++......++.++|
T Consensus 171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~D 210 (287)
T 4f0f_A 171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKAD 210 (287)
T ss_dssp CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHH
T ss_pred CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhh
Confidence 999999754332 2446789999999998544456666665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=251.70 Aligned_cols=187 Identities=27% Similarity=0.313 Sum_probs=148.8
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC------CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS------KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 4556688999999999999975 5789999998642 34457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 036471 400 YEFVSNGSLEKFIYRNSSS----------------------------------IENHKLTWETLLQIAVGIARGLEYLHL 445 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~ 445 (516)
|||+++|+|.+++...... .....+++..++.++.||+.||+|||
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH- 185 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH- 185 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence 9999999999998532100 00123467888999999999999999
Q ss_pred CCCCCeeeCCCCCCcEEECCCC--cEEEeecCCcccccCCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 446 GCSTRILHFDIKPHNILLDEDF--CPKISDFGLAKICNRKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 446 ~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..+.++.++|
T Consensus 186 --~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 186 --NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp --HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred --HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 89999999999999998776 8999999999876443221 122456789999999999654456777766
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=240.34 Aligned_cols=180 Identities=31% Similarity=0.385 Sum_probs=151.5
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 3455678999999999999986 68999999996533 33477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||.+......
T Consensus 88 ~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 88 SGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp TTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999988532 56899999999999999999999 899999999999999999999999999999876544
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..........|++.|+|||++.+. ...+.++|
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 190 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRR-EFHAEPVD 190 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHH
T ss_pred cchhcccCCccccCccChHHHhcC-CCCCCcch
Confidence 332223456789999999998542 22355554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-29 Score=240.11 Aligned_cols=178 Identities=27% Similarity=0.347 Sum_probs=148.2
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|++.... ....++.+|+..+.++ +||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 3455678999999999999986 68999999997542 2346788999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---------------
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED--------------- 466 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~--------------- 466 (516)
|+++++|.+++..... ....+++..++.++.||+.||+||| +++|+||||||+||+++.+
T Consensus 92 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 92 YCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp CCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred ecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999976421 1256899999999999999999999 8999999999999999844
Q ss_pred ----CcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 467 ----FCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 467 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..+||+|||.+....... ...||+.|+|||++.+. ..++.++|
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~D 213 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKAD 213 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhh
Confidence 479999999998765432 24589999999999653 34555555
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=253.68 Aligned_cols=186 Identities=31% Similarity=0.476 Sum_probs=152.8
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.+.||+|+||.||+|.... ...||+|.+..... ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 344556789999999999998753 24799999975432 346789999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSS--------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC 468 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 468 (516)
++||||+++|+|.+++...... .....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCe
Confidence 9999999999999999764210 01246899999999999999999999 899999999999999999999
Q ss_pred EEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 469 PKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 469 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+||+|||++................+|+.|+|||++.+ +.++.++|
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 248 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--CVYTVQSD 248 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--CCCCHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhcc--CCCChHHH
Confidence 99999999987655543333344567889999999854 56777665
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=239.38 Aligned_cols=174 Identities=26% Similarity=0.401 Sum_probs=150.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 345678999999999999986 4778999998642 23446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999764 46899999999999999999999 99999999999999999999999999999976543
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....|++.|+|||++.+ ..++.++|
T Consensus 167 ~~~----~~~~~~~~y~aPE~~~~--~~~~~~~D 194 (284)
T 2vgo_A 167 LRR----RTMCGTLDYLPPEMIEG--KTHDEKVD 194 (284)
T ss_dssp SCB----CCCCSCGGGCCHHHHTT--CCBCTTHH
T ss_pred ccc----ccccCCCCcCCHHHhcc--CCCCcccc
Confidence 321 34568999999999954 56777766
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=244.04 Aligned_cols=177 Identities=24% Similarity=0.381 Sum_probs=141.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345678999999999999986 5889999999654322 36788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 116 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 116 INGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp CCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999764 46899999999999999999999 89999999999999999999999999999976654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......|++.|+|||++.+ +.++.++|
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 217 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSE--SHATYRAD 217 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCH
T ss_pred cccc-cccccCCCcCccCHHHHcC--CCCCchHh
Confidence 3321 1234568999999999955 67788877
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=239.88 Aligned_cols=175 Identities=29% Similarity=0.364 Sum_probs=150.1
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.||+|+||.||+++..+ ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 345789999999999999864 7889999986543 22357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 98 RRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp TTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999998764 46899999999999999999999 899999999999999999999999999999876543
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....|++.|+|||++.+ ..++.++|
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 197 (294)
T 2rku_A 169 GER--KKVLCGTPNYIAPEVLSK--KGHSFEVD 197 (294)
T ss_dssp TCC--BCCCCSCCSSCCHHHHTT--SCBCTHHH
T ss_pred ccc--cccccCCCCcCCcchhcc--CCCCchhh
Confidence 322 234568999999999854 56666665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=249.52 Aligned_cols=175 Identities=26% Similarity=0.436 Sum_probs=147.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-C-------CEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-G-------SNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
.+.+.+.||+|+||.||+|+... + ..||+|++.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 34456789999999999998653 3 469999986543 44577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--------E
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--------P 469 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~ 469 (516)
+||||+++++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++. +
T Consensus 89 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp EEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999997642 45899999999999999999999 899999999999999998887 9
Q ss_pred EEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||++...... ....|++.|+|||++.+. +.++.++|
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~D 200 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATD 200 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHH
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhH
Confidence 99999999755332 223468899999998542 45676665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=240.36 Aligned_cols=177 Identities=20% Similarity=0.332 Sum_probs=150.2
Q ss_pred HhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|+||.||+|+. .+++.||+|++.... ..+.+.+|+..+.++ +|+|++++++++.+....++||||+ +
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 34557899999999999997 468999999986543 346789999999999 8999999999999999999999999 9
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-----EEEeecCCcccc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-----PKISDFGLAKIC 480 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~ 480 (516)
++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++..
T Consensus 90 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 90 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred CCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999997642 46999999999999999999999 999999999999999987776 999999999877
Q ss_pred cCCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......||+.|+|||++.+ ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 200 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDD 200 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcC--CCCChHHH
Confidence 5543221 1244669999999999855 56777765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=248.70 Aligned_cols=174 Identities=26% Similarity=0.398 Sum_probs=146.3
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||+++.+ +++.||+|++..... ...+|++++.++ +||||+++++++.+++..++||||++
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 4556688999999999999986 588999999976543 356788888888 79999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC----CcEEEeecCCcccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED----FCPKISDFGLAKIC 480 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~ 480 (516)
+|+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||+..+ +.+||+|||+++..
T Consensus 100 gg~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 100 GGELLDKILRQ------KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp SCBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999653 56999999999999999999999 8999999999999998543 35999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....||+.|+|||++.+ ..++.++|
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 202 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLER--QGYDAACD 202 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHH--HHHHHHHH
T ss_pred cCCCCc--eeccCCCccccCHHHhcC--CCCCCccC
Confidence 544322 234678999999999854 45666655
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=243.97 Aligned_cols=178 Identities=25% Similarity=0.423 Sum_probs=137.0
Q ss_pred HHhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 44566789999999999998753 45699999865332 2367889999999999999999999874 56789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999997642 46899999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....+++.|+|||++.. +.++.++|
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~D 199 (281)
T 1mp8_A 167 EDSTYYK-ASKGKLPIKWMAPESINF--RRFTSASD 199 (281)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHH
T ss_pred Ccccccc-cccCCCcccccChhhccc--CCCCCccC
Confidence 5443221 233456889999999854 56776665
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=257.26 Aligned_cols=172 Identities=19% Similarity=0.179 Sum_probs=139.6
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC---------CchhHHHHHHHhhccC---------CcceeeE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---------NGEEFINEVASISRTS---------HVNVVTL 386 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------h~nIv~l 386 (516)
...+.+.+.||+|+||+||+|++ +|+.||||++..... ..+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 44566778999999999999998 789999999975422 2267889999988885 8888877
Q ss_pred EEEEe------------------------------ecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 036471 387 LGFCF------------------------------EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGI 436 (516)
Q Consensus 387 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i 436 (516)
.+.+. +.+..++||||+++|++.+.+.+ ..+++..++.++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHH
Confidence 77643 26789999999999976666532 458999999999999
Q ss_pred HHHHHHHhcCCCCCeeeCCCCCCcEEECCCC--------------------cEEEeecCCcccccCCCcceeeccCCCCc
Q 036471 437 ARGLEYLHLGCSTRILHFDIKPHNILLDEDF--------------------CPKISDFGLAKICNRKESIISMTGARGTV 496 (516)
Q Consensus 437 ~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 496 (516)
+.||+|||+ +++|+||||||+||||+.++ .+||+|||+|+..... ...||+
T Consensus 171 ~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 999999993 37999999999999999887 9999999999876532 236899
Q ss_pred cccccccccccccccccCCC
Q 036471 497 GYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 497 ~y~aPE~l~~~~~~~s~~sD 516 (516)
.|+|||++.++ .+.++|
T Consensus 242 ~y~aPE~~~g~---~~~~~D 258 (336)
T 2vuw_A 242 VSMDEDLFTGD---GDYQFD 258 (336)
T ss_dssp CTTCSGGGCCC---SSHHHH
T ss_pred cccChhhhcCC---Ccccee
Confidence 99999999653 255544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=243.76 Aligned_cols=169 Identities=28% Similarity=0.436 Sum_probs=139.4
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhc--cCCcceeeEEEEEee----cCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFCFE----GRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+ ....++|||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 34567899999999999998 7899999998643 33556667777666 799999999998765 346889999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC-----STRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
|+++|+|.++++. ..+++..++.++.|++.||+|||... +++|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 87 YHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp CCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred hccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999943 46999999999999999999999321 57999999999999999999999999999
Q ss_pred cccccCCCccee--eccCCCCccccccccccc
Q 036471 477 AKICNRKESIIS--MTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 477 a~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~ 506 (516)
++.......... .....||+.|+|||++.+
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred eeecccccccccccccccccccceeChhhhcC
Confidence 987655443221 233478999999999965
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=240.80 Aligned_cols=172 Identities=34% Similarity=0.548 Sum_probs=136.4
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCC-----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|.+. ++.||+|+++... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 345578999999999999984 8899999986432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eeeCCCCCCcEEECC--------CCcEEE
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR---ILHFDIKPHNILLDE--------DFCPKI 471 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~---ivH~dlkp~NIll~~--------~~~~kl 471 (516)
+++++|.+++.. ..+++..++.++.|++.||+||| +++ |+||||||+||+++. ++.+||
T Consensus 88 ~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 88 ARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999842 56899999999999999999999 777 999999999999986 778999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||++........ ....|++.|+|||++.+ ..++.++|
T Consensus 158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~D 196 (271)
T 3dtc_A 158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRA--SMFSKGSD 196 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHH--CCCSHHHH
T ss_pred ccCCcccccccccc----cCCCCccceeCHHHhcc--CCCCchhh
Confidence 99999986654332 24568999999999854 56777665
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=246.21 Aligned_cols=176 Identities=29% Similarity=0.360 Sum_probs=150.8
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+++..+ ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 3445789999999999999864 7899999986543 2336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 123 ~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 123 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999998764 46899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....|++.|+|||++.+ ..++.++|
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 223 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSK--KGHSFEVD 223 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHT--SCBCTHHH
T ss_pred Cccc--ccccCCCccccCHHHhcc--CCCCchhh
Confidence 3322 234568999999999854 55666665
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=248.36 Aligned_cols=185 Identities=32% Similarity=0.467 Sum_probs=139.9
Q ss_pred HHhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecC-----
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGR----- 394 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 394 (516)
.+.+.+.||+|+||.||+|.... +..||+|+++..... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 34456789999999999998642 458999999754332 356889999999999999999999998755
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..++||||+++++|.+++...........+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 34999999999999999965443234467999999999999999999999 999999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++................+++.|+|||++.+ ..++.++|
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 231 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSD 231 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS--SCCCHHHH
T ss_pred CcceecccccccCcccccCCCccccCchhhcC--CCccchhh
Confidence 99987655433222334567889999999954 56777665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.38 Aligned_cols=176 Identities=30% Similarity=0.441 Sum_probs=150.8
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec---CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
..+.+.+.||+|+||.||+++.. +++.||+|++.. .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 45667789999999999999986 689999999864 23455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCcEEEeecCCcc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAK 478 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~ 478 (516)
|+++++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++
T Consensus 102 ~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 102 LYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999998764 46999999999999999999999 89999999999999995 55689999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++.+ .++.++|
T Consensus 173 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~D 204 (486)
T 3mwu_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCD 204 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS---CCCHHHH
T ss_pred ECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhh
Confidence 7654432 244678999999999853 4676665
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=248.55 Aligned_cols=176 Identities=28% Similarity=0.435 Sum_probs=141.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 44578999999999999986 68999999996432 222456789999999999999999999999999999999997
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 84 KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 59999987643 56999999999999999999999 89999999999999999999999999999976543322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+. ..++.++|
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 183 (324)
T 3mtl_A 156 T--YDNEVVTLWYRPPDILLGS-TDYSTQID 183 (324)
T ss_dssp ---------CGGGCCHHHHTTC-CCCCTHHH
T ss_pred c--cccccCcccccChhhhcCC-CCCCcHHH
Confidence 1 2345689999999998542 45676665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=250.88 Aligned_cols=179 Identities=23% Similarity=0.327 Sum_probs=143.1
Q ss_pred HHhhhhhcccCCcEEEEEEEECC------CCEEEEEEeecCCC------------CchhHHHHHHHhhccCCcceeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID------GSNVAVKVLNDSKG------------NGEEFINEVASISRTSHVNVVTLLG 388 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~nIv~l~~ 388 (516)
.+.+.+.||+|+||.||+|.+.. ++.||+|++..... ....+.+|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45566789999999999998865 47899999865431 1123445566677788999999999
Q ss_pred EEeec----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC
Q 036471 389 FCFEG----RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD 464 (516)
Q Consensus 389 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~ 464 (516)
++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence 98875 4589999999 999999997642 56999999999999999999999 89999999999999998
Q ss_pred --CCCcEEEeecCCcccccCCCccee-----eccCCCCccccccccccccccccccCCC
Q 036471 465 --EDFCPKISDFGLAKICNRKESIIS-----MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 465 --~~~~~kl~Dfg~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.++.+||+|||+++.+........ .....||+.|+|||++.+ ..++.++|
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 243 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGD 243 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHH
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhh
Confidence 889999999999987654332211 123459999999999955 56777766
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.09 Aligned_cols=169 Identities=27% Similarity=0.331 Sum_probs=136.9
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhc-cCCcceeeEEEEEee----cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISR-TSHVNVVTLLGFCFE----GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~lv~e~~~~ 405 (516)
+.||+|+||+||++... +++.||||+++. ...+.+|++++.+ .+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999986 588999999963 2567889888755 489999999999876 5678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 144 g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 144 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999997642 246999999999999999999999 899999999999999987 78999999999986654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|+|||++.+ +.++.++|
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 245 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGP--EKYDKSCD 245 (400)
T ss_dssp -------------CTTCCGGGSCC--CCSSSHHH
T ss_pred CCc---cccCCCCCCccCHhhcCC--CCCCCccc
Confidence 322 244678999999999954 57777765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=251.77 Aligned_cols=178 Identities=28% Similarity=0.390 Sum_probs=137.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccC-CcceeeEEEEEeecC--eeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTS-HVNVVTLLGFCFEGR--RRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv 399 (516)
.+.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.++.++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 3445678999999999999875 589999999865322 3356789999999997 999999999997644 68999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++ ++|.++++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99997 599999865 36899999999999999999999 89999999999999999999999999999986
Q ss_pred ccCCC-------------------cceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKE-------------------SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.... .....+...||+.|+|||++.+. ..++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 213 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGID 213 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhh
Confidence 54311 01112445799999999998652 46777665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=248.49 Aligned_cols=185 Identities=27% Similarity=0.447 Sum_probs=152.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+|++. +++.||+|.+..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 4455688999999999999864 367899999975432 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 399 IYEFVSNGSLEKFIYRNSSS----IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
||||+++++|.+++...... .....+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999999764210 01145789999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++...............+|+.|+|||++.+ +.++.++|
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 222 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSD 222 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHH
T ss_pred ccccccccccccccccCCCCCCCccChhhhcc--CCCCchhh
Confidence 99987654433222234457889999999854 56777665
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=241.68 Aligned_cols=176 Identities=31% Similarity=0.405 Sum_probs=149.0
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
..+.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 34556688999999999999986 68999999997543 34467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCcccc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKIC 480 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~ 480 (516)
++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++...
T Consensus 89 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 89 SGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999754 46899999999999999999999 8999999999999999 78899999999999765
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....|++.|+|||++.+ +.++.++|
T Consensus 160 ~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~D 189 (304)
T 2jam_A 160 QNGIM----STACGTPGYVAPEVLAQ--KPYSKAVD 189 (304)
T ss_dssp CCBTT----HHHHSCCCBCCTTTBSS--CSCCHHHH
T ss_pred CCCcc----ccccCCCCccChHHhcc--CCCCchhh
Confidence 43321 23458999999999954 56777665
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=241.08 Aligned_cols=177 Identities=31% Similarity=0.424 Sum_probs=149.2
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
.+.+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 3445578999999999999986 48999999997643 457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ..+++..++.++.|++.||+||| ..+|+|+||||+||+++.++.+||+|||++........
T Consensus 109 ~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 109 GSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999997532 56899999999999999999999 89999999999999999999999999999977654322
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ ..++.++|
T Consensus 181 ~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 207 (314)
T 3com_A 181 K--RNTVIGTPFWMAPEVIQE--IGYNCVAD 207 (314)
T ss_dssp C--BCCCCSCGGGCCHHHHSS--SCBCTTHH
T ss_pred c--cCccCCCCCccChhhcCC--CCCCcccc
Confidence 1 234568999999999954 56777776
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-29 Score=246.60 Aligned_cols=184 Identities=34% Similarity=0.551 Sum_probs=138.4
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
|+....+.+.++||+|+||.||+|++. ..||+|+++..... .+.+.+|+.++++++||||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 444445566788999999999999864 46999999754433 36789999999999999999999964 5567899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 97 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp EEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred EEEecCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecc
Confidence 99999999999999653 256999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
...............||+.|+|||++... .+.++.++|
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 207 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHH
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccc
Confidence 66543333333456789999999998521 245666655
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=242.01 Aligned_cols=176 Identities=26% Similarity=0.333 Sum_probs=142.4
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 56999999999999865 68999999997543 3457889999999985 799999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---EEEeecCCcccccCCCc
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDFGLAKICNRKES 485 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~~ 485 (516)
.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKR------RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999764 46899999999999999999999 899999999999999998775 99999999976543221
Q ss_pred c-----eeeccCCCCcccccccccccc---ccccccCCC
Q 036471 486 I-----ISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 486 ~-----~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
. .......||+.|+|||++.+. .+.++.++|
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 208 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccc
Confidence 1 111234589999999998531 134666665
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=256.69 Aligned_cols=176 Identities=31% Similarity=0.438 Sum_probs=147.8
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
..+.+.++||+|+||.||+|+.. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34566788999999999999986 5889999999753 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAK 478 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~ 478 (516)
|+++|+|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++. ++.+||+|||++.
T Consensus 117 ~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 117 CYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999998764 46899999999999999999999 899999999999999976 4559999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++. +.++.++|
T Consensus 188 ~~~~~~~---~~~~~gt~~y~aPE~l~---~~~~~~~D 219 (494)
T 3lij_A 188 VFENQKK---MKERLGTAYYIAPEVLR---KKYDEKCD 219 (494)
T ss_dssp ECBTTBC---BCCCCSCTTTCCHHHHT---TCBCTHHH
T ss_pred ECCCCcc---ccccCCCcCeeCHHHHc---ccCCCchh
Confidence 7654432 24467899999999984 35777665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=236.71 Aligned_cols=172 Identities=27% Similarity=0.416 Sum_probs=145.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEee----cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 400 (516)
.+.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 34567999999999999875 578899999875432 33678899999999999999999999875 35689999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEC-CCCcEEEeecCCc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLA 477 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a 477 (516)
||+++++|.+++.+. ..+++..++.++.|++.||+||| +.+ |+||||||+||+++ .++.+||+|||++
T Consensus 109 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999764 46899999999999999999999 888 99999999999997 7899999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ....||+.|+|||++. +.++.++|
T Consensus 180 ~~~~~~~~----~~~~~t~~y~aPE~~~---~~~~~~~D 211 (290)
T 1t4h_A 180 TLKRASFA----KAVIGTPEFMAPEMYE---EKYDESVD 211 (290)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGG---TCCCTHHH
T ss_pred cccccccc----ccccCCcCcCCHHHHh---ccCCCcch
Confidence 75544322 3456899999999984 35676665
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=257.25 Aligned_cols=174 Identities=34% Similarity=0.448 Sum_probs=147.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--------------CCchhHHHHHHHhhccCCcceeeEEEEEee
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--------------GNGEEFINEVASISRTSHVNVVTLLGFCFE 392 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 392 (516)
+.+.++||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445678999999999999986 47899999996532 234678999999999999999999999999
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC---cE
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF---CP 469 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~ 469 (516)
....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999764 46999999999999999999999 89999999999999998776 69
Q ss_pred EEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 470 KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 470 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+|||++........ .....||+.|+|||++. +.++.++|
T Consensus 189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~D 229 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK---KKYNEKCD 229 (504)
T ss_dssp EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT---TCBCTHHH
T ss_pred EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc---cCCCchHH
Confidence 9999999987755432 24467899999999984 35777665
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=243.40 Aligned_cols=178 Identities=34% Similarity=0.571 Sum_probs=144.5
Q ss_pred hhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEe-ecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCF-EGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e 401 (516)
.+.+.||+|+||.||+|++.+ ...||+|.+..... ..+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 355789999999999998643 23589999865332 3367889999999999999999999865 4567899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.++++.. ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 108 ~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 108 YMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCTTCBHHHHHHCT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CCCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 99999999999753 256899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .......+|+.|+|||++.+ ..++.++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 214 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSD 214 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHH
T ss_pred ccchhccccccCCCCCccccChHHhcC--CCCChHHH
Confidence 43321 12244567889999999954 56777665
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=239.35 Aligned_cols=174 Identities=28% Similarity=0.398 Sum_probs=150.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
...+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 34578999999999999875 5899999999754 33457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.. ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 105 ~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 105 GSALDLLEP-------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999853 46899999999999999999999 89999999999999999999999999999987654432
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....|++.|+|||++.+ +.++.++|
T Consensus 175 ~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 201 (303)
T 3a7i_A 175 K--RNTFVGTPFWMAPEVIKQ--SAYDSKAD 201 (303)
T ss_dssp C--BCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred c--cCccCCCcCccCHHHHhc--CCCCchhh
Confidence 1 244678999999999954 56776665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=246.06 Aligned_cols=178 Identities=29% Similarity=0.500 Sum_probs=139.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCE----EEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSN----VAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.+.||+|+||.||+|++. +++. |++|.+... ....+.+.+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 345578999999999999975 3443 577777542 345578999999999999999999999988754 78999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp CCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999997643 56999999999999999999999 899999999999999999999999999999877
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.............+|+.|+|||++.+ ..++.++|
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 201 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSD 201 (327)
T ss_dssp ------------CCCGGGSCHHHHHH--CCCCHHHH
T ss_pred cCccccccccCCCccccccCHHHHcC--CCCChHHH
Confidence 55544333345567889999999965 56777765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=245.54 Aligned_cols=179 Identities=27% Similarity=0.396 Sum_probs=147.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEee--------cCe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFE--------GRR 395 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~ 395 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++.+ .+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 445678999999999999984 68999999985432 234678899999999999999999999987 346
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.++||||+++ +|.+.+.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 8999999975 8888776532 56999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++.+...... .......||+.|+|||++.+. ..++.++|
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 211 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPID 211 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhH
Confidence 99876533211 122446789999999998543 45677665
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-29 Score=247.85 Aligned_cols=178 Identities=31% Similarity=0.398 Sum_probs=146.5
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC------CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
.+.+.+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 3445678999999999999986 58999999986432 1235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++ +|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999986 8999886532 56888999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++.+. ..++.++|
T Consensus 162 ~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 195 (346)
T 1ua2_A 162 FGSPNRA--YTHQVVTRWYRAPELLFGA-RMYGVGVD 195 (346)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHH
T ss_pred ccCCccc--CCcccccccccCchHhhCC-CCCCchhh
Confidence 6543322 2446789999999998542 34666665
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=240.12 Aligned_cols=174 Identities=28% Similarity=0.494 Sum_probs=146.3
Q ss_pred hhcccCCcEEEEEEEEC---CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 332 YKLGQGGYGSVYKGKLI---DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999864 57789999997643 2346789999999999999999999998 556789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 95 ~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 95 PLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CHHHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 999999643 256999999999999999999999 899999999999999999999999999999877544332
Q ss_pred ee-eccCCCCccccccccccccccccccCCC
Q 036471 487 IS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....+|+.|+|||++.+ ..++.++|
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 195 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINF--RKFSSRSD 195 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHH--CEECHHHH
T ss_pred eeccccccccccccCHHHhcc--CCCCchhh
Confidence 21 233456899999999854 56676665
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=246.59 Aligned_cols=176 Identities=31% Similarity=0.444 Sum_probs=139.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.++||+|+||.||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 445578999999999999875 68899999996433 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE-----CCCCcEEEeecCCcc
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL-----DEDFCPKISDFGLAK 478 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll-----~~~~~~kl~Dfg~a~ 478 (516)
++ +|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+++
T Consensus 116 ~~-~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 116 EN-DLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp SE-EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred CC-CHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 85 999999764 46899999999999999999999 8999999999999999 455569999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .....||+.|+|||++.+. ..++.++|
T Consensus 186 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 220 (329)
T 3gbz_A 186 AFGIPIRQ--FTHEIITLWYRPPEILLGS-RHYSTSVD 220 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTC-CCCCTHHH
T ss_pred ccCCcccc--cCCCcCCccccCHHHhcCC-CCCCcHHH
Confidence 76543221 2345679999999998552 34677765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=249.65 Aligned_cols=174 Identities=24% Similarity=0.372 Sum_probs=148.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 445578999999999999986 589999999976432 23678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+++|.+++... ..+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 115 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp TCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999764 46899999999999999999999 75 8999999999999999999999999999765432
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|+|||++.+ ..++.++|
T Consensus 186 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~D 212 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERLQG--THYSVQSD 212 (360)
T ss_dssp C--------CCCCTTCCHHHHTT--CCCSHHHH
T ss_pred c----ccCCCCCCCeECHHHHcC--CCCCchhh
Confidence 2 134578999999999955 56777665
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=247.75 Aligned_cols=180 Identities=29% Similarity=0.447 Sum_probs=150.2
Q ss_pred HHhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEe--ecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCF--EGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 398 (516)
.+.+.+.||+|+||.||++++ .+++.||+|++.... ...+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 344567899999999999984 357899999997543 23366899999999999999999999887 4556889
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999997643 46999999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... ......||+.|+|||++.+ ..++.++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 212 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSD 212 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHh
Confidence 775544322 2234568889999999854 56676665
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=258.00 Aligned_cols=177 Identities=29% Similarity=0.422 Sum_probs=152.6
Q ss_pred HHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
...+.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345666788999999999999986 6899999999653 23457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCC
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGL 476 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~ 476 (516)
|||+++++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+
T Consensus 105 ~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp ECCCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998653 56999999999999999999999 8999999999999999 5678999999999
Q ss_pred cccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++........ ....||+.|+|||++.+ .++.++|
T Consensus 176 a~~~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~D 209 (484)
T 3nyv_A 176 STHFEASKKM---KDKIGTAYYIAPEVLHG---TYDEKCD 209 (484)
T ss_dssp HHHBCCCCSH---HHHTTGGGTCCHHHHHT---CCCTHHH
T ss_pred eEEccccccc---ccCCCCccccCceeecC---CCCCcce
Confidence 9876544322 34568999999999843 5677665
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=244.56 Aligned_cols=177 Identities=28% Similarity=0.433 Sum_probs=144.3
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+|+... ++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 3445789999999999999864 899999998654433 245789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 107 ~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 107 DHTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp SEEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CcchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999998887533 56999999999999999999999 899999999999999999999999999999876543
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....|++.|+|||++.++ ..++.++|
T Consensus 178 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~D 207 (331)
T 4aaa_A 178 GEV--YDDEVATRWYRAPELLVGD-VKYGKAVD 207 (331)
T ss_dssp --------CCCCCTTCCHHHHTTC-TTCCTHHH
T ss_pred ccc--cCCCcCCccccCcccccCC-CCcchHHH
Confidence 322 2345689999999998542 35666665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-29 Score=252.20 Aligned_cols=178 Identities=34% Similarity=0.587 Sum_probs=136.8
Q ss_pred hhhhhcccCCcEEEEEEEECC--C--CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID--G--SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 401 (516)
.+.+.||+|+||.||+|++.+ + ..||+|.++... ...+++.+|+.++++++||||+++++++.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 345789999999999998642 2 368999986533 234678999999999999999999998754 567899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.++++... ..+++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 172 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999997542 56889999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCcc--eeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .......+++.|+|||++.+ +.++.++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 278 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSD 278 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHH
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHH
Confidence 43221 11234567889999999954 56777766
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=242.03 Aligned_cols=179 Identities=31% Similarity=0.477 Sum_probs=145.0
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEee------cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFE------GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~lv~ 400 (516)
.+.+.||+|+||.||+|++. +++.||+|++.......+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 34578999999999999985 689999999987766778899999999999 89999999999987 46789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.... ...+++..++.++.||+.||+||| ..+|+|+||||+||+++.++.+||+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp ECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999997642 256899999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
...... .....|++.|+|||++... .+.++.++|
T Consensus 180 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 216 (326)
T 2x7f_A 180 DRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSD 216 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHH
T ss_pred CcCccc--cccccCCccccChhhhccccccCcCCCccch
Confidence 433221 2345689999999998521 245666665
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=254.67 Aligned_cols=177 Identities=25% Similarity=0.363 Sum_probs=138.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---------CCchhHHHHHHHhhccCCcceeeEEEEEeecCee
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 396 (516)
.+.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 4556688999999999999876 47999999986432 12246889999999999999999999875 4568
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CcEEEee
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISD 473 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~D 473 (516)
++||||+++++|.+++.. ...+++..++.++.|++.||+||| +++|+||||||+|||++.+ +.+||+|
T Consensus 215 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEEEECCTTCBGGGGTSS------SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence 999999999999988853 257999999999999999999999 8999999999999999754 4599999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
||+++....... .....||+.|+|||++.. ..+.++.++|
T Consensus 286 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 326 (419)
T 3i6u_A 286 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHH
T ss_pred cccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhh
Confidence 999987654322 234678999999999853 1245666655
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=243.48 Aligned_cols=174 Identities=30% Similarity=0.474 Sum_probs=138.1
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
.+.+.||+|+||.||++++ .++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||+++++|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence 4557899999999999998 4788999998643 34577899999999999999999999876 457899999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc-EEEeecCCcccccCCCcce
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC-PKISDFGLAKICNRKESII 487 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~ 487 (516)
.++++... ....+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++.......
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 87 YNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp HHHHHCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 99997542 1235789999999999999999999221189999999999999998886 7999999997654332
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....||+.|+|||++.+ +.++.++|
T Consensus 161 --~~~~gt~~y~aPE~~~~--~~~~~~~D 185 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEG--SNYSEKCD 185 (307)
T ss_dssp ------CCTTSSCHHHHTC--CCCCTHHH
T ss_pred --ccCCCCCceEChhhhCC--CCCCcHHH
Confidence 33468999999999954 56777766
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=236.12 Aligned_cols=176 Identities=27% Similarity=0.409 Sum_probs=142.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 345578999999999999986 6899999998642 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 93 VSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred cCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999764 46899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....|++.|+|||++.+. ...+.++|
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~D 193 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVD 193 (276)
T ss_dssp ----------------CCTGGGTTS-CCCHHHHH
T ss_pred Ccc---eecccCCccccCHHHHcCC-CCCCccch
Confidence 432 1335689999999998542 22245554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-29 Score=245.48 Aligned_cols=186 Identities=29% Similarity=0.454 Sum_probs=151.9
Q ss_pred HHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecC-e
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGR-R 395 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~ 395 (516)
..+.+.+.||+|+||.||+|++ .+++.||+|++..... ..+.+.+|+.++.++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3445668899999999999984 2467899999976433 235788999999999 7999999999988755 5
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSI----------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
.++||||+++++|.+++....... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECC
Confidence 899999999999999998653210 0123899999999999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+++...............||+.|+|||++.+ +.++.++|
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~D 232 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSD 232 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc--ccccchhH
Confidence 99999999999987755544333345667899999999855 56777665
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=252.90 Aligned_cols=170 Identities=28% Similarity=0.426 Sum_probs=144.7
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecC--eeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--RRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|++.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 3455789999999999999864 8999999997532 34577889999999999999999999998765 67999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCcEEEeecCCcc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAK 478 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 478 (516)
+++|+|.++++... ....+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 91 CPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CTTEEHHHHTTSGG---GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred CCCCCHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999997542 2234999999999999999999999 8999999999999999 778889999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccc
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
....... .....||+.|+|||++.+
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhc
Confidence 7654432 234678999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=259.50 Aligned_cols=172 Identities=28% Similarity=0.319 Sum_probs=139.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 345578999999999999876 58899999997532 2346788999999999999999999999754 3569
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++ +|.+.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 144 lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 99999976 5666663 34899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....||+.|+|||++.+ ..++.++|
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 245 (464)
T 3ttj_A 212 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 245 (464)
T ss_dssp -----CCC---C----CCCTTCCHHHHTT--CCCCTTHH
T ss_pred eecCCCcc---cCCCcccccccCHHHHcC--CCCCHHHH
Confidence 87654322 245678999999999965 57888776
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=264.69 Aligned_cols=173 Identities=28% Similarity=0.490 Sum_probs=142.2
Q ss_pred hcccCCcEEEEEEEEC---CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLI---DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+||+|+||.||+|.+. ++..||||+++.. ....+++.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 4567999999754 3355789999999999999999999999876 56899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 422 L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999653 256999999999999999999999 8999999999999999999999999999998765443221
Q ss_pred e-eccCCCCccccccccccccccccccCCC
Q 036471 488 S-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....+++.|+|||++.. +.++.++|
T Consensus 494 ~~~~~~~~~~~y~APE~~~~--~~~~~~sD 521 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINF--RKFSSRSD 521 (613)
T ss_dssp --------CCTTSCHHHHHH--CCCCHHHH
T ss_pred eeccCCCCccceeCHhhhcC--CCCCcHHH
Confidence 1 123345789999999954 67887776
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.48 Aligned_cols=172 Identities=30% Similarity=0.395 Sum_probs=140.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecC------eeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGR------RRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 397 (516)
+.+.+.||+|+||.||+|.+. +|+.||+|++...... .+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 344577999999999999985 5899999999654322 356889999999999999999999998653 459
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+ +++|.++++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 107 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 999999 7899999965 35899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..... .....+|+.|+|||++.+. ..++.++|
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D 208 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVD 208 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhh
Confidence 875433 2446789999999998542 46777766
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.20 Aligned_cols=178 Identities=28% Similarity=0.502 Sum_probs=141.5
Q ss_pred hhhhhcccCCcEEEEEEEECC-----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.||+|+||.||+|+... +..||+|+++.... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 345679999999999998653 23599999975432 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 127 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 127 YMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp CCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999997642 56999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......+++.|+|||++.+ +.++.++|
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 232 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASD 232 (333)
T ss_dssp ------------CCCGGGSCHHHHHS--CCCCHHHH
T ss_pred cccccccccCCCCccccccCchhccc--CCCCchhh
Confidence 443211 1223456889999999954 56777665
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=242.22 Aligned_cols=176 Identities=31% Similarity=0.460 Sum_probs=147.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-----CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-----DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALI 399 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 399 (516)
.+.++||+|+||.||++.+. +++.||+|+++.... ..+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45678999999999998653 578899999976432 246789999999999999999999999874 578999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.+++.+ ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 114 ~e~~~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ECCCTTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EecccCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999964 34899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ......+++.|+|||++.+ ..++.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 219 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASD 219 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHH
Confidence 76543321 1234567889999999954 56666665
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=237.11 Aligned_cols=177 Identities=29% Similarity=0.399 Sum_probs=146.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
..||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 36999999999999975 58899999997543 34577899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcccccCCCccee
Q 036471 410 KFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 410 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
+++.... ....+++..++.++.|++.||+||| +.+|+|+||||+||+++. ++.+||+|||++.........
T Consensus 108 ~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 108 ALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp HHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 9998653 2245789999999999999999999 899999999999999987 899999999999876543221
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....|++.|+|||++.+....++.++|
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~D 207 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAAD 207 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHH
Confidence 2345689999999999653223566655
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=240.69 Aligned_cols=176 Identities=30% Similarity=0.475 Sum_probs=146.0
Q ss_pred hhhcccCCcEEEEEEEECC-C---CEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCee-EEEEEec
Q 036471 331 KYKLGQGGYGSVYKGKLID-G---SNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRR-ALIYEFV 403 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~e~~ 403 (516)
.+.||+|+||.||+|++.+ + ..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4679999999999998643 2 3699999865332 336788999999999999999999999876655 9999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
.+++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSP-----QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999753 256899999999999999999999 899999999999999999999999999999866443
Q ss_pred Ccc--eeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESI--ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .......+++.|+|||++.+ ..++.++|
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 210 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT--YRFTTKSD 210 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHH
T ss_pred cccccccCcCCCCCccccChhhhcc--CCCChhhc
Confidence 211 11234567899999999954 56777665
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=247.88 Aligned_cols=177 Identities=25% Similarity=0.338 Sum_probs=143.3
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeec------------
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG------------ 393 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------------ 393 (516)
.+.+.+.||+|+||.||+|+.. +|+.||+|++..... ...+|+.++++++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3445678999999999999874 689999999975433 234799999999999999999998543
Q ss_pred --------------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 036471 394 --------------------------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447 (516)
Q Consensus 394 --------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~ 447 (516)
...++||||++ ++|.+.+..... ....+++..++.++.||++||+|||
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH--- 158 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGFIH--- 158 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 34789999998 588888765321 2367999999999999999999999
Q ss_pred CCCeeeCCCCCCcEEEC-CCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 448 STRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+|+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+|||++.+. ..++.++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~D 224 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSID 224 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchh
Confidence 99999999999999997 6889999999999876554432 345679999999998652 35777765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=248.13 Aligned_cols=188 Identities=29% Similarity=0.446 Sum_probs=148.1
Q ss_pred HHHHHhhhhhcccCCcEEEEEEEE------CCCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCe
Q 036471 324 KKMTNSFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 324 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 395 (516)
....+.+.+.||+|+||.||+|++ .+++.||+|++.... ....++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 334455668899999999999984 247789999996432 234678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEE
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSI-ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKI 471 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl 471 (516)
.++||||+++++|.+++....... ....+++..++.++.|++.||+||| +.+|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999998754211 2245999999999999999999999 899999999999999984 446999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||++................|++.|+|||++.+ +.++.++|
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 227 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTD 227 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--CCCCHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC--CCCCchhh
Confidence 99999976654433222234567899999999855 56777665
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=238.81 Aligned_cols=181 Identities=25% Similarity=0.336 Sum_probs=146.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-----CCCchhHHHHHHHhhccCCcceeeEEEEEe--ecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-----KGNGEEFINEVASISRTSHVNVVTLLGFCF--EGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv 399 (516)
+.+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++++++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 345678999999999999975 5889999999643 334578899999999999999999999984 45688999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++++ |.+++.... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 87 ~e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ehhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999876 888876642 357999999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..............|++.|+|||++.+.....+.++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 195 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhh
Confidence 6544333333456789999999998543233354554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=265.19 Aligned_cols=173 Identities=28% Similarity=0.479 Sum_probs=141.7
Q ss_pred hhcccCCcEEEEEEEEC---CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++||+|+||.||+|.+. .++.||||+++.... ..+++.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 46999999999999653 367899999975432 34789999999999999999999999864 568899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.++++.. ..+++..++.|+.||+.||+||| +++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999754 56899999999999999999999 89999999999999999999999999999987755432
Q ss_pred ce-eeccCCCCccccccccccccccccccCCC
Q 036471 486 II-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ......+|+.|+|||++.+ +.++.++|
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~--~~~~~~sD 554 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINY--YKFSSKSD 554 (635)
T ss_dssp ----------CGGGSCHHHHHH--CCCCHHHH
T ss_pred ccccccCCCCceeeeChhhhcC--CCCCcHHH
Confidence 21 1233457889999999954 67787776
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.41 Aligned_cols=165 Identities=33% Similarity=0.503 Sum_probs=132.8
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHH--HhhccCCcceeeEEEEEee-----cCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVA--SISRTSHVNVVTLLGFCFE-----GRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~--~l~~l~h~nIv~l~~~~~~-----~~~~~lv~e 401 (516)
.+.+.||+|+||.||+|+. +++.||||++..... ..+..|.+ .+..++||||+++++.+.. ....++|||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 3457899999999999987 789999999975432 34444444 4556899999999986543 235689999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeeeCCCCCCcEEECCCCcEEEe
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST---------RILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~---------~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
|+++|+|.+++... ..++..++.++.||+.||+||| +. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 93 YYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred cCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 99999999999653 3588999999999999999999 78 99999999999999999999999
Q ss_pred ecCCcccccCCCc------ceeeccCCCCccccccccccc
Q 036471 473 DFGLAKICNRKES------IISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 473 Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~ 506 (516)
|||+++.+..... ........||+.|+|||++.+
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 9999987654321 111234569999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=241.54 Aligned_cols=188 Identities=23% Similarity=0.354 Sum_probs=151.5
Q ss_pred cccHHHHHHHHHhhh-hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhcc-CCcceeeEEEEE
Q 036471 317 RYSYADIKKMTNSFK-YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRT-SHVNVVTLLGFC 390 (516)
Q Consensus 317 ~~~~~el~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 390 (516)
.|...+.....+.+. +.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344444444444454 78999999999999986 58999999997533 2346789999999999 569999999999
Q ss_pred eecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CC
Q 036471 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DF 467 (516)
Q Consensus 391 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~ 467 (516)
.+.+..++||||+++++|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++. ++
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC----C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999998543 2357999999999999999999999 899999999999999987 78
Q ss_pred cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 468 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+||+|||+++....... .....||+.|+|||++.+ +.++.++|
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 215 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNY--DPITTATD 215 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTT--CCCCTHHH
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCeeecC--CCCCchhh
Confidence 999999999987654432 234578999999999954 56777765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=241.99 Aligned_cols=179 Identities=30% Similarity=0.507 Sum_probs=148.8
Q ss_pred HhhhhhcccCCcEEEEEEEE-----CCCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecC--eeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKL-----IDGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGR--RRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 399 (516)
+.+.+.||+|+||.||++++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 44567899999999999984 358899999997543 23467899999999999999999999987654 78999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 123 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999997643 46899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....++..|+|||++.+ ..++.++|
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 230 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASD 230 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcC--CCCCchhh
Confidence 765543221 233457888999999854 46666665
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=236.53 Aligned_cols=176 Identities=26% Similarity=0.352 Sum_probs=148.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----------CchhHHHHHHHhhccC-CcceeeEEEEEeecCee
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----------NGEEFINEVASISRTS-HVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 396 (516)
.+.+.||+|++|.||+|... +++.||+|++..... ..+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34578999999999999986 588999999975431 1256789999999995 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGL 476 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 476 (516)
++||||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 100 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp EEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 9999999999999999764 46899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCcceeeccCCCCcccccccccccc----ccccccCCC
Q 036471 477 AKICNRKESIISMTGARGTVGYIAPEVFCRN----IGEVSYKSD 516 (516)
Q Consensus 477 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~sD 516 (516)
+........ .....|++.|+|||++... ...++.++|
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~D 211 (298)
T 1phk_A 171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211 (298)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH
T ss_pred hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccc
Confidence 987654432 2345689999999998521 234565554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=239.09 Aligned_cols=180 Identities=26% Similarity=0.434 Sum_probs=140.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 456678999999999999974 68999999997532 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++..... ....+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 114 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp CCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred CCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999975321 2356899999999999999999999 89999999999999999999999999999986654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....|++.|+|||++.+ +.++.++|
T Consensus 189 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 218 (310)
T 2wqm_A 189 KTTA--AHSLVGTPYYMSPERIHE--NGYNFKSD 218 (310)
T ss_dssp ------------CCSSCCHHHHTT--CCCCHHHH
T ss_pred CCcc--ccccCCCeeEeChHHhCC--CCCCchhh
Confidence 3321 134568999999999854 56676665
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=240.15 Aligned_cols=180 Identities=27% Similarity=0.409 Sum_probs=149.9
Q ss_pred cccHHHHHHHHHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhc--cCCcceeeEEEEEeecC
Q 036471 317 RYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISR--TSHVNVVTLLGFCFEGR 394 (516)
Q Consensus 317 ~~~~~el~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~ 394 (516)
.+...+.....+.+.+.||+|+||.||+|+. +++.||+|++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3444455556677778999999999999998 5899999999643 34677888888887 79999999999998876
Q ss_pred ----eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCcEEECC
Q 036471 395 ----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC-----STRILHFDIKPHNILLDE 465 (516)
Q Consensus 395 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~ 465 (516)
..++||||+++|+|.+++++ ..+++..++.++.|++.||+|||... +.+|+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 78999999999999999965 35899999999999999999999321 479999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcce--eeccCCCCccccccccccc
Q 036471 466 DFCPKISDFGLAKICNRKESII--SMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~ 506 (516)
++.+||+|||++.......... ......||+.|+|||++.+
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 9999999999998776554322 1234578999999999855
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=239.56 Aligned_cols=171 Identities=26% Similarity=0.425 Sum_probs=146.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEee--cCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFE--GRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+|+.. +++.||+|+++. ...+.+.+|+.++++++ ||||+++++++.+ ....++||||+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 445678999999999999874 689999999863 34578999999999997 9999999999987 66789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 482 (516)
++++|.++++ .+++..++.++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+++....
T Consensus 116 ~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 116 NNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred CchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999873 4889999999999999999999 89999999999999999776 899999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....|++.|+|||++.+. ..++.++|
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~D 213 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLD 213 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHH
T ss_pred CCc---cccccccccccChhhhcCC-CcCCchhh
Confidence 432 2345689999999998542 45677665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=237.77 Aligned_cols=175 Identities=29% Similarity=0.501 Sum_probs=143.1
Q ss_pred hhh-hcccCCcEEEEEEEEC---CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKY-KLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+ .||+|+||.||+|.+. .++.||+|+++..... .+++.+|+.++++++||||+++++++ +.+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 444 7999999999999653 3678999999754322 46789999999999999999999998 66778999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 99 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999764 46899999999999999999999 89999999999999999999999999999987755
Q ss_pred CCccee-eccCCCCccccccccccccccccccCCC
Q 036471 483 KESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .....+++.|+|||++.+ ..++.++|
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 202 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY--YKFSSKSD 202 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH--CEEEHHHH
T ss_pred CCCcccccccCCCCceeeChHHhcc--CCCChhhh
Confidence 443221 223456789999999854 56666665
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=236.99 Aligned_cols=177 Identities=29% Similarity=0.458 Sum_probs=143.7
Q ss_pred HhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|++.+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 3455789999999999998643 2369999987543 234678999999999999999999998765 45789999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.+++.+.. ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 93 LYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp CCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred cCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999997643 56899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......+++.|+|||++.+ +.++.++|
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~D 196 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINF--RRFTTASD 196 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHH--CCCCHHHH
T ss_pred ccccc-ccccCCCCcceeCchhhcc--CCCCchhc
Confidence 44321 1234567889999999854 56777665
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=233.02 Aligned_cols=164 Identities=26% Similarity=0.445 Sum_probs=141.6
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeec--CeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEG--RRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||+|++ +++.||+|+++..... .+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 34557899999999999998 4889999999764322 35789999999999999999999999887 788999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+++++|.+++.+.. ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.++|.|||++...
T Consensus 91 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 91 MPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999997642 246999999999999999999999 888 999999999999999999999999887643
Q ss_pred cCCCcceeeccCCCCccccccccccc
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
.. ....||+.|+|||++.+
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHS
T ss_pred cc-------cCccCCccccChhhhcc
Confidence 22 23467999999999855
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=245.41 Aligned_cols=184 Identities=22% Similarity=0.307 Sum_probs=144.5
Q ss_pred HHHHHHHHhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecCCC------------CchhHHHHHHHhhccCCccee
Q 036471 321 ADIKKMTNSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKG------------NGEEFINEVASISRTSHVNVV 384 (516)
Q Consensus 321 ~el~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~nIv 384 (516)
.++....+.+.+.||+|+||.||+|+.. ++..+|+|++..... ..+.+.+|+..+..++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3344445566788999999999999986 578899999875432 223467788889999999999
Q ss_pred eEEEEEee----cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 385 TLLGFCFE----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 385 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
++++++.+ ....++||||+ +++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 181 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAAN 181 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHH
Confidence 99999988 67899999999 99999998653 47999999999999999999999 8999999999999
Q ss_pred EEECCCC--cEEEeecCCcccccCCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDF--CPKISDFGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||++.++ .+||+|||+++.+....... ......||+.|+|||++.+ ..++.++|
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 242 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSD 242 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHH
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhh
Confidence 9998887 99999999998765432211 1134578999999999955 56777766
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=246.62 Aligned_cols=176 Identities=27% Similarity=0.342 Sum_probs=141.2
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe------eEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR------RALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv~e 401 (516)
+.+.+.||+|+||.||+|+...+..||+|++...... ..+|++++++++||||+++++++...+. .++|||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 4456789999999999999988778999988654322 3479999999999999999999865443 789999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCcEEEeecCCcccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKIC 480 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~ 480 (516)
|++++.+........ ....+++..++.++.||+.||+||| +++|+||||||+||||+ .++.+||+|||+++..
T Consensus 119 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 119 YVPETVYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp CCSEEHHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ccCccHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 998754433332211 2367999999999999999999999 89999999999999999 7999999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ....||+.|+|||++.+. ..++.++|
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~D 224 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGA-TNYTTNID 224 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTC-SSCCTHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCC-CCCCcHHH
Confidence 544332 345789999999998553 45777665
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=238.36 Aligned_cols=173 Identities=29% Similarity=0.520 Sum_probs=139.3
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeec-CeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG-RRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~g 406 (516)
+.+.+.||+|+||.||+++. +++.||+|+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||++++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 34567899999999999988 58899999997543 457899999999999999999999987654 4789999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 101 SLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp EHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999997642 134889999999999999999999 8999999999999999999999999999997654332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||++.+ +.++.++|
T Consensus 172 ---~~~~~~~~y~aPE~~~~--~~~~~~~D 196 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALRE--KKFSTKSD 196 (278)
T ss_dssp -------CCTTTSCHHHHHH--CCCCHHHH
T ss_pred ---cCCCccccccCHHHhCC--CCCCchhc
Confidence 22456889999999854 56676665
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=245.07 Aligned_cols=174 Identities=23% Similarity=0.301 Sum_probs=137.2
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC------------chhHHHHHHHhhccCCcceeeEEEEEee-----
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN------------GEEFINEVASISRTSHVNVVTLLGFCFE----- 392 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~nIv~l~~~~~~----- 392 (516)
+.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 34789999999999999988999999998543221 1678999999999999999999999854
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEe
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKIS 472 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 472 (516)
....++||||++ |+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ-----RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cceEEEEEccCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEE
Confidence 336799999998 5888888643 257999999999999999999999 8999999999999999999999999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||+++....... .....||+.|+|||++.+. +.++.++|
T Consensus 177 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~D 216 (362)
T 3pg1_A 177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVD 216 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTC-TTCCTHHH
T ss_pred ecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhH
Confidence 9999975543332 2345689999999998542 45666665
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=240.83 Aligned_cols=178 Identities=25% Similarity=0.344 Sum_probs=144.5
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---------CCchhHHHHHHHhhccCCcceeeEEEEEeecCe
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 395 (516)
..+.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 45566788999999999999976 47899999986432 22346889999999999999999999987655
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---EEEe
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKIS 472 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~ 472 (516)
.++||||+++++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++. +||+
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 89999999999999998543 56999999999999999999999 899999999999999987654 9999
Q ss_pred ecCCcccccCCCcceeeccCCCCccccccccccc-cccccccCCC
Q 036471 473 DFGLAKICNRKESIISMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 473 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
|||+++....... .....||+.|+|||++.. ....++.++|
T Consensus 160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 201 (322)
T 2ycf_A 160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201 (322)
T ss_dssp CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHH
T ss_pred cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhh
Confidence 9999987654321 123468999999999742 1245666665
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=249.56 Aligned_cols=174 Identities=25% Similarity=0.319 Sum_probs=147.8
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhcc------CCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRT------SHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+.+.+.||+|+||.||+|.... ++.||||+++......+.+.+|+.++..+ +|+||+++++++...+..++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 4556789999999999998764 88999999976554456778888888776 5779999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc--EEEeecCCcc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC--PKISDFGLAK 478 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~ 478 (516)
||++ ++|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++. +||+|||++.
T Consensus 179 e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp CCCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9996 69999997653 245999999999999999999999 899999999999999999887 9999999997
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ....||+.|+|||++.+ ..++.++|
T Consensus 251 ~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 281 (429)
T 3kvw_A 251 YEHQRV-----YTYIQSRFYRAPEVILG--ARYGMPID 281 (429)
T ss_dssp ETTCCC-----CSSCSCGGGCCHHHHHT--BCCCTHHH
T ss_pred ecCCcc-----cccCCCCCccChHHHhC--CCCCchHH
Confidence 654332 34578999999999965 56777766
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=252.33 Aligned_cols=167 Identities=18% Similarity=0.186 Sum_probs=133.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHH---HHhhccCCcceeeEE-------EEEeecC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEV---ASISRTSHVNVVTLL-------GFCFEGR 394 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~~~~~~ 394 (516)
+.+.||+|+||.||+|++. +|+.||||++... ....+.+.+|+ ..+++++||||++++ +++.+.+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 4578999999999999974 6899999999643 23346788999 556666899999998 6666553
Q ss_pred -----------------eeEEEEEecCCCCHHHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 036471 395 -----------------RRALIYEFVSNGSLEKFIYRNSSS-IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDI 456 (516)
Q Consensus 395 -----------------~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dl 456 (516)
..++||||+ +|+|.+++...... .....+++..++.|+.||+.||+||| +++|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 278999999 67999999864210 11234556888999999999999999 899999999
Q ss_pred CCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 457 KPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 457 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
||+||||+.++.+||+|||+++.... ......| +.|+|||++.+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcc
Confidence 99999999999999999999985432 1244567 99999999965
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=241.38 Aligned_cols=181 Identities=29% Similarity=0.498 Sum_probs=145.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCE--EEEEEeecC--CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSN--VAVKVLNDS--KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.+.||+|+||.||+|+.. ++.. |++|.+... ....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 446678999999999999875 4554 499988652 34457789999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEE
Q 036471 402 FVSNGSLEKFIYRNSS----------SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 471 (516)
|+++++|.+++..... ......+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence 9999999999976420 012247999999999999999999999 899999999999999999999999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||+++...... ......+++.|+|||++.+ ..++.++|
T Consensus 184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~D 223 (327)
T 1fvr_A 184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNY--SVYTTNSD 223 (327)
T ss_dssp CCTTCEESSCEEC---CC----CCTTTCCHHHHHH--CEECHHHH
T ss_pred cccCcCccccccc---cccCCCCCccccChhhhcc--ccCCchhc
Confidence 9999987433221 1133456889999999854 56666665
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=246.76 Aligned_cols=176 Identities=29% Similarity=0.375 Sum_probs=141.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~ 400 (516)
+.+.+.||+|+||.||+|++. +++.||||++.... +...+|++++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 344578999999999999986 58999999996543 2345799999999999999999998542 2367899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-CcEEEeecCCccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKI 479 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~ 479 (516)
||+++ +|.+++.... .....+++..++.++.||++||+||| +++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 133 e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp ECCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hcccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 99976 6777665421 12367999999999999999999999 9999999999999999965 5789999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... ....||+.|+|||++.+. ..++.++|
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~D 239 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGA-TDYTSSID 239 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHH
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhh
Confidence 6544322 345789999999998642 35777665
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=237.79 Aligned_cols=179 Identities=28% Similarity=0.423 Sum_probs=145.9
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEe
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEF 402 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~ 402 (516)
.+.+.||+|+||.||+++.. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34578999999999999986 589999999975432 23568899999999999999999998754 5688999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR-----ILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~-----ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+++++|.+++..... ....+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 89 CEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp CTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred CCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999976421 2345999999999999999999999 777 999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....|++.|+|||++.+ ..++.++|
T Consensus 164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~D 198 (279)
T 2w5a_A 164 RILNHDTSF--AKTFVGTPYYMSPEQMNR--MSYNEKSD 198 (279)
T ss_dssp HHC---CHH--HHHHHSCCTTCCHHHHHC--C-CCHHHH
T ss_pred eeecccccc--ccccCCCccccChHHhcc--CCCCchhh
Confidence 876544321 123468999999999854 56676665
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=242.99 Aligned_cols=172 Identities=28% Similarity=0.317 Sum_probs=136.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecC------eeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGR------RRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 397 (516)
+.+.+.||+|+||.||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 345578999999999999875 5889999999754322 356889999999999999999999998655 789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+++ +|.+++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 107 lv~e~~~~-~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEECCSE-EHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred EEEEcCCC-CHHHHHh--------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 99999975 7888874 34889999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....||+.|+|||++.+ ..++.++|
T Consensus 175 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~D 208 (371)
T 2xrw_A 175 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 208 (371)
T ss_dssp ------------------CTTCCHHHHTT--CCCCTTHH
T ss_pred cccccccc---cCCceecCCccCHHHhcC--CCCCchHh
Confidence 86643321 234678999999999965 56787776
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=242.88 Aligned_cols=177 Identities=25% Similarity=0.373 Sum_probs=146.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv 399 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++.+++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 445578999999999999976 578899999975332 236788999999999999999999998765 368999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++ ++|.++++. ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 109 ~e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 109 QDLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EcccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99997 599999865 35899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....||+.|+|||++.+. ..++.++|
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 214 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSID 214 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCC-CCCCcchh
Confidence 654432211 2345789999999997543 45677665
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=245.09 Aligned_cols=176 Identities=20% Similarity=0.281 Sum_probs=146.2
Q ss_pred HHhhhhhcccCCcEEEEEEEECC---------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcceee------------
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID---------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVT------------ 385 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~------------ 385 (516)
.+.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 45566889999999999999764 789999999754 56889999999999999987
Q ss_pred ---EEEEEee-cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 386 ---LLGFCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 386 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||+||| +++|+||||||+||
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI 190 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI 190 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence 6777766 67889999999 999999998641 257999999999999999999999 89999999999999
Q ss_pred EECCCC--cEEEeecCCcccccCCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDF--CPKISDFGLAKICNRKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++.++ .+||+|||+++.+....... ......||+.|+|||++.+ ..++.++|
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 250 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSD 250 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhh
Confidence 999998 99999999998765433211 1133578999999999955 56777765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=250.44 Aligned_cols=183 Identities=28% Similarity=0.359 Sum_probs=149.4
Q ss_pred cHHHHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC--------CcceeeEEEE
Q 036471 319 SYADIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS--------HVNVVTLLGF 389 (516)
Q Consensus 319 ~~~el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~ 389 (516)
...++....+.+.++||+|+||.||+|+.. +++.||+|+++......+.+.+|+.++++++ |+||++++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 333433445666788999999999999875 5789999999765555577889999999985 8889999999
Q ss_pred Ee----ecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEEC
Q 036471 390 CF----EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLD 464 (516)
Q Consensus 390 ~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~ 464 (516)
+. .....++||||+ +++|.+++.... ...+++..++.++.||+.||+||| ++ +|+||||||+||||+
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEEC
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEe
Confidence 87 556889999999 557766665432 256999999999999999999999 77 999999999999999
Q ss_pred CCC-------------------------------------------------cEEEeecCCcccccCCCcceeeccCCCC
Q 036471 465 EDF-------------------------------------------------CPKISDFGLAKICNRKESIISMTGARGT 495 (516)
Q Consensus 465 ~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 495 (516)
.++ .+||+|||++....... ....||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCC
Confidence 775 79999999998765432 345789
Q ss_pred ccccccccccccccccccCCC
Q 036471 496 VGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 496 ~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.|+|||++.+ ..++.++|
T Consensus 257 ~~y~aPE~~~~--~~~~~~~D 275 (397)
T 1wak_A 257 RQYRSLEVLIG--SGYNTPAD 275 (397)
T ss_dssp GGGCCHHHHHT--SCCCTHHH
T ss_pred CcccCChhhcC--CCCCcHHH
Confidence 99999999965 56777766
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=239.67 Aligned_cols=175 Identities=25% Similarity=0.356 Sum_probs=148.6
Q ss_pred HHhhhhhcccCCcEEEEEEEE-C-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc------eeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-I-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN------VVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+|.. . +++.||+|+++......+.+.+|+.++.+++|++ ++++++++.+.+..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 345567899999999999987 3 5789999999765555577889999999887665 9999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-------------
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE------------- 465 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~------------- 465 (516)
||||+ +++|.+++.... ...+++..++.++.|++.||+||| +++|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999 889999997653 246899999999999999999999 899999999999999987
Q ss_pred ------CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 ------DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||++....... ....||+.|+|||++.+ ..++.++|
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 216 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILA--LGWSQPCD 216 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTT--SCCCTHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhC--CCCCcchh
Confidence 6689999999998654332 34578999999999955 56777766
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=233.07 Aligned_cols=180 Identities=28% Similarity=0.413 Sum_probs=151.7
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeE
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 397 (516)
......+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 334456667788999999999999986 6899999998643 334578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC---CcEEEeec
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED---FCPKISDF 474 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Df 474 (516)
+||||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.+ +.+||+||
T Consensus 98 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 999999999999998754 46899999999999999999999 8999999999999999754 47999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++......... ....|++.|+|||++.+ .++.++|
T Consensus 169 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~D 204 (287)
T 2wei_A 169 GLSTCFQQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCD 204 (287)
T ss_dssp TGGGTBCCCSSC---SCHHHHHTTCCHHHHTT---CCCTHHH
T ss_pred CcceeecCCCcc---ccccCcccccChHHhcC---CCCCchh
Confidence 999876544321 23457899999999843 4666665
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=238.88 Aligned_cols=179 Identities=27% Similarity=0.425 Sum_probs=145.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 345577999999999999986 4889999998653 34557899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 101 GAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999987643 56999999999999999999999 89999999999999999999999999998754322111
Q ss_pred ceeeccCCCCccccccccccc---cccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCR---NIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~---~~~~~s~~sD 516 (516)
......|++.|+|||++.. ....++.++|
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 204 (302)
T 2j7t_A 173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 204 (302)
T ss_dssp --C-----CCGGGCCHHHHHHHHTTSTTTTTHHH
T ss_pred --ccccccCChhhcCCeeeccccCCCCCCchhhh
Confidence 1133568999999999842 1245666655
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=240.12 Aligned_cols=185 Identities=26% Similarity=0.353 Sum_probs=133.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|+||.||+|... +++.||+|++... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 345678999999999999865 6899999998643 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 405 NGSLEKFIYRNSS--SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 405 ~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|.+++..... ......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9999999975211 112356999999999999999999999 89999999999999999999999999999976644
Q ss_pred CCcc---eeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESI---ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .......||+.|+|||++.+. ..++.++|
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 209 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKAD 209 (303)
T ss_dssp --------------CCCTTCCHHHHHHH-HCCCTHHH
T ss_pred CCCccchhhhcccCCCccccCHHHhccc-cCCCchhh
Confidence 3211 111335689999999998542 34666655
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=235.86 Aligned_cols=176 Identities=32% Similarity=0.510 Sum_probs=145.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC--CCCEEEEEEeecC---CCCchhHHHHHHHhhcc---CCcceeeEEEEEe-----ecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI--DGSNVAVKVLNDS---KGNGEEFINEVASISRT---SHVNVVTLLGFCF-----EGR 394 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~~ 394 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++... ......+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 345578999999999999983 5789999998643 22335677888887776 8999999999987 556
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..++||||++ ++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 7899999998 59999997653 245899999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++....... .....|++.|+|||++.+ +.++.++|
T Consensus 165 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~D 201 (326)
T 1blx_A 165 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQ--SSYATPVD 201 (326)
T ss_dssp CSCCCCCGGGG---GCCCCCCCTTCCHHHHTT--CCCCTHHH
T ss_pred cccccccCCCC---ccccccccceeCHHHHhc--CCCCcchh
Confidence 99986653322 244678999999999955 56777665
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=243.93 Aligned_cols=176 Identities=27% Similarity=0.398 Sum_probs=148.8
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC---C-c--------------hhHHHHHHHhhccCCcceeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---N-G--------------EEFINEVASISRTSHVNVVTLLGF 389 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-~--------------~~~~~E~~~l~~l~h~nIv~l~~~ 389 (516)
+.+.+.||+|+||.||+|+. +++.||+|++..... . . +.+.+|+.++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 44567899999999999999 999999999864211 1 1 789999999999999999999999
Q ss_pred EeecCeeEEEEEecCCCCHHHH------HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEE
Q 036471 390 CFEGRRRALIYEFVSNGSLEKF------IYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS-TRILHFDIKPHNIL 462 (516)
Q Consensus 390 ~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~-~~ivH~dlkp~NIl 462 (516)
+.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+||| + .+|+||||||+||+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKN----YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSS----SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc----cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 9999999999999999999998 4321 1467999999999999999999999 7 99999999999999
Q ss_pred ECCCCcEEEeecCCcccccCCCcceeeccCCCCcccccccccccccccccc-CCC
Q 036471 463 LDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSY-KSD 516 (516)
Q Consensus 463 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~-~sD 516 (516)
++.++.+||+|||.+...... ......|++.|+|||++.+. ..++. ++|
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~D 234 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVD 234 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhh
Confidence 999999999999999876443 22456789999999999652 24443 444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=239.60 Aligned_cols=185 Identities=29% Similarity=0.386 Sum_probs=146.7
Q ss_pred HHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEee----cCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 400 (516)
.+.+.+.||+|+||.||+++. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 445567899999999999997 46899999998653 2344678999999999999999999999873 44788999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++++|.+++.+... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 110 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp ECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999976421 2367999999999999999999999 899999999999999999999999999998765
Q ss_pred cCCCcc-------eeeccCCCCccccccccccccc-cccccCCC
Q 036471 481 NRKESI-------ISMTGARGTVGYIAPEVFCRNI-GEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~-~~~s~~sD 516 (516)
...... .......||+.|+|||++.+.. ..++.++|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 322110 0012345799999999985431 23566655
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=245.71 Aligned_cols=180 Identities=27% Similarity=0.396 Sum_probs=132.4
Q ss_pred hhhcccCCcEEEEEEEEC---CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEEecCC
Q 036471 331 KYKLGQGGYGSVYKGKLI---DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYEFVSN 405 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~ 405 (516)
.++||+|+||.||+|+.. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 357999999999999975 47899999997543 33678899999999999999999999964 6788999999975
Q ss_pred CCHHHHHhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE----CCCCcEEEeecCCcc
Q 036471 406 GSLEKFIYRNSS---SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL----DEDFCPKISDFGLAK 478 (516)
Q Consensus 406 gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 478 (516)
+|.+++..... ......+++..++.++.||+.||+||| +.+|+||||||+|||| +.++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 88888764321 011235999999999999999999999 8999999999999999 778899999999998
Q ss_pred cccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .......||+.|+|||++.+. ..++.++|
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 218 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAID 218 (405)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCC-Ccccchhh
Confidence 76543221 122446789999999998652 34676665
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=237.74 Aligned_cols=180 Identities=28% Similarity=0.358 Sum_probs=133.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCc---hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.+.+.||+|+||.||+++.. +++.||+|+++...... +.+.++...++.++||||+++++++.+++..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 445678999999999999975 68899999997543222 23444555578889999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++ +|.+++..... ....+++..++.++.|++.||+||| ++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 89 DT-SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp SE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred cc-chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 74 88888765321 2357999999999999999999999 77 999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccc--cccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR--NIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~s~~sD 516 (516)
.... ....||+.|+|||++.. ..+.++.++|
T Consensus 163 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~D 195 (290)
T 3fme_A 163 DVAK---DIDAGCKPYMAPERINPELNQKGYSVKSD 195 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHH
T ss_pred cccc---cccCCCccccChhhcChhhcCcCCCcHHH
Confidence 4321 33468999999999731 1245666655
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=237.96 Aligned_cols=181 Identities=25% Similarity=0.297 Sum_probs=137.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCe-------eEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRR-------RALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-------~~lv 399 (516)
+.+.+.||+|+||.||+|+.. +++.||||++.........+.+|+..+..++||||+++++++...+. .++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 345578999999999999985 58999999997766666778889999999999999999999876443 7899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecCCcc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFGLAK 478 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~ 478 (516)
|||+++ +|.+.+.... .....+++..++.++.|++.||.||| .++.+|+||||||+|||++. ++.+||+|||+++
T Consensus 105 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred eecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 999986 5555544321 12367899999999999999999999 33689999999999999996 8999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ....||+.|+|||++.+. ..++.++|
T Consensus 181 ~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~D 214 (360)
T 3e3p_A 181 KLSPSEPN---VAYICSRYYRAPELIFGN-QHYTTAVD 214 (360)
T ss_dssp CCCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCTHHH
T ss_pred ecCCCCCc---ccccCCcceeCHHHHcCC-CCCCcHHH
Confidence 77654332 345689999999998543 34677665
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-28 Score=247.77 Aligned_cols=173 Identities=13% Similarity=0.064 Sum_probs=127.1
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC----CchhHHHHHH---HhhccCCcceeeEE-------EEEeec
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG----NGEEFINEVA---SISRTSHVNVVTLL-------GFCFEG 393 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~---~l~~l~h~nIv~l~-------~~~~~~ 393 (516)
.+.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+. .++. +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEET
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecC
Confidence 34578999999999999976 689999999986543 2355677754 5555 799988865 444332
Q ss_pred -----------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCC
Q 036471 394 -----------------RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETL------LQIAVGIARGLEYLHLGCSTR 450 (516)
Q Consensus 394 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~aL~~LH~~~~~~ 450 (516)
...++||||++ ++|.+++.... ..+++..+ +.++.||+.||+||| +++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ 214 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQ---SKG 214 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence 33799999998 89999998642 23455555 788899999999999 899
Q ss_pred eeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 451 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 451 ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+....++.++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCcccc
Confidence 9999999999999999999999999998664321 134567999999999543346777765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=232.24 Aligned_cols=178 Identities=26% Similarity=0.367 Sum_probs=145.0
Q ss_pred HHhhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEE-eecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFC-FEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||+|+. .+++.||+|++..... .+++.+|+.++.+++|++++..+..+ .+.+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 345568899999999999997 4688999998765432 35688999999999988877666655 5677889999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 481 (516)
+++|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999999997542 56999999999999999999999 8999999999999999 788999999999998775
Q ss_pred CCCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......||+.|+|||++.+ ..++.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 197 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDD 197 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcC--CCCCchhH
Confidence 543311 1234578999999999955 56777765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=256.42 Aligned_cols=160 Identities=18% Similarity=0.207 Sum_probs=124.3
Q ss_pred hcccCCcEEEEEEEE-CCCCEEEEEEeecCC-----------CCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEE
Q 036471 333 KLGQGGYGSVYKGKL-IDGSNVAVKVLNDSK-----------GNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 399 (516)
....|+.|.+..++. --|+.+++|.+.... .+.++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 355666666655432 248899999996532 1225689999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||++|++|.++|.+. .++++. +|+.||+.||+|+| ++|||||||||+||||+++|.+||+|||+|+.
T Consensus 321 MEyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 9999999999999754 456654 58899999999999 99999999999999999999999999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccc
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
....... .....||+.|||||++.+
T Consensus 389 ~~~~~~~--~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 389 TPQDCSW--PTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp CC---CC--SHHHHHHHHHHHHHHC--
T ss_pred CCCCCcc--ccCceechhhccHHHhCC
Confidence 6554322 244679999999999954
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=231.07 Aligned_cols=176 Identities=26% Similarity=0.378 Sum_probs=145.3
Q ss_pred hhhhhcccCCcEEEEEEEE-CCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEE-eecCeeEEEEEecCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKL-IDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFC-FEGRRRALIYEFVSNG 406 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~g 406 (516)
.+.+.||+|+||.||+|+. .+++.||+|++.... ..+++.+|+.++++++|++++..+..+ .+.+..++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 4457899999999999997 468999999986543 335789999999999988866656555 5677889999999 89
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCcccccCC
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 483 (516)
+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||+ ++++.+||+|||++......
T Consensus 90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 90 SLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9999997542 56999999999999999999999 8999999999999999 48889999999999877654
Q ss_pred Ccce-----eeccCCCCccccccccccccccccccCCC
Q 036471 484 ESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ......||+.|+|||++.+ ..++.++|
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 197 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDD 197 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred ccccccccccccccccccccCChhhhcC--CCCCcchh
Confidence 3311 1234578999999999955 56777766
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-28 Score=243.89 Aligned_cols=172 Identities=31% Similarity=0.406 Sum_probs=128.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeec------CeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 397 (516)
+.+.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 344577999999999999875 588999999965432 236788999999999999999999998754 5679
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+|+|++ +++|.++++. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 111 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 999999 6899998853 46999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..... .....||+.|+|||++.+. ..++.++|
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D 212 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVD 212 (367)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCTTHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCC-cCCCchhh
Confidence 865432 2446789999999998542 46777766
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=238.63 Aligned_cols=176 Identities=26% Similarity=0.375 Sum_probs=143.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~ 400 (516)
.+.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|+.++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34578999999999999986 588999999964332 235678999999999999999999988764 6789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||++ ++|.+++.. ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 94 e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 9997 599999865 45899999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcce--------eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII--------SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......||+.|+|||++.+. +.++.++|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~D 205 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMD 205 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccC-CCccchhh
Confidence 5432111 11235689999999998542 46666665
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-28 Score=234.80 Aligned_cols=179 Identities=29% Similarity=0.427 Sum_probs=138.4
Q ss_pred HHhhhhhcccCCcEEEEEEEEC--CCC--EEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI--DGS--NVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+|++. +++ .||+|+++... ...+.+.+|+.++++++||||+++++++.++. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3445678999999999999863 233 68999986532 23467889999999999999999999988765 889
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++.... ..+++..++.++.|++.||+||| +++|+|+||||+||+++.++.+||+|||++.
T Consensus 98 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 999999999999997642 56899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.......... .....+++.|+|||++.+ ..++.++|
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 206 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASD 206 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcC--CCCCchhh
Confidence 7755443221 233457889999999854 55666665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=236.92 Aligned_cols=183 Identities=25% Similarity=0.344 Sum_probs=133.7
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccC-CcceeeEEEEEe--------ecCe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTS-HVNVVTLLGFCF--------EGRR 395 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~~~~ 395 (516)
.+.+.++||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4556688999999999999975 68999999985443 33467889999999996 999999999984 3445
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEECCCCcEEEee
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~D 473 (516)
.++||||++ |+|.+++.... ....+++..++.++.||+.||+||| ..+ |+||||||+|||++.++.+||+|
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred EEEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 789999996 69999987632 2356999999999999999999999 888 99999999999999999999999
Q ss_pred cCCcccccCCCcce----------eeccCCCCccccccccccc-cccccccCCC
Q 036471 474 FGLAKICNRKESII----------SMTGARGTVGYIAPEVFCR-NIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~~~s~~sD 516 (516)
||+++......... ......||+.|+|||++.. ....++.++|
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 99998765432211 0113458999999999832 1245666655
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=233.61 Aligned_cols=168 Identities=20% Similarity=0.307 Sum_probs=137.2
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCC---CchhHHHHHHHhhccC--CcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG---NGEEFINEVASISRTS--HVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++.+++ |+||+++++++.+.+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 445578999999999999998899999999975433 2367889999999997 5999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+.+++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+||++++ +.+||+|||++.....
T Consensus 109 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 109 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 5688999999764 46899999999999999999999 899999999999999965 7999999999987755
Q ss_pred CCcceeeccCCCCccccccccccc
Q 036471 483 KESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
...........|++.|+|||++.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp -----------CCGGGCCHHHHTT
T ss_pred ccccccccCCCCCCCcCCHHHHhh
Confidence 443322334568999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=235.44 Aligned_cols=175 Identities=28% Similarity=0.311 Sum_probs=147.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhccC--CcceeeEEEEEeecCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRTS--HVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 397 (516)
+.+.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 445678999999999999875 588999999965432 3367788999999996 599999999999999999
Q ss_pred EEEEecCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCcEEEeecC
Q 036471 398 LIYEFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFG 475 (516)
Q Consensus 398 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg 475 (516)
+|||++.+ ++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||
T Consensus 125 lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999976 8999999764 46899999999999999999999 89999999999999999 78899999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++....... ....||+.|+|||++.+. ...+.++|
T Consensus 196 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~D 231 (320)
T 3a99_A 196 SGALLKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAA 231 (320)
T ss_dssp TCEECCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHH
T ss_pred cccccccccc----cCCCCCccCCChHHhccC-CCCCccch
Confidence 9987654322 345689999999998542 22355544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=257.87 Aligned_cols=180 Identities=24% Similarity=0.429 Sum_probs=145.3
Q ss_pred HHHHhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 325 KMTNSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 325 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
...+.+.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3344556789999999999998743 45799999865332 2367899999999999999999999985 467899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++|+|.++++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 468 v~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 999999999999997642 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ ......+++.|+|||++.+ +.++.++|
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~D 574 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINF--RRFTSASD 574 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHH--CCCCHHHH
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcC--CCCCchhh
Confidence 76544322 1233457889999999954 56777765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.32 Aligned_cols=171 Identities=30% Similarity=0.407 Sum_probs=141.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCee------E
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRRR------A 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~------~ 397 (516)
+.+.+.||+|+||.||+|.+. +|+.||+|++...... .+.+.+|+.++++++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 334567999999999999876 5889999999764333 36788999999999999999999999877655 9
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||++ ++|.+++. ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 124 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 9999997 58888762 35899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..... .....||+.|+|||++.+. ..++.++|
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D 224 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVD 224 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCC-SCCCTTHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCC-CCCCcHHh
Confidence 865433 2446789999999998542 46777766
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=236.12 Aligned_cols=172 Identities=27% Similarity=0.364 Sum_probs=139.3
Q ss_pred HHHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC-------CchhHHHHHHHhhcc----CCcceeeEEEE
Q 036471 322 DIKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG-------NGEEFINEVASISRT----SHVNVVTLLGF 389 (516)
Q Consensus 322 el~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~nIv~l~~~ 389 (516)
+.....+.+.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334455667788999999999999875 588999999965432 335567899999998 89999999999
Q ss_pred EeecCeeEEEEEe-cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCC
Q 036471 390 CFEGRRRALIYEF-VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDF 467 (516)
Q Consensus 390 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~ 467 (516)
+.+.+..++|||+ +++++|.+++.+. ..+++..++.++.||+.||+||| +.+|+||||||+||+++ .++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTT
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCC
Confidence 9999999999999 7899999999764 46899999999999999999999 89999999999999999 889
Q ss_pred cEEEeecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 468 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
.+||+|||++........ ....|++.|+|||++.+
T Consensus 178 ~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~ 212 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISR 212 (312)
T ss_dssp EEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHH
T ss_pred eEEEEEcchhhhcccCcc----cccCCcccccCceeeec
Confidence 999999999987654432 34568999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=242.66 Aligned_cols=177 Identities=28% Similarity=0.373 Sum_probs=146.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCC-cceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.++||+|+||.||+|++. +++.||||++..... .+++.+|++++..++| ++|..+..+..+.+..+|||||+ +
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 345678999999999999974 689999998865433 3568899999999976 55666666677788899999999 9
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---CCCCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL---DEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 482 (516)
++|.+++.... ..+++..++.|+.||+.||+||| .++|+||||||+|||| +.++.+||+|||+++.+..
T Consensus 87 ~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 87 PSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999997542 56999999999999999999999 8999999999999999 6889999999999987765
Q ss_pred CCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 483 KESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......||+.|+|||++.+ ..++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sD 195 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDD 195 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred CccccccccccccccCCCccccCHHHhcC--CCCChHHH
Confidence 43321 1125679999999999955 56777665
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=233.78 Aligned_cols=176 Identities=27% Similarity=0.364 Sum_probs=137.0
Q ss_pred hhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEe--------------e
Q 036471 329 SFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCF--------------E 392 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--------------~ 392 (516)
.+.+.||+|+||.||+|.... ++.||+|++.... ...+++.+|+.++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 345779999999999999875 8999999986543 33467899999999999999999999874 3
Q ss_pred cCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC-CCCcEEE
Q 036471 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD-EDFCPKI 471 (516)
Q Consensus 393 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl 471 (516)
....++||||++ |+|.+++.. ..+++..++.++.|++.||+||| +++|+||||||+||+++ +++.+||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 467899999998 599999853 46899999999999999999999 89999999999999997 5679999
Q ss_pred eecCCcccccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 472 SDFGLAKICNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|||+++........ .......+++.|+|||++.+. +.++.++|
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 207 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAID 207 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhh
Confidence 999999876533211 112334578999999998542 45666665
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=235.28 Aligned_cols=175 Identities=22% Similarity=0.318 Sum_probs=146.7
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CC-CEEEEEEeecCCCCchhHHHHHHHhhccCCcc------eeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DG-SNVAVKVLNDSKGNGEEFINEVASISRTSHVN------VVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l 398 (516)
.+.+.+.||+|+||.||+|... ++ +.||+|+++......+.+.+|+.++++++|++ ++.+++++...+..++
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 4456678999999999999975 34 68999999765555577889999999997766 9999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE---------------
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL--------------- 463 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll--------------- 463 (516)
||||+ +++|.+++.... ...+++..++.++.||+.||+||| +++|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 99999 667777776542 246999999999999999999999 9999999999999999
Q ss_pred ----CCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 464 ----DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 464 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 221 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILE--LGWAQPCD 221 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTT--CCCCTHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeec--CCCCCccc
Confidence 567899999999998654332 34578999999999955 56777766
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=232.30 Aligned_cols=168 Identities=29% Similarity=0.365 Sum_probs=121.7
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHH-HHhhccCCcceeeEEEEEee----cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEV-ASISRTSHVNVVTLLGFCFE----GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|+.. +++.||+|++.... ...+|+ ..+..++||||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999986 58999999996532 223333 34566799999999999876 4458999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
|+|.+++.+.. ...+++..++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+++....
T Consensus 111 g~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 111 GELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp EEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred CCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999997642 256999999999999999999999 899999999999999976 45699999999986553
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+ +.++.++|
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~--~~~~~~~D 211 (336)
T 3fhr_A 184 NA----LQTPCYTPYYVAPEVLGP--EKYDKSCD 211 (336)
T ss_dssp --------------------------CHHHHHHH
T ss_pred cc----cccCCCCcCccChhhhCC--CCCCchhh
Confidence 32 134567999999999844 56666655
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=257.08 Aligned_cols=168 Identities=27% Similarity=0.352 Sum_probs=140.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC--CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCe-----eEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI--DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRR-----RAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~l 398 (516)
+.+.+.||+|+||.||++++. +++.||||++..... ..+.+.+|+.++.+++||||+++++++.+.+. .+|
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 445678999999999999985 589999999865332 23568899999999999999999999987665 699
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++. ..+++..++.++.||+.||+||| +++|+||||||+|||++.+ .+||+|||+++
T Consensus 162 v~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999998763 36899999999999999999999 8999999999999999986 89999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....||+.|+|||++.+ ..+.++|
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~---~~~~~sD 258 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRT---GPTVATD 258 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHH---CSCHHHH
T ss_pred hcccC------CccCCCccccCHHHHcC---CCCCcee
Confidence 76543 34568999999999854 2366655
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=236.51 Aligned_cols=170 Identities=31% Similarity=0.413 Sum_probs=139.5
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecCe------eEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGRR------RAL 398 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~l 398 (516)
.+.+.||+|+||.||+|+.. +|+.||||++...... .+.+.+|+.++++++||||+++++++...+. .++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 34567999999999999975 5899999999754332 3578899999999999999999999987654 499
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||++ ++|.+++. ..+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 107 v~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp EEECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred Eecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 999997 58877662 35899999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|+|||++.+. ..++.++|
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~D 206 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVD 206 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCC-SCCCTTHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhh
Confidence 65433 2345789999999998542 46677765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=236.55 Aligned_cols=177 Identities=23% Similarity=0.258 Sum_probs=146.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-Cc-----ceeeEEEEEeecCeeEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HV-----NVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~~~lv 399 (516)
.+.+.+.||+|+||+||+|+.. +++.||||+++......+++.+|+.++..++ |+ +|+++++++...+..++|
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 3445678999999999999976 5788999999765444567778888888774 44 499999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCcEEEeecCCc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLA 477 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a 477 (516)
|||++ ++|.+++.... ...+++..++.++.|++.||+|||+ ...+|+||||||+|||++ .++.+||+|||++
T Consensus 135 ~e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTN----FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EECCC-CBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EecCC-CCHHHHHhhcC----cCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99996 59999997653 2468999999999999999999992 146899999999999994 5778999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... ....||+.|+|||++.+ ..++.++|
T Consensus 209 ~~~~~~~-----~~~~~t~~y~aPE~~~~--~~~~~~~D 240 (382)
T 2vx3_A 209 CQLGQRI-----YQYIQSRFYRSPEVLLG--MPYDLAID 240 (382)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHTT--CCCCTHHH
T ss_pred eeccccc-----ccccCCccccChHHHcC--CCCCcHHH
Confidence 8764332 34678999999999965 56777766
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=239.80 Aligned_cols=175 Identities=25% Similarity=0.375 Sum_probs=147.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-----------CcceeeEEEEEeecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-----------HVNVVTLLGFCFEGR 394 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~ 394 (516)
.+.+.+.||+|+||.||+|+.. +++.||+|++.......+.+.+|+.++.+++ |+||+++++++...+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 4556688999999999999974 6889999999765555577889999999886 899999999988654
Q ss_pred ----eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEEC-----
Q 036471 395 ----RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLD----- 464 (516)
Q Consensus 395 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~----- 464 (516)
..++||||+ +++|.+++.... ...+++..++.++.||+.||+||| ++ +|+||||||+|||++
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence 788999999 889999998643 256999999999999999999999 77 999999999999994
Q ss_pred -CCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 465 -EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 465 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..+.+||+|||++....... ....||+.|+|||++.+ ..++.++|
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~--~~~~~~~D 217 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLG--APWGCGAD 217 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT--CCCCTHHH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhC--CCCCchHh
Confidence 44589999999998765432 34578999999999965 56777766
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=242.94 Aligned_cols=180 Identities=27% Similarity=0.333 Sum_probs=134.3
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 3679999999998777778999999998653 235678999999886 89999999999999999999999996 6999
Q ss_pred HHHhhcCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC-------------CcEEEeecC
Q 036471 410 KFIYRNSSSIEN-HKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-------------FCPKISDFG 475 (516)
Q Consensus 410 ~~l~~~~~~~~~-~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-------------~~~kl~Dfg 475 (516)
+++......... ...++..++.++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999765321111 11234456789999999999999 8999999999999999754 489999999
Q ss_pred CcccccCCCcce--eeccCCCCcccccccccccc-----ccccccCCC
Q 036471 476 LAKICNRKESII--SMTGARGTVGYIAPEVFCRN-----IGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-----~~~~s~~sD 516 (516)
+++......... ......||+.|+|||++.+. .+.++.++|
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 221 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence 998776543221 12345799999999999541 145666655
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=241.29 Aligned_cols=177 Identities=27% Similarity=0.361 Sum_probs=136.1
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
...+.||+|+||+|+.....+++.||||++... ....+.+|+.+++++ +||||+++++++.+....++||||++ |+
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE--CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTT--TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 345679999999976665668999999999643 334578999999999 89999999999999999999999996 59
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----CCcEEEeecCCcccccC
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKICNR 482 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~ 482 (516)
|.+++.... ....+..++.++.||+.||+||| +.+|+||||||+|||++. ...+||+|||+++....
T Consensus 104 L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 104 LQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp HHHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred HHHHHHhcC-----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 999997643 23445567899999999999999 899999999999999953 33688999999987754
Q ss_pred CCcc-eeeccCCCCcccccccccccc-ccccccCCC
Q 036471 483 KESI-ISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 483 ~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
.... .......||+.|+|||++.+. ...++.++|
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D 211 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence 4321 122446799999999999642 244555555
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=234.73 Aligned_cols=168 Identities=28% Similarity=0.428 Sum_probs=136.7
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.+.||+|+||.||+|++.+ .+|+|+++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3456789999999999999753 5999998643 2344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||++.......
T Consensus 113 ~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 113 GRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp SEEHHHHTTSS-----CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred CCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999653 246899999999999999999999 89999999999999998 6799999999987653221
Q ss_pred cc---eeeccCCCCccccccccccc
Q 036471 485 SI---ISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 485 ~~---~~~~~~~gt~~y~aPE~l~~ 506 (516)
.. .......|++.|+|||++.+
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSC
T ss_pred ccccccccccCCCcccccChHHhhh
Confidence 11 11233558999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=229.73 Aligned_cols=179 Identities=27% Similarity=0.353 Sum_probs=126.2
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHH-HhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVA-SISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.||+|+||.||+|... +++.||+|++..... ...++.+|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 4567999999999999985 588999999976432 2245566666 67778999999999999999999999999985
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|.+++..... .....+++..+..++.|++.||.||| .. +|+||||||+||+++.++.+||+|||+++......
T Consensus 106 -~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 106 -SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp -EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred -ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 88888764211 12367999999999999999999999 77 99999999999999999999999999998765432
Q ss_pred cceeeccCCCCcccccccccccc--ccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRN--IGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~--~~~~s~~sD 516 (516)
. .....||+.|+|||++... .+.++.++|
T Consensus 181 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D 211 (327)
T 3aln_A 181 A---KTRDAGCRPYMAPERIDPSASRQGYDVRSD 211 (327)
T ss_dssp ----------------------------CCSHHH
T ss_pred c---cccCCCCccccCceeeccccCcCCCCchhh
Confidence 2 1334689999999998321 145666655
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=227.11 Aligned_cols=176 Identities=24% Similarity=0.339 Sum_probs=126.2
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCc---hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.||+|+||.||+|++. +++.||+|++....... +.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34567999999999999986 68999999997654322 23344445677889999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
++.+..+.... ...+++..++.++.|++.||+||| ++ +|+|+||||+||+++.++.+||+|||++......
T Consensus 107 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 107 GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 55666665443 256899999999999999999999 75 9999999999999999999999999999766543
Q ss_pred CcceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
.. .....|++.|+|||++... ...++.++|
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 211 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHH
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccc
Confidence 32 1345689999999998431 235565554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=248.68 Aligned_cols=179 Identities=30% Similarity=0.409 Sum_probs=150.1
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEee------cCeeE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFE------GRRRA 397 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 397 (516)
.+.+.+.||+|+||.||+|.+. +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 4566788999999999999875 58999999986542 234678899999999999999999998765 66789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCc---EEEeec
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFC---PKISDF 474 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Df 474 (516)
+||||+++++|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+||
T Consensus 95 LVmEy~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CEEECCSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEeCCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 9999999999999997643 2246899999999999999999999 899999999999999997664 999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|++........ .....||+.|+|||++.+ +.++.++|
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~--~~~s~ksD 205 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQ--KKYTVTVD 205 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCC--SCCSTTHH
T ss_pred ccccccccccc---cccccCCcccCChHHhcc--CCCCchhH
Confidence 99987654432 234678999999999954 67888776
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-26 Score=239.28 Aligned_cols=165 Identities=18% Similarity=0.182 Sum_probs=125.9
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---------chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---------GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.||+|+||.||++.. .++.+++|+....... .+.+.+|++++++++||||+++..+....+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35799999999999954 6788999987543221 2347899999999999999965555567778899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++++|.++++. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999842 5689999999999999 899999999999999998 99999999998875
Q ss_pred CCCcce-----eeccCCCCccccccccccccccccccCC
Q 036471 482 RKESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKS 515 (516)
Q Consensus 482 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~s 515 (516)
...... ......||+.|||||++......|+.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~ 519 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVY 519 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHH
Confidence 543211 1134578999999999954223344433
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=207.42 Aligned_cols=142 Identities=11% Similarity=0.036 Sum_probs=125.2
Q ss_pred HHhhhhhcccCCcEEEEEEEECC-CCEEEEEEeecCCCCc----hhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
.+.+.+.||+|+||.||+|++.. ++.||+|++....... +.+.+|+..+.+++||||+++++++.+.+..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 45566789999999999999864 8999999997654432 678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|+++++|.+++++ . ....++..++.|++.||+||| +++|+||||||+|||++.++.+||++++....
T Consensus 112 ~~~g~~L~~~l~~-------~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~~ 178 (286)
T 3uqc_A 112 WIRGGSLQEVADT-------S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMPD 178 (286)
T ss_dssp CCCEEEHHHHHTT-------C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCTT
T ss_pred ecCCCCHHHHHhc-------C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccCC
Confidence 9999999999943 2 355678899999999999999 89999999999999999999999998876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=222.51 Aligned_cols=165 Identities=19% Similarity=0.205 Sum_probs=122.8
Q ss_pred hhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCC-cce---------e-----------
Q 036471 331 KYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSH-VNV---------V----------- 384 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h-~nI---------v----------- 384 (516)
.+.||+|+||.||+|++. +|+.||||++... ....+.+.+|+.++..++| +|. +
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 467999999999999965 5899999998732 2335789999999999977 211 1
Q ss_pred -eEEEEEee-----cCeeEEEEEecCCCCHHHHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 036471 385 -TLLGFCFE-----GRRRALIYEFVSNGSLEKFIYRNSS-SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIK 457 (516)
Q Consensus 385 -~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlk 457 (516)
.+..+... ....+++|+++ +++|.++++.... ......+++..++.++.||++||+||| +++|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcc
Confidence 11111111 12346667765 6799999852210 012356888999999999999999999 8999999999
Q ss_pred CCcEEECCCCcEEEeecCCcccccCCCcceeeccCCCCcccccccccc
Q 036471 458 PHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505 (516)
Q Consensus 458 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 505 (516)
|+||||+.++.+||+|||+++..... .....| +.|+|||++.
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhh
Confidence 99999999999999999998765433 244567 9999999984
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-23 Score=201.74 Aligned_cols=141 Identities=26% Similarity=0.326 Sum_probs=124.6
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHh-hccCCcceeeEEEEEee----cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASI-SRTSHVNVVTLLGFCFE----GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||++... +++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 56999999999999975 589999999964 35678899888 55699999999999887 6788999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++.....
T Consensus 100 ~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 100 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172 (299)
T ss_dssp CBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence 99999998753 256999999999999999999999 899999999999999998 78999999999977654
Q ss_pred C
Q 036471 483 K 483 (516)
Q Consensus 483 ~ 483 (516)
.
T Consensus 173 ~ 173 (299)
T 3m2w_A 173 E 173 (299)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-23 Score=199.26 Aligned_cols=140 Identities=16% Similarity=0.096 Sum_probs=112.7
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCCC-------------------CchhHHHHHHHhhccCCcceeeEEEEEe
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKG-------------------NGEEFINEVASISRTSHVNVVTLLGFCF 391 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 391 (516)
.+.||+|+||.||+|.+.+|+.||+|+++.... ....+.+|++++++++| +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~- 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY- 170 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE-
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE-
Confidence 377999999999999997799999999964221 13458899999999984 4444443
Q ss_pred ecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEE
Q 036471 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKI 471 (516)
Q Consensus 392 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 471 (516)
+.+..++||||+++++|.+ +.. .....++.|++.||+||| +.+|+||||||+|||++ ++.+||
T Consensus 171 ~~~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 171 AWEGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp EEETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEE
T ss_pred eccceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEE
Confidence 3356799999999999987 411 224579999999999999 99999999999999999 999999
Q ss_pred eecCCcccccCCCcceeeccCCCCccccccccccc
Q 036471 472 SDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 472 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 506 (516)
+|||+|+. +..++|||++.+
T Consensus 234 ~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EECCCCeE---------------CCCCCHHHHHHH
Confidence 99999863 335788998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=173.22 Aligned_cols=136 Identities=18% Similarity=0.196 Sum_probs=105.5
Q ss_pred hhhhcccCCcEEEEEEEE-CCCCE--EEEEEeecCCCC-------------------------chhHHHHHHHhhccCCc
Q 036471 330 FKYKLGQGGYGSVYKGKL-IDGSN--VAVKVLNDSKGN-------------------------GEEFINEVASISRTSHV 381 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ 381 (516)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..+.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 446799999999999998 67888 999997543211 02578899999999887
Q ss_pred ce--eeEEEEEeecCeeEEEEEecCC-C----CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 036471 382 NV--VTLLGFCFEGRRRALIYEFVSN-G----SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHF 454 (516)
Q Consensus 382 nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~ 454 (516)
++ +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.|||. ..+|+||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~--~~givHr 195 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQ--EAELVHA 195 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence 54 444442 367899999942 4 67766421 2345678899999999999994 5799999
Q ss_pred CCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 455 DIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 455 dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
||||+|||+++ .++|+|||+|.....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999998 999999999976543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=166.38 Aligned_cols=134 Identities=15% Similarity=0.153 Sum_probs=96.9
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC---------------chhH--------HHHHHHhhccCCcce--
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN---------------GEEF--------INEVASISRTSHVNV-- 383 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~~--------~~E~~~l~~l~h~nI-- 383 (516)
.+.+.||+|++|.||+|...+|+.||||+++..... .... .+|...|.++.+.++
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 345679999999999999989999999997532100 0111 235556666644433
Q ss_pred eeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q 036471 384 VTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463 (516)
Q Consensus 384 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll 463 (516)
...++. ...+|||||++|++|.++.. .+....++.|++.+|.+|| ..|||||||||.|||+
T Consensus 178 p~p~~~----~~~~LVME~i~G~~L~~l~~------------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 178 PEPIAQ----SRHTIVMSLVDALPMRQVSS------------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILI 238 (397)
T ss_dssp CCEEEE----ETTEEEEECCSCEEGGGCCC------------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred Ceeeec----cCceEEEEecCCccHhhhcc------------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence 222221 23479999999988865421 1234578899999999999 8999999999999999
Q ss_pred CCCC----------cEEEeecCCccccc
Q 036471 464 DEDF----------CPKISDFGLAKICN 481 (516)
Q Consensus 464 ~~~~----------~~kl~Dfg~a~~~~ 481 (516)
++++ .+.|+||+-+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 8876 48999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.9e-12 Score=122.20 Aligned_cols=137 Identities=15% Similarity=0.045 Sum_probs=107.2
Q ss_pred hhhcccCCcEEEEEEEECCCCEEEEEEeecCC-CCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 331 KYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-GNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 331 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
...++.|+.+.||++.. +++.+++|+..... .....+.+|+++++.+. +..+.+++++..+.+..++||||++|.+|
T Consensus 19 ~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 45567777889999985 47899999986422 33457899999999884 67788999999988899999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG------------------------------------------ 446 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------------ 446 (516)
.+.+. +......++.+++++|+.||..
T Consensus 98 ~~~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 98 SEEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp HHHCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred hhccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 87531 1122347888999999999951
Q ss_pred --------------CCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 447 --------------CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 447 --------------~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
....++|+|++|.||+++++..+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998765667999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=116.42 Aligned_cols=131 Identities=18% Similarity=0.101 Sum_probs=98.6
Q ss_pred cc-cCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc--eeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 334 LG-QGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN--VVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 334 ig-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
++ .|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 44 45569999998777888999997644 3356889999999885444 566888888888899999999998884
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC------------------------------------------- 447 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------------- 447 (516)
.. ..+ ...++.++++.|..||...
T Consensus 104 -~~---------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 -SS---------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp -TS---------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred -cC---------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 21 111 2356777888888888321
Q ss_pred ------------CCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 448 ------------STRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 448 ------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
...++|+|++|.||++++++.++|+||+.+...
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999987766779999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=116.91 Aligned_cols=139 Identities=19% Similarity=0.186 Sum_probs=105.5
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEee--cCC--CCchhHHHHHHHhhccC--CcceeeEEEEEeec---CeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLN--DSK--GNGEEFINEVASISRTS--HVNVVTLLGFCFEG---RRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e~ 402 (516)
+.++.|.++.||+.... +..+++|+.. ... .....+.+|..+++.+. +..+++++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 35888999999999874 4688888876 332 23467889999999986 45688899888776 458999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC----------------------------------- 447 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~----------------------------------- 447 (516)
++|..+.+.. ...++..+...++.+++++|+.||...
T Consensus 123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9998774311 134778888999999999999999520
Q ss_pred --------------------CCCeeeCCCCCCcEEECCCCc--EEEeecCCccc
Q 036471 448 --------------------STRILHFDIKPHNILLDEDFC--PKISDFGLAKI 479 (516)
Q Consensus 448 --------------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 479 (516)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.61 E-value=4.2e-08 Score=95.34 Aligned_cols=135 Identities=21% Similarity=0.227 Sum_probs=98.7
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcc--eeeEEEEEeecC---eeEEEEEecCCC
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVN--VVTLLGFCFEGR---RRALIYEFVSNG 406 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~e~~~~g 406 (516)
.++.|....||+.. ..+++|+.... .....+.+|.+.++.+ .+.. +.+++......+ ..|+|||+++|.
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 47889999999863 56888886432 2346788999999887 3333 455555544333 358899999998
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC--------------------------------------- 447 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--------------------------------------- 447 (516)
+|.+... ..++.++...++.++++.|+.||...
T Consensus 102 ~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 102 PLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 8875432 34677788888888888888888410
Q ss_pred ----------------CCCeeeCCCCCCcEEECC--CCcEEEeecCCcccc
Q 036471 448 ----------------STRILHFDIKPHNILLDE--DFCPKISDFGLAKIC 480 (516)
Q Consensus 448 ----------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~ 480 (516)
...++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135799999999999998 556889999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=3.3e-07 Score=89.11 Aligned_cols=135 Identities=19% Similarity=0.152 Sum_probs=95.2
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc---ceeeEEEEEe-ecCeeEEEEEecCCCCH
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV---NVVTLLGFCF-EGRRRALIYEFVSNGSL 408 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~gsL 408 (516)
.++.|....||+. ++.+++|+-. .......+.+|.+++..+.+. .+.+++.+.. ..+..++|||+++|.+|
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 4778888899988 5778888853 222346788999999998642 3567777664 45567899999999888
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG------------------------------------------ 446 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~------------------------------------------ 446 (516)
.+... ..++..+...++.++++.|+.||..
T Consensus 101 ~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 101 GEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp HHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred chhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 76321 2245555556666666666666631
Q ss_pred ---------------CCCCeeeCCCCCCcEEECC---CCc-EEEeecCCcccc
Q 036471 447 ---------------CSTRILHFDIKPHNILLDE---DFC-PKISDFGLAKIC 480 (516)
Q Consensus 447 ---------------~~~~ivH~dlkp~NIll~~---~~~-~kl~Dfg~a~~~ 480 (516)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1335699999999999987 455 489999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=6.7e-07 Score=85.07 Aligned_cols=135 Identities=16% Similarity=0.119 Sum_probs=97.4
Q ss_pred cccCCcE-EEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 334 LGQGGYG-SVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 334 ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
+..|..+ .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.+++.+..+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4445444 68988765 4678999986533 3456788999888773 4447788999999999999999999988877
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 036471 411 FIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC------------------------------------------- 447 (516)
Q Consensus 411 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------------- 447 (516)
..... ......+..+++..|.-||...
T Consensus 110 ~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 110 VLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 65321 1223456666777777777310
Q ss_pred ------------CCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 448 ------------STRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 448 ------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
...++|+|+++.|||++.++.+-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 112789999999999998877789999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=7.4e-07 Score=88.54 Aligned_cols=77 Identities=9% Similarity=-0.014 Sum_probs=55.4
Q ss_pred hc-ccCCcEEEEEEEEC-------CCCEEEEEEeecCC----CCchhHHHHHHHhhccCC---cceeeEEEEEeec---C
Q 036471 333 KL-GQGGYGSVYKGKLI-------DGSNVAVKVLNDSK----GNGEEFINEVASISRTSH---VNVVTLLGFCFEG---R 394 (516)
Q Consensus 333 ~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~ 394 (516)
.| +.|....+|+.... +++.+++|+..... .....+.+|+.+++.+.. ..+.+++.+..+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 46 77888999998764 26788999875432 123568889998888742 3577888877655 3
Q ss_pred eeEEEEEecCCCCHH
Q 036471 395 RRALIYEFVSNGSLE 409 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~ 409 (516)
..++||||++|.++.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 568999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=2.6e-05 Score=78.53 Aligned_cols=73 Identities=12% Similarity=0.024 Sum_probs=49.5
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--------CCchhHHHHHHHhhccCC--c-ceeeEEEEEeecCeeEEE
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--------GNGEEFINEVASISRTSH--V-NVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~lv 399 (516)
+.||.|..+.||++... +++.+++|...... ...+.+..|.+++..+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 35899999999999764 46889999864321 123556789988887732 3 44566654 44567899
Q ss_pred EEecCCC
Q 036471 400 YEFVSNG 406 (516)
Q Consensus 400 ~e~~~~g 406 (516)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.1e-05 Score=79.21 Aligned_cols=142 Identities=16% Similarity=0.160 Sum_probs=80.2
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCC--cceeeEEE------EEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSH--VNVVTLLG------FCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~e~~~~ 405 (516)
|+.|..+.||+....+| .+++|+.... ..++..|..++..+.. -.+++++. +....+..+++|||++|
T Consensus 40 l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 40 IQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp CC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred ccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 55566889999987554 5889988652 2344455555555431 12333332 11345678899999998
Q ss_pred CCHH--------------HHHhhcCCCC--C-C-----CCCCHHH-------------------------------HHHH
Q 036471 406 GSLE--------------KFIYRNSSSI--E-N-----HKLTWET-------------------------------LLQI 432 (516)
Q Consensus 406 gsL~--------------~~l~~~~~~~--~-~-----~~l~~~~-------------------------------~~~i 432 (516)
.++. ..++...... . . ..-.|.. +..+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6542 1122211100 0 0 0112221 1111
Q ss_pred HHHHHHHHHHHhc----------CCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 433 AVGIARGLEYLHL----------GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 433 ~~~i~~aL~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
..++..++++|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 2234445666652 1257899999999999998888999999998853
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.86 E-value=4.3e-05 Score=73.76 Aligned_cols=70 Identities=9% Similarity=0.183 Sum_probs=44.6
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEec-CCCCH
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFV-SNGSL 408 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~gsL 408 (516)
+.|+.|....+|+. +.+++|+.........+..+|+..++.+....+ .++++. +.+..++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45888889999998 668899886543333344678877776642222 455554 344467899999 66444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00014 Score=70.34 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=91.6
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccC---CcceeeEEEEEeecCeeEEEEEecCCCCHH
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS---HVNVVTLLGFCFEGRRRALIYEFVSNGSLE 409 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 409 (516)
.|+.|....+|+... +++.+++|+.... ....+.+|.+.|+.+. ...+++++.+....+..++||||+++..+.
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 478899999999986 5778999987643 2466888988888873 367889999888888899999999987641
Q ss_pred --------H---HHhhcCC-CCC---------------CCCCCHHHHH---HHH----------------HHHHHHH-HH
Q 036471 410 --------K---FIYRNSS-SIE---------------NHKLTWETLL---QIA----------------VGIARGL-EY 442 (516)
Q Consensus 410 --------~---~l~~~~~-~~~---------------~~~l~~~~~~---~i~----------------~~i~~aL-~~ 442 (516)
+ .|++... ..- .-.-+|.... ++. .+++..+ ..
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 1 2333221 000 0012344321 111 1112122 23
Q ss_pred Hh-cCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 443 LH-LGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 443 LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
|. ......++|+|+.+.|++++.++ +.|+|+.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 42 12356799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00051 Score=65.64 Aligned_cols=72 Identities=24% Similarity=0.322 Sum_probs=52.9
Q ss_pred hhcccCCcEEEEEEEECCCCEEEEEEeecCC-CCchhHHHHHHHhhccCC---cceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 332 YKLGQGGYGSVYKGKLIDGSNVAVKVLNDSK-GNGEEFINEVASISRTSH---VNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+.+|.|..+.||+.+..+|+.|++|+..... .....+.+|+..|+.+.. -.+++++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 3478899999999999999999999876443 233567889998887742 235566654 23478999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0004 Score=67.85 Aligned_cols=143 Identities=14% Similarity=0.101 Sum_probs=74.9
Q ss_pred cccCCcEE-EEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCC--cceeeEEEEEeecCeeEEEEEecCCCCHHH
Q 036471 334 LGQGGYGS-VYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSH--VNVVTLLGFCFEGRRRALIYEFVSNGSLEK 410 (516)
Q Consensus 334 ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 410 (516)
|+.|.... +|+....+++.+++|...... .+++..|+.++..+.. -.+.+++.+..+. .+++||++.+.++.+
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFTE 101 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchHH
Confidence 54554444 667765447778887654432 1345566666666532 3356677653333 378999998777765
Q ss_pred HHhhcC-------------------CCCC-CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---cCC
Q 036471 411 FIYRNS-------------------SSIE-NHKLTWETLL-------Q-------------IAVGIARGLEYLH---LGC 447 (516)
Q Consensus 411 ~l~~~~-------------------~~~~-~~~l~~~~~~-------~-------------i~~~i~~aL~~LH---~~~ 447 (516)
.+.... .... ...++..... . ....+...++.|. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 443210 0000 0112221110 0 0011222223331 112
Q ss_pred CCCeeeCCCCCCcEEECCC----CcEEEeecCCcccc
Q 036471 448 STRILHFDIKPHNILLDED----FCPKISDFGLAKIC 480 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~ 480 (516)
...++|+|+++.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 68999999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00052 Score=66.84 Aligned_cols=143 Identities=15% Similarity=0.141 Sum_probs=82.8
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCc--ceeeEEEE-----EeecCeeEEEEEecCCC
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHV--NVVTLLGF-----CFEGRRRALIYEFVSNG 406 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~e~~~~g 406 (516)
++ |....||+....+|+.+++|...........+..|..++..+... .+++++.. ....+..+++|||++|.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 44 677789998877788899999875444556777888887777422 23444432 12245667899999875
Q ss_pred CHH-----------HH---HhhcCCCC---CCCCCCHHHH----------------------HHHHHHHHHHHHHHhc-C
Q 036471 407 SLE-----------KF---IYRNSSSI---ENHKLTWETL----------------------LQIAVGIARGLEYLHL-G 446 (516)
Q Consensus 407 sL~-----------~~---l~~~~~~~---~~~~l~~~~~----------------------~~i~~~i~~aL~~LH~-~ 446 (516)
++. +. ++...... .....++... ...+.+++..++-+.. .
T Consensus 113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 192 (328)
T 1zyl_A 113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 192 (328)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 431 11 12111000 0111222211 1112222222222211 1
Q ss_pred CCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 447 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 246789999999999999 4 899999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0004 Score=70.33 Aligned_cols=32 Identities=13% Similarity=0.272 Sum_probs=28.6
Q ss_pred CCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
...++|+|++|.|||++.++ ++|+||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 78899999999999998876 999999988653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00022 Score=71.02 Aligned_cols=143 Identities=14% Similarity=0.139 Sum_probs=83.5
Q ss_pred hcccCCcEEEEEEEEC--------CCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEec
Q 036471 333 KLGQGGYGSVYKGKLI--------DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+..|-...+|+.... +++.+++|+..........+.+|..+++.+. +.-..++++.+.+ .+||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 3656777788998864 2578999987443334567778999888774 2223566766543 2999999
Q ss_pred CCCCHH--------------HHH---hhcCCCCCCCCC-CHHHHHHHHHHHHH-------------------HHHHHh--
Q 036471 404 SNGSLE--------------KFI---YRNSSSIENHKL-TWETLLQIAVGIAR-------------------GLEYLH-- 444 (516)
Q Consensus 404 ~~gsL~--------------~~l---~~~~~~~~~~~l-~~~~~~~i~~~i~~-------------------aL~~LH-- 444 (516)
+|.+|. +.| +........... -+.++.++..++.. .+..|.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 875542 111 111111111111 24555555544322 233332
Q ss_pred --c-CCCCCeeeCCCCCCcEEECCC----CcEEEeecCCccc
Q 036471 445 --L-GCSTRILHFDIKPHNILLDED----FCPKISDFGLAKI 479 (516)
Q Consensus 445 --~-~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 479 (516)
. .....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123468999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00045 Score=70.57 Aligned_cols=72 Identities=14% Similarity=0.058 Sum_probs=47.5
Q ss_pred hcccCCcEEEEEEEECC-CCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCCCCH
Q 036471 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
.|+.|-...+|+....+ +..+++|+........-+..+|..++..+...++ .++++.+. + .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 47778889999998865 4788999875433222233688888888865444 56777653 2 259999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00025 Score=70.54 Aligned_cols=71 Identities=14% Similarity=0.139 Sum_probs=43.8
Q ss_pred hcccCCcEEEEEEEECC---------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcc-eeeEEEEEeecCeeEEEEEe
Q 036471 333 KLGQGGYGSVYKGKLID---------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVN-VVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~ 402 (516)
.|+.|....+|+....+ ++.+++|+.........+...|..++..+...+ ..++++.. . -++||||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 46677778999998754 278999987543222223467888888774333 44666543 2 3689999
Q ss_pred cCCCC
Q 036471 403 VSNGS 407 (516)
Q Consensus 403 ~~~gs 407 (516)
++|.+
T Consensus 116 i~G~~ 120 (369)
T 3c5i_A 116 LYGDP 120 (369)
T ss_dssp CCSEE
T ss_pred ecCCc
Confidence 98754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.001 Score=67.51 Aligned_cols=70 Identities=13% Similarity=0.230 Sum_probs=48.3
Q ss_pred hcccCCcEEEEEEEECC--------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEec
Q 036471 333 KLGQGGYGSVYKGKLID--------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~ 403 (516)
.|+.|....+|+....+ ++.+++|+.... ...+.+.+|..++..+...++ +++++.+.+ .+|+||+
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 47778889999998753 578999988432 122567789998888743333 567765432 3899999
Q ss_pred CCCC
Q 036471 404 SNGS 407 (516)
Q Consensus 404 ~~gs 407 (516)
+|.+
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 8633
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00081 Score=65.24 Aligned_cols=145 Identities=16% Similarity=0.157 Sum_probs=79.6
Q ss_pred hcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcc--eeeEEEE------EeecCeeEEEEEecC
Q 036471 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVN--VVTLLGF------CFEGRRRALIYEFVS 404 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~~~ 404 (516)
.|+.|....+|+....+| .+++|..... ...+.+..|+.++..+.... +.+++.. ....+..+++++|++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 366687889999987555 6889988652 23345667777777663222 2333321 122456789999998
Q ss_pred CCCHH-----------H---HHhhcCCCCCCC---CC---CHHHHHH------------HHHHHHHHHHHHhc----CCC
Q 036471 405 NGSLE-----------K---FIYRNSSSIENH---KL---TWETLLQ------------IAVGIARGLEYLHL----GCS 448 (516)
Q Consensus 405 ~gsL~-----------~---~l~~~~~~~~~~---~l---~~~~~~~------------i~~~i~~aL~~LH~----~~~ 448 (516)
|..+. + .++......... .. .|...+. +...+.+.++.++. ...
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 86531 1 122211100000 01 1221110 01123444555542 124
Q ss_pred CCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 449 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
.+++|+|+++.|||++++..+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5799999999999998876668999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0046 Score=60.51 Aligned_cols=33 Identities=21% Similarity=0.272 Sum_probs=28.6
Q ss_pred CCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 448 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
...++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 357999999999999998888999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.022 Score=57.28 Aligned_cols=142 Identities=13% Similarity=0.181 Sum_probs=84.2
Q ss_pred hcccCCcEEEEEEEECC--------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcc-eeeEEEEEeecCeeEEEEEec
Q 036471 333 KLGQGGYGSVYKGKLID--------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVN-VVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+..|-...+|+....+ ++.+++|+........-+..+|..+++.+...+ ..++++.+ . -++|+||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 46667778899998753 588999987543333344567888888774222 34556533 2 37899999
Q ss_pred CCCCHH--------------HHHh---hcCC-----CC--CCCCCCHHHHHHHHHHH-------------------HHHH
Q 036471 404 SNGSLE--------------KFIY---RNSS-----SI--ENHKLTWETLLQIAVGI-------------------ARGL 440 (516)
Q Consensus 404 ~~gsL~--------------~~l~---~~~~-----~~--~~~~l~~~~~~~i~~~i-------------------~~aL 440 (516)
+|.+|. +.|. .... +. ...+.-+.++.++..++ ...+
T Consensus 153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~ 232 (424)
T 3mes_A 153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI 232 (424)
T ss_dssp CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence 986531 1111 1000 00 11122244444444332 2223
Q ss_pred HHHhc---------------------CCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 441 EYLHL---------------------GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 441 ~~LH~---------------------~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
.+|.. .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 33321 11345899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.99 E-value=0.18 Score=50.32 Aligned_cols=30 Identities=30% Similarity=0.305 Sum_probs=25.4
Q ss_pred CeeeCCCCCCcEEE------CCCCcEEEeecCCccc
Q 036471 450 RILHFDIKPHNILL------DEDFCPKISDFGLAKI 479 (516)
Q Consensus 450 ~ivH~dlkp~NIll------~~~~~~kl~Dfg~a~~ 479 (516)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.25 Score=31.78 Aligned_cols=26 Identities=15% Similarity=0.406 Sum_probs=10.2
Q ss_pred hhHHHHHHHHHHHHHHH-HHhhhhccc
Q 036471 266 LGLGLGGGSIVLIALLS-FWIMFYRKF 291 (516)
Q Consensus 266 ~~i~i~~~~~~li~~~~-~~~~~~~k~ 291 (516)
++.++++++++++++.. ++++++||+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 33444444444333333 334444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.56 E-value=0.3 Score=31.28 Aligned_cols=26 Identities=27% Similarity=0.418 Sum_probs=10.3
Q ss_pred hhHHHHHHHHHHHHHHH-HHhhhhccc
Q 036471 266 LGLGLGGGSIVLIALLS-FWIMFYRKF 291 (516)
Q Consensus 266 ~~i~i~~~~~~li~~~~-~~~~~~~k~ 291 (516)
++.++++++++++++.. ++++++||+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 33444444444333333 334444433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.97 E-value=0.92 Score=40.67 Aligned_cols=84 Identities=14% Similarity=0.176 Sum_probs=61.1
Q ss_pred CCcceeeEEEEEeecCeeEEEEEecCCC-CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeeCCC
Q 036471 379 SHVNVVTLLGFCFEGRRRALIYEFVSNG-SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE-YLHLGCSTRILHFDI 456 (516)
Q Consensus 379 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~-~LH~~~~~~ivH~dl 456 (516)
.||.+ -..+-.+++.+.+.++.-+++ ++. .+ ..++...+++++..|+.... +++ .-+|--|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEE
Confidence 67777 334446677777777765333 444 33 35788899999998887766 444 5678899
Q ss_pred CCCcEEECCCCcEEEeecCCccc
Q 036471 457 KPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 457 kp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|+||+++.++.+++.-.|+-..
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTT
T ss_pred eCceEEEeCCCcEEEEEcCCccc
Confidence 99999999999999988876543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.16 E-value=0.72 Score=41.23 Aligned_cols=86 Identities=14% Similarity=0.174 Sum_probs=62.7
Q ss_pred cCCcceeeEEEEEeecCeeEEEEEecC-CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 036471 378 TSHVNVVTLLGFCFEGRRRALIYEFVS-NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDI 456 (516)
Q Consensus 378 l~h~nIv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dl 456 (516)
..||+++.. .+-.+++.+.+.++.-+ .-++.. + ..++....++++..|+...++++ .=+|--|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L 105 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVL 105 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCC
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEE
Confidence 368888865 45556666666665543 223333 2 45788999999999998886555 4578899
Q ss_pred CCCcEEECCCCcEEEeecCCccc
Q 036471 457 KPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 457 kp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
+|+||+++.++.+++.--|+-..
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~ 128 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNV 128 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTT
T ss_pred ecceEEEcCCCCEEEEEccCccC
Confidence 99999999999999998876443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.57 E-value=1.5 Score=28.03 Aligned_cols=7 Identities=29% Similarity=0.434 Sum_probs=2.7
Q ss_pred Hhhhhcc
Q 036471 284 WIMFYRK 290 (516)
Q Consensus 284 ~~~~~~k 290 (516)
.++++||
T Consensus 32 ~~~~RRR 38 (44)
T 2jwa_A 32 GILIKRR 38 (44)
T ss_dssp HHHHHHH
T ss_pred Hhheehh
Confidence 3334443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 516 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-52
Identities = 60/188 (31%), Positives = 98/188 (52%), Gaps = 15/188 (7%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNG---EEFINEVASISRTSHVNVVTLLGF 389
++G G +G+VYKGK +VAVK+LN + + F NEV + +T HVN++ +G+
Sbjct: 15 RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ A++ ++ SL ++ K L+ IA A+G++YLH
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CRNI 508
I+H D+K +NI L ED KI DFGLA + +R G++ ++APEV ++
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 509 GEVSYKSD 516
S++SD
Sbjct: 184 NPYSFQSD 191
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-47
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 11/187 (5%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
F ++G G +G V+ G ++ VA+K + + + E+FI E + + SH +V L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
C E L++EF+ +G L ++ ETLL + + + G+ YL
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYL---EEA 120
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
++H D+ N L+ E+ K+SDFG+ + + S G + V + +PEVF
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF--S 177
Query: 510 EVSYKSD 516
S KSD
Sbjct: 178 RYSSKSD 184
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-47
Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 11/187 (5%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
F +LG G +G V GK +VA+K++ + + +EFI E + SH +V L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
C + R +I E+++NG L ++ H+ + LL++ + +EYL S
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+ LH D+ N L+++ K+SDFGL++ E S G++ V + PEV
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMY--S 176
Query: 510 EVSYKSD 516
+ S KSD
Sbjct: 177 KFSSKSD 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+LG G +G V+ G + VAVK L + + F+ E + + H +V L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 393 GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRIL 452
+I E++ NGSL F+ KLT LL +A IA G+ ++ +
Sbjct: 80 EPIY-IITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 453 HFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVS 512
H D++ NIL+ + KI+DFGLA++ E + GA+ + + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--GTFT 188
Query: 513 YKSD 516
KSD
Sbjct: 189 IKSD 192
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 2e-45
Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 21/190 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
++G G +G+VY + + + VA+K ++ S E I EV + + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G L+ E+ + + L + + G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF-CR 506
S ++H D+K NILL E K+ DFG A I S + GT ++APEV
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAM 186
Query: 507 NIGEVSYKSD 516
+ G+ K D
Sbjct: 187 DEGQYDGKVD 196
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-45
Identities = 49/195 (25%), Positives = 88/195 (45%), Gaps = 19/195 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G V++GK G VAVK+ + + E+ H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 393 GRRRA----LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC- 447
L+ ++ +GSL ++ R + +T E ++++A+ A GL +LH+
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 448 ----STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMTGARGTVGYIAP 501
I H D+K NIL+ ++ I+D GLA + I+ GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 502 EVFCRNIGEVSYKSD 516
EV +I ++S
Sbjct: 182 EVLDDSINMKHFESF 196
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-44
Identities = 42/187 (22%), Positives = 82/187 (43%), Gaps = 17/187 (9%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVTLLGF 389
+LG G G V+K G +A K+++ + I E+ + + +V G
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ ++ E + GSL++ + + ++ + L ++++ + +GL YL
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH-- 124
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+I+H D+KP NIL++ K+ DFG++ + GT Y++PE
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQG--T 178
Query: 510 EVSYKSD 516
S +SD
Sbjct: 179 HYSVQSD 185
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 11/187 (5%)
Query: 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+ KLGQG +G V+ G + VA+K L + E F+ E + + H +V L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
++ E++S GSL F+ L L+ +A IA G+ Y+
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVE---RM 132
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
+H D++ NIL+ E+ K++DFGLA++ E + GA+ + + APE G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--G 189
Query: 510 EVSYKSD 516
+ KSD
Sbjct: 190 RFTIKSD 196
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 1e-43
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 312 SLAPRRYSYAD--IKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEF 368
++ P +Y +++ + K+KLG G YG VY+G VAVK L + EEF
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 369 INEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWET 428
+ E A + H N+V LLG C +I EF++ G+L ++ + +++
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN----RQEVSAVV 116
Query: 429 LLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488
LL +A I+ +EYL +H D+ N L+ E+ K++DFGL+++ ++ +
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 172
Query: 489 MTGARGTVGYIAPEVFCRNIGEVSYKS 515
GA+ + + APE + S KS
Sbjct: 173 HAGAKFPIKWTAPESLAY--NKFSIKS 197
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 317 RYSYADIKKMTNSFKY-----------KLGQGGYGSVYKGKLIDGSN------VAVKVLN 359
Y Y D ++ K+ LG G +G V S VAVK+L
Sbjct: 17 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76
Query: 360 DSKGNGE--EFINEVASISR-TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIY--- 413
+ + E ++E+ +++ SH N+V LLG C LI+E+ G L ++
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 414 --------------RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459
R + + LT+E LL A +A+G+E+L +H D+
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193
Query: 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
N+L+ KI DFGLA+ + + AR V ++APE G + KSD
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSD 248
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
+LG G +G VYK + + A KV++ S+ E+++ E+ ++ H N+V LL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ ++ EF + G+++ + LT + + L YLH +
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLEL-----ERPLTESQIQVVCKQTLDALNYLH---DNK 130
Query: 451 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF---CRN 507
I+H D+K NIL D K++DFG++ R GT ++APEV
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSK 188
Query: 508 IGEVSYKSD 516
YK+D
Sbjct: 189 DRPYDYKAD 197
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-43
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 17/185 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE 392
+G+G +G V G G+ VAVK + + + F+ E + +++ H N+V LLG E
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 393 GRRR-ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+ ++ E+++ GSL ++ L + LL+ ++ + +EYL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 452 LHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEV 511
+H D+ N+L+ ED K+SDFGL K + + + V + APE +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE--KKF 177
Query: 512 SYKSD 516
S KSD
Sbjct: 178 STKSD 182
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-43
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 14/195 (7%)
Query: 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVT 385
Y +G G YG K + DG + K L+ ++ + ++EV + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 386 LLGFCFE--GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
+ ++ E+ G L I + + E L E +L++ + L+
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKEC 125
Query: 444 HL--GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
H +LH D+KP N+ LD K+ DFGLA+I N S GT Y++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSP 183
Query: 502 EVFCRNIGEVSYKSD 516
E R + KSD
Sbjct: 184 EQMNR--MSYNEKSD 196
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 2e-42
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 318 YSYADIKKMTNSFKY-----------KLGQGGYGSVYKGKLIDGSN----VAVKVLND-- 360
+++ D + F +G G +G V G L VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 361 SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIE 420
++ +F++E + + + H NV+ L G + +I EF+ NGSL+ F+ +N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----- 121
Query: 421 NHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480
+ + T L+ + GIA G++YL +H D+ NIL++ + K+SDFGL++
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 481 NRKESIISMT---GARGTVGYIAPEVFCRNIGEVSYKSD 516
S + T G + + + APE + + SD
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASD 215
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 6e-42
Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 20/189 (10%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLL 387
LG+G +G+VY + +A+KVL ++ + EV S H N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G+ + R LI E+ G++ + + + S K + +A L Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCH--- 123
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S R++H DIKP N+LL KI+DFG + T GT+ Y+ PE+
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG- 178
Query: 508 IGEVSYKSD 516
K D
Sbjct: 179 -RMHDEKVD 186
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-42
Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 23/196 (11%)
Query: 330 FKYKLGQGGYGSVYKGKLID-GSNVAVKVLND---SKGNGEEFINEVASISRTSHVNVVT 385
F ++G+G + +VYKG + VA L D +K + F E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 386 LLGFCFEGRRR----ALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ L+ E +++G+L+ ++ R + + L I +GL+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR------FKVMKIKVLRSWCRQILKGLQ 126
Query: 442 YLHLGCSTRILHFDIKPHNILL-DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
+LH + I+H D+K NI + KI D GLA + GT ++A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMA 181
Query: 501 PEVFCRNIGEVSYKSD 516
PE++ + D
Sbjct: 182 PEMYE---EKYDESVD 194
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 331 KYKLGQGGYGSVYKGKLIDGSN---VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
+LG G +GSV +G VA+KVL K + EE + E + + + +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
L+G C + L+ E G L KF+ ++ + ++ ++ G++YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE- 126
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES-IISMTGARGTVGYIAPEVF 504
+H D+ N+LL KISDFGL+K +S + + + + + APE
Sbjct: 127 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 505 CRNIGEVSYKSD 516
+ S +SD
Sbjct: 185 NF--RKFSSRSD 194
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 2e-41
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 328 NSFKY--KLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGNG--EEFINEVASISR 377
N+ +Y +G+G +G V++ + + VAVK+L + +F E A ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 378 TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS------------------SSI 419
+ N+V LLG C G+ L++E+++ G L +F+ S SS
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 420 ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479
L+ L IA +A G+ YL + +H D+ N L+ E+ KI+DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
+ + + ++ PE N + +SD
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESD 224
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-41
Identities = 56/187 (29%), Positives = 78/187 (41%), Gaps = 13/187 (6%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG--EEFINEVASISRTSHVNVVTLLGF 389
LG+G YG V + VAVK+++ + E E+ +H NVV G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
EG + L E+ S G L I + + + + G+ YLH
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLH---GI 122
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
I H DIKP N+LLDE KISDFGLA + + GT+ Y+APE+ R
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181
Query: 510 EVSYKSD 516
+ D
Sbjct: 182 FHAEPVD 188
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-41
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 320 YADIKKMTNSFKYKLGQGGYGSVYKGKLID---GSNVAVKVLNDSKGNG---EEFINEVA 373
Y D K +T K +LG G +G+V KG VAVK+L + + +E + E
Sbjct: 2 YLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 374 SISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIA 433
+ + + +V ++G C E L+ E G L K++ +N + + ++++
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELV 113
Query: 434 VGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGA 492
++ G++YL + +H D+ N+LL KISDFGL+K + + + T
Sbjct: 114 HQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 493 RGTVGYIAPEVFCRNIGEVSYKSD 516
+ V + APE + S KSD
Sbjct: 171 KWPVKWYAPECINY--YKFSSKSD 192
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-41
Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 27/224 (12%)
Query: 308 RNHGSLAPRRYSYAD---IKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVL 358
N+ + P + Y + SF LG G +G V + VAVK+L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 359 NDSKGNG--EEFINEVASISR-TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRN 415
S E ++E+ +S +H+N+V LLG C G +I E+ G L F+ R
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 416 SSSI------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILL 463
S + L E LL + +A+G+ +L S +H D+ NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178
Query: 464 DEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
KI DFGLA+ + + AR V ++APE
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-39
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 301 LNIETFLRNHGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSN----VAVK 356
++I+ N + ++ + F +G+G +G VY G L+D AVK
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 357 VLNDSKGNGE--EFINEVASISRTSHVNVVTLLGFCFEGRRRA-LIYEFVSNGSLEKFIY 413
LN GE +F+ E + SH NV++LLG C ++ ++ +G L FI
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 414 RNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473
E H T + L+ + +A+G+ S + +H D+ N +LDE F K++D
Sbjct: 122 N-----ETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVAD 173
Query: 474 FGLAKICNRKE--SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
FGLA+ KE S+ + TGA+ V ++A E + + KSD
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSD 216
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 1e-38
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN-DSKGNGEEFINEVASISRTSHVNVVTLLGFC 390
K+GQG G+VY + G VA++ +N + E INE+ + + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
G ++ E+++ GSL + + + + + LE+LH S +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 451 ILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGE 510
++H DIK NILL D K++DFG ++S + GT ++APEV R
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR--KA 192
Query: 511 VSYKSD 516
K D
Sbjct: 193 YGPKVD 198
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 315 PRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLIDGSN---VAVKVLND--SKGNGEEFI 369
P Y D + F+ +G+G +G V K ++ A+K + + SK + +F
Sbjct: 1 PTIYPVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 370 NEVASISR-TSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS----------SS 418
E+ + + H N++ LLG C L E+ +G+L F+ ++ ++
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 419 IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
L+ + LL A +ARG++YL + +H D+ NIL+ E++ KI+DFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
E + T R V ++A E + SD
Sbjct: 176 GQ---EVYVKKTMGRLPVRWMAIESLNY--SVYTTNSD 208
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-38
Identities = 52/191 (27%), Positives = 88/191 (46%), Gaps = 18/191 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN-----VAVKVLND--SKGNGEEFINEVASISRTSHVNVVT 385
LG G +G+VYKG I VA+K L + S +E ++E ++ + +V
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LLG C + LI + + G L ++ + + + LL V IA+G+ YL
Sbjct: 76 LLGICLTSTVQ-LITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYL-- 127
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
R++H D+ N+L+ KI+DFGLAK+ +E G + + ++A E
Sbjct: 128 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 506 RNIGEVSYKSD 516
+++SD
Sbjct: 187 H--RIYTHQSD 195
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-37
Identities = 52/191 (27%), Positives = 96/191 (50%), Gaps = 18/191 (9%)
Query: 334 LGQGGYGSVYKGKLIDGSN-----VAVKVLNDSKGNGE--EFINEVASISRTSHVNVVTL 386
+G G +G VYKG L S VA+K L + +F+ E + + SH N++ L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G + + +I E++ NG+L+KF+ + + + L+ + GIA G++YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMKYLA-- 127
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC-NRKESIISMTGARGTVGYIAPEVFC 505
+ +H D+ NIL++ + K+SDFGL+++ + E+ + +G + + + APE
Sbjct: 128 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 506 RNIGEVSYKSD 516
+ + SD
Sbjct: 187 Y--RKFTSASD 195
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (352), Expect = 1e-37
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 17/188 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG-EEFINEVASISRTSHVNVVTLLGFC 390
+LG G +G V++ G+N A K + + E E+ ++S H +V L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ +IYEF+S G L + + E++K++ + ++ + +GL ++H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMH---ENN 144
Query: 451 ILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+H D+KP NI+ K+ DFGL + K+S+ TG + APEV
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG-- 199
Query: 509 GEVSYKSD 516
V Y +D
Sbjct: 200 KPVGYYTD 207
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-37
Identities = 50/189 (26%), Positives = 73/189 (38%), Gaps = 16/189 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
LG+G + +V + L A+K+L E E +SR H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ + + NG L K+I + I LEYLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLH--- 125
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
I+H D+KP NILL+ED +I+DFG AK+ + + GT Y++PE+
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 184
Query: 508 IGEVSYKSD 516
SD
Sbjct: 185 -KSACKSSD 192
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLNDSKGNG--EEFINEVASISRTSHVNVVTL 386
+G+G +G V++G + N VA+K + + E+F+ E ++ + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+G E +I E + G L F+ + L +L+ A ++ L YL
Sbjct: 74 IGVITENPVW-IIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLE-- 125
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S R +H DI N+L+ + C K+ DFGL++ + G + + ++APE
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESI-- 181
Query: 507 NIGEVSYKSD 516
N + SD
Sbjct: 182 NFRRFTSASD 191
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-37
Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 20/193 (10%)
Query: 333 KLGQGGYGSVYKGKLIDGSN----VAVKVLNDSKGNG----EEFINEVASISRTSHVNVV 384
KLG G +G V +G+ S VAVK L + ++FI EV ++ H N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L G + ++ E GSL + ++ TL + AV +A G+ YL
Sbjct: 75 RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK-ICNRKESIISMTGARGTVGYIAPEV 503
S R +H D+ N+LL KI DFGL + + + + + + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 504 FCRNIGEVSYKSD 516
S+ SD
Sbjct: 186 LKT--RTFSHASD 196
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-37
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 23/192 (11%)
Query: 333 KLGQGGYGSVYKG------KLIDGSNVAVKVLNDSKGNGE--EFINEVASISRTSH-VNV 383
LG+G +G V + K VAVK+L + + E ++E+ + H +NV
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 384 VTLLGFCFE-GRRRALIYEFVSNGSLEKFIYRNSSSIENHK----------LTWETLLQI 432
V LLG C + G +I EF G+L ++ + +K LT E L+
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 433 AVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGA 492
+ +A+G+E+L S + +H D+ NILL E KI DFGLA+ + + A
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 493 RGTVGYIAPEVF 504
R + ++APE
Sbjct: 197 RLPLKWMAPETI 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 8e-36
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 315 PRRYSYADIKKMTN--------SFKYKLGQGGYGSVYKGKL------IDGSNVAVKVLND 360
P +S AD+ + +LGQG +G VY+G + VA+K +N+
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 361 SKGNGE--EFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSS 418
+ E EF+NE + + + +VV LLG +G+ +I E ++ G L+ ++ +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 419 IENHK----LTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474
+ N+ + ++Q+A IA G+ YL + + +H D+ N ++ EDF KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 475 GLAKICNRKESIISMTGARGTVGYIAPEVF 504
G+ + + V +++PE
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (337), Expect = 1e-35
Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 15/179 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE-FINEVASISRTSHVNVVTLLGFC 390
+LG G +G V++ G K +N + NE++ +++ H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
+ LI EF+S G L I ++K++ ++ GL+++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMH---EHS 147
Query: 451 ILHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
I+H DIKP NI+ + KI DFGLA N E + T T + APE+ R
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 203
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-35
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 333 KLGQGGYGSVYKGKLI--------DGSNVAVKVLND--SKGNGEEFINEVASISR-TSHV 381
LG+G +G V + I + VAVK+L ++ + + I+E+ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYR----------NSSSIENHKLTWETLLQ 431
N++ LLG C + +I E+ S G+L +++ N S +L+ + L+
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 432 IAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTG 491
A +ARG+EYL S + +H D+ N+L+ ED KI+DFGLA+ + + T
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 492 ARGTVGYIAPEVFCRNIGEVSYKSD 516
R V ++APE +++SD
Sbjct: 197 GRLPVKWMAPEALFD--RIYTHQSD 219
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (326), Expect = 5e-34
Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 333 KLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEE-------FINEVASISRTSHVNVV 384
+G+GG+G VY + D G A+K L+ + ++ ++ +S +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
+ + + I + ++ G L + ++ + + A I GLE++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMH 124
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
+ +++ D+KP NILLDE +ISD GLA ++K+ S+ GT GY+APEV
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 177
Query: 505 CRNIGEVSYKSD 516
+ + +D
Sbjct: 178 QKGVA-YDSSAD 188
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (320), Expect = 6e-34
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 28/200 (14%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG----------EEFINEVASISRTS-H 380
LG+G V + AVK+++ + G E + EV + + S H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
N++ L L+++ + G L ++ L+ + +I + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVI 123
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
LH I+H D+KP NILLD+D K++DFG + + E + GT Y+A
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 177
Query: 501 PEVF----CRNIGEVSYKSD 516
PE+ N + D
Sbjct: 178 PEIIECSMNDNHPGYGKEVD 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-34
Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 10/181 (5%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN--DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
+G+G YG V ++ VA+K ++ + + + + E+ + R H N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+ ++ + +Y+ ++ L+ + + I RGL+Y+H S
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQILRGLKYIH---SA 128
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE-SIISMTGARGTVGYIAPEVFCRNI 508
+LH D+KP N+LL+ KI DFGLA++ + +T T Y APE+ +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 509 G 509
G
Sbjct: 189 G 189
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 1e-33
Identities = 51/190 (26%), Positives = 74/190 (38%), Gaps = 14/190 (7%)
Query: 330 FKYKLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE--FINEVASISRTSHVNVVTL 386
F+ LG G + V + VA+K + G+E NE+A + + H N+V L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
G LI + VS G L I T ++ + ++YLH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
LDED ISDFGL+K+ + ++ A GT GY+APEV +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 507 NIGEVSYKSD 516
S D
Sbjct: 184 --KPYSKAVD 191
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 16/187 (8%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
LG+G +G V++ K + + E++ ++ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+I+EF+S + + I + +L ++ + L++LH S I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 452 LHFDIKPHNILLDEDFCP--KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
HFDI+P NI+ KI +FG A+ + + Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH--D 178
Query: 510 EVSYKSD 516
VS +D
Sbjct: 179 VVSTATD 185
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (312), Expect = 7e-33
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 21/194 (10%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEE----FINEVASISRTSHVNVVTLL 387
LG GG V+ + L +VAVKVL F E + + +H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 388 GFCFE----GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYL 443
G ++ E+V +L ++ +T + +++ + L +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFS 127
Query: 444 HLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGAR-GTVGYIAPE 502
I+H D+KP NI++ K+ DFG+A+ + ++ T A GT Y++PE
Sbjct: 128 ---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 503 VFCRNIGEVSYKSD 516
V +SD
Sbjct: 185 QARG--DSVDARSD 196
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 6e-32
Identities = 46/190 (24%), Positives = 75/190 (39%), Gaps = 19/190 (10%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEE----FINEVASISRT-SHVNVVTL 386
LG+G +G V+ + A+K L ++ + E +S H + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 387 LGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG 446
+ E+++ G L I HK A I GL++L
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFL--- 119
Query: 447 CSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCR 506
S I++ D+K NILLD+D KI+DFG+ K ++ GT YIAPE+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177
Query: 507 NIGEVSYKSD 516
+ ++ D
Sbjct: 178 --QKYNHSVD 185
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-31
Identities = 59/215 (27%), Positives = 85/215 (39%), Gaps = 29/215 (13%)
Query: 310 HGSLAPRRYSYADIKKMTNSFKYKLGQGGYGSVYKGKLID-GSNVAVKVLNDSKGNGEEF 368
G P+ SY D K +G G +G VY+ KL D G VA+K + K
Sbjct: 12 QGPDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFK 60
Query: 369 INEVASISRTSHVNVVTLLGFCFEGRRR------ALIYEFVSNGSLEKFIYRNSSSIENH 422
E+ + + H N+V L F + + L+ ++V + +
Sbjct: 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR---AKQ 117
Query: 423 KLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICN 481
L + + R L Y+H S I H DIKP N+LLD D K+ DFG AK
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
R E +S +R Y APE+ + D
Sbjct: 175 RGEPNVSYICSR---YYRAPELIFGATD-YTSSID 205
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 46/192 (23%), Positives = 70/192 (36%), Gaps = 25/192 (13%)
Query: 334 LGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFC- 390
LG G G V + A+K+L D + EV R S ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75
Query: 391 ---FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ ++ E + G L I + T +I I ++YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 448 STRILHFDIKPHNILLDEDFCP---KISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S I H D+KP N+L K++DFG AK S+ + T Y+APEV
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVL 185
Query: 505 CRNIGEVSYKSD 516
+ D
Sbjct: 186 GP--EKYDKSCD 195
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 117 bits (293), Expect = 3e-30
Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 15/187 (8%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLGF 389
K+G+G YG VYK + G A+K + + +G I E++ + H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 390 CFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST 449
+R L++E + + L T + + G+ Y H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 450 RILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIG 509
R+LH D+KP N+L++ + KI+DFGLA+ T T+ Y AP+V +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-K 176
Query: 510 EVSYKSD 516
+ S D
Sbjct: 177 KYSTTID 183
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-30
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 333 KLGQGGYGSVYKGKLI--DGSNVAVKVLN---DSKGNGEEFINEVA---SISRTSHVNVV 384
++G+G YG V+K + + G VA+K + +G I EVA + H NVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
L C R + +++ + + + ET+ + + RGL++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 445 LGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVF 504
S R++H D+KP NIL+ K++DFGLA+I + + ++ S+ T+ Y APEV
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVL 187
Query: 505 CRNIGEVSYKSD 516
+ + D
Sbjct: 188 LQ--SSYATPVD 197
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (291), Expect = 8e-30
Identities = 32/195 (16%), Positives = 73/195 (37%), Gaps = 22/195 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
++G+G +G +++G L++ VA+K + + + +E + + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 392 EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRI 451
+ ++ + SLE + K + +T+ A + ++ +H +
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIH---EKSL 122
Query: 452 LHFDIKPHNILLDEDFCP-----KISDFGLAKICNRKES-----IISMTGARGTVGYIAP 501
++ DIKP N L+ + DFG+ K + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 502 EVFCRNIGEVSYKSD 516
E S + D
Sbjct: 183 NTHLGR--EQSRRDD 195
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (290), Expect = 2e-29
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 21/189 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLL 387
LG G +G V+ + +G A+KVL E +E +S +H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
G + ++ +I +++ G L + ++ + A + LEYLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLH--- 121
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S I++ D+KP NILLD++ KI+DFG AK GT YIAPEV
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST- 175
Query: 508 IGEVSYKSD 516
+ D
Sbjct: 176 -KPYNKSID 183
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 19/191 (9%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNG------EEFINEVASISRTSHVNVVT 385
LG+G + +VYK + VA+K + + + E+ + SH N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 386 LLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHL 445
LL +L+++F+ + LT + + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLH- 117
Query: 446 GCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFC 505
ILH D+KP+N+LLDE+ K++DFGLAK + T T Y APE+
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLF 173
Query: 506 RNIGEVSYKSD 516
D
Sbjct: 174 GARM-YGVGVD 183
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 6e-29
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 22/194 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCF 391
K+G G +G +Y G + G VA+K+ + + E + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 392 -EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR 450
EG ++ E + + F + + K + +T+L +A + +EY+H S
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 451 ILHFDIKPHNIL---LDEDFCPKISDFGLAKICNRKES-----IISMTGARGTVGYIAPE 502
+H D+KP N L + I DFGLAK + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 503 VFCRNIGEVSYKSD 516
E S + D
Sbjct: 184 THLG--IEQSRRDD 195
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-28
Identities = 46/183 (25%), Positives = 64/183 (34%), Gaps = 23/183 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSK-------GNGEEFINEVASISRTS--HVN 382
LG GG+GSVY G + D VA+K + + NG EV + + S
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
V+ LL + LI E E L E + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRH 125
Query: 443 LHLGCSTRILHFDIKPHNILLDED-FCPKISDFGLAKICNRKESIISMTGARGTVGYIAP 501
+ +LH DIK NIL+D + K+ DFG + T GT Y P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178
Query: 502 EVF 504
E
Sbjct: 179 EWI 181
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-28
Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 15/188 (7%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG VYK + + G VA+K + +++G I E++ + +H N+V LL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ L++EF+ + L+KF+ + + + + +GL + S
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFC---HS 120
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
R+LH D+KP N+L++ + K++DFGLA+ T T+ Y APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGC- 177
Query: 509 GEVSYKSD 516
S D
Sbjct: 178 KYYSTAVD 185
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 51/189 (26%), Positives = 75/189 (39%), Gaps = 18/189 (9%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN----DSKGNGEEFINEVASISRTSHVNVVTLL 387
LG+G +G V + G A+K+L +K + E + T H + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
R + E+ + G L + R T E I LEYLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH--- 122
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S +++ DIK N++LD+D KI+DFGL K + +M GT Y+APEV
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED- 179
Query: 508 IGEVSYKSD 516
+ D
Sbjct: 180 -NDYGRAVD 187
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 21/209 (10%)
Query: 318 YSYADIKKMTNSF--KY----KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEE 367
+ ++ K Y +G G YG+V G+ VA+K L S+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 368 FINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWE 427
E+ + H NV+ LL +F + +++ KL +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGED 121
Query: 428 TLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487
+ + + +GL Y+H + I+H D+KP N+ ++ED KI DFGLA+ + +
Sbjct: 122 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---- 174
Query: 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516
MTG T Y APEV N + D
Sbjct: 175 -MTGYVVTRWYRAPEVI-LNWMRYTQTVD 201
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 8e-28
Identities = 47/198 (23%), Positives = 81/198 (40%), Gaps = 24/198 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVL---NDSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+GQG +G V+K + G VA+K + N+ +G + E+ + H NVV L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 389 FCFEGRRRA--------LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGL 440
C L+++F + K T + ++ + GL
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 130
Query: 441 EYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES--IISMTGARGTVGY 498
Y+ +ILH D+K N+L+ D K++DFGLA+ + ++ T T+ Y
Sbjct: 131 YYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 499 IAPEVFCRNIGEVSYKSD 516
PE+ + D
Sbjct: 188 RPPELL-LGERDYGPPID 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 55/196 (28%), Positives = 79/196 (40%), Gaps = 26/196 (13%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG-------EEFINEVASISRTSHVNVV 384
+LG G + V K + G A K + + E+ EV+ + H NV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 385 TLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLH 444
TL LI E V+ G L F+ LT E + I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLH 130
Query: 445 LGCSTRILHFDIKPHNILLDEDFCP----KISDFGLAKICNRKESIISMTGARGTVGYIA 500
S +I HFD+KP NI+L + P KI DFGLA + GT ++A
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVA 184
Query: 501 PEVFCRNIGEVSYKSD 516
PE+ + ++D
Sbjct: 185 PEIVNY--EPLGLEAD 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 6e-27
Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 21/189 (11%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNG----EEFINEVASISRTSHVNVVTLL 387
LG G +G V K G++ A+K+L+ K E +NE + + +V L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 388 GFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC 447
+ ++ E+V+ G + + R + + A I EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLH--- 158
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S +++ D+KP N+L+D+ +++DFG AK + GT +APE+
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS- 212
Query: 508 IGEVSYKSD 516
+ D
Sbjct: 213 -KGYNKAVD 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 6e-26
Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFC 390
KLG+G Y V++ + + V VK+L ++ E+ + N++TL
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADIV 99
Query: 391 FE--GRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
+ R AL++E V+N ++ LT + I + L+Y H S
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCH---S 147
Query: 449 TRILHFDIKPHNILLDEDFCP-KISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
I+H D+KPHN+++D + ++ D+GLA+ + + + + PE+ +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL-LVD 203
Query: 508 IGEVSYKSD 516
Y D
Sbjct: 204 YQMYDYSLD 212
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 8e-26
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 16/188 (8%)
Query: 333 KLGQGGYGSVYKGKLI-DGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
K+G+G YG+V+K K VA+K + D +G + E+ + H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCS 448
++ L++EF + F N ++ + + L+ L S
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---------LFQLLKGLGFCHS 119
Query: 449 TRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNI 508
+LH D+KP N+L++ + K+++FGLA+ S T+ Y P+V
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV--VTLWYRPPDVLFGA- 176
Query: 509 GEVSYKSD 516
S D
Sbjct: 177 KLYSTSID 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 4e-23
Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 20/194 (10%)
Query: 333 KLGQGGYGSVYKGKLI----DGSNVAVKVLNDSKGNG-----EEFINEVASISRTSHV-N 382
LG G YG V+ + I G A+KVL + E E +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 383 VVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
+VTL + LI ++++ G L + + + T + I LE+
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEH 144
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
LH I++ DIK NILLD + ++DFGL+K E+ + GT+ Y+AP+
Sbjct: 145 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-CGTIEYMAPD 200
Query: 503 VFCRNIGEVSYKSD 516
+ D
Sbjct: 201 IVRGGDSGHDKAVD 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 6e-23
Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 16/196 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFC- 390
KLG G + +V+ K +++ ++VA+K++ K E +E+ + R + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 391 ---------FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
F + ++ + L + + E+ + + QI+ + GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 442 YLHLGCSTRILHFDIKPHNILLD-EDFCPKISDFGLAKICNRKESIISMTGARGTVGYIA 500
Y+H C I+H DIKP N+L++ D + +A + N T + T Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 501 PEVFCRNIGEVSYKSD 516
PEV +D
Sbjct: 198 PEVLLG--APWGCGAD 211
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 3e-22
Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 25/185 (13%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
+G G G V + NVA+K L+ ++ + + E+ + +H N+++LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 389 FCF------EGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEY 442
E + L+ E + + E + + + G+++
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---------HERMSYLLYQMLCGIKH 134
Query: 443 LHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPE 502
LH S I+H D+KP NI++ D KI DFGLA+ MT T Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188
Query: 503 VFCRN 507
V
Sbjct: 189 VILGM 193
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 2e-21
Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 17/189 (8%)
Query: 333 KLGQGGYGSVYKGK-LIDGSNVAVKVLN---DSKGNGEEFINEVASISRTSHVNVVTLLG 388
+G G YGSV G VAVK L+ S + + E+ + H NV+ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 389 FCFEGRRRALIYEFVSNGSLEKFIYRNSSSI-ENHKLTWETLLQIAVGIARGLEYLHLGC 447
R + EF + + + ++I + KLT + + + I RGL+Y+H
Sbjct: 85 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 448 STRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRN 507
S I+H D+KP N+ ++ED KI DFGLA+ + + MTG T Y APE+
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 193
Query: 508 IGEVSYKSD 516
+ D
Sbjct: 194 -MHYNQTVD 201
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 5e-19
Identities = 24/157 (15%), Positives = 47/157 (29%), Gaps = 24/157 (15%)
Query: 333 KLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-----------GEEFINEVASISRTSHV 381
+G+G +V+ VK + F +R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 382 NVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLE 441
+ L G Y + N L + I E +++ E ++ I +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVLMELIDAK----ELYRVRVENPDEVLDMILEEVA 117
Query: 442 YLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478
+ I+H D+ +N+L+ + I DF +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.98 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.98 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.98 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.89 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.54 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-39 Score=309.10 Aligned_cols=184 Identities=32% Similarity=0.517 Sum_probs=161.4
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEE
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
|....+.+.++||+|+||+||+|++. +++.||||+++.+....+++.+|+.++++++|||||++++++.+++..++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 44444556788999999999999986 48899999998877777899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.+++.+.. ...+++..++.++.||++||+||| +++|+||||||+||||++++.+||+|||+|+...
T Consensus 94 ~~~~g~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 94 FMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp CCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred cccCcchHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999997643 367999999999999999999999 8999999999999999999999999999998776
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......|++.|||||++.+ +.++.|+|
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~--~~~~~k~D 198 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAY--NKFSIKSD 198 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHH--CCCSHHHH
T ss_pred CCCce-eeccccccccccChHHHcC--CCCCchhh
Confidence 54432 2345568999999999955 67888876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=303.56 Aligned_cols=177 Identities=30% Similarity=0.546 Sum_probs=147.8
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
++.++||+|+||+||+|++.+++.||||+++......+++.+|++++++++|||||+++|++.+++..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 35678999999999999998899999999988777778999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.... ..++++.++.++.|+++||+||| +++|+||||||+||||++++.+||+|||+++.........
T Consensus 88 ~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~- 158 (263)
T d1sm2a_ 88 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS- 158 (263)
T ss_dssp HHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred HHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCcee-
Confidence 99987543 56899999999999999999999 8999999999999999999999999999998775543322
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ +.++.|+|
T Consensus 159 ~~~~~gt~~y~aPE~l~~--~~~~~k~D 184 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF--SRYSSKSD 184 (263)
T ss_dssp ------CTTSCCHHHHTT--CCCCHHHH
T ss_pred ecceecCcccCChHHhcC--CCCCchhh
Confidence 234578999999999955 67888877
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=303.14 Aligned_cols=179 Identities=31% Similarity=0.387 Sum_probs=152.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+++.++||+|+||+||+|+.+ +|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 345678999999999999985 58999999996532 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.+++++. ..+++.+++.++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 87 gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 87 GGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999998543 57999999999999999999999 8999999999999999999999999999998876554
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.........||+.|||||++.++ ..++.++|
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~D 188 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVD 188 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCS-SBCHHHHH
T ss_pred ccccccceeeCcCccCHhHhcCC-CCCCCcee
Confidence 43334567899999999999652 22356665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-38 Score=297.68 Aligned_cols=174 Identities=29% Similarity=0.411 Sum_probs=154.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||+||+|+.+ +++.||+|++.+ .....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456688999999999999986 588999999864 234457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.+. ..+++..+..++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999764 56999999999999999999999 89999999999999999999999999999986654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....||+.|||||++.+ ..++.++|
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~--~~~~~~~D 186 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEG--RMHDEKVD 186 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTT--CCCCTTHH
T ss_pred Ccc----cccCCCCcccCHHHHcC--CCCCchhh
Confidence 432 34679999999999965 57888887
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=304.21 Aligned_cols=179 Identities=31% Similarity=0.503 Sum_probs=156.0
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+++.++||+|+||+||+|++++++.||||+++......+++.+|+.++++++|||||++++++.+ +..++||||+++|
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 345667899999999999999888999999998777777899999999999999999999998754 5679999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|.+++.... ...+++..++.|+.||++||+||| +++|+||||||+||||++++.+||+|||+|+.+......
T Consensus 93 ~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 93 SLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp BHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred cHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999875432 246999999999999999999999 899999999999999999999999999999987654332
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|||||++.. +.++.++|
T Consensus 166 -~~~~~~gt~~y~APE~~~~--~~~~~~sD 192 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINY--GTFTIKSD 192 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHH--CEECHHHH
T ss_pred -cccccCCcccccChHHHhC--CCCCchhh
Confidence 2345678999999999954 67888876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=298.26 Aligned_cols=175 Identities=29% Similarity=0.427 Sum_probs=153.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 445578999999999999975 58999999997543 3457799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+ ..+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999998864 45899999999999999999999 89999999999999999999999999999987755433
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|||||++.+ +.++.++|
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~--~~~~~~~D 198 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTR--KAYGPKVD 198 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSS--SCBCTHHH
T ss_pred c--ccccccCCCccChhhhcC--CCCCchhc
Confidence 2 245679999999999965 67888876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=298.70 Aligned_cols=178 Identities=28% Similarity=0.395 Sum_probs=152.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.+.||+|+||+||+|+.+ +++.||||++++ .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 456788999999999999985 689999999964 234457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++... ..+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999998765 57999999999999999999999 89999999999999999999999999999988765
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...........||+.|||||++.+ ..++.++|
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~--~~~~~~~D 192 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTE--KSACKSSD 192 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--CCCCHHHH
T ss_pred CCcccccccccCCccccCceeecc--CCCCcccc
Confidence 543333345679999999999965 57788776
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=292.36 Aligned_cols=177 Identities=32% Similarity=0.527 Sum_probs=158.8
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
.+.++||+|+||+||+|++++++.||||+++......+++.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 35678999999999999998888999999998877889999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCccee
Q 036471 409 EKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESIIS 488 (516)
Q Consensus 409 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 488 (516)
.+++.... ..+++..+++++.|+++||+||| +++|+||||||+|||+++++.+||+|||+++.+...... .
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 87 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp HHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred HHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence 99986542 67899999999999999999999 899999999999999999999999999999877655433 2
Q ss_pred eccCCCCccccccccccccccccccCCC
Q 036471 489 MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 489 ~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.....||+.|+|||++.+ +.++.|+|
T Consensus 158 ~~~~~~t~~y~aPE~~~~--~~~~~ksD 183 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY--SKFSSKSD 183 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH--CCCCHHHH
T ss_pred ecccCCCCCcCCcHHhcC--CCCCccee
Confidence 345678999999999965 67888876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-38 Score=300.13 Aligned_cols=178 Identities=34% Similarity=0.556 Sum_probs=144.6
Q ss_pred HhhhhhcccCCcEEEEEEEECCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.+.++||+|+||+||+|+++ ..||||+++.. ....+.|.+|+.++++++|||||++++++. ++..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 345678999999999999864 46999999653 333468899999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+|+|.++++... ..+++..++.++.||++||+||| +++||||||||+||||+.++.+||+|||+|+......
T Consensus 87 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 87 GSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999997543 56999999999999999999999 8999999999999999999999999999998776554
Q ss_pred cceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
.........||+.|||||++..+ .+.++.++|
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sD 191 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHH
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhh
Confidence 43344567899999999998643 245787776
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-38 Score=306.87 Aligned_cols=175 Identities=24% Similarity=0.376 Sum_probs=152.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
.+.+.++||+|+||+||+|+.. +|+.||+|+++... ...+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3445578999999999999975 58999999997543 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCST-RILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
++|+|.+++.+. ..+++..+..++.|++.||+||| ++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 87 ~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 87 DGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999765 46999999999999999999999 64 899999999999999999999999999987644
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....||+.|||||++.+ ..++.++|
T Consensus 158 ~~~----~~~~GT~~Y~APEvl~~--~~y~~~~D 185 (322)
T d1s9ja_ 158 SMA----NSFVGTRSYMSPERLQG--THYSVQSD 185 (322)
T ss_dssp HTC-------CCSSCCCCHHHHHC--SCCCTTHH
T ss_pred Ccc----ccccCCccccCchHHcC--CCCCcHHH
Confidence 322 34689999999999965 67888887
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=296.60 Aligned_cols=179 Identities=27% Similarity=0.402 Sum_probs=153.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC-CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS-KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++.++||+|+||+||+|++. +++.||||+++.. ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 345678999999999999986 5899999999754 34557899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++.+.. ..+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 94 GAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999987643 56999999999999999999999 89999999999999999999999999999976543322
Q ss_pred ceeeccCCCCcccccccccccc---ccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRN---IGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~---~~~~s~~sD 516 (516)
......||+.|||||++..+ .+.++.++|
T Consensus 166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~D 197 (288)
T d2jfla1 166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197 (288)
T ss_dssp --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHH
T ss_pred --cccccccccccCCHHHHhhcccCCCCCChhhh
Confidence 12456799999999998532 245677766
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-37 Score=298.39 Aligned_cols=189 Identities=29% Similarity=0.502 Sum_probs=145.3
Q ss_pred ccHHHHHHHHHhh-----------hhhcccCCcEEEEEEEECC-C---CEEEEEEeecCCC--CchhHHHHHHHhhccCC
Q 036471 318 YSYADIKKMTNSF-----------KYKLGQGGYGSVYKGKLID-G---SNVAVKVLNDSKG--NGEEFINEVASISRTSH 380 (516)
Q Consensus 318 ~~~~el~~~~~~~-----------~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h 380 (516)
++++|+.+++.+| .+.||+|+||+||+|+++. + ..||||++..... ..++|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555565555544 3579999999999998753 3 2588998865432 34679999999999999
Q ss_pred cceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q 036471 381 VNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHN 460 (516)
Q Consensus 381 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~N 460 (516)
||||+++|++.+++..++||||+++|+|.+++.... ..+++.+++.++.||++||+||| +++|+||||||+|
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~N 158 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARN 158 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccce
Confidence 999999999999999999999999999999987542 56999999999999999999999 8999999999999
Q ss_pred EEECCCCcEEEeecCCcccccCCCccee---eccCCCCccccccccccccccccccCCC
Q 036471 461 ILLDEDFCPKISDFGLAKICNRKESIIS---MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 461 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||++++.+||+|||+|+.+........ .....||+.|||||++.+ +.++.++|
T Consensus 159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sD 215 (299)
T d1jpaa_ 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASD 215 (299)
T ss_dssp EEECTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHH
T ss_pred EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccc
Confidence 9999999999999999987765433221 123457999999999954 67888776
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=288.01 Aligned_cols=172 Identities=27% Similarity=0.416 Sum_probs=146.4
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEee----cCeeEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFE----GRRRALIY 400 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 400 (516)
++.++||+|+||+||+|++. +++.||+|++..... ..+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35567999999999999986 588999999875432 23578899999999999999999999875 34679999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEC-CCCcEEEeecCCc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTR--ILHFDIKPHNILLD-EDFCPKISDFGLA 477 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a 477 (516)
||+++|+|.+++++. ..+++..++.++.||++||+||| +++ |+||||||+||||+ +++.+||+|||+|
T Consensus 92 E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999764 56999999999999999999999 787 99999999999996 5789999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... ....||+.|||||++. +.++.++|
T Consensus 163 ~~~~~~~~----~~~~GT~~Y~aPE~~~---~~~~~~~D 194 (270)
T d1t4ha_ 163 TLKRASFA----KAVIGTPEFMAPEMYE---EKYDESVD 194 (270)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGG---TCCCTHHH
T ss_pred eeccCCcc----CCcccCccccCHHHhC---CCCCCcCc
Confidence 86543322 3467999999999984 35788776
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=294.06 Aligned_cols=183 Identities=28% Similarity=0.409 Sum_probs=139.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEee--cCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFE--GRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e 401 (516)
+++.+.||+|+||+||+|+.+ +|+.||+|+++..... .+.+.+|++++++++|||||++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 345678999999999999975 5899999999764332 3568899999999999999999999865 456899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGC--STRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|+++|+|.+++.+... ....+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 86 y~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 86 YCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp CCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred cCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999975421 2357999999999999999999999310 13499999999999999999999999999988
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... .....||+.|||||++.+ +.++.++|
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~--~~~~~~~D 196 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNR--MSYNEKSD 196 (269)
T ss_dssp C-------------CCCSCCCHHHHTT--CCCCHHHH
T ss_pred cccCCCc--cccCCCCcccCCHHHHcC--CCCChHHH
Confidence 7554322 245678999999999954 67888876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-36 Score=294.14 Aligned_cols=174 Identities=28% Similarity=0.395 Sum_probs=150.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+...++||+|+||+||+|+.. +++.||||+++..... .+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 445578999999999999975 5889999999764432 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|..++... ..+++.+++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+....
T Consensus 97 ~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 97 CLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred cCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999998776543 57999999999999999999999 89999999999999999999999999999986543
Q ss_pred CCcceeeccCCCCcccccccccccc-ccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRN-IGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~s~~sD 516 (516)
. ....||+.|||||++.+. .+.++.++|
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~D 196 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVD 196 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHH
T ss_pred C------CccccCccccCHHHHhccCCCCcCchhh
Confidence 3 345799999999998642 356787776
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=296.32 Aligned_cols=179 Identities=30% Similarity=0.495 Sum_probs=150.0
Q ss_pred HHhhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
.+++.+.||+|+||+||+|++++++.||||+++......+.|.+|+.++++++|||||++++++. ++..++||||+++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCC
Confidence 35567889999999999999988889999999877777789999999999999999999999985 45689999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcc
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESI 486 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 486 (516)
+|..++.... ...+++.+++.++.||+.||+||| .++|+||||||+||||++++.+||+|||+|+........
T Consensus 97 ~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 97 SLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp BHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred chhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999987642 256999999999999999999999 899999999999999999999999999999876544322
Q ss_pred eeeccCCCCccccccccccccccccccCCC
Q 036471 487 ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 487 ~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......||+.|+|||++.+ +.++.++|
T Consensus 170 -~~~~~~gt~~y~aPE~~~~--~~~~~ksD 196 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALY--GRFTIKSD 196 (285)
T ss_dssp -------CCGGGSCHHHHHH--CCCCHHHH
T ss_pred -eeccccccccccChHHHhC--CCCCcHHh
Confidence 2244678999999999955 67888876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-36 Score=294.40 Aligned_cols=176 Identities=29% Similarity=0.352 Sum_probs=155.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.+.||+|+||.||+|+.+ +|+.||+|++++. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 345678999999999999975 6899999999742 34557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++++|.+||+|||+|+....
T Consensus 87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999765 56899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....||+.|||||++.+ ..++.++|
T Consensus 158 ~~~~--~~~~~GT~~Y~aPE~~~~--~~y~~~~D 187 (337)
T d1o6la_ 158 DGAT--MKTFCGTPEYLAPEVLED--NDYGRAVD 187 (337)
T ss_dssp TTCC--BCCCEECGGGCCGGGGSS--SCBCTTHH
T ss_pred CCcc--cccceeCHHHhhhhhccC--CCCChhhc
Confidence 3322 245679999999999965 67888877
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-36 Score=290.81 Aligned_cols=173 Identities=29% Similarity=0.388 Sum_probs=153.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.++||+|+||+||+|+.+ +|+.||||++++ .....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 445688999999999999985 589999999964 234557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+++|+|..++... ..+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+....
T Consensus 86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999998754 56889999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....||+.|||||++.+ ..++.++|
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~--~~y~~~~D 183 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVST--KPYNKSID 183 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTT--CCBCTTHH
T ss_pred cc-----ccccCcccccCHHHHcC--CCCCchhh
Confidence 32 34679999999999955 57888876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=298.06 Aligned_cols=186 Identities=31% Similarity=0.485 Sum_probs=154.2
Q ss_pred HHHhhhhhcccCCcEEEEEEEECC-C-----CEEEEEEeecC--CCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCee
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLID-G-----SNVAVKVLNDS--KGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRR 396 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 396 (516)
..+.+.++||+|+||+||+|++.. + ..||+|++... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345567889999999999998643 2 36899998543 34457899999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 036471 397 ALIYEFVSNGSLEKFIYRNSSSI-----------------ENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPH 459 (516)
Q Consensus 397 ~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~ 459 (516)
++||||+++|+|.++|+..+... ....+++..++.++.||++||+||| +++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999998654211 1245899999999999999999999 899999999999
Q ss_pred cEEECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 460 NILLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 460 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|||++.++.+||+|||+|+...............||+.|||||++.+ +.++.++|
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~D 248 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSD 248 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHH
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCccee
Confidence 99999999999999999988766655444455678999999999965 67888876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-36 Score=287.29 Aligned_cols=173 Identities=28% Similarity=0.476 Sum_probs=144.5
Q ss_pred hhcccCCcEEEEEEEECC---CCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLID---GSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++||+|+||+||+|.+.+ ++.||||+++.... ..+++.+|++++++++|||||++++++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 46899999965332 23679999999999999999999999865 467899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
|+|.+++++. ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999764 56999999999999999999999 89999999999999999999999999999987765543
Q ss_pred cee-eccCCCCccccccccccccccccccCCC
Q 036471 486 IIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|||||++.+ +.++.+||
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~--~~~~~~sD 192 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY--YKFSSKSD 192 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH--CEEEHHHH
T ss_pred ccccccccCCCceecCchhhcC--CCCCchhh
Confidence 322 234578999999999955 67888876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-36 Score=293.22 Aligned_cols=175 Identities=31% Similarity=0.431 Sum_probs=137.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+++.+.||+|+||+||+|+.+ +++.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 556788999999999999986 58999999997543 334567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC---CCCcEEEeecCCccccc
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD---EDFCPKISDFGLAKICN 481 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 481 (516)
+|+|.+++.+. ..+++.++..++.||+.||+||| +++|+||||||+|||+. +++.+||+|||+|+...
T Consensus 91 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 91 GGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp SCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999653 57999999999999999999999 89999999999999994 57899999999998765
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....||+.|||||++.+ +.++.++|
T Consensus 162 ~~~~---~~~~~GT~~y~APE~~~~--~~~~~~~D 191 (307)
T d1a06a_ 162 PGSV---LSTACGTPGYVAPEVLAQ--KPYSKAVD 191 (307)
T ss_dssp --------------CTTSCHHHHTT--CCCCTHHH
T ss_pred CCCe---eeeeeeCccccCcHHHcC--CCCCcHHH
Confidence 4432 234679999999999965 57888876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-36 Score=286.64 Aligned_cols=173 Identities=28% Similarity=0.488 Sum_probs=147.4
Q ss_pred hcccCCcEEEEEEEEC---CCCEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCCC
Q 036471 333 KLGQGGYGSVYKGKLI---DGSNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNGS 407 (516)
Q Consensus 333 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 407 (516)
+||+|+||+||+|.++ ++..||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999764 34579999997543 234679999999999999999999999865 56899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.+++...+ ..+++..++.++.||++||+||| +++|+||||||+||||+.++.+||+|||+|+.+.......
T Consensus 95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999986532 57999999999999999999999 8999999999999999999999999999998876554332
Q ss_pred e-eccCCCCccccccccccccccccccCCC
Q 036471 488 S-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....||+.|||||++.. +.++.++|
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksD 194 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINF--RKFSSRSD 194 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHH--CEECHHHH
T ss_pred ccccccccCccccChHHHhC--CCCCccch
Confidence 2 234568999999999954 67888876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=290.68 Aligned_cols=177 Identities=28% Similarity=0.505 Sum_probs=143.3
Q ss_pred hhhhcccCCcEEEEEEEECCC-----CEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLIDG-----SNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+.+.||+|+||+||+|+++.. ..||||+++.... ...+|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 457799999999999987542 3699999965432 235789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+.+++|.+++.... ..+++.+++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+++.+..
T Consensus 91 ~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 91 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred cccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999887643 57999999999999999999999 89999999999999999999999999999987754
Q ss_pred CCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .......||+.|||||++.+ +.++.++|
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sD 195 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISY--RKFTSASD 195 (283)
T ss_dssp -----------CCCGGGSCHHHHHS--CCCCHHHH
T ss_pred CCccceEeccCCCCccccCHHHHcc--CCCCCccc
Confidence 4322 12234568999999999954 67888876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-35 Score=283.74 Aligned_cols=176 Identities=31% Similarity=0.413 Sum_probs=153.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-------CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-------GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+++.++||+|+||+||+|+.+ +|+.||||++++.. ...+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3556688999999999999985 68999999996432 123678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC----cEEEeec
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF----CPKISDF 474 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df 474 (516)
||||+++|+|.+++.+. ..+++..++.++.|++.||+||| +++|+||||||+|||++.++ .+||+||
T Consensus 91 v~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999764 46999999999999999999999 99999999999999998776 5999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|+....... .....||+.|+|||++.+ +.++.++|
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~--~~~~~~~D 198 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNY--EPLGLEAD 198 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTT--CCBCTHHH
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcC--CCCCCccc
Confidence 99987755433 244678999999999954 57888776
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-35 Score=293.83 Aligned_cols=177 Identities=27% Similarity=0.427 Sum_probs=153.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.+.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3556788999999999999975 58999999996543 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCcEEEeecCCcccccC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNR 482 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~ 482 (516)
+|+|.+++.+. ...+++..++.++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 107 gg~L~~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 107 GGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp SCBHHHHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999643 256999999999999999999999 89999999999999996 467899999999988765
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... ....||+.|||||++.+ ..++.++|
T Consensus 179 ~~~~---~~~~gT~~Y~aPEv~~~--~~~~~~~D 207 (350)
T d1koaa2 179 KQSV---KVTTGTAEFAAPEVAEG--KPVGYYTD 207 (350)
T ss_dssp TSCE---EEECSCTTTCCHHHHHT--CCBCHHHH
T ss_pred cccc---ceecCcccccCHHHHcC--CCCChhHh
Confidence 5432 34678999999999955 56777766
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-35 Score=291.55 Aligned_cols=176 Identities=27% Similarity=0.389 Sum_probs=153.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+++.+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.++++++|||||++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 556788999999999999975 69999999997543 2345778999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEC--CCCcEEEeecCCcccccCC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLD--EDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~ 483 (516)
|+|.+++... ...+++.+++.|+.||+.||+||| ++||+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 111 g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 111 GELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred ChHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999887543 256999999999999999999999 89999999999999997 6789999999999887655
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... ....||+.|||||++.+ ..++.++|
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~--~~~~~~~D 210 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDR--EPVGFYTD 210 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTT--CCBCHHHH
T ss_pred Cce---eeccCcccccCHHHHcC--CCCCCccc
Confidence 432 34568999999999965 57887776
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-35 Score=288.63 Aligned_cols=173 Identities=25% Similarity=0.307 Sum_probs=153.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeec----CCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLND----SKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 402 (516)
+++.++||+|+||.||+|+++ +|+.||||++.+ .....+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 445678999999999999985 699999999964 234457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccC
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNR 482 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 482 (516)
+.+|+|.+++.+. ..+++..++.++.||+.||+||| +++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 123 ~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 123 VAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999765 46999999999999999999999 89999999999999999999999999999987754
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....||+.|||||++.+ ..++.++|
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~--~~~~~~~D 220 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILS--KGYNKAVD 220 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTT--CCBCTHHH
T ss_pred cc-----ccccCccccCCHHHHcC--CCCCcccc
Confidence 32 34678999999999965 57788776
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=281.71 Aligned_cols=176 Identities=27% Similarity=0.347 Sum_probs=152.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHHHHHHhh-ccCCcceeeEEEEEeecCeeEEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFINEVASIS-RTSHVNVVTLLGFCFEGRRRALIYE 401 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv~e 401 (516)
+.+.++||+|+||+||+|+.+ +++.||||++++. ....+.+.+|..++. .++|||||++++++.+++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456688999999999999986 5899999999642 344566777877765 5899999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.++++.. ..+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++...
T Consensus 84 y~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999765 56899999999999999999999 8999999999999999999999999999998665
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... .....||+.|+|||++.+ +.++.++|
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~D 185 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLG--QKYNHSVD 185 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTT--CCBCTHHH
T ss_pred ccccc--ccccCCCCCcCCHHHHcC--CCCCchhh
Confidence 44332 245679999999999965 67888877
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=284.20 Aligned_cols=178 Identities=29% Similarity=0.490 Sum_probs=146.4
Q ss_pred HhhhhhcccCCcEEEEEEEECC-CC----EEEEEEeecC--CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID-GS----NVAVKVLNDS--KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~-~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
+++.++||+|+||+||+|++.. |+ +||+|+++.. ....+++.+|+.++++++|||||+++|++.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 4456789999999999998753 43 5889988643 34557899999999999999999999998764 567889
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+.+|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|+..
T Consensus 90 e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp ECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 9999999999987643 67999999999999999999999 899999999999999999999999999999987
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.............||+.|||||++.+ +.++.++|
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sD 195 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSD 195 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHH--CCCCHHHH
T ss_pred ccccccccccccccCccccChHHHhc--CCCChhhh
Confidence 66555444455678999999999965 67888876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-34 Score=286.84 Aligned_cols=175 Identities=28% Similarity=0.389 Sum_probs=148.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC----CCCchhHHH---HHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS----KGNGEEFIN---EVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+++.+.||+|+||.||+|+.. +|+.||||++.+. ......+.+ |+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 345678999999999999986 5899999998642 222233444 46677788999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++|+|.++|.+. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999765 56899999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+..... ....||+.|||||++.+. ..++.++|
T Consensus 157 ~~~~~~----~~~~GT~~y~APE~~~~~-~~~~~~~D 188 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSAD 188 (364)
T ss_dssp CSSSCC----CSCCSCGGGCCHHHHSTT-CCCCTHHH
T ss_pred cCCCcc----cccccccccchhHHhhcC-CCCCcccc
Confidence 765432 446799999999999542 45777776
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-34 Score=273.54 Aligned_cols=177 Identities=26% Similarity=0.353 Sum_probs=151.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----------chhHHHHHHHhhccC-CcceeeEEEEEeecCe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----------GEEFINEVASISRTS-HVNVVTLLGFCFEGRR 395 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 395 (516)
+.+.+.||+|+||+||+|+.. +|+.||||+++..... .+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 345678999999999999975 6889999999754321 135789999999997 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.+|||||+++|+|.++|+.+ ..+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999764 56999999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcceeeccCCCCcccccccccccc----ccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRN----IGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~s~~sD 516 (516)
+++.+..... .....||+.|+|||++... ...++.++|
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~D 197 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchhe
Confidence 9988765432 2446799999999998542 123455555
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=281.94 Aligned_cols=176 Identities=23% Similarity=0.302 Sum_probs=152.5
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSNG 406 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 406 (516)
|.+.+.||+|+||+||+|..+ +++.||||+++....+...+.+|+++|++++|||||++++++.+++..|+||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 456678999999999999986 5889999999876555567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCC--CcEEEeecCCcccccCCC
Q 036471 407 SLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDED--FCPKISDFGLAKICNRKE 484 (516)
Q Consensus 407 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~ 484 (516)
+|.+++... ...+++.+++.++.||+.||+||| +++|+||||||+|||++.+ ..+||+|||+++......
T Consensus 87 ~L~~~i~~~-----~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999653 246999999999999999999999 8999999999999999854 489999999998765543
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. ....+|+.|+|||.+.+ ..++.++|
T Consensus 159 ~~---~~~~~t~~y~ape~~~~--~~~~~~~D 185 (321)
T d1tkia_ 159 NF---RLLFTAPEYYAPEVHQH--DVVSTATD 185 (321)
T ss_dssp EE---EEEESCGGGSCHHHHTT--CEECHHHH
T ss_pred cc---cccccccccccchhccC--CCCCchhh
Confidence 32 33567999999999854 56777766
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-34 Score=281.63 Aligned_cols=184 Identities=26% Similarity=0.455 Sum_probs=153.3
Q ss_pred HhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+++.++||+|+||+||+|+++ +++.||||+++..... .+++.+|++++++++||||+++++++.+.+..+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 345678999999999999864 3578999999754322 36799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 400 YEFVSNGSLEKFIYRNSSS------------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
|||+++|+|.++++..... .....+++..++.|+.|++.||+||| +++||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccce
Confidence 9999999999999764311 11245899999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+.++.+||+|||+|+.+.............|++.|+|||++.+ ..++.++|
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksD 224 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESD 224 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--CCCChhhh
Confidence 999999999999999987765544443445678999999999965 67888877
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=279.40 Aligned_cols=173 Identities=29% Similarity=0.357 Sum_probs=144.8
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC------CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG------NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
+.||+|+||+||+|+++ +|+.||||+++.... ..+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 46999999999999975 589999999864321 23578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
++++..+... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~~~~~~~~~~------~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhc------ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 8777665532 356899999999999999999999 9999999999999999999999999999998765543
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++.+. ..++.++|
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~D 183 (299)
T d1ua2a_ 155 RA--YTHQVVTRWYRAPELLFGA-RMYGVGVD 183 (299)
T ss_dssp CC--CCCSCCCCTTCCHHHHTTC-SCCCHHHH
T ss_pred cc--ccceecChhhccHHHHccC-CCCChhhh
Confidence 22 2345789999999998542 45677776
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-34 Score=277.04 Aligned_cols=169 Identities=28% Similarity=0.418 Sum_probs=137.7
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeecC----eeEEEEEecCC
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEGR----RRALIYEFVSN 405 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~~ 405 (516)
+.++||+|+||+||+|++ +|+.||||+++...........|+..+.+++|||||++++++.+.+ ..++||||+++
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 457899999999999997 6899999999654332222334555667789999999999998654 57899999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLG-----CSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
|+|.++|++ ..+++..++.++.|++.||+|||+. ..++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 86 GSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999975 3589999999999999999999932 1369999999999999999999999999999887
Q ss_pred cCCCcce--eeccCCCCccccccccccc
Q 036471 481 NRKESII--SMTGARGTVGYIAPEVFCR 506 (516)
Q Consensus 481 ~~~~~~~--~~~~~~gt~~y~aPE~l~~ 506 (516)
....... ......||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred cCCCcceeccccceecccCcCChhhccc
Confidence 6544322 2234679999999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=274.71 Aligned_cols=172 Identities=29% Similarity=0.529 Sum_probs=141.3
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEEEEEecCCCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRALIYEFVSNGS 407 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~gs 407 (516)
++.+.||+|+||.||+|++ .|..||||+++.+. ..+++.+|++++++++||||++++|++.+ .+..++||||+++|+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 4567899999999999998 57899999997543 44789999999999999999999999865 456899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCcce
Q 036471 408 LEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKESII 487 (516)
Q Consensus 408 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 487 (516)
|.++|.... ...+++..+++++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 88 LVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp HHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999997642 245899999999999999999999 8999999999999999999999999999998654332
Q ss_pred eeccCCCCccccccccccccccccccCCC
Q 036471 488 SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 488 ~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....+++.|+|||++.+ +.++.+||
T Consensus 158 --~~~~~~~~y~aPE~l~~--~~~t~~sD 182 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALRE--KKFSTKSD 182 (262)
T ss_dssp ------CCTTTSCHHHHHH--CCCCHHHH
T ss_pred --ccccccccCCChHHHhC--CCCChHHH
Confidence 33567899999999965 68888877
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=277.70 Aligned_cols=178 Identities=25% Similarity=0.423 Sum_probs=138.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECC----CCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID----GSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIY 400 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 400 (516)
.+++.+.||+|+||.||+|++.. +..||||.++.... ..+.+.+|+.++++++|||||++++++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 45567889999999999998753 34688998865332 2367899999999999999999999985 56789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
||+++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+||++++++.+||+|||+|+.+
T Consensus 87 E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999887643 57899999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... .....||+.|+|||++.+ +.++.++|
T Consensus 159 ~~~~~~~-~~~~~gt~~y~apE~l~~--~~~~~~~D 191 (273)
T d1mp8a_ 159 EDSTYYK-ASKGKLPIKWMAPESINF--RRFTSASD 191 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHH
T ss_pred cCCccee-ccceecCcccchhhHhcc--CCCCCccc
Confidence 5443322 244668999999999954 67888776
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=280.57 Aligned_cols=189 Identities=32% Similarity=0.491 Sum_probs=159.4
Q ss_pred HHHHHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeec
Q 036471 323 IKKMTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEG 393 (516)
Q Consensus 323 l~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 393 (516)
+....+.+.++||+|+||.||+|++. +++.||||+++.... ...++.+|+.+++++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 43445567789999999999999852 356899999976443 335789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSS------------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNI 461 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NI 461 (516)
+..++||||+++|+|.+++++.... .....+++..++.++.||++||+||| +++|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 9999999999999999999875421 12246999999999999999999999 89999999999999
Q ss_pred EECCCCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 462 LLDEDFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 462 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++.++.+||+|||.++...............||+.|+|||++.+ +.++.++|
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 229 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESD 229 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCccc
Confidence 999999999999999998776655445556789999999999954 67888776
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=281.14 Aligned_cols=186 Identities=29% Similarity=0.463 Sum_probs=144.2
Q ss_pred HHHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCC--CCchhHHHHHHHhhcc-CCcceeeEEEEEeec-Ce
Q 036471 326 MTNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSK--GNGEEFINEVASISRT-SHVNVVTLLGFCFEG-RR 395 (516)
Q Consensus 326 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~ 395 (516)
..+.+.++||+|+||.||+|++. +++.||||+++... ...+.+.+|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34556788999999999999863 24689999997533 2345678888888877 789999999998764 46
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
.++||||+++|+|.++|+..... .....+++.+++.++.||++||+||| +++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 89999999999999999765311 11245899999999999999999999 899999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+|+...............||+.|||||++.+ +.++.++|
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sD 218 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSD 218 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccc
Confidence 99999999999987765554444455779999999999965 67888876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7e-34 Score=273.11 Aligned_cols=178 Identities=23% Similarity=0.331 Sum_probs=143.6
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC----chhHHHHHHHhhccCCcceeeEEEEEeecC----eeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN----GEEFINEVASISRTSHVNVVTLLGFCFEGR----RRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 398 (516)
+.+.+.||+|+||+||+|+.. +|+.||||+++..... .+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 456678999999999999975 6899999999764332 246889999999999999999999988654 3789
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
||||+++++|.+++... ..+++.+++.++.||+.||+||| +++|+||||||+|||++.++..+|+|||.+.
T Consensus 89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence 99999999999998765 56999999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCcc-eeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESI-ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
........ .......||+.|||||++.+ +.+++++|
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~D 196 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSD 196 (277)
T ss_dssp ECC----------------TTCCHHHHTT--CCCCHHHH
T ss_pred hhccccccccccccccCcccccCHHHHcC--CCCCccee
Confidence 65443221 22345679999999999954 67888876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=277.29 Aligned_cols=169 Identities=27% Similarity=0.330 Sum_probs=144.6
Q ss_pred hhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhcc-CCcceeeEEEEEee----cCeeEEEEEecCC
Q 036471 332 YKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRT-SHVNVVTLLGFCFE----GRRRALIYEFVSN 405 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~~lv~e~~~~ 405 (516)
+.||+|+||.||+|++. +++.||||+++. .+.+.+|++++.++ +|||||++++++.+ ....++||||+++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 45999999999999974 689999999964 35678899987665 89999999999876 4678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
|+|.++|.+.. ...+++.+++.++.||+.||+||| +++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 94 g~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 94 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp EEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccC
Confidence 99999997542 257999999999999999999999 999999999999999975 56799999999987765
Q ss_pred CCcceeeccCCCCccccccccccccccccccCCC
Q 036471 483 KESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....||+.|||||++.+ ..++.++|
T Consensus 167 ~~~---~~~~~gt~~y~aPE~~~~--~~y~~~~D 195 (335)
T d2ozaa1 167 HNS---LTTPCYTPYYVAPEVLGP--EKYDKSCD 195 (335)
T ss_dssp CCC---CCCCSCCCSSCCCCCCCG--GGGSHHHH
T ss_pred CCc---cccccCCcccCCcHHHcC--CCCCHHHH
Confidence 443 245679999999999955 57888776
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=274.32 Aligned_cols=178 Identities=34% Similarity=0.576 Sum_probs=149.2
Q ss_pred hhhhhcccCCcEEEEEEEECCC----CEEEEEEeecCC--CCchhHHHHHHHhhccCCcceeeEEEEEee-cCeeEEEEE
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDG----SNVAVKVLNDSK--GNGEEFINEVASISRTSHVNVVTLLGFCFE-GRRRALIYE 401 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 401 (516)
+|.++||+|+||+||+|++.++ ..||||+++... ...++|.+|++++++++||||++++|++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4467899999999999997542 258999996432 234679999999999999999999999876 568899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccccc
Q 036471 402 FVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICN 481 (516)
Q Consensus 402 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 481 (516)
|+++|+|.++++... ..+++..++.++.|++.||.||| +++|+||||||+||||++++.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 999999999987543 56788999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCcce--eeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ......||+.|+|||++.. +.++.++|
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksD 216 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSD 216 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHH
T ss_pred ccccccceecccccccccccChHHHhc--CCCCChhH
Confidence 443221 2234578999999999955 67888876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.9e-34 Score=279.82 Aligned_cols=185 Identities=27% Similarity=0.441 Sum_probs=155.2
Q ss_pred HHhhhhhcccCCcEEEEEEEEC------CCCEEEEEEeecCCCC--chhHHHHHHHhhccCCcceeeEEEEEeecCeeEE
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI------DGSNVAVKVLNDSKGN--GEEFINEVASISRTSHVNVVTLLGFCFEGRRRAL 398 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 398 (516)
.+.+.++||+|+||+||+|.+. +++.||||+++..... ...+.+|++++++++||||+++++++..++..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 3456688999999999999863 2578999999754322 2468999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 399 IYEFVSNGSLEKFIYRNSSS----IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
||||+++|+|.+++...+.. .....+++..+..++.|+++||.||| +++|+||||||+||||++++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998754210 11245799999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+|+.+.............||+.|+|||.+.+ +.++.++|
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~D 217 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSD 217 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--CCCCHHHH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHcc--CCCCcccc
Confidence 99988766555444455678999999999965 67777765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.6e-33 Score=272.00 Aligned_cols=177 Identities=29% Similarity=0.438 Sum_probs=146.6
Q ss_pred hhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC---CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecC
Q 036471 329 SFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK---GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVS 404 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 404 (516)
.+.++||+|+||+||+|++. +|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 34578999999999999974 68999999996432 335788999999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCC
Q 036471 405 NGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKE 484 (516)
Q Consensus 405 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 484 (516)
+ ++.+++... ....+++..++.++.||+.||+||| +++||||||||+|||++.++.+||+|||.|+......
T Consensus 85 ~-~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 85 Q-DLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp E-EHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred C-chhhhhhhh----cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 6 455555433 2356999999999999999999999 8999999999999999999999999999998765443
Q ss_pred cceeeccCCCCccccccccccccccccccCCC
Q 036471 485 SIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 485 ~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.. .....||+.|+|||++... ..++.++|
T Consensus 157 ~~--~~~~~gt~~y~apE~~~~~-~~~~~~~D 185 (298)
T d1gz8a_ 157 RT--YTHEVVTLWYRAPEILLGC-KYYSTAVD 185 (298)
T ss_dssp BC--TTCCBCCCTTCCHHHHTTC-SSCCTHHH
T ss_pred cc--ceeecccceeeehhhhccc-cCCCcccc
Confidence 22 2446789999999998553 34566665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-33 Score=274.87 Aligned_cols=185 Identities=30% Similarity=0.471 Sum_probs=151.7
Q ss_pred HHhhhhhcccCCcEEEEEEEECC--------CCEEEEEEeecCCC--CchhHHHHHHHhhcc-CCcceeeEEEEEeecCe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLID--------GSNVAVKVLNDSKG--NGEEFINEVASISRT-SHVNVVTLLGFCFEGRR 395 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 395 (516)
.+.+.+.||+|+||.||+|+... +..||||+++.... ...++.+|...+.++ +|||||++++++.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 44566889999999999998532 24799999976543 336788899999888 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSS----------IENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE 465 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 465 (516)
.++||||+++|+|.++|+..... .....+++.+++.++.||+.||+||| +++||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecC
Confidence 99999999999999999765321 12356899999999999999999999 999999999999999999
Q ss_pred CCcEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 466 DFCPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 466 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
++.+||+|||+++...............|++.|+|||++.+ +.++.|+|
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~D 219 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSD 219 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhh
Confidence 99999999999988766654444455678999999999955 78888877
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.4e-33 Score=268.53 Aligned_cols=175 Identities=28% Similarity=0.313 Sum_probs=146.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCC-------CCchhHHHHHHHhhccC--CcceeeEEEEEeecCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSK-------GNGEEFINEVASISRTS--HVNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 397 (516)
+.+.+.||+|+||+||+|+.. +|+.||||+++... ....++.+|+.++++++ |||||++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 456678999999999999975 68999999996532 12345789999999986 899999999999999999
Q ss_pred EEEEecCC-CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-CCcEEEeecC
Q 036471 398 LIYEFVSN-GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-DFCPKISDFG 475 (516)
Q Consensus 398 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 475 (516)
+||||+.+ +++.+++... ..+++++++.++.||++||+||| +++|+||||||+|||++. ++.+||+|||
T Consensus 86 lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence 99999976 6888888654 56999999999999999999999 899999999999999985 4799999999
Q ss_pred CcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+|+...... .+...||+.|+|||++.++ ..++.++|
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~D 192 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAA 192 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHH
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccc
Confidence 998654432 2456799999999999653 23355555
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.7e-33 Score=274.62 Aligned_cols=179 Identities=29% Similarity=0.512 Sum_probs=147.2
Q ss_pred hhhhcccCCcEEEEEEEECC-CC--EEEEEEeec--CCCCchhHHHHHHHhhcc-CCcceeeEEEEEeecCeeEEEEEec
Q 036471 330 FKYKLGQGGYGSVYKGKLID-GS--NVAVKVLND--SKGNGEEFINEVASISRT-SHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+.++||+|+||+||+|++++ +. .||||+++. .....+++.+|+++|+++ +|||||++++++.+++..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 56789999999999998764 43 578888754 334557899999999998 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEee
Q 036471 404 SNGSLEKFIYRNSS----------SIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISD 473 (516)
Q Consensus 404 ~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 473 (516)
++|+|.++|+.... ......+++..++.++.||++||.||| +++|+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEcc
Confidence 99999999975421 112367999999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 474 FGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 474 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
||+++....... .....||..|+|||.+.+ +.++.+||
T Consensus 171 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~sD 208 (309)
T d1fvra_ 171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNY--SVYTTNSD 208 (309)
T ss_dssp TTCEESSCEECC---C----CCTTTCCHHHHHH--CEECHHHH
T ss_pred cccccccccccc---ccceecCCcccchHHhcc--CCCCccce
Confidence 999976543322 234568999999999955 67888877
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.2e-34 Score=271.47 Aligned_cols=178 Identities=29% Similarity=0.427 Sum_probs=139.8
Q ss_pred HhhhhhcccCCcEEEEEEEECC--C--CEEEEEEeecCC----CCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLID--G--SNVAVKVLNDSK----GNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 399 (516)
+++.+.||+|+||+||+|++.. + ..||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3456789999999999998632 2 368999986532 223678999999999999999999999965 467899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 400 YEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 400 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|||+++|+|.+++..+. ..+++..++.++.||+.||+||| +++|+||||||+||+|+.++.+||+|||+++.
T Consensus 89 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999887643 56999999999999999999999 89999999999999999999999999999998
Q ss_pred ccCCCccee-eccCCCCccccccccccccccccccCCC
Q 036471 480 CNRKESIIS-MTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 480 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
......... .....|+..|+|||++.+ +.++.++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~D 196 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASD 196 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhC--CCCCcchh
Confidence 765543322 233557889999999965 67887776
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=4.9e-33 Score=268.58 Aligned_cols=176 Identities=28% Similarity=0.378 Sum_probs=147.3
Q ss_pred hhhhhcccCCcEEEEEEEECCCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEecCC
Q 036471 329 SFKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 329 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
++.++||+|+||+||+|++++|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 345789999999999999999999999999653 23357899999999999999999999999999999999999988
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCCCc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRKES 485 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 485 (516)
+.+..+... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+........
T Consensus 85 ~~~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 85 DLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EHHHHHHTS------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred hhHHHHHhh------cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 766666543 267999999999999999999999 89999999999999999999999999999987654432
Q ss_pred ceeeccCCCCccccccccccccccccccCCC
Q 036471 486 IISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 486 ~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
. .....+++.|+|||.+.+. ..++.++|
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~-~~~~~~~D 183 (286)
T d1ob3a_ 156 K--YTHEIVTLWYRAPDVLMGS-KKYSTTID 183 (286)
T ss_dssp --------CCCTTCCHHHHTTC-CSCCTHHH
T ss_pred c--cceecccchhhhHHHHhCC-CCCCccee
Confidence 2 2345689999999998653 56677766
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.6e-32 Score=263.11 Aligned_cols=176 Identities=31% Similarity=0.469 Sum_probs=143.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-C-CCEEEEEEeecC---CCCchhHHHHHHHhhcc---CCcceeeEEEEEee-----cC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-D-GSNVAVKVLNDS---KGNGEEFINEVASISRT---SHVNVVTLLGFCFE-----GR 394 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 394 (516)
+++.++||+|+||+||+|++. + ++.||||+++.. ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 445578999999999999974 4 567999998642 23345677888877765 79999999999863 34
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeec
Q 036471 395 RRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDF 474 (516)
Q Consensus 395 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 474 (516)
..+++|||++++.+....... ...+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 678999999887776554432 367999999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 475 GLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 475 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
|+++....... .....||+.|||||++.+ ..++.++|
T Consensus 161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~--~~y~~~~D 197 (305)
T d1blxa_ 161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQ--SSYATPVD 197 (305)
T ss_dssp CSCCCCCGGGG---GCCCCCCCTTCCHHHHTT--CCCCTHHH
T ss_pred hhhhhhccccc---CCCcccChhhcCcchhcC--CCCChheh
Confidence 99986544332 245779999999999965 67888876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=266.12 Aligned_cols=174 Identities=29% Similarity=0.355 Sum_probs=141.1
Q ss_pred hhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcceeeEEEEEeec------CeeEEEEEe
Q 036471 330 FKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVVTLLGFCFEG------RRRALIYEF 402 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~ 402 (516)
..++||+|+||+||+|++. +|+.||||++..... ...+|+++|++++||||+++++++... ...++||||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 3467999999999999986 589999999976543 335799999999999999999998643 246899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 481 (516)
++++.+..+.+... ....+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++...
T Consensus 101 ~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 101 VPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp CSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred cCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 98764444433221 2357999999999999999999999 99999999999999999775 89999999998775
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ....||+.|+|||.+.+. ..++.++|
T Consensus 175 ~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~D 205 (350)
T d1q5ka_ 175 RGEPN---VSYICSRYYRAPELIFGA-TDYTSSID 205 (350)
T ss_dssp TTSCC---CSCCSCTTSCCHHHHTTC-SSCCTHHH
T ss_pred CCccc---ccccccccccChHHhhcc-cCCCccee
Confidence 54432 346789999999998653 46777766
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=3.6e-31 Score=255.93 Aligned_cols=177 Identities=20% Similarity=0.331 Sum_probs=148.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCC-cceeeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSH-VNVVTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.+.||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.+..++| +|++.+++++.++...++||||+ +
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 456688999999999999976 58899999986543 34567889999999965 89999999999999999999998 6
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC-----CCcEEEeecCCcccc
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE-----DFCPKISDFGLAKIC 480 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~ 480 (516)
++|.++++... ..+++..+..++.|++.||+||| +++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 85 ~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 85 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred CCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 89999987643 56999999999999999999999 999999999999999974 578999999999876
Q ss_pred cCCCcc-----eeeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESI-----ISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... .......||+.|||||++.+ ..++.++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~D 195 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDD 195 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHH
Confidence 543221 11234679999999999965 67888776
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1.8e-31 Score=262.76 Aligned_cols=172 Identities=26% Similarity=0.433 Sum_probs=145.0
Q ss_pred HHhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-CcceeeEEEEEee--cCeeEEEEEe
Q 036471 327 TNSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-HVNVVTLLGFCFE--GRRRALIYEF 402 (516)
Q Consensus 327 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~ 402 (516)
.+.+.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 3556688999999999999985 5899999999643 4577899999999995 9999999999875 3568999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC-cEEEeecCCccccc
Q 036471 403 VSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF-CPKISDFGLAKICN 481 (516)
Q Consensus 403 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 481 (516)
+++++|..+. +.+++..+..++.||+.||+||| +++|+||||||+||||+.++ .+||+|||+|+...
T Consensus 114 ~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 114 VNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred cCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999997653 46999999999999999999999 99999999999999998655 69999999998776
Q ss_pred CCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 482 RKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 482 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.... .....+|+.|+|||++.+. ..++.++|
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~D 212 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDY-QMYDYSLD 212 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHH
T ss_pred CCCc---ccccccCccccCcccccCC-CCCCcccc
Confidence 5433 2446789999999998653 45677665
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=264.30 Aligned_cols=178 Identities=25% Similarity=0.360 Sum_probs=143.1
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC--CchhHHHHHHHhhccCCcceeeEEEEEeecC----eeEEEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG--NGEEFINEVASISRTSHVNVVTLLGFCFEGR----RRALIY 400 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~ 400 (516)
+++.++||+|+||+||+|+.. +|+.||||+++.... ..+.+++|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 344578999999999999874 699999999975432 2357889999999999999999999987653 335556
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccc
Q 036471 401 EFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKIC 480 (516)
Q Consensus 401 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 480 (516)
+++.+|+|.+++.. ..+++..++.++.||+.||+||| +++|+||||||+||||+.++.+||+|||+|...
T Consensus 90 ~~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 90 THLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 67779999999964 35899999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCcce-eeccCCCCccccccccccccccccccCCC
Q 036471 481 NRKESII-SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 481 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
....... ......||+.|+|||++... ..++.++|
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~D 195 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSID 195 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHH
T ss_pred cCCCccceeeccccccceechHHHhhcC-CCCCchhh
Confidence 5443221 12446689999999998553 45666665
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=263.74 Aligned_cols=172 Identities=29% Similarity=0.383 Sum_probs=140.2
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeecC------eeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEGR------RRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 397 (516)
+.+.++||+|+||+||+|.+. +|+.||||+++..... .+.+.+|+.+|++++|||||++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 344578999999999999975 5999999999754333 356889999999999999999999998654 469
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+ +.+|..+++. ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|
T Consensus 100 lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence 999999 5688887754 46999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+...... +...||+.|+|||++.+. ..++.++|
T Consensus 169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~D 201 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVD 201 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHH
T ss_pred eccCCcc-----ccccccccccCHHHHcCC-CCCCccch
Confidence 8765432 456789999999998653 45677766
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.9e-31 Score=259.15 Aligned_cols=179 Identities=26% Similarity=0.372 Sum_probs=142.9
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecC---CCCchhHHHHHHHhhccCCcceeeEEEEEee--------cCe
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDS---KGNGEEFINEVASISRTSHVNVVTLLGFCFE--------GRR 395 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~ 395 (516)
+++.++||+|+||+||+|++. +|+.||||++... ....+++.+|+.+|++++||||+++++.+.. .+.
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 345578999999999999975 6899999998543 2344678999999999999999999998865 346
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecC
Q 036471 396 RALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFG 475 (516)
Q Consensus 396 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 475 (516)
.++||||++++.+..+.. ....+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 92 ~~iv~e~~~~~~~~~~~~------~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp EEEEEECCCEEHHHHHTC------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccCCCccchhhh------cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence 789999998876654432 2357899999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcce--eeccCCCCccccccccccccccccccCCC
Q 036471 476 LAKICNRKESII--SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 476 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+++......... ......||+.|+|||++.+. ..+++++|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~D 204 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPID 204 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHH
Confidence 998765433221 12335689999999998653 46777776
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=260.31 Aligned_cols=179 Identities=27% Similarity=0.310 Sum_probs=150.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC----CCCEEEEEEeecC-----CCCchhHHHHHHHhhccCC-cceeeEEEEEeecCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI----DGSNVAVKVLNDS-----KGNGEEFINEVASISRTSH-VNVVTLLGFCFEGRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~ 397 (516)
+++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 556788999999999999852 4789999998542 2345678899999999966 89999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
++|||+.+|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 106 ~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999765 46788999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+.+........ ....|++.|+|||.+.++...++.++|
T Consensus 177 ~~~~~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksD 214 (322)
T d1vzoa_ 177 KEFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVD 214 (322)
T ss_dssp EECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHH
T ss_pred hhhcccccccc-cccccccccchhHHhhcCCcCCCchhh
Confidence 87654433222 346789999999999765445677766
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.8e-31 Score=253.09 Aligned_cols=177 Identities=25% Similarity=0.356 Sum_probs=151.0
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCC---CchhHHHHHHHhhccCCcceeeEEEEEeecCeeEEEEEec
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKG---NGEEFINEVASISRTSHVNVVTLLGFCFEGRRRALIYEFV 403 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 403 (516)
+++.++||+|+||+||+|++. +++.||||+++.... ..+++.+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 344578999999999999985 688999999965432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcccccCC
Q 036471 404 SNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAKICNRK 483 (516)
Q Consensus 404 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 483 (516)
.+++|..++... ..+++..+..++.|++.||+||| .++|+||||||+|||++.++.+||+|||.++.....
T Consensus 84 ~~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 84 DQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SEEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred cccccccccccc------cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999998887643 57899999999999999999999 899999999999999999999999999999877654
Q ss_pred CcceeeccCCCCccccccccccccccccccCCC
Q 036471 484 ESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 484 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
... .....+++.|+|||++..+ ..++.++|
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~D 184 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGA-KLYSTSID 184 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTC-SCCCTHHH
T ss_pred Ccc--ceeeccccchhhhhHhccC-CCCCchhh
Confidence 432 2345678899999998653 44677766
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=3.1e-30 Score=250.39 Aligned_cols=177 Identities=26% Similarity=0.323 Sum_probs=142.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccCCcce-eeEEEEEeecCeeEEEEEecCC
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV-VTLLGFCFEGRRRALIYEFVSN 405 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~ 405 (516)
+.+.++||+|+||.||+|++. +|+.||||++..... .+++.+|++++++++|+|+ +.+.++..+.+..++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 456688999999999999975 588999999875433 3568899999999977665 55556667788889999999 5
Q ss_pred CCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECC---CCcEEEeecCCcccccC
Q 036471 406 GSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDE---DFCPKISDFGLAKICNR 482 (516)
Q Consensus 406 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~ 482 (516)
++|.+.+... ...+++..+..++.|++.||+||| +++|+||||||+|||++. +..+||+|||+|+.+..
T Consensus 87 ~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 87 PSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Cchhhhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 5777776543 257999999999999999999999 899999999999999864 55799999999988765
Q ss_pred CCcce-----eeccCCCCccccccccccccccccccCCC
Q 036471 483 KESII-----SMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 483 ~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
..... ......||+.|||||++.+ ..++.++|
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 195 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDD 195 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhC--CCCCChhh
Confidence 43221 1234579999999999965 56888776
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=254.59 Aligned_cols=172 Identities=28% Similarity=0.315 Sum_probs=133.8
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEee------cCeeE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFE------GRRRA 397 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~ 397 (516)
+++.++||+|+||+||+|++. +|+.||||+++..... .+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 334568999999999999986 5999999999765433 2468899999999999999999999864 36789
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCc
Q 036471 398 LIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLA 477 (516)
Q Consensus 398 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 477 (516)
+||||+.++ +.+.+. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+|++|||++
T Consensus 99 iv~Ey~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEECCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEeccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhh
Confidence 999999765 444442 45899999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 478 KICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 478 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
+....... .....+|+.|+|||++.+ ..+++++|
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~l~~--~~~~~~~D 200 (355)
T d2b1pa1 167 RTAGTSFM---MTPYVVTRYYRAPEVILG--MGYKENVD 200 (355)
T ss_dssp -----------------CCTTCCHHHHTT--CCCCTTHH
T ss_pred hccccccc---cccccccccccChhhhcC--CCCCCCcc
Confidence 86654432 244568999999999965 57888876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-30 Score=255.22 Aligned_cols=173 Identities=30% Similarity=0.384 Sum_probs=141.4
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCC---chhHHHHHHHhhccCCcceeeEEEEEeec-----CeeEE
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGN---GEEFINEVASISRTSHVNVVTLLGFCFEG-----RRRAL 398 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 398 (516)
+++.++||+|+||+||+|+.. +|+.||||+++..... .+.+.+|+++|++++|||||++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 445578999999999999975 6999999999764433 35688999999999999999999998643 34567
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEEEeecCCcc
Q 036471 399 IYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPKISDFGLAK 478 (516)
Q Consensus 399 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 478 (516)
+++|+.+|+|.++++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||++.
T Consensus 100 i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 7788889999999853 46999999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 479 ICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 479 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
...... ....|++.|+|||++.+. ..++.++|
T Consensus 170 ~~~~~~-----~~~~g~~~y~apE~~~~~-~~~~~~~D 201 (348)
T d2gfsa1 170 HTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVD 201 (348)
T ss_dssp CCTGGG-----SSSCHHHHTSCHHHHTTC-SCCCTTHH
T ss_pred ccCccc-----ccccccccccCchhhcCC-ccCCcccc
Confidence 654332 446789999999997553 45677766
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=4.1e-26 Score=227.25 Aligned_cols=177 Identities=25% Similarity=0.320 Sum_probs=138.7
Q ss_pred HhhhhhcccCCcEEEEEEEEC-CCCEEEEEEeecCCCCchhHHHHHHHhhccC-----------CcceeeEEEEEee--c
Q 036471 328 NSFKYKLGQGGYGSVYKGKLI-DGSNVAVKVLNDSKGNGEEFINEVASISRTS-----------HVNVVTLLGFCFE--G 393 (516)
Q Consensus 328 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~--~ 393 (516)
|.+.++||+|+||+||+|+.. +|+.||||+++......+.+.+|+.++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 566788999999999999985 6899999999766544567788998888775 5789999988765 3
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCC------
Q 036471 394 RRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDF------ 467 (516)
Q Consensus 394 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~------ 467 (516)
...++++++...+.......... ....+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cceeeeeeecccccccccccccc---cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 45666777665554333332222 34678999999999999999999993 38999999999999998665
Q ss_pred cEEEeecCCcccccCCCcceeeccCCCCccccccccccccccccccCCC
Q 036471 468 CPKISDFGLAKICNRKESIISMTGARGTVGYIAPEVFCRNIGEVSYKSD 516 (516)
Q Consensus 468 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~s~~sD 516 (516)
.+||+|||.+....... ....||+.|+|||++.. +.++.++|
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~D 211 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLG--APWGCGAD 211 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT--CCCCTHHH
T ss_pred eeeEeeccccccccccc-----ccccccccccChhhccc--cCCCcccc
Confidence 49999999997654332 34678999999999865 67787776
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.1e-22 Score=183.18 Aligned_cols=131 Identities=17% Similarity=0.165 Sum_probs=104.6
Q ss_pred hhhhcccCCcEEEEEEEECCCCEEEEEEeecCCCC-------------------chhHHHHHHHhhccCCcceeeEEEEE
Q 036471 330 FKYKLGQGGYGSVYKGKLIDGSNVAVKVLNDSKGN-------------------GEEFINEVASISRTSHVNVVTLLGFC 390 (516)
Q Consensus 330 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~nIv~l~~~~ 390 (516)
+.++||+|+||+||+|++.+|+.||||+++..... .....+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 56789999999999999989999999987532110 02234678889999999999988653
Q ss_pred eecCeeEEEEEecCCCCHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEECCCCcEE
Q 036471 391 FEGRRRALIYEFVSNGSLEKFIYRNSSSIENHKLTWETLLQIAVGIARGLEYLHLGCSTRILHFDIKPHNILLDEDFCPK 470 (516)
Q Consensus 391 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~k 470 (516)
..+++|||+++..+.+ +++.....++.|++++|+||| .++|+||||||+|||++++ .++
T Consensus 84 ----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEE
T ss_pred ----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEE
Confidence 2479999998765432 344556789999999999999 8999999999999999976 589
Q ss_pred EeecCCccccc
Q 036471 471 ISDFGLAKICN 481 (516)
Q Consensus 471 l~Dfg~a~~~~ 481 (516)
|+|||.|....
T Consensus 143 liDFG~a~~~~ 153 (191)
T d1zara2 143 IIDFPQSVEVG 153 (191)
T ss_dssp ECCCTTCEETT
T ss_pred EEECCCcccCC
Confidence 99999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=5.6e-07 Score=82.86 Aligned_cols=129 Identities=16% Similarity=0.099 Sum_probs=90.0
Q ss_pred cEEEEEEEECCCCEEEEEEeecC-CCCchhHHHHHHHhhccC-CcceeeEEEEEeecCeeEEEEEecCCCCHHHHHhhcC
Q 036471 339 YGSVYKGKLIDGSNVAVKVLNDS-KGNGEEFINEVASISRTS-HVNVVTLLGFCFEGRRRALIYEFVSNGSLEKFIYRNS 416 (516)
Q Consensus 339 ~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 416 (516)
.+.||+... +++.+++|+.... ......+.+|...+..+. +--+.+++.+..+++..++||++++|.++.+....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-- 103 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-- 103 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--
Confidence 468998875 5667788887543 344456788988887763 44467888888888899999999999887654311
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 036471 417 SSIENHKLTWETLLQIAVGIARGLEYLHLGC------------------------------------------------- 447 (516)
Q Consensus 417 ~~~~~~~l~~~~~~~i~~~i~~aL~~LH~~~------------------------------------------------- 447 (516)
. .....++.++++.|+.||+..
T Consensus 104 ------~---~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 ------E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp ------C---SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ------c---ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 0 112234455555555565210
Q ss_pred -------CCCeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 448 -------STRILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 448 -------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
...++|+|+.|.|||+++++..-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=4.3e-06 Score=76.33 Aligned_cols=73 Identities=21% Similarity=0.141 Sum_probs=53.5
Q ss_pred cccCC-cEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccC--CcceeeEEEEEeecCeeEEEEEecCCCCH
Q 036471 334 LGQGG-YGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTS--HVNVVTLLGFCFEGRRRALIYEFVSNGSL 408 (516)
Q Consensus 334 ig~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 408 (516)
+..|. .+.||+....++..+++|..... ....+..|...++.+. .-.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 36799999878888999986543 2345778888887763 33367788888888899999999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.89 E-value=3.3e-05 Score=75.20 Aligned_cols=74 Identities=14% Similarity=0.058 Sum_probs=49.0
Q ss_pred hhcccCCcEEEEEEEECC-CCEEEEEEeecC--------CCCchhHHHHHHHhhccC-C--cceeeEEEEEeecCeeEEE
Q 036471 332 YKLGQGGYGSVYKGKLID-GSNVAVKVLNDS--------KGNGEEFINEVASISRTS-H--VNVVTLLGFCFEGRRRALI 399 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv 399 (516)
+.||.|....||+....+ ++.|+||.-... ....++...|.+.|..+. + ..+++++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 358999999999998754 678999975321 123345567888777652 2 446666654 45567899
Q ss_pred EEecCCCC
Q 036471 400 YEFVSNGS 407 (516)
Q Consensus 400 ~e~~~~gs 407 (516)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.48 E-value=0.00011 Score=69.43 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=81.3
Q ss_pred EEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCccee--eEEE-----EEeecCeeEEEEEecCCCCHH---
Q 036471 340 GSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNVV--TLLG-----FCFEGRRRALIYEFVSNGSLE--- 409 (516)
Q Consensus 340 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nIv--~l~~-----~~~~~~~~~lv~e~~~~gsL~--- 409 (516)
-.||++...+|+.+++|+.+......+++..|...+..+....+. ..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 489999999999999999987766778888898888877432221 1111 123456678899998763221
Q ss_pred --------HH---Hhhc---CCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCee
Q 036471 410 --------KF---IYRN---SSSIENHKLTWE----------------------TLLQIAVGIARGLEYL-HLGCSTRIL 452 (516)
Q Consensus 410 --------~~---l~~~---~~~~~~~~l~~~----------------------~~~~i~~~i~~aL~~L-H~~~~~~iv 452 (516)
.. ++.. ........++.. .....+.++...+.-+ ......+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 11 1111 000011112211 1222233333333322 122346799
Q ss_pred eCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 453 HFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 453 H~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
|+|+.+.|||++++ ..++||+.+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.94 E-value=0.0015 Score=62.97 Aligned_cols=72 Identities=14% Similarity=0.205 Sum_probs=49.0
Q ss_pred hhcccCCcEEEEEEEECC--------CCEEEEEEeecCCCCchhHHHHHHHhhccCCcc-eeeEEEEEeecCeeEEEEEe
Q 036471 332 YKLGQGGYGSVYKGKLID--------GSNVAVKVLNDSKGNGEEFINEVASISRTSHVN-VVTLLGFCFEGRRRALIYEF 402 (516)
Q Consensus 332 ~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~ 402 (516)
+.|+.|-.-.+|++...+ .+.|++++.-. .....+..+|..+++.+.-.+ ..++++++.. .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 347778888999998754 35677777653 333456678888888874334 4577776642 588999
Q ss_pred cCCCCH
Q 036471 403 VSNGSL 408 (516)
Q Consensus 403 ~~~gsL 408 (516)
++|.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.54 E-value=0.0045 Score=57.42 Aligned_cols=144 Identities=13% Similarity=0.044 Sum_probs=73.5
Q ss_pred cccCCcEEEEEEEECCCCEEEEEEeecCCCCchhHHHHHHHhhccCCcce--eeEEE------EEeecCeeEEEEEecCC
Q 036471 334 LGQGGYGSVYKGKLIDGSNVAVKVLNDSKGNGEEFINEVASISRTSHVNV--VTLLG------FCFEGRRRALIYEFVSN 405 (516)
Q Consensus 334 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~------~~~~~~~~~lv~e~~~~ 405 (516)
|..|---+.|+.+..+| .+++|+.... ...+++..|++++..+...++ ...+. +.........++.+..+
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g 103 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 103 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence 55666678899987655 5899988543 234556667777776643222 11110 11123445566666654
Q ss_pred CCH--------------HHHHhhcCCCCC---CCCC------------------CHHHHHHHHHHHHHHHHHHh-cCCCC
Q 036471 406 GSL--------------EKFIYRNSSSIE---NHKL------------------TWETLLQIAVGIARGLEYLH-LGCST 449 (516)
Q Consensus 406 gsL--------------~~~l~~~~~~~~---~~~l------------------~~~~~~~i~~~i~~aL~~LH-~~~~~ 449 (516)
... ...++....... .... ........+..+...+.-.+ .....
T Consensus 104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~ 183 (316)
T d2ppqa1 104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 183 (316)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence 322 111111100000 0000 01112222333333333333 12356
Q ss_pred CeeeCCCCCCcEEECCCCcEEEeecCCccc
Q 036471 450 RILHFDIKPHNILLDEDFCPKISDFGLAKI 479 (516)
Q Consensus 450 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 479 (516)
++||+|+.++||+++.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 899999999999999987778999998853
|